data_1p89_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1p89 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.464 0.236 0 N-CA-C 111.852 0.315 . . . . 2.1200000000000001 111.852 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -60.66 -47.17 87.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.078 0.466 . . . . 2.6400000000000001 110.214 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.46 -33.31 72.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.767 -0.651 . . . . 1.1200000000000001 110.768 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.499 ' CD1' ' HG ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -61.23 -54.57 42.51 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.229 0.537 . . . . 1.6699999999999999 110.695 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 7.1 tp -66.79 -51.39 56.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.292 -0.867 . . . . 1.1399999999999999 111.216 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.443 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 63.7 mt -54.64 -35.84 63.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.022 0.439 . . . . 1.1899999999999999 110.804 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.571 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -72.91 -29.97 63.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.673 -0.694 . . . . 1.0600000000000001 110.787 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 78' ' ' ASN . . . -71.48 -32.28 68.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.817 -0.628 . . . . 0.98999999999999999 111.592 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.799 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.74 -11.21 42.91 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.826 0.346 . . . . 1.0 111.111 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -80.93 163.19 23.52 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.041 -0.527 . . . . 1.01 110.144 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.486 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 70.9 m80 -96.51 97.27 9.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.004 0.43 . . . . 0.20999999999999999 110.079 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.5 146.97 7.94 Favored Glycine 0 C--N 1.313 -0.712 0 C-N-CA 120.796 -0.716 . . . . 0.20000000000000001 111.751 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -71.74 138.06 48.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.105 0.479 . . . . 2.73 111.654 -179.51 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.434 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -131.74 164.59 25.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.64 -0.709 . . . . 1.04 110.165 179.316 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.522 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 88.9 t -110.43 142.7 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 111.911 0.337 . . . . 1.0700000000000001 111.911 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -130.18 110.67 11.76 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.834 -0.802 . . . . 1.23 108.834 178.257 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.769 HG21 ' HA ' ' A' ' 238' ' ' LEU . 0.0 OUTLIER -100.55 169.56 8.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.112 0.482 . . . . 1.1100000000000001 111.568 -178.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.497 ' HB2' ' CD1' ' A' ' 238' ' ' LEU . 1.5 t30 67.24 21.09 10.02 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.629 -0.714 . . . . 1.4099999999999999 110.703 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.425 ' HB3' ' HA ' ' A' ' 71' ' ' THR . 0.8 OUTLIER -60.14 154.69 18.94 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.555 -0.535 . . . . 1.0900000000000001 109.555 178.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.6 tp -91.27 114.3 26.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.93 0.395 . . . . 1.0800000000000001 111.418 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -73.72 77.74 1.55 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.973 -0.558 . . . . 2.0499999999999998 110.27 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -137.38 -163.88 1.5 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.875 -0.602 . . . . 1.5600000000000001 110.841 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.515 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 10.0 m-20 -96.91 -19.05 19.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.19 -0.459 . . . . 1.8600000000000001 111.076 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.01 -26.53 61.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.177 -0.465 . . . . 1.97 109.919 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.48 ' O ' HD13 ' A' ' 54' ' ' LEU . 26.5 t -90.04 -52.42 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.813 -0.63 . . . . 1.1100000000000001 111.45 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -53.07 -26.53 16.38 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.53 -0.468 . . . . 3.0899999999999999 110.558 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -73.4 -37.57 65.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.698 -0.683 . . . . 0.73999999999999999 109.637 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.501 ' O ' HD22 ' A' ' 57' ' ' LEU . 5.4 tpt -65.0 -47.35 77.82 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.565 -0.902 . . . . 1.3899999999999999 108.565 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.499 ' HG ' ' CD1' ' A' ' 29' ' ' LEU . 1.1 mp -61.95 -47.13 86.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.611 -0.722 . . . . 1.05 110.051 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.403 ' HA ' ' CG2' ' A' ' 58' ' ' THR . 0.9 OUTLIER -59.57 -28.17 66.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.111 0.481 . . . . 2.0299999999999998 109.979 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.527 ' HB2' HD12 ' A' ' 90' ' ' LEU . . . -68.73 -43.85 75.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.631 -0.713 . . . . 1.0800000000000001 111.965 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.501 HD22 ' O ' ' A' ' 53' ' ' MET . 0.1 OUTLIER -71.87 -50.45 29.31 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.774 -0.37 . . . . 1.4199999999999999 110.768 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.464 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.9 t -52.16 -29.81 23.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.07 0.462 . . . . 1.01 110.371 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.437 ' CB ' ' CD2' ' A' ' 90' ' ' LEU . . . -59.82 -45.0 93.73 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.57 -0.741 . . . . 0.94999999999999996 110.523 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.706 HD23 ' HB3' ' A' ' 82' ' ' LEU . 3.0 mp -74.87 -24.37 58.55 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.454 0.645 . . . . 1.01 109.952 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.4 0.24 5.85 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.004 -0.998 . . . . 0.26000000000000001 114.146 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 63' ' ' SER . 34.0 t -61.77 150.12 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 118.041 0.921 . . . . 1.0800000000000001 110.364 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.486 ' CB ' HG13 ' A' ' 76' ' ' ILE . 2.5 m -111.23 104.91 13.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.815 -0.629 . . . . 0.90000000000000002 111.595 -178.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.464 ' CE2' ' HB ' ' A' ' 58' ' ' THR . 6.7 p90 -117.83 159.14 23.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.148 -0.933 . . . . 1.03 110.946 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.552 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 3.5 m -152.65 114.84 4.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 1.0800000000000001 110.214 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.704 HD11 ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -84.19 178.7 7.7 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.997 0.427 . . . . 1.05 110.735 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.489 ' H ' HD12 ' A' ' 66' ' ' LEU . 2.0 t -94.33 -179.92 5.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.803 -0.635 . . . . 1.6000000000000001 110.946 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.02 -19.41 61.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.176 -0.466 . . . . 1.0700000000000001 111.517 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.22 5.99 14.9 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.897 0.379 . . . . 1.5600000000000001 110.564 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.1 mtt-85 59.42 41.42 19.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.119 -0.491 . . . . 2.75 110.974 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -121.91 -0.03 9.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.651 -0.704 . . . . 1.04 110.887 179.111 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.589 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -143.54 115.35 8.24 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.446 -0.576 . . . . 2.2799999999999998 109.446 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.704 ' HB2' HD11 ' A' ' 66' ' ' LEU . 1.4 t -120.99 150.2 41.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.7 -0.682 . . . . 0.81000000000000005 112.141 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.428 ' HB3' ' HD3' ' A' ' 38' ' ' LYS . 4.2 mt-10 -118.18 103.79 10.19 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.477 -0.934 . . . . 1.53 108.477 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -99.19 126.74 52.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.567 0.699 . . . . 1.05 112.661 -178.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.486 HG13 ' CB ' ' A' ' 63' ' ' SER . 0.9 OUTLIER -78.54 110.81 14.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.478 -1.237 . . . . 1.8100000000000001 111.233 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.571 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -54.32 112.8 2.86 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.799 -0.637 . . . . 0.17999999999999999 114.047 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.0 OUTLIER -61.86 -19.6 62.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.187 0.518 . . . . 1.95 109.943 178.279 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.486 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 89.69 -23.21 20.84 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.611 -0.722 . . . . 0.16 112.671 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.799 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -136.92 -149.81 5.69 Favored Glycine 0 CA--C 1.507 -0.464 0 N-CA-C 109.998 -1.241 . . . . 0.17000000000000001 109.998 178.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.817 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 5.1 Cg_exo -78.71 164.43 25.67 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 CA-C-N 119.469 1.635 . . . . 0.14000000000000001 109.163 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.706 ' HB3' HD23 ' A' ' 60' ' ' LEU . 3.7 mm? -63.36 93.95 0.08 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.816 1.294 . . . . 1.04 108.217 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.817 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 28.9 m170 -87.8 120.18 28.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 112.435 -2.166 . . . . 0.14999999999999999 112.928 -175.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.421 ' HB3' ' CB ' ' A' ' 60' ' ' LEU . . . -149.21 109.4 4.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.882 -0.599 . . . . 0.89000000000000001 110.912 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -107.9 91.64 3.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.769 0.319 . . . . 1.51 111.139 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.98 19.94 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.544 -0.836 . . . . 0.28000000000000003 113.432 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.71 50.82 13.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.308 0.575 . . . . 1.1000000000000001 110.006 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.691 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 3.5 tp -77.12 136.03 38.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.315 -0.857 . . . . 1.1399999999999999 110.959 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 1.2 tt0 -116.6 127.46 54.49 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.158 0.504 . . . . 1.3500000000000001 110.395 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.527 HD12 ' HB2' ' A' ' 56' ' ' ALA . 50.8 mt -109.68 163.38 13.54 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.49 -0.777 . . . . 1.3 112.655 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -125.56 106.68 9.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.897 -1.047 . . . . 0.54000000000000004 109.892 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.531 ' HG ' ' HA ' ' A' ' 99' ' ' MET . 1.2 mm? -93.2 6.05 49.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.176 -0.465 . . . . 1.51 111.485 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 42.3 -141.42 1.7 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.051 -0.595 . . . . 0.29999999999999999 113.009 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -96.9 51.7 1.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.133 0.492 . . . . 2.1200000000000001 110.733 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.75 -73.71 0.49 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.811 -0.631 . . . . 1.03 111.071 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.0 -18.93 13.61 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.002 -0.618 . . . . 0.34000000000000002 113.092 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.85 -9.21 29.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.807 0.337 . . . . 1.5600000000000001 110.658 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.63 -12.75 6.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.1 -0.5 . . . . 1.05 111.523 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.531 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 4.6 ttm -79.36 -36.32 39.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.551 -0.295 . . . . 1.24 111.458 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.5 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -77.95 -48.91 2.07 Favored Pre-proline 0 N--CA 1.45 -0.45 0 CA-C-O 120.503 0.192 . . . . 2.6600000000000001 111.236 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.651 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 24.4 Cg_exo -64.18 -43.06 15.91 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.793 2.329 . . . . 0.32000000000000001 112.734 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.495 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 2.2 tm? -71.0 -30.37 66.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.996 -0.547 . . . . 1.05 111.168 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.62 -49.22 74.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.195 0.522 . . . . 0.95999999999999996 110.633 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.423 ' CB ' HD21 ' A' ' 133' ' ' LEU . . . -72.5 -34.75 67.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.366 0.876 . . . . 1.01 113.366 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.486 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -57.76 -44.27 86.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.034 0.445 . . . . 1.05 111.968 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -71.0 -21.19 62.33 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.927 -0.579 . . . . 1.0600000000000001 112.01 -178.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.459 ' O ' ' HA2' ' A' ' 155' ' ' GLY . 98.1 m -58.26 -12.56 3.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.938 -0.574 . . . . 0.70999999999999996 111.73 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.663 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 9.8 mt -80.62 167.85 19.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.695 0.283 . . . . 1.04 110.638 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 50.16 -110.83 0.96 Allowed Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.08 -0.581 . . . . 0.16 112.559 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.433 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.1 OUTLIER -162.37 102.47 1.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.797 0.332 . . . . 1.1100000000000001 110.3 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 1.4 m-20 -138.84 135.97 35.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 1.96 111.243 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 4.6 m-20 -102.79 109.48 21.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.052 -0.522 . . . . 1.26 109.813 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.691 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 5.2 mp -143.39 140.85 26.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.499 -0.319 . . . . 1.3 111.249 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.57 HG11 ' HG ' ' A' ' 143' ' ' LEU . 17.5 t -112.2 112.7 41.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.767 -0.457 . . . . 1.0600000000000001 109.767 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.467 HD22 ' HA ' ' A' ' 115' ' ' LEU . 31.8 mt -81.02 158.62 25.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.383 0.611 . . . . 1.05 111.91 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.3 m -160.84 162.98 32.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.99 -1.005 . . . . 1.6399999999999999 110.219 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.21 -165.39 13.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.885 -1.15 . . . . 0.27000000000000002 113.7 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.492 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 0.8 OUTLIER -71.74 175.86 2.66 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.26 -0.47 . . . . 1.5700000000000001 111.134 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 32.1 Cg_exo -60.47 -37.29 82.03 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.337 2.025 . . . . 0.88 112.436 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.503 HH11 ' CG ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -76.3 -36.98 58.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.765 0.317 . . . . 2.7400000000000002 110.796 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.49 ' HA ' ' HG3' ' A' ' 124' ' ' ARG . 7.5 tpt -58.59 -22.31 55.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 1.4199999999999999 110.21 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.459 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 2.9 mmtt -63.64 -10.38 18.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.05 -0.523 . . . . 2.29 111.97 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.585 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 4.4 pt-20 -121.22 28.2 7.96 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.638 -0.425 . . . . 1.9199999999999999 111.539 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.49 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 1.2 mmp_? -101.39 95.05 4.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.195 -0.457 . . . . 3.2000000000000002 110.725 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.7 Cg_endo -47.43 129.03 15.78 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.732 2.288 . . . . 0.59999999999999998 112.2 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.446 ' O ' HG12 ' A' ' 126' ' ' ILE . 19.9 tt -138.35 31.48 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.745 0.783 . . . . 1.01 110.143 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -74.93 -49.49 9.9 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.633 -1.167 . . . . 0.23000000000000001 112.668 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.437 ' HB2' ' CD2' ' A' ' 172' ' ' PHE . 0.1 OUTLIER -53.65 -33.0 53.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.825 0.345 . . . . 0.31 110.5 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.54 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 25.9 tp -76.48 -62.84 1.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 1.04 110.165 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.2 t -51.94 -26.89 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 1.03 111.604 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 2.7 t0 -71.93 -45.46 61.08 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.27 0.47 . . . . 1.4299999999999999 112.27 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.803 ' HA ' HD13 ' A' ' 135' ' ' LEU . . . -63.82 -54.19 38.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.863 0.363 . . . . 1.04 111.129 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.622 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -55.12 -44.78 75.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.343 0.592 . . . . 1.0600000000000001 109.547 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -57.76 -40.11 78.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.133 -0.94 . . . . 3.4500000000000002 110.314 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.803 HD13 ' HA ' ' A' ' 132' ' ' ALA . 3.1 mt -63.93 -32.93 74.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 1.02 110.686 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.435 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -76.53 -13.81 83.08 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.489 -0.862 . . . . 0.14000000000000001 112.929 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 127.05 4.46 5.99 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.54 -0.838 . . . . 0.16 113.192 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.98 150.41 45.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.878 0.371 . . . . 1.05 111.51 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -116.35 96.76 5.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 3.0 111.317 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 133' ' ' LEU . 10.6 mt -124.41 168.39 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.088 0.47 . . . . 1.0600000000000001 111.403 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.449 ' H ' ' CG2' ' A' ' 140' ' ' ILE . 0.4 OUTLIER -150.36 174.4 12.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.699 -0.682 . . . . 1.0900000000000001 110.603 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.531 ' CD2' ' HA ' ' A' ' 146' ' ' GLU . 23.6 m-85 -116.61 107.91 15.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.709 -0.849 . . . . 0.79000000000000004 108.709 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.57 ' HG ' HG11 ' A' ' 114' ' ' VAL . 2.3 mm? -75.25 -23.46 57.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.886 -0.597 . . . . 1.05 112.074 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.676 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 2.5 mt-10 -129.53 -67.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.745 -0.382 . . . . 2.1899999999999999 110.977 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.711 ' HB2' ' HD2' ' A' ' 148' ' ' TYR . 53.6 mt-30 -125.63 157.82 36.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.091 0.472 . . . . 3.46 111.774 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.531 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 47.4 mt-10 -75.31 131.46 40.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.676 . . . . 2.0099999999999998 110.826 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 16.6 m-20 67.46 44.3 1.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 1.72 111.822 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.711 ' HD2' ' HB2' ' A' ' 145' ' ' GLN . 7.8 m-30 -140.55 164.26 37.93 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.353 -0.385 . . . . 1.1499999999999999 110.65 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.52 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 6.3 Cg_exo -37.73 -44.12 1.57 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 124.146 3.231 . . . . 0.31 115.38 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.676 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 24.3 Cg_endo -61.41 95.18 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 121.202 1.268 . . . . 0.26000000000000001 111.041 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 141' ' ' THR . 94.4 mt -132.41 123.29 26.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.534 -0.757 . . . . 1.03 111.71 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.452 ' HB3' HD11 ' A' ' 143' ' ' LEU . 1.4 ttm180 -101.7 110.83 22.89 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.221 -1.029 . . . . 3.0899999999999999 108.221 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 2.0 mt -92.93 158.27 15.91 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.768 0.318 . . . . 1.0800000000000001 111.21 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 6.4 mt-30 -146.17 22.77 1.36 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.146 -0.479 . . . . 1.75 110.712 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 107' ' ' CYS . . . 56.35 -167.16 3.92 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.501 -0.856 . . . . 0.14999999999999999 112.193 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.94 -4.29 28.85 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.532 -0.842 . . . . 0.17000000000000001 112.814 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.622 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 2.0 t80 -62.43 110.54 1.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.922 0.391 . . . . 0.96999999999999997 111.141 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 71.5 p -109.49 -50.67 2.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.573 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.45 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 145.98 -161.91 28.31 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.276 -0.964 . . . . 0.19 113.58 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 113.88 168.82 16.62 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 111.738 -0.545 . . . . 0.17000000000000001 111.738 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.9 129.71 43.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.88 0.34 . . . . 1.5600000000000001 110.323 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.434 HG11 HD13 ' A' ' 135' ' ' LEU . 61.4 t -136.56 156.99 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 120.932 0.396 . . . . 1.03 111.131 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.4 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 1.1 m-20 -127.9 116.51 20.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.421 -0.585 . . . . 1.1000000000000001 109.421 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -118.73 145.86 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 120.392 -0.523 . . . . 1.0 112.278 -178.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.403 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 1.8 t70 -85.07 130.28 34.64 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.87 -0.605 . . . . 1.25 110.215 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.6 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -72.1 -45.34 41.3 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.799 -0.715 . . . . 0.14999999999999999 113.507 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.35 160.97 0.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.116 0.484 . . . . 1.5800000000000001 112.06 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 9.4 t 71.73 59.59 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 115.649 -0.705 . . . . 1.0700000000000001 111.06 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.421 ' HA ' HG13 ' A' ' 196' ' ' VAL . 15.3 m 60.81 154.03 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.871 -0.604 . . . . 1.1699999999999999 110.722 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.8 t -82.82 1.8 37.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 1.7 111.007 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 66.5 mm-40 -56.92 -21.0 26.45 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.543 -0.299 . . . . 1.8999999999999999 110.816 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.442 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 3.9 m-85 -71.88 -61.83 1.64 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.107 0.479 . . . . 0.23000000000000001 110.332 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.485 HD23 HD13 ' A' ' 191' ' ' ILE . 64.4 tp -68.77 -33.32 73.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.664 -0.698 . . . . 1.0800000000000001 109.768 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.577 ' O ' ' CG ' ' A' ' 178' ' ' MET . 52.5 m -59.76 -33.56 71.83 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.593 -0.731 . . . . 1.55 109.951 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.651 ' HB3' ' HA ' ' A' ' 101' ' ' PRO . . . -71.64 -45.07 63.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 1.0800000000000001 111.692 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 133' ' ' LEU . 1.6 mt -72.84 -31.11 64.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.145 -0.48 . . . . 1.04 110.435 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.548 ' O ' ' HG3' ' A' ' 181' ' ' PRO . 10.4 mt -66.78 -28.13 68.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.957 -0.565 . . . . 1.03 111.553 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.577 ' CG ' ' O ' ' A' ' 174' ' ' THR . 0.0 OUTLIER -98.75 -29.44 13.0 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 120.13 -0.628 . . . . 1.9299999999999999 110.43 179.178 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' ' 105' ' ' ALA . 83.0 m -81.79 -46.14 14.61 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.637 -0.711 . . . . 1.02 111.521 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.676 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -60.17 -40.9 81.24 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 113.286 0.847 . . . . 1.0600000000000001 113.286 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.5 Cg_endo -54.39 -35.57 84.93 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.426 1.418 . . . . 0.14999999999999999 112.545 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.99 -11.74 54.79 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.862 0.363 . . . . 1.0800000000000001 110.478 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.64 124.21 80.24 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.97 -0.559 . . . . 1.0700000000000001 109.788 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.1 -32.95 5.21 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.917 2.412 . . . . 0.42999999999999999 113.77 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -103.81 154.68 19.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.105 0.478 . . . . 1.75 111.431 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.419 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 12.4 t0 -67.39 122.54 18.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.603 -0.726 . . . . 1.3799999999999999 110.505 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.527 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 24.3 m -107.69 136.31 47.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.247 -0.433 . . . . 0.98999999999999999 111.435 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.476 HG22 ' CG1' ' A' ' 224' ' ' VAL . 45.4 t -126.5 97.93 4.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.979 -0.555 . . . . 1.03 110.053 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.561 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.4 mt -89.43 143.87 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-N 116.124 -0.489 . . . . 1.03 110.03 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.778 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -114.64 170.7 8.12 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.153 -1.054 . . . . 3.2200000000000002 108.153 177.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.485 HD13 HD23 ' A' ' 173' ' ' LEU . 0.9 OUTLIER -111.05 96.44 4.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 C-N-CA 120.767 -0.373 . . . . 1.05 111.126 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -59.09 -80.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.965 -0.561 . . . . 2.0600000000000001 110.662 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -81.24 167.18 48.95 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.838 -0.696 . . . . 0.19 112.567 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.15 126.22 26.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.641 0.258 . . . . 2.04 110.777 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.6 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.4 OUTLIER -61.49 144.1 54.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.987 0.423 . . . . 1.04 110.18 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.421 HG13 ' HA ' ' A' ' 169' ' ' SER . 14.5 p -100.48 -17.96 6.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.04 -0.527 . . . . 1.1100000000000001 111.541 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.537 ' CB ' ' HB2' ' A' ' 200' ' ' TYR . 0.1 OUTLIER -131.51 46.7 2.62 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.541 -0.754 . . . . 1.01 109.847 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.535 ' HA ' HD22 ' A' ' 195' ' ' LEU . 0.3 OUTLIER -40.0 -59.58 1.74 Allowed Pre-proline 0 N--CA 1.466 0.37 0 CA-C-N 115.453 -0.794 . . . . 1.9399999999999999 113.051 -178.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 59.3 Cg_endo -71.24 -16.04 31.59 Favored 'Trans proline' 0 CA--C 1.516 -0.402 0 C-N-CA 121.987 1.791 . . . . 0.83999999999999997 112.762 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.537 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 28.3 m-85 -79.23 -27.77 42.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.416 -0.356 . . . . 1.4099999999999999 110.332 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.473 HG12 ' CD2' ' A' ' 173' ' ' LEU . 7.7 tp -69.96 -31.44 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 116.214 -0.448 . . . . 1.02 110.259 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.4 OUTLIER -63.05 -32.21 73.53 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.643 -0.503 . . . . 1.3200000000000001 109.643 178.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' ' 207' ' ' LEU . 31.1 mt -67.76 -31.08 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.804 -0.634 . . . . 1.1200000000000001 110.356 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.408 HG21 ' HB3' ' A' ' 177' ' ' LEU . 42.0 m -60.65 -52.3 65.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.692 -0.485 . . . . 1.0700000000000001 109.692 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.486 ' CD2' HG12 ' A' ' 215' ' ' ILE . 41.1 mt -70.95 -35.12 72.07 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.958 -0.565 . . . . 1.01 110.557 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 202' ' ' ASP . 1.6 t30 -63.86 -30.7 71.77 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 109.529 -0.545 . . . . 1.51 109.529 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -76.69 -42.79 40.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.55 -0.75 . . . . 1.4299999999999999 109.373 178.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.416 ' HE1' ' HG3' ' A' ' 181' ' ' PRO . 30.4 mtp -64.89 -45.95 83.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.16 -0.927 . . . . 1.0700000000000001 111.255 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 210' ' ' THR . 0.0 OUTLIER -60.46 -44.17 96.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.438 -0.346 . . . . 2.7000000000000002 110.759 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.416 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.5 OUTLIER -57.89 -31.71 67.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.147 0.499 . . . . 1.2 109.88 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.551 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 1.6 m-85 -71.86 -51.54 21.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.488 -0.778 . . . . 0.52000000000000002 110.857 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 158.27 -4.82 0.14 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.522 -0.846 . . . . 0.26000000000000001 113.497 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.473 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 78.1 t -120.31 139.11 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.429 0.529 . . . . 1.0600000000000001 112.429 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -131.14 156.28 45.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.649 -0.705 . . . . 1.3300000000000001 110.568 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.486 HG12 ' CD2' ' A' ' 205' ' ' LEU . 1.8 pp -129.23 177.17 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 115.485 -0.78 . . . . 1.1599999999999999 111.782 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.836 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 2.8 tt0 -92.38 126.2 37.36 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.827 0.346 . . . . 1.8400000000000001 110.479 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -101.9 99.65 9.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.162 0.506 . . . . 2.2599999999999998 110.403 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.641 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 1.4 mm-40 -66.85 -166.35 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.652 -0.704 . . . . 1.8600000000000001 109.419 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.29 49.16 0.35 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.407 -0.36 . . . . 3.1000000000000001 110.611 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.455 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 56.7 20.05 4.79 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.016 0.436 . . . . 0.82999999999999996 110.926 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.435 ' O ' ' N ' ' A' ' 191' ' ' ILE . 54.6 mt-30 -111.66 -24.24 10.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 2.3399999999999999 110.106 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.778 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 41.2 mt-30 -146.63 140.93 26.39 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 120.979 0.418 . . . . 2.3399999999999999 111.168 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.561 ' N ' ' O ' ' A' ' 189' ' ' ILE . 19.6 m-85 -111.31 96.17 5.96 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.616 -0.883 . . . . 0.20000000000000001 108.616 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.836 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 52.1 t -86.36 110.76 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.042 0.448 . . . . 1.0700000000000001 110.935 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 187' ' ' THR . 7.4 m -103.03 120.71 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.662 -0.699 . . . . 1.05 111.669 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -62.89 112.59 2.63 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.497 -0.774 . . . . 2.21 109.797 178.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.419 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -66.55 151.3 52.24 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.159 -0.928 . . . . 0.20000000000000001 113.039 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.77 10.63 62.87 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.591 -0.814 . . . . 0.27000000000000002 113.473 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 181' ' ' PRO . 75.0 mm-40 -73.2 -175.42 1.85 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.34 0.591 . . . . 1.75 110.992 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.539 ' HA ' HD22 ' A' ' 182' ' ' LEU . 1.2 m -176.6 103.25 0.06 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.273 -0.876 . . . . 0.89000000000000001 109.813 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 27.4 m-85 -54.73 152.24 7.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.196 -0.457 . . . . 0.66000000000000003 111.261 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.607 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 16.6 pt20 -122.13 154.25 37.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.06 -0.719 . . . . 2.73 109.06 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 9.5 t -64.97 102.93 0.37 Allowed Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 112.404 0.52 . . . . 1.6000000000000001 112.404 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.607 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 58.2 Cg_endo -68.93 -33.15 20.59 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.284 1.989 . . . . 0.88 111.466 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 121.54 -123.7 5.57 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.697 -0.683 . . . . 0.26000000000000001 111.645 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.522 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -91.38 117.38 29.62 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.83 -0.433 . . . . 1.0600000000000001 109.83 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.436 ' CE2' HD13 ' A' ' 207' ' ' LEU . 62.5 t80 -122.75 144.65 49.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.859 0.361 . . . . 1.3799999999999999 111.674 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.769 ' HA ' HG21 ' A' ' 42' ' ' THR . 25.0 tp . . . . . 0 N--CA 1.451 -0.39 0 CA-C-N 116.293 -0.412 . . . . 1.8799999999999999 110.651 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.573 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 7.5 p30 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.981 0.419 . . . . 0.0 111.027 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -65.57 -40.3 92.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.789 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.04 -36.46 40.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.993 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.588 HD21 ' HG ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -60.39 -51.63 68.66 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.922 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.544 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 2.4 tp -70.07 -43.21 71.63 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.891 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.531 HD12 ' HB3' ' A' ' 207' ' ' LEU . 48.6 mt -61.02 -35.9 78.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.005 0.431 . . . . 0.0 110.738 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.677 ' HA ' ' CE1' ' A' ' 211' ' ' PHE . . . -71.06 -29.97 66.0 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.737 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.593 ' O ' ' HB2' ' A' ' 78' ' ' ASN . . . -70.08 -30.62 67.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.542 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.895 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -89.39 -11.29 43.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.902 0.382 . . . . 0.0 111.102 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.45 165.57 20.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.212 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.524 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 75.7 m80 -99.07 98.68 9.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.967 0.413 . . . . 0.0 110.079 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.6 141.51 6.88 Favored Glycine 0 C--N 1.315 -0.637 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.162 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.73 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 13.6 tttt -62.6 132.83 53.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.085 0.469 . . . . 0.0 111.78 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.495 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.7 OUTLIER -128.22 152.71 47.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.917 178.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.643 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 58.5 t -100.85 141.2 17.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.021 0.439 . . . . 0.0 111.925 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -126.93 110.95 13.55 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.606 HG23 ' HA ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -101.99 166.94 10.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.121 0.486 . . . . 0.0 111.467 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 71' ' ' THR . 2.1 t30 70.6 19.35 6.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.879 -177.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -60.89 156.52 17.24 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.414 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.492 ' HG ' ' HB2' ' A' ' 47' ' ' SER . 16.8 tp -93.71 115.65 28.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.0 0.428 . . . . 0.0 111.617 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -76.37 64.49 2.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.439 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.492 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.3 OUTLIER -124.8 -159.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.063 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.704 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -97.39 -21.07 17.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.988 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.403 ' HA ' ' CB ' ' A' ' 95' ' ' ALA . 4.0 p-10 -72.77 -27.39 61.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.268 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 45' ' ' LEU . 13.3 t -88.46 -51.99 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.368 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.704 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 2.1 ptm180 -51.21 -28.53 11.62 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.209 0.528 . . . . 0.0 109.924 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -71.5 -39.82 70.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.246 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.573 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 3.0 tpt -62.54 -50.1 72.67 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 1.1 mt -60.01 -52.98 63.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.785 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.8 m120 -54.22 -22.86 12.65 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.851 178.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.433 ' O ' ' CD1' ' A' ' 60' ' ' LEU . . . -74.4 -48.11 29.83 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.597 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.579 ' CD1' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -72.06 -49.9 32.82 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.145 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.529 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 7.2 t -50.85 -30.88 15.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.158 0.504 . . . . 0.0 110.286 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.494 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -59.61 -49.5 77.5 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.958 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.73 HD22 ' HB3' ' A' ' 82' ' ' LEU . 3.6 mp -67.47 -28.46 67.88 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.584 0.707 . . . . 0.0 109.825 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.53 -0.24 5.47 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.537 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.599 HG13 ' N ' ' A' ' 63' ' ' SER . 13.8 t -58.7 147.97 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 117.491 0.645 . . . . 0.0 110.343 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.599 ' N ' HG13 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -111.69 107.65 16.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.636 -178.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 6.8 p90 -122.7 160.52 25.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.157 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.624 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -149.31 116.41 6.03 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.662 179.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -86.52 174.09 9.17 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.228 0.537 . . . . 0.0 111.735 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.489 ' CB ' ' HG3' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -85.16 178.55 7.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.634 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.23 -14.79 53.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.091 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.95 2.93 12.8 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.003 0.43 . . . . 0.0 110.239 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.58 ' O ' HD22 ' A' ' 44' ' ' LEU . 1.3 mtm-85 62.51 47.5 5.0 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.121 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -127.05 -2.54 6.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.271 179.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -141.27 109.75 5.96 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -114.41 147.67 38.89 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.255 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.611 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 7.2 mt-10 -114.62 102.52 10.11 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -95.27 131.93 40.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.455 HG12 ' HE3' ' A' ' 38' ' ' LYS . 8.6 mm -80.53 104.34 8.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.807 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.632 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -51.31 112.85 1.94 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.512 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.593 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.2 m-20 -59.61 -17.18 31.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.969 0.414 . . . . 0.0 110.378 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.524 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 88.08 -22.49 18.54 Favored Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.281 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.895 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -139.13 -143.22 4.39 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.783 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 6.2 Cg_exo -80.52 171.12 15.09 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 121.95 1.767 . . . . 0.0 109.319 177.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.73 ' HB3' HD22 ' A' ' 60' ' ' LEU . 4.3 mm? -69.78 90.68 0.6 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.783 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 35.5 m170 -83.08 119.54 24.61 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.281 -1.781 . . . . 0.0 112.749 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 111' ' ' ASN . . . -143.54 106.76 4.54 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.334 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -105.09 86.73 2.49 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.346 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.62 23.41 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.897 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 53.93 51.02 15.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.526 0.679 . . . . 0.0 109.75 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.696 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 3.1 tp -80.88 137.33 36.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.252 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.616 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 3.3 tt0 -115.68 129.93 56.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.272 0.558 . . . . 0.0 110.766 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.493 HD22 ' HB1' ' A' ' 59' ' ' ALA . 4.3 mt -105.99 154.75 20.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.378 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -120.21 107.26 12.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.862 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.621 ' HG ' ' HA ' ' A' ' 99' ' ' MET . 1.6 mm? -93.33 3.47 55.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.378 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.422 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 40.53 -143.57 0.6 Allowed Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.166 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.476 ' OD1' ' HB3' ' A' ' 120' ' ' ARG . 1.0 OUTLIER -92.04 50.58 1.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.985 0.421 . . . . 0.0 110.88 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.403 ' CB ' ' HA ' ' A' ' 49' ' ' ASP . . . -92.34 -73.79 0.54 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.923 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.51 -17.46 14.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.465 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.425 ' HA ' ' OE1' ' A' ' 171' ' ' GLN . 6.0 p -96.59 -9.16 29.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.845 0.355 . . . . 0.0 111.271 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.4 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -128.02 -13.64 5.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.695 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.621 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 3.4 ttm -73.7 -54.8 7.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.082 0.467 . . . . 0.0 111.033 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.726 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -58.98 -50.8 86.03 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.475 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.626 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 28.2 Cg_exo -63.14 -47.18 8.62 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.721 2.28 . . . . 0.0 112.863 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.735 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 2.0 tm? -65.24 -37.74 88.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.754 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.3 -48.35 82.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.441 0.638 . . . . 0.0 110.077 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 175' ' ' ALA . . . -66.09 -41.47 90.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.519 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.509 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -59.1 -39.36 81.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.389 . . . . 0.0 112.041 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.735 ' HG ' ' O ' ' A' ' 102' ' ' LEU . 0.9 OUTLIER -73.3 -21.14 60.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.849 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.482 ' O ' ' HA2' ' A' ' 155' ' ' GLY . 10.8 m -63.86 -6.37 5.81 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.453 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.697 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 7.2 mt -85.13 168.5 14.77 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.554 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 56.11 -113.44 4.06 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.607 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.412 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.1 OUTLIER -167.9 94.18 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.972 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.601 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 44.4 p-10 -138.54 145.21 40.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.833 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.0 OUTLIER -102.83 111.65 24.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.808 179.361 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.696 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 5.0 mp -141.2 143.59 27.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.235 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.768 HG12 ' HG ' ' A' ' 143' ' ' LEU . 41.2 t -115.59 113.62 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 120.67 0.272 . . . . 0.0 110.615 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 115' ' ' LEU . 25.2 mt -81.89 156.82 24.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.428 0.632 . . . . 0.0 111.767 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.6 m -163.76 166.66 21.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.587 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -154.36 -166.11 14.66 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 119.928 -1.13 . . . . 0.0 113.708 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.645 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 11.7 mm-40 -69.48 173.17 4.22 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.46 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.645 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 24.3 Cg_endo -61.56 -24.48 78.1 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.979 1.786 . . . . 0.0 112.173 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.515 ' HD3' ' HG2' ' A' ' 123' ' ' GLU . 4.1 tpp180 -88.05 -33.47 18.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.536 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.491 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 9.2 tpt -59.96 -17.68 39.82 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.597 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 12.2 mttm -68.93 -5.51 21.84 Favored 'General case' 0 C--N 1.334 -0.09 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.524 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -119.09 22.62 11.78 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.141 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.421 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 17.0 mmm180 -102.24 86.73 0.94 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.766 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.774 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 4.4 Cg_endo -47.02 134.42 18.37 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.918 2.412 . . . . 0.0 112.581 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.49 HD13 ' HA ' ' A' ' 100' ' ' ARG . 21.4 tt -135.78 32.22 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.79 0.805 . . . . 0.0 109.682 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -70.99 -51.6 17.95 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.612 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.639 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -58.85 -29.55 67.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.767 0.318 . . . . 0.0 110.447 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.622 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 29.6 tp -76.76 -61.03 2.11 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.474 ' HA ' HD13 ' A' ' 133' ' ' LEU . 61.9 t -57.06 -25.62 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.653 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -70.42 -45.42 65.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.584 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.77 ' HA ' HD11 ' A' ' 135' ' ' LEU . . . -66.1 -46.89 76.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.915 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.63 HD13 HD11 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -60.43 -46.33 90.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.97 -38.1 72.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.549 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.77 HD11 ' HA ' ' A' ' 132' ' ' ALA . 3.8 mt -66.71 -32.31 73.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.271 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.474 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -76.09 -16.82 80.42 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.555 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 127.6 5.47 5.43 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.309 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.44 148.48 41.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.83 0.348 . . . . 0.0 111.439 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -117.2 94.04 4.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.391 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.63 HD11 HD13 ' A' ' 133' ' ' LEU . 14.1 mt -116.95 174.73 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.93 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.541 HG23 ' HB3' ' A' ' 152' ' ' ARG . 0.6 OUTLIER -153.17 -175.19 5.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.043 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -125.35 106.87 10.15 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.768 ' HG ' HG12 ' A' ' 114' ' ' VAL . 2.2 mm? -79.91 -13.58 59.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.734 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 45.8 mt-10 -142.98 -71.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.062 0.458 . . . . 0.0 110.896 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.729 ' HB3' ' CD2' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -113.48 147.37 37.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.647 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.472 ' O ' ' CD2' ' A' ' 148' ' ' TYR . 2.2 mt-10 -76.68 131.97 39.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.47 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.774 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 82.5 m-20 62.84 48.97 3.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.125 0.488 . . . . 0.0 109.72 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.791 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 50.5 m-85 -147.44 176.2 2.33 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.503 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.791 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 2.3 Cg_endo -44.25 -43.4 13.28 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.518 2.812 . . . . 0.0 115.461 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.734 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 30.5 Cg_endo -61.94 101.29 0.22 Allowed 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 121.539 1.493 . . . . 0.0 111.751 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.526 HD21 ' O ' ' A' ' 141' ' ' THR . 91.0 mt -138.72 123.62 18.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.622 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -104.63 112.3 25.33 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 176.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.574 HD12 ' HB2' ' A' ' 106' ' ' LEU . 1.2 mt -94.49 156.15 16.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.434 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.601 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 19.1 mt-30 -142.91 27.22 1.65 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.752 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 107' ' ' CYS . . . 53.86 -165.29 2.34 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.595 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.77 -5.15 36.86 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.901 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.573 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 3.2 t80 -60.53 108.01 0.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 0.0 110.668 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 68.3 p -107.53 -47.24 3.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.006 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.565 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 141.26 -159.91 26.74 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 119.976 -1.107 . . . . 0.0 114.175 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.455 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 114.82 175.47 18.6 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.47 128.01 34.85 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.533 HG11 ' N ' ' A' ' 163' ' ' ASP . 59.4 t -137.34 151.26 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.966 0.412 . . . . 0.0 111.858 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.533 ' N ' HG11 ' A' ' 162' ' ' VAL . 1.9 m-20 -118.27 116.51 26.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.113 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -118.04 144.82 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.754 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.639 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.2 OUTLIER -83.75 138.0 33.47 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.621 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -80.05 -44.84 8.68 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.355 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.14 164.04 0.08 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.808 0.337 . . . . 0.0 111.189 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 4.0 t 70.73 56.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.491 ' HA ' HG12 ' A' ' 196' ' ' VAL . 53.2 m 59.25 156.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.192 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 48.5 p -80.28 -0.9 38.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.165 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.726 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 77.3 mm-40 -52.8 -23.72 7.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.759 0.314 . . . . 0.0 111.278 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.471 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 3.8 m-85 -71.55 -54.27 11.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.033 0.444 . . . . 0.0 110.447 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.477 ' CD2' HG12 ' A' ' 201' ' ' ILE . 18.8 tp -78.02 -35.86 49.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.391 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.459 ' O ' ' HG2' ' A' ' 178' ' ' MET . 92.3 m -55.65 -37.01 67.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.165 0.507 . . . . 0.0 109.69 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.626 ' HB2' ' HA ' ' A' ' 101' ' ' PRO . . . -71.56 -51.44 23.45 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.411 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.65 ' HB3' HD12 ' A' ' 189' ' ' ILE . 3.1 mt -65.41 -35.8 82.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.458 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.523 ' O ' ' HG3' ' A' ' 181' ' ' PRO . 10.6 mt -66.53 -28.8 68.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.115 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.474 ' SD ' ' HG ' ' A' ' 30' ' ' LEU . 5.9 ptp -95.32 -27.53 15.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.169 0.509 . . . . 0.0 110.958 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.634 ' O ' HD13 ' A' ' 108' ' ' LEU . 80.3 m -87.44 -46.44 9.61 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.131 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.704 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -63.02 -36.29 23.88 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.704 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.5 Cg_endo -53.24 -36.91 79.66 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 121.28 1.32 . . . . 0.0 111.8 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.564 HD22 ' HA ' ' A' ' 230' ' ' SER . 0.9 OUTLIER -84.22 -10.83 57.38 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.655 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.4 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . . . -64.49 119.52 57.52 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.747 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 3.4 Cg_exo -41.09 -29.67 0.55 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.478 2.785 . . . . 0.0 114.291 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.32 153.36 22.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.17 0.51 . . . . 0.0 111.59 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.524 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 6.0 t70 -67.28 116.6 8.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.84 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.731 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 26.3 m -102.87 135.65 44.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.295 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.431 HG22 ' CG1' ' A' ' 224' ' ' VAL . 39.4 t -126.13 99.16 5.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.147 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.65 HD12 ' HB3' ' A' ' 176' ' ' LEU . 3.0 mt -90.87 142.0 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.238 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.808 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.3 OUTLIER -112.99 171.14 7.72 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.734 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.643 HG23 HD11 ' A' ' 195' ' ' LEU . 1.0 OUTLIER -110.59 97.42 5.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.918 0.39 . . . . 0.0 111.339 -178.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.428 ' HG2' ' HE ' ' A' ' 190' ' ' ARG . 15.1 mtmt -57.15 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.651 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -82.58 170.44 50.28 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.216 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.08 124.17 20.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.61 0.243 . . . . 0.0 110.604 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.643 HD11 HG23 ' A' ' 191' ' ' ILE . 0.4 OUTLIER -58.48 144.88 40.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.995 0.426 . . . . 0.0 110.461 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 169' ' ' SER . 14.8 p -101.13 -20.57 5.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.79 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.709 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -128.39 46.19 2.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.376 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.594 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . 5.5 ttpt -40.44 -62.11 1.02 Allowed Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.825 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 59.1 Cg_endo -70.21 -16.44 35.67 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 121.586 1.524 . . . . 0.0 112.209 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.709 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 14.6 m-85 -75.74 -30.11 59.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.234 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.477 HG12 ' CD2' ' A' ' 173' ' ' LEU . 7.3 tp -68.28 -33.83 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.026 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.446 ' N ' HG21 ' A' ' 201' ' ' ILE . 0.6 OUTLIER -59.24 -31.27 68.92 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.658 ' O ' ' HB2' ' A' ' 207' ' ' LEU . 20.7 mt -70.44 -30.77 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.236 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 201' ' ' ILE . 24.2 m -59.25 -55.1 39.16 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.506 HD12 ' CD1' ' A' ' 215' ' ' ILE . 21.7 mt -71.26 -35.73 71.51 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.296 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.743 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 58.4 m-20 -64.35 -28.67 69.86 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.658 ' HB2' ' O ' ' A' ' 203' ' ' ILE . 0.1 OUTLIER -76.55 -44.41 34.96 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.862 177.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.482 ' HB3' ' HE1' ' A' ' 231' ' ' TYR . 9.5 mtp -66.8 -41.09 88.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.449 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.743 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 17.1 pttt -61.07 -43.79 98.36 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.712 0.291 . . . . 0.0 110.337 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.636 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.6 OUTLIER -59.59 -29.68 68.14 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.677 ' CE1' ' HA ' ' A' ' 32' ' ' ALA . 1.3 m-85 -72.94 -50.78 21.49 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.504 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.413 ' HA3' ' HG2' ' A' ' 232' ' ' GLN . . . 153.98 -7.69 0.4 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.53 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.623 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 65.4 t -118.92 140.34 43.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -135.58 156.65 48.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.625 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.521 ' CG2' HG13 ' A' ' 225' ' ' VAL . 1.8 pp -127.77 175.3 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.94 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.883 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 6.4 tp10 -88.8 126.33 35.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.645 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -102.87 101.17 11.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.033 0.444 . . . . 0.0 110.573 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.735 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.7 OUTLIER -65.33 -166.64 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.453 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -73.37 49.02 0.26 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.842 0.353 . . . . 0.0 110.537 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.548 ' CZ ' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 57.48 19.81 5.55 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.129 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 191' ' ' ILE . 2.2 mt-30 -112.98 -21.42 11.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.826 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.808 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 23.9 mt-30 -149.17 140.11 22.87 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.967 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.59 ' N ' ' O ' ' A' ' 189' ' ' ILE . 27.5 m-85 -112.36 98.53 7.35 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.883 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 58.6 t -84.55 110.79 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 121.222 0.534 . . . . 0.0 111.283 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.731 ' CG2' ' HB ' ' A' ' 187' ' ' THR . 3.4 m -98.75 115.31 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.964 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.661 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -64.59 103.53 0.69 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.895 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.524 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.99 153.81 25.1 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.935 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.07 10.75 62.21 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.492 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.661 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 6.7 mm-40 -77.21 -179.15 5.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.223 0.535 . . . . 0.0 110.791 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.564 ' HA ' HD22 ' A' ' 182' ' ' LEU . 2.1 m -174.5 105.03 0.1 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.993 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.623 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 35.0 m-85 -55.52 151.85 9.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.67 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 16.7 pt20 -119.66 159.44 24.44 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 51.6 p -75.48 98.35 0.24 Allowed Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.67 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 52.8 Cg_endo -65.88 -32.73 44.93 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.497 2.131 . . . . 0.0 112.011 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 122.45 -121.14 4.56 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.643 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.3 OUTLIER -92.56 116.88 29.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 63.6 t80 -122.54 138.6 54.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.53 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.606 ' HA ' HG23 ' A' ' 42' ' ' THR . 3.6 tp . . . . . 0 CA--C 1.513 -0.461 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.173 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 18.5 p30 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.902 0.382 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -62.48 -38.8 91.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.651 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 41' ' ' LEU . . . -78.55 -34.76 46.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.241 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.607 HD22 ' CG ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -62.3 -53.24 58.03 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.996 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 4.7 tp -67.77 -45.3 75.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.521 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.758 HD11 ' HB3' ' A' ' 207' ' ' LEU . 38.6 mt -58.97 -34.82 72.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.325 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.647 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -75.41 -30.06 59.96 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.729 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 78' ' ' ASN . . . -69.67 -32.57 71.27 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.611 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.874 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -87.77 -12.12 46.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.006 0.432 . . . . 0.0 110.804 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.0 163.71 21.94 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.73 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.538 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 75.0 m80 -97.44 97.07 8.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.86 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.34 144.6 7.38 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.018 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 16.2 tttt -66.6 134.8 53.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.076 0.465 . . . . 0.0 111.975 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.562 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -128.85 154.87 46.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.766 178.534 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.629 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 54.5 t -101.87 141.64 17.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.789 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -127.12 111.45 14.02 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.736 HG21 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -104.7 167.4 9.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.156 0.503 . . . . 0.0 111.719 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 71' ' ' THR . 0.3 OUTLIER 67.45 20.47 9.85 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.794 -177.248 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.468 HD21 ' O ' ' A' ' 70' ' ' ARG . 0.6 OUTLIER -59.08 157.24 10.54 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.565 178.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.544 ' O ' HG21 ' A' ' 50' ' ' VAL . 28.9 tp -95.32 114.3 26.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.122 0.487 . . . . 0.0 111.704 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -73.6 59.34 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.13 0.49 . . . . 0.0 110.53 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.8 p -115.87 -162.69 0.85 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.087 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.655 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 42.5 m-20 -97.94 -22.8 16.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.491 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.635 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 4.8 p-10 -73.34 -24.01 60.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.228 0.537 . . . . 0.0 110.0 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.544 HG21 ' O ' ' A' ' 45' ' ' LEU . 19.2 t -89.02 -55.2 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.103 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.664 ' O ' ' HB2' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -51.3 -29.47 15.01 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 109.842 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -71.12 -37.87 72.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.892 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.487 ' O ' HD22 ' A' ' 57' ' ' LEU . 9.3 tpt -63.83 -51.15 66.0 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.642 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 1.2 mp -62.04 -47.46 84.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.664 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -56.25 -26.1 50.28 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.336 179.076 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.522 ' HA ' HD12 ' A' ' 90' ' ' LEU . . . -74.18 -46.31 42.92 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.631 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.573 HD13 HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -68.27 -49.6 59.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.818 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.525 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 7.2 t -49.74 -31.47 11.47 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.204 0.526 . . . . 0.0 109.888 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.521 ' HB2' HD22 ' A' ' 88' ' ' LEU . . . -59.7 -52.36 65.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.093 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.847 HD23 ' HB3' ' A' ' 82' ' ' LEU . 4.1 mp -65.42 -28.63 69.38 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.524 0.678 . . . . 0.0 110.035 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.92 -1.23 6.26 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.758 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.657 HG21 HD12 ' A' ' 82' ' ' LEU . 22.8 t -56.27 152.81 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 117.639 0.72 . . . . 0.0 110.069 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.628 ' N ' HG12 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -114.28 108.68 17.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.005 -179.442 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.642 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 9.1 p90 -126.95 156.95 40.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 32.1 m -150.33 116.62 5.7 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.68 0.276 . . . . 0.0 111.078 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.634 ' CD2' HD22 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -85.62 177.44 7.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.197 0.522 . . . . 0.0 111.63 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.766 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 3.6 t -88.02 178.82 6.56 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.993 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.91 -12.72 39.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.584 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -117.71 2.61 12.29 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.866 0.365 . . . . 0.0 110.667 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.468 ' O ' HD21 ' A' ' 44' ' ' LEU . 10.9 mtt180 61.35 44.5 9.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.355 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -126.56 -2.6 6.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.562 179.446 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.766 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -141.21 110.25 6.19 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 65' ' ' THR . 3.0 t -114.75 149.88 36.21 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 43.7 mt-10 -115.85 102.85 10.07 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.684 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.6 mp -96.11 132.61 39.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.1 0.476 . . . . 0.0 111.995 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.632 HD13 ' HB2' ' A' ' 38' ' ' LYS . 15.1 mm -82.12 107.5 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.944 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -54.07 112.61 2.67 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.684 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -61.33 -17.06 51.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.973 0.416 . . . . 0.0 110.519 178.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.538 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 86.76 -21.63 17.98 Favored Glycine 0 C--O 1.228 -0.248 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.41 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.874 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.62 -144.88 4.7 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.788 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 6.2 Cg_exo -79.96 168.44 19.03 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 121.858 1.705 . . . . 0.0 109.289 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.847 ' HB3' HD23 ' A' ' 60' ' ' LEU . 4.2 mm? -66.89 90.56 0.18 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.788 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 29.7 m170 -82.48 118.75 23.47 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.073 -1.876 . . . . 0.0 112.858 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HB3' HD21 ' A' ' 60' ' ' LEU . . . -144.42 111.29 5.77 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.793 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -114.02 90.8 3.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.77 0.319 . . . . 0.0 111.524 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.03 22.6 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.736 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.7 52.28 11.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.453 0.644 . . . . 0.0 109.777 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.707 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 4.5 tp -82.71 130.53 35.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.256 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.635 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 0.7 OUTLIER -111.87 129.85 56.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.915 0.388 . . . . 0.0 110.519 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 56' ' ' ALA . 16.3 mt -114.04 154.39 27.78 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.459 ' CE1' ' HA2' ' A' ' 93' ' ' GLY . 43.9 t80 -121.01 102.26 8.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.642 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.705 ' HB2' ' HE2' ' A' ' 99' ' ' MET . 2.0 mm? -89.09 8.39 30.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.893 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.55 ' CA ' ' HG3' ' A' ' 118' ' ' GLU . . . 45.23 -142.91 3.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.898 -0.667 . . . . 0.0 113.203 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.485 ' ND2' ' HB3' ' A' ' 120' ' ' ARG . 16.6 t-20 -94.05 51.58 1.53 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.866 0.365 . . . . 0.0 111.081 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.635 ' HB3' ' HA ' ' A' ' 49' ' ' ASP . . . -90.15 -73.13 0.53 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.115 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.45 -16.38 18.83 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.073 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.436 ' HA ' ' CD ' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -95.15 -8.23 36.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.328 . . . . 0.0 111.103 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.428 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -127.46 -17.6 4.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.708 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.705 ' HE2' ' HB2' ' A' ' 92' ' ' LEU . 41.4 tpp -67.65 -54.72 17.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.097 0.475 . . . . 0.0 110.76 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.755 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -59.22 -53.37 66.94 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.474 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.644 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 31.3 Cg_exo -60.35 -47.15 15.18 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.731 2.287 . . . . 0.0 112.831 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.725 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 3.4 tm? -69.34 -38.92 78.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.553 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.92 -47.79 84.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.485 0.66 . . . . 0.0 109.988 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.695 ' HB3' ' CD2' ' A' ' 133' ' ' LEU . . . -68.17 -36.42 79.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.847 -1.069 . . . . 0.0 113.23 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.5 ' HB1' HD21 ' A' ' 30' ' ' LEU . . . -61.75 -44.21 97.34 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 102' ' ' LEU . 0.2 OUTLIER -69.74 -19.96 63.52 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.56 -179.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.558 ' SG ' HD11 ' A' ' 140' ' ' ILE . 56.6 m -60.06 -11.52 6.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.169 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.711 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 7.7 mt -84.17 168.92 15.34 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 52.66 -108.96 0.8 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.374 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.4 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 11.3 p -166.93 100.86 0.55 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.689 0.281 . . . . 0.0 110.497 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.578 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 9.7 m-20 -138.3 136.82 36.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.119 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 4.5 m-20 -101.42 111.21 23.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.476 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.707 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 4.3 mp -142.55 141.76 27.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.324 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.635 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 10.5 t -112.31 114.15 46.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.594 HD11 ' SD ' ' A' ' 99' ' ' MET . 59.5 mt -87.35 156.74 19.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.551 0.691 . . . . 0.0 112.288 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.466 HG22 ' H ' ' A' ' 117' ' ' GLY . 0.6 OUTLIER -159.03 175.25 13.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.071 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.466 ' H ' HG22 ' A' ' 116' ' ' THR . . . -164.15 -168.5 26.31 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 119.902 -1.142 . . . . 0.0 114.253 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.732 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 36.5 mt-10 -67.7 174.8 1.98 Allowed Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 122.877 0.471 . . . . 0.0 110.453 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.732 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 24.1 Cg_endo -61.39 -38.44 64.25 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.988 1.792 . . . . 0.0 112.267 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.485 ' HB3' ' ND2' ' A' ' 94' ' ' ASN . 15.0 tpp85 -76.88 -30.07 56.05 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.276 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.677 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 11.2 tpt -65.0 -11.59 40.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.205 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.727 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 10.4 mttt -76.33 -6.53 51.96 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.652 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 9.9 pt-20 -121.62 23.37 10.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.973 0.416 . . . . 0.0 111.166 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.422 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 5.1 mmp_? -96.94 94.75 1.89 Allowed Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.541 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.644 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 10.3 Cg_endo -53.66 123.09 12.53 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.499 2.133 . . . . 0.0 112.572 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.539 ' O ' HG12 ' A' ' 126' ' ' ILE . 13.3 tt -127.82 32.07 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.617 0.723 . . . . 0.0 110.225 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -74.3 -49.98 11.04 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.479 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.791 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -52.1 -28.42 17.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.047 0.451 . . . . 0.0 110.656 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.566 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 15.8 tp -82.37 -65.44 1.01 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.546 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.569 ' HA ' ' CD1' ' A' ' 133' ' ' LEU . 47.8 t -51.1 -28.23 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.179 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 13.0 t70 -68.43 -45.93 71.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.496 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.717 ' HA ' HD13 ' A' ' 135' ' ' LEU . . . -66.5 -48.78 68.72 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.695 ' CD2' ' HB3' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -58.34 -43.08 88.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.36 0.6 . . . . 0.0 109.684 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.53 -33.88 73.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.698 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.717 HD13 ' HA ' ' A' ' 132' ' ' ALA . 3.4 mt -69.79 -31.12 68.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.991 0.424 . . . . 0.0 110.266 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.552 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -77.79 -17.12 79.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.379 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.78 3.98 5.33 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.141 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.25 147.24 48.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 111.105 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 1.9 mmtp -113.94 91.22 3.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.454 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.631 HD13 HD11 ' A' ' 133' ' ' LEU . 8.1 mt -116.45 174.63 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.515 ' CG2' ' N ' ' A' ' 142' ' ' TYR . 0.5 OUTLIER -151.49 -167.15 2.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.144 0.497 . . . . 0.0 111.187 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.515 ' N ' ' CG2' ' A' ' 141' ' ' THR . 24.4 m-85 -136.17 99.1 4.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.929 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.493 ' HG ' HG13 ' A' ' 114' ' ' VAL . 2.4 mm? -68.25 -13.07 61.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.584 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.745 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 40.1 mm-40 -142.0 -73.8 0.31 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.069 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.492 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -120.43 150.09 41.34 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.145 0.498 . . . . 0.0 111.526 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.479 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 16.6 pt-20 -68.21 128.0 34.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.258 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.644 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 8.3 m-20 68.73 51.58 0.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.248 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.798 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.0 m-30 -145.17 177.29 1.82 Allowed Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.798 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 4.5 Cg_endo -48.08 -43.38 30.82 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.026 2.484 . . . . 0.0 114.974 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.745 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 27.8 Cg_endo -62.4 100.95 0.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 120.989 1.126 . . . . 0.0 111.276 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.509 HD22 ' O ' ' A' ' 141' ' ' THR . 61.8 mt -136.97 123.32 20.68 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.412 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 140' ' ' ILE . 2.8 mtp180 -103.93 112.11 24.95 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.502 HD12 HD12 ' A' ' 106' ' ' LEU . 1.7 mt -93.83 158.75 15.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.318 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 28.2 mt-30 -149.44 22.66 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.079 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.485 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 53.68 -166.87 1.71 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.707 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 109.29 -2.23 31.15 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.957 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.625 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 2.5 t80 -60.38 108.21 0.78 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.943 0.372 . . . . 0.0 110.949 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 68.5 p -105.09 -49.29 3.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.054 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.619 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 142.43 -163.58 27.13 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.168 -1.015 . . . . 0.0 114.019 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.445 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 116.7 172.56 16.42 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -65.29 128.32 35.36 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 117.245 0.523 . . . . 0.0 109.732 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.532 HG11 HD13 ' A' ' 135' ' ' LEU . 59.5 t -135.9 157.35 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.149 0.5 . . . . 0.0 111.31 -178.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.453 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.7 OUTLIER -125.34 117.94 24.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.518 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.456 HG12 HD12 ' A' ' 173' ' ' LEU . 0.5 OUTLIER -117.91 147.19 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.945 -178.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.791 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.2 OUTLIER -85.77 133.04 34.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.613 178.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.687 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -74.52 -44.67 26.14 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.304 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.489 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 0.2 OUTLIER -49.8 163.15 0.14 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.915 0.388 . . . . 0.0 111.805 -179.56 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 169' ' ' SER . 8.2 t 71.27 61.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.844 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.612 ' HB3' ' HG2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER 54.56 156.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.468 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.46 ' OG ' ' OG1' ' A' ' 174' ' ' THR . 6.7 t -79.61 2.21 23.28 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.877 0.37 . . . . 0.0 110.891 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.755 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 82.6 mm-40 -54.05 -24.14 16.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.328 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.541 ' CD2' ' HB2' ' A' ' 128' ' ' HIS . 2.1 m-85 -73.71 -58.48 3.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.352 0.596 . . . . 0.0 110.587 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.54 HD23 ' CE1' ' A' ' 223' ' ' PHE . 18.0 tp -72.25 -37.29 69.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.861 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.46 ' OG1' ' OG ' ' A' ' 170' ' ' SER . 66.8 m -57.29 -36.47 71.09 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.241 0.543 . . . . 0.0 109.772 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.544 ' CB ' ' HA ' ' A' ' 101' ' ' PRO . . . -71.76 -51.28 23.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.25 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.613 ' HB3' HD11 ' A' ' 189' ' ' ILE . 3.2 mt -64.12 -38.53 91.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.466 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.526 HD13 ' CD1' ' A' ' 201' ' ' ILE . 12.5 mt -65.61 -26.55 67.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.07 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.518 ' HA ' ' HH ' ' A' ' 231' ' ' TYR . 20.2 ptp -96.16 -27.03 15.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.175 0.512 . . . . 0.0 110.637 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.552 ' O ' HD12 ' A' ' 108' ' ' LEU . 65.5 m -86.26 -47.0 9.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.795 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.667 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -61.56 -38.49 52.04 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 9.2 Cg_endo -53.57 -35.98 78.9 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 121.28 1.32 . . . . 0.0 111.895 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.68 -9.25 58.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.676 -179.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.417 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . . . -65.75 123.95 86.16 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.935 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 1.5 Cg_endo -43.58 -31.26 3.09 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.333 2.688 . . . . 0.0 113.993 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -106.02 153.46 21.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.137 0.494 . . . . 0.0 111.879 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.594 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 75.5 m-20 -67.03 113.15 4.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.78 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.704 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 41.1 m -99.6 135.18 41.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.167 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.477 HG12 HG21 ' A' ' 224' ' ' VAL . 35.3 t -125.83 99.0 5.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.324 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.613 HD11 ' HB3' ' A' ' 176' ' ' LEU . 3.5 mt -89.58 144.17 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.462 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.808 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -114.21 170.93 7.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.618 HG23 HD11 ' A' ' 195' ' ' LEU . 1.4 mm -110.65 96.35 4.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 120.858 0.361 . . . . 0.0 111.007 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -59.33 -81.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.483 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -81.43 167.8 49.29 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.164 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.94 122.97 16.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.555 0.217 . . . . 0.0 110.546 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.794 HD22 ' HA ' ' A' ' 198' ' ' LYS . 0.8 OUTLIER -56.24 148.2 19.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.228 0.537 . . . . 0.0 110.535 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 169' ' ' SER . 13.8 p -105.81 -21.78 5.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.225 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.668 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -126.65 47.42 2.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.794 ' HA ' HD22 ' A' ' 195' ' ' LEU . 0.1 OUTLIER -44.1 -65.15 0.64 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.904 -178.114 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.541 ' CD ' ' HB3' ' A' ' 198' ' ' LYS . 43.0 Cg_endo -65.6 -18.18 58.55 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 121.545 1.497 . . . . 0.0 111.542 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.668 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 13.3 m-85 -73.81 -30.03 62.49 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.561 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.526 ' CD1' HD13 ' A' ' 177' ' ' LEU . 8.0 tp -69.55 -33.32 56.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.422 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.3 OUTLIER -60.9 -35.5 76.84 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.559 HD13 ' HA ' ' A' ' 200' ' ' TYR . 15.8 mt -65.93 -30.27 49.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.62 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.477 ' O ' ' HG3' ' A' ' 208' ' ' MET . 45.0 m -60.99 -55.76 29.14 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.607 HD21 HG12 ' A' ' 215' ' ' ILE . 35.5 mt -70.25 -33.71 71.96 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.473 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.552 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -66.14 -29.44 69.74 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.758 ' HB3' HD11 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -77.08 -44.92 28.81 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.115 178.371 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.477 ' HG3' ' O ' ' A' ' 204' ' ' THR . 12.7 mtp -64.62 -42.61 95.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.2 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.602 ' HG3' ' N ' ' A' ' 210' ' ' THR . 4.4 ptmt -61.53 -46.08 91.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.64 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.602 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.3 OUTLIER -59.11 -29.57 67.47 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.777 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 0.8 OUTLIER -70.76 -49.67 44.22 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.485 179.277 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 155.63 -7.52 0.28 Allowed Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.337 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.701 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 49.3 t -119.18 141.82 37.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -135.59 155.67 50.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.401 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.607 HG12 HD21 ' A' ' 205' ' ' LEU . 2.3 pp -129.1 175.87 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.754 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.916 -177.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.98 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 7.2 tp10 -88.74 125.2 34.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.529 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -101.53 101.02 11.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.424 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.823 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.6 OUTLIER -66.77 -168.14 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.499 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -74.37 48.42 0.33 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.816 0.341 . . . . 0.0 110.427 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.605 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 58.14 20.13 6.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.036 0.446 . . . . 0.0 111.252 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 191' ' ' ILE . 3.8 mt-30 -112.23 -20.52 11.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.77 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.823 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 17.6 mt-30 -151.2 140.87 21.74 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.901 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.576 ' N ' ' O ' ' A' ' 189' ' ' ILE . 11.0 m-85 -113.19 98.99 7.48 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.98 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 45.9 t -84.71 110.89 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.143 0.497 . . . . 0.0 111.25 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.704 ' CG2' ' HB ' ' A' ' 187' ' ' THR . 3.2 m -99.02 111.61 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.927 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.705 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.6 OUTLIER -62.02 101.21 0.2 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.035 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.594 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -55.94 155.85 11.56 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.402 -0.817 . . . . 0.0 113.029 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.34 10.92 63.35 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.326 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.705 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 81.6 mm-40 -78.06 -177.67 5.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.444 0.64 . . . . 0.0 111.327 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.573 ' HA ' HD21 ' A' ' 182' ' ' LEU . 2.7 m -175.87 104.75 0.08 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.212 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.701 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 24.8 m-85 -54.11 152.44 6.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.825 0.345 . . . . 0.0 111.118 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.777 ' HG2' ' O ' ' A' ' 211' ' ' PHE . 7.5 pt20 -122.68 155.7 35.87 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 35.2 t -69.26 100.42 0.26 Allowed Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.673 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 56.9 Cg_endo -67.8 -32.75 28.95 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.387 2.058 . . . . 0.0 111.76 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 123.4 -119.01 3.69 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.962 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.629 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.8 OUTLIER -96.69 117.32 30.75 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 52.7 t80 -121.53 135.3 55.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.013 -178.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.736 ' HA ' HG21 ' A' ' 42' ' ' THR . 8.7 tp . . . . . 0 CA--C 1.515 -0.366 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.582 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.668 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 4.4 p30 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.899 0.38 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.411 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 52.0 mtt180 -67.96 -42.05 81.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HB2' ' CD2' ' A' ' 41' ' ' LEU . . . -74.68 -32.98 62.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.832 HD23 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -62.07 -48.82 78.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.186 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.557 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 17.0 tp -73.93 -43.93 56.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.453 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.716 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 61.8 mt -59.89 -31.9 70.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.109 0.48 . . . . 0.0 110.899 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.658 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -78.6 -30.66 46.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.595 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.644 ' O ' ' HB2' ' A' ' 78' ' ' ASN . . . -69.37 -32.12 70.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.62 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.895 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -88.74 -12.28 42.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.145 0.497 . . . . 0.0 110.966 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -80.43 166.17 21.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.409 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.494 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 78.6 m80 -101.21 97.83 8.3 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.14 142.28 6.77 Favored Glycine 0 C--N 1.315 -0.611 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.828 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 17.4 ttpp -67.02 138.91 57.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.236 0.541 . . . . 0.0 112.027 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.703 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.7 OUTLIER -132.93 156.13 47.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.333 179.076 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.621 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 61.9 t -102.75 142.87 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.317 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.449 ' CD2' ' HB2' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -127.79 111.94 14.2 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 1.084 ' HB ' ' HD3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -97.65 167.85 10.71 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.02 0.438 . . . . 0.0 111.179 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.628 ' HB2' HD11 ' A' ' 238' ' ' LEU . 0.2 OUTLIER 61.55 21.35 12.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.065 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.599 HD22 HG11 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -58.88 159.35 7.06 Favored 'General case' 0 N--CA 1.46 0.069 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.472 ' HB3' HG23 ' A' ' 50' ' ' VAL . 31.4 tp -92.63 114.6 27.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.022 0.439 . . . . 0.0 111.659 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -76.1 65.46 2.11 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.179 0.514 . . . . 0.0 109.995 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.411 ' HB3' ' H ' ' A' ' 48' ' ' ASP . 8.3 m -128.31 -162.41 1.18 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.284 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.676 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -96.97 -19.94 18.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.246 0.546 . . . . 0.0 110.841 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.756 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 30.1 m-20 -69.95 -28.63 65.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.123 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.599 HG11 HD22 ' A' ' 44' ' ' LEU . 25.8 t -89.74 -50.89 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.752 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.676 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -49.21 -29.08 5.17 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.116 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.49 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . 8.4 m-70 -73.32 -37.56 66.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.298 178.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.668 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 3.2 tpt -64.73 -47.86 76.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.832 HD23 HD23 ' A' ' 29' ' ' LEU . 1.6 mp -68.43 -43.93 76.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.602 ' HA ' HG22 ' A' ' 58' ' ' THR . 1.2 m-80 -58.5 -22.72 56.01 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.955 0.407 . . . . 0.0 110.319 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.536 ' CB ' ' HG ' ' A' ' 102' ' ' LEU . . . -75.82 -48.57 21.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.62 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.513 HD22 ' O ' ' A' ' 53' ' ' MET . 0.1 OUTLIER -67.41 -48.13 68.24 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.593 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.657 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.0 t -52.39 -30.67 30.22 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.16 0.505 . . . . 0.0 110.247 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.668 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -61.77 -47.98 82.71 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.296 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.802 HD21 ' HB3' ' A' ' 82' ' ' LEU . 3.3 mp -71.22 -24.88 62.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.212 0.53 . . . . 0.0 110.184 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.71 0.65 7.16 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.434 -0.889 . . . . 0.0 114.067 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.655 HG23 HD13 ' A' ' 82' ' ' LEU . 11.3 t -56.73 156.49 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 117.58 0.69 . . . . 0.0 110.536 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.712 ' O ' HD11 ' A' ' 76' ' ' ILE . 2.8 m -113.66 110.09 19.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.733 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.657 ' CE2' ' HB ' ' A' ' 58' ' ' THR . 20.7 p90 -132.58 152.45 51.61 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.552 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.698 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -147.94 116.17 6.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.715 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.641 HD11 ' HB2' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -84.24 175.35 9.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.152 0.501 . . . . 0.0 111.104 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.63 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -87.25 179.22 6.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.092 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.83 -14.55 34.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.225 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.87 8.04 11.05 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.856 0.36 . . . . 0.0 110.606 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.557 ' O ' HD23 ' A' ' 44' ' ' LEU . 1.4 mtp180 58.75 47.04 13.35 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.421 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.418 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -129.23 -2.05 5.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.601 179.157 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 1.084 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -138.78 109.07 6.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.929 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.698 ' HA ' ' O ' ' A' ' 65' ' ' THR . 3.4 t -120.04 146.81 45.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.259 0.552 . . . . 0.0 112.185 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.637 ' HB3' ' HD2' ' A' ' 38' ' ' LYS . 1.2 mp0 -115.69 102.56 9.85 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.104 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -95.95 124.34 48.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.712 HD11 ' O ' ' A' ' 63' ' ' SER . 1.8 mp -79.22 104.25 7.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.215 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.658 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -48.8 118.53 5.01 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.877 -0.601 . . . . 0.0 114.346 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.644 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 2.3 m-20 -64.02 -15.94 60.54 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.093 0.473 . . . . 0.0 110.022 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.494 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.15 -20.73 14.84 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.218 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.895 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -137.44 -155.38 6.9 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.838 ' HA ' HD22 ' A' ' 34' ' ' LEU . 3.0 Cg_exo -74.35 166.37 29.63 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 121.865 1.71 . . . . 0.0 108.738 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.839 HD21 HD21 ' A' ' 34' ' ' LEU . 4.3 mm? -64.62 90.03 0.07 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.328 1.061 . . . . 0.0 108.293 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.832 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 31.3 m170 -82.55 118.59 23.38 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.675 -176.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 111' ' ' ASN . . . -142.93 109.42 5.37 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.971 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -112.76 93.42 4.42 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.222 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.86 21.26 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.282 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 56.72 50.24 12.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.469 0.652 . . . . 0.0 110.302 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.688 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 4.8 tp -79.77 137.94 37.13 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.189 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.607 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -117.04 124.06 48.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.139 0.495 . . . . 0.0 110.733 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.471 HD23 HD12 ' A' ' 88' ' ' LEU . 10.1 mt -105.47 162.99 12.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.475 0.655 . . . . 0.0 112.274 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.595 ' HA ' ' O ' ' A' ' 116' ' ' THR . 30.2 t80 -127.22 106.86 9.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.466 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.926 ' HG ' ' HA ' ' A' ' 99' ' ' MET . 2.5 mm? -94.67 6.83 47.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.474 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 44.37 -137.89 5.08 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.791 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.519 ' N ' ' HG3' ' A' ' 118' ' ' GLU . 9.8 t-20 -104.47 55.18 0.72 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.911 0.386 . . . . 0.0 110.671 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.756 ' HB1' ' HA ' ' A' ' 49' ' ' ASP . . . -98.65 -66.35 0.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.917 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.589 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 78.48 -17.09 6.87 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.867 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.442 ' HA ' ' CD ' ' A' ' 171' ' ' GLN . 1.7 p -92.71 -6.92 48.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.737 0.303 . . . . 0.0 111.238 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.487 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -131.97 -20.71 2.47 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.926 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 2.2 ttt -68.19 -51.48 45.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.941 0.401 . . . . 0.0 110.53 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.631 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 2.5 mpt_? -58.83 -53.68 63.98 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.561 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.675 ' HA ' ' HB1' ' A' ' 175' ' ' ALA . 24.3 Cg_exo -64.57 -46.74 6.6 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.853 2.369 . . . . 0.0 113.164 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.69 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 3.1 tm? -64.0 -37.78 88.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.23 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.41 ' HB1' ' CD1' ' A' ' 115' ' ' LEU . . . -62.15 -48.38 80.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.443 0.639 . . . . 0.0 110.285 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 107' ' ' CYS . . . -67.3 -40.77 86.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.566 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.46 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -58.68 -42.98 89.78 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.851 HD11 ' CD1' ' A' ' 153' ' ' LEU . 0.6 OUTLIER -68.78 -21.37 64.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.276 0.56 . . . . 0.0 110.884 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.659 ' SG ' HD11 ' A' ' 140' ' ' ILE . 99.6 m -61.65 -10.33 8.2 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.727 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.717 HD11 ' O ' ' A' ' 179' ' ' THR . 13.0 mt -81.08 167.4 19.77 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 52.65 -111.74 1.78 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.393 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.457 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 14.7 m -162.59 99.59 1.02 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.949 0.404 . . . . 0.0 110.287 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.575 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 20.5 m-20 -138.94 136.11 35.1 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 0.9 OUTLIER -100.2 111.23 23.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.015 178.468 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.688 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 4.6 mp -144.23 142.7 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.411 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.797 HG11 ' HG ' ' A' ' 143' ' ' LEU . 29.5 t -115.44 111.37 35.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.044 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 115' ' ' LEU . 33.7 mt -79.75 156.95 27.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.567 0.698 . . . . 0.0 112.359 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 19.0 m -159.51 156.34 28.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.795 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.3 -166.78 11.33 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.448 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.572 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 3.3 mm-40 -70.89 176.97 1.65 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.572 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 38.7 Cg_exo -62.22 -35.47 74.23 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.208 1.939 . . . . 0.0 112.222 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.597 ' HD3' ' HG2' ' A' ' 123' ' ' GLU . 19.5 tpp85 -79.71 -33.91 40.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.943 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.611 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 11.1 tpt -60.19 -18.11 45.88 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.72 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 5.1 mmtp -69.61 -4.84 20.98 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.066 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.597 ' HG2' ' HD3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -120.17 27.14 8.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.836 0.351 . . . . 0.0 110.903 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.431 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 11.4 mmm-85 -107.22 87.08 2.9 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.513 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.806 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.9 Cg_endo -47.82 123.8 8.95 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.753 2.302 . . . . 0.0 111.698 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.595 ' O ' HG23 ' A' ' 130' ' ' VAL . 19.1 tt -125.04 28.28 2.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.81 0.814 . . . . 0.0 110.31 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.628 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -67.04 -51.16 41.19 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.548 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.637 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -52.63 -31.62 37.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.085 0.469 . . . . 0.0 110.88 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.816 HD12 ' CD2' ' A' ' 133' ' ' LEU . 31.9 tp -79.23 -65.08 1.04 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.808 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 126' ' ' ILE . 54.1 t -52.33 -26.19 8.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.54 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.628 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.4 OUTLIER -72.04 -47.79 49.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.093 0.473 . . . . 0.0 111.048 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.871 ' HA ' HD11 ' A' ' 135' ' ' LEU . . . -60.58 -48.85 79.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.426 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.816 ' CD2' HD12 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -61.4 -43.26 99.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.548 0.689 . . . . 0.0 109.707 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -61.51 -33.38 73.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.643 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.871 HD11 ' HA ' ' A' ' 132' ' ' ALA . 2.8 mt -69.33 -30.03 67.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.83 0.348 . . . . 0.0 110.075 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.43 -18.39 79.19 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.585 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 131.37 1.38 4.79 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.023 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 107' ' ' CYS . . . -71.39 146.87 48.46 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.937 0.399 . . . . 0.0 111.45 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.0 mttt -116.29 94.38 4.62 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.235 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.659 HD11 ' SG ' ' A' ' 107' ' ' CYS . 9.0 mt -116.85 178.69 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.93 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.65 ' H ' HG21 ' A' ' 140' ' ' ILE . 0.7 OUTLIER -161.38 -174.79 4.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.008 0.432 . . . . 0.0 111.205 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.49 ' CG ' ' HA ' ' A' ' 146' ' ' GLU . 24.5 m-85 -123.94 108.86 12.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.869 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.797 ' HG ' HG11 ' A' ' 114' ' ' VAL . 1.4 mm? -85.51 -14.46 45.91 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.493 ' HB3' ' CB ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -137.48 -69.79 0.45 Allowed 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.164 0.506 . . . . 0.0 109.705 179.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.752 ' HB3' ' CD2' ' A' ' 148' ' ' TYR . 2.8 mt-30 -118.2 145.63 44.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.675 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.49 ' HA ' ' CG ' ' A' ' 142' ' ' TYR . 12.3 mt-10 -76.8 128.82 35.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.787 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.806 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 31.1 m-20 65.22 49.47 1.96 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.824 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 42.6 m-85 -149.15 179.02 1.28 Allowed Pre-proline 0 CA--C 1.549 0.904 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.594 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.824 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -43.9 -44.41 11.9 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 123.965 3.11 . . . . 0.0 115.167 -178.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.688 ' HD3' ' HE3' ' A' ' 122' ' ' LYS . 46.5 Cg_endo -64.6 102.65 0.42 Allowed 'Trans proline' 0 CA--C 1.509 -0.73 0 C-N-CA 121.701 1.601 . . . . 0.0 111.937 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.582 HD23 ' O ' ' A' ' 141' ' ' THR . 88.0 mt -139.43 124.11 18.45 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.057 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.572 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.1 OUTLIER -104.24 112.57 25.64 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.851 ' CD1' HD11 ' A' ' 106' ' ' LEU . 2.3 mt -93.61 159.97 14.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.191 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 2.0 mt-30 -147.51 23.97 1.12 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.964 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 107' ' ' CYS . . . 55.48 -166.07 3.47 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.597 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.44 -5.47 38.1 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.798 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.698 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 42.1 t80 -62.95 109.06 1.34 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.92 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 69.0 p -106.93 -47.7 3.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.958 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.6 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.55 -168.58 26.25 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.845 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.589 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 122.98 170.56 13.52 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -64.69 124.91 23.13 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.709 HG13 ' HB2' ' A' ' 132' ' ' ALA . 48.8 t -136.66 153.8 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 111.653 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.586 ' HB2' ' HE2' ' A' ' 192' ' ' LYS . 1.2 m-20 -119.01 118.03 30.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.729 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.839 HG13 HD13 ' A' ' 173' ' ' LEU . 0.9 OUTLIER -117.6 147.03 21.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.006 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.637 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 3.6 t0 -82.86 134.88 35.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.932 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.696 ' HA2' HD11 ' A' ' 195' ' ' LEU . . . -77.9 -44.2 12.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.299 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.21 166.51 0.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.611 0.243 . . . . 0.0 111.141 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.436 HG23 ' HE1' ' A' ' 128' ' ' HIS . 2.2 t 68.5 54.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.106 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.517 ' HA ' HG13 ' A' ' 196' ' ' VAL . 0.3 OUTLIER 61.53 141.23 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.1 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.523 ' CB ' ' HB2' ' A' ' 197' ' ' SER . 0.4 OUTLIER -69.63 -5.02 21.94 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.319 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.61 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 18.2 mm100 -50.66 -23.69 2.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.849 0.357 . . . . 0.0 111.046 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.522 ' HD2' ' HB2' ' A' ' 128' ' ' HIS . 3.0 m-85 -68.83 -54.72 14.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.494 0.664 . . . . 0.0 109.992 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.839 HD13 HG13 ' A' ' 164' ' ' VAL . 58.9 tp -76.75 -30.9 56.76 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.249 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.465 HG21 ' SD ' ' A' ' 178' ' ' MET . 33.2 m -61.06 -33.39 73.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.181 0.515 . . . . 0.0 109.849 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.675 ' HB1' ' HA ' ' A' ' 101' ' ' PRO . . . -70.02 -51.55 31.36 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.796 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.662 ' HB3' HD13 ' A' ' 189' ' ' ILE . 1.6 mt -67.1 -35.87 80.73 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.382 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.579 HD12 ' CD2' ' A' ' 223' ' ' PHE . 10.5 mt -69.02 -25.71 64.62 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.323 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.573 ' HG2' HD21 ' A' ' 31' ' ' LEU . 44.9 mtp -95.27 -27.05 15.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.265 0.555 . . . . 0.0 110.959 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.717 ' O ' HD11 ' A' ' 108' ' ' LEU . 88.7 m -91.93 -47.21 7.42 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.682 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.729 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -60.8 -36.21 32.83 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 13.0 Cg_endo -54.14 -37.92 87.48 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.154 1.236 . . . . 0.0 111.541 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.708 HD22 ' HA ' ' A' ' 230' ' ' SER . 1.1 mp -83.56 -8.87 59.25 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.047 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.41 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . . . -67.21 120.15 70.12 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.148 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 5.9 Cg_exo -38.8 -28.92 0.15 Allowed 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.456 2.77 . . . . 0.0 114.224 -178.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -107.55 151.44 25.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 111.807 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.631 ' OD1' ' HA ' ' A' ' 226' ' ' LYS . 32.2 t70 -66.53 117.05 8.18 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.451 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.786 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 28.3 m -103.38 135.48 44.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.249 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.465 HG11 HG23 ' A' ' 224' ' ' VAL . 31.7 t -125.65 98.84 5.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.337 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.662 HD13 ' HB3' ' A' ' 176' ' ' LEU . 3.0 mp -89.62 141.62 14.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.324 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.799 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.4 OUTLIER -112.17 171.11 7.7 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.924 HG21 HD13 ' A' ' 195' ' ' LEU . 1.6 mm -110.18 97.61 5.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 120.981 0.42 . . . . 0.0 111.52 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.586 ' HE2' ' HB2' ' A' ' 163' ' ' ASP . 17.2 mttt -59.85 -82.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.884 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -80.95 175.0 54.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.77 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.39 124.67 22.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.649 0.261 . . . . 0.0 110.569 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.924 HD13 HG21 ' A' ' 191' ' ' ILE . 0.9 OUTLIER -60.95 148.25 40.51 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.01 0.433 . . . . 0.0 109.975 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 169' ' ' SER . 12.1 p -104.91 -19.33 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.557 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.8 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 3.8 m -131.36 45.46 2.8 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.04 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.833 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . 2.8 tttt -42.0 -65.41 0.52 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 114.896 -1.047 . . . . 0.0 113.283 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.833 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 15.9 Cg_exo -68.04 -17.88 45.95 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.517 1.478 . . . . 0.0 111.841 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.8 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 45.4 m-85 -75.11 -29.28 60.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.405 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 198' ' ' LYS . 9.5 tp -69.68 -30.95 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.126 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.64 -32.59 74.11 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.627 ' O ' HD22 ' A' ' 207' ' ' LEU . 33.0 mt -64.93 -32.63 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.147 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 54.7 m -60.06 -53.74 54.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.376 0.608 . . . . 0.0 109.772 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.862 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 44.4 mt -68.59 -37.56 79.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.792 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -62.05 -29.29 70.19 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.716 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 2.1 mm? -76.66 -42.06 43.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.793 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.654 ' SD ' ' HG3' ' A' ' 181' ' ' PRO . 9.3 mtm -59.53 -42.92 93.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.796 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.862 ' HG3' ' O ' ' A' ' 205' ' ' LEU . 10.1 mtpt -64.96 -55.55 18.44 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.222 0.534 . . . . 0.0 110.2 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -50.76 -27.43 7.17 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.129 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.89 ' HA ' ' HG3' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -78.85 -50.2 11.65 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.561 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 152.58 0.82 0.22 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.967 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.503 ' HB ' ' CD1' ' A' ' 231' ' ' TYR . 53.8 t -118.78 139.81 44.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.138 0.494 . . . . 0.0 112.062 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.612 ' HG2' ' HG2' ' A' ' 209' ' ' LYS . 62.6 mt-10 -132.05 157.68 43.53 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.024 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.71 HD13 HD11 ' A' ' 205' ' ' LEU . 2.8 pp -138.16 175.26 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.909 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 1.08 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 33.0 tt0 -92.03 123.15 35.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.328 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -99.56 100.82 11.88 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.708 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.802 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.5 OUTLIER -67.33 -168.77 0.08 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.801 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -73.63 47.66 0.25 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.863 0.363 . . . . 0.0 110.364 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.644 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 0.1 OUTLIER 58.44 19.77 6.79 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.933 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 191' ' ' ILE . 18.7 mt-30 -111.67 -22.34 11.24 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.802 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 41.4 mt-30 -148.15 141.84 25.59 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.579 ' CD2' HD12 ' A' ' 177' ' ' LEU . 7.3 m-85 -112.59 95.93 5.7 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 1.08 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 41.5 t -80.36 110.98 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.062 0.458 . . . . 0.0 111.174 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.786 ' CG2' ' HB ' ' A' ' 187' ' ' THR . 2.6 m -96.96 107.72 20.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.931 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.65 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -57.41 100.96 0.06 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.592 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.586 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -55.66 154.52 12.7 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.51 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.34 9.13 65.46 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.088 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.65 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 1.9 mm-40 -77.16 176.97 8.24 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.812 0.815 . . . . 0.0 112.19 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.708 ' HA ' HD22 ' A' ' 182' ' ' LEU . 3.4 m -175.6 105.01 0.08 Allowed 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.614 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 17.5 m-85 -53.63 152.57 5.04 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.478 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 211' ' ' PHE . 15.0 pt20 -121.4 142.5 49.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.787 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 34.6 t -51.18 99.64 0.21 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.197 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.89 ' HG3' ' HA ' ' A' ' 211' ' ' PHE . 14.7 Cg_exo -68.79 -29.03 29.51 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.454 2.103 . . . . 0.0 111.635 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.18 -122.52 5.56 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.361 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.621 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -91.97 116.08 28.61 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.023 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.687 ' CZ ' HD13 ' A' ' 207' ' ' LEU . 58.0 t80 -113.52 140.99 47.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.293 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 1.006 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.317 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.582 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 13.0 m-20 . . . . . 0 N--CA 1.448 -0.536 0 CA-C-O 121.028 0.442 . . . . 0.0 110.454 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.26 -43.01 82.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.296 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.37 -32.19 58.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.729 HD11 ' HG ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -61.39 -54.25 46.13 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.25 0.548 . . . . 0.0 110.276 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.848 ' HB2' ' HE3' ' A' ' 53' ' ' MET . 9.4 tp -63.78 -55.28 24.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.448 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.706 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 29.6 mt -52.57 -34.89 52.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.134 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.647 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -76.21 -29.24 57.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.375 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.559 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . -73.08 -32.99 65.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.538 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.869 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -87.55 -13.13 43.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.927 0.394 . . . . 0.0 110.907 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -81.9 164.34 21.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.737 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.491 ' CE1' ' HB3' ' A' ' 230' ' ' SER . 75.4 m80 -97.24 96.14 8.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.479 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.34 141.36 5.98 Favored Glycine 0 C--N 1.318 -0.442 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.936 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.752 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -62.12 129.18 39.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.509 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.7 OUTLIER -122.67 155.49 36.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.147 178.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.674 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 46.7 t -102.63 142.17 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.332 -0.394 . . . . 0.0 112.013 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.592 ' HA ' ' O ' ' A' ' 237' ' ' TYR . 0.0 OUTLIER -129.41 111.97 13.34 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.055 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.964 ' HB ' ' HD3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -103.4 170.76 7.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.072 0.463 . . . . 0.0 111.595 -179.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.424 ' HB2' ' CD1' ' A' ' 238' ' ' LEU . 29.0 t-20 62.11 20.28 11.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.056 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.563 HD23 ' O ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -58.76 158.34 8.19 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.574 ' HB3' HG23 ' A' ' 50' ' ' VAL . 24.7 tp -90.74 114.36 26.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.097 0.475 . . . . 0.0 111.551 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -76.01 65.0 1.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.235 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 74.6 m -125.2 -163.49 1.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.898 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.706 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 1.3 m-20 -96.77 -19.08 19.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.399 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.433 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 8.6 m-20 -70.98 -29.86 65.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.968 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.626 HG13 HD11 ' A' ' 54' ' ' LEU . 39.1 t -88.11 -53.36 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.377 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.706 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 9.5 ptp180 -50.62 -30.73 14.11 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.039 0.447 . . . . 0.0 110.005 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -72.94 -35.3 66.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.039 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.848 ' HE3' ' HB2' ' A' ' 30' ' ' LEU . 10.9 tpt -64.93 -49.87 68.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.729 ' HG ' HD11 ' A' ' 29' ' ' LEU . 1.2 mp -66.14 -45.86 79.52 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.606 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.7 m-20 -57.29 -22.67 43.29 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.022 0.439 . . . . 0.0 109.987 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.541 ' HB2' HD12 ' A' ' 90' ' ' LEU . . . -74.77 -48.76 23.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.599 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.768 HD21 ' HE2' ' A' ' 53' ' ' MET . 0.1 OUTLIER -68.2 -49.65 59.42 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.903 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.474 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 5.3 t -50.48 -33.81 22.62 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.339 0.59 . . . . 0.0 110.304 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.643 ' CB ' HD23 ' A' ' 90' ' ' LEU . . . -59.36 -48.89 79.92 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.213 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.837 HD23 ' HB3' ' A' ' 82' ' ' LEU . 3.9 mp -67.13 -29.12 68.76 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.483 0.658 . . . . 0.0 109.831 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.13 -1.65 4.59 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 114.81 -1.087 . . . . 0.0 113.815 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.609 HG11 ' N ' ' A' ' 63' ' ' SER . 13.0 t -58.96 153.92 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 117.644 0.722 . . . . 0.0 110.247 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.609 ' N ' HG11 ' A' ' 62' ' ' VAL . 3.8 m -116.97 108.92 16.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.151 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 16.6 p90 -124.76 157.23 36.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.726 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -148.03 116.1 6.48 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.812 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.766 HD12 ' HB2' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -87.16 175.19 8.19 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.237 0.542 . . . . 0.0 111.38 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -89.48 179.4 6.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.859 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.35 -14.62 28.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.439 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.63 6.09 11.63 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.816 0.341 . . . . 0.0 110.656 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.565 ' HG2' ' HG ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER 59.07 45.59 14.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.503 -179.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -129.27 -2.16 5.04 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.999 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.964 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 1.2 mmm180 -136.58 109.34 7.54 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.766 ' HB2' HD12 ' A' ' 66' ' ' LEU . 5.4 t -120.62 154.04 36.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.376 0.607 . . . . 0.0 112.637 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.619 ' HB3' ' HD3' ' A' ' 38' ' ' LYS . 2.9 mt-10 -121.39 104.66 9.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.141 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.752 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -96.57 128.03 48.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.711 HG12 ' HG3' ' A' ' 38' ' ' LYS . 18.9 mt -81.67 103.06 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.112 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -47.9 113.78 1.54 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.695 -0.684 . . . . 0.0 114.197 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.559 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 25.0 t-20 -60.01 -17.36 38.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.112 0.482 . . . . 0.0 110.117 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.436 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 86.49 -22.96 10.92 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.363 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.869 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.65 -148.79 5.36 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.827 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 2.6 Cg_exo -77.09 169.01 22.3 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 CA-C-N 119.708 1.754 . . . . 0.0 109.261 177.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.837 ' HB3' HD23 ' A' ' 60' ' ' LEU . 4.5 mm? -67.43 90.51 0.24 Allowed 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 122.445 1.117 . . . . 0.0 108.078 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.827 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 30.3 m170 -82.26 118.67 23.29 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 112.877 -1.965 . . . . 0.0 112.671 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.528 ' HB2' HD21 ' A' ' 60' ' ' LEU . . . -144.87 113.07 6.49 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.644 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.15 86.35 2.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.795 0.331 . . . . 0.0 111.295 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -173.82 20.07 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.654 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.74 52.16 8.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.418 0.628 . . . . 0.0 109.852 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.707 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 4.1 tp -80.73 134.37 35.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.221 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.609 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 1.2 tt0 -113.87 128.94 56.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.228 0.537 . . . . 0.0 110.523 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.643 HD23 ' CB ' ' A' ' 59' ' ' ALA . 28.3 mt -112.4 154.09 26.32 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.465 ' HA ' HG22 ' A' ' 116' ' ' THR . 52.6 t80 -116.39 105.35 12.42 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.663 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.701 ' HG ' ' HA ' ' A' ' 99' ' ' MET . 3.0 mm? -90.2 8.9 30.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.275 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.447 ' HA2' ' CE1' ' A' ' 91' ' ' PHE . . . 37.73 -143.93 0.2 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.249 -0.501 . . . . 0.0 113.216 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.42 HD22 ' HB3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -96.09 50.94 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.242 0.544 . . . . 0.0 110.025 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.433 ' HB1' ' HA ' ' A' ' 49' ' ' ASP . . . -90.0 -72.96 0.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.608 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.37 -19.44 8.54 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.444 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.0 m -93.92 -7.23 43.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.769 0.319 . . . . 0.0 111.099 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.479 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -129.88 -17.09 3.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.355 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.701 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 21.9 tpp -70.23 -55.13 10.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.935 0.398 . . . . 0.0 111.009 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.835 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.6 mpt_? -60.07 -49.36 91.39 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.938 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.594 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 20.6 Cg_exo -66.79 -47.15 2.85 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.814 2.343 . . . . 0.0 112.95 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.697 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 3.3 tm? -68.55 -34.14 75.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.661 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 99' ' ' MET . . . -63.36 -47.98 79.86 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.645 0.736 . . . . 0.0 109.78 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.745 ' HB1' ' HB1' ' A' ' 175' ' ' ALA . . . -70.25 -39.18 75.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.094 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.529 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -56.6 -40.92 76.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 111.949 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 102' ' ' LEU . 0.4 OUTLIER -71.72 -21.48 61.76 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.568 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.517 ' SG ' HD12 ' A' ' 140' ' ' ILE . 89.6 m -60.8 -10.55 5.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.102 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.696 HD11 ' O ' ' A' ' 179' ' ' THR . 13.9 mt -83.3 168.48 16.63 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 53.95 -108.09 0.77 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.428 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.466 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.3 OUTLIER -167.68 99.6 0.48 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.843 0.354 . . . . 0.0 110.398 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 8.5 m-20 -138.5 135.79 35.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.134 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 18.3 m-20 -99.42 111.0 23.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.841 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.707 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 4.8 mp -143.0 140.79 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 5.8 t -109.46 113.71 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.613 HD13 ' SD ' ' A' ' 99' ' ' MET . 37.2 mt -89.71 154.61 19.81 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.125 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 90' ' ' LEU . 13.0 t -155.46 -170.27 3.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.296 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -173.45 -167.8 33.71 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 119.988 -1.101 . . . . 0.0 113.901 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.497 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 2.9 mm-40 -69.59 178.09 1.08 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.319 -0.441 . . . . 0.0 110.919 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.497 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 31.8 Cg_exo -61.88 -38.49 58.55 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.048 1.832 . . . . 0.0 112.214 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.796 HH11 ' HG3' ' A' ' 123' ' ' GLU . 3.2 tpt180 -79.55 -23.75 42.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.026 0.441 . . . . 0.0 110.204 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.584 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 10.8 tpt -69.17 -15.54 63.42 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.724 ' HE2' ' HD3' ' A' ' 150' ' ' PRO . 0.8 OUTLIER -74.44 -4.71 38.25 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.162 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.796 ' HG3' HH11 ' A' ' 120' ' ' ARG . 0.1 OUTLIER -127.65 26.02 5.96 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.293 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.485 ' HB2' ' HE2' ' A' ' 121' ' ' MET . 2.5 mmp_? -100.56 91.43 1.8 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.493 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.652 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.7 Cg_endo -47.87 127.06 13.89 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.593 2.195 . . . . 0.0 112.589 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.494 HD11 HD22 ' A' ' 129' ' ' LEU . 18.5 tt -130.88 31.24 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 121.732 0.777 . . . . 0.0 109.943 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.615 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -71.61 -51.98 14.16 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 114.772 -1.103 . . . . 0.0 112.735 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.531 ' HB2' ' CD2' ' A' ' 172' ' ' PHE . 0.1 OUTLIER -52.31 -26.49 12.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.927 0.394 . . . . 0.0 110.562 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.8 HD11 HD21 ' A' ' 133' ' ' LEU . 39.6 tp -84.69 -65.05 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.545 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.527 ' HA ' HD11 ' A' ' 133' ' ' LEU . 47.6 t -52.55 -26.02 9.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.49 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.615 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -73.23 -44.6 59.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.651 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.876 ' HA ' HD13 ' A' ' 135' ' ' LEU . . . -66.64 -47.98 70.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.571 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.8 HD21 HD11 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -58.26 -45.47 87.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.514 0.673 . . . . 0.0 109.52 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -33.79 71.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.816 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.876 HD13 ' HA ' ' A' ' 132' ' ' ALA . 5.1 mt -70.19 -31.99 69.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.977 0.417 . . . . 0.0 110.104 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -74.78 -17.99 80.09 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.514 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.81 2.9 5.13 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.596 -0.812 . . . . 0.0 113.114 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.446 ' CB ' ' HB3' ' A' ' 107' ' ' CYS . . . -70.11 146.73 50.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 111.027 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 46.3 mmtt -113.43 81.47 1.51 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.473 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.618 HD11 HD11 ' A' ' 133' ' ' LEU . 9.3 mt -107.44 176.12 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.531 ' O ' HD22 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -153.24 -169.03 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.028 0.442 . . . . 0.0 111.225 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.477 ' N ' ' CG2' ' A' ' 141' ' ' THR . 19.3 m-85 -131.72 104.18 6.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.014 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.508 ' HG ' HG12 ' A' ' 114' ' ' VAL . 2.4 mm? -75.02 -13.22 60.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.522 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.724 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 5.0 mt-10 -138.99 -73.23 0.39 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.209 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.591 ' HB2' ' HD2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -123.98 156.43 36.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.227 0.537 . . . . 0.0 111.735 -179.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -70.95 125.83 27.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.616 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.652 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 0.9 OUTLIER 70.41 50.43 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.044 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.709 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.0 m-30 -141.75 173.82 4.39 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.709 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 6.3 Cg_endo -49.18 -40.79 42.4 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.159 2.573 . . . . 0.0 115.068 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.724 ' HD3' ' HE2' ' A' ' 122' ' ' LYS . 18.7 Cg_endo -62.26 101.79 0.25 Allowed 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 120.849 1.033 . . . . 0.0 110.745 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.531 HD22 ' O ' ' A' ' 141' ' ' THR . 83.2 mt -137.11 123.17 20.31 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.549 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.606 ' CG ' HG21 ' A' ' 114' ' ' VAL . 2.6 mtp85 -102.47 111.78 24.23 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.638 ' CD1' HD12 ' A' ' 106' ' ' LEU . 3.7 mt -93.88 158.05 15.83 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.053 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.565 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 13.8 mt-30 -148.39 25.24 0.99 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.683 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.476 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 53.69 -166.35 1.88 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.537 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 108.2 -4.07 33.42 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.9 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.631 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 2.5 t80 -60.46 105.45 0.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.887 0.375 . . . . 0.0 110.828 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 67.9 p -104.56 -51.04 3.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.562 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.666 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 144.44 -163.95 27.77 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.065 -1.064 . . . . 0.0 114.269 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.548 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 118.04 170.74 15.11 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -64.2 126.3 27.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.26 0.53 . . . . 0.0 109.866 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.555 HG12 ' N ' ' A' ' 163' ' ' ASP . 59.0 t -136.99 152.65 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.966 0.412 . . . . 0.0 111.259 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.555 ' N ' HG12 ' A' ' 162' ' ' VAL . 0.9 OUTLIER -119.05 119.05 33.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.861 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.54 HG13 HD13 ' A' ' 173' ' ' LEU . 0.3 OUTLIER -118.78 141.98 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.984 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.498 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 3.9 t70 -79.77 137.14 36.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.835 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.649 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -79.52 -44.54 9.36 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.899 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.45 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 8.0 m -51.66 164.76 0.21 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.716 0.293 . . . . 0.0 111.175 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.8 t 70.55 55.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.294 0.569 . . . . 0.0 110.227 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.655 ' N ' HG12 ' A' ' 196' ' ' VAL . 4.9 m 57.09 149.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.478 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.537 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 0.6 OUTLIER -72.67 -3.83 27.39 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.546 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.835 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 57.1 mm-40 -49.79 -24.34 2.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.67 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.531 ' CD2' ' HB2' ' A' ' 128' ' ' HIS . 2.0 m-85 -72.58 -55.01 7.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.412 0.625 . . . . 0.0 110.283 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.54 HD13 HG13 ' A' ' 164' ' ' VAL . 26.3 tp -73.71 -38.89 64.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.511 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.598 ' O ' ' HG3' ' A' ' 178' ' ' MET . 20.5 m -59.02 -33.06 70.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.279 0.561 . . . . 0.0 109.678 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.745 ' HB1' ' HB1' ' A' ' 104' ' ' ALA . . . -72.84 -47.18 48.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.977 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.68 ' CD2' HD22 ' A' ' 133' ' ' LEU . 2.9 mt -69.88 -35.98 75.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.605 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.669 HD12 ' CD2' ' A' ' 223' ' ' PHE . 12.5 mt -68.47 -27.33 66.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.612 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.598 ' HG3' ' O ' ' A' ' 174' ' ' THR . 39.5 mtm -95.56 -26.99 15.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.245 0.545 . . . . 0.0 110.489 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.696 ' O ' HD11 ' A' ' 108' ' ' LEU . 51.6 m -88.79 -46.92 8.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.759 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.782 ' CB ' HG23 ' A' ' 225' ' ' VAL . . . -60.58 -39.07 63.64 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -177.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.3 Cg_endo -53.13 -36.01 75.24 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.347 1.364 . . . . 0.0 111.892 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.599 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.1 mp -85.04 -6.82 59.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.767 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -67.26 121.26 77.8 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.817 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -38.76 -32.58 0.29 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.47 2.78 . . . . 0.0 113.91 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.47 155.8 19.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.05 0.453 . . . . 0.0 111.7 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.543 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 1.8 t70 -69.57 117.44 11.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.748 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.738 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 40.8 m -102.48 135.31 44.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.147 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.448 HG22 ' CG1' ' A' ' 224' ' ' VAL . 36.0 t -124.87 99.15 5.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.922 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.667 HD11 ' HB3' ' A' ' 176' ' ' LEU . 2.9 mp -90.01 142.53 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.391 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.82 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -113.47 170.68 8.06 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.651 ' CG2' HD13 ' A' ' 195' ' ' LEU . 1.5 mm -110.61 97.91 6.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 121.002 0.429 . . . . 0.0 111.363 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.55 ' HA ' ' NH1' ' A' ' 190' ' ' ARG . 4.9 mtmt -59.69 -82.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.133 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -79.1 168.21 53.12 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.36 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -59.9 122.45 14.29 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.667 HD22 ' HA ' ' A' ' 198' ' ' LYS . 0.8 OUTLIER -56.89 146.57 26.15 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.355 0.598 . . . . 0.0 110.61 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.655 HG12 ' N ' ' A' ' 169' ' ' SER . 12.5 p -104.1 -21.59 5.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.089 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.693 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -126.78 45.24 2.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.197 -179.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.667 ' HA ' HD22 ' A' ' 195' ' ' LEU . 6.1 ttpt -41.53 -65.63 0.48 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.04 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 51.4 Cg_endo -68.11 -16.77 45.2 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 121.556 1.504 . . . . 0.0 112.308 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.693 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 88.6 m-85 -75.34 -27.57 59.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.39 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.489 ' CD1' HD11 ' A' ' 177' ' ' LEU . 6.1 tp -71.23 -33.14 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.762 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -32.5 71.99 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.526 ' CG2' HD21 ' A' ' 207' ' ' LEU . 28.4 mt -68.32 -29.8 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.605 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.435 HG23 HG21 ' A' ' 174' ' ' THR . 52.5 m -61.38 -52.55 64.15 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.262 0.553 . . . . 0.0 109.806 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.661 HD12 ' CD1' ' A' ' 215' ' ' ILE . 30.9 mt -70.44 -38.37 74.52 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.191 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.651 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 39.4 t30 -63.65 -28.04 69.63 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.706 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 1.0 OUTLIER -78.36 -40.62 35.81 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.489 178.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.445 ' HB3' ' HE1' ' A' ' 231' ' ' TYR . 17.2 mtp -68.9 -39.42 79.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.857 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.651 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 17.7 ptpt -65.37 -45.24 84.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.099 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.641 HG21 ' O ' ' A' ' 207' ' ' LEU . 2.0 t -57.71 -29.31 64.62 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.217 0.532 . . . . 0.0 109.798 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.587 ' HE2' ' HA ' ' A' ' 32' ' ' ALA . 1.3 m-85 -74.75 -53.04 9.94 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.587 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 158.82 -2.55 0.1 Allowed Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.644 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.634 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 53.7 t -119.0 142.44 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 117.08 0.44 . . . . 0.0 112.028 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -135.46 155.15 51.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.811 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.661 ' CD1' HD12 ' A' ' 205' ' ' LEU . 2.3 pp -130.43 175.53 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.378 -178.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 1.01 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 6.3 tp10 -91.57 127.43 37.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . 0.538 ' H ' ' ND2' ' A' ' 217' ' ' ASN . 0.1 OUTLIER -102.31 101.3 11.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.42 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.847 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 4.8 mm-40 -66.71 -168.06 0.06 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.858 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -74.12 48.0 0.3 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.802 0.334 . . . . 0.0 110.633 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.557 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.1 OUTLIER 58.82 19.69 7.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.018 0.437 . . . . 0.0 111.26 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 191' ' ' ILE . 7.1 mm-40 -112.7 -22.38 10.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.713 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.847 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 29.5 mt-30 -149.22 141.87 24.48 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.088 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.669 ' CD2' HD12 ' A' ' 177' ' ' LEU . 14.6 m-85 -112.91 97.77 6.75 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 1.01 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 39.1 t -81.9 110.9 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.334 0.588 . . . . 0.0 111.341 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.782 HG23 ' CB ' ' A' ' 180' ' ' ALA . 1.9 m -97.95 112.09 29.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.977 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.676 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 4.9 mptp? -63.26 104.37 0.59 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.807 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.543 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.93 158.69 14.83 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.114 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.07 9.44 80.38 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.474 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 19.5 mm-40 -76.28 178.76 6.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.441 0.639 . . . . 0.0 111.576 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.599 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.9 m -174.06 106.36 0.12 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.265 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.634 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 22.9 m-85 -55.24 152.23 8.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.511 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.533 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 7.7 pt20 -122.97 138.34 54.71 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 7.0 t -46.54 98.04 0.17 Allowed Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 39.5 Cg_endo -64.89 -29.33 58.3 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.331 2.021 . . . . 0.0 111.804 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 117.39 -123.77 5.89 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.884 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.674 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -91.0 116.96 29.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.039 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 68.0 t80 -121.7 126.58 49.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.531 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.73 ' HA ' HG21 ' A' ' 42' ' ' THR . 3.9 tp . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 121.252 0.548 . . . . 0.0 111.206 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.529 ' OD1' ' HA ' ' A' ' 50' ' ' VAL . 43.1 m-20 . . . . . 0 C--O 1.233 0.207 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -67.65 -43.29 80.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.17 0.51 . . . . 0.0 110.491 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.485 ' CB ' ' HB3' ' A' ' 41' ' ' LEU . . . -75.17 -31.96 61.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.978 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.729 HD22 HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -66.07 -52.22 50.89 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.115 0.483 . . . . 0.0 110.218 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 8.1 tp -64.94 -53.76 41.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.278 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.909 HD11 ' HB3' ' A' ' 207' ' ' LEU . 62.6 mt -53.5 -36.35 61.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.411 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.697 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -76.99 -29.94 55.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.448 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.531 ' O ' ' HB2' ' A' ' 78' ' ' ASN . . . -70.29 -33.2 71.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.526 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.887 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -88.81 -12.61 41.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.813 0.339 . . . . 0.0 111.145 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -81.72 166.06 20.42 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.687 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.521 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 77.5 m80 -99.89 97.7 8.56 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.042 0.449 . . . . 0.0 109.885 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.01 142.28 6.6 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.385 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.747 ' HB2' HD12 ' A' ' 76' ' ' ILE . 1.3 ttpm? -66.36 140.55 58.09 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.096 0.474 . . . . 0.0 112.035 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.29 154.33 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.289 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.699 HG23 ' HG2' ' A' ' 74' ' ' GLU . 55.8 t -100.72 142.78 15.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.122 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 237' ' ' TYR . 0.0 OUTLIER -129.25 111.69 13.14 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.823 HG21 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -97.98 164.63 12.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.333 0.587 . . . . 0.0 112.136 -178.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.429 ' HB2' HD11 ' A' ' 238' ' ' LEU . 19.4 t30 63.21 23.38 13.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.287 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.592 HD22 HG13 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -58.87 153.61 16.84 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.328 179.093 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.445 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 27.2 tp -83.35 114.26 21.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.059 0.457 . . . . 0.0 111.342 -178.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.01 68.57 4.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.995 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.4 m -130.01 -163.91 1.36 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.893 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.584 ' HA ' ' CD ' ' A' ' 51' ' ' ARG . 25.1 t0 -97.11 -20.45 17.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.031 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.508 ' HB3' ' HG1' ' A' ' 97' ' ' THR . 14.3 m-20 -70.45 -30.06 66.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.713 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.592 HG13 HD22 ' A' ' 44' ' ' LEU . 12.4 t -83.1 -54.84 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.105 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.584 ' CD ' ' HA ' ' A' ' 48' ' ' ASP . 11.9 ptm180 -49.67 -27.18 4.39 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.004 0.43 . . . . 0.0 110.013 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -71.02 -39.86 72.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.571 ' O ' HD21 ' A' ' 57' ' ' LEU . 7.1 tpt -64.29 -50.93 65.95 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.678 ' CD2' HD23 ' A' ' 29' ' ' LEU . 1.5 mp -62.11 -47.49 84.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.004 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.503 ' HA ' HG23 ' A' ' 58' ' ' THR . 11.8 t30 -58.43 -23.26 56.95 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.815 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.72 ' HA ' HD12 ' A' ' 90' ' ' LEU . . . -76.28 -49.0 18.18 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.138 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.729 HD12 HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -64.72 -49.73 69.68 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.271 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.503 HG23 ' HA ' ' A' ' 55' ' ' ASN . 8.7 t -50.37 -30.52 12.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.245 0.545 . . . . 0.0 109.983 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.523 ' CB ' HD23 ' A' ' 88' ' ' LEU . . . -59.22 -44.2 92.3 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.618 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.755 HD23 ' HB3' ' A' ' 82' ' ' LEU . 2.7 mp -79.56 -19.53 49.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.211 0.529 . . . . 0.0 110.656 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.13 -0.87 7.72 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.852 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.64 HG21 HD12 ' A' ' 82' ' ' LEU . 15.2 t -58.88 155.66 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 117.586 0.693 . . . . 0.0 110.086 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.61 ' N ' HG11 ' A' ' 62' ' ' VAL . 2.9 m -117.57 108.93 16.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.07 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 10.0 p90 -124.06 153.59 41.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.172 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.723 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 11.7 m -147.61 116.53 6.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.028 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.74 HD12 ' HB2' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -88.81 172.25 9.34 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.138 0.494 . . . . 0.0 111.088 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.664 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 65.1 p -88.04 179.57 6.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.781 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.19 -14.72 27.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.407 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.42 7.03 12.67 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.791 0.329 . . . . 0.0 110.68 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.458 ' O ' HD23 ' A' ' 44' ' ' LEU . 10.0 mtm180 57.08 41.91 26.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.116 0.484 . . . . 0.0 110.943 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.45 -2.14 8.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.604 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.664 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 4.8 mmt180 -136.94 110.53 8.02 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.841 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.74 ' HB2' HD12 ' A' ' 66' ' ' LEU . 4.0 t -120.22 151.57 38.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.452 0.644 . . . . 0.0 112.405 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.699 ' HG2' HG23 ' A' ' 40' ' ' VAL . 55.0 mt-10 -118.63 102.93 9.24 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.108 178.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.739 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -95.34 128.2 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-O 121.375 0.607 . . . . 0.0 112.213 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 38' ' ' LYS . 15.9 mm -80.51 103.32 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.871 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.697 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -49.73 114.66 2.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.958 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.3 t-20 -61.51 -16.78 50.71 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 110.194 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.521 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.27 -22.02 11.27 Favored Glycine 0 C--O 1.226 -0.384 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.427 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.887 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.53 -149.03 5.41 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.803 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 5.4 Cg_exo -78.77 168.3 21.19 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.853 1.702 . . . . 0.0 109.209 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.755 ' HB3' HD23 ' A' ' 60' ' ' LEU . 4.5 mm? -66.62 91.14 0.18 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.803 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 29.3 m170 -84.14 118.02 23.84 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 113.158 -1.837 . . . . 0.0 112.779 -176.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.487 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . . . -144.21 108.26 4.75 Favored 'General case' 0 C--O 1.227 -0.08 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.354 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -109.83 90.69 3.38 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.541 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -175.69 17.35 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.742 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.479 ' H ' ' HB2' ' A' ' 112' ' ' ASP . . . 55.2 47.81 20.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.565 0.697 . . . . 0.0 109.794 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 1.0 OUTLIER -81.3 129.14 34.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.31 -178.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.764 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 1.6 tt0 -105.7 127.76 53.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.122 0.487 . . . . 0.0 110.658 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.72 HD12 ' HA ' ' A' ' 56' ' ' ALA . 61.1 mt -111.97 157.5 20.63 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.418 ' CE1' ' O ' ' A' ' 117' ' ' GLY . 31.9 t80 -112.88 101.62 9.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.243 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.635 ' CD1' ' HA ' ' A' ' 99' ' ' MET . 0.1 OUTLIER -96.47 18.23 14.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.922 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 36.53 -154.47 0.01 OUTLIER Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.923 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.513 ' HA ' ' HB2' ' A' ' 121' ' ' MET . 10.6 t30 -87.6 50.1 1.93 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.287 0.565 . . . . 0.0 110.062 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 92' ' ' LEU . . . -82.25 -77.04 0.24 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.426 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 82.32 -13.77 38.03 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.644 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.508 ' HG1' ' HB3' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -97.02 -5.39 37.79 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.073 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' A' ' 53' ' ' MET . . . -133.7 -22.7 1.87 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.339 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.635 ' HA ' ' CD1' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -62.08 -58.73 6.72 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.235 0.541 . . . . 0.0 110.337 179.299 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.866 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.8 mpt_? -59.76 -52.13 76.01 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.075 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.67 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 36.8 Cg_exo -61.99 -45.13 17.24 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.457 2.105 . . . . 0.0 113.192 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.663 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 2.6 tm? -74.04 -31.55 62.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.814 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 99' ' ' MET . . . -60.98 -48.29 82.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.407 0.622 . . . . 0.0 110.474 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 107' ' ' CYS . . . -71.94 -36.82 70.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.006 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.498 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -57.67 -43.24 84.87 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.724 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.69 HD22 ' HB2' ' A' ' 82' ' ' LEU . 0.7 OUTLIER -69.72 -24.24 63.53 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.33 0.586 . . . . 0.0 111.116 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.586 ' SG ' HD13 ' A' ' 140' ' ' ILE . 86.5 m -59.11 -10.59 2.82 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.059 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.67 HD11 ' O ' ' A' ' 179' ' ' THR . 12.0 mt -82.06 169.03 17.18 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 50.84 -110.39 0.94 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.513 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.431 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 2.4 p -161.67 101.35 1.17 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.037 -0.356 . . . . 0.0 110.037 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.603 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 12.9 m-20 -138.95 135.15 34.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.547 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.0 OUTLIER -101.93 110.67 22.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.812 178.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.666 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 4.6 mp -145.9 140.66 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.58 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.804 HG11 ' HG ' ' A' ' 143' ' ' LEU . 27.0 t -111.03 112.4 40.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.248 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.48 HD23 HD12 ' A' ' 92' ' ' LEU . 13.2 mt -82.09 150.58 27.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.385 0.612 . . . . 0.0 111.587 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.6 m -155.25 177.25 11.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.419 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.418 ' O ' ' CE1' ' A' ' 91' ' ' PHE . . . -165.08 -165.37 22.27 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.251 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.551 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 2.3 mm-40 -70.92 176.07 2.25 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.551 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 37.2 Cg_exo -62.4 -28.95 78.69 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 121.793 1.662 . . . . 0.0 111.97 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.492 ' HD2' ' CG ' ' A' ' 123' ' ' GLU . 6.0 tpt180 -80.44 -37.29 32.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.958 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.628 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 34.8 tpp -59.56 -15.72 20.21 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.718 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 6.3 mttm -69.8 -5.79 27.88 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.554 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 2.0 pt-20 -120.98 26.97 8.73 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.066 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.574 ' HA ' ' HE ' ' A' ' 124' ' ' ARG . 1.6 mmp_? -105.91 94.16 8.67 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.062 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.634 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 10.6 Cg_endo -53.56 129.03 31.81 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.954 2.436 . . . . 0.0 112.559 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.544 ' O ' HG21 ' A' ' 130' ' ' VAL . 18.1 tt -132.78 29.35 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.724 0.774 . . . . 0.0 110.127 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -68.35 -51.06 34.34 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.184 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.702 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -54.29 -28.58 43.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.924 0.392 . . . . 0.0 110.668 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.737 HD12 HD22 ' A' ' 133' ' ' LEU . 23.6 tp -81.8 -61.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.885 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.584 ' HA ' HD12 ' A' ' 133' ' ' LEU . 59.8 t -53.35 -26.5 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.947 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 20.0 t0 -71.63 -43.43 66.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.007 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.846 ' HA ' HD13 ' A' ' 135' ' ' LEU . . . -65.43 -51.86 57.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 121.074 0.464 . . . . 0.0 111.528 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.737 HD22 HD12 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -57.38 -43.78 83.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.818 179.65 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -33.91 73.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.803 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.846 HD13 ' HA ' ' A' ' 132' ' ' ALA . 2.7 mt -68.79 -30.14 68.66 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.235 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.466 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -78.42 -17.84 77.07 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.669 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 130.14 4.31 4.6 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.302 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 107' ' ' CYS . . . -71.23 146.8 48.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.833 0.349 . . . . 0.0 111.557 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -114.75 94.57 4.83 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.075 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.682 HD12 HD12 ' A' ' 133' ' ' LEU . 11.5 mt -118.75 175.39 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.829 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.617 ' O ' HD23 ' A' ' 151' ' ' LEU . 1.0 OUTLIER -153.29 -166.15 2.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.267 0.556 . . . . 0.0 111.632 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.536 ' N ' HG21 ' A' ' 141' ' ' THR . 29.0 m-85 -135.92 101.51 4.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.921 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.804 ' HG ' HG11 ' A' ' 114' ' ' VAL . 2.4 mm? -72.86 -13.55 61.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.602 -177.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.738 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 4.8 mt-10 -139.52 -73.2 0.38 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.635 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.62 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.2 OUTLIER -121.35 147.23 45.98 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.217 0.532 . . . . 0.0 111.704 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.454 ' HA ' ' CG ' ' A' ' 142' ' ' TYR . 10.3 mt-10 -68.22 131.92 46.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.301 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.634 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 87.2 m-20 65.95 51.9 1.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.691 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.847 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.6 m-85 -148.03 -179.72 1.02 Allowed Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.129 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.847 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 5.7 Cg_endo -50.66 -43.1 47.53 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.969 2.446 . . . . 0.0 115.143 -177.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.738 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 32.8 Cg_endo -62.73 102.18 0.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.149 1.233 . . . . 0.0 111.425 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 141' ' ' THR . 67.3 mt -138.58 122.92 18.26 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.848 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.605 ' HB2' HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -105.51 112.33 25.39 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.129 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 4.5 mt -93.18 157.95 16.01 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.266 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.603 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -145.53 24.79 1.38 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.469 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.48 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 54.84 -166.05 2.83 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.535 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 108.72 -5.27 32.71 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.888 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.642 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 3.0 t80 -60.66 106.13 0.52 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.712 0.291 . . . . 0.0 110.721 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 185' ' ' GLU . 69.1 p -106.97 -46.12 4.0 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.098 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.687 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.39 -165.98 26.94 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.158 -1.02 . . . . 0.0 114.185 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.524 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 118.8 170.21 14.68 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.47 128.54 36.24 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 62.4 t -138.27 151.32 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 120.786 0.326 . . . . 0.0 111.733 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.481 ' N ' HG12 ' A' ' 162' ' ' VAL . 2.4 m-20 -118.89 117.85 29.96 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.583 HG12 HD12 ' A' ' 173' ' ' LEU . 0.9 OUTLIER -118.63 147.86 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 120.574 -0.451 . . . . 0.0 112.018 -178.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.702 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.4 OUTLIER -85.4 133.59 34.11 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.338 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.7 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -76.03 -44.62 18.23 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.279 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.403 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 83.2 p -51.55 163.69 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.942 0.401 . . . . 0.0 111.593 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 169' ' ' SER . 3.7 t 71.59 60.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.242 0.544 . . . . 0.0 110.658 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.628 ' N ' HG12 ' A' ' 196' ' ' VAL . 0.7 OUTLIER 54.81 154.95 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.409 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.621 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 0.1 OUTLIER -76.71 3.01 12.62 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.966 0.412 . . . . 0.0 111.097 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.866 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 55.8 mm-40 -54.11 -22.72 11.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.726 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.519 ' CD2' ' HB2' ' A' ' 128' ' ' HIS . 1.9 m-85 -78.21 -55.77 5.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.935 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.625 ' HB3' HD12 ' A' ' 201' ' ' ILE . 22.3 tp -73.51 -38.32 65.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.869 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.47 ' HG1' ' HB3' ' A' ' 170' ' ' SER . 91.4 m -60.31 -33.07 71.85 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.188 0.518 . . . . 0.0 109.706 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 101' ' ' PRO . . . -72.79 -50.18 25.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.734 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.644 ' HB3' HD12 ' A' ' 189' ' ' ILE . 2.3 mt -66.96 -38.78 86.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.749 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.796 HD13 HD11 ' A' ' 201' ' ' ILE . 12.7 mt -68.47 -24.87 64.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.282 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.6 ' HA ' ' HH ' ' A' ' 231' ' ' TYR . 46.5 mtm -94.52 -28.2 15.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.34 0.591 . . . . 0.0 110.779 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.67 ' O ' HD11 ' A' ' 108' ' ' LEU . 84.5 m -91.28 -46.84 7.83 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.068 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.708 ' CB ' HG23 ' A' ' 225' ' ' VAL . . . -59.21 -39.27 71.84 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 9.3 Cg_endo -53.33 -36.71 79.63 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 121.095 1.197 . . . . 0.0 111.706 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.485 HD22 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -85.12 -5.7 59.33 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.163 -179.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -67.09 120.9 75.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -37.12 -32.93 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.554 2.836 . . . . 0.0 114.018 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 158' ' ' THR . 0.3 OUTLIER -107.33 153.43 22.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.332 . . . . 0.0 111.562 -179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.566 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 0.4 OUTLIER -67.44 118.24 10.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.693 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.765 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 31.4 m -103.1 137.59 41.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.304 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.447 HG22 ' CG1' ' A' ' 224' ' ' VAL . 40.5 t -125.85 99.15 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.094 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.644 HD12 ' HB3' ' A' ' 176' ' ' LEU . 3.3 mt -90.55 141.98 13.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.395 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.837 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.3 OUTLIER -113.54 170.97 7.85 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.65 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.659 HG22 ' CD1' ' A' ' 195' ' ' LEU . 1.7 mm -110.38 97.26 5.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 120.985 0.421 . . . . 0.0 111.31 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.51 ' HG2' ' HE ' ' A' ' 190' ' ' ARG . 8.1 mtmp? -59.94 -81.37 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.464 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -78.85 168.44 53.53 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.309 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.45 122.3 15.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.54 0.209 . . . . 0.0 110.73 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.802 HD22 ' HA ' ' A' ' 198' ' ' LYS . 0.5 OUTLIER -57.26 146.64 27.84 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.985 0.422 . . . . 0.0 110.302 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.628 HG12 ' N ' ' A' ' 169' ' ' SER . 13.0 p -104.43 -19.75 6.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.384 0.611 . . . . 0.0 111.507 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.724 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.6 OUTLIER -127.74 45.31 2.76 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.627 -179.208 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.802 ' HA ' HD22 ' A' ' 195' ' ' LEU . 0.0 OUTLIER -41.19 -64.75 0.56 Allowed Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.702 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.628 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 55.2 Cg_endo -68.54 -16.92 43.37 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 121.603 1.535 . . . . 0.0 111.941 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.724 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 31.3 m-85 -76.0 -29.35 58.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.13 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.796 HD11 HD13 ' A' ' 177' ' ' LEU . 8.4 tp -70.53 -31.63 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.622 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.499 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.1 OUTLIER -61.52 -33.74 74.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.525 ' O ' ' HB2' ' A' ' 207' ' ' LEU . 36.3 mt -66.21 -31.37 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.706 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 54.0 m -60.26 -52.67 64.29 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.376 0.608 . . . . 0.0 109.823 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.55 HD13 HD11 ' A' ' 215' ' ' ILE . 44.9 mt -72.74 -35.48 67.54 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.59 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.706 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 4.9 t-20 -65.62 -24.81 67.14 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.909 ' HB3' HD11 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -82.68 -40.76 20.23 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.537 178.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.499 ' HG2' ' CZ ' ' A' ' 231' ' ' TYR . 12.0 mtp -69.0 -36.49 77.87 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.905 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.706 ' HE3' ' HA ' ' A' ' 206' ' ' ASN . 13.2 ptpt -66.56 -46.52 75.77 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.203 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 207' ' ' LEU . 5.2 t -57.55 -29.65 64.56 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.101 0.477 . . . . 0.0 109.862 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.601 ' CE2' ' HA ' ' A' ' 32' ' ' ALA . 1.8 m-85 -71.21 -54.1 12.12 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.301 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 155.78 -0.71 0.15 Allowed Glycine 0 CA--C 1.52 0.396 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.048 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.575 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 70.2 t -118.24 139.63 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.263 0.554 . . . . 0.0 111.679 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -135.95 156.12 49.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.994 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.55 HD11 HD13 ' A' ' 205' ' ' LEU . 2.0 pp -128.77 175.56 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.336 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.987 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 23.7 tt0 -89.88 125.15 35.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.156 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.71 101.04 11.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.016 0.436 . . . . 0.0 110.761 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.571 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -67.65 -166.52 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.589 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.64 47.69 0.42 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.084 0.468 . . . . 0.0 110.334 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.603 ' CZ ' ' HD3' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 58.22 19.39 6.15 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 -179.349 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 191' ' ' ILE . 14.2 mt-30 -110.6 -21.5 12.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.545 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.837 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 16.8 mt-30 -149.81 140.29 22.43 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.885 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.705 ' CD2' HD11 ' A' ' 177' ' ' LEU . 10.3 m-85 -112.35 96.39 5.98 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.987 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 27.6 t -80.54 111.27 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-O 121.06 0.457 . . . . 0.0 110.91 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.765 ' CG2' ' HB ' ' A' ' 187' ' ' THR . 2.7 m -97.68 112.96 30.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.12 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.688 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 5.7 mptt -61.38 104.16 0.38 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.584 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.566 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -59.57 157.39 25.22 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.825 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.44 8.74 84.56 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.339 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.688 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 15.1 mm-40 -73.38 178.99 4.21 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.401 0.619 . . . . 0.0 111.439 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.485 ' HA ' HD22 ' A' ' 182' ' ' LEU . 18.1 m -167.93 106.26 0.51 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.362 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.672 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 24.4 m-85 -54.03 142.02 26.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.163 0.506 . . . . 0.0 111.573 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.666 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 66.7 mt-30 -107.62 149.92 27.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.77 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 18.9 t -68.4 98.56 0.18 Allowed Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.745 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 47.8 Cg_endo -64.72 -33.36 54.73 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.498 2.132 . . . . 0.0 112.219 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 117.43 -114.09 2.87 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.581 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.6 OUTLIER -95.94 117.55 30.84 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 178.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 37.3 t80 -119.93 136.01 54.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.793 0.33 . . . . 0.0 111.251 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.823 ' HA ' HG21 ' A' ' 42' ' ' THR . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.433 0 CA-C-O 121.2 0.524 . . . . 0.0 110.679 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.619 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 2.9 m120 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.961 0.41 . . . . 0.0 111.463 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -68.34 -38.19 81.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.565 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.466 ' HB2' HD23 ' A' ' 41' ' ' LEU . . . -79.06 -34.58 43.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.75 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.593 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -62.23 -53.72 51.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.459 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.629 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 4.9 tp -66.93 -47.93 70.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.194 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.598 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 33.1 mt -56.87 -33.88 67.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.459 . . . . 0.0 110.862 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.659 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -76.42 -28.87 56.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.923 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.589 ' HB1' HD22 ' A' ' 82' ' ' LEU . . . -73.55 -29.61 62.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.616 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.88 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.35 -12.39 40.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.012 0.434 . . . . 0.0 110.858 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.642 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.23 164.89 20.9 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.609 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.515 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 75.2 m80 -98.21 97.7 9.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.065 0.459 . . . . 0.0 110.173 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.06 142.26 6.58 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.255 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.75 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 10.9 tttt -65.69 135.23 54.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.996 0.427 . . . . 0.0 111.788 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.517 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -129.98 159.32 37.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.468 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.591 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 61.7 t -103.82 142.44 17.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.631 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -128.38 111.75 13.68 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.0 OUTLIER -100.96 170.74 8.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.096 0.474 . . . . 0.0 111.767 -179.329 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.517 ' HB2' ' CD1' ' A' ' 238' ' ' LEU . 0.1 OUTLIER 64.99 21.29 12.29 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.384 -179.165 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.609 HD23 ' CD1' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -60.35 157.43 13.75 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.533 179.047 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.584 ' HB3' HG21 ' A' ' 50' ' ' VAL . 23.4 tp -93.13 113.78 26.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.129 0.49 . . . . 0.0 111.464 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 p-10 -72.82 62.93 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.438 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.498 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.5 OUTLIER -124.85 -162.25 1.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.147 -179.036 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.637 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 51.3 m-20 -97.63 -20.47 17.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.179 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.661 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 5.0 p-10 -71.25 -27.65 63.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.947 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.598 ' HA ' HD22 ' A' ' 26' ' ' ASN . 23.9 t -89.09 -53.26 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.595 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.65 ' O ' ' HB2' ' A' ' 55' ' ' ASN . 2.9 ptm180 -50.02 -30.29 10.4 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.678 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.421 ' CD2' ' O ' ' A' ' 48' ' ' ASP . 10.5 m-70 -72.63 -35.49 67.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.41 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.619 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 3.8 tpt -65.87 -47.85 73.49 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.687 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 1.6 mp -65.42 -48.84 71.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.65 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -53.17 -25.54 13.99 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.321 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.512 ' HA ' HD12 ' A' ' 90' ' ' LEU . . . -75.25 -44.21 47.31 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.652 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.506 ' CD1' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -69.74 -49.48 52.73 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.389 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.503 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 5.1 t -52.05 -32.35 34.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.203 0.525 . . . . 0.0 109.898 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.524 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -59.01 -46.01 89.26 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.127 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.797 HD23 ' HB3' ' A' ' 82' ' ' LEU . 3.6 mp -72.27 -26.8 62.13 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.498 0.666 . . . . 0.0 109.801 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.41 -0.35 5.11 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.713 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.63 HG21 HD13 ' A' ' 82' ' ' LEU . 18.6 t -58.34 152.42 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 117.718 0.759 . . . . 0.0 110.193 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.618 ' N ' HG13 ' A' ' 62' ' ' VAL . 3.7 m -116.16 108.68 16.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.932 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.687 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 15.0 p90 -127.53 154.62 44.93 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.22 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.626 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.9 OUTLIER -145.54 116.49 7.79 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.903 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.609 ' CD1' HD23 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -85.11 176.09 8.6 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.097 0.475 . . . . 0.0 111.842 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.832 ' HB3' ' HG3' ' A' ' 72' ' ' ARG . 50.4 p -86.3 178.99 6.98 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.051 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.94 -13.53 26.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.617 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -119.38 3.79 11.27 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.591 0.234 . . . . 0.0 110.877 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.428 ' O ' HD22 ' A' ' 44' ' ' LEU . 37.5 mmt-85 61.84 45.82 7.35 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 110.416 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -125.76 -3.11 7.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.367 179.339 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.832 ' HG3' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER -142.04 112.67 7.23 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.041 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 65' ' ' THR . 6.9 t -116.34 152.46 33.85 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.919 -0.712 . . . . 0.0 112.294 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.65 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 0.8 OUTLIER -116.2 102.61 9.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.878 178.662 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.75 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -96.04 127.63 47.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 14.3 mt -82.32 102.76 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.077 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.659 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -45.4 115.57 1.6 Allowed Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.999 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -61.24 -16.97 50.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.979 0.419 . . . . 0.0 110.1 178.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.515 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 86.16 -20.06 23.31 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.404 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.88 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -140.84 -148.28 5.08 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.811 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 3.8 Cg_exo -77.18 170.88 18.81 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.052 1.835 . . . . 0.0 109.183 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.797 ' HB3' HD23 ' A' ' 60' ' ' LEU . 4.2 mm? -69.31 92.19 0.57 Allowed 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.811 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 31.0 m170 -83.67 118.06 23.61 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.23 -1.805 . . . . 0.0 112.784 -175.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.471 ' HB3' ' CB ' ' A' ' 60' ' ' LEU . . . -144.45 109.04 4.89 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.361 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -111.58 91.65 3.74 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.418 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.63 20.37 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.773 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 54.95 49.37 17.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.366 0.603 . . . . 0.0 109.779 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.707 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 4.0 tp -81.78 135.96 35.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.425 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.629 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 1.2 tt0 -114.31 128.71 56.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.261 0.553 . . . . 0.0 110.605 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 56' ' ' ALA . 18.0 mt -111.14 158.99 18.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.468 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.436 ' CE1' ' HA2' ' A' ' 93' ' ' GLY . 41.8 t80 -123.83 103.39 8.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.428 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.687 HD22 ' HE1' ' A' ' 99' ' ' MET . 0.9 OUTLIER -90.05 6.5 42.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.09 -179.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.522 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 45.52 -145.52 2.74 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.283 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -86.65 47.99 1.57 Allowed 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 120.764 0.316 . . . . 0.0 111.387 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.661 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -90.43 -76.35 0.43 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.948 0.404 . . . . 0.0 111.124 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.55 -14.04 31.96 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.232 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 101' ' ' PRO . 65.3 p -97.0 -7.89 31.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.665 0.269 . . . . 0.0 111.015 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.508 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -126.85 -21.65 4.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.174 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.687 ' HE1' HD22 ' A' ' 92' ' ' LEU . 23.5 tpp -66.43 -50.44 63.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 0.0 110.018 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.666 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -61.6 -53.86 57.34 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.481 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.666 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 34.7 Cg_exo -61.31 -45.33 19.09 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.703 2.269 . . . . 0.0 112.79 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.559 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 2.7 tm? -70.8 -34.41 71.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.321 -178.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 99' ' ' MET . . . -60.4 -47.72 84.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.366 0.603 . . . . 0.0 110.564 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.487 ' HB1' ' CD2' ' A' ' 133' ' ' LEU . . . -71.97 -34.2 68.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.356 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.618 ' HB1' HD22 ' A' ' 30' ' ' LEU . . . -60.31 -45.16 94.38 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.878 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.578 HD22 ' CB ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -69.35 -20.49 63.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.662 -179.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.603 ' SG ' HD13 ' A' ' 140' ' ' ILE . 6.4 m -62.17 -8.12 5.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.976 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.718 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 15.8 mt -87.44 165.57 15.45 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 57.2 -109.76 1.87 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.083 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.416 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -165.8 99.48 0.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.765 0.317 . . . . 0.0 110.299 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.606 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 3.4 m120 -138.44 135.44 35.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 0.8 OUTLIER -102.78 110.65 22.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.381 178.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.707 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 4.5 mp -143.88 142.28 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.216 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.796 HG13 ' HG ' ' A' ' 143' ' ' LEU . 32.5 t -113.66 112.29 39.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.557 HD11 ' SD ' ' A' ' 99' ' ' MET . 39.0 mt -81.7 157.23 24.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.451 0.643 . . . . 0.0 112.194 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.6 m -163.2 166.93 22.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.165 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -154.68 -166.14 14.82 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.023 -1.084 . . . . 0.0 113.497 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.565 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 22.5 mm-40 -69.15 178.25 0.97 Allowed Pre-proline 0 C--N 1.33 -0.267 0 C-N-CA 122.674 0.39 . . . . 0.0 110.78 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.565 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 36.4 Cg_exo -61.8 -39.59 51.28 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.892 1.728 . . . . 0.0 112.524 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -76.2 -33.07 59.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.977 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.538 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 10.0 tpt -60.75 -17.24 47.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.278 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.692 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 6.2 mmtp -71.46 -4.9 29.1 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.63 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 0.1 OUTLIER -125.52 32.24 5.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.014 0.435 . . . . 0.0 111.03 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.532 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 2.2 mmp_? -103.95 87.43 1.55 Allowed Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.822 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.734 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 1.1 Cg_endo -43.92 129.79 7.7 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.075 2.517 . . . . 0.0 112.406 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.536 ' O ' HG12 ' A' ' 126' ' ' ILE . 15.0 tt -140.63 30.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.703 0.763 . . . . 0.0 110.29 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -70.11 -49.52 33.34 Favored Glycine 0 C--N 1.317 -0.523 0 CA-C-N 114.814 -1.085 . . . . 0.0 113.25 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.647 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -55.27 -25.31 33.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.819 -179.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.812 HD12 HD21 ' A' ' 133' ' ' LEU . 30.9 tp -83.88 -65.74 0.97 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.813 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 126' ' ' ILE . 60.3 t -51.15 -26.53 5.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.223 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 1.7 m-20 -73.2 -46.37 50.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.667 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.899 ' HA ' HD11 ' A' ' 135' ' ' LEU . . . -63.48 -48.71 76.54 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.284 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.812 HD21 HD12 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -59.86 -44.36 94.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.385 0.612 . . . . 0.0 109.692 179.573 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -59.18 -34.92 72.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.421 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.899 HD11 ' HA ' ' A' ' 132' ' ' ALA . 2.2 mt -68.86 -28.0 66.32 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.21 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.5 -11.37 85.21 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.611 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 121.24 6.13 9.13 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.931 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.29 149.2 37.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 111.3 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.45 ' HA ' ' HE3' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -115.4 95.95 5.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.082 0.468 . . . . 0.0 111.594 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.603 HD13 ' SG ' ' A' ' 107' ' ' CYS . 12.1 mt -118.26 177.05 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.395 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.575 ' O ' HD23 ' A' ' 151' ' ' LEU . 1.0 OUTLIER -154.11 -167.69 2.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.18 0.514 . . . . 0.0 111.403 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.532 ' CD2' ' HG2' ' A' ' 146' ' ' GLU . 23.6 m-85 -135.56 102.66 5.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.796 ' HG ' HG13 ' A' ' 114' ' ' VAL . 2.2 mm? -75.7 -13.86 60.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.932 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.673 ' HG3' ' N ' ' A' ' 145' ' ' GLN . 0.0 OUTLIER -135.63 -69.75 0.49 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.357 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.673 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.4 OUTLIER -132.15 163.86 27.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.912 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.532 ' HG2' ' CD2' ' A' ' 142' ' ' TYR . 23.4 mt-10 -74.97 143.46 43.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.556 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.734 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 0.5 OUTLIER 51.54 42.32 29.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.012 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.695 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.4 m-30 -130.24 174.43 4.64 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.262 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.695 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 8.6 Cg_endo -50.76 -40.65 56.44 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.921 2.414 . . . . 0.0 114.316 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 149' ' ' PRO . 40.1 Cg_endo -60.97 100.28 0.16 Allowed 'Trans proline' 0 CA--C 1.511 -0.625 0 C-N-CA 121.797 1.665 . . . . 0.0 111.514 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.575 HD23 ' O ' ' A' ' 141' ' ' THR . 92.6 mt -137.89 123.02 19.2 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.24 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -105.63 112.07 25.01 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 1.4 mt -94.0 158.22 15.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.045 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 32.4 mt-30 -145.72 24.45 1.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.784 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.486 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 53.59 -165.71 1.99 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.679 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.85 -3.73 38.93 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.105 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.663 ' HE2' ' HA ' ' A' ' 133' ' ' LEU . 44.5 t80 -61.81 107.35 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.846 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 53.3 p -103.02 -50.47 3.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.697 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.599 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 146.24 -165.25 28.24 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.138 -1.03 . . . . 0.0 114.19 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.481 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 119.23 168.37 14.0 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -62.43 125.87 25.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.004 0.402 . . . . 0.0 110.15 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.547 HG11 ' N ' ' A' ' 163' ' ' ASP . 44.3 t -135.02 153.02 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.756 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.547 ' N ' HG11 ' A' ' 162' ' ' VAL . 0.4 OUTLIER -119.3 115.57 24.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.032 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.441 HG13 HD13 ' A' ' 173' ' ' LEU . 0.5 OUTLIER -113.87 147.4 17.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.647 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.9 OUTLIER -85.64 134.14 34.0 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.481 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.698 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -76.54 -44.7 15.5 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.759 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.9 t -50.39 163.02 0.18 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.055 0.455 . . . . 0.0 111.832 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.2 t 71.3 59.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.898 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.434 ' HA ' HG13 ' A' ' 196' ' ' VAL . 75.7 m 57.68 153.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.262 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.455 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 0.5 OUTLIER -78.14 -2.4 37.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.249 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.597 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 90.6 mm-40 -51.55 -23.36 4.04 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.819 0.342 . . . . 0.0 111.365 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.539 ' CD2' ' HB2' ' A' ' 128' ' ' HIS . 2.8 m-85 -72.16 -58.94 3.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.252 0.549 . . . . 0.0 110.702 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.577 ' HG ' HD11 ' A' ' 177' ' ' LEU . 39.5 tp -73.49 -34.28 65.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.821 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.516 ' O ' ' HG2' ' A' ' 178' ' ' MET . 89.8 m -60.01 -31.33 69.83 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.66 ' HB2' ' HA ' ' A' ' 101' ' ' PRO . . . -73.15 -52.23 14.95 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.059 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.661 HD23 HD23 ' A' ' 133' ' ' LEU . 2.6 mt -65.46 -38.19 89.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.741 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.577 HD11 ' HG ' ' A' ' 173' ' ' LEU . 11.7 mt -64.57 -28.28 69.53 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.225 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.517 ' HA ' ' HH ' ' A' ' 231' ' ' TYR . 9.6 ptp -97.3 -27.52 14.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.193 0.521 . . . . 0.0 110.894 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.671 ' O ' HD11 ' A' ' 108' ' ' LEU . 23.0 m -85.03 -46.75 10.89 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.929 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.674 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -61.44 -38.67 54.64 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.2 Cg_endo -53.73 -35.66 79.24 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.516 1.478 . . . . 0.0 112.016 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.684 HD21 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.75 -7.77 59.08 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.988 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -66.42 122.75 83.21 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.06 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -43.12 -27.84 1.15 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.939 2.426 . . . . 0.0 113.614 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -107.17 153.06 23.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.013 0.435 . . . . 0.0 111.292 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.566 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 52.1 t0 -70.33 115.1 9.13 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.289 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.741 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 45.0 m -100.57 136.66 40.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.365 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.447 HG22 ' CG1' ' A' ' 224' ' ' VAL . 26.0 t -125.52 99.43 5.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.763 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.576 ' O ' ' N ' ' A' ' 223' ' ' PHE . 4.7 mt -90.57 143.65 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.132 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.824 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 2.2 ptm180 -115.28 170.95 8.0 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.588 ' CG2' HD13 ' A' ' 195' ' ' LEU . 1.4 mm -111.1 97.86 6.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-O 120.977 0.418 . . . . 0.0 111.267 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.501 ' HZ2' ' HB2' ' A' ' 165' ' ' ASP . 4.9 mtmp? -62.31 -80.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.581 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -76.84 167.81 54.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.146 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -62.6 122.26 15.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.656 0.265 . . . . 0.0 110.952 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.698 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.7 OUTLIER -57.37 146.45 29.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.891 0.377 . . . . 0.0 110.395 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.447 HG11 ' N ' ' A' ' 197' ' ' SER . 11.6 p -103.34 -20.09 5.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.318 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.684 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -128.9 46.33 2.64 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.248 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.62 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . 0.9 OUTLIER -41.96 -64.79 0.6 Allowed Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.039 -178.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 60.0 Cg_endo -70.73 -16.83 33.46 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 121.519 1.479 . . . . 0.0 111.457 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.684 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 21.5 m-85 -74.2 -30.02 62.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.204 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 198' ' ' LYS . 8.8 tp -68.54 -31.84 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.405 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.416 ' N ' HG22 ' A' ' 201' ' ' ILE . 6.6 m-20 -58.93 -29.64 67.26 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.651 ' O ' ' HB2' ' A' ' 207' ' ' LEU . 33.4 mt -70.68 -29.91 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.253 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 51.6 m -61.73 -55.22 32.56 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.16 0.505 . . . . 0.0 109.677 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' A' ' 215' ' ' ILE . 21.5 mt -69.19 -33.71 73.77 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.859 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.789 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 47.7 t30 -68.94 -24.74 64.31 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.651 ' HB2' ' O ' ' A' ' 203' ' ' ILE . 0.2 OUTLIER -78.96 -41.56 28.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.073 178.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.415 ' HB3' ' HE1' ' A' ' 231' ' ' TYR . 12.0 mtp -70.26 -39.14 75.16 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.4 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.789 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -64.97 -42.35 94.64 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.398 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 207' ' ' LEU . 1.0 OUTLIER -59.61 -30.72 68.89 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.054 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.624 ' CE2' ' HA ' ' A' ' 32' ' ' ALA . 1.5 m-85 -71.18 -53.43 14.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.85 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 158.21 -3.45 0.13 Allowed Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.543 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.579 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 55.6 t -119.8 142.97 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.144 0.497 . . . . 0.0 112.231 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -135.52 156.03 49.54 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.442 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.63 ' CD1' HD12 ' A' ' 205' ' ' LEU . 2.4 pp -129.07 176.14 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.52 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 1.037 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 8.3 tp10 -90.4 126.27 35.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.135 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -101.47 101.25 11.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.632 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.696 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.7 OUTLIER -67.38 -168.87 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.611 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -73.9 48.44 0.29 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.811 0.339 . . . . 0.0 110.489 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.562 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 58.9 18.73 6.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.222 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 191' ' ' ILE . 11.6 pt20 -111.67 -22.57 11.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.761 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.824 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 27.8 mt-30 -148.0 139.86 23.96 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.13 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.576 ' N ' ' O ' ' A' ' 189' ' ' ILE . 13.6 m-85 -111.15 98.37 7.47 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 1.037 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 37.2 t -82.4 111.42 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-O 121.153 0.501 . . . . 0.0 111.068 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.741 ' CG2' ' HB ' ' A' ' 187' ' ' THR . 2.4 m -98.43 113.57 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.789 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 2.0 mptp? -65.03 103.83 0.79 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.757 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.566 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -58.51 156.71 21.33 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.94 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.36 10.91 70.08 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.367 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.546 HE21 ' HA ' ' A' ' 229' ' ' GLN . 1.3 mm-40 -80.53 179.51 7.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.563 0.697 . . . . 0.0 111.901 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.684 ' HA ' HD21 ' A' ' 182' ' ' LEU . 4.0 m -173.69 106.88 0.13 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.448 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.642 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 22.9 m-85 -54.9 151.84 8.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.211 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.56 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 8.6 pt20 -122.11 142.46 50.36 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.6 t -48.6 98.74 0.19 Allowed Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.56 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 55.0 Cg_endo -67.22 -25.95 42.59 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.336 2.024 . . . . 0.0 111.976 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 112.49 -119.03 4.83 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.591 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -95.71 117.31 30.28 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.484 ' CE2' HD13 ' A' ' 207' ' ' LEU . 41.7 t80 -116.54 130.6 56.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.598 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.647 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.58 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 5.2 p30 . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 120.933 0.397 . . . . 0.0 110.75 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -67.58 -42.91 81.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.683 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.429 ' HB3' ' CD2' ' A' ' 41' ' ' LEU . . . -77.65 -34.33 53.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.937 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.848 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -58.32 -48.93 78.95 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.366 0.603 . . . . 0.0 110.504 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.607 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 3.2 tp -72.57 -49.29 33.44 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.225 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.685 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 31.7 mt -56.36 -33.07 65.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.732 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.66 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . . . -75.16 -29.88 60.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.695 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 78' ' ' ASN . . . -71.67 -29.19 64.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.651 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.901 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.23 -13.23 38.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.046 0.451 . . . . 0.0 110.855 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.26 168.01 18.05 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.779 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.53 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 80.4 m80 -101.98 97.74 8.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.079 0.466 . . . . 0.0 110.011 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.94 140.64 6.01 Favored Glycine 0 C--N 1.316 -0.579 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.436 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.789 ' HD3' ' HB3' ' A' ' 74' ' ' GLU . 2.1 ttmm -66.96 139.96 57.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.983 0.421 . . . . 0.0 112.028 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.809 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -130.71 156.47 44.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.7 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.647 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 57.4 t -102.64 142.27 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.994 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' A' ' 237' ' ' TYR . 0.0 OUTLIER -127.76 111.94 14.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.98 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.7 OUTLIER -102.1 164.96 11.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.894 0.378 . . . . 0.0 110.838 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.471 ' HB2' ' CD1' ' A' ' 238' ' ' LEU . 0.1 OUTLIER 66.56 19.09 10.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.726 -178.281 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 70' ' ' ARG . 0.6 OUTLIER -58.78 152.72 18.42 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.327 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.578 ' HB3' HG23 ' A' ' 50' ' ' VAL . 18.1 tp -82.54 114.95 21.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.22 0.533 . . . . 0.0 111.235 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -78.95 69.7 5.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.464 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.9 m -133.68 -160.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.379 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.624 ' HA ' ' CG ' ' A' ' 51' ' ' ARG . 76.9 m-20 -98.0 -19.42 18.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.014 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.422 ' OD2' ' HA ' ' A' ' 95' ' ' ALA . 4.0 m-20 -70.25 -32.2 69.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.885 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.578 HG23 ' HB3' ' A' ' 45' ' ' LEU . 21.1 t -84.72 -52.85 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.237 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.624 ' CG ' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -50.51 -28.7 8.96 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.913 179.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -72.68 -35.95 67.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.198 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.689 ' HE3' HD23 ' A' ' 57' ' ' LEU . 7.8 tpt -65.33 -48.93 71.32 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.848 ' HG ' HD12 ' A' ' 29' ' ' LEU . 1.5 mp -64.78 -47.9 76.43 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -55.63 -24.09 31.55 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.451 179.39 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.494 ' HB3' ' HG ' ' A' ' 102' ' ' LEU . . . -75.72 -48.99 19.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.726 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.689 HD23 ' HE3' ' A' ' 53' ' ' MET . 0.1 OUTLIER -66.48 -49.97 64.85 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.878 -179.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.492 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.3 t -51.9 -32.29 31.92 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.302 0.572 . . . . 0.0 110.034 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HB3' HD22 ' A' ' 88' ' ' LEU . . . -59.21 -48.05 83.07 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.106 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.726 HD23 ' HB3' ' A' ' 82' ' ' LEU . 3.7 mp -69.37 -27.38 65.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.394 0.616 . . . . 0.0 110.084 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.41 -1.97 4.93 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.6 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.733 HG21 HD11 ' A' ' 82' ' ' LEU . 13.6 t -59.59 155.79 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 117.641 0.72 . . . . 0.0 110.056 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.626 ' N ' HG13 ' A' ' 62' ' ' VAL . 1.7 m -116.95 107.71 14.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.991 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.645 ' CE2' ' HB3' ' A' ' 54' ' ' LEU . 8.3 p90 -122.24 153.43 38.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.861 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 1.7 m -147.99 116.33 6.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.877 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.748 HD11 ' HB2' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -87.97 177.32 6.98 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.085 0.469 . . . . 0.0 111.198 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.499 ' H ' HD12 ' A' ' 66' ' ' LEU . 12.9 p -93.97 179.68 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.479 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.94 -14.59 36.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.751 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -118.12 6.8 12.06 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.888 0.375 . . . . 0.0 110.74 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.635 ' O ' HD23 ' A' ' 44' ' ' LEU . 3.9 mmt180 57.14 43.85 23.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.817 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -126.49 -2.32 6.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.436 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.924 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -136.54 109.73 7.79 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.822 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.748 ' HB2' HD11 ' A' ' 66' ' ' LEU . 5.7 t -118.11 153.99 32.86 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.461 0.648 . . . . 0.0 112.669 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.789 ' HB3' ' HD3' ' A' ' 38' ' ' LYS . 0.6 OUTLIER -121.49 103.45 8.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.054 178.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.706 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -98.96 125.05 52.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.591 HG13 ' CB ' ' A' ' 63' ' ' SER . 8.3 mm -78.97 104.16 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.308 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.632 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -51.82 115.77 4.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.882 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -63.56 -14.87 55.56 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.914 0.388 . . . . 0.0 110.439 178.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.53 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 83.6 -19.88 13.51 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.336 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.901 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.75 -151.28 5.73 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 178.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.815 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 3.8 Cg_exo -77.47 171.0 18.35 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 119.638 1.719 . . . . 0.0 109.222 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.733 HD11 HG21 ' A' ' 62' ' ' VAL . 4.1 mm? -68.09 90.99 0.34 Allowed 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.815 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 32.7 m170 -84.21 120.74 26.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 113.062 -1.881 . . . . 0.0 112.368 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.695 ' O ' ' HB2' ' A' ' 111' ' ' ASN . . . -144.13 106.83 4.44 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.274 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.08 88.63 2.78 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.545 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.07 21.18 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.803 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.47 50.07 15.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.421 0.629 . . . . 0.0 109.904 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.687 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 2.8 tp -78.4 135.87 37.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.041 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.621 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -116.63 126.49 53.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.274 0.559 . . . . 0.0 110.286 179.157 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 56' ' ' ALA . 19.7 mt -107.91 156.25 19.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.762 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.555 ' HA ' ' O ' ' A' ' 116' ' ' THR . 49.5 t80 -122.07 102.15 7.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.884 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.75 HD23 ' HE3' ' A' ' 99' ' ' MET . 1.9 mm? -91.74 6.86 44.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.275 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 43.5 -142.84 2.04 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.859 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -92.92 50.43 1.56 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.169 0.509 . . . . 0.0 110.824 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.422 ' HA ' ' OD2' ' A' ' 49' ' ' ASP . . . -84.23 -77.03 0.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.218 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.537 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.54 -16.43 19.06 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.36 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.426 ' HA ' ' NE2' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -96.22 -9.9 29.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.851 0.358 . . . . 0.0 110.474 179.013 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.443 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -130.8 -15.94 3.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.731 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.75 ' HE3' HD23 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -67.95 -54.42 18.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.074 0.464 . . . . 0.0 110.459 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.593 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -60.48 -53.13 67.58 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.383 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.718 ' HB3' ' HE1' ' A' ' 178' ' ' MET . 33.4 Cg_exo -59.9 -47.05 16.73 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.86 2.373 . . . . 0.0 112.894 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.746 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 2.7 tm? -68.54 -34.42 75.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.504 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.68 -47.65 85.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.523 0.677 . . . . 0.0 110.542 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.679 ' HB3' HD21 ' A' ' 133' ' ' LEU . . . -72.45 -39.85 67.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.077 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.553 ' HB3' HD23 ' A' ' 30' ' ' LEU . . . -56.57 -39.77 74.04 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.214 0.531 . . . . 0.0 111.735 -177.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.91 ' HB3' HD22 ' A' ' 111' ' ' ASN . 1.3 mt -72.58 -22.01 61.05 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.039 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.592 ' SG ' HD13 ' A' ' 140' ' ' ILE . 84.9 m -61.92 -8.55 5.22 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.344 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.715 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 11.2 mt -85.6 165.05 17.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.04 -113.58 5.23 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.33 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.42 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 1.4 p -168.66 95.33 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.886 0.374 . . . . 0.0 111.242 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.91 HD22 ' HB3' ' A' ' 106' ' ' LEU . 51.1 p-10 -138.99 143.25 38.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.039 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.52 ' C ' HD12 ' A' ' 113' ' ' ILE . 1.5 m-20 -101.08 111.55 23.78 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.18 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.687 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 5.0 mp -141.49 142.4 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.023 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.795 HG11 ' HG ' ' A' ' 143' ' ' LEU . 22.5 t -116.09 112.06 38.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.744 0.307 . . . . 0.0 110.377 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.8 mt -79.08 157.14 28.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.415 0.626 . . . . 0.0 111.787 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 35.2 m -161.99 154.74 20.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.758 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.441 ' N ' HG23 ' A' ' 116' ' ' THR . . . -140.69 -167.1 10.94 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 119.897 -1.144 . . . . 0.0 113.425 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.627 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 2.3 mt-10 -70.65 173.03 5.12 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.387 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 20.2 Cg_endo -61.19 -24.39 78.98 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.598 1.532 . . . . 0.0 111.972 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.493 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 2.3 tpp180 -90.23 -33.14 16.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.261 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.606 ' HE3' ' HB2' ' A' ' 124' ' ' ARG . 6.0 tpt -60.12 -19.55 54.0 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.657 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 7.6 mttm -68.33 -4.92 16.09 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.122 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.614 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -121.29 30.48 6.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.886 0.374 . . . . 0.0 110.986 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.606 ' HB2' ' HE3' ' A' ' 121' ' ' MET . 4.0 mmp_? -108.96 93.75 13.26 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.758 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 8.2 Cg_endo -50.1 128.62 22.83 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.559 2.173 . . . . 0.0 112.466 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.492 ' CD1' HD22 ' A' ' 129' ' ' LEU . 17.3 tt -133.83 31.12 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.766 0.793 . . . . 0.0 110.215 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.498 ' HA3' ' OD1' ' A' ' 147' ' ' ASN . . . -71.8 -51.57 14.88 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.202 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.778 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.2 OUTLIER -53.14 -26.9 18.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.962 0.41 . . . . 0.0 110.727 -179.299 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.767 HD12 ' CD2' ' A' ' 133' ' ' LEU . 35.4 tp -82.63 -66.5 0.88 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.749 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.559 ' HA ' HD13 ' A' ' 133' ' ' LEU . 61.1 t -52.13 -25.44 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.312 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 30.9 t0 -72.16 -45.31 60.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.585 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.851 ' HA ' HD13 ' A' ' 135' ' ' LEU . . . -64.89 -51.83 59.8 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.834 0.35 . . . . 0.0 111.513 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.767 ' CD2' HD12 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -56.62 -43.01 79.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.221 0.534 . . . . 0.0 109.874 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -60.06 -32.67 71.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.048 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.851 HD13 ' HA ' ' A' ' 132' ' ' ALA . 2.2 mt -72.09 -26.75 62.27 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.462 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.523 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -80.82 -13.55 81.16 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.659 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.82 4.04 6.24 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.302 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.88 145.71 48.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.923 0.392 . . . . 0.0 111.53 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 0.2 OUTLIER -114.29 90.83 3.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.54 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.662 HD12 HD13 ' A' ' 133' ' ' LEU . 7.0 mt -117.48 174.54 3.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.957 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.632 ' O ' HD21 ' A' ' 151' ' ' LEU . 0.8 OUTLIER -152.43 -168.08 2.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 111.39 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.556 ' N ' HG21 ' A' ' 141' ' ' THR . 25.7 m-85 -131.77 105.65 7.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.097 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.795 ' HG ' HG11 ' A' ' 114' ' ' VAL . 2.1 mm? -79.69 -8.88 59.5 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.798 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 27.5 mt-10 -141.33 -73.68 0.33 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.349 . . . . 0.0 110.379 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.619 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.1 OUTLIER -123.87 148.63 46.63 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.252 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.443 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 4.3 mt-10 -70.24 135.64 49.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.12 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.611 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 1.3 m-80 64.59 49.59 2.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.319 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.84 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.8 m-85 -148.29 179.6 1.15 Allowed Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.734 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.84 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 8.0 Cg_endo -50.22 -40.36 51.77 Favored 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 123.331 2.687 . . . . 0.0 115.037 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.798 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 36.7 Cg_endo -62.05 100.94 0.22 Allowed 'Trans proline' 0 CA--C 1.516 -0.375 0 C-N-CA 121.513 1.475 . . . . 0.0 111.586 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.632 HD21 ' O ' ' A' ' 141' ' ' THR . 91.5 mt -139.56 122.95 17.14 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.802 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.605 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.9 OUTLIER -104.49 112.55 25.65 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.727 ' CD1' HD12 ' A' ' 106' ' ' LEU . 1.2 mt -96.07 155.39 16.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.254 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.598 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 18.8 mt-30 -142.55 24.34 1.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.615 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.44 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 56.49 -165.91 4.66 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.433 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.97 -4.98 34.1 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.13 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.645 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 3.5 t80 -60.8 107.34 0.69 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.863 0.332 . . . . 0.0 110.494 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 185' ' ' GLU . 76.4 p -105.61 -46.39 4.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.889 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.649 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 141.73 -162.3 27.02 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.136 -1.03 . . . . 0.0 113.981 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.531 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 115.71 172.67 17.04 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -65.16 126.76 29.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.583 HG12 HD13 ' A' ' 135' ' ' LEU . 58.0 t -135.5 157.54 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-O 121.132 0.491 . . . . 0.0 111.47 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.512 ' O ' ' HE2' ' A' ' 192' ' ' LYS . 3.2 m-20 -123.65 119.66 30.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.384 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.517 ' C ' ' HE3' ' A' ' 192' ' ' LYS . 0.4 OUTLIER -121.74 139.13 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.548 -0.461 . . . . 0.0 112.101 -178.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.778 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.3 OUTLIER -78.93 133.5 36.91 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.267 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.685 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -75.43 -44.64 21.1 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.105 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.478 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 54.4 p -52.91 165.44 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.922 0.391 . . . . 0.0 111.359 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.6 t 72.61 50.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.01 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.474 ' HA ' HG13 ' A' ' 196' ' ' VAL . 1.4 m 63.62 150.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.424 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.523 ' OG ' HD12 ' A' ' 201' ' ' ILE . 12.2 t -77.68 3.65 13.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.711 0.291 . . . . 0.0 111.412 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.593 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 18.9 mm100 -54.49 -20.68 8.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.983 0.42 . . . . 0.0 111.42 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.624 ' CD2' ' HB2' ' A' ' 128' ' ' HIS . 1.6 m-85 -76.09 -54.29 7.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.619 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.485 ' CD2' HG12 ' A' ' 201' ' ' ILE . 21.0 tp -77.33 -35.03 55.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.593 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.449 ' O ' ' HG2' ' A' ' 178' ' ' MET . 79.8 m -58.99 -33.46 70.71 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.026 0.441 . . . . 0.0 110.029 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.625 ' CB ' ' HA ' ' A' ' 101' ' ' PRO . . . -76.33 -51.96 10.9 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.966 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.747 ' HB3' HD12 ' A' ' 189' ' ' ILE . 3.2 mt -61.99 -43.08 99.6 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.507 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.564 HD21 ' HB3' ' A' ' 223' ' ' PHE . 12.6 mt -60.75 -28.07 68.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.867 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.718 ' HE1' ' HB3' ' A' ' 101' ' ' PRO . 4.9 ptp -96.39 -26.24 15.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.325 0.583 . . . . 0.0 110.492 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.676 ' O ' HD13 ' A' ' 108' ' ' LEU . 74.1 m -85.17 -47.55 10.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.157 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 1.031 ' HB1' HG22 ' A' ' 225' ' ' VAL . . . -63.74 -35.84 18.44 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 9.7 Cg_endo -53.17 -37.77 80.35 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 121.129 1.219 . . . . 0.0 111.376 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.78 -8.06 58.96 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -67.43 115.8 30.4 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.057 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -33.58 -34.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.69 2.927 . . . . 0.0 114.33 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 158' ' ' THR . 3.1 mt-10 -103.65 152.92 21.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.005 0.431 . . . . 0.0 111.77 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.573 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 40.9 t0 -67.29 114.68 6.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.708 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.759 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 29.2 m -99.7 135.23 41.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.098 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.438 HG11 HG22 ' A' ' 224' ' ' VAL . 25.4 t -125.8 99.22 5.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.881 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.747 HD12 ' HB3' ' A' ' 176' ' ' LEU . 3.5 mt -91.11 144.49 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.267 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.809 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -114.93 170.98 7.93 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.589 HG23 ' CD1' ' A' ' 195' ' ' LEU . 1.4 mm -111.54 97.15 5.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.269 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.587 ' HE3' ' N ' ' A' ' 165' ' ' ASP . 9.3 mtmt -57.0 -81.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.681 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -83.21 168.0 46.06 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.361 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -59.61 122.64 14.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.568 0.223 . . . . 0.0 110.84 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.4 OUTLIER -55.65 147.6 17.97 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.22 0.533 . . . . 0.0 110.841 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.478 ' HB ' ' HA ' ' A' ' 167' ' ' SER . 11.8 p -103.81 -21.06 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.134 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.3 OUTLIER -128.11 46.15 2.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.125 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.751 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . 0.6 OUTLIER -43.62 -61.64 1.81 Allowed Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 114.854 -1.066 . . . . 0.0 113.11 -178.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.751 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 15.0 Cg_exo -69.37 -17.28 39.44 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 121.476 1.451 . . . . 0.0 111.55 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.549 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 26.9 m-85 -75.08 -30.69 61.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.113 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.523 HD12 ' OG ' ' A' ' 170' ' ' SER . 8.0 tp -67.95 -33.6 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.229 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.548 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 9.9 t70 -59.79 -33.71 72.07 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.547 ' O ' ' HB2' ' A' ' 207' ' ' LEU . 13.1 mt -68.32 -29.86 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.622 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.461 ' O ' ' HG3' ' A' ' 208' ' ' MET . 71.7 m -61.0 -54.71 41.6 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.124 0.488 . . . . 0.0 109.716 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.591 HD11 ' CD1' ' A' ' 215' ' ' ILE . 28.7 mt -70.4 -34.64 72.77 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.231 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.732 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 0.9 OUTLIER -63.6 -29.93 71.11 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.299 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.685 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -77.73 -40.82 39.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.613 178.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.464 ' HG2' ' HH ' ' A' ' 231' ' ' TYR . 10.4 mtp -68.76 -38.56 80.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.966 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.732 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -66.7 -45.26 79.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.384 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.657 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 2.0 t -58.71 -26.08 63.53 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.317 0.58 . . . . 0.0 109.529 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.899 ' HA ' ' HG3' ' A' ' 234' ' ' PRO . 2.1 m-85 -74.92 -54.56 7.02 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.602 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 156.67 -1.56 0.13 Allowed Glycine 0 CA--C 1.52 0.351 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.883 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.619 ' HB ' ' CD1' ' A' ' 231' ' ' TYR . 53.0 t -117.75 138.22 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.046 0.451 . . . . 0.0 111.767 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -135.49 155.12 51.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.535 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.591 ' CD1' HD11 ' A' ' 205' ' ' LEU . 2.4 pp -129.31 175.5 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.956 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.317 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 1.016 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 18.7 tt0 -89.91 125.52 35.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.874 0.368 . . . . 0.0 110.37 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -101.14 100.95 11.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.248 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.698 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 2.1 mm-40 -66.74 -167.08 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.75 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.46 48.26 0.34 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.901 0.381 . . . . 0.0 110.341 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.555 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 57.88 19.65 5.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.254 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 191' ' ' ILE . 3.1 pt20 -112.94 -19.72 11.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.83 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.809 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 32.5 mt-30 -150.34 141.67 23.27 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.701 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.585 ' N ' ' O ' ' A' ' 189' ' ' ILE . 19.4 m-85 -114.14 96.76 5.97 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 1.016 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 31.1 t -82.8 110.97 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 121.167 0.508 . . . . 0.0 111.235 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 1.031 HG22 ' HB1' ' A' ' 180' ' ' ALA . 3.0 m -99.87 113.15 34.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.964 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.627 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 1.3 mptm? -62.74 103.82 0.47 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.998 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.573 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.25 155.86 16.36 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.947 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.97 8.77 75.23 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.445 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 69.8 mm-40 -73.16 178.54 4.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.473 0.654 . . . . 0.0 111.546 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.572 ' HA ' HD21 ' A' ' 182' ' ' LEU . 4.9 m -167.68 105.55 0.52 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.863 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 22.7 m-85 -55.15 142.53 30.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.108 0.48 . . . . 0.0 111.368 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.583 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 78.9 mt-30 -108.21 148.58 29.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.673 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 56.6 p -64.13 103.05 0.37 Allowed Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.155 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.899 ' HG3' ' HA ' ' A' ' 211' ' ' PHE . 7.7 Cg_exo -71.36 -31.39 14.17 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.705 2.27 . . . . 0.0 111.966 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.01 -120.79 5.22 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.647 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -92.9 116.8 29.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.615 ' CE2' HD21 ' A' ' 207' ' ' LEU . 88.1 t80 -123.78 136.8 54.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.519 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.98 ' HA ' HG22 ' A' ' 42' ' ' THR . 4.0 tp . . . . . 0 CA--C 1.514 -0.408 0 CA-C-O 121.261 0.553 . . . . 0.0 111.707 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.715 ' OD1' ' HA ' ' A' ' 50' ' ' VAL . 64.3 m-20 . . . . . 0 CA--C 1.519 -0.229 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.421 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 35.0 mtt85 -62.19 -40.41 95.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.053 0.454 . . . . 0.0 110.293 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -74.32 -37.63 63.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.908 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.635 ' CD1' ' HG ' ' A' ' 54' ' ' LEU . 55.1 mt -58.36 -47.19 84.61 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.862 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.612 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 14.9 tp -77.82 -48.84 15.55 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.651 HD21 ' HG2' ' A' ' 178' ' ' MET . 27.7 mt -55.05 -35.19 64.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.467 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.68 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -78.17 -29.7 48.74 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.675 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.583 ' HB3' HD23 ' A' ' 82' ' ' LEU . . . -70.26 -30.58 67.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.939 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.853 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.35 -12.54 40.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.996 0.427 . . . . 0.0 111.065 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.679 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -80.42 168.68 18.68 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.239 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.59 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 76.9 m80 -103.19 98.42 8.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.217 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.71 141.06 6.95 Favored Glycine 0 C--N 1.314 -0.657 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.627 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.712 ' HB2' HG13 ' A' ' 76' ' ' ILE . 1.6 ttpm? -64.84 138.53 58.43 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.37 157.74 44.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.374 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.57 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 94.1 t -104.83 141.46 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.372 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -127.93 111.62 13.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.888 178.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.843 HG21 ' HA ' ' A' ' 238' ' ' LEU . 0.1 OUTLIER -98.31 171.03 8.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 111.783 -179.743 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.548 ' HB2' ' CD1' ' A' ' 238' ' ' LEU . 1.8 t30 66.03 18.17 10.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.233 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.604 HD23 HG12 ' A' ' 50' ' ' VAL . 1.2 tp -58.61 163.64 3.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.482 ' O ' HG22 ' A' ' 50' ' ' VAL . 38.5 tp -97.64 116.63 30.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.009 0.433 . . . . 0.0 111.425 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -75.64 71.85 2.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.749 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.523 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 63.1 m -134.85 -162.98 1.31 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.899 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.609 ' HA ' ' CG ' ' A' ' 51' ' ' ARG . 1.5 t70 -98.19 -22.11 16.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.896 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.457 ' CG ' ' HA ' ' A' ' 95' ' ' ALA . 8.2 m-20 -66.61 -30.4 70.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.78 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.715 ' HA ' ' OD1' ' A' ' 26' ' ' ASN . 21.3 t -84.48 -56.02 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.058 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.609 ' CG ' ' HA ' ' A' ' 48' ' ' ASP . 1.1 ptm180 -49.99 -26.97 4.77 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -71.41 -40.77 70.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.296 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.459 ' SD ' ' HB3' ' A' ' 26' ' ' ASN . 7.1 tpt -64.87 -47.43 77.91 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.635 ' HG ' ' CD1' ' A' ' 29' ' ' LEU . 1.3 mp -65.33 -47.21 77.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 8.4 t-20 -57.39 -23.01 46.64 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.0 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 53' ' ' MET . . . -74.76 -48.1 27.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.056 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.609 HD11 ' HB3' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -68.18 -49.44 60.87 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.771 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.515 HG21 ' HA ' ' A' ' 55' ' ' ASN . 6.0 t -51.65 -30.23 20.86 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.281 0.562 . . . . 0.0 110.201 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.507 ' CB ' HD22 ' A' ' 90' ' ' LEU . . . -59.31 -52.49 65.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.962 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.763 HD22 HD21 ' A' ' 106' ' ' LEU . 3.8 mp -65.14 -28.38 69.38 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.83 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.76 0.61 5.23 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 114.834 -1.075 . . . . 0.0 113.494 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.671 HG13 ' N ' ' A' ' 63' ' ' SER . 22.9 t -56.55 154.2 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 117.609 0.705 . . . . 0.0 110.391 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.709 ' O ' HD12 ' A' ' 76' ' ' ILE . 11.9 m -115.16 112.27 22.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.379 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 7.5 p90 -129.71 156.95 43.45 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.875 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -149.25 116.05 5.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.823 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.616 HD12 ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -90.32 175.55 7.07 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.232 0.539 . . . . 0.0 111.645 -179.424 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.809 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 1.3 t -87.85 179.42 6.47 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.709 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.33 -14.36 49.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.33 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.98 2.39 11.5 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.866 0.365 . . . . 0.0 110.705 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.476 ' O ' HD21 ' A' ' 44' ' ' LEU . 0.3 OUTLIER 61.33 45.29 8.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.428 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.481 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -124.03 -2.72 8.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.974 179.021 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.809 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -142.54 110.62 5.97 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.429 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.68 ' HA ' ' O ' ' A' ' 65' ' ' THR . 0.6 OUTLIER -114.93 152.62 32.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.256 0.55 . . . . 0.0 112.064 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 1.1 mt-10 -118.11 102.85 9.34 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.689 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.692 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -99.44 126.44 52.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.712 HG13 ' HB2' ' A' ' 38' ' ' LYS . 3.1 mp -80.94 103.81 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.425 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.68 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -48.08 118.79 4.76 Favored Glycine 0 N--CA 1.453 -0.186 0 CA-C-N 116.017 -0.538 . . . . 0.0 114.136 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.572 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -63.77 -15.38 58.5 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.987 0.423 . . . . 0.0 110.357 178.552 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.59 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.02 -19.71 20.17 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.827 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.853 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -139.73 -150.22 5.47 Favored Glycine 0 C--O 1.224 -0.519 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.787 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 4.3 Cg_exo -77.57 170.08 19.85 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 CA-C-N 119.711 1.755 . . . . 0.0 108.828 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.756 ' HB3' HD21 ' A' ' 60' ' ' LEU . 4.3 mm? -68.43 89.59 0.35 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.787 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 34.1 m170 -83.44 118.34 23.68 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.012 -1.904 . . . . 0.0 112.333 -176.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.527 ' H ' ' HB3' ' A' ' 111' ' ' ASN . . . -143.27 107.65 4.79 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.773 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -106.88 89.33 2.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.733 0.302 . . . . 0.0 110.947 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.63 20.45 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.74 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.32 48.11 19.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.394 0.616 . . . . 0.0 110.263 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 3.9 tp -76.57 131.6 39.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.261 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.585 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 6.9 tt0 -110.64 128.26 55.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.261 0.553 . . . . 0.0 110.096 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.507 HD22 ' CB ' ' A' ' 59' ' ' ALA . 48.6 mt -110.69 156.99 20.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.118 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' A' ' 116' ' ' THR . 45.4 t80 -119.57 105.15 10.93 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.628 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.723 ' HG ' ' HA ' ' A' ' 99' ' ' MET . 2.8 mm? -91.47 8.17 37.68 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.798 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 121' ' ' MET . . . 39.72 -139.82 0.93 Allowed Glycine 0 CA--C 1.523 0.556 0 C-N-CA 121.327 -0.463 . . . . 0.0 113.781 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.655 ' OD1' ' HB3' ' A' ' 120' ' ' ARG . 0.7 OUTLIER -91.32 46.57 1.31 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.023 0.44 . . . . 0.0 111.084 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 92' ' ' LEU . . . -90.52 -77.44 0.41 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.47 ' O ' ' HG2' ' A' ' 171' ' ' GLN . . . 78.65 -14.36 13.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.99 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.56 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -96.29 -11.47 25.88 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 120.81 0.338 . . . . 0.0 110.429 178.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.467 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -125.05 -21.27 4.7 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.49 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.723 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 10.4 ttm -66.8 -52.02 48.86 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.263 0.554 . . . . 0.0 110.47 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.881 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -57.77 -55.39 45.4 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.156 -179.522 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.627 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 24.1 Cg_exo -63.45 -46.8 8.75 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.53 2.153 . . . . 0.0 112.886 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.625 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 2.9 tm? -61.3 -40.81 95.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.78 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.441 ' HB3' ' CD1' ' A' ' 115' ' ' LEU . . . -58.94 -48.48 81.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.65 0.738 . . . . 0.0 109.736 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.738 ' HB3' HD21 ' A' ' 133' ' ' LEU . . . -68.01 -40.11 83.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.779 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.435 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -56.16 -42.49 77.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.042 0.449 . . . . 0.0 111.315 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.763 HD21 HD22 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -71.74 -21.32 61.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.399 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 104' ' ' ALA . 82.6 m -58.36 -11.76 3.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.669 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.688 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 12.3 mt -84.43 167.68 16.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.716 0.293 . . . . 0.0 110.244 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 55.04 -110.75 1.86 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.076 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.474 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.9 OUTLIER -171.3 96.25 0.19 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.954 0.407 . . . . 0.0 111.207 179.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.579 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 0.5 OUTLIER -137.28 139.61 41.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.974 -179.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.0 OUTLIER -99.77 111.3 23.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.752 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.682 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 4.3 mp -141.02 139.85 33.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.224 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.723 HG11 ' HG ' ' A' ' 143' ' ' LEU . 21.3 t -112.2 113.41 44.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.541 HD23 HD22 ' A' ' 92' ' ' LEU . 18.1 mt -80.44 155.46 27.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.467 0.651 . . . . 0.0 112.215 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 11.2 m -162.72 156.88 20.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.294 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -147.58 -165.34 11.81 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 119.972 -1.109 . . . . 0.0 113.662 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.562 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 1.7 mt-10 -71.38 177.86 1.44 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.312 -0.444 . . . . 0.0 110.507 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.562 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 38.7 Cg_exo -61.74 -26.43 79.77 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.177 1.918 . . . . 0.0 112.52 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.655 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 11.7 tpt180 -87.25 -38.56 16.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.714 0.292 . . . . 0.0 110.483 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.705 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 8.7 tpt -59.6 -19.21 47.32 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 11.8 mttp -72.32 -4.5 30.19 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.82 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.673 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 5.4 pt-20 -126.62 25.06 6.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.981 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.419 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 33.2 mmt180 -100.15 87.23 0.71 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.271 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.616 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 1.3 Cg_endo -42.32 126.82 3.99 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.958 2.439 . . . . 0.0 112.449 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.566 ' O ' HG12 ' A' ' 126' ' ' ILE . 16.5 tt -131.6 31.71 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.818 0.818 . . . . 0.0 110.103 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -70.7 -52.64 14.63 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.517 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.527 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -54.3 -25.45 23.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.737 0.303 . . . . 0.0 110.686 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.693 HD13 HD21 ' A' ' 133' ' ' LEU . 26.5 tp -84.39 -66.21 0.92 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.885 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.571 ' HA ' ' CD1' ' A' ' 133' ' ' LEU . 48.0 t -52.82 -25.2 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.189 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.566 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 10.8 t0 -72.55 -46.58 53.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.388 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.903 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -65.07 -46.76 79.83 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.661 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.738 HD21 ' HB3' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -60.77 -42.27 97.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.362 0.601 . . . . 0.0 109.777 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.48 -34.8 74.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.056 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.903 HD12 ' HA ' ' A' ' 132' ' ' ALA . 3.4 mt -68.51 -30.58 69.43 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.253 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.21 -18.49 80.04 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.541 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.3 4.58 5.38 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.231 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.99 148.35 49.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.85 0.357 . . . . 0.0 111.406 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.57 87.47 2.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.402 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.661 HD13 HD11 ' A' ' 133' ' ' LEU . 6.8 mt -114.56 175.34 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.47 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.54 ' O ' HD23 ' A' ' 151' ' ' LEU . 1.0 OUTLIER -152.32 -167.22 2.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.232 0.539 . . . . 0.0 111.152 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.444 ' CD2' ' HA ' ' A' ' 146' ' ' GLU . 23.5 m-85 -133.64 105.98 7.14 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.723 ' HG ' HG11 ' A' ' 114' ' ' VAL . 2.0 mm? -81.04 -14.75 57.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.738 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.655 ' HB3' ' HG3' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -134.67 -68.31 0.54 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.996 0.427 . . . . 0.0 109.92 179.439 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.645 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -132.38 150.89 52.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.229 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.444 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 66.3 mt-10 -69.0 131.87 45.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.235 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 13.4 m-20 65.55 50.39 1.66 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.081 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.855 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.3 m-30 -143.03 -178.95 0.86 Allowed Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.855 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 11.9 Cg_endo -59.0 -36.59 96.52 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.599 2.199 . . . . 0.0 114.548 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 149' ' ' PRO . 39.0 Cg_endo -62.94 93.77 0.15 Allowed 'Trans proline' 0 CA--C 1.515 -0.465 0 C-N-CA 121.465 1.443 . . . . 0.0 111.221 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.54 HD23 ' O ' ' A' ' 141' ' ' THR . 72.0 mt -132.54 123.49 26.63 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.513 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -103.11 111.54 23.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 1.1 mt -94.07 159.35 15.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.458 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.579 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -147.2 23.62 1.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.662 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.498 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 55.84 -165.5 4.11 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.318 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.96 -2.38 35.59 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.64 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.688 ' HE1' ' HA ' ' A' ' 133' ' ' LEU . 40.9 t80 -63.44 111.92 2.53 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.029 0.442 . . . . 0.0 110.752 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 78.1 p -106.99 -47.64 3.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.462 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.597 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 140.09 -161.66 26.38 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.913 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.558 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 115.96 170.44 15.9 Favored Glycine 0 CA--C 1.519 0.289 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -66.51 123.26 19.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.056 0.428 . . . . 0.0 110.191 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.462 HG11 HD12 ' A' ' 135' ' ' LEU . 38.8 t -131.6 157.05 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 111.512 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.444 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 2.5 m-20 -120.97 115.24 22.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.606 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.516 HG22 ' HB2' ' A' ' 132' ' ' ALA . 0.5 OUTLIER -116.49 145.62 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 120.176 -0.609 . . . . 0.0 112.201 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.9 OUTLIER -82.9 132.86 35.14 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.925 179.3 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.661 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -74.61 -44.73 25.36 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.369 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.421 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 0.6 OUTLIER -52.02 165.71 0.19 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.879 0.371 . . . . 0.0 111.28 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 4.1 t 71.8 54.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.979 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.509 ' HA ' HG13 ' A' ' 196' ' ' VAL . 69.6 m 59.26 160.02 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.266 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.71 ' HB2' ' HB2' ' A' ' 197' ' ' SER . 34.8 t -80.55 -1.63 42.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.881 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 2.2 mp0 -51.34 -22.16 2.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.671 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.502 ' CD2' ' HB2' ' A' ' 128' ' ' HIS . 2.7 m-85 -78.5 -54.94 5.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.942 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.488 ' CD2' HG12 ' A' ' 201' ' ' ILE . 32.1 tp -73.18 -41.04 64.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.399 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.512 ' CG2' ' HA ' ' A' ' 171' ' ' GLN . 14.7 t -58.64 -32.71 69.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.433 0.635 . . . . 0.0 109.499 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.648 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -64.88 -52.27 57.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.021 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.58 ' CD2' ' HB1' ' A' ' 132' ' ' ALA . 1.9 mt -71.28 -36.09 71.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.187 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.63 HD13 ' CD2' ' A' ' 223' ' ' PHE . 9.8 mt -66.2 -29.83 70.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.123 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.651 ' HG2' HD21 ' A' ' 31' ' ' LEU . 23.6 mtp -93.98 -27.54 16.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.259 0.552 . . . . 0.0 110.64 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.624 ' O ' HD21 ' A' ' 108' ' ' LEU . 87.6 m -88.12 -46.83 8.96 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.141 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.648 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -62.28 -36.71 30.4 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.648 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.4 Cg_endo -54.46 -37.72 89.7 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 CA-C-N 120.297 1.142 . . . . 0.0 111.506 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -83.79 -5.74 59.27 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.229 -179.55 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.1 124.66 90.16 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.1 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -43.74 -29.88 2.61 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.95 2.433 . . . . 0.0 113.535 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -107.75 151.53 25.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.067 0.46 . . . . 0.0 111.652 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.561 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 20.6 t0 -64.55 118.03 8.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.655 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.743 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 41.1 m -102.26 133.85 46.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.817 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.43 HG23 ' CG1' ' A' ' 224' ' ' VAL . 33.3 t -126.0 99.16 5.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.273 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.58 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.2 mt -91.71 145.94 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.116 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.838 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.1 OUTLIER -118.19 171.04 8.39 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.594 ' N ' ' O ' ' A' ' 221' ' ' GLN . 1.6 mm -111.69 98.17 6.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-O 121.096 0.474 . . . . 0.0 111.467 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -60.14 -81.01 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.381 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -81.09 166.75 48.74 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.422 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -57.61 126.32 26.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.65 0.262 . . . . 0.0 111.168 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.853 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.4 OUTLIER -62.48 147.21 49.48 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.013 0.435 . . . . 0.0 110.711 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 169' ' ' SER . 11.6 p -104.21 -20.55 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.797 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.71 ' HB2' ' HB2' ' A' ' 170' ' ' SER . 0.4 OUTLIER -128.28 45.32 2.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.378 0.608 . . . . 0.0 109.589 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.853 ' HA ' HD23 ' A' ' 195' ' ' LEU . 0.0 OUTLIER -41.72 -63.9 0.76 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.541 -179.081 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 49.0 Cg_endo -68.42 -17.33 44.03 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 121.707 1.605 . . . . 0.0 111.479 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.615 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 17.2 m-85 -76.88 -26.74 54.55 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.264 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.56 HD11 HD12 ' A' ' 177' ' ' LEU . 6.3 tp -73.08 -33.61 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.847 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.1 OUTLIER -61.89 -35.0 77.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.226 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.519 ' O ' ' HB2' ' A' ' 207' ' ' LEU . 10.1 mt -66.7 -28.67 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.175 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.53 ' O ' ' HG3' ' A' ' 208' ' ' MET . 53.9 m -61.45 -55.16 34.29 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.639 HD22 HG12 ' A' ' 215' ' ' ILE . 41.3 mt -70.05 -34.28 73.02 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.549 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.59 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 8.8 t30 -64.84 -25.51 67.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.193 0.521 . . . . 0.0 109.839 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.571 HD22 ' CE1' ' A' ' 237' ' ' TYR . 0.2 OUTLIER -83.9 -40.32 18.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.308 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.566 ' HB3' ' CE1' ' A' ' 231' ' ' TYR . 11.2 mtp -69.24 -39.41 78.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.018 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.59 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.1 OUTLIER -65.91 -44.45 85.16 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.53 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 207' ' ' LEU . 1.3 t -59.02 -28.98 66.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.426 0.632 . . . . 0.0 109.39 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.666 ' CE2' ' HA ' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -71.33 -51.41 24.42 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.926 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 157.39 -5.85 0.18 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.531 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.669 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 54.9 t -118.84 137.33 53.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.972 0.415 . . . . 0.0 111.857 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.421 ' C ' HG21 ' A' ' 215' ' ' ILE . 5.8 mt-10 -135.05 156.13 49.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.629 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.639 HG12 HD22 ' A' ' 205' ' ' LEU . 2.0 pp -132.44 175.99 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.932 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.846 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 4.5 tt0 -88.02 122.94 32.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.161 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.61 100.88 10.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.274 0.559 . . . . 0.0 109.778 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.717 ' HB2' ' HG2' ' A' ' 222' ' ' GLN . 1.5 tm0? -72.92 -161.87 0.1 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.044 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -74.32 46.28 0.25 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.499 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.691 ' CE2' ' HD3' ' A' ' 198' ' ' LYS . 0.3 OUTLIER 58.45 22.37 9.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.143 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 191' ' ' ILE . 23.3 mt-30 -109.0 -37.39 5.84 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.021 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.838 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 5.0 pt20 -136.12 139.19 42.75 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.278 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.63 ' CD2' HD13 ' A' ' 177' ' ' LEU . 28.2 m-85 -108.93 95.57 5.73 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.846 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 81.3 t -86.11 112.94 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.265 -177.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.743 ' CG2' ' HB ' ' A' ' 187' ' ' THR . 6.3 m -101.1 115.78 43.43 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.555 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.568 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -64.41 101.47 0.44 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.956 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.561 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -53.51 156.43 5.74 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.256 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.26 10.85 67.86 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.236 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 60.3 mm-40 -75.84 -179.63 4.93 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.53 0.681 . . . . 0.0 111.657 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.487 ' HA ' HD23 ' A' ' 182' ' ' LEU . 3.9 m -170.68 105.9 0.27 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.863 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.679 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 21.9 m-85 -53.64 149.13 8.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.933 0.397 . . . . 0.0 111.079 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.608 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 60.8 mt-30 -115.15 163.49 15.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.024 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 15.2 t -82.61 98.88 0.53 Allowed Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.987 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 50.4 Cg_endo -66.52 -31.32 41.97 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.587 2.191 . . . . 0.0 112.384 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.86 -121.52 5.18 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.57 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -94.19 115.85 28.17 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.571 ' CE1' HD22 ' A' ' 207' ' ' LEU . 0.0 OUTLIER -130.12 146.87 51.8 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.508 -178.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.843 ' HA ' HG21 ' A' ' 42' ' ' THR . 6.7 tp . . . . . 0 CA--C 1.514 -0.419 0 CA-C-O 121.043 0.449 . . . . 0.0 110.716 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.568 ' OD1' ' HA ' ' A' ' 50' ' ' VAL . 59.1 m-20 . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.675 0.274 . . . . 0.0 111.735 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 -65.59 -46.68 78.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.835 0.35 . . . . 0.0 110.767 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.419 ' CB ' ' HB3' ' A' ' 41' ' ' LEU . . . -69.39 -35.84 76.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.401 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.817 HD23 HD21 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -59.96 -53.96 51.76 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.237 0.542 . . . . 0.0 110.705 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.643 ' HB2' ' HE3' ' A' ' 53' ' ' MET . 11.8 tp -63.54 -54.35 37.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.951 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.656 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 78.0 mt -52.73 -34.1 51.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.929 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.685 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -78.09 -29.28 49.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.658 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.612 ' O ' ' HB2' ' A' ' 78' ' ' ASN . . . -73.89 -31.66 63.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.422 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.853 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -88.98 -12.04 42.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.362 . . . . 0.0 110.955 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -80.4 169.46 17.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.735 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.554 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 75.4 m80 -102.64 97.35 7.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.171 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.53 141.77 6.55 Favored Glycine 0 C--N 1.317 -0.519 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.257 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.717 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 7.1 tttt -64.28 134.92 55.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.083 0.468 . . . . 0.0 111.745 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.619 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.8 OUTLIER -131.59 155.08 48.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.616 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.743 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 26.2 t -100.87 141.17 18.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.052 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -128.08 111.2 13.22 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.269 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.819 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.7 OUTLIER -103.79 164.73 11.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.323 0.582 . . . . 0.0 111.886 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.539 ' N ' ' O ' ' A' ' 71' ' ' THR . 27.9 t30 71.28 21.25 4.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.325 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.538 HD23 HG13 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -58.51 160.35 5.51 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.296 178.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.643 ' HB3' HG23 ' A' ' 50' ' ' VAL . 25.6 tp -92.86 114.2 26.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.008 0.432 . . . . 0.0 111.415 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -75.0 68.78 1.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.599 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 t -129.34 -163.4 1.29 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.052 0.454 . . . . 0.0 111.322 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.541 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 48.9 m-20 -98.27 -20.65 17.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.714 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.454 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 3.7 p-10 -72.43 -27.03 62.08 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.007 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.643 HG23 ' HB3' ' A' ' 45' ' ' LEU . 17.8 t -89.07 -51.7 11.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.708 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.541 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -51.25 -27.63 9.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.181 0.515 . . . . 0.0 110.015 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.442 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . 3.4 m-70 -73.35 -36.6 66.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.962 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.643 ' HE3' ' HB2' ' A' ' 30' ' ' LEU . 13.4 tpt -64.56 -50.62 66.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.817 HD21 HD23 ' A' ' 29' ' ' LEU . 1.4 mp -62.41 -48.93 77.53 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 17.7 t-20 -57.13 -22.35 39.28 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.99 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.604 ' HB3' HD12 ' A' ' 90' ' ' LEU . . . -75.08 -46.4 34.94 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.53 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.555 HD21 ' O ' ' A' ' 53' ' ' MET . 0.1 OUTLIER -69.28 -49.46 55.87 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.861 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.465 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 4.9 t -50.8 -30.41 14.15 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.273 0.559 . . . . 0.0 110.298 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.566 ' CB ' HD21 ' A' ' 90' ' ' LEU . . . -59.83 -51.13 71.04 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.077 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.831 HD22 ' HB3' ' A' ' 82' ' ' LEU . 3.8 mp -66.1 -27.92 68.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.878 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.16 -0.9 5.73 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 114.77 -1.105 . . . . 0.0 113.67 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.601 HG22 HD13 ' A' ' 82' ' ' LEU . 12.0 t -58.34 149.71 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 117.695 0.747 . . . . 0.0 110.359 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.581 ' N ' HG13 ' A' ' 62' ' ' VAL . 4.0 m -113.48 108.45 17.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.214 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.642 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 12.9 p90 -126.67 159.75 32.75 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.173 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.624 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 72.3 m -149.76 116.78 5.97 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.984 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.651 HD13 ' HB2' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -88.2 173.24 8.91 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.332 0.587 . . . . 0.0 112.142 -179.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.673 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -82.51 178.57 8.15 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.621 178.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.56 -12.59 46.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.705 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.14 1.38 11.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.239 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.507 ' O ' HD21 ' A' ' 44' ' ' LEU . 1.6 mmt180 63.54 44.51 5.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.59 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -123.08 -2.84 8.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.229 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.673 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.1 OUTLIER -141.65 112.32 7.16 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.651 ' HB2' HD13 ' A' ' 66' ' ' LEU . 2.3 t -116.38 147.25 41.81 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 1.6 mt-10 -112.51 103.07 11.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.717 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -96.8 126.68 49.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 8.5 mt -80.96 102.89 7.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.007 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.685 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -46.6 113.0 1.01 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.957 -0.565 . . . . 0.0 113.974 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.612 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -60.35 -16.81 38.59 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.969 0.414 . . . . 0.0 110.341 178.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.554 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.45 -20.64 16.79 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.348 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.853 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.46 -151.67 5.84 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.806 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 5.4 Cg_exo -75.88 170.73 19.55 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 CA-C-N 119.653 1.726 . . . . 0.0 109.167 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.831 ' HB3' HD22 ' A' ' 60' ' ' LEU . 4.3 mm? -67.84 89.68 0.28 Allowed 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.806 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 27.8 m170 -81.68 119.38 23.76 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.017 -1.901 . . . . 0.0 112.688 -176.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.475 ' HB2' ' CB ' ' A' ' 60' ' ' LEU . . . -145.9 111.2 5.37 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.952 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -112.46 88.79 2.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.511 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -176.18 20.16 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.701 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.45 49.99 15.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.412 0.625 . . . . 0.0 110.037 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.672 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 5.6 tp -79.01 133.14 36.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.09 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.677 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 1.4 tm-20 -112.11 128.66 56.28 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.636 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.604 HD12 ' HB3' ' A' ' 56' ' ' ALA . 39.0 mt -110.37 158.59 18.28 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.448 ' CE1' ' CA ' ' A' ' 93' ' ' GLY . 21.5 t80 -126.51 106.63 9.58 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.844 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.679 ' HB2' ' HE2' ' A' ' 99' ' ' MET . 2.1 mm? -95.82 8.28 43.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.184 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.448 ' CA ' ' CE1' ' A' ' 91' ' ' PHE . . . 46.95 -142.55 5.8 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.724 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.414 HD21 ' HB3' ' A' ' 120' ' ' ARG . 17.0 t-20 -93.15 49.61 1.43 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.892 0.377 . . . . 0.0 111.039 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 92' ' ' LEU . . . -86.77 -75.82 0.38 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.089 0.471 . . . . 0.0 111.156 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.34 -17.46 13.39 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.089 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.401 HG23 ' NE2' ' A' ' 171' ' ' GLN . 3.9 p -94.06 -9.73 35.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.862 0.363 . . . . 0.0 111.052 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.8 -22.45 4.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.524 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.679 ' HE2' ' HB2' ' A' ' 92' ' ' LEU . 5.5 tpp -66.11 -51.23 59.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.818 0.342 . . . . 0.0 110.75 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.75 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -61.48 -56.11 36.49 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.283 -179.319 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.672 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 38.5 Cg_exo -59.43 -46.01 23.45 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.308 2.005 . . . . 0.0 112.668 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.653 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 3.1 tm? -69.42 -35.28 75.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.481 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 99' ' ' MET . . . -61.92 -48.24 81.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.284 0.564 . . . . 0.0 110.79 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.523 ' CB ' HD21 ' A' ' 133' ' ' LEU . . . -72.17 -34.65 68.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.846 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.587 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -59.04 -44.12 91.72 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.95 0.405 . . . . 0.0 111.865 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 102' ' ' LEU . 0.6 OUTLIER -69.74 -22.44 63.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.373 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.582 ' SG ' HD12 ' A' ' 140' ' ' ILE . 23.1 m -60.26 -10.3 4.45 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.907 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.651 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 11.5 mt -82.86 169.68 15.82 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 51.87 -110.97 1.25 Allowed Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.406 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.438 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 62.7 m -162.73 99.42 1.0 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.753 0.311 . . . . 0.0 110.354 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 2.6 m-20 -138.18 135.33 35.54 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.554 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 2.8 m-20 -102.41 111.1 23.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.292 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 4.9 mp -144.39 142.74 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.202 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.721 HG12 ' HG ' ' A' ' 143' ' ' LEU . 21.7 t -113.87 112.51 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.844 0.354 . . . . 0.0 110.252 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 90' ' ' LEU . 28.7 mt -83.91 156.93 22.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.565 0.697 . . . . 0.0 112.14 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 m -160.55 174.89 13.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.813 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -160.65 -164.84 16.32 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.774 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.638 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 6.8 mt-10 -69.51 174.97 2.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.26 -0.47 . . . . 0.0 110.82 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.638 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 22.6 Cg_endo -61.81 -36.08 75.37 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.169 1.913 . . . . 0.0 112.077 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.535 ' O ' ' HG2' ' A' ' 123' ' ' GLU . 8.2 tpt180 -78.96 -31.08 44.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.815 0.341 . . . . 0.0 110.338 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.503 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 11.0 tpt -62.4 -16.12 52.94 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.261 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.634 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 10.3 mmtp -68.65 -8.98 47.16 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.645 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 0.3 OUTLIER -120.79 26.33 9.16 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.142 179.005 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.408 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 2.1 mmp_? -98.55 89.02 0.76 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.482 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.7 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.1 Cg_endo -47.85 135.72 22.82 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.582 2.188 . . . . 0.0 112.373 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.494 HD13 ' HG3' ' A' ' 100' ' ' ARG . 19.3 tt -142.21 32.42 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.735 0.779 . . . . 0.0 110.233 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.609 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -73.85 -51.13 9.54 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.889 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.687 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -52.15 -31.16 29.94 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.02 0.438 . . . . 0.0 110.653 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.74 HD11 HD21 ' A' ' 133' ' ' LEU . 22.8 tp -78.63 -62.93 1.53 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.455 HG11 ' CD1' ' A' ' 140' ' ' ILE . 67.2 t -52.33 -26.17 8.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.363 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.609 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -73.71 -43.81 58.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.675 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.886 ' HA ' HD13 ' A' ' 135' ' ' LEU . . . -65.87 -52.1 53.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.912 0.387 . . . . 0.0 111.322 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.74 HD21 HD11 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -56.3 -45.89 80.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.364 0.602 . . . . 0.0 109.641 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -58.91 -36.19 74.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.354 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.886 HD13 ' HA ' ' A' ' 132' ' ' ALA . 4.6 mt -65.76 -33.72 76.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.028 0.442 . . . . 0.0 110.077 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.483 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -74.6 -18.87 80.02 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.603 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 130.68 3.43 4.59 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.276 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.412 ' CB ' ' HB3' ' A' ' 107' ' ' CYS . . . -70.3 147.54 49.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.909 0.355 . . . . 0.0 111.225 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 9.2 mtmm -114.15 94.32 4.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.582 HD12 ' SG ' ' A' ' 107' ' ' CYS . 11.1 mt -118.18 175.35 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.966 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.528 ' H ' ' CG2' ' A' ' 140' ' ' ILE . 0.5 OUTLIER -150.31 -167.97 2.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.037 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.48 ' N ' ' CG2' ' A' ' 141' ' ' THR . 24.6 m-85 -136.16 100.85 4.52 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.721 ' HG ' HG12 ' A' ' 114' ' ' VAL . 2.2 mm? -71.67 -12.97 61.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.846 -177.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.787 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 2.5 mt-10 -140.19 -71.57 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.92 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.506 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -124.15 150.28 45.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.025 0.441 . . . . 0.0 111.426 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.451 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 61.3 mt-10 -69.38 130.4 42.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.809 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.7 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 6.6 m-20 67.49 50.04 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.418 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.69 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 2.8 m-30 -145.53 174.53 3.37 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.096 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.69 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 4.8 Cg_endo -45.7 -40.53 19.0 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.487 2.791 . . . . 0.0 114.904 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.787 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 36.9 Cg_endo -62.47 101.38 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.386 1.39 . . . . 0.0 111.26 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 141' ' ' THR . 79.1 mt -139.23 123.61 18.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.734 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -106.17 112.27 25.23 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 4.8 mt -94.18 158.92 15.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.33 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.57 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.6 mt-30 -146.12 24.67 1.29 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.508 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 58.26 -161.65 11.1 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.362 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.18 -3.94 55.17 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.742 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.678 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 3.4 t80 -61.39 107.48 0.78 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.984 0.421 . . . . 0.0 110.714 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 71.3 p -105.16 -50.83 3.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.173 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.551 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.08 -162.33 27.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.0 -1.095 . . . . 0.0 114.326 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.481 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 116.26 169.43 15.41 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.92 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -61.97 126.67 28.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.934 0.367 . . . . 0.0 110.034 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 47.9 t -136.57 154.49 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 120.903 0.382 . . . . 0.0 111.793 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.462 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.6 OUTLIER -120.93 117.14 26.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.491 HG11 HD13 ' A' ' 173' ' ' LEU . 0.3 OUTLIER -118.72 140.79 41.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.939 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.687 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.5 OUTLIER -78.6 135.39 37.25 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.114 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -76.4 -44.62 16.41 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.061 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.446 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 3.2 m -49.1 164.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.918 0.39 . . . . 0.0 111.611 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.0 t 70.26 54.58 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.074 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.45 ' HA ' HG12 ' A' ' 196' ' ' VAL . 6.4 m 59.86 154.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.934 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.462 ' HB3' ' CB ' ' A' ' 197' ' ' SER . 18.9 p -77.36 1.24 19.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.044 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.75 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 44.0 mm-40 -53.59 -23.27 10.37 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.874 0.368 . . . . 0.0 111.34 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.507 ' CG ' ' HB2' ' A' ' 129' ' ' LEU . 1.9 m-85 -76.43 -56.06 4.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.14 0.495 . . . . 0.0 110.572 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.567 ' HG ' HD11 ' A' ' 201' ' ' ILE . 37.4 tp -72.96 -41.04 64.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.309 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.416 HG21 ' SD ' ' A' ' 178' ' ' MET . 38.2 m -55.94 -34.51 65.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.753 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.529 ' CB ' ' HA ' ' A' ' 101' ' ' PRO . . . -70.86 -50.87 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.108 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.572 HD22 ' N ' ' A' ' 133' ' ' LEU . 1.4 mt -67.33 -38.07 84.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.609 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.499 ' O ' ' HG3' ' A' ' 181' ' ' PRO . 8.9 mt -65.57 -25.29 67.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.686 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.538 ' HG2' HD23 ' A' ' 31' ' ' LEU . 9.8 mtp -96.64 -28.79 14.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.166 0.508 . . . . 0.0 111.031 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.637 ' O ' HD12 ' A' ' 108' ' ' LEU . 55.4 m -89.12 -46.19 9.01 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.815 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.681 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -60.74 -37.13 42.25 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.8 Cg_endo -53.15 -37.36 79.75 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 121.101 1.2 . . . . 0.0 111.967 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.48 -7.01 59.42 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.955 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -67.54 119.5 66.21 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.881 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -37.47 -32.68 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.684 2.922 . . . . 0.0 114.417 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.81 151.8 23.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.056 0.455 . . . . 0.0 111.616 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.561 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 3.6 t0 -65.74 116.92 7.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.481 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.689 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 28.2 m -102.63 134.94 45.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.339 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 224' ' ' VAL . 41.1 t -125.45 99.3 5.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.091 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.605 ' O ' ' N ' ' A' ' 223' ' ' PHE . 4.0 mt -90.4 143.56 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.311 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.826 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -115.01 171.25 7.77 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 177.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.767 HG22 HD13 ' A' ' 195' ' ' LEU . 1.2 mm -110.9 97.27 5.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 120.969 0.414 . . . . 0.0 111.314 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 12.3 mtmt -61.14 -80.96 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.468 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -79.23 167.84 52.65 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.212 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.48 124.67 21.05 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.767 HD13 HG22 ' A' ' 191' ' ' ILE . 1.5 tp -59.35 146.36 40.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.105 0.478 . . . . 0.0 110.539 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 169' ' ' SER . 12.6 p -104.45 -18.66 6.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.203 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.684 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.6 OUTLIER -129.29 45.63 2.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.498 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.59 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . 3.8 ttpt -41.98 -60.87 1.75 Allowed Pre-proline 0 N--CA 1.466 0.338 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.784 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 12.1 Cg_exo -70.7 -16.44 33.61 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 121.871 1.714 . . . . 0.0 111.786 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.684 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 14.4 m-85 -76.36 -26.27 55.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.715 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.567 HD11 ' HG ' ' A' ' 173' ' ' LEU . 7.2 tp -75.19 -31.47 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.744 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 5.0 t70 -61.9 -34.25 75.69 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.618 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.8 mt -67.23 -27.35 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.259 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 42.1 m -60.86 -57.45 12.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.541 0.686 . . . . 0.0 109.615 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.636 HD12 ' CD1' ' A' ' 215' ' ' ILE . 19.2 mt -70.32 -32.04 69.61 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.539 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.68 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 1.5 m-20 -66.73 -30.62 70.89 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.656 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -75.72 -46.23 32.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.154 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.522 ' HG2' ' CZ ' ' A' ' 231' ' ' TYR . 18.6 mtp -62.67 -39.57 94.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.318 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.68 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -68.04 -41.89 81.39 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.003 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.539 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.4 OUTLIER -61.65 -28.15 69.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.126 0.489 . . . . 0.0 109.736 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.724 ' HA ' ' HG3' ' A' ' 234' ' ' PRO . 0.8 OUTLIER -76.04 -50.99 13.26 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.761 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 156.51 -1.59 0.14 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.283 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.522 ' HB ' ' CD1' ' A' ' 231' ' ' TYR . 61.1 t -117.54 139.05 46.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.968 0.413 . . . . 0.0 111.701 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -134.11 153.94 51.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.713 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.636 ' CD1' HD12 ' A' ' 205' ' ' LEU . 2.4 pp -131.81 175.16 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.611 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.965 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 30.5 tt0 -89.99 125.74 35.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.753 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -101.27 101.04 11.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.128 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.681 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -67.02 -166.18 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.472 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -76.14 48.36 0.5 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.888 0.375 . . . . 0.0 110.362 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.523 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.1 OUTLIER 57.28 21.21 6.45 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.135 -179.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 191' ' ' ILE . 22.5 tt0 -113.11 -22.77 10.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.517 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.826 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 42.1 mt-30 -147.37 140.26 24.99 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.605 ' N ' ' O ' ' A' ' 189' ' ' ILE . 24.6 m-85 -112.59 96.73 6.15 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.965 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 42.5 t -84.05 111.13 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.06 0.457 . . . . 0.0 111.199 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.689 ' CG2' ' HB ' ' A' ' 187' ' ' THR . 3.6 m -99.71 116.75 43.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.142 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.639 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 3.0 mptt -62.64 103.99 0.48 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.127 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.561 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.05 154.33 19.32 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.98 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.6 8.56 76.83 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.367 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.639 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 64.2 mm-40 -71.6 -179.57 2.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.421 0.629 . . . . 0.0 111.184 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.534 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.2 m -170.43 105.71 0.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.688 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.656 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 22.8 m-85 -53.58 146.03 13.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.085 0.469 . . . . 0.0 111.309 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.618 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 90.2 mt-30 -110.93 153.19 25.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.58 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 27.5 p -78.07 103.06 1.13 Allowed Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.231 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.724 ' HG3' ' HA ' ' A' ' 211' ' ' PHE . 10.5 Cg_exo -73.86 -37.16 3.04 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.849 2.366 . . . . 0.0 111.577 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 128.8 -120.24 3.24 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.418 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.743 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -91.08 116.52 28.87 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.593 ' OH ' HD23 ' A' ' 207' ' ' LEU . 67.1 t80 -124.08 141.49 52.01 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.644 -0.422 . . . . 0.0 112.085 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.819 ' HA ' HG22 ' A' ' 42' ' ' THR . 6.5 tp . . . . . 0 CA--C 1.514 -0.432 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.134 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.536 ' HA ' HD12 ' A' ' 29' ' ' LEU . 13.6 p30 . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 120.93 0.395 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.417 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 3.0 mtm105 -62.02 -51.06 69.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.399 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.569 ' HB1' ' CD2' ' A' ' 41' ' ' LEU . . . -65.87 -41.11 92.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.379 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.63 HD21 ' CD2' ' A' ' 54' ' ' LEU . 12.1 mt -59.8 -50.6 73.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 0.0 110.81 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.488 HD21 ' HE3' ' A' ' 53' ' ' MET . 9.4 tp -69.12 -46.15 68.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.976 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.601 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 65.2 mt -61.01 -28.68 69.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.736 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.637 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . . . -77.11 -28.72 54.53 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.552 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.681 ' HB1' ' CD2' ' A' ' 57' ' ' LEU . . . -68.57 -31.12 70.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.875 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.876 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.82 -11.67 41.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.016 0.436 . . . . 0.0 110.883 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -79.85 167.77 20.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.764 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.572 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 73.8 m80 -101.31 98.92 9.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.595 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 114.63 142.18 7.83 Favored Glycine 0 C--N 1.314 -0.643 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.568 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.83 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 3.3 tttt -64.27 128.7 36.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.248 0.547 . . . . 0.0 111.938 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.525 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -123.6 160.9 26.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.06 178.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 91.9 t -110.99 140.78 28.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.32 . . . . 0.0 111.781 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.627 ' HA ' ' O ' ' A' ' 237' ' ' TYR . 0.0 OUTLIER -129.39 111.29 12.66 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.113 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.813 HG23 ' HA ' ' A' ' 238' ' ' LEU . 0.0 OUTLIER -96.04 172.14 8.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.188 0.518 . . . . 0.0 111.534 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 71' ' ' THR . 0.1 OUTLIER 66.77 18.79 10.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.729 -178.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.662 HD22 HG12 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -58.73 164.43 2.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.868 179.078 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.472 ' H ' ' HG ' ' A' ' 44' ' ' LEU . 27.7 tp -99.37 112.7 24.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.892 0.377 . . . . 0.0 111.721 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -71.69 68.14 0.59 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.555 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.455 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 12.8 t -129.48 -163.54 1.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.212 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.551 ' HA ' ' HE ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -98.59 -22.87 15.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.768 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.577 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 2.1 p30 -69.05 -26.02 64.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.727 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.662 HG12 HD22 ' A' ' 44' ' ' LEU . 24.0 t -88.07 -56.59 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.295 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.567 ' O ' ' HB2' ' A' ' 55' ' ' ASN . 1.8 ptt180 -52.83 -24.41 8.95 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.197 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 55' ' ' ASN . 4.6 m-70 -75.52 -38.08 59.63 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.726 ' O ' HD11 ' A' ' 57' ' ' LEU . 8.6 tpt -60.27 -54.65 43.17 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.746 ' HA ' HD13 ' A' ' 57' ' ' LEU . 1.9 mp -59.34 -47.97 83.4 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.712 177.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.567 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -48.51 -30.71 5.49 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.639 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.633 ' CB ' ' HG ' ' A' ' 102' ' ' LEU . . . -69.17 -51.36 38.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.298 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.746 HD13 ' HA ' ' A' ' 54' ' ' LEU . 3.4 mp -60.12 -49.18 78.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.812 0.339 . . . . 0.0 110.636 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.584 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.8 t -53.8 -30.79 46.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.095 0.474 . . . . 0.0 110.24 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.657 ' HB1' HD13 ' A' ' 88' ' ' LEU . . . -60.37 -50.88 71.84 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.168 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 82' ' ' LEU . 3.9 mp -65.84 -27.75 68.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.484 0.659 . . . . 0.0 110.131 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.92 -0.0 7.13 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 114.725 -1.125 . . . . 0.0 113.03 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.593 HG11 ' N ' ' A' ' 63' ' ' SER . 13.5 t -55.19 159.99 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 117.216 0.508 . . . . 0.0 110.47 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.593 ' N ' HG11 ' A' ' 62' ' ' VAL . 3.3 m -122.22 109.52 14.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.623 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.677 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 10.1 p90 -126.57 158.98 34.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.607 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 25.1 m -150.64 116.83 5.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.658 0.266 . . . . 0.0 111.267 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.741 HD11 ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -86.38 178.09 7.24 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.216 0.532 . . . . 0.0 111.748 -179.651 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.702 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -90.1 178.58 6.15 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.811 179.122 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.24 -11.88 45.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.596 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.4 1.45 11.79 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.876 0.37 . . . . 0.0 110.462 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.5 ' O ' HD23 ' A' ' 44' ' ' LEU . 3.1 mtt85 61.57 43.27 10.25 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.84 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.477 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -124.05 -2.27 8.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.293 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.702 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -143.0 111.13 6.06 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.968 0.413 . . . . 0.0 109.937 179.001 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.741 ' HB2' HD11 ' A' ' 66' ' ' LEU . 1.6 t -113.17 155.92 24.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.677 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 5.9 mt-10 -119.76 102.94 8.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.964 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.83 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -102.32 129.26 54.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 10.3 mt -82.16 102.3 7.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.351 178.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.611 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -48.43 111.97 1.04 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.771 -0.65 . . . . 0.0 113.681 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.628 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -57.2 -17.58 11.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 110.616 178.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.572 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 88.12 -22.36 19.39 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.446 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.876 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -139.96 -145.15 4.63 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.734 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 4.1 Cg_exo -79.15 168.24 20.68 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 121.969 1.779 . . . . 0.0 108.984 177.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.869 ' HB3' HD23 ' A' ' 60' ' ' LEU . 4.4 mm? -66.55 91.04 0.17 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.734 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 27.8 m170 -83.93 118.88 24.29 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 113.44 -1.709 . . . . 0.0 113.133 -175.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.536 ' HB2' HD21 ' A' ' 60' ' ' LEU . . . -148.84 110.58 4.52 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.898 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.4 87.88 2.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.59 0.233 . . . . 0.0 111.557 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -174.45 22.83 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.873 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 56.76 53.76 7.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.492 0.663 . . . . 0.0 110.096 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.719 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 5.2 tp -85.92 135.37 33.71 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.939 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.66 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 4.0 tt0 -115.27 130.16 56.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.242 0.544 . . . . 0.0 110.689 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.541 HD22 HD22 ' A' ' 88' ' ' LEU . 3.5 mt -108.68 153.79 22.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.744 -178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.468 ' CE1' ' CA ' ' A' ' 93' ' ' GLY . 53.8 t80 -118.52 106.59 12.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.817 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.747 HD22 ' N ' ' A' ' 92' ' ' LEU . 1.8 mm? -91.61 3.56 54.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.251 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.569 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 43.12 -140.34 2.59 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 116.207 -0.451 . . . . 0.0 113.625 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -93.54 52.03 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.07 0.462 . . . . 0.0 111.1 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.577 ' HB3' ' HA ' ' A' ' 49' ' ' ASP . . . -94.05 -75.51 0.5 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.376 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.97 -19.78 9.27 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.392 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.479 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -96.59 -9.56 29.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.772 0.32 . . . . 0.0 110.862 179.175 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 53' ' ' MET . . . -123.04 -19.99 5.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.773 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.713 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 9.7 ttm -70.72 -54.18 12.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.982 0.42 . . . . 0.0 111.164 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.72 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.2 mpt_? -57.72 -53.53 64.68 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.091 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.584 ' HA ' ' CB ' ' A' ' 175' ' ' ALA . 31.3 Cg_exo -59.3 -47.34 17.44 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.84 2.36 . . . . 0.0 113.135 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.633 ' HG ' ' CB ' ' A' ' 56' ' ' ALA . 3.0 tm? -66.67 -33.97 76.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.554 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.66 -47.37 85.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.464 0.649 . . . . 0.0 110.215 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 107' ' ' CYS . . . -71.46 -37.33 71.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.749 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.511 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -57.14 -43.4 82.41 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.897 0.38 . . . . 0.0 111.393 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.564 ' CD2' HD23 ' A' ' 60' ' ' LEU . 1.7 mt -70.58 -23.11 62.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.41 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.491 ' SG ' HD13 ' A' ' 140' ' ' ILE . 87.7 m -59.33 -11.11 3.68 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.019 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.694 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 12.6 mt -83.33 166.11 18.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.67 0.271 . . . . 0.0 110.318 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 54.56 -112.1 2.52 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.272 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.5 97.74 0.99 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 2.8 m120 -138.32 138.35 38.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.775 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.656 ' O ' HD13 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -104.1 110.41 22.58 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.58 178.667 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.719 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 25.1 mm -136.66 143.38 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.528 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.66 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 19.4 t -115.33 113.42 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.454 HD22 HD21 ' A' ' 92' ' ' LEU . 17.6 mt -82.42 152.98 25.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.495 0.664 . . . . 0.0 112.325 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.509 HG21 ' O ' ' A' ' 90' ' ' LEU . 9.5 t -160.27 163.59 33.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.892 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -157.57 -167.54 18.72 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.647 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.569 ' HG2' ' HA2' ' A' ' 93' ' ' GLY . 8.4 mm-40 -67.67 172.98 3.29 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.846 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.469 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 33.0 Cg_exo -62.07 -23.8 75.99 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.364 2.043 . . . . 0.0 112.171 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.443 ' HD2' ' CG ' ' A' ' 123' ' ' GLU . 8.1 tpt180 -85.56 -39.47 17.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.836 0.35 . . . . 0.0 110.556 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.596 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 10.8 tpt -59.48 -20.18 53.34 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.635 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 20.6 mttt -68.8 -7.13 31.29 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.255 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.544 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 3.9 pt-20 -120.0 28.17 8.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.115 0.483 . . . . 0.0 110.728 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.415 ' HA ' ' NE ' ' A' ' 124' ' ' ARG . 6.5 mmp_? -103.51 112.97 65.94 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.582 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 24.8 Cg_exo -60.84 137.01 69.79 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.274 1.983 . . . . 0.0 112.023 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.605 HG12 HG21 ' A' ' 130' ' ' VAL . 17.3 tt -145.01 30.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.849 0.833 . . . . 0.0 109.966 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -77.0 -50.44 6.87 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 114.39 -1.277 . . . . 0.0 112.101 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.647 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -57.26 -28.4 62.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.865 0.364 . . . . 0.0 110.668 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.558 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 20.6 tp -79.14 -63.85 1.32 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.859 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.605 HG21 HG12 ' A' ' 126' ' ' ILE . 60.6 t -55.28 -24.61 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.337 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.4 OUTLIER -70.6 -45.2 65.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.352 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.918 ' HA ' HD13 ' A' ' 135' ' ' LEU . . . -65.81 -53.25 42.65 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.418 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.646 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -55.86 -44.23 77.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.101 0.477 . . . . 0.0 109.77 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.63 -38.99 75.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.449 179.267 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.918 HD13 ' HA ' ' A' ' 132' ' ' ALA . 2.4 mt -64.91 -30.6 71.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.436 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.482 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -78.22 -18.15 76.88 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.471 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.65 2.98 5.19 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.165 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.95 146.48 54.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.944 0.372 . . . . 0.0 111.248 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -114.75 88.72 2.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.241 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.575 HD12 HD11 ' A' ' 133' ' ' LEU . 6.3 mt -115.59 176.63 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.085 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.533 ' O ' HD22 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -154.45 -174.92 5.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.919 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.475 ' CD2' ' HA ' ' A' ' 146' ' ' GLU . 20.1 m-85 -126.63 106.98 9.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.049 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.486 ' HG ' HG13 ' A' ' 114' ' ' VAL . 2.4 mm? -77.36 -18.65 57.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.389 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.624 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 1.7 mm-40 -134.71 -73.04 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.969 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.594 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -123.27 149.81 44.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.727 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.475 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 4.6 pt-20 -69.61 135.12 49.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.093 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 12.1 m-20 64.92 46.99 2.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.48 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.797 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 4.6 m-85 -144.08 176.64 2.15 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.111 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.797 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 10.3 Cg_endo -52.01 -39.89 68.78 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.131 2.554 . . . . 0.0 115.629 -177.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.624 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 19.7 Cg_endo -61.9 100.4 0.2 Allowed 'Trans proline' 0 CA--C 1.515 -0.458 0 C-N-CA 120.861 1.041 . . . . 0.0 110.944 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.533 HD22 ' O ' ' A' ' 141' ' ' THR . 84.1 mt -137.05 123.89 21.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.817 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 1.6 ttm180 -105.03 111.83 24.74 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 1.5 mt -94.98 160.12 14.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.684 -178.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.585 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 4.1 mt-30 -148.86 25.69 0.92 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.906 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.475 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 54.5 -166.45 2.44 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.477 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 109.84 -4.87 30.66 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.946 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.646 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 2.3 t80 -60.89 106.99 0.64 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.783 0.325 . . . . 0.0 110.681 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 43.5 p -104.97 -48.65 3.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.614 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.53 -162.23 27.67 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 119.889 -1.148 . . . . 0.0 114.293 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.421 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 114.36 168.94 16.3 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 114.937 -0.632 . . . . 0.0 112.003 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -63.08 126.2 26.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.432 HG13 ' HB1' ' A' ' 132' ' ' ALA . 62.1 t -133.51 157.63 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.091 0.472 . . . . 0.0 111.578 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.442 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.7 OUTLIER -124.31 116.12 22.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.891 179.267 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.02 150.92 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.92 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.647 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 2.7 t0 -89.83 127.36 35.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.667 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.689 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -70.16 -44.68 59.4 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.651 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.423 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 1.4 m -50.91 164.76 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.837 0.351 . . . . 0.0 111.517 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.1 t 69.17 56.75 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 121.275 0.559 . . . . 0.0 111.112 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.418 ' HA ' HG11 ' A' ' 196' ' ' VAL . 2.0 m 58.3 159.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.458 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.429 ' HB3' ' CB ' ' A' ' 197' ' ' SER . 12.4 p -82.65 0.43 43.19 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.807 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.72 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 2.1 mp0 -51.12 -21.91 2.2 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.934 0.397 . . . . 0.0 111.049 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.472 ' HA ' HD13 ' A' ' 129' ' ' LEU . 1.4 m-85 -78.96 -53.95 6.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.765 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.506 HD21 ' CE1' ' A' ' 223' ' ' PHE . 22.7 tp -74.71 -40.5 61.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.441 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.48 ' CG2' ' HA ' ' A' ' 171' ' ' GLN . 13.6 t -57.96 -34.31 69.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' A' ' 101' ' ' PRO . . . -68.37 -51.12 47.83 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.497 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.5 ' HB3' HD13 ' A' ' 189' ' ' ILE . 2.6 mt -67.78 -37.0 81.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.541 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.508 ' O ' ' HG3' ' A' ' 181' ' ' PRO . 8.2 mt -67.88 -24.63 65.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.075 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.499 ' HA ' ' OH ' ' A' ' 231' ' ' TYR . 13.5 ptp -98.92 -28.48 13.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.12 0.486 . . . . 0.0 110.811 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.614 ' O ' HD11 ' A' ' 108' ' ' LEU . 27.4 m -86.37 -46.22 10.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.991 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.693 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -60.94 -37.26 42.72 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.693 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 12.1 Cg_endo -54.54 -36.69 89.43 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 121.232 1.288 . . . . 0.0 111.797 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.592 HD22 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -85.16 -6.48 59.29 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.828 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -66.9 114.99 20.51 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.16 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -31.09 -36.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.073 3.182 . . . . 0.0 114.642 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -105.47 153.34 21.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.968 0.413 . . . . 0.0 111.797 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.573 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 1.3 t0 -63.92 118.27 8.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.568 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.677 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 61.4 m -104.16 133.75 48.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.056 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.555 HG12 HG21 ' A' ' 224' ' ' VAL . 35.3 t -125.43 99.63 6.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.252 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.1 mt -90.82 143.56 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.418 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.819 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -114.33 171.07 7.84 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.572 HG21 ' CD1' ' A' ' 195' ' ' LEU . 1.1 mm -111.41 96.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 120.973 0.415 . . . . 0.0 111.17 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -60.83 -81.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.625 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.431 ' HA3' ' OD1' ' A' ' 165' ' ' ASP . . . -78.12 168.4 53.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.269 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -61.41 122.62 15.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.635 0.255 . . . . 0.0 110.856 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.689 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.8 OUTLIER -58.43 143.63 44.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.96 0.41 . . . . 0.0 110.577 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 167' ' ' SER . 13.1 p -103.58 -18.82 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.512 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' SER . . . . . 0.643 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.6 OUTLIER -126.6 45.62 2.64 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.489 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.62 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . 0.4 OUTLIER -42.15 -60.44 2.07 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.196 -0.911 . . . . 0.0 113.122 -178.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 7.6 Cg_exo -72.68 -16.32 26.76 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 121.908 1.739 . . . . 0.0 111.987 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.643 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 16.5 m-85 -75.64 -29.91 59.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.255 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.464 HG12 ' CD2' ' A' ' 173' ' ' LEU . 6.2 tp -70.69 -35.64 61.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -59.35 -33.16 70.83 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.147 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.543 ' O ' ' HB2' ' A' ' 207' ' ' LEU . 15.1 mt -67.71 -32.86 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.238 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 52.4 m -57.44 -52.64 64.54 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.651 HD12 ' CD1' ' A' ' 215' ' ' ILE . 13.3 mt -73.82 -35.45 64.85 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.92 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 202' ' ' ASP . 0.7 OUTLIER -64.0 -28.03 69.53 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.171 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.601 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -79.17 -44.02 22.77 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.842 178.473 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' MET . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 231' ' ' TYR . 22.4 mtp -65.0 -38.83 92.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.456 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.502 ' HG3' ' N ' ' A' ' 210' ' ' THR . 0.0 OUTLIER -65.21 -48.94 71.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.666 0.269 . . . . 0.0 110.64 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.502 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.5 OUTLIER -56.53 -29.28 61.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.278 0.561 . . . . 0.0 109.843 179.064 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.637 ' CE2' ' HA ' ' A' ' 32' ' ' ALA . 1.1 m-85 -71.48 -48.84 46.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.002 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.453 ' HA3' ' HG2' ' A' ' 232' ' ' GLN . . . 153.21 -4.84 0.36 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.114 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.618 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 73.4 t -120.19 140.78 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.09 0.472 . . . . 0.0 111.823 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -134.08 156.0 49.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.662 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.651 ' CD1' HD12 ' A' ' 205' ' ' LEU . 2.3 pp -132.75 175.72 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.891 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.948 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 41.3 tt0 -90.36 124.66 35.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.068 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.99 100.87 11.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.003 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.707 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 2.1 mm-40 -66.64 -166.72 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.612 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -74.74 48.58 0.37 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.884 0.373 . . . . 0.0 110.41 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . 0.514 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 57.47 20.66 6.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 -179.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 191' ' ' ILE . 66.3 mt-30 -112.69 -21.55 11.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.738 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' GLN . . . . . 0.819 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 46.6 mt-30 -149.04 141.34 24.1 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.902 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.603 ' N ' ' O ' ' A' ' 189' ' ' ILE . 19.7 m-85 -113.32 96.53 5.95 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.948 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 48.4 t -83.9 111.15 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 120.797 0.332 . . . . 0.0 111.429 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.677 ' CG2' ' HB ' ' A' ' 187' ' ' THR . 5.5 m -99.68 117.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.931 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.806 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -61.71 103.07 0.3 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.009 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.573 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -55.96 156.0 11.36 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.738 -0.665 . . . . 0.0 113.044 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.48 8.46 84.91 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.559 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . 0.806 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 26.0 mm100 -71.05 -176.52 1.42 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.358 0.579 . . . . 0.0 110.781 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.592 ' HA ' HD22 ' A' ' 182' ' ' LEU . 2.5 m -177.1 104.91 0.06 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.39 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.618 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 21.2 m-85 -55.66 151.94 10.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.163 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . 0.657 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 9.2 pt20 -123.01 154.76 38.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 68.7 p -67.6 101.11 0.27 Allowed Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' PRO . . . . . 0.657 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 59.5 Cg_endo -68.13 -27.94 34.97 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.656 2.237 . . . . 0.0 111.898 178.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.39 -125.26 6.53 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' THR . . . . . 0.508 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -92.0 116.54 29.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.627 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 63.5 t80 -124.73 143.2 50.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.331 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.813 ' HA ' HG23 ' A' ' 42' ' ' THR . 5.7 tp . . . . . 0 CA--C 1.515 -0.386 0 CA-C-O 121.145 0.498 . . . . 0.0 110.752 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.577 ' HB3' ' H ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.218 0.532 . . . . 1.28 110.726 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.24 -24.74 42.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.534 -0.757 . . . . 2.1200000000000001 111.852 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -60.66 -47.17 87.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.078 0.466 . . . . 2.6400000000000001 110.214 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.46 -33.31 72.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.767 -0.651 . . . . 1.1200000000000001 110.768 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.499 ' CD1' ' HG ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -61.23 -54.57 42.51 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.229 0.537 . . . . 1.6699999999999999 110.695 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 7.1 tp -66.79 -51.39 56.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.292 -0.867 . . . . 1.1399999999999999 111.216 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.443 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 63.7 mt -54.64 -35.84 63.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.022 0.439 . . . . 1.1899999999999999 110.804 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.571 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -72.91 -29.97 63.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.673 -0.694 . . . . 1.0600000000000001 110.787 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 78' ' ' ASN . . . -71.48 -32.28 68.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.817 -0.628 . . . . 0.98999999999999999 111.592 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.799 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.74 -11.21 42.91 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.826 0.346 . . . . 1.0 111.111 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -80.93 163.19 23.52 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.041 -0.527 . . . . 1.01 110.144 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.486 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 70.9 m80 -96.51 97.27 9.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.004 0.43 . . . . 0.20999999999999999 110.079 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.5 146.97 7.94 Favored Glycine 0 C--N 1.313 -0.712 0 C-N-CA 120.796 -0.716 . . . . 0.20000000000000001 111.751 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -71.74 138.06 48.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.105 0.479 . . . . 2.73 111.654 -179.51 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.434 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -131.74 164.59 25.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.64 -0.709 . . . . 1.04 110.165 179.316 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.522 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 88.9 t -110.43 142.7 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 111.911 0.337 . . . . 1.0700000000000001 111.911 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -130.18 110.67 11.76 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.834 -0.802 . . . . 1.23 108.834 178.257 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.769 HG21 ' HA ' ' A' ' 238' ' ' LEU . 0.0 OUTLIER -100.55 169.56 8.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.112 0.482 . . . . 1.1100000000000001 111.568 -178.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.497 ' HB2' ' CD1' ' A' ' 238' ' ' LEU . 1.5 t30 67.24 21.09 10.02 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.629 -0.714 . . . . 1.4099999999999999 110.703 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.425 ' HB3' ' HA ' ' A' ' 71' ' ' THR . 0.8 OUTLIER -60.14 154.69 18.94 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.555 -0.535 . . . . 1.0900000000000001 109.555 178.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.577 ' H ' ' HB3' ' A' ' 25' ' ' SER . 17.6 tp -91.27 114.3 26.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.93 0.395 . . . . 1.0800000000000001 111.418 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -73.72 77.74 1.55 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.973 -0.558 . . . . 2.0499999999999998 110.27 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -137.38 -163.88 1.5 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.875 -0.602 . . . . 1.5600000000000001 110.841 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.515 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 10.0 m-20 -96.91 -19.05 19.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.19 -0.459 . . . . 1.8600000000000001 111.076 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.01 -26.53 61.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.177 -0.465 . . . . 1.97 109.919 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.48 ' O ' HD13 ' A' ' 54' ' ' LEU . 26.5 t -90.04 -52.42 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.813 -0.63 . . . . 1.1100000000000001 111.45 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -53.07 -26.53 16.38 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.53 -0.468 . . . . 3.0899999999999999 110.558 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -73.4 -37.57 65.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.698 -0.683 . . . . 0.73999999999999999 109.637 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.501 ' O ' HD22 ' A' ' 57' ' ' LEU . 5.4 tpt -65.0 -47.35 77.82 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.565 -0.902 . . . . 1.3899999999999999 108.565 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.499 ' HG ' ' CD1' ' A' ' 29' ' ' LEU . 1.1 mp -61.95 -47.13 86.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.611 -0.722 . . . . 1.05 110.051 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.403 ' HA ' ' CG2' ' A' ' 58' ' ' THR . 0.9 OUTLIER -59.57 -28.17 66.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.111 0.481 . . . . 2.0299999999999998 109.979 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.527 ' HB2' HD12 ' A' ' 90' ' ' LEU . . . -68.73 -43.85 75.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.631 -0.713 . . . . 1.0800000000000001 111.965 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.501 HD22 ' O ' ' A' ' 53' ' ' MET . 0.1 OUTLIER -71.87 -50.45 29.31 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.774 -0.37 . . . . 1.4199999999999999 110.768 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.464 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.9 t -52.16 -29.81 23.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.07 0.462 . . . . 1.01 110.371 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.437 ' CB ' ' CD2' ' A' ' 90' ' ' LEU . . . -59.82 -45.0 93.73 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.57 -0.741 . . . . 0.94999999999999996 110.523 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.706 HD23 ' HB3' ' A' ' 82' ' ' LEU . 3.0 mp -74.87 -24.37 58.55 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.454 0.645 . . . . 1.01 109.952 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.4 0.24 5.85 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.004 -0.998 . . . . 0.26000000000000001 114.146 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 63' ' ' SER . 34.0 t -61.77 150.12 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 118.041 0.921 . . . . 1.0800000000000001 110.364 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.486 ' CB ' HG13 ' A' ' 76' ' ' ILE . 2.5 m -111.23 104.91 13.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.815 -0.629 . . . . 0.90000000000000002 111.595 -178.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.464 ' CE2' ' HB ' ' A' ' 58' ' ' THR . 6.7 p90 -117.83 159.14 23.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.148 -0.933 . . . . 1.03 110.946 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.552 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 3.5 m -152.65 114.84 4.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 1.0800000000000001 110.214 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.704 HD11 ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -84.19 178.7 7.7 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.997 0.427 . . . . 1.05 110.735 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.489 ' H ' HD12 ' A' ' 66' ' ' LEU . 2.0 t -94.33 -179.92 5.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.803 -0.635 . . . . 1.6000000000000001 110.946 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.02 -19.41 61.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.176 -0.466 . . . . 1.0700000000000001 111.517 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.22 5.99 14.9 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.897 0.379 . . . . 1.5600000000000001 110.564 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.1 mtt-85 59.42 41.42 19.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.119 -0.491 . . . . 2.75 110.974 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -121.91 -0.03 9.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.651 -0.704 . . . . 1.04 110.887 179.111 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.589 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -143.54 115.35 8.24 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.446 -0.576 . . . . 2.2799999999999998 109.446 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.704 ' HB2' HD11 ' A' ' 66' ' ' LEU . 1.4 t -120.99 150.2 41.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.7 -0.682 . . . . 0.81000000000000005 112.141 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.428 ' HB3' ' HD3' ' A' ' 38' ' ' LYS . 4.2 mt-10 -118.18 103.79 10.19 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.477 -0.934 . . . . 1.53 108.477 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -99.19 126.74 52.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.567 0.699 . . . . 1.05 112.661 -178.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.486 HG13 ' CB ' ' A' ' 63' ' ' SER . 0.9 OUTLIER -78.54 110.81 14.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.478 -1.237 . . . . 1.8100000000000001 111.233 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.571 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -54.32 112.8 2.86 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.799 -0.637 . . . . 0.17999999999999999 114.047 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.0 OUTLIER -61.86 -19.6 62.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.187 0.518 . . . . 1.95 109.943 178.279 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.486 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 89.69 -23.21 20.84 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.611 -0.722 . . . . 0.16 112.671 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.799 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -136.92 -149.81 5.69 Favored Glycine 0 CA--C 1.507 -0.464 0 N-CA-C 109.998 -1.241 . . . . 0.17000000000000001 109.998 178.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.817 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 5.1 Cg_exo -78.71 164.43 25.67 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 CA-C-N 119.469 1.635 . . . . 0.14000000000000001 109.163 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.706 ' HB3' HD23 ' A' ' 60' ' ' LEU . 3.7 mm? -63.36 93.95 0.08 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.816 1.294 . . . . 1.04 108.217 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.817 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 28.9 m170 -87.8 120.18 28.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 112.435 -2.166 . . . . 0.14999999999999999 112.928 -175.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.421 ' HB3' ' CB ' ' A' ' 60' ' ' LEU . . . -149.21 109.4 4.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.882 -0.599 . . . . 0.89000000000000001 110.912 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -107.9 91.64 3.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.769 0.319 . . . . 1.51 111.139 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.98 19.94 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.544 -0.836 . . . . 0.28000000000000003 113.432 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.71 50.82 13.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.308 0.575 . . . . 1.1000000000000001 110.006 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.691 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 3.5 tp -77.12 136.03 38.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.315 -0.857 . . . . 1.1399999999999999 110.959 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 114' ' ' VAL . 1.2 tt0 -116.6 127.46 54.49 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.158 0.504 . . . . 1.3500000000000001 110.395 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.527 HD12 ' HB2' ' A' ' 56' ' ' ALA . 50.8 mt -109.68 163.38 13.54 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.49 -0.777 . . . . 1.3 112.655 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -125.56 106.68 9.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.897 -1.047 . . . . 0.54000000000000004 109.892 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.531 ' HG ' ' HA ' ' A' ' 99' ' ' MET . 1.2 mm? -93.2 6.05 49.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.176 -0.465 . . . . 1.51 111.485 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 42.3 -141.42 1.7 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.051 -0.595 . . . . 0.29999999999999999 113.009 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -96.9 51.7 1.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.133 0.492 . . . . 2.1200000000000001 110.733 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.75 -73.71 0.49 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.811 -0.631 . . . . 1.03 111.071 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.0 -18.93 13.61 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.002 -0.618 . . . . 0.34000000000000002 113.092 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.85 -9.21 29.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.807 0.337 . . . . 1.5600000000000001 110.658 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.63 -12.75 6.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.1 -0.5 . . . . 1.05 111.523 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.531 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 4.6 ttm -79.36 -36.32 39.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.551 -0.295 . . . . 1.24 111.458 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.5 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -77.95 -48.91 2.07 Favored Pre-proline 0 N--CA 1.45 -0.45 0 CA-C-O 120.503 0.192 . . . . 2.6600000000000001 111.236 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.651 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 24.4 Cg_exo -64.18 -43.06 15.91 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.793 2.329 . . . . 0.32000000000000001 112.734 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.495 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 2.2 tm? -71.0 -30.37 66.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.996 -0.547 . . . . 1.05 111.168 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.62 -49.22 74.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.195 0.522 . . . . 0.95999999999999996 110.633 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.423 ' CB ' HD21 ' A' ' 133' ' ' LEU . . . -72.5 -34.75 67.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.366 0.876 . . . . 1.01 113.366 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.486 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -57.76 -44.27 86.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.034 0.445 . . . . 1.05 111.968 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -71.0 -21.19 62.33 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.927 -0.579 . . . . 1.0600000000000001 112.01 -178.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.459 ' O ' ' HA2' ' A' ' 155' ' ' GLY . 98.1 m -58.26 -12.56 3.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.938 -0.574 . . . . 0.70999999999999996 111.73 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.663 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 9.8 mt -80.62 167.85 19.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.695 0.283 . . . . 1.04 110.638 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 50.16 -110.83 0.96 Allowed Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.08 -0.581 . . . . 0.16 112.559 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.433 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.1 OUTLIER -162.37 102.47 1.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.797 0.332 . . . . 1.1100000000000001 110.3 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 1.4 m-20 -138.84 135.97 35.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 1.96 111.243 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 4.6 m-20 -102.79 109.48 21.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.052 -0.522 . . . . 1.26 109.813 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.691 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 5.2 mp -143.39 140.85 26.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.499 -0.319 . . . . 1.3 111.249 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.57 HG11 ' HG ' ' A' ' 143' ' ' LEU . 17.5 t -112.2 112.7 41.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.767 -0.457 . . . . 1.0600000000000001 109.767 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.467 HD22 ' HA ' ' A' ' 115' ' ' LEU . 31.8 mt -81.02 158.62 25.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.383 0.611 . . . . 1.05 111.91 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.3 m -160.84 162.98 32.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.99 -1.005 . . . . 1.6399999999999999 110.219 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.21 -165.39 13.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.885 -1.15 . . . . 0.27000000000000002 113.7 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.492 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 0.8 OUTLIER -71.74 175.86 2.66 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.26 -0.47 . . . . 1.5700000000000001 111.134 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 32.1 Cg_exo -60.47 -37.29 82.03 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.337 2.025 . . . . 0.88 112.436 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.503 HH11 ' CG ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -76.3 -36.98 58.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.765 0.317 . . . . 2.7400000000000002 110.796 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.49 ' HA ' ' HG3' ' A' ' 124' ' ' ARG . 7.5 tpt -58.59 -22.31 55.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 1.4199999999999999 110.21 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.459 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 2.9 mmtt -63.64 -10.38 18.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.05 -0.523 . . . . 2.29 111.97 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.585 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 4.4 pt-20 -121.22 28.2 7.96 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.638 -0.425 . . . . 1.9199999999999999 111.539 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.49 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 1.2 mmp_? -101.39 95.05 4.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.195 -0.457 . . . . 3.2000000000000002 110.725 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.7 Cg_endo -47.43 129.03 15.78 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.732 2.288 . . . . 0.59999999999999998 112.2 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.446 ' O ' HG12 ' A' ' 126' ' ' ILE . 19.9 tt -138.35 31.48 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.745 0.783 . . . . 1.01 110.143 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -74.93 -49.49 9.9 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.633 -1.167 . . . . 0.23000000000000001 112.668 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.437 ' HB2' ' CD2' ' A' ' 172' ' ' PHE . 0.1 OUTLIER -53.65 -33.0 53.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.825 0.345 . . . . 0.31 110.5 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.54 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 25.9 tp -76.48 -62.84 1.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 1.04 110.165 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.2 t -51.94 -26.89 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 1.03 111.604 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 2.7 t0 -71.93 -45.46 61.08 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.27 0.47 . . . . 1.4299999999999999 112.27 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.803 ' HA ' HD13 ' A' ' 135' ' ' LEU . . . -63.82 -54.19 38.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.863 0.363 . . . . 1.04 111.129 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.622 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -55.12 -44.78 75.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.343 0.592 . . . . 1.0600000000000001 109.547 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -57.76 -40.11 78.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.133 -0.94 . . . . 3.4500000000000002 110.314 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.803 HD13 ' HA ' ' A' ' 132' ' ' ALA . 3.1 mt -63.93 -32.93 74.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 1.02 110.686 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.435 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -76.53 -13.81 83.08 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.489 -0.862 . . . . 0.14000000000000001 112.929 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 127.05 4.46 5.99 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.54 -0.838 . . . . 0.16 113.192 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.98 150.41 45.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.878 0.371 . . . . 1.05 111.51 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -116.35 96.76 5.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 3.0 111.317 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 133' ' ' LEU . 10.6 mt -124.41 168.39 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.088 0.47 . . . . 1.0600000000000001 111.403 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.449 ' H ' ' CG2' ' A' ' 140' ' ' ILE . 0.4 OUTLIER -150.36 174.4 12.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.699 -0.682 . . . . 1.0900000000000001 110.603 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.531 ' CD2' ' HA ' ' A' ' 146' ' ' GLU . 23.6 m-85 -116.61 107.91 15.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.709 -0.849 . . . . 0.79000000000000004 108.709 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.57 ' HG ' HG11 ' A' ' 114' ' ' VAL . 2.3 mm? -75.25 -23.46 57.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.886 -0.597 . . . . 1.05 112.074 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.676 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 2.5 mt-10 -129.53 -67.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.745 -0.382 . . . . 2.1899999999999999 110.977 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.711 ' HB2' ' HD2' ' A' ' 148' ' ' TYR . 53.6 mt-30 -125.63 157.82 36.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.091 0.472 . . . . 3.46 111.774 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.531 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 47.4 mt-10 -75.31 131.46 40.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.676 . . . . 2.0099999999999998 110.826 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 16.6 m-20 67.46 44.3 1.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 1.72 111.822 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.711 ' HD2' ' HB2' ' A' ' 145' ' ' GLN . 7.8 m-30 -140.55 164.26 37.93 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.353 -0.385 . . . . 1.1499999999999999 110.65 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.52 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 6.3 Cg_exo -37.73 -44.12 1.57 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 124.146 3.231 . . . . 0.31 115.38 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.676 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 24.3 Cg_endo -61.41 95.18 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 121.202 1.268 . . . . 0.26000000000000001 111.041 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 141' ' ' THR . 94.4 mt -132.41 123.29 26.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.534 -0.757 . . . . 1.03 111.71 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.452 ' HB3' HD11 ' A' ' 143' ' ' LEU . 1.4 ttm180 -101.7 110.83 22.89 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.221 -1.029 . . . . 3.0899999999999999 108.221 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 2.0 mt -92.93 158.27 15.91 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.768 0.318 . . . . 1.0800000000000001 111.21 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 6.4 mt-30 -146.17 22.77 1.36 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.146 -0.479 . . . . 1.75 110.712 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 107' ' ' CYS . . . 56.35 -167.16 3.92 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.501 -0.856 . . . . 0.14999999999999999 112.193 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 110.94 -4.29 28.85 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.532 -0.842 . . . . 0.17000000000000001 112.814 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.622 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 2.0 t80 -62.43 110.54 1.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.922 0.391 . . . . 0.96999999999999997 111.141 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 71.5 p -109.49 -50.67 2.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.573 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.45 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 145.98 -161.91 28.31 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.276 -0.964 . . . . 0.19 113.58 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 113.88 168.82 16.62 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 111.738 -0.545 . . . . 0.17000000000000001 111.738 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.9 129.71 43.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.88 0.34 . . . . 1.5600000000000001 110.323 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.434 HG11 HD13 ' A' ' 135' ' ' LEU . 61.4 t -136.56 156.99 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 120.932 0.396 . . . . 1.03 111.131 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.4 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 1.1 m-20 -127.9 116.51 20.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.421 -0.585 . . . . 1.1000000000000001 109.421 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -118.73 145.86 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 120.392 -0.523 . . . . 1.0 112.278 -178.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.403 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 1.8 t70 -85.07 130.28 34.64 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.87 -0.605 . . . . 1.25 110.215 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.6 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -72.1 -45.34 41.3 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.799 -0.715 . . . . 0.14999999999999999 113.507 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.35 160.97 0.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.116 0.484 . . . . 1.5800000000000001 112.06 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 9.4 t 71.73 59.59 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 115.649 -0.705 . . . . 1.0700000000000001 111.06 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.421 ' HA ' HG13 ' A' ' 196' ' ' VAL . 15.3 m 60.81 154.03 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.871 -0.604 . . . . 1.1699999999999999 110.722 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.8 t -82.82 1.8 37.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 1.7 111.007 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 66.5 mm-40 -56.92 -21.0 26.45 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.543 -0.299 . . . . 1.8999999999999999 110.816 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.442 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 3.9 m-85 -71.88 -61.83 1.64 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.107 0.479 . . . . 0.23000000000000001 110.332 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.485 HD23 HD13 ' A' ' 191' ' ' ILE . 64.4 tp -68.77 -33.32 73.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.664 -0.698 . . . . 1.0800000000000001 109.768 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.577 ' O ' ' CG ' ' A' ' 178' ' ' MET . 52.5 m -59.76 -33.56 71.83 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.593 -0.731 . . . . 1.55 109.951 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.651 ' HB3' ' HA ' ' A' ' 101' ' ' PRO . . . -71.64 -45.07 63.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 1.0800000000000001 111.692 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 133' ' ' LEU . 1.6 mt -72.84 -31.11 64.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.145 -0.48 . . . . 1.04 110.435 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.548 ' O ' ' HG3' ' A' ' 181' ' ' PRO . 10.4 mt -66.78 -28.13 68.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.957 -0.565 . . . . 1.03 111.553 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.577 ' CG ' ' O ' ' A' ' 174' ' ' THR . 0.0 OUTLIER -98.75 -29.44 13.0 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 120.13 -0.628 . . . . 1.9299999999999999 110.43 179.178 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' ' 105' ' ' ALA . 83.0 m -81.79 -46.14 14.61 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.637 -0.711 . . . . 1.02 111.521 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.676 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -60.17 -40.9 81.24 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 113.286 0.847 . . . . 1.0600000000000001 113.286 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.676 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.5 Cg_endo -54.39 -35.57 84.93 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.426 1.418 . . . . 0.14999999999999999 112.545 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.99 -11.74 54.79 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.862 0.363 . . . . 1.0800000000000001 110.478 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.64 124.21 80.24 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.97 -0.559 . . . . 1.0700000000000001 109.788 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.1 -32.95 5.21 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.917 2.412 . . . . 0.42999999999999999 113.77 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -103.81 154.68 19.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.105 0.478 . . . . 1.75 111.431 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.419 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 12.4 t0 -67.39 122.54 18.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.603 -0.726 . . . . 1.3799999999999999 110.505 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.527 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 24.3 m -107.69 136.31 47.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.247 -0.433 . . . . 0.98999999999999999 111.435 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.476 HG22 ' CG1' ' A' ' 224' ' ' VAL . 45.4 t -126.5 97.93 4.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.979 -0.555 . . . . 1.03 110.053 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.561 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.4 mt -89.43 143.87 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-N 116.124 -0.489 . . . . 1.03 110.03 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.778 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -114.64 170.7 8.12 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.153 -1.054 . . . . 3.2200000000000002 108.153 177.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.485 HD13 HD23 ' A' ' 173' ' ' LEU . 0.9 OUTLIER -111.05 96.44 4.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 C-N-CA 120.767 -0.373 . . . . 1.05 111.126 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -59.09 -80.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.965 -0.561 . . . . 2.0600000000000001 110.662 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -81.24 167.18 48.95 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.838 -0.696 . . . . 0.19 112.567 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.15 126.22 26.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.641 0.258 . . . . 2.04 110.777 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.6 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.4 OUTLIER -61.49 144.1 54.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.987 0.423 . . . . 1.04 110.18 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.421 HG13 ' HA ' ' A' ' 169' ' ' SER . 14.5 p -100.48 -17.96 6.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.04 -0.527 . . . . 1.1100000000000001 111.541 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.537 ' CB ' ' HB2' ' A' ' 200' ' ' TYR . 0.1 OUTLIER -131.51 46.7 2.62 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.541 -0.754 . . . . 1.01 109.847 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.535 ' HA ' HD22 ' A' ' 195' ' ' LEU . 0.3 OUTLIER -40.0 -59.58 1.74 Allowed Pre-proline 0 N--CA 1.466 0.37 0 CA-C-N 115.453 -0.794 . . . . 1.9399999999999999 113.051 -178.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 59.3 Cg_endo -71.24 -16.04 31.59 Favored 'Trans proline' 0 CA--C 1.516 -0.402 0 C-N-CA 121.987 1.791 . . . . 0.83999999999999997 112.762 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.537 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 28.3 m-85 -79.23 -27.77 42.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.416 -0.356 . . . . 1.4099999999999999 110.332 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.473 HG12 ' CD2' ' A' ' 173' ' ' LEU . 7.7 tp -69.96 -31.44 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 116.214 -0.448 . . . . 1.02 110.259 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.4 OUTLIER -63.05 -32.21 73.53 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.643 -0.503 . . . . 1.3200000000000001 109.643 178.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' ' 207' ' ' LEU . 31.1 mt -67.76 -31.08 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.804 -0.634 . . . . 1.1200000000000001 110.356 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.408 HG21 ' HB3' ' A' ' 177' ' ' LEU . 42.0 m -60.65 -52.3 65.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.692 -0.485 . . . . 1.0700000000000001 109.692 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.486 ' CD2' HG12 ' A' ' 215' ' ' ILE . 41.1 mt -70.95 -35.12 72.07 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.958 -0.565 . . . . 1.01 110.557 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 202' ' ' ASP . 1.6 t30 -63.86 -30.7 71.77 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 109.529 -0.545 . . . . 1.51 109.529 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -76.69 -42.79 40.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.55 -0.75 . . . . 1.4299999999999999 109.373 178.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.416 ' HE1' ' HG3' ' A' ' 181' ' ' PRO . 30.4 mtp -64.89 -45.95 83.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.16 -0.927 . . . . 1.0700000000000001 111.255 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 210' ' ' THR . 0.0 OUTLIER -60.46 -44.17 96.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.438 -0.346 . . . . 2.7000000000000002 110.759 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.416 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.5 OUTLIER -57.89 -31.71 67.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.147 0.499 . . . . 1.2 109.88 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.551 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 1.6 m-85 -71.86 -51.54 21.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.488 -0.778 . . . . 0.52000000000000002 110.857 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 158.27 -4.82 0.14 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.522 -0.846 . . . . 0.26000000000000001 113.497 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.473 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 78.1 t -120.31 139.11 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.429 0.529 . . . . 1.0600000000000001 112.429 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -131.14 156.28 45.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.649 -0.705 . . . . 1.3300000000000001 110.568 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.486 HG12 ' CD2' ' A' ' 205' ' ' LEU . 1.8 pp -129.23 177.17 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 115.485 -0.78 . . . . 1.1599999999999999 111.782 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.836 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 2.8 tt0 -92.38 126.2 37.36 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.827 0.346 . . . . 1.8400000000000001 110.479 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -101.9 99.65 9.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.162 0.506 . . . . 2.2599999999999998 110.403 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.641 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 1.4 mm-40 -66.85 -166.35 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.652 -0.704 . . . . 1.8600000000000001 109.419 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.29 49.16 0.35 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.407 -0.36 . . . . 3.1000000000000001 110.611 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.455 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 56.7 20.05 4.79 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.016 0.436 . . . . 0.82999999999999996 110.926 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.435 ' O ' ' N ' ' A' ' 191' ' ' ILE . 54.6 mt-30 -111.66 -24.24 10.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 2.3399999999999999 110.106 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.778 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 41.2 mt-30 -146.63 140.93 26.39 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 120.979 0.418 . . . . 2.3399999999999999 111.168 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.561 ' N ' ' O ' ' A' ' 189' ' ' ILE . 19.6 m-85 -111.31 96.17 5.96 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.616 -0.883 . . . . 0.20000000000000001 108.616 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.836 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 52.1 t -86.36 110.76 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.042 0.448 . . . . 1.0700000000000001 110.935 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 187' ' ' THR . 7.4 m -103.03 120.71 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.662 -0.699 . . . . 1.05 111.669 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -62.89 112.59 2.63 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.497 -0.774 . . . . 2.21 109.797 178.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.419 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -66.55 151.3 52.24 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.159 -0.928 . . . . 0.20000000000000001 113.039 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.77 10.63 62.87 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.591 -0.814 . . . . 0.27000000000000002 113.473 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 181' ' ' PRO . 75.0 mm-40 -73.2 -175.42 1.85 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.34 0.591 . . . . 1.75 110.992 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.539 ' HA ' HD22 ' A' ' 182' ' ' LEU . 1.2 m -176.6 103.25 0.06 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.273 -0.876 . . . . 0.89000000000000001 109.813 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 27.4 m-85 -54.73 152.24 7.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.196 -0.457 . . . . 0.66000000000000003 111.261 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.607 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 16.6 pt20 -122.13 154.25 37.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.06 -0.719 . . . . 2.73 109.06 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 9.5 t -64.97 102.93 0.37 Allowed Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 112.404 0.52 . . . . 1.6000000000000001 112.404 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.607 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 58.2 Cg_endo -68.93 -33.15 20.59 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.284 1.989 . . . . 0.88 111.466 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 121.54 -123.7 5.57 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.697 -0.683 . . . . 0.26000000000000001 111.645 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.522 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -91.38 117.38 29.62 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.83 -0.433 . . . . 1.0600000000000001 109.83 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.436 ' CE2' HD13 ' A' ' 207' ' ' LEU . 62.5 t80 -122.75 144.65 49.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.859 0.361 . . . . 1.3799999999999999 111.674 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.769 ' HA ' HG21 ' A' ' 42' ' ' THR . 25.0 tp -99.35 117.78 34.54 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.293 -0.412 . . . . 1.8799999999999999 110.651 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 57.9 t -56.78 -73.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.988 -0.551 . . . . 1.4099999999999999 111.07 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.469 ' H ' ' HB3' ' A' ' 43' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.235 -0.888 . . . . 2.6200000000000001 111.154 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.51 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . 2.6 m . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.49 0.662 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.573 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 7.5 p30 -81.61 -22.32 37.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.027 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -65.57 -40.3 92.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.789 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.04 -36.46 40.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.993 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.588 HD21 ' HG ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -60.39 -51.63 68.66 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.922 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.544 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 2.4 tp -70.07 -43.21 71.63 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.891 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.531 HD12 ' HB3' ' A' ' 207' ' ' LEU . 48.6 mt -61.02 -35.9 78.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.005 0.431 . . . . 0.0 110.738 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.677 ' HA ' ' CE1' ' A' ' 211' ' ' PHE . . . -71.06 -29.97 66.0 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.737 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.593 ' O ' ' HB2' ' A' ' 78' ' ' ASN . . . -70.08 -30.62 67.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.542 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.895 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -89.39 -11.29 43.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.902 0.382 . . . . 0.0 111.102 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.45 165.57 20.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.212 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.524 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 75.7 m80 -99.07 98.68 9.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.967 0.413 . . . . 0.0 110.079 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.6 141.51 6.88 Favored Glycine 0 C--N 1.315 -0.637 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.162 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.73 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 13.6 tttt -62.6 132.83 53.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.085 0.469 . . . . 0.0 111.78 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.495 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.7 OUTLIER -128.22 152.71 47.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.917 178.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.643 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 58.5 t -100.85 141.2 17.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.021 0.439 . . . . 0.0 111.925 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -126.93 110.95 13.55 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.606 HG23 ' HA ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -101.99 166.94 10.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.121 0.486 . . . . 0.0 111.467 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 71' ' ' THR . 2.1 t30 70.6 19.35 6.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.879 -177.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -60.89 156.52 17.24 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.414 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.492 ' HG ' ' HB2' ' A' ' 47' ' ' SER . 16.8 tp -93.71 115.65 28.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.0 0.428 . . . . 0.0 111.617 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -76.37 64.49 2.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.439 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.492 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.3 OUTLIER -124.8 -159.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.063 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.704 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -97.39 -21.07 17.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.988 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.403 ' HA ' ' CB ' ' A' ' 95' ' ' ALA . 4.0 p-10 -72.77 -27.39 61.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.268 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 45' ' ' LEU . 13.3 t -88.46 -51.99 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.368 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.704 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 2.1 ptm180 -51.21 -28.53 11.62 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.209 0.528 . . . . 0.0 109.924 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -71.5 -39.82 70.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.246 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.573 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 3.0 tpt -62.54 -50.1 72.67 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 1.1 mt -60.01 -52.98 63.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.785 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.8 m120 -54.22 -22.86 12.65 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.851 178.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.433 ' O ' ' CD1' ' A' ' 60' ' ' LEU . . . -74.4 -48.11 29.83 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.597 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.579 ' CD1' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -72.06 -49.9 32.82 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.145 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.529 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 7.2 t -50.85 -30.88 15.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.158 0.504 . . . . 0.0 110.286 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.494 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -59.61 -49.5 77.5 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.958 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.73 HD22 ' HB3' ' A' ' 82' ' ' LEU . 3.6 mp -67.47 -28.46 67.88 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.584 0.707 . . . . 0.0 109.825 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.53 -0.24 5.47 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.537 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.599 HG13 ' N ' ' A' ' 63' ' ' SER . 13.8 t -58.7 147.97 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 117.491 0.645 . . . . 0.0 110.343 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.599 ' N ' HG13 ' A' ' 62' ' ' VAL . 1.0 OUTLIER -111.69 107.65 16.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.636 -178.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 6.8 p90 -122.7 160.52 25.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.157 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.624 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -149.31 116.41 6.03 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.662 179.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -86.52 174.09 9.17 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.228 0.537 . . . . 0.0 111.735 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.489 ' CB ' ' HG3' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -85.16 178.55 7.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.634 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.23 -14.79 53.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.091 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.95 2.93 12.8 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.003 0.43 . . . . 0.0 110.239 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.58 ' O ' HD22 ' A' ' 44' ' ' LEU . 1.3 mtm-85 62.51 47.5 5.0 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.121 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -127.05 -2.54 6.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.271 179.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -141.27 109.75 5.96 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -114.41 147.67 38.89 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.255 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.611 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 7.2 mt-10 -114.62 102.52 10.11 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -95.27 131.93 40.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.455 HG12 ' HE3' ' A' ' 38' ' ' LYS . 8.6 mm -80.53 104.34 8.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.807 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.632 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -51.31 112.85 1.94 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.512 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.593 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.2 m-20 -59.61 -17.18 31.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.969 0.414 . . . . 0.0 110.378 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.524 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 88.08 -22.49 18.54 Favored Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.281 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.895 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -139.13 -143.22 4.39 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.783 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 6.2 Cg_exo -80.52 171.12 15.09 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 121.95 1.767 . . . . 0.0 109.319 177.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.73 ' HB3' HD22 ' A' ' 60' ' ' LEU . 4.3 mm? -69.78 90.68 0.6 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.783 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 35.5 m170 -83.08 119.54 24.61 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.281 -1.781 . . . . 0.0 112.749 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 111' ' ' ASN . . . -143.54 106.76 4.54 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.334 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -105.09 86.73 2.49 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.346 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.62 23.41 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.897 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 53.93 51.02 15.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.526 0.679 . . . . 0.0 109.75 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.696 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 3.1 tp -80.88 137.33 36.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.252 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.616 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 3.3 tt0 -115.68 129.93 56.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.272 0.558 . . . . 0.0 110.766 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.493 HD22 ' HB1' ' A' ' 59' ' ' ALA . 4.3 mt -105.99 154.75 20.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.378 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -120.21 107.26 12.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.862 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.621 ' HG ' ' HA ' ' A' ' 99' ' ' MET . 1.6 mm? -93.33 3.47 55.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.378 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.422 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 40.53 -143.57 0.6 Allowed Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.166 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.476 ' OD1' ' HB3' ' A' ' 120' ' ' ARG . 1.0 OUTLIER -92.04 50.58 1.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.985 0.421 . . . . 0.0 110.88 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.403 ' CB ' ' HA ' ' A' ' 49' ' ' ASP . . . -92.34 -73.79 0.54 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.923 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.51 -17.46 14.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.465 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.425 ' HA ' ' OE1' ' A' ' 171' ' ' GLN . 6.0 p -96.59 -9.16 29.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.845 0.355 . . . . 0.0 111.271 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.4 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -128.02 -13.64 5.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.695 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.621 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 3.4 ttm -73.7 -54.8 7.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.082 0.467 . . . . 0.0 111.033 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.726 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -58.98 -50.8 86.03 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.475 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.626 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 28.2 Cg_exo -63.14 -47.18 8.62 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.721 2.28 . . . . 0.0 112.863 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.735 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 2.0 tm? -65.24 -37.74 88.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.754 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.3 -48.35 82.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.441 0.638 . . . . 0.0 110.077 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 175' ' ' ALA . . . -66.09 -41.47 90.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.519 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.509 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -59.1 -39.36 81.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.389 . . . . 0.0 112.041 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.735 ' HG ' ' O ' ' A' ' 102' ' ' LEU . 0.9 OUTLIER -73.3 -21.14 60.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.849 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.482 ' O ' ' HA2' ' A' ' 155' ' ' GLY . 10.8 m -63.86 -6.37 5.81 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.453 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.697 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 7.2 mt -85.13 168.5 14.77 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.554 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 56.11 -113.44 4.06 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.607 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.412 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.1 OUTLIER -167.9 94.18 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.972 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.601 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 44.4 p-10 -138.54 145.21 40.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.833 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.0 OUTLIER -102.83 111.65 24.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.808 179.361 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.696 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 5.0 mp -141.2 143.59 27.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.235 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.768 HG12 ' HG ' ' A' ' 143' ' ' LEU . 41.2 t -115.59 113.62 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 120.67 0.272 . . . . 0.0 110.615 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 115' ' ' LEU . 25.2 mt -81.89 156.82 24.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.428 0.632 . . . . 0.0 111.767 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.6 m -163.76 166.66 21.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.587 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -154.36 -166.11 14.66 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 119.928 -1.13 . . . . 0.0 113.708 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.645 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 11.7 mm-40 -69.48 173.17 4.22 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.46 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.645 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 24.3 Cg_endo -61.56 -24.48 78.1 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.979 1.786 . . . . 0.0 112.173 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.515 ' HD3' ' HG2' ' A' ' 123' ' ' GLU . 4.1 tpp180 -88.05 -33.47 18.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.536 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.491 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 9.2 tpt -59.96 -17.68 39.82 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.597 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 12.2 mttm -68.93 -5.51 21.84 Favored 'General case' 0 C--N 1.334 -0.09 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.524 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -119.09 22.62 11.78 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.141 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.421 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 17.0 mmm180 -102.24 86.73 0.94 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.766 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.774 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 4.4 Cg_endo -47.02 134.42 18.37 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.918 2.412 . . . . 0.0 112.581 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.49 HD13 ' HA ' ' A' ' 100' ' ' ARG . 21.4 tt -135.78 32.22 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.79 0.805 . . . . 0.0 109.682 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -70.99 -51.6 17.95 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.612 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.639 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -58.85 -29.55 67.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.767 0.318 . . . . 0.0 110.447 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.622 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 29.6 tp -76.76 -61.03 2.11 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.474 ' HA ' HD13 ' A' ' 133' ' ' LEU . 61.9 t -57.06 -25.62 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.653 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -70.42 -45.42 65.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.584 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.77 ' HA ' HD11 ' A' ' 135' ' ' LEU . . . -66.1 -46.89 76.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.915 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.63 HD13 HD11 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -60.43 -46.33 90.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.97 -38.1 72.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.549 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.77 HD11 ' HA ' ' A' ' 132' ' ' ALA . 3.8 mt -66.71 -32.31 73.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.271 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.474 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -76.09 -16.82 80.42 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.555 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 127.6 5.47 5.43 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.309 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.44 148.48 41.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.83 0.348 . . . . 0.0 111.439 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -117.2 94.04 4.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.391 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.63 HD11 HD13 ' A' ' 133' ' ' LEU . 14.1 mt -116.95 174.73 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.93 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.541 HG23 ' HB3' ' A' ' 152' ' ' ARG . 0.6 OUTLIER -153.17 -175.19 5.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.043 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -125.35 106.87 10.15 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.768 ' HG ' HG12 ' A' ' 114' ' ' VAL . 2.2 mm? -79.91 -13.58 59.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.734 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 45.8 mt-10 -142.98 -71.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.062 0.458 . . . . 0.0 110.896 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.729 ' HB3' ' CD2' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -113.48 147.37 37.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.647 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.472 ' O ' ' CD2' ' A' ' 148' ' ' TYR . 2.2 mt-10 -76.68 131.97 39.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.47 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.774 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 82.5 m-20 62.84 48.97 3.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.125 0.488 . . . . 0.0 109.72 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.791 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 50.5 m-85 -147.44 176.2 2.33 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.503 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.791 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 2.3 Cg_endo -44.25 -43.4 13.28 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.518 2.812 . . . . 0.0 115.461 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.734 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 30.5 Cg_endo -61.94 101.29 0.22 Allowed 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 121.539 1.493 . . . . 0.0 111.751 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.526 HD21 ' O ' ' A' ' 141' ' ' THR . 91.0 mt -138.72 123.62 18.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.622 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -104.63 112.3 25.33 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 176.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.574 HD12 ' HB2' ' A' ' 106' ' ' LEU . 1.2 mt -94.49 156.15 16.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.434 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.601 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 19.1 mt-30 -142.91 27.22 1.65 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.752 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 107' ' ' CYS . . . 53.86 -165.29 2.34 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.595 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.77 -5.15 36.86 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.901 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.573 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 3.2 t80 -60.53 108.01 0.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 0.0 110.668 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 68.3 p -107.53 -47.24 3.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.006 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.565 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 141.26 -159.91 26.74 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 119.976 -1.107 . . . . 0.0 114.175 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.455 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 114.82 175.47 18.6 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.47 128.01 34.85 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.533 HG11 ' N ' ' A' ' 163' ' ' ASP . 59.4 t -137.34 151.26 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.966 0.412 . . . . 0.0 111.858 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.533 ' N ' HG11 ' A' ' 162' ' ' VAL . 1.9 m-20 -118.27 116.51 26.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.113 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -118.04 144.82 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.754 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.639 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.2 OUTLIER -83.75 138.0 33.47 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.621 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -80.05 -44.84 8.68 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.355 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.14 164.04 0.08 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.808 0.337 . . . . 0.0 111.189 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 4.0 t 70.73 56.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.491 ' HA ' HG12 ' A' ' 196' ' ' VAL . 53.2 m 59.25 156.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.192 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 48.5 p -80.28 -0.9 38.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.165 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.726 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 77.3 mm-40 -52.8 -23.72 7.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.759 0.314 . . . . 0.0 111.278 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.471 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 3.8 m-85 -71.55 -54.27 11.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.033 0.444 . . . . 0.0 110.447 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.477 ' CD2' HG12 ' A' ' 201' ' ' ILE . 18.8 tp -78.02 -35.86 49.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.391 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.459 ' O ' ' HG2' ' A' ' 178' ' ' MET . 92.3 m -55.65 -37.01 67.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.165 0.507 . . . . 0.0 109.69 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.626 ' HB2' ' HA ' ' A' ' 101' ' ' PRO . . . -71.56 -51.44 23.45 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.411 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.65 ' HB3' HD12 ' A' ' 189' ' ' ILE . 3.1 mt -65.41 -35.8 82.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.458 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.523 ' O ' ' HG3' ' A' ' 181' ' ' PRO . 10.6 mt -66.53 -28.8 68.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.115 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.474 ' SD ' ' HG ' ' A' ' 30' ' ' LEU . 5.9 ptp -95.32 -27.53 15.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.169 0.509 . . . . 0.0 110.958 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.634 ' O ' HD13 ' A' ' 108' ' ' LEU . 80.3 m -87.44 -46.44 9.61 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.131 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.704 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -63.02 -36.29 23.88 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.704 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.5 Cg_endo -53.24 -36.91 79.66 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 121.28 1.32 . . . . 0.0 111.8 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.564 HD22 ' HA ' ' A' ' 230' ' ' SER . 0.9 OUTLIER -84.22 -10.83 57.38 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.655 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.4 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . . . -64.49 119.52 57.52 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.747 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 3.4 Cg_exo -41.09 -29.67 0.55 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.478 2.785 . . . . 0.0 114.291 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.32 153.36 22.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.17 0.51 . . . . 0.0 111.59 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.524 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 6.0 t70 -67.28 116.6 8.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.84 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.731 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 26.3 m -102.87 135.65 44.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.295 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.431 HG22 ' CG1' ' A' ' 224' ' ' VAL . 39.4 t -126.13 99.16 5.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.147 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.65 HD12 ' HB3' ' A' ' 176' ' ' LEU . 3.0 mt -90.87 142.0 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.238 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.808 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.3 OUTLIER -112.99 171.14 7.72 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.734 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.643 HG23 HD11 ' A' ' 195' ' ' LEU . 1.0 OUTLIER -110.59 97.42 5.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.918 0.39 . . . . 0.0 111.339 -178.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.428 ' HG2' ' HE ' ' A' ' 190' ' ' ARG . 15.1 mtmt -57.15 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.651 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -82.58 170.44 50.28 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.216 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.08 124.17 20.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.61 0.243 . . . . 0.0 110.604 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.643 HD11 HG23 ' A' ' 191' ' ' ILE . 0.4 OUTLIER -58.48 144.88 40.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.995 0.426 . . . . 0.0 110.461 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 169' ' ' SER . 14.8 p -101.13 -20.57 5.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.79 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.709 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -128.39 46.19 2.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.376 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.594 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . 5.5 ttpt -40.44 -62.11 1.02 Allowed Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.825 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 59.1 Cg_endo -70.21 -16.44 35.67 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 121.586 1.524 . . . . 0.0 112.209 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.709 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 14.6 m-85 -75.74 -30.11 59.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.234 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.477 HG12 ' CD2' ' A' ' 173' ' ' LEU . 7.3 tp -68.28 -33.83 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.026 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.446 ' N ' HG21 ' A' ' 201' ' ' ILE . 0.6 OUTLIER -59.24 -31.27 68.92 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.658 ' O ' ' HB2' ' A' ' 207' ' ' LEU . 20.7 mt -70.44 -30.77 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.236 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 201' ' ' ILE . 24.2 m -59.25 -55.1 39.16 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.506 HD12 ' CD1' ' A' ' 215' ' ' ILE . 21.7 mt -71.26 -35.73 71.51 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.296 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.743 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 58.4 m-20 -64.35 -28.67 69.86 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.658 ' HB2' ' O ' ' A' ' 203' ' ' ILE . 0.1 OUTLIER -76.55 -44.41 34.96 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.862 177.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.482 ' HB3' ' HE1' ' A' ' 231' ' ' TYR . 9.5 mtp -66.8 -41.09 88.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.449 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.743 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 17.1 pttt -61.07 -43.79 98.36 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.712 0.291 . . . . 0.0 110.337 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.636 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.6 OUTLIER -59.59 -29.68 68.14 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.677 ' CE1' ' HA ' ' A' ' 32' ' ' ALA . 1.3 m-85 -72.94 -50.78 21.49 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.504 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.413 ' HA3' ' HG2' ' A' ' 232' ' ' GLN . . . 153.98 -7.69 0.4 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.53 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.623 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 65.4 t -118.92 140.34 43.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -135.58 156.65 48.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.625 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.521 ' CG2' HG13 ' A' ' 225' ' ' VAL . 1.8 pp -127.77 175.3 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.94 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.883 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 6.4 tp10 -88.8 126.33 35.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.645 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -102.87 101.17 11.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.033 0.444 . . . . 0.0 110.573 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.735 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.7 OUTLIER -65.33 -166.64 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.453 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -73.37 49.02 0.26 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.842 0.353 . . . . 0.0 110.537 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.548 ' CZ ' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 57.48 19.81 5.55 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.129 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 191' ' ' ILE . 2.2 mt-30 -112.98 -21.42 11.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.826 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.808 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 23.9 mt-30 -149.17 140.11 22.87 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.967 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.59 ' N ' ' O ' ' A' ' 189' ' ' ILE . 27.5 m-85 -112.36 98.53 7.35 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.883 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 58.6 t -84.55 110.79 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 121.222 0.534 . . . . 0.0 111.283 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.731 ' CG2' ' HB ' ' A' ' 187' ' ' THR . 3.4 m -98.75 115.31 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.964 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.661 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -64.59 103.53 0.69 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.895 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.524 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.99 153.81 25.1 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.935 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.07 10.75 62.21 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.492 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.661 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 6.7 mm-40 -77.21 -179.15 5.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.223 0.535 . . . . 0.0 110.791 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.564 ' HA ' HD22 ' A' ' 182' ' ' LEU . 2.1 m -174.5 105.03 0.1 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.993 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.623 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 35.0 m-85 -55.52 151.85 9.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.67 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 16.7 pt20 -119.66 159.44 24.44 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 51.6 p -75.48 98.35 0.24 Allowed Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.67 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 52.8 Cg_endo -65.88 -32.73 44.93 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.497 2.131 . . . . 0.0 112.011 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 122.45 -121.14 4.56 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.643 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.3 OUTLIER -92.56 116.88 29.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 63.6 t80 -122.54 138.6 54.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.53 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.606 ' HA ' HG23 ' A' ' 42' ' ' THR . 3.6 tp -93.57 120.42 33.82 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.173 178.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 25' ' ' SER . 40.7 t -61.5 -75.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.821 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.431 ' H ' ' HB3' ' A' ' 43' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.935 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.601 ' HB3' ' H ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 121.427 0.632 . . . . 0.0 110.399 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 18.5 p30 -78.76 -26.23 44.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.787 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -62.48 -38.8 91.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.651 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 41' ' ' LEU . . . -78.55 -34.76 46.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.241 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.607 HD22 ' CG ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -62.3 -53.24 58.03 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.996 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 4.7 tp -67.77 -45.3 75.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.521 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.758 HD11 ' HB3' ' A' ' 207' ' ' LEU . 38.6 mt -58.97 -34.82 72.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.325 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.647 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -75.41 -30.06 59.96 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.729 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 78' ' ' ASN . . . -69.67 -32.57 71.27 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.611 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.874 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -87.77 -12.12 46.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.006 0.432 . . . . 0.0 110.804 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.0 163.71 21.94 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.73 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.538 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 75.0 m80 -97.44 97.07 8.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.86 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.34 144.6 7.38 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.018 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 16.2 tttt -66.6 134.8 53.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.076 0.465 . . . . 0.0 111.975 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.562 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -128.85 154.87 46.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.766 178.534 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.629 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 54.5 t -101.87 141.64 17.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.789 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -127.12 111.45 14.02 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.736 HG21 ' HA ' ' A' ' 238' ' ' LEU . 0.5 OUTLIER -104.7 167.4 9.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.156 0.503 . . . . 0.0 111.719 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.626 ' HB3' ' H ' ' A' ' 240' ' ' GLU . 0.3 OUTLIER 67.45 20.47 9.85 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.794 -177.248 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.535 ' HG ' ' HB3' ' A' ' 25' ' ' SER . 0.6 OUTLIER -59.08 157.24 10.54 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.565 178.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.601 ' H ' ' HB3' ' A' ' 25' ' ' SER . 28.9 tp -95.32 114.3 26.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.122 0.487 . . . . 0.0 111.704 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -73.6 59.34 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.13 0.49 . . . . 0.0 110.53 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.8 p -115.87 -162.69 0.85 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.087 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.655 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 42.5 m-20 -97.94 -22.8 16.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.491 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.635 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 4.8 p-10 -73.34 -24.01 60.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.228 0.537 . . . . 0.0 110.0 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.544 HG21 ' O ' ' A' ' 45' ' ' LEU . 19.2 t -89.02 -55.2 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.103 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.664 ' O ' ' HB2' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -51.3 -29.47 15.01 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 109.842 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -71.12 -37.87 72.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.892 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.487 ' O ' HD22 ' A' ' 57' ' ' LEU . 9.3 tpt -63.83 -51.15 66.0 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.642 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 1.2 mp -62.04 -47.46 84.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.664 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -56.25 -26.1 50.28 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.336 179.076 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.522 ' HA ' HD12 ' A' ' 90' ' ' LEU . . . -74.18 -46.31 42.92 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.631 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.573 HD13 HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -68.27 -49.6 59.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.818 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.525 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 7.2 t -49.74 -31.47 11.47 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.204 0.526 . . . . 0.0 109.888 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.521 ' HB2' HD22 ' A' ' 88' ' ' LEU . . . -59.7 -52.36 65.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.093 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.847 HD23 ' HB3' ' A' ' 82' ' ' LEU . 4.1 mp -65.42 -28.63 69.38 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.524 0.678 . . . . 0.0 110.035 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.92 -1.23 6.26 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.758 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.657 HG21 HD12 ' A' ' 82' ' ' LEU . 22.8 t -56.27 152.81 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 117.639 0.72 . . . . 0.0 110.069 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.628 ' N ' HG12 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -114.28 108.68 17.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.005 -179.442 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.642 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 9.1 p90 -126.95 156.95 40.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 32.1 m -150.33 116.62 5.7 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.68 0.276 . . . . 0.0 111.078 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.634 ' CD2' HD22 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -85.62 177.44 7.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.197 0.522 . . . . 0.0 111.63 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.766 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 3.6 t -88.02 178.82 6.56 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.993 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.91 -12.72 39.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.584 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -117.71 2.61 12.29 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.866 0.365 . . . . 0.0 110.667 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.468 ' O ' HD21 ' A' ' 44' ' ' LEU . 10.9 mtt180 61.35 44.5 9.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.355 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -126.56 -2.6 6.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.562 179.446 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.766 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -141.21 110.25 6.19 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 65' ' ' THR . 3.0 t -114.75 149.88 36.21 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 43.7 mt-10 -115.85 102.85 10.07 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.684 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.6 mp -96.11 132.61 39.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.1 0.476 . . . . 0.0 111.995 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.632 HD13 ' HB2' ' A' ' 38' ' ' LYS . 15.1 mm -82.12 107.5 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.944 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -54.07 112.61 2.67 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.684 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -61.33 -17.06 51.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.973 0.416 . . . . 0.0 110.519 178.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.538 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 86.76 -21.63 17.98 Favored Glycine 0 C--O 1.228 -0.248 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.41 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.874 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.62 -144.88 4.7 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.788 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 6.2 Cg_exo -79.96 168.44 19.03 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 121.858 1.705 . . . . 0.0 109.289 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.847 ' HB3' HD23 ' A' ' 60' ' ' LEU . 4.2 mm? -66.89 90.56 0.18 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.788 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 29.7 m170 -82.48 118.75 23.47 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.073 -1.876 . . . . 0.0 112.858 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HB3' HD21 ' A' ' 60' ' ' LEU . . . -144.42 111.29 5.77 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.793 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -114.02 90.8 3.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.77 0.319 . . . . 0.0 111.524 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.03 22.6 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.736 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.7 52.28 11.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.453 0.644 . . . . 0.0 109.777 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.707 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 4.5 tp -82.71 130.53 35.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.256 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.635 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 0.7 OUTLIER -111.87 129.85 56.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.915 0.388 . . . . 0.0 110.519 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 56' ' ' ALA . 16.3 mt -114.04 154.39 27.78 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.459 ' CE1' ' HA2' ' A' ' 93' ' ' GLY . 43.9 t80 -121.01 102.26 8.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.642 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.705 ' HB2' ' HE2' ' A' ' 99' ' ' MET . 2.0 mm? -89.09 8.39 30.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.893 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.55 ' CA ' ' HG3' ' A' ' 118' ' ' GLU . . . 45.23 -142.91 3.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.898 -0.667 . . . . 0.0 113.203 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.485 ' ND2' ' HB3' ' A' ' 120' ' ' ARG . 16.6 t-20 -94.05 51.58 1.53 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.866 0.365 . . . . 0.0 111.081 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.635 ' HB3' ' HA ' ' A' ' 49' ' ' ASP . . . -90.15 -73.13 0.53 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.115 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.45 -16.38 18.83 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.073 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.436 ' HA ' ' CD ' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -95.15 -8.23 36.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.328 . . . . 0.0 111.103 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.428 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -127.46 -17.6 4.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.708 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.705 ' HE2' ' HB2' ' A' ' 92' ' ' LEU . 41.4 tpp -67.65 -54.72 17.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.097 0.475 . . . . 0.0 110.76 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.755 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -59.22 -53.37 66.94 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.474 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.644 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 31.3 Cg_exo -60.35 -47.15 15.18 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.731 2.287 . . . . 0.0 112.831 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.725 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 3.4 tm? -69.34 -38.92 78.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.553 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.92 -47.79 84.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.485 0.66 . . . . 0.0 109.988 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.695 ' HB3' ' CD2' ' A' ' 133' ' ' LEU . . . -68.17 -36.42 79.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.847 -1.069 . . . . 0.0 113.23 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.5 ' HB1' HD21 ' A' ' 30' ' ' LEU . . . -61.75 -44.21 97.34 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.725 ' HG ' ' O ' ' A' ' 102' ' ' LEU . 0.2 OUTLIER -69.74 -19.96 63.52 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.56 -179.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.558 ' SG ' HD11 ' A' ' 140' ' ' ILE . 56.6 m -60.06 -11.52 6.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.169 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.711 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 7.7 mt -84.17 168.92 15.34 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 52.66 -108.96 0.8 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.374 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.4 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 11.3 p -166.93 100.86 0.55 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.689 0.281 . . . . 0.0 110.497 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.578 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 9.7 m-20 -138.3 136.82 36.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.119 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 4.5 m-20 -101.42 111.21 23.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.476 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.707 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 4.3 mp -142.55 141.76 27.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.324 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.635 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 10.5 t -112.31 114.15 46.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.594 HD11 ' SD ' ' A' ' 99' ' ' MET . 59.5 mt -87.35 156.74 19.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.551 0.691 . . . . 0.0 112.288 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.466 HG22 ' H ' ' A' ' 117' ' ' GLY . 0.6 OUTLIER -159.03 175.25 13.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.071 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.466 ' H ' HG22 ' A' ' 116' ' ' THR . . . -164.15 -168.5 26.31 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 119.902 -1.142 . . . . 0.0 114.253 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.732 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 36.5 mt-10 -67.7 174.8 1.98 Allowed Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 122.877 0.471 . . . . 0.0 110.453 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.732 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 24.1 Cg_endo -61.39 -38.44 64.25 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.988 1.792 . . . . 0.0 112.267 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.485 ' HB3' ' ND2' ' A' ' 94' ' ' ASN . 15.0 tpp85 -76.88 -30.07 56.05 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.276 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.677 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 11.2 tpt -65.0 -11.59 40.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.205 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.727 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 10.4 mttt -76.33 -6.53 51.96 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.652 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 9.9 pt-20 -121.62 23.37 10.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.973 0.416 . . . . 0.0 111.166 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.422 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 5.1 mmp_? -96.94 94.75 1.89 Allowed Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.541 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.644 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 10.3 Cg_endo -53.66 123.09 12.53 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.499 2.133 . . . . 0.0 112.572 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.539 ' O ' HG12 ' A' ' 126' ' ' ILE . 13.3 tt -127.82 32.07 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.617 0.723 . . . . 0.0 110.225 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -74.3 -49.98 11.04 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.479 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.791 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -52.1 -28.42 17.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.047 0.451 . . . . 0.0 110.656 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.566 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 15.8 tp -82.37 -65.44 1.01 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.546 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.569 ' HA ' ' CD1' ' A' ' 133' ' ' LEU . 47.8 t -51.1 -28.23 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.179 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 13.0 t70 -68.43 -45.93 71.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.496 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.717 ' HA ' HD13 ' A' ' 135' ' ' LEU . . . -66.5 -48.78 68.72 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.695 ' CD2' ' HB3' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -58.34 -43.08 88.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.36 0.6 . . . . 0.0 109.684 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.53 -33.88 73.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.698 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.717 HD13 ' HA ' ' A' ' 132' ' ' ALA . 3.4 mt -69.79 -31.12 68.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.991 0.424 . . . . 0.0 110.266 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.552 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -77.79 -17.12 79.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.379 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.78 3.98 5.33 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.141 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.25 147.24 48.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 111.105 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 1.9 mmtp -113.94 91.22 3.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.454 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.631 HD13 HD11 ' A' ' 133' ' ' LEU . 8.1 mt -116.45 174.63 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.515 ' CG2' ' N ' ' A' ' 142' ' ' TYR . 0.5 OUTLIER -151.49 -167.15 2.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.144 0.497 . . . . 0.0 111.187 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.515 ' N ' ' CG2' ' A' ' 141' ' ' THR . 24.4 m-85 -136.17 99.1 4.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.929 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.493 ' HG ' HG13 ' A' ' 114' ' ' VAL . 2.4 mm? -68.25 -13.07 61.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.584 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.745 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 40.1 mm-40 -142.0 -73.8 0.31 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.069 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.492 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -120.43 150.09 41.34 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.145 0.498 . . . . 0.0 111.526 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.479 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 16.6 pt-20 -68.21 128.0 34.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.258 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.644 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 8.3 m-20 68.73 51.58 0.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.248 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.798 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.0 m-30 -145.17 177.29 1.82 Allowed Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.798 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 4.5 Cg_endo -48.08 -43.38 30.82 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.026 2.484 . . . . 0.0 114.974 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.745 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 27.8 Cg_endo -62.4 100.95 0.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 120.989 1.126 . . . . 0.0 111.276 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.509 HD22 ' O ' ' A' ' 141' ' ' THR . 61.8 mt -136.97 123.32 20.68 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.412 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 140' ' ' ILE . 2.8 mtp180 -103.93 112.11 24.95 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.502 HD12 HD12 ' A' ' 106' ' ' LEU . 1.7 mt -93.83 158.75 15.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.318 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 28.2 mt-30 -149.44 22.66 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.079 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.485 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 53.68 -166.87 1.71 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.707 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 109.29 -2.23 31.15 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.957 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.625 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 2.5 t80 -60.38 108.21 0.78 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.943 0.372 . . . . 0.0 110.949 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 68.5 p -105.09 -49.29 3.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.054 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.619 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 142.43 -163.58 27.13 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.168 -1.015 . . . . 0.0 114.019 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.445 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 116.7 172.56 16.42 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -65.29 128.32 35.36 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 117.245 0.523 . . . . 0.0 109.732 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.532 HG11 HD13 ' A' ' 135' ' ' LEU . 59.5 t -135.9 157.35 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.149 0.5 . . . . 0.0 111.31 -178.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.453 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.7 OUTLIER -125.34 117.94 24.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.518 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.456 HG12 HD12 ' A' ' 173' ' ' LEU . 0.5 OUTLIER -117.91 147.19 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.945 -178.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.791 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.2 OUTLIER -85.77 133.04 34.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.613 178.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.687 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -74.52 -44.67 26.14 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.304 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.489 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 0.2 OUTLIER -49.8 163.15 0.14 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.915 0.388 . . . . 0.0 111.805 -179.56 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 169' ' ' SER . 8.2 t 71.27 61.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.844 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.612 ' HB3' ' HG2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER 54.56 156.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.468 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.46 ' OG ' ' OG1' ' A' ' 174' ' ' THR . 6.7 t -79.61 2.21 23.28 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.877 0.37 . . . . 0.0 110.891 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.755 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 82.6 mm-40 -54.05 -24.14 16.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.328 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.541 ' CD2' ' HB2' ' A' ' 128' ' ' HIS . 2.1 m-85 -73.71 -58.48 3.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.352 0.596 . . . . 0.0 110.587 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.54 HD23 ' CE1' ' A' ' 223' ' ' PHE . 18.0 tp -72.25 -37.29 69.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.861 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.46 ' OG1' ' OG ' ' A' ' 170' ' ' SER . 66.8 m -57.29 -36.47 71.09 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.241 0.543 . . . . 0.0 109.772 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.544 ' CB ' ' HA ' ' A' ' 101' ' ' PRO . . . -71.76 -51.28 23.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.25 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.613 ' HB3' HD11 ' A' ' 189' ' ' ILE . 3.2 mt -64.12 -38.53 91.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.466 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.526 HD13 ' CD1' ' A' ' 201' ' ' ILE . 12.5 mt -65.61 -26.55 67.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.07 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.518 ' HA ' ' HH ' ' A' ' 231' ' ' TYR . 20.2 ptp -96.16 -27.03 15.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.175 0.512 . . . . 0.0 110.637 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.552 ' O ' HD12 ' A' ' 108' ' ' LEU . 65.5 m -86.26 -47.0 9.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.795 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.667 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -61.56 -38.49 52.04 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 9.2 Cg_endo -53.57 -35.98 78.9 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 121.28 1.32 . . . . 0.0 111.895 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.68 -9.25 58.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.676 -179.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.417 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . . . -65.75 123.95 86.16 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.935 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 1.5 Cg_endo -43.58 -31.26 3.09 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.333 2.688 . . . . 0.0 113.993 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -106.02 153.46 21.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.137 0.494 . . . . 0.0 111.879 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.594 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 75.5 m-20 -67.03 113.15 4.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.78 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.704 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 41.1 m -99.6 135.18 41.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.167 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.477 HG12 HG21 ' A' ' 224' ' ' VAL . 35.3 t -125.83 99.0 5.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.324 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.613 HD11 ' HB3' ' A' ' 176' ' ' LEU . 3.5 mt -89.58 144.17 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.462 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.808 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -114.21 170.93 7.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.618 HG23 HD11 ' A' ' 195' ' ' LEU . 1.4 mm -110.65 96.35 4.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 120.858 0.361 . . . . 0.0 111.007 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -59.33 -81.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.483 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -81.43 167.8 49.29 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.164 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.94 122.97 16.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.555 0.217 . . . . 0.0 110.546 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.794 HD22 ' HA ' ' A' ' 198' ' ' LYS . 0.8 OUTLIER -56.24 148.2 19.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.228 0.537 . . . . 0.0 110.535 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 169' ' ' SER . 13.8 p -105.81 -21.78 5.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.225 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.668 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -126.65 47.42 2.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.794 ' HA ' HD22 ' A' ' 195' ' ' LEU . 0.1 OUTLIER -44.1 -65.15 0.64 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.904 -178.114 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.541 ' CD ' ' HB3' ' A' ' 198' ' ' LYS . 43.0 Cg_endo -65.6 -18.18 58.55 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 121.545 1.497 . . . . 0.0 111.542 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.668 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 13.3 m-85 -73.81 -30.03 62.49 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.561 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.526 ' CD1' HD13 ' A' ' 177' ' ' LEU . 8.0 tp -69.55 -33.32 56.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.422 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.3 OUTLIER -60.9 -35.5 76.84 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.559 HD13 ' HA ' ' A' ' 200' ' ' TYR . 15.8 mt -65.93 -30.27 49.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.62 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.477 ' O ' ' HG3' ' A' ' 208' ' ' MET . 45.0 m -60.99 -55.76 29.14 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.607 HD21 HG12 ' A' ' 215' ' ' ILE . 35.5 mt -70.25 -33.71 71.96 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.473 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.552 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -66.14 -29.44 69.74 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.758 ' HB3' HD11 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -77.08 -44.92 28.81 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.115 178.371 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.477 ' HG3' ' O ' ' A' ' 204' ' ' THR . 12.7 mtp -64.62 -42.61 95.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.2 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.602 ' HG3' ' N ' ' A' ' 210' ' ' THR . 4.4 ptmt -61.53 -46.08 91.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.64 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.602 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.3 OUTLIER -59.11 -29.57 67.47 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.777 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 0.8 OUTLIER -70.76 -49.67 44.22 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.485 179.277 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 155.63 -7.52 0.28 Allowed Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.337 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.701 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 49.3 t -119.18 141.82 37.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -135.59 155.67 50.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.401 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.607 HG12 HD21 ' A' ' 205' ' ' LEU . 2.3 pp -129.1 175.87 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.754 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.916 -177.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.98 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 7.2 tp10 -88.74 125.2 34.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.529 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -101.53 101.02 11.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.424 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.823 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.6 OUTLIER -66.77 -168.14 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.499 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -74.37 48.42 0.33 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.816 0.341 . . . . 0.0 110.427 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.605 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 58.14 20.13 6.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.036 0.446 . . . . 0.0 111.252 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 191' ' ' ILE . 3.8 mt-30 -112.23 -20.52 11.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.77 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.823 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 17.6 mt-30 -151.2 140.87 21.74 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.901 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.576 ' N ' ' O ' ' A' ' 189' ' ' ILE . 11.0 m-85 -113.19 98.99 7.48 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.98 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 45.9 t -84.71 110.89 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.143 0.497 . . . . 0.0 111.25 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.704 ' CG2' ' HB ' ' A' ' 187' ' ' THR . 3.2 m -99.02 111.61 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.927 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.705 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.6 OUTLIER -62.02 101.21 0.2 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.035 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.594 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -55.94 155.85 11.56 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.402 -0.817 . . . . 0.0 113.029 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.34 10.92 63.35 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.326 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.705 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 81.6 mm-40 -78.06 -177.67 5.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.444 0.64 . . . . 0.0 111.327 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.573 ' HA ' HD21 ' A' ' 182' ' ' LEU . 2.7 m -175.87 104.75 0.08 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.212 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.701 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 24.8 m-85 -54.11 152.44 6.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.825 0.345 . . . . 0.0 111.118 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.777 ' HG2' ' O ' ' A' ' 211' ' ' PHE . 7.5 pt20 -122.68 155.7 35.87 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 35.2 t -69.26 100.42 0.26 Allowed Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.673 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 56.9 Cg_endo -67.8 -32.75 28.95 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.387 2.058 . . . . 0.0 111.76 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 123.4 -119.01 3.69 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.962 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.629 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.8 OUTLIER -96.69 117.32 30.75 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 52.7 t80 -121.53 135.3 55.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.013 -178.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.736 ' HA ' HG21 ' A' ' 42' ' ' THR . 8.7 tp -95.51 111.35 23.28 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.582 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.9 -71.46 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.035 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.626 ' H ' ' HB3' ' A' ' 43' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.013 -0.994 . . . . 0.0 111.072 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.708 ' O ' HD13 ' A' ' 29' ' ' LEU . 19.2 p . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.68 0.276 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.668 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 4.4 p30 -84.87 -25.78 27.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.535 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.411 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 52.0 mtt180 -67.96 -42.05 81.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HB2' ' CD2' ' A' ' 41' ' ' LEU . . . -74.68 -32.98 62.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.832 HD23 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -62.07 -48.82 78.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.186 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.557 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 17.0 tp -73.93 -43.93 56.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.453 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.716 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 61.8 mt -59.89 -31.9 70.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.109 0.48 . . . . 0.0 110.899 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.658 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -78.6 -30.66 46.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.595 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.644 ' O ' ' HB2' ' A' ' 78' ' ' ASN . . . -69.37 -32.12 70.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.62 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.895 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -88.74 -12.28 42.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.145 0.497 . . . . 0.0 110.966 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -80.43 166.17 21.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.409 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.494 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 78.6 m80 -101.21 97.83 8.3 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.14 142.28 6.77 Favored Glycine 0 C--N 1.315 -0.611 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.828 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 17.4 ttpp -67.02 138.91 57.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.236 0.541 . . . . 0.0 112.027 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.703 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.7 OUTLIER -132.93 156.13 47.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.333 179.076 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.621 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 61.9 t -102.75 142.87 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.317 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.449 ' CD2' ' HB2' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -127.79 111.94 14.2 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 1.084 ' HB ' ' HD3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -97.65 167.85 10.71 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.02 0.438 . . . . 0.0 111.179 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.628 ' HB2' HD11 ' A' ' 238' ' ' LEU . 0.2 OUTLIER 61.55 21.35 12.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.065 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.608 HD11 ' HA ' ' A' ' 25' ' ' SER . 0.5 OUTLIER -58.88 159.35 7.06 Favored 'General case' 0 N--CA 1.46 0.069 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.472 ' HB3' HG23 ' A' ' 50' ' ' VAL . 31.4 tp -92.63 114.6 27.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.022 0.439 . . . . 0.0 111.659 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -76.1 65.46 2.11 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.179 0.514 . . . . 0.0 109.995 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.411 ' HB3' ' H ' ' A' ' 48' ' ' ASP . 8.3 m -128.31 -162.41 1.18 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.284 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.676 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -96.97 -19.94 18.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.246 0.546 . . . . 0.0 110.841 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.756 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 30.1 m-20 -69.95 -28.63 65.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.123 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.635 HG22 ' HB2' ' A' ' 25' ' ' SER . 25.8 t -89.74 -50.89 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.752 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.676 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -49.21 -29.08 5.17 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.116 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.49 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . 8.4 m-70 -73.32 -37.56 66.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.298 178.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.668 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 3.2 tpt -64.73 -47.86 76.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.832 HD23 HD23 ' A' ' 29' ' ' LEU . 1.6 mp -68.43 -43.93 76.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.602 ' HA ' HG22 ' A' ' 58' ' ' THR . 1.2 m-80 -58.5 -22.72 56.01 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.955 0.407 . . . . 0.0 110.319 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.536 ' CB ' ' HG ' ' A' ' 102' ' ' LEU . . . -75.82 -48.57 21.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.62 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.513 HD22 ' O ' ' A' ' 53' ' ' MET . 0.1 OUTLIER -67.41 -48.13 68.24 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.593 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.657 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.0 t -52.39 -30.67 30.22 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.16 0.505 . . . . 0.0 110.247 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.668 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -61.77 -47.98 82.71 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.296 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.802 HD21 ' HB3' ' A' ' 82' ' ' LEU . 3.3 mp -71.22 -24.88 62.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.212 0.53 . . . . 0.0 110.184 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.71 0.65 7.16 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.434 -0.889 . . . . 0.0 114.067 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.655 HG23 HD13 ' A' ' 82' ' ' LEU . 11.3 t -56.73 156.49 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 117.58 0.69 . . . . 0.0 110.536 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.712 ' O ' HD11 ' A' ' 76' ' ' ILE . 2.8 m -113.66 110.09 19.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.733 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.657 ' CE2' ' HB ' ' A' ' 58' ' ' THR . 20.7 p90 -132.58 152.45 51.61 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.552 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.698 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -147.94 116.17 6.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.715 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.641 HD11 ' HB2' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -84.24 175.35 9.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.152 0.501 . . . . 0.0 111.104 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.63 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -87.25 179.22 6.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.092 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.83 -14.55 34.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.225 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.87 8.04 11.05 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.856 0.36 . . . . 0.0 110.606 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.557 ' O ' HD23 ' A' ' 44' ' ' LEU . 1.4 mtp180 58.75 47.04 13.35 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.421 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.418 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -129.23 -2.05 5.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.601 179.157 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 1.084 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -138.78 109.07 6.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.929 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.698 ' HA ' ' O ' ' A' ' 65' ' ' THR . 3.4 t -120.04 146.81 45.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.259 0.552 . . . . 0.0 112.185 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.637 ' HB3' ' HD2' ' A' ' 38' ' ' LYS . 1.2 mp0 -115.69 102.56 9.85 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.104 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -95.95 124.34 48.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.712 HD11 ' O ' ' A' ' 63' ' ' SER . 1.8 mp -79.22 104.25 7.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.215 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.658 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -48.8 118.53 5.01 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.877 -0.601 . . . . 0.0 114.346 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.644 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 2.3 m-20 -64.02 -15.94 60.54 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.093 0.473 . . . . 0.0 110.022 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.494 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.15 -20.73 14.84 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.218 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.895 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -137.44 -155.38 6.9 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.838 ' HA ' HD22 ' A' ' 34' ' ' LEU . 3.0 Cg_exo -74.35 166.37 29.63 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 121.865 1.71 . . . . 0.0 108.738 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.839 HD21 HD21 ' A' ' 34' ' ' LEU . 4.3 mm? -64.62 90.03 0.07 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.328 1.061 . . . . 0.0 108.293 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.832 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 31.3 m170 -82.55 118.59 23.38 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.675 -176.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 111' ' ' ASN . . . -142.93 109.42 5.37 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.971 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -112.76 93.42 4.42 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.222 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.86 21.26 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.282 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 56.72 50.24 12.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.469 0.652 . . . . 0.0 110.302 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.688 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 4.8 tp -79.77 137.94 37.13 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.189 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.607 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -117.04 124.06 48.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.139 0.495 . . . . 0.0 110.733 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.471 HD23 HD12 ' A' ' 88' ' ' LEU . 10.1 mt -105.47 162.99 12.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.475 0.655 . . . . 0.0 112.274 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.595 ' HA ' ' O ' ' A' ' 116' ' ' THR . 30.2 t80 -127.22 106.86 9.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.466 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.926 ' HG ' ' HA ' ' A' ' 99' ' ' MET . 2.5 mm? -94.67 6.83 47.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.474 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 44.37 -137.89 5.08 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.791 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.519 ' N ' ' HG3' ' A' ' 118' ' ' GLU . 9.8 t-20 -104.47 55.18 0.72 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.911 0.386 . . . . 0.0 110.671 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.756 ' HB1' ' HA ' ' A' ' 49' ' ' ASP . . . -98.65 -66.35 0.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.917 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.589 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 78.48 -17.09 6.87 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.867 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.442 ' HA ' ' CD ' ' A' ' 171' ' ' GLN . 1.7 p -92.71 -6.92 48.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.737 0.303 . . . . 0.0 111.238 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.487 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -131.97 -20.71 2.47 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.926 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 2.2 ttt -68.19 -51.48 45.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.941 0.401 . . . . 0.0 110.53 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.631 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 2.5 mpt_? -58.83 -53.68 63.98 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.561 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.675 ' HA ' ' HB1' ' A' ' 175' ' ' ALA . 24.3 Cg_exo -64.57 -46.74 6.6 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.853 2.369 . . . . 0.0 113.164 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.69 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 3.1 tm? -64.0 -37.78 88.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.23 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.41 ' HB1' ' CD1' ' A' ' 115' ' ' LEU . . . -62.15 -48.38 80.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.443 0.639 . . . . 0.0 110.285 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.559 ' O ' ' HB2' ' A' ' 107' ' ' CYS . . . -67.3 -40.77 86.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.566 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.46 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -58.68 -42.98 89.78 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.851 HD11 ' CD1' ' A' ' 153' ' ' LEU . 0.6 OUTLIER -68.78 -21.37 64.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.276 0.56 . . . . 0.0 110.884 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.659 ' SG ' HD11 ' A' ' 140' ' ' ILE . 99.6 m -61.65 -10.33 8.2 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.727 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.717 HD11 ' O ' ' A' ' 179' ' ' THR . 13.0 mt -81.08 167.4 19.77 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 52.65 -111.74 1.78 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.393 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.457 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 14.7 m -162.59 99.59 1.02 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.949 0.404 . . . . 0.0 110.287 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.575 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 20.5 m-20 -138.94 136.11 35.1 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 0.9 OUTLIER -100.2 111.23 23.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.015 178.468 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.688 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 4.6 mp -144.23 142.7 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.411 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.797 HG11 ' HG ' ' A' ' 143' ' ' LEU . 29.5 t -115.44 111.37 35.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.044 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 115' ' ' LEU . 33.7 mt -79.75 156.95 27.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.567 0.698 . . . . 0.0 112.359 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 19.0 m -159.51 156.34 28.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.795 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.3 -166.78 11.33 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.448 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.572 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 3.3 mm-40 -70.89 176.97 1.65 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.572 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 38.7 Cg_exo -62.22 -35.47 74.23 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.208 1.939 . . . . 0.0 112.222 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.597 ' HD3' ' HG2' ' A' ' 123' ' ' GLU . 19.5 tpp85 -79.71 -33.91 40.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.943 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.611 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 11.1 tpt -60.19 -18.11 45.88 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.72 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 5.1 mmtp -69.61 -4.84 20.98 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.066 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.597 ' HG2' ' HD3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -120.17 27.14 8.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.836 0.351 . . . . 0.0 110.903 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.431 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 11.4 mmm-85 -107.22 87.08 2.9 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.513 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.806 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.9 Cg_endo -47.82 123.8 8.95 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.753 2.302 . . . . 0.0 111.698 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.595 ' O ' HG23 ' A' ' 130' ' ' VAL . 19.1 tt -125.04 28.28 2.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.81 0.814 . . . . 0.0 110.31 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.628 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -67.04 -51.16 41.19 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.548 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.637 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -52.63 -31.62 37.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.085 0.469 . . . . 0.0 110.88 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.816 HD12 ' CD2' ' A' ' 133' ' ' LEU . 31.9 tp -79.23 -65.08 1.04 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.808 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 126' ' ' ILE . 54.1 t -52.33 -26.19 8.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.54 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.628 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.4 OUTLIER -72.04 -47.79 49.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.093 0.473 . . . . 0.0 111.048 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.871 ' HA ' HD11 ' A' ' 135' ' ' LEU . . . -60.58 -48.85 79.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.426 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.816 ' CD2' HD12 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -61.4 -43.26 99.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.548 0.689 . . . . 0.0 109.707 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -61.51 -33.38 73.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.643 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.871 HD11 ' HA ' ' A' ' 132' ' ' ALA . 2.8 mt -69.33 -30.03 67.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.83 0.348 . . . . 0.0 110.075 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.43 -18.39 79.19 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.585 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 131.37 1.38 4.79 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.023 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 107' ' ' CYS . . . -71.39 146.87 48.46 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.937 0.399 . . . . 0.0 111.45 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.0 mttt -116.29 94.38 4.62 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.235 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.659 HD11 ' SG ' ' A' ' 107' ' ' CYS . 9.0 mt -116.85 178.69 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.93 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.65 ' H ' HG21 ' A' ' 140' ' ' ILE . 0.7 OUTLIER -161.38 -174.79 4.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.008 0.432 . . . . 0.0 111.205 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.49 ' CG ' ' HA ' ' A' ' 146' ' ' GLU . 24.5 m-85 -123.94 108.86 12.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.869 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.797 ' HG ' HG11 ' A' ' 114' ' ' VAL . 1.4 mm? -85.51 -14.46 45.91 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.493 ' HB3' ' CB ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -137.48 -69.79 0.45 Allowed 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.164 0.506 . . . . 0.0 109.705 179.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.752 ' HB3' ' CD2' ' A' ' 148' ' ' TYR . 2.8 mt-30 -118.2 145.63 44.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.675 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.49 ' HA ' ' CG ' ' A' ' 142' ' ' TYR . 12.3 mt-10 -76.8 128.82 35.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.787 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.806 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 31.1 m-20 65.22 49.47 1.96 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.824 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 42.6 m-85 -149.15 179.02 1.28 Allowed Pre-proline 0 CA--C 1.549 0.904 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.594 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.824 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -43.9 -44.41 11.9 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 123.965 3.11 . . . . 0.0 115.167 -178.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.688 ' HD3' ' HE3' ' A' ' 122' ' ' LYS . 46.5 Cg_endo -64.6 102.65 0.42 Allowed 'Trans proline' 0 CA--C 1.509 -0.73 0 C-N-CA 121.701 1.601 . . . . 0.0 111.937 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.582 HD23 ' O ' ' A' ' 141' ' ' THR . 88.0 mt -139.43 124.11 18.45 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.057 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.572 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.1 OUTLIER -104.24 112.57 25.64 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.851 ' CD1' HD11 ' A' ' 106' ' ' LEU . 2.3 mt -93.61 159.97 14.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.191 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 2.0 mt-30 -147.51 23.97 1.12 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.964 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 107' ' ' CYS . . . 55.48 -166.07 3.47 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.597 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.44 -5.47 38.1 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.798 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.698 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 42.1 t80 -62.95 109.06 1.34 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.92 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 69.0 p -106.93 -47.7 3.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.958 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.6 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.55 -168.58 26.25 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.845 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.589 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 122.98 170.56 13.52 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -64.69 124.91 23.13 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.709 HG13 ' HB2' ' A' ' 132' ' ' ALA . 48.8 t -136.66 153.8 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 111.653 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.586 ' HB2' ' HE2' ' A' ' 192' ' ' LYS . 1.2 m-20 -119.01 118.03 30.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.729 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.839 HG13 HD13 ' A' ' 173' ' ' LEU . 0.9 OUTLIER -117.6 147.03 21.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.006 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.637 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 3.6 t0 -82.86 134.88 35.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.932 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.696 ' HA2' HD11 ' A' ' 195' ' ' LEU . . . -77.9 -44.2 12.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.299 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.21 166.51 0.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.611 0.243 . . . . 0.0 111.141 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.436 HG23 ' HE1' ' A' ' 128' ' ' HIS . 2.2 t 68.5 54.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.106 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.517 ' HA ' HG13 ' A' ' 196' ' ' VAL . 0.3 OUTLIER 61.53 141.23 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.1 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.523 ' CB ' ' HB2' ' A' ' 197' ' ' SER . 0.4 OUTLIER -69.63 -5.02 21.94 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.319 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.61 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 18.2 mm100 -50.66 -23.69 2.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.849 0.357 . . . . 0.0 111.046 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.522 ' HD2' ' HB2' ' A' ' 128' ' ' HIS . 3.0 m-85 -68.83 -54.72 14.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.494 0.664 . . . . 0.0 109.992 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.839 HD13 HG13 ' A' ' 164' ' ' VAL . 58.9 tp -76.75 -30.9 56.76 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.249 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.465 HG21 ' SD ' ' A' ' 178' ' ' MET . 33.2 m -61.06 -33.39 73.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.181 0.515 . . . . 0.0 109.849 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.675 ' HB1' ' HA ' ' A' ' 101' ' ' PRO . . . -70.02 -51.55 31.36 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.796 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.662 ' HB3' HD13 ' A' ' 189' ' ' ILE . 1.6 mt -67.1 -35.87 80.73 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.382 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.579 HD12 ' CD2' ' A' ' 223' ' ' PHE . 10.5 mt -69.02 -25.71 64.62 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.323 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.573 ' HG2' HD21 ' A' ' 31' ' ' LEU . 44.9 mtp -95.27 -27.05 15.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.265 0.555 . . . . 0.0 110.959 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.717 ' O ' HD11 ' A' ' 108' ' ' LEU . 88.7 m -91.93 -47.21 7.42 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.682 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.729 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -60.8 -36.21 32.83 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 13.0 Cg_endo -54.14 -37.92 87.48 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.154 1.236 . . . . 0.0 111.541 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.708 HD22 ' HA ' ' A' ' 230' ' ' SER . 1.1 mp -83.56 -8.87 59.25 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.047 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.41 ' HA ' ' HD2' ' A' ' 184' ' ' PRO . . . -67.21 120.15 70.12 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.148 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 5.9 Cg_exo -38.8 -28.92 0.15 Allowed 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.456 2.77 . . . . 0.0 114.224 -178.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -107.55 151.44 25.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 111.807 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.631 ' OD1' ' HA ' ' A' ' 226' ' ' LYS . 32.2 t70 -66.53 117.05 8.18 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.451 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.786 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 28.3 m -103.38 135.48 44.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.249 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.465 HG11 HG23 ' A' ' 224' ' ' VAL . 31.7 t -125.65 98.84 5.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.337 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.662 HD13 ' HB3' ' A' ' 176' ' ' LEU . 3.0 mp -89.62 141.62 14.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.324 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.799 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.4 OUTLIER -112.17 171.11 7.7 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.924 HG21 HD13 ' A' ' 195' ' ' LEU . 1.6 mm -110.18 97.61 5.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 120.981 0.42 . . . . 0.0 111.52 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.586 ' HE2' ' HB2' ' A' ' 163' ' ' ASP . 17.2 mttt -59.85 -82.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.884 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -80.95 175.0 54.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.77 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.39 124.67 22.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.649 0.261 . . . . 0.0 110.569 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.924 HD13 HG21 ' A' ' 191' ' ' ILE . 0.9 OUTLIER -60.95 148.25 40.51 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.01 0.433 . . . . 0.0 109.975 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 169' ' ' SER . 12.1 p -104.91 -19.33 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.557 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.8 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 3.8 m -131.36 45.46 2.8 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.04 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.833 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . 2.8 tttt -42.0 -65.41 0.52 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 114.896 -1.047 . . . . 0.0 113.283 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.833 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 15.9 Cg_exo -68.04 -17.88 45.95 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.517 1.478 . . . . 0.0 111.841 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.8 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 45.4 m-85 -75.11 -29.28 60.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.405 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 198' ' ' LYS . 9.5 tp -69.68 -30.95 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.126 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.64 -32.59 74.11 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.627 ' O ' HD22 ' A' ' 207' ' ' LEU . 33.0 mt -64.93 -32.63 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.147 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 54.7 m -60.06 -53.74 54.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.376 0.608 . . . . 0.0 109.772 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.862 ' O ' ' HG3' ' A' ' 209' ' ' LYS . 44.4 mt -68.59 -37.56 79.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.792 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -62.05 -29.29 70.19 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.716 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 2.1 mm? -76.66 -42.06 43.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.793 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.654 ' SD ' ' HG3' ' A' ' 181' ' ' PRO . 9.3 mtm -59.53 -42.92 93.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.796 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.862 ' HG3' ' O ' ' A' ' 205' ' ' LEU . 10.1 mtpt -64.96 -55.55 18.44 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.222 0.534 . . . . 0.0 110.2 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -50.76 -27.43 7.17 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.129 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.89 ' HA ' ' HG3' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -78.85 -50.2 11.65 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.561 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 152.58 0.82 0.22 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.967 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.503 ' HB ' ' CD1' ' A' ' 231' ' ' TYR . 53.8 t -118.78 139.81 44.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.138 0.494 . . . . 0.0 112.062 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.612 ' HG2' ' HG2' ' A' ' 209' ' ' LYS . 62.6 mt-10 -132.05 157.68 43.53 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.024 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.71 HD13 HD11 ' A' ' 205' ' ' LEU . 2.8 pp -138.16 175.26 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.909 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 1.08 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 33.0 tt0 -92.03 123.15 35.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.328 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -99.56 100.82 11.88 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.708 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.802 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.5 OUTLIER -67.33 -168.77 0.08 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.801 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -73.63 47.66 0.25 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.863 0.363 . . . . 0.0 110.364 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.644 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 0.1 OUTLIER 58.44 19.77 6.79 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.933 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 191' ' ' ILE . 18.7 mt-30 -111.67 -22.34 11.24 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.802 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 41.4 mt-30 -148.15 141.84 25.59 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.579 ' CD2' HD12 ' A' ' 177' ' ' LEU . 7.3 m-85 -112.59 95.93 5.7 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 1.08 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 41.5 t -80.36 110.98 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.062 0.458 . . . . 0.0 111.174 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.786 ' CG2' ' HB ' ' A' ' 187' ' ' THR . 2.6 m -96.96 107.72 20.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.931 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.65 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -57.41 100.96 0.06 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.592 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.586 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -55.66 154.52 12.7 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.51 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.34 9.13 65.46 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.088 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.65 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 1.9 mm-40 -77.16 176.97 8.24 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.812 0.815 . . . . 0.0 112.19 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.708 ' HA ' HD22 ' A' ' 182' ' ' LEU . 3.4 m -175.6 105.01 0.08 Allowed 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.614 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 17.5 m-85 -53.63 152.57 5.04 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.478 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 211' ' ' PHE . 15.0 pt20 -121.4 142.5 49.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.787 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 34.6 t -51.18 99.64 0.21 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.197 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.89 ' HG3' ' HA ' ' A' ' 211' ' ' PHE . 14.7 Cg_exo -68.79 -29.03 29.51 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.454 2.103 . . . . 0.0 111.635 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.18 -122.52 5.56 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.361 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.621 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -91.97 116.08 28.61 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.023 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.687 ' CZ ' HD13 ' A' ' 207' ' ' LEU . 58.0 t80 -113.52 140.99 47.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.293 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 1.006 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.1 OUTLIER -99.71 108.07 20.32 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.317 179.325 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.699 ' O ' ' HG3' ' A' ' 240' ' ' GLU . 54.0 t -50.68 -44.53 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.247 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.699 ' HG3' ' O ' ' A' ' 239' ' ' VAL . 1.3 pt-20 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 117.971 -1.014 . . . . 0.0 111.597 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.631 ' O ' HD12 ' A' ' 29' ' ' LEU . 2.4 p . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 121.549 0.69 . . . . 0.0 109.688 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.582 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 13.0 m-20 -87.6 -22.93 24.47 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.454 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.26 -43.01 82.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.296 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.37 -32.19 58.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.729 HD11 ' HG ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -61.39 -54.25 46.13 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.25 0.548 . . . . 0.0 110.276 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.848 ' HB2' ' HE3' ' A' ' 53' ' ' MET . 9.4 tp -63.78 -55.28 24.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.448 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.706 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 29.6 mt -52.57 -34.89 52.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.134 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.647 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -76.21 -29.24 57.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.375 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.559 ' O ' ' HB3' ' A' ' 78' ' ' ASN . . . -73.08 -32.99 65.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.538 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.869 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -87.55 -13.13 43.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.927 0.394 . . . . 0.0 110.907 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -81.9 164.34 21.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.737 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.491 ' CE1' ' HB3' ' A' ' 230' ' ' SER . 75.4 m80 -97.24 96.14 8.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.479 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.34 141.36 5.98 Favored Glycine 0 C--N 1.318 -0.442 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.936 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.752 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -62.12 129.18 39.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.509 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.7 OUTLIER -122.67 155.49 36.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.147 178.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.674 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 46.7 t -102.63 142.17 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.332 -0.394 . . . . 0.0 112.013 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.592 ' HA ' ' O ' ' A' ' 237' ' ' TYR . 0.0 OUTLIER -129.41 111.97 13.34 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.055 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.964 ' HB ' ' HD3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -103.4 170.76 7.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.072 0.463 . . . . 0.0 111.595 -179.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.481 ' HB3' ' H ' ' A' ' 240' ' ' GLU . 29.0 t-20 62.11 20.28 11.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.056 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.563 HD23 ' O ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER -58.76 158.34 8.19 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.574 ' HB3' HG23 ' A' ' 50' ' ' VAL . 24.7 tp -90.74 114.36 26.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.097 0.475 . . . . 0.0 111.551 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -76.01 65.0 1.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.235 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 74.6 m -125.2 -163.49 1.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.898 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.706 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 1.3 m-20 -96.77 -19.08 19.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.399 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.433 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 8.6 m-20 -70.98 -29.86 65.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.968 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.626 HG13 HD11 ' A' ' 54' ' ' LEU . 39.1 t -88.11 -53.36 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.377 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.706 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 9.5 ptp180 -50.62 -30.73 14.11 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.039 0.447 . . . . 0.0 110.005 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -72.94 -35.3 66.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.039 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.848 ' HE3' ' HB2' ' A' ' 30' ' ' LEU . 10.9 tpt -64.93 -49.87 68.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.729 ' HG ' HD11 ' A' ' 29' ' ' LEU . 1.2 mp -66.14 -45.86 79.52 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.606 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.7 m-20 -57.29 -22.67 43.29 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.022 0.439 . . . . 0.0 109.987 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.541 ' HB2' HD12 ' A' ' 90' ' ' LEU . . . -74.77 -48.76 23.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.599 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.768 HD21 ' HE2' ' A' ' 53' ' ' MET . 0.1 OUTLIER -68.2 -49.65 59.42 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.903 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.474 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 5.3 t -50.48 -33.81 22.62 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.339 0.59 . . . . 0.0 110.304 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.643 ' CB ' HD23 ' A' ' 90' ' ' LEU . . . -59.36 -48.89 79.92 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.213 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.837 HD23 ' HB3' ' A' ' 82' ' ' LEU . 3.9 mp -67.13 -29.12 68.76 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.483 0.658 . . . . 0.0 109.831 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.13 -1.65 4.59 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 114.81 -1.087 . . . . 0.0 113.815 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.609 HG11 ' N ' ' A' ' 63' ' ' SER . 13.0 t -58.96 153.92 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 117.644 0.722 . . . . 0.0 110.247 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.609 ' N ' HG11 ' A' ' 62' ' ' VAL . 3.8 m -116.97 108.92 16.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.151 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 16.6 p90 -124.76 157.23 36.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.726 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -148.03 116.1 6.48 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.812 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.766 HD12 ' HB2' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -87.16 175.19 8.19 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.237 0.542 . . . . 0.0 111.38 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -89.48 179.4 6.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.859 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.35 -14.62 28.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.439 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.63 6.09 11.63 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.816 0.341 . . . . 0.0 110.656 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.565 ' HG2' ' HG ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER 59.07 45.59 14.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.503 -179.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -129.27 -2.16 5.04 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.999 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.964 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 1.2 mmm180 -136.58 109.34 7.54 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.766 ' HB2' HD12 ' A' ' 66' ' ' LEU . 5.4 t -120.62 154.04 36.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.376 0.607 . . . . 0.0 112.637 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.619 ' HB3' ' HD3' ' A' ' 38' ' ' LYS . 2.9 mt-10 -121.39 104.66 9.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.141 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.752 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -96.57 128.03 48.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.711 HG12 ' HG3' ' A' ' 38' ' ' LYS . 18.9 mt -81.67 103.06 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.112 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -47.9 113.78 1.54 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.695 -0.684 . . . . 0.0 114.197 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.559 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 25.0 t-20 -60.01 -17.36 38.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.112 0.482 . . . . 0.0 110.117 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.436 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 86.49 -22.96 10.92 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.363 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.869 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.65 -148.79 5.36 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.827 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 2.6 Cg_exo -77.09 169.01 22.3 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 CA-C-N 119.708 1.754 . . . . 0.0 109.261 177.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.837 ' HB3' HD23 ' A' ' 60' ' ' LEU . 4.5 mm? -67.43 90.51 0.24 Allowed 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 122.445 1.117 . . . . 0.0 108.078 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.827 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 30.3 m170 -82.26 118.67 23.29 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 112.877 -1.965 . . . . 0.0 112.671 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.528 ' HB2' HD21 ' A' ' 60' ' ' LEU . . . -144.87 113.07 6.49 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.644 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.15 86.35 2.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.795 0.331 . . . . 0.0 111.295 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -173.82 20.07 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.654 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.74 52.16 8.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.418 0.628 . . . . 0.0 109.852 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.707 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 4.1 tp -80.73 134.37 35.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.221 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.609 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 1.2 tt0 -113.87 128.94 56.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.228 0.537 . . . . 0.0 110.523 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.643 HD23 ' CB ' ' A' ' 59' ' ' ALA . 28.3 mt -112.4 154.09 26.32 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.465 ' HA ' HG22 ' A' ' 116' ' ' THR . 52.6 t80 -116.39 105.35 12.42 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.663 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.701 ' HG ' ' HA ' ' A' ' 99' ' ' MET . 3.0 mm? -90.2 8.9 30.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.275 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.447 ' HA2' ' CE1' ' A' ' 91' ' ' PHE . . . 37.73 -143.93 0.2 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.249 -0.501 . . . . 0.0 113.216 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.42 HD22 ' HB3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -96.09 50.94 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.242 0.544 . . . . 0.0 110.025 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.433 ' HB1' ' HA ' ' A' ' 49' ' ' ASP . . . -90.0 -72.96 0.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.608 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.37 -19.44 8.54 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.444 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.0 m -93.92 -7.23 43.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.769 0.319 . . . . 0.0 111.099 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.479 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -129.88 -17.09 3.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.355 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.701 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 21.9 tpp -70.23 -55.13 10.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.935 0.398 . . . . 0.0 111.009 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.835 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.6 mpt_? -60.07 -49.36 91.39 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.938 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.594 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 20.6 Cg_exo -66.79 -47.15 2.85 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.814 2.343 . . . . 0.0 112.95 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.697 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 3.3 tm? -68.55 -34.14 75.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.661 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 99' ' ' MET . . . -63.36 -47.98 79.86 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.645 0.736 . . . . 0.0 109.78 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.745 ' HB1' ' HB1' ' A' ' 175' ' ' ALA . . . -70.25 -39.18 75.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.094 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.529 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -56.6 -40.92 76.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 111.949 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 102' ' ' LEU . 0.4 OUTLIER -71.72 -21.48 61.76 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.568 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.517 ' SG ' HD12 ' A' ' 140' ' ' ILE . 89.6 m -60.8 -10.55 5.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.102 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.696 HD11 ' O ' ' A' ' 179' ' ' THR . 13.9 mt -83.3 168.48 16.63 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 53.95 -108.09 0.77 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.428 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.466 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.3 OUTLIER -167.68 99.6 0.48 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.843 0.354 . . . . 0.0 110.398 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 8.5 m-20 -138.5 135.79 35.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.134 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 18.3 m-20 -99.42 111.0 23.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.841 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.707 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 4.8 mp -143.0 140.79 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 5.8 t -109.46 113.71 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.613 HD13 ' SD ' ' A' ' 99' ' ' MET . 37.2 mt -89.71 154.61 19.81 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.125 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 90' ' ' LEU . 13.0 t -155.46 -170.27 3.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.296 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -173.45 -167.8 33.71 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 119.988 -1.101 . . . . 0.0 113.901 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.497 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 2.9 mm-40 -69.59 178.09 1.08 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.319 -0.441 . . . . 0.0 110.919 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.497 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 31.8 Cg_exo -61.88 -38.49 58.55 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.048 1.832 . . . . 0.0 112.214 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.796 HH11 ' HG3' ' A' ' 123' ' ' GLU . 3.2 tpt180 -79.55 -23.75 42.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.026 0.441 . . . . 0.0 110.204 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.584 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 10.8 tpt -69.17 -15.54 63.42 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.724 ' HE2' ' HD3' ' A' ' 150' ' ' PRO . 0.8 OUTLIER -74.44 -4.71 38.25 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.162 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.796 ' HG3' HH11 ' A' ' 120' ' ' ARG . 0.1 OUTLIER -127.65 26.02 5.96 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.293 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.485 ' HB2' ' HE2' ' A' ' 121' ' ' MET . 2.5 mmp_? -100.56 91.43 1.8 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.493 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.652 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.7 Cg_endo -47.87 127.06 13.89 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.593 2.195 . . . . 0.0 112.589 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.494 HD11 HD22 ' A' ' 129' ' ' LEU . 18.5 tt -130.88 31.24 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 121.732 0.777 . . . . 0.0 109.943 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.615 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -71.61 -51.98 14.16 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 114.772 -1.103 . . . . 0.0 112.735 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.531 ' HB2' ' CD2' ' A' ' 172' ' ' PHE . 0.1 OUTLIER -52.31 -26.49 12.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.927 0.394 . . . . 0.0 110.562 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.8 HD11 HD21 ' A' ' 133' ' ' LEU . 39.6 tp -84.69 -65.05 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.545 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.527 ' HA ' HD11 ' A' ' 133' ' ' LEU . 47.6 t -52.55 -26.02 9.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.49 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.615 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -73.23 -44.6 59.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.651 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.876 ' HA ' HD13 ' A' ' 135' ' ' LEU . . . -66.64 -47.98 70.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.571 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.8 HD21 HD11 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -58.26 -45.47 87.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.514 0.673 . . . . 0.0 109.52 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -33.79 71.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.816 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.876 HD13 ' HA ' ' A' ' 132' ' ' ALA . 5.1 mt -70.19 -31.99 69.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.977 0.417 . . . . 0.0 110.104 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.512 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -74.78 -17.99 80.09 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.514 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.81 2.9 5.13 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.596 -0.812 . . . . 0.0 113.114 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.446 ' CB ' ' HB3' ' A' ' 107' ' ' CYS . . . -70.11 146.73 50.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 111.027 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 46.3 mmtt -113.43 81.47 1.51 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.473 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.618 HD11 HD11 ' A' ' 133' ' ' LEU . 9.3 mt -107.44 176.12 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.531 ' O ' HD22 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -153.24 -169.03 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.028 0.442 . . . . 0.0 111.225 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.477 ' N ' ' CG2' ' A' ' 141' ' ' THR . 19.3 m-85 -131.72 104.18 6.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.014 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.508 ' HG ' HG12 ' A' ' 114' ' ' VAL . 2.4 mm? -75.02 -13.22 60.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.522 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.724 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 5.0 mt-10 -138.99 -73.23 0.39 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.209 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.591 ' HB2' ' HD2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -123.98 156.43 36.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.227 0.537 . . . . 0.0 111.735 -179.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -70.95 125.83 27.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.616 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.652 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 0.9 OUTLIER 70.41 50.43 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.044 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.709 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.0 m-30 -141.75 173.82 4.39 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.709 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 6.3 Cg_endo -49.18 -40.79 42.4 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.159 2.573 . . . . 0.0 115.068 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.724 ' HD3' ' HE2' ' A' ' 122' ' ' LYS . 18.7 Cg_endo -62.26 101.79 0.25 Allowed 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 120.849 1.033 . . . . 0.0 110.745 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.531 HD22 ' O ' ' A' ' 141' ' ' THR . 83.2 mt -137.11 123.17 20.31 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.549 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.606 ' CG ' HG21 ' A' ' 114' ' ' VAL . 2.6 mtp85 -102.47 111.78 24.23 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.638 ' CD1' HD12 ' A' ' 106' ' ' LEU . 3.7 mt -93.88 158.05 15.83 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.053 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.565 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 13.8 mt-30 -148.39 25.24 0.99 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.683 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.476 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 53.69 -166.35 1.88 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.537 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 108.2 -4.07 33.42 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.9 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.631 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 2.5 t80 -60.46 105.45 0.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.887 0.375 . . . . 0.0 110.828 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 67.9 p -104.56 -51.04 3.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.562 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.666 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 144.44 -163.95 27.77 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.065 -1.064 . . . . 0.0 114.269 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.548 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 118.04 170.74 15.11 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -64.2 126.3 27.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.26 0.53 . . . . 0.0 109.866 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.555 HG12 ' N ' ' A' ' 163' ' ' ASP . 59.0 t -136.99 152.65 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.966 0.412 . . . . 0.0 111.259 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.555 ' N ' HG12 ' A' ' 162' ' ' VAL . 0.9 OUTLIER -119.05 119.05 33.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.861 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.54 HG13 HD13 ' A' ' 173' ' ' LEU . 0.3 OUTLIER -118.78 141.98 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.984 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.498 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 3.9 t70 -79.77 137.14 36.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.835 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.649 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -79.52 -44.54 9.36 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.899 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.45 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 8.0 m -51.66 164.76 0.21 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.716 0.293 . . . . 0.0 111.175 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.8 t 70.55 55.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.294 0.569 . . . . 0.0 110.227 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.655 ' N ' HG12 ' A' ' 196' ' ' VAL . 4.9 m 57.09 149.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.478 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.537 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 0.6 OUTLIER -72.67 -3.83 27.39 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.546 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.835 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 57.1 mm-40 -49.79 -24.34 2.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.67 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.531 ' CD2' ' HB2' ' A' ' 128' ' ' HIS . 2.0 m-85 -72.58 -55.01 7.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.412 0.625 . . . . 0.0 110.283 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.54 HD13 HG13 ' A' ' 164' ' ' VAL . 26.3 tp -73.71 -38.89 64.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.511 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.598 ' O ' ' HG3' ' A' ' 178' ' ' MET . 20.5 m -59.02 -33.06 70.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.279 0.561 . . . . 0.0 109.678 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.745 ' HB1' ' HB1' ' A' ' 104' ' ' ALA . . . -72.84 -47.18 48.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.977 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.68 ' CD2' HD22 ' A' ' 133' ' ' LEU . 2.9 mt -69.88 -35.98 75.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.605 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.669 HD12 ' CD2' ' A' ' 223' ' ' PHE . 12.5 mt -68.47 -27.33 66.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.612 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.598 ' HG3' ' O ' ' A' ' 174' ' ' THR . 39.5 mtm -95.56 -26.99 15.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.245 0.545 . . . . 0.0 110.489 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.696 ' O ' HD11 ' A' ' 108' ' ' LEU . 51.6 m -88.79 -46.92 8.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.759 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.782 ' CB ' HG23 ' A' ' 225' ' ' VAL . . . -60.58 -39.07 63.64 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -177.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.3 Cg_endo -53.13 -36.01 75.24 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.347 1.364 . . . . 0.0 111.892 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.599 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.1 mp -85.04 -6.82 59.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.767 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -67.26 121.26 77.8 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.817 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -38.76 -32.58 0.29 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.47 2.78 . . . . 0.0 113.91 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.47 155.8 19.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.05 0.453 . . . . 0.0 111.7 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.543 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 1.8 t70 -69.57 117.44 11.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.748 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.738 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 40.8 m -102.48 135.31 44.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.147 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.448 HG22 ' CG1' ' A' ' 224' ' ' VAL . 36.0 t -124.87 99.15 5.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.922 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.667 HD11 ' HB3' ' A' ' 176' ' ' LEU . 2.9 mp -90.01 142.53 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.391 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.82 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -113.47 170.68 8.06 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.651 ' CG2' HD13 ' A' ' 195' ' ' LEU . 1.5 mm -110.61 97.91 6.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 121.002 0.429 . . . . 0.0 111.363 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.55 ' HA ' ' NH1' ' A' ' 190' ' ' ARG . 4.9 mtmt -59.69 -82.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.133 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -79.1 168.21 53.12 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.36 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -59.9 122.45 14.29 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.667 HD22 ' HA ' ' A' ' 198' ' ' LYS . 0.8 OUTLIER -56.89 146.57 26.15 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.355 0.598 . . . . 0.0 110.61 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.655 HG12 ' N ' ' A' ' 169' ' ' SER . 12.5 p -104.1 -21.59 5.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.089 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.693 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -126.78 45.24 2.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.197 -179.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.667 ' HA ' HD22 ' A' ' 195' ' ' LEU . 6.1 ttpt -41.53 -65.63 0.48 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.04 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 51.4 Cg_endo -68.11 -16.77 45.2 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 121.556 1.504 . . . . 0.0 112.308 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.693 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 88.6 m-85 -75.34 -27.57 59.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.39 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.489 ' CD1' HD11 ' A' ' 177' ' ' LEU . 6.1 tp -71.23 -33.14 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.762 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -32.5 71.99 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.526 ' CG2' HD21 ' A' ' 207' ' ' LEU . 28.4 mt -68.32 -29.8 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.605 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.435 HG23 HG21 ' A' ' 174' ' ' THR . 52.5 m -61.38 -52.55 64.15 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.262 0.553 . . . . 0.0 109.806 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.661 HD12 ' CD1' ' A' ' 215' ' ' ILE . 30.9 mt -70.44 -38.37 74.52 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.191 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.651 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 39.4 t30 -63.65 -28.04 69.63 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.706 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 1.0 OUTLIER -78.36 -40.62 35.81 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.489 178.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.445 ' HB3' ' HE1' ' A' ' 231' ' ' TYR . 17.2 mtp -68.9 -39.42 79.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.857 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.651 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 17.7 ptpt -65.37 -45.24 84.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.099 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.641 HG21 ' O ' ' A' ' 207' ' ' LEU . 2.0 t -57.71 -29.31 64.62 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.217 0.532 . . . . 0.0 109.798 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.587 ' HE2' ' HA ' ' A' ' 32' ' ' ALA . 1.3 m-85 -74.75 -53.04 9.94 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.587 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 158.82 -2.55 0.1 Allowed Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.644 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.634 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 53.7 t -119.0 142.44 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 117.08 0.44 . . . . 0.0 112.028 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -135.46 155.15 51.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.811 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.661 ' CD1' HD12 ' A' ' 205' ' ' LEU . 2.3 pp -130.43 175.53 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.378 -178.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 1.01 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 6.3 tp10 -91.57 127.43 37.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.538 ' H ' ' ND2' ' A' ' 217' ' ' ASN . 0.1 OUTLIER -102.31 101.3 11.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.42 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.847 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 4.8 mm-40 -66.71 -168.06 0.06 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.858 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -74.12 48.0 0.3 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.802 0.334 . . . . 0.0 110.633 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.557 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.1 OUTLIER 58.82 19.69 7.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.018 0.437 . . . . 0.0 111.26 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 191' ' ' ILE . 7.1 mm-40 -112.7 -22.38 10.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.713 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.847 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 29.5 mt-30 -149.22 141.87 24.48 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.088 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.669 ' CD2' HD12 ' A' ' 177' ' ' LEU . 14.6 m-85 -112.91 97.77 6.75 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 1.01 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 39.1 t -81.9 110.9 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.334 0.588 . . . . 0.0 111.341 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.782 HG23 ' CB ' ' A' ' 180' ' ' ALA . 1.9 m -97.95 112.09 29.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.977 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.676 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 4.9 mptp? -63.26 104.37 0.59 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.807 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.543 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.93 158.69 14.83 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.114 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.07 9.44 80.38 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.474 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 19.5 mm-40 -76.28 178.76 6.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.441 0.639 . . . . 0.0 111.576 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.599 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.9 m -174.06 106.36 0.12 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.265 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.634 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 22.9 m-85 -55.24 152.23 8.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.511 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.533 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 7.7 pt20 -122.97 138.34 54.71 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 7.0 t -46.54 98.04 0.17 Allowed Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 39.5 Cg_endo -64.89 -29.33 58.3 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.331 2.021 . . . . 0.0 111.804 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 117.39 -123.77 5.89 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.884 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.674 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -91.0 116.96 29.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.039 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 68.0 t80 -121.7 126.58 49.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.531 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.73 ' HA ' HG21 ' A' ' 42' ' ' THR . 3.9 tp -91.43 119.01 31.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.252 0.548 . . . . 0.0 111.206 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.464 HG21 ' H3 ' ' A' ' 25' ' ' SER . 78.2 t -51.29 -79.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.808 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.481 ' H ' ' HB3' ' A' ' 43' ' ' ASN . 2.6 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.639 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.685 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.941 0.401 . . . . 0.0 111.623 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.529 ' OD1' ' HA ' ' A' ' 50' ' ' VAL . 43.1 m-20 -82.82 -23.15 33.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.899 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -67.65 -43.29 80.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.17 0.51 . . . . 0.0 110.491 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.485 ' CB ' ' HB3' ' A' ' 41' ' ' LEU . . . -75.17 -31.96 61.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.978 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.729 HD22 HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -66.07 -52.22 50.89 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.115 0.483 . . . . 0.0 110.218 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 8.1 tp -64.94 -53.76 41.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.278 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.909 HD11 ' HB3' ' A' ' 207' ' ' LEU . 62.6 mt -53.5 -36.35 61.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.411 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.697 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -76.99 -29.94 55.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.448 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.531 ' O ' ' HB2' ' A' ' 78' ' ' ASN . . . -70.29 -33.2 71.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.526 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.887 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -88.81 -12.61 41.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.813 0.339 . . . . 0.0 111.145 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -81.72 166.06 20.42 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.687 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.521 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 77.5 m80 -99.89 97.7 8.56 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.042 0.449 . . . . 0.0 109.885 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.01 142.28 6.6 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.385 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.747 ' HB2' HD12 ' A' ' 76' ' ' ILE . 1.3 ttpm? -66.36 140.55 58.09 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.096 0.474 . . . . 0.0 112.035 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.29 154.33 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.289 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.699 HG23 ' HG2' ' A' ' 74' ' ' GLU . 55.8 t -100.72 142.78 15.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.122 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 237' ' ' TYR . 0.0 OUTLIER -129.25 111.69 13.14 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.823 HG21 ' HA ' ' A' ' 238' ' ' LEU . 0.6 OUTLIER -97.98 164.63 12.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.333 0.587 . . . . 0.0 112.136 -178.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.429 ' HB2' HD11 ' A' ' 238' ' ' LEU . 19.4 t30 63.21 23.38 13.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.287 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.592 HD22 HG13 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -58.87 153.61 16.84 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.328 179.093 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.649 ' H ' ' HB3' ' A' ' 25' ' ' SER . 27.2 tp -83.35 114.26 21.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.059 0.457 . . . . 0.0 111.342 -178.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.01 68.57 4.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.995 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.4 m -130.01 -163.91 1.36 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.893 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.584 ' HA ' ' CD ' ' A' ' 51' ' ' ARG . 25.1 t0 -97.11 -20.45 17.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.031 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.508 ' HB3' ' HG1' ' A' ' 97' ' ' THR . 14.3 m-20 -70.45 -30.06 66.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.713 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.592 HG13 HD22 ' A' ' 44' ' ' LEU . 12.4 t -83.1 -54.84 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.105 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.584 ' CD ' ' HA ' ' A' ' 48' ' ' ASP . 11.9 ptm180 -49.67 -27.18 4.39 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.004 0.43 . . . . 0.0 110.013 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -71.02 -39.86 72.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.571 ' O ' HD21 ' A' ' 57' ' ' LEU . 7.1 tpt -64.29 -50.93 65.95 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.678 ' CD2' HD23 ' A' ' 29' ' ' LEU . 1.5 mp -62.11 -47.49 84.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.004 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.503 ' HA ' HG23 ' A' ' 58' ' ' THR . 11.8 t30 -58.43 -23.26 56.95 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.815 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.72 ' HA ' HD12 ' A' ' 90' ' ' LEU . . . -76.28 -49.0 18.18 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.138 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.729 HD12 HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -64.72 -49.73 69.68 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.271 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.503 HG23 ' HA ' ' A' ' 55' ' ' ASN . 8.7 t -50.37 -30.52 12.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.245 0.545 . . . . 0.0 109.983 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.523 ' CB ' HD23 ' A' ' 88' ' ' LEU . . . -59.22 -44.2 92.3 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.618 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.755 HD23 ' HB3' ' A' ' 82' ' ' LEU . 2.7 mp -79.56 -19.53 49.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.211 0.529 . . . . 0.0 110.656 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.13 -0.87 7.72 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.852 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.64 HG21 HD12 ' A' ' 82' ' ' LEU . 15.2 t -58.88 155.66 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 117.586 0.693 . . . . 0.0 110.086 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.61 ' N ' HG11 ' A' ' 62' ' ' VAL . 2.9 m -117.57 108.93 16.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.07 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 10.0 p90 -124.06 153.59 41.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.172 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.723 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 11.7 m -147.61 116.53 6.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.028 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.74 HD12 ' HB2' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -88.81 172.25 9.34 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.138 0.494 . . . . 0.0 111.088 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.664 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 65.1 p -88.04 179.57 6.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.781 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.19 -14.72 27.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.407 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.42 7.03 12.67 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.791 0.329 . . . . 0.0 110.68 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.458 ' O ' HD23 ' A' ' 44' ' ' LEU . 10.0 mtm180 57.08 41.91 26.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.116 0.484 . . . . 0.0 110.943 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.45 -2.14 8.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.604 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.664 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 4.8 mmt180 -136.94 110.53 8.02 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.841 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.74 ' HB2' HD12 ' A' ' 66' ' ' LEU . 4.0 t -120.22 151.57 38.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.452 0.644 . . . . 0.0 112.405 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.699 ' HG2' HG23 ' A' ' 40' ' ' VAL . 55.0 mt-10 -118.63 102.93 9.24 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.108 178.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.739 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -95.34 128.2 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-O 121.375 0.607 . . . . 0.0 112.213 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 38' ' ' LYS . 15.9 mm -80.51 103.32 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.871 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.697 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -49.73 114.66 2.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.958 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.3 t-20 -61.51 -16.78 50.71 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 110.194 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.521 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.27 -22.02 11.27 Favored Glycine 0 C--O 1.226 -0.384 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.427 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.887 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.53 -149.03 5.41 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.803 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 5.4 Cg_exo -78.77 168.3 21.19 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.853 1.702 . . . . 0.0 109.209 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.755 ' HB3' HD23 ' A' ' 60' ' ' LEU . 4.5 mm? -66.62 91.14 0.18 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.803 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 29.3 m170 -84.14 118.02 23.84 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 113.158 -1.837 . . . . 0.0 112.779 -176.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.487 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . . . -144.21 108.26 4.75 Favored 'General case' 0 C--O 1.227 -0.08 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.354 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -109.83 90.69 3.38 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.541 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -175.69 17.35 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.742 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.479 ' H ' ' HB2' ' A' ' 112' ' ' ASP . . . 55.2 47.81 20.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.565 0.697 . . . . 0.0 109.794 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.666 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 1.0 OUTLIER -81.3 129.14 34.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.31 -178.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.764 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 1.6 tt0 -105.7 127.76 53.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.122 0.487 . . . . 0.0 110.658 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.72 HD12 ' HA ' ' A' ' 56' ' ' ALA . 61.1 mt -111.97 157.5 20.63 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.418 ' CE1' ' O ' ' A' ' 117' ' ' GLY . 31.9 t80 -112.88 101.62 9.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.243 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.635 ' CD1' ' HA ' ' A' ' 99' ' ' MET . 0.1 OUTLIER -96.47 18.23 14.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.922 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 36.53 -154.47 0.01 OUTLIER Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.923 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.513 ' HA ' ' HB2' ' A' ' 121' ' ' MET . 10.6 t30 -87.6 50.1 1.93 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.287 0.565 . . . . 0.0 110.062 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 92' ' ' LEU . . . -82.25 -77.04 0.24 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.426 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 82.32 -13.77 38.03 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.644 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.508 ' HG1' ' HB3' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -97.02 -5.39 37.79 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.073 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' A' ' 53' ' ' MET . . . -133.7 -22.7 1.87 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.339 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.635 ' HA ' ' CD1' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -62.08 -58.73 6.72 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.235 0.541 . . . . 0.0 110.337 179.299 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.866 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.8 mpt_? -59.76 -52.13 76.01 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.075 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.67 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 36.8 Cg_exo -61.99 -45.13 17.24 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.457 2.105 . . . . 0.0 113.192 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.663 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 2.6 tm? -74.04 -31.55 62.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.814 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 99' ' ' MET . . . -60.98 -48.29 82.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.407 0.622 . . . . 0.0 110.474 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 107' ' ' CYS . . . -71.94 -36.82 70.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.006 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.498 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -57.67 -43.24 84.87 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.724 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.69 HD22 ' HB2' ' A' ' 82' ' ' LEU . 0.7 OUTLIER -69.72 -24.24 63.53 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.33 0.586 . . . . 0.0 111.116 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.586 ' SG ' HD13 ' A' ' 140' ' ' ILE . 86.5 m -59.11 -10.59 2.82 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.059 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.67 HD11 ' O ' ' A' ' 179' ' ' THR . 12.0 mt -82.06 169.03 17.18 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 50.84 -110.39 0.94 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.513 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.431 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 2.4 p -161.67 101.35 1.17 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.037 -0.356 . . . . 0.0 110.037 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.603 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 12.9 m-20 -138.95 135.15 34.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.547 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.0 OUTLIER -101.93 110.67 22.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.812 178.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.666 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 4.6 mp -145.9 140.66 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.58 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.804 HG11 ' HG ' ' A' ' 143' ' ' LEU . 27.0 t -111.03 112.4 40.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.248 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.48 HD23 HD12 ' A' ' 92' ' ' LEU . 13.2 mt -82.09 150.58 27.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.385 0.612 . . . . 0.0 111.587 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.6 m -155.25 177.25 11.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.419 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.418 ' O ' ' CE1' ' A' ' 91' ' ' PHE . . . -165.08 -165.37 22.27 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.251 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.551 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 2.3 mm-40 -70.92 176.07 2.25 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.551 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 37.2 Cg_exo -62.4 -28.95 78.69 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 121.793 1.662 . . . . 0.0 111.97 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.492 ' HD2' ' CG ' ' A' ' 123' ' ' GLU . 6.0 tpt180 -80.44 -37.29 32.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.958 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.628 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 34.8 tpp -59.56 -15.72 20.21 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.718 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 6.3 mttm -69.8 -5.79 27.88 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.554 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 2.0 pt-20 -120.98 26.97 8.73 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.066 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.574 ' HA ' ' HE ' ' A' ' 124' ' ' ARG . 1.6 mmp_? -105.91 94.16 8.67 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.062 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.634 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 10.6 Cg_endo -53.56 129.03 31.81 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.954 2.436 . . . . 0.0 112.559 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.544 ' O ' HG21 ' A' ' 130' ' ' VAL . 18.1 tt -132.78 29.35 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.724 0.774 . . . . 0.0 110.127 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -68.35 -51.06 34.34 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.184 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.702 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -54.29 -28.58 43.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.924 0.392 . . . . 0.0 110.668 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.737 HD12 HD22 ' A' ' 133' ' ' LEU . 23.6 tp -81.8 -61.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.885 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.584 ' HA ' HD12 ' A' ' 133' ' ' LEU . 59.8 t -53.35 -26.5 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.947 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 20.0 t0 -71.63 -43.43 66.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.007 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.846 ' HA ' HD13 ' A' ' 135' ' ' LEU . . . -65.43 -51.86 57.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 121.074 0.464 . . . . 0.0 111.528 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.737 HD22 HD12 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -57.38 -43.78 83.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.818 179.65 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -33.91 73.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.803 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.846 HD13 ' HA ' ' A' ' 132' ' ' ALA . 2.7 mt -68.79 -30.14 68.66 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.235 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.466 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -78.42 -17.84 77.07 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.669 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 130.14 4.31 4.6 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.302 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 107' ' ' CYS . . . -71.23 146.8 48.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.833 0.349 . . . . 0.0 111.557 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -114.75 94.57 4.83 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.075 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.682 HD12 HD12 ' A' ' 133' ' ' LEU . 11.5 mt -118.75 175.39 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.829 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.617 ' O ' HD23 ' A' ' 151' ' ' LEU . 1.0 OUTLIER -153.29 -166.15 2.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.267 0.556 . . . . 0.0 111.632 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.536 ' N ' HG21 ' A' ' 141' ' ' THR . 29.0 m-85 -135.92 101.51 4.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.921 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.804 ' HG ' HG11 ' A' ' 114' ' ' VAL . 2.4 mm? -72.86 -13.55 61.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.602 -177.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.738 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 4.8 mt-10 -139.52 -73.2 0.38 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.635 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.62 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.2 OUTLIER -121.35 147.23 45.98 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.217 0.532 . . . . 0.0 111.704 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.454 ' HA ' ' CG ' ' A' ' 142' ' ' TYR . 10.3 mt-10 -68.22 131.92 46.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.301 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.634 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 87.2 m-20 65.95 51.9 1.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.691 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.847 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.6 m-85 -148.03 -179.72 1.02 Allowed Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.129 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.847 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 5.7 Cg_endo -50.66 -43.1 47.53 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.969 2.446 . . . . 0.0 115.143 -177.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.738 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 32.8 Cg_endo -62.73 102.18 0.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.149 1.233 . . . . 0.0 111.425 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.617 HD23 ' O ' ' A' ' 141' ' ' THR . 67.3 mt -138.58 122.92 18.26 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.848 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.605 ' HB2' HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -105.51 112.33 25.39 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.129 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 4.5 mt -93.18 157.95 16.01 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.266 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.603 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -145.53 24.79 1.38 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.469 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.48 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 54.84 -166.05 2.83 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.535 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 108.72 -5.27 32.71 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.888 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.642 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 3.0 t80 -60.66 106.13 0.52 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.712 0.291 . . . . 0.0 110.721 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 185' ' ' GLU . 69.1 p -106.97 -46.12 4.0 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.098 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.687 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.39 -165.98 26.94 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.158 -1.02 . . . . 0.0 114.185 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.524 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 118.8 170.21 14.68 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.47 128.54 36.24 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 62.4 t -138.27 151.32 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 120.786 0.326 . . . . 0.0 111.733 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.481 ' N ' HG12 ' A' ' 162' ' ' VAL . 2.4 m-20 -118.89 117.85 29.96 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.583 HG12 HD12 ' A' ' 173' ' ' LEU . 0.9 OUTLIER -118.63 147.86 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 120.574 -0.451 . . . . 0.0 112.018 -178.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.702 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.4 OUTLIER -85.4 133.59 34.11 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.338 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.7 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -76.03 -44.62 18.23 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.279 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.403 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 83.2 p -51.55 163.69 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.942 0.401 . . . . 0.0 111.593 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 169' ' ' SER . 3.7 t 71.59 60.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.242 0.544 . . . . 0.0 110.658 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.628 ' N ' HG12 ' A' ' 196' ' ' VAL . 0.7 OUTLIER 54.81 154.95 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.409 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.621 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 0.1 OUTLIER -76.71 3.01 12.62 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.966 0.412 . . . . 0.0 111.097 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.866 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 55.8 mm-40 -54.11 -22.72 11.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.726 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.519 ' CD2' ' HB2' ' A' ' 128' ' ' HIS . 1.9 m-85 -78.21 -55.77 5.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.935 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.625 ' HB3' HD12 ' A' ' 201' ' ' ILE . 22.3 tp -73.51 -38.32 65.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.869 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.47 ' HG1' ' HB3' ' A' ' 170' ' ' SER . 91.4 m -60.31 -33.07 71.85 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.188 0.518 . . . . 0.0 109.706 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 101' ' ' PRO . . . -72.79 -50.18 25.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.734 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.644 ' HB3' HD12 ' A' ' 189' ' ' ILE . 2.3 mt -66.96 -38.78 86.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.749 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.796 HD13 HD11 ' A' ' 201' ' ' ILE . 12.7 mt -68.47 -24.87 64.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.282 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.6 ' HA ' ' HH ' ' A' ' 231' ' ' TYR . 46.5 mtm -94.52 -28.2 15.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.34 0.591 . . . . 0.0 110.779 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.67 ' O ' HD11 ' A' ' 108' ' ' LEU . 84.5 m -91.28 -46.84 7.83 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.068 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.708 ' CB ' HG23 ' A' ' 225' ' ' VAL . . . -59.21 -39.27 71.84 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 9.3 Cg_endo -53.33 -36.71 79.63 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 121.095 1.197 . . . . 0.0 111.706 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.485 HD22 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -85.12 -5.7 59.33 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.163 -179.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -67.09 120.9 75.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -37.12 -32.93 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.554 2.836 . . . . 0.0 114.018 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 158' ' ' THR . 0.3 OUTLIER -107.33 153.43 22.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.332 . . . . 0.0 111.562 -179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.566 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 0.4 OUTLIER -67.44 118.24 10.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.693 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.765 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 31.4 m -103.1 137.59 41.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.304 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.447 HG22 ' CG1' ' A' ' 224' ' ' VAL . 40.5 t -125.85 99.15 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.094 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.644 HD12 ' HB3' ' A' ' 176' ' ' LEU . 3.3 mt -90.55 141.98 13.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.395 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.837 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.3 OUTLIER -113.54 170.97 7.85 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.65 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.659 HG22 ' CD1' ' A' ' 195' ' ' LEU . 1.7 mm -110.38 97.26 5.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 120.985 0.421 . . . . 0.0 111.31 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.51 ' HG2' ' HE ' ' A' ' 190' ' ' ARG . 8.1 mtmp? -59.94 -81.37 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.464 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -78.85 168.44 53.53 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.309 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.45 122.3 15.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.54 0.209 . . . . 0.0 110.73 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.802 HD22 ' HA ' ' A' ' 198' ' ' LYS . 0.5 OUTLIER -57.26 146.64 27.84 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.985 0.422 . . . . 0.0 110.302 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.628 HG12 ' N ' ' A' ' 169' ' ' SER . 13.0 p -104.43 -19.75 6.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.384 0.611 . . . . 0.0 111.507 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.724 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.6 OUTLIER -127.74 45.31 2.76 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.627 -179.208 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.802 ' HA ' HD22 ' A' ' 195' ' ' LEU . 0.0 OUTLIER -41.19 -64.75 0.56 Allowed Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.702 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.628 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 55.2 Cg_endo -68.54 -16.92 43.37 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 121.603 1.535 . . . . 0.0 111.941 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.724 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 31.3 m-85 -76.0 -29.35 58.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.13 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.796 HD11 HD13 ' A' ' 177' ' ' LEU . 8.4 tp -70.53 -31.63 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.622 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.499 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.1 OUTLIER -61.52 -33.74 74.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.525 ' O ' ' HB2' ' A' ' 207' ' ' LEU . 36.3 mt -66.21 -31.37 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.706 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 54.0 m -60.26 -52.67 64.29 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.376 0.608 . . . . 0.0 109.823 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.55 HD13 HD11 ' A' ' 215' ' ' ILE . 44.9 mt -72.74 -35.48 67.54 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.59 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.706 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 4.9 t-20 -65.62 -24.81 67.14 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.909 ' HB3' HD11 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -82.68 -40.76 20.23 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.537 178.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.499 ' HG2' ' CZ ' ' A' ' 231' ' ' TYR . 12.0 mtp -69.0 -36.49 77.87 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.905 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.706 ' HE3' ' HA ' ' A' ' 206' ' ' ASN . 13.2 ptpt -66.56 -46.52 75.77 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.203 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 207' ' ' LEU . 5.2 t -57.55 -29.65 64.56 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.101 0.477 . . . . 0.0 109.862 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.601 ' CE2' ' HA ' ' A' ' 32' ' ' ALA . 1.8 m-85 -71.21 -54.1 12.12 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.301 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 155.78 -0.71 0.15 Allowed Glycine 0 CA--C 1.52 0.396 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.048 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.575 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 70.2 t -118.24 139.63 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.263 0.554 . . . . 0.0 111.679 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -135.95 156.12 49.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.994 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.55 HD11 HD13 ' A' ' 205' ' ' LEU . 2.0 pp -128.77 175.56 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.336 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.987 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 23.7 tt0 -89.88 125.15 35.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.156 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.71 101.04 11.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.016 0.436 . . . . 0.0 110.761 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.571 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -67.65 -166.52 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.589 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.64 47.69 0.42 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.084 0.468 . . . . 0.0 110.334 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.603 ' CZ ' ' HD3' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 58.22 19.39 6.15 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 -179.349 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 191' ' ' ILE . 14.2 mt-30 -110.6 -21.5 12.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.545 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.837 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 16.8 mt-30 -149.81 140.29 22.43 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.885 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.705 ' CD2' HD11 ' A' ' 177' ' ' LEU . 10.3 m-85 -112.35 96.39 5.98 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.987 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 27.6 t -80.54 111.27 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-O 121.06 0.457 . . . . 0.0 110.91 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.765 ' CG2' ' HB ' ' A' ' 187' ' ' THR . 2.7 m -97.68 112.96 30.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.12 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.688 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 5.7 mptt -61.38 104.16 0.38 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.584 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.566 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -59.57 157.39 25.22 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.825 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.44 8.74 84.56 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.339 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.688 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 15.1 mm-40 -73.38 178.99 4.21 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.401 0.619 . . . . 0.0 111.439 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.485 ' HA ' HD22 ' A' ' 182' ' ' LEU . 18.1 m -167.93 106.26 0.51 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.362 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.672 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 24.4 m-85 -54.03 142.02 26.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.163 0.506 . . . . 0.0 111.573 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.666 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 66.7 mt-30 -107.62 149.92 27.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.77 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 18.9 t -68.4 98.56 0.18 Allowed Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.745 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 47.8 Cg_endo -64.72 -33.36 54.73 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.498 2.132 . . . . 0.0 112.219 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 117.43 -114.09 2.87 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.581 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.6 OUTLIER -95.94 117.55 30.84 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 178.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 37.3 t80 -119.93 136.01 54.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.793 0.33 . . . . 0.0 111.251 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.823 ' HA ' HG21 ' A' ' 42' ' ' THR . 0.3 OUTLIER -102.28 111.43 23.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.2 0.524 . . . . 0.0 110.679 178.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.611 ' N ' HD13 ' A' ' 238' ' ' LEU . 46.0 t -52.09 -61.74 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.771 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.457 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.73 ' O ' HD13 ' A' ' 29' ' ' LEU . 47.0 m . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.906 0.384 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.619 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 2.9 m120 -87.96 -27.08 22.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.463 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -68.34 -38.19 81.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.565 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.466 ' HB2' HD23 ' A' ' 41' ' ' LEU . . . -79.06 -34.58 43.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.75 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.73 HD13 ' O ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -62.23 -53.72 51.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.459 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.629 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 4.9 tp -66.93 -47.93 70.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.194 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.598 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 33.1 mt -56.87 -33.88 67.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.459 . . . . 0.0 110.862 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.659 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -76.42 -28.87 56.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.923 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.589 ' HB1' HD22 ' A' ' 82' ' ' LEU . . . -73.55 -29.61 62.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.616 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.88 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.35 -12.39 40.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.012 0.434 . . . . 0.0 110.858 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.642 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.23 164.89 20.9 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.609 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.515 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 75.2 m80 -98.21 97.7 9.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.065 0.459 . . . . 0.0 110.173 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.06 142.26 6.58 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.255 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.75 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 10.9 tttt -65.69 135.23 54.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.996 0.427 . . . . 0.0 111.788 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.517 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -129.98 159.32 37.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.468 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.591 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 61.7 t -103.82 142.44 17.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.631 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -128.38 111.75 13.68 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.0 OUTLIER -100.96 170.74 8.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.096 0.474 . . . . 0.0 111.767 -179.329 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.517 ' HB2' ' CD1' ' A' ' 238' ' ' LEU . 0.1 OUTLIER 64.99 21.29 12.29 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.384 -179.165 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.609 HD23 ' CD1' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -60.35 157.43 13.75 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.533 179.047 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.584 ' HB3' HG21 ' A' ' 50' ' ' VAL . 23.4 tp -93.13 113.78 26.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.129 0.49 . . . . 0.0 111.464 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 p-10 -72.82 62.93 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.438 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.498 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.5 OUTLIER -124.85 -162.25 1.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.147 -179.036 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.637 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 51.3 m-20 -97.63 -20.47 17.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.179 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.661 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 5.0 p-10 -71.25 -27.65 63.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.947 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.598 ' HA ' HD22 ' A' ' 26' ' ' ASN . 23.9 t -89.09 -53.26 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.595 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.65 ' O ' ' HB2' ' A' ' 55' ' ' ASN . 2.9 ptm180 -50.02 -30.29 10.4 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.678 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.421 ' CD2' ' O ' ' A' ' 48' ' ' ASP . 10.5 m-70 -72.63 -35.49 67.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.41 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.619 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 3.8 tpt -65.87 -47.85 73.49 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.687 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 1.6 mp -65.42 -48.84 71.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.65 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -53.17 -25.54 13.99 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.321 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.512 ' HA ' HD12 ' A' ' 90' ' ' LEU . . . -75.25 -44.21 47.31 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.652 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.506 ' CD1' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -69.74 -49.48 52.73 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.389 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.503 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 5.1 t -52.05 -32.35 34.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.203 0.525 . . . . 0.0 109.898 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.524 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -59.01 -46.01 89.26 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.127 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.797 HD23 ' HB3' ' A' ' 82' ' ' LEU . 3.6 mp -72.27 -26.8 62.13 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.498 0.666 . . . . 0.0 109.801 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.41 -0.35 5.11 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.713 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.63 HG21 HD13 ' A' ' 82' ' ' LEU . 18.6 t -58.34 152.42 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 117.718 0.759 . . . . 0.0 110.193 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.618 ' N ' HG13 ' A' ' 62' ' ' VAL . 3.7 m -116.16 108.68 16.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.932 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.687 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 15.0 p90 -127.53 154.62 44.93 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.22 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.626 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.9 OUTLIER -145.54 116.49 7.79 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.903 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.609 ' CD1' HD23 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -85.11 176.09 8.6 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.097 0.475 . . . . 0.0 111.842 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.832 ' HB3' ' HG3' ' A' ' 72' ' ' ARG . 50.4 p -86.3 178.99 6.98 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.051 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.94 -13.53 26.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.617 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -119.38 3.79 11.27 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.591 0.234 . . . . 0.0 110.877 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.428 ' O ' HD22 ' A' ' 44' ' ' LEU . 37.5 mmt-85 61.84 45.82 7.35 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 110.416 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -125.76 -3.11 7.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.367 179.339 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.832 ' HG3' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER -142.04 112.67 7.23 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.041 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 65' ' ' THR . 6.9 t -116.34 152.46 33.85 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.919 -0.712 . . . . 0.0 112.294 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.65 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 0.8 OUTLIER -116.2 102.61 9.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.878 178.662 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.75 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -96.04 127.63 47.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 14.3 mt -82.32 102.76 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.077 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.659 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -45.4 115.57 1.6 Allowed Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.999 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -61.24 -16.97 50.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.979 0.419 . . . . 0.0 110.1 178.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.515 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 86.16 -20.06 23.31 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.404 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.88 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -140.84 -148.28 5.08 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.811 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 3.8 Cg_exo -77.18 170.88 18.81 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.052 1.835 . . . . 0.0 109.183 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.797 ' HB3' HD23 ' A' ' 60' ' ' LEU . 4.2 mm? -69.31 92.19 0.57 Allowed 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.811 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 31.0 m170 -83.67 118.06 23.61 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.23 -1.805 . . . . 0.0 112.784 -175.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.471 ' HB3' ' CB ' ' A' ' 60' ' ' LEU . . . -144.45 109.04 4.89 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.361 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -111.58 91.65 3.74 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.418 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.63 20.37 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.773 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 54.95 49.37 17.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.366 0.603 . . . . 0.0 109.779 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.707 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 4.0 tp -81.78 135.96 35.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.425 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.629 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 1.2 tt0 -114.31 128.71 56.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.261 0.553 . . . . 0.0 110.605 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 56' ' ' ALA . 18.0 mt -111.14 158.99 18.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.468 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.436 ' CE1' ' HA2' ' A' ' 93' ' ' GLY . 41.8 t80 -123.83 103.39 8.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.428 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.687 HD22 ' HE1' ' A' ' 99' ' ' MET . 0.9 OUTLIER -90.05 6.5 42.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.09 -179.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.522 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 45.52 -145.52 2.74 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.283 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -86.65 47.99 1.57 Allowed 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 120.764 0.316 . . . . 0.0 111.387 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.661 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -90.43 -76.35 0.43 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.948 0.404 . . . . 0.0 111.124 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.55 -14.04 31.96 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.232 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 101' ' ' PRO . 65.3 p -97.0 -7.89 31.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.665 0.269 . . . . 0.0 111.015 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.508 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -126.85 -21.65 4.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.174 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.687 ' HE1' HD22 ' A' ' 92' ' ' LEU . 23.5 tpp -66.43 -50.44 63.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 0.0 110.018 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.666 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -61.6 -53.86 57.34 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.481 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.666 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 34.7 Cg_exo -61.31 -45.33 19.09 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.703 2.269 . . . . 0.0 112.79 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.559 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 2.7 tm? -70.8 -34.41 71.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.321 -178.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 99' ' ' MET . . . -60.4 -47.72 84.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.366 0.603 . . . . 0.0 110.564 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.487 ' HB1' ' CD2' ' A' ' 133' ' ' LEU . . . -71.97 -34.2 68.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.356 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.618 ' HB1' HD22 ' A' ' 30' ' ' LEU . . . -60.31 -45.16 94.38 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.878 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.578 HD22 ' CB ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -69.35 -20.49 63.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.662 -179.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.603 ' SG ' HD13 ' A' ' 140' ' ' ILE . 6.4 m -62.17 -8.12 5.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.976 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.718 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 15.8 mt -87.44 165.57 15.45 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 57.2 -109.76 1.87 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.083 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.416 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -165.8 99.48 0.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.765 0.317 . . . . 0.0 110.299 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.606 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 3.4 m120 -138.44 135.44 35.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 0.8 OUTLIER -102.78 110.65 22.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.381 178.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.707 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 4.5 mp -143.88 142.28 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.216 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.796 HG13 ' HG ' ' A' ' 143' ' ' LEU . 32.5 t -113.66 112.29 39.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.557 HD11 ' SD ' ' A' ' 99' ' ' MET . 39.0 mt -81.7 157.23 24.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.451 0.643 . . . . 0.0 112.194 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.6 m -163.2 166.93 22.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.165 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -154.68 -166.14 14.82 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.023 -1.084 . . . . 0.0 113.497 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.565 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 22.5 mm-40 -69.15 178.25 0.97 Allowed Pre-proline 0 C--N 1.33 -0.267 0 C-N-CA 122.674 0.39 . . . . 0.0 110.78 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.565 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 36.4 Cg_exo -61.8 -39.59 51.28 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.892 1.728 . . . . 0.0 112.524 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -76.2 -33.07 59.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.977 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.538 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 10.0 tpt -60.75 -17.24 47.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.278 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.692 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 6.2 mmtp -71.46 -4.9 29.1 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.63 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 0.1 OUTLIER -125.52 32.24 5.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.014 0.435 . . . . 0.0 111.03 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.532 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 2.2 mmp_? -103.95 87.43 1.55 Allowed Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.822 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.734 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 1.1 Cg_endo -43.92 129.79 7.7 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.075 2.517 . . . . 0.0 112.406 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.536 ' O ' HG12 ' A' ' 126' ' ' ILE . 15.0 tt -140.63 30.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.703 0.763 . . . . 0.0 110.29 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -70.11 -49.52 33.34 Favored Glycine 0 C--N 1.317 -0.523 0 CA-C-N 114.814 -1.085 . . . . 0.0 113.25 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.647 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -55.27 -25.31 33.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.819 -179.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.812 HD12 HD21 ' A' ' 133' ' ' LEU . 30.9 tp -83.88 -65.74 0.97 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.813 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 126' ' ' ILE . 60.3 t -51.15 -26.53 5.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.223 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 1.7 m-20 -73.2 -46.37 50.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.667 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.899 ' HA ' HD11 ' A' ' 135' ' ' LEU . . . -63.48 -48.71 76.54 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.284 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.812 HD21 HD12 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -59.86 -44.36 94.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.385 0.612 . . . . 0.0 109.692 179.573 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -59.18 -34.92 72.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.421 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.899 HD11 ' HA ' ' A' ' 132' ' ' ALA . 2.2 mt -68.86 -28.0 66.32 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.21 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.5 -11.37 85.21 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.611 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 121.24 6.13 9.13 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.931 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.29 149.2 37.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 111.3 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.45 ' HA ' ' HE3' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -115.4 95.95 5.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.082 0.468 . . . . 0.0 111.594 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.603 HD13 ' SG ' ' A' ' 107' ' ' CYS . 12.1 mt -118.26 177.05 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.395 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.575 ' O ' HD23 ' A' ' 151' ' ' LEU . 1.0 OUTLIER -154.11 -167.69 2.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.18 0.514 . . . . 0.0 111.403 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.532 ' CD2' ' HG2' ' A' ' 146' ' ' GLU . 23.6 m-85 -135.56 102.66 5.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.796 ' HG ' HG13 ' A' ' 114' ' ' VAL . 2.2 mm? -75.7 -13.86 60.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.932 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.673 ' HG3' ' N ' ' A' ' 145' ' ' GLN . 0.0 OUTLIER -135.63 -69.75 0.49 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.357 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.673 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.4 OUTLIER -132.15 163.86 27.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.912 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.532 ' HG2' ' CD2' ' A' ' 142' ' ' TYR . 23.4 mt-10 -74.97 143.46 43.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.556 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.734 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 0.5 OUTLIER 51.54 42.32 29.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.012 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.695 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.4 m-30 -130.24 174.43 4.64 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.262 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.695 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 8.6 Cg_endo -50.76 -40.65 56.44 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.921 2.414 . . . . 0.0 114.316 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 149' ' ' PRO . 40.1 Cg_endo -60.97 100.28 0.16 Allowed 'Trans proline' 0 CA--C 1.511 -0.625 0 C-N-CA 121.797 1.665 . . . . 0.0 111.514 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.575 HD23 ' O ' ' A' ' 141' ' ' THR . 92.6 mt -137.89 123.02 19.2 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.24 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -105.63 112.07 25.01 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 1.4 mt -94.0 158.22 15.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.045 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 32.4 mt-30 -145.72 24.45 1.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.784 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.486 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 53.59 -165.71 1.99 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.679 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.85 -3.73 38.93 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.105 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.663 ' HE2' ' HA ' ' A' ' 133' ' ' LEU . 44.5 t80 -61.81 107.35 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.846 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 53.3 p -103.02 -50.47 3.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.697 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.599 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 146.24 -165.25 28.24 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.138 -1.03 . . . . 0.0 114.19 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.481 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 119.23 168.37 14.0 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -62.43 125.87 25.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.004 0.402 . . . . 0.0 110.15 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.547 HG11 ' N ' ' A' ' 163' ' ' ASP . 44.3 t -135.02 153.02 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.756 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.547 ' N ' HG11 ' A' ' 162' ' ' VAL . 0.4 OUTLIER -119.3 115.57 24.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.032 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.441 HG13 HD13 ' A' ' 173' ' ' LEU . 0.5 OUTLIER -113.87 147.4 17.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.647 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.9 OUTLIER -85.64 134.14 34.0 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.481 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.698 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -76.54 -44.7 15.5 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.759 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.9 t -50.39 163.02 0.18 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.055 0.455 . . . . 0.0 111.832 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.2 t 71.3 59.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.898 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.434 ' HA ' HG13 ' A' ' 196' ' ' VAL . 75.7 m 57.68 153.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.262 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.455 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 0.5 OUTLIER -78.14 -2.4 37.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.249 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.597 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 90.6 mm-40 -51.55 -23.36 4.04 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.819 0.342 . . . . 0.0 111.365 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.539 ' CD2' ' HB2' ' A' ' 128' ' ' HIS . 2.8 m-85 -72.16 -58.94 3.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.252 0.549 . . . . 0.0 110.702 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.577 ' HG ' HD11 ' A' ' 177' ' ' LEU . 39.5 tp -73.49 -34.28 65.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.821 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.516 ' O ' ' HG2' ' A' ' 178' ' ' MET . 89.8 m -60.01 -31.33 69.83 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.66 ' HB2' ' HA ' ' A' ' 101' ' ' PRO . . . -73.15 -52.23 14.95 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.059 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.661 HD23 HD23 ' A' ' 133' ' ' LEU . 2.6 mt -65.46 -38.19 89.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.741 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.577 HD11 ' HG ' ' A' ' 173' ' ' LEU . 11.7 mt -64.57 -28.28 69.53 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.225 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.517 ' HA ' ' HH ' ' A' ' 231' ' ' TYR . 9.6 ptp -97.3 -27.52 14.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.193 0.521 . . . . 0.0 110.894 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.671 ' O ' HD11 ' A' ' 108' ' ' LEU . 23.0 m -85.03 -46.75 10.89 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.929 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.674 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -61.44 -38.67 54.64 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.2 Cg_endo -53.73 -35.66 79.24 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.516 1.478 . . . . 0.0 112.016 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.684 HD21 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.75 -7.77 59.08 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.988 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -66.42 122.75 83.21 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.06 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -43.12 -27.84 1.15 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.939 2.426 . . . . 0.0 113.614 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -107.17 153.06 23.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.013 0.435 . . . . 0.0 111.292 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.566 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 52.1 t0 -70.33 115.1 9.13 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.289 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.741 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 45.0 m -100.57 136.66 40.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.365 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.447 HG22 ' CG1' ' A' ' 224' ' ' VAL . 26.0 t -125.52 99.43 5.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.763 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.576 ' O ' ' N ' ' A' ' 223' ' ' PHE . 4.7 mt -90.57 143.65 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.132 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.824 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 2.2 ptm180 -115.28 170.95 8.0 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.588 ' CG2' HD13 ' A' ' 195' ' ' LEU . 1.4 mm -111.1 97.86 6.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-O 120.977 0.418 . . . . 0.0 111.267 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.501 ' HZ2' ' HB2' ' A' ' 165' ' ' ASP . 4.9 mtmp? -62.31 -80.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.581 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -76.84 167.81 54.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.146 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -62.6 122.26 15.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.656 0.265 . . . . 0.0 110.952 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.698 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.7 OUTLIER -57.37 146.45 29.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.891 0.377 . . . . 0.0 110.395 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.447 HG11 ' N ' ' A' ' 197' ' ' SER . 11.6 p -103.34 -20.09 5.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.318 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.684 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -128.9 46.33 2.64 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.248 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.62 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . 0.9 OUTLIER -41.96 -64.79 0.6 Allowed Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.039 -178.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 60.0 Cg_endo -70.73 -16.83 33.46 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 121.519 1.479 . . . . 0.0 111.457 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.684 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 21.5 m-85 -74.2 -30.02 62.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.204 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 198' ' ' LYS . 8.8 tp -68.54 -31.84 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.405 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.416 ' N ' HG22 ' A' ' 201' ' ' ILE . 6.6 m-20 -58.93 -29.64 67.26 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.651 ' O ' ' HB2' ' A' ' 207' ' ' LEU . 33.4 mt -70.68 -29.91 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.253 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 51.6 m -61.73 -55.22 32.56 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.16 0.505 . . . . 0.0 109.677 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' A' ' 215' ' ' ILE . 21.5 mt -69.19 -33.71 73.77 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.859 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.789 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 47.7 t30 -68.94 -24.74 64.31 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.651 ' HB2' ' O ' ' A' ' 203' ' ' ILE . 0.2 OUTLIER -78.96 -41.56 28.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.073 178.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.415 ' HB3' ' HE1' ' A' ' 231' ' ' TYR . 12.0 mtp -70.26 -39.14 75.16 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.4 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.789 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -64.97 -42.35 94.64 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.398 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 207' ' ' LEU . 1.0 OUTLIER -59.61 -30.72 68.89 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.054 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.624 ' CE2' ' HA ' ' A' ' 32' ' ' ALA . 1.5 m-85 -71.18 -53.43 14.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.85 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 158.21 -3.45 0.13 Allowed Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.543 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.579 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 55.6 t -119.8 142.97 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.144 0.497 . . . . 0.0 112.231 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -135.52 156.03 49.54 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.442 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.63 ' CD1' HD12 ' A' ' 205' ' ' LEU . 2.4 pp -129.07 176.14 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.52 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 1.037 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 8.3 tp10 -90.4 126.27 35.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.135 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -101.47 101.25 11.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.632 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.696 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.7 OUTLIER -67.38 -168.87 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.611 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -73.9 48.44 0.29 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.811 0.339 . . . . 0.0 110.489 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.562 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 58.9 18.73 6.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.222 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 191' ' ' ILE . 11.6 pt20 -111.67 -22.57 11.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.761 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.824 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 27.8 mt-30 -148.0 139.86 23.96 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.13 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.576 ' N ' ' O ' ' A' ' 189' ' ' ILE . 13.6 m-85 -111.15 98.37 7.47 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 1.037 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 37.2 t -82.4 111.42 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-O 121.153 0.501 . . . . 0.0 111.068 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.741 ' CG2' ' HB ' ' A' ' 187' ' ' THR . 2.4 m -98.43 113.57 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.789 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 2.0 mptp? -65.03 103.83 0.79 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.757 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.566 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -58.51 156.71 21.33 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.94 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.36 10.91 70.08 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.367 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.546 HE21 ' HA ' ' A' ' 229' ' ' GLN . 1.3 mm-40 -80.53 179.51 7.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.563 0.697 . . . . 0.0 111.901 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.684 ' HA ' HD21 ' A' ' 182' ' ' LEU . 4.0 m -173.69 106.88 0.13 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.448 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.642 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 22.9 m-85 -54.9 151.84 8.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.211 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.56 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 8.6 pt20 -122.11 142.46 50.36 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.6 t -48.6 98.74 0.19 Allowed Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.56 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 55.0 Cg_endo -67.22 -25.95 42.59 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.336 2.024 . . . . 0.0 111.976 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 112.49 -119.03 4.83 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.591 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -95.71 117.31 30.28 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.484 ' CE2' HD13 ' A' ' 207' ' ' LEU . 41.7 t80 -116.54 130.6 56.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.598 ' HA ' HG22 ' A' ' 42' ' ' THR . 0.1 OUTLIER -93.39 106.08 18.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.647 179.229 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.538 ' CG1' ' H2 ' ' A' ' 25' ' ' SER . 78.3 t -48.78 -52.9 8.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.125 0.488 . . . . 0.0 110.512 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.544 ' N ' HD13 ' A' ' 238' ' ' LEU . 24.0 tt0 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.069 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.654 ' O ' HD13 ' A' ' 29' ' ' LEU . 79.5 p . . . . . 0 N--CA 1.484 1.237 0 CA-C-O 121.25 0.548 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.58 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 5.2 p30 -86.91 -23.83 25.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.75 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -67.58 -42.91 81.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.683 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.429 ' HB3' ' CD2' ' A' ' 41' ' ' LEU . . . -77.65 -34.33 53.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.937 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.848 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -58.32 -48.93 78.95 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.366 0.603 . . . . 0.0 110.504 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.607 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 3.2 tp -72.57 -49.29 33.44 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.225 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.685 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 31.7 mt -56.36 -33.07 65.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.732 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.66 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . . . -75.16 -29.88 60.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.695 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.595 ' O ' ' HB2' ' A' ' 78' ' ' ASN . . . -71.67 -29.19 64.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.651 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.901 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.23 -13.23 38.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.046 0.451 . . . . 0.0 110.855 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.26 168.01 18.05 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.779 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.53 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 80.4 m80 -101.98 97.74 8.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.079 0.466 . . . . 0.0 110.011 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.94 140.64 6.01 Favored Glycine 0 C--N 1.316 -0.579 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.436 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.789 ' HD3' ' HB3' ' A' ' 74' ' ' GLU . 2.1 ttmm -66.96 139.96 57.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.983 0.421 . . . . 0.0 112.028 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.809 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -130.71 156.47 44.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.7 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.647 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 57.4 t -102.64 142.27 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.994 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' A' ' 237' ' ' TYR . 0.0 OUTLIER -127.76 111.94 14.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.98 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.7 OUTLIER -102.1 164.96 11.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.894 0.378 . . . . 0.0 110.838 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.471 ' HB2' ' CD1' ' A' ' 238' ' ' LEU . 0.1 OUTLIER 66.56 19.09 10.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.726 -178.281 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 70' ' ' ARG . 0.6 OUTLIER -58.78 152.72 18.42 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.327 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.578 ' HB3' HG23 ' A' ' 50' ' ' VAL . 18.1 tp -82.54 114.95 21.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.22 0.533 . . . . 0.0 111.235 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -78.95 69.7 5.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.464 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.9 m -133.68 -160.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.379 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.624 ' HA ' ' CG ' ' A' ' 51' ' ' ARG . 76.9 m-20 -98.0 -19.42 18.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.014 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.422 ' OD2' ' HA ' ' A' ' 95' ' ' ALA . 4.0 m-20 -70.25 -32.2 69.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.885 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.578 HG23 ' HB3' ' A' ' 45' ' ' LEU . 21.1 t -84.72 -52.85 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.237 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.624 ' CG ' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -50.51 -28.7 8.96 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.913 179.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -72.68 -35.95 67.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.198 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.689 ' HE3' HD23 ' A' ' 57' ' ' LEU . 7.8 tpt -65.33 -48.93 71.32 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.848 ' HG ' HD12 ' A' ' 29' ' ' LEU . 1.5 mp -64.78 -47.9 76.43 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -55.63 -24.09 31.55 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.451 179.39 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.494 ' HB3' ' HG ' ' A' ' 102' ' ' LEU . . . -75.72 -48.99 19.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.726 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.689 HD23 ' HE3' ' A' ' 53' ' ' MET . 0.1 OUTLIER -66.48 -49.97 64.85 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.878 -179.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.492 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.3 t -51.9 -32.29 31.92 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.302 0.572 . . . . 0.0 110.034 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HB3' HD22 ' A' ' 88' ' ' LEU . . . -59.21 -48.05 83.07 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.106 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.726 HD23 ' HB3' ' A' ' 82' ' ' LEU . 3.7 mp -69.37 -27.38 65.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.394 0.616 . . . . 0.0 110.084 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.41 -1.97 4.93 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.6 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.733 HG21 HD11 ' A' ' 82' ' ' LEU . 13.6 t -59.59 155.79 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 117.641 0.72 . . . . 0.0 110.056 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.626 ' N ' HG13 ' A' ' 62' ' ' VAL . 1.7 m -116.95 107.71 14.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.991 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.645 ' CE2' ' HB3' ' A' ' 54' ' ' LEU . 8.3 p90 -122.24 153.43 38.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.861 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 1.7 m -147.99 116.33 6.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.877 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.748 HD11 ' HB2' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -87.97 177.32 6.98 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.085 0.469 . . . . 0.0 111.198 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.499 ' H ' HD12 ' A' ' 66' ' ' LEU . 12.9 p -93.97 179.68 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.479 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.94 -14.59 36.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.751 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -118.12 6.8 12.06 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.888 0.375 . . . . 0.0 110.74 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.635 ' O ' HD23 ' A' ' 44' ' ' LEU . 3.9 mmt180 57.14 43.85 23.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.817 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -126.49 -2.32 6.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.436 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.924 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -136.54 109.73 7.79 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.822 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.748 ' HB2' HD11 ' A' ' 66' ' ' LEU . 5.7 t -118.11 153.99 32.86 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.461 0.648 . . . . 0.0 112.669 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.789 ' HB3' ' HD3' ' A' ' 38' ' ' LYS . 0.6 OUTLIER -121.49 103.45 8.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.054 178.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.706 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -98.96 125.05 52.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.591 HG13 ' CB ' ' A' ' 63' ' ' SER . 8.3 mm -78.97 104.16 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.308 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.632 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -51.82 115.77 4.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.882 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -63.56 -14.87 55.56 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.914 0.388 . . . . 0.0 110.439 178.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.53 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 83.6 -19.88 13.51 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.336 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.901 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.75 -151.28 5.73 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 178.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.815 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 3.8 Cg_exo -77.47 171.0 18.35 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 119.638 1.719 . . . . 0.0 109.222 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.733 HD11 HG21 ' A' ' 62' ' ' VAL . 4.1 mm? -68.09 90.99 0.34 Allowed 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.815 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 32.7 m170 -84.21 120.74 26.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 113.062 -1.881 . . . . 0.0 112.368 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.695 ' O ' ' HB2' ' A' ' 111' ' ' ASN . . . -144.13 106.83 4.44 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.274 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.08 88.63 2.78 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.545 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.07 21.18 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.803 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.47 50.07 15.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.421 0.629 . . . . 0.0 109.904 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.687 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 2.8 tp -78.4 135.87 37.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.041 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.621 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -116.63 126.49 53.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.274 0.559 . . . . 0.0 110.286 179.157 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 56' ' ' ALA . 19.7 mt -107.91 156.25 19.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.762 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.555 ' HA ' ' O ' ' A' ' 116' ' ' THR . 49.5 t80 -122.07 102.15 7.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.884 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.75 HD23 ' HE3' ' A' ' 99' ' ' MET . 1.9 mm? -91.74 6.86 44.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.275 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 43.5 -142.84 2.04 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.859 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -92.92 50.43 1.56 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.169 0.509 . . . . 0.0 110.824 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.422 ' HA ' ' OD2' ' A' ' 49' ' ' ASP . . . -84.23 -77.03 0.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.218 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.537 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.54 -16.43 19.06 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.36 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.426 ' HA ' ' NE2' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -96.22 -9.9 29.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.851 0.358 . . . . 0.0 110.474 179.013 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.443 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -130.8 -15.94 3.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.731 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.75 ' HE3' HD23 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -67.95 -54.42 18.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.074 0.464 . . . . 0.0 110.459 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.593 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -60.48 -53.13 67.58 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.383 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.718 ' HB3' ' HE1' ' A' ' 178' ' ' MET . 33.4 Cg_exo -59.9 -47.05 16.73 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.86 2.373 . . . . 0.0 112.894 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.746 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 2.7 tm? -68.54 -34.42 75.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.504 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.68 -47.65 85.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.523 0.677 . . . . 0.0 110.542 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.679 ' HB3' HD21 ' A' ' 133' ' ' LEU . . . -72.45 -39.85 67.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.077 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.553 ' HB3' HD23 ' A' ' 30' ' ' LEU . . . -56.57 -39.77 74.04 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.214 0.531 . . . . 0.0 111.735 -177.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.91 ' HB3' HD22 ' A' ' 111' ' ' ASN . 1.3 mt -72.58 -22.01 61.05 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.039 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.592 ' SG ' HD13 ' A' ' 140' ' ' ILE . 84.9 m -61.92 -8.55 5.22 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.344 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.715 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 11.2 mt -85.6 165.05 17.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.04 -113.58 5.23 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.33 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.42 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 1.4 p -168.66 95.33 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.886 0.374 . . . . 0.0 111.242 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.91 HD22 ' HB3' ' A' ' 106' ' ' LEU . 51.1 p-10 -138.99 143.25 38.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.039 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.52 ' C ' HD12 ' A' ' 113' ' ' ILE . 1.5 m-20 -101.08 111.55 23.78 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.18 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.687 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 5.0 mp -141.49 142.4 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.023 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.795 HG11 ' HG ' ' A' ' 143' ' ' LEU . 22.5 t -116.09 112.06 38.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.744 0.307 . . . . 0.0 110.377 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.8 mt -79.08 157.14 28.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.415 0.626 . . . . 0.0 111.787 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 35.2 m -161.99 154.74 20.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.758 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.441 ' N ' HG23 ' A' ' 116' ' ' THR . . . -140.69 -167.1 10.94 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 119.897 -1.144 . . . . 0.0 113.425 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.627 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 2.3 mt-10 -70.65 173.03 5.12 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.387 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 20.2 Cg_endo -61.19 -24.39 78.98 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.598 1.532 . . . . 0.0 111.972 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.493 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 2.3 tpp180 -90.23 -33.14 16.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.261 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.606 ' HE3' ' HB2' ' A' ' 124' ' ' ARG . 6.0 tpt -60.12 -19.55 54.0 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.657 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 7.6 mttm -68.33 -4.92 16.09 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.122 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.614 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -121.29 30.48 6.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.886 0.374 . . . . 0.0 110.986 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.606 ' HB2' ' HE3' ' A' ' 121' ' ' MET . 4.0 mmp_? -108.96 93.75 13.26 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.758 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 8.2 Cg_endo -50.1 128.62 22.83 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.559 2.173 . . . . 0.0 112.466 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.492 ' CD1' HD22 ' A' ' 129' ' ' LEU . 17.3 tt -133.83 31.12 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.766 0.793 . . . . 0.0 110.215 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.498 ' HA3' ' OD1' ' A' ' 147' ' ' ASN . . . -71.8 -51.57 14.88 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.202 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.778 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.2 OUTLIER -53.14 -26.9 18.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.962 0.41 . . . . 0.0 110.727 -179.299 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.767 HD12 ' CD2' ' A' ' 133' ' ' LEU . 35.4 tp -82.63 -66.5 0.88 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.749 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.559 ' HA ' HD13 ' A' ' 133' ' ' LEU . 61.1 t -52.13 -25.44 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.312 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 30.9 t0 -72.16 -45.31 60.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.585 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.851 ' HA ' HD13 ' A' ' 135' ' ' LEU . . . -64.89 -51.83 59.8 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.834 0.35 . . . . 0.0 111.513 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.767 ' CD2' HD12 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -56.62 -43.01 79.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.221 0.534 . . . . 0.0 109.874 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -60.06 -32.67 71.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.048 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.851 HD13 ' HA ' ' A' ' 132' ' ' ALA . 2.2 mt -72.09 -26.75 62.27 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.462 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.523 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -80.82 -13.55 81.16 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.659 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.82 4.04 6.24 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.302 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.88 145.71 48.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.923 0.392 . . . . 0.0 111.53 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 0.2 OUTLIER -114.29 90.83 3.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.54 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.662 HD12 HD13 ' A' ' 133' ' ' LEU . 7.0 mt -117.48 174.54 3.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.957 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.632 ' O ' HD21 ' A' ' 151' ' ' LEU . 0.8 OUTLIER -152.43 -168.08 2.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 111.39 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.556 ' N ' HG21 ' A' ' 141' ' ' THR . 25.7 m-85 -131.77 105.65 7.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.097 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.795 ' HG ' HG11 ' A' ' 114' ' ' VAL . 2.1 mm? -79.69 -8.88 59.5 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.798 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 27.5 mt-10 -141.33 -73.68 0.33 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.349 . . . . 0.0 110.379 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.619 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.1 OUTLIER -123.87 148.63 46.63 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.252 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.443 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 4.3 mt-10 -70.24 135.64 49.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.12 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.611 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 1.3 m-80 64.59 49.59 2.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.319 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.84 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.8 m-85 -148.29 179.6 1.15 Allowed Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.734 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.84 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 8.0 Cg_endo -50.22 -40.36 51.77 Favored 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 123.331 2.687 . . . . 0.0 115.037 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.798 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 36.7 Cg_endo -62.05 100.94 0.22 Allowed 'Trans proline' 0 CA--C 1.516 -0.375 0 C-N-CA 121.513 1.475 . . . . 0.0 111.586 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.632 HD21 ' O ' ' A' ' 141' ' ' THR . 91.5 mt -139.56 122.95 17.14 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.802 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.605 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.9 OUTLIER -104.49 112.55 25.65 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.727 ' CD1' HD12 ' A' ' 106' ' ' LEU . 1.2 mt -96.07 155.39 16.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.254 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.598 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 18.8 mt-30 -142.55 24.34 1.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.615 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.44 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 56.49 -165.91 4.66 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.433 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.97 -4.98 34.1 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.13 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.645 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 3.5 t80 -60.8 107.34 0.69 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.863 0.332 . . . . 0.0 110.494 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 185' ' ' GLU . 76.4 p -105.61 -46.39 4.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.889 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.649 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 141.73 -162.3 27.02 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.136 -1.03 . . . . 0.0 113.981 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.531 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 115.71 172.67 17.04 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -65.16 126.76 29.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.583 HG12 HD13 ' A' ' 135' ' ' LEU . 58.0 t -135.5 157.54 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-O 121.132 0.491 . . . . 0.0 111.47 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.512 ' O ' ' HE2' ' A' ' 192' ' ' LYS . 3.2 m-20 -123.65 119.66 30.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.384 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.517 ' C ' ' HE3' ' A' ' 192' ' ' LYS . 0.4 OUTLIER -121.74 139.13 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.548 -0.461 . . . . 0.0 112.101 -178.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.778 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.3 OUTLIER -78.93 133.5 36.91 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.267 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.685 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -75.43 -44.64 21.1 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.105 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.478 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 54.4 p -52.91 165.44 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.922 0.391 . . . . 0.0 111.359 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.6 t 72.61 50.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.01 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.474 ' HA ' HG13 ' A' ' 196' ' ' VAL . 1.4 m 63.62 150.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.424 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.523 ' OG ' HD12 ' A' ' 201' ' ' ILE . 12.2 t -77.68 3.65 13.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.711 0.291 . . . . 0.0 111.412 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.593 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 18.9 mm100 -54.49 -20.68 8.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.983 0.42 . . . . 0.0 111.42 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.624 ' CD2' ' HB2' ' A' ' 128' ' ' HIS . 1.6 m-85 -76.09 -54.29 7.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.619 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.485 ' CD2' HG12 ' A' ' 201' ' ' ILE . 21.0 tp -77.33 -35.03 55.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.593 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.449 ' O ' ' HG2' ' A' ' 178' ' ' MET . 79.8 m -58.99 -33.46 70.71 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.026 0.441 . . . . 0.0 110.029 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.625 ' CB ' ' HA ' ' A' ' 101' ' ' PRO . . . -76.33 -51.96 10.9 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.966 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.747 ' HB3' HD12 ' A' ' 189' ' ' ILE . 3.2 mt -61.99 -43.08 99.6 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.507 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.564 HD21 ' HB3' ' A' ' 223' ' ' PHE . 12.6 mt -60.75 -28.07 68.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.867 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.718 ' HE1' ' HB3' ' A' ' 101' ' ' PRO . 4.9 ptp -96.39 -26.24 15.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.325 0.583 . . . . 0.0 110.492 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.676 ' O ' HD13 ' A' ' 108' ' ' LEU . 74.1 m -85.17 -47.55 10.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.157 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 1.031 ' HB1' HG22 ' A' ' 225' ' ' VAL . . . -63.74 -35.84 18.44 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 9.7 Cg_endo -53.17 -37.77 80.35 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 121.129 1.219 . . . . 0.0 111.376 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.78 -8.06 58.96 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -67.43 115.8 30.4 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.057 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -33.58 -34.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.69 2.927 . . . . 0.0 114.33 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 158' ' ' THR . 3.1 mt-10 -103.65 152.92 21.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.005 0.431 . . . . 0.0 111.77 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.573 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 40.9 t0 -67.29 114.68 6.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.708 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.759 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 29.2 m -99.7 135.23 41.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.098 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.438 HG11 HG22 ' A' ' 224' ' ' VAL . 25.4 t -125.8 99.22 5.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.881 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.747 HD12 ' HB3' ' A' ' 176' ' ' LEU . 3.5 mt -91.11 144.49 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.267 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.809 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.2 OUTLIER -114.93 170.98 7.93 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.589 HG23 ' CD1' ' A' ' 195' ' ' LEU . 1.4 mm -111.54 97.15 5.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.269 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.587 ' HE3' ' N ' ' A' ' 165' ' ' ASP . 9.3 mtmt -57.0 -81.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.681 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -83.21 168.0 46.06 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.361 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -59.61 122.64 14.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.568 0.223 . . . . 0.0 110.84 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.4 OUTLIER -55.65 147.6 17.97 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.22 0.533 . . . . 0.0 110.841 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.478 ' HB ' ' HA ' ' A' ' 167' ' ' SER . 11.8 p -103.81 -21.06 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.134 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.3 OUTLIER -128.11 46.15 2.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.125 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.751 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . 0.6 OUTLIER -43.62 -61.64 1.81 Allowed Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 114.854 -1.066 . . . . 0.0 113.11 -178.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.751 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 15.0 Cg_exo -69.37 -17.28 39.44 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 121.476 1.451 . . . . 0.0 111.55 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.549 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 26.9 m-85 -75.08 -30.69 61.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.113 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.523 HD12 ' OG ' ' A' ' 170' ' ' SER . 8.0 tp -67.95 -33.6 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.229 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.548 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 9.9 t70 -59.79 -33.71 72.07 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.547 ' O ' ' HB2' ' A' ' 207' ' ' LEU . 13.1 mt -68.32 -29.86 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.622 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.461 ' O ' ' HG3' ' A' ' 208' ' ' MET . 71.7 m -61.0 -54.71 41.6 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.124 0.488 . . . . 0.0 109.716 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.591 HD11 ' CD1' ' A' ' 215' ' ' ILE . 28.7 mt -70.4 -34.64 72.77 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.231 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.732 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 0.9 OUTLIER -63.6 -29.93 71.11 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.299 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.685 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -77.73 -40.82 39.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.613 178.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.464 ' HG2' ' HH ' ' A' ' 231' ' ' TYR . 10.4 mtp -68.76 -38.56 80.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.966 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.732 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -66.7 -45.26 79.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.384 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.657 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 2.0 t -58.71 -26.08 63.53 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.317 0.58 . . . . 0.0 109.529 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.899 ' HA ' ' HG3' ' A' ' 234' ' ' PRO . 2.1 m-85 -74.92 -54.56 7.02 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.602 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 156.67 -1.56 0.13 Allowed Glycine 0 CA--C 1.52 0.351 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.883 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.619 ' HB ' ' CD1' ' A' ' 231' ' ' TYR . 53.0 t -117.75 138.22 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.046 0.451 . . . . 0.0 111.767 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -135.49 155.12 51.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.535 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.591 ' CD1' HD11 ' A' ' 205' ' ' LEU . 2.4 pp -129.31 175.5 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.956 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.317 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 1.016 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 18.7 tt0 -89.91 125.52 35.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.874 0.368 . . . . 0.0 110.37 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -101.14 100.95 11.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.248 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.698 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 2.1 mm-40 -66.74 -167.08 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.75 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.46 48.26 0.34 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.901 0.381 . . . . 0.0 110.341 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.555 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 57.88 19.65 5.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.254 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 191' ' ' ILE . 3.1 pt20 -112.94 -19.72 11.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.83 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.809 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 32.5 mt-30 -150.34 141.67 23.27 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.701 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.585 ' N ' ' O ' ' A' ' 189' ' ' ILE . 19.4 m-85 -114.14 96.76 5.97 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 1.016 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 31.1 t -82.8 110.97 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 121.167 0.508 . . . . 0.0 111.235 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 1.031 HG22 ' HB1' ' A' ' 180' ' ' ALA . 3.0 m -99.87 113.15 34.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.964 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.627 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 1.3 mptm? -62.74 103.82 0.47 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.998 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.573 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.25 155.86 16.36 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.947 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.97 8.77 75.23 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.445 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 69.8 mm-40 -73.16 178.54 4.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.473 0.654 . . . . 0.0 111.546 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.572 ' HA ' HD21 ' A' ' 182' ' ' LEU . 4.9 m -167.68 105.55 0.52 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.863 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 22.7 m-85 -55.15 142.53 30.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.108 0.48 . . . . 0.0 111.368 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.583 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 78.9 mt-30 -108.21 148.58 29.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.673 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 56.6 p -64.13 103.05 0.37 Allowed Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.155 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.899 ' HG3' ' HA ' ' A' ' 211' ' ' PHE . 7.7 Cg_exo -71.36 -31.39 14.17 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.705 2.27 . . . . 0.0 111.966 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.01 -120.79 5.22 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.647 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -92.9 116.8 29.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.615 ' CE2' HD21 ' A' ' 207' ' ' LEU . 88.1 t80 -123.78 136.8 54.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.519 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.98 ' HA ' HG22 ' A' ' 42' ' ' THR . 4.0 tp -98.18 119.46 36.87 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.261 0.553 . . . . 0.0 111.707 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.439 HG11 ' N ' ' A' ' 25' ' ' SER . 92.8 t -52.84 -81.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.052 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.457 ' H ' ' HB3' ' A' ' 43' ' ' ASN . 2.8 tt0 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.712 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.695 ' HB2' HG13 ' A' ' 50' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.902 0.382 . . . . 0.0 111.054 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.715 ' OD1' ' HA ' ' A' ' 50' ' ' VAL . 64.3 m-20 -74.83 -22.39 58.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.964 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.421 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 35.0 mtt85 -62.19 -40.41 95.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.053 0.454 . . . . 0.0 110.293 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 41' ' ' LEU . . . -74.32 -37.63 63.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.908 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.635 ' CD1' ' HG ' ' A' ' 54' ' ' LEU . 55.1 mt -58.36 -47.19 84.61 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.862 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.612 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 14.9 tp -77.82 -48.84 15.55 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.651 HD21 ' HG2' ' A' ' 178' ' ' MET . 27.7 mt -55.05 -35.19 64.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.467 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.68 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -78.17 -29.7 48.74 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.675 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.583 ' HB3' HD23 ' A' ' 82' ' ' LEU . . . -70.26 -30.58 67.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.939 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.853 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.35 -12.54 40.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.996 0.427 . . . . 0.0 111.065 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.679 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -80.42 168.68 18.68 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.239 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.59 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 76.9 m80 -103.19 98.42 8.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.217 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.71 141.06 6.95 Favored Glycine 0 C--N 1.314 -0.657 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.627 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.712 ' HB2' HG13 ' A' ' 76' ' ' ILE . 1.6 ttpm? -64.84 138.53 58.43 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.37 157.74 44.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.374 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.57 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 94.1 t -104.83 141.46 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.372 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.663 ' HB2' ' CG2' ' A' ' 239' ' ' VAL . 0.0 OUTLIER -127.93 111.62 13.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.888 178.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.843 HG21 ' HA ' ' A' ' 238' ' ' LEU . 0.1 OUTLIER -98.31 171.03 8.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 111.783 -179.743 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.548 ' HB2' ' CD1' ' A' ' 238' ' ' LEU . 1.8 t30 66.03 18.17 10.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.233 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.604 HD23 HG12 ' A' ' 50' ' ' VAL . 1.2 tp -58.61 163.64 3.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.626 ' H ' ' HB3' ' A' ' 25' ' ' SER . 38.5 tp -97.64 116.63 30.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.009 0.433 . . . . 0.0 111.425 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -75.64 71.85 2.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.749 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.523 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 63.1 m -134.85 -162.98 1.31 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.899 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.609 ' HA ' ' CG ' ' A' ' 51' ' ' ARG . 1.5 t70 -98.19 -22.11 16.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.896 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.457 ' CG ' ' HA ' ' A' ' 95' ' ' ALA . 8.2 m-20 -66.61 -30.4 70.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.78 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.715 ' HA ' ' OD1' ' A' ' 26' ' ' ASN . 21.3 t -84.48 -56.02 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.058 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.609 ' CG ' ' HA ' ' A' ' 48' ' ' ASP . 1.1 ptm180 -49.99 -26.97 4.77 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -71.41 -40.77 70.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.296 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.459 ' SD ' ' HB3' ' A' ' 26' ' ' ASN . 7.1 tpt -64.87 -47.43 77.91 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.635 ' HG ' ' CD1' ' A' ' 29' ' ' LEU . 1.3 mp -65.33 -47.21 77.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 8.4 t-20 -57.39 -23.01 46.64 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.0 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 53' ' ' MET . . . -74.76 -48.1 27.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.056 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.609 HD11 ' HB3' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -68.18 -49.44 60.87 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.771 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.515 HG21 ' HA ' ' A' ' 55' ' ' ASN . 6.0 t -51.65 -30.23 20.86 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.281 0.562 . . . . 0.0 110.201 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.507 ' CB ' HD22 ' A' ' 90' ' ' LEU . . . -59.31 -52.49 65.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.962 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.763 HD22 HD21 ' A' ' 106' ' ' LEU . 3.8 mp -65.14 -28.38 69.38 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.83 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.76 0.61 5.23 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 114.834 -1.075 . . . . 0.0 113.494 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.671 HG13 ' N ' ' A' ' 63' ' ' SER . 22.9 t -56.55 154.2 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 117.609 0.705 . . . . 0.0 110.391 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.709 ' O ' HD12 ' A' ' 76' ' ' ILE . 11.9 m -115.16 112.27 22.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.379 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 7.5 p90 -129.71 156.95 43.45 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.875 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -149.25 116.05 5.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.823 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.616 HD12 ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -90.32 175.55 7.07 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.232 0.539 . . . . 0.0 111.645 -179.424 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.809 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 1.3 t -87.85 179.42 6.47 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.709 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.33 -14.36 49.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.33 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.98 2.39 11.5 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.866 0.365 . . . . 0.0 110.705 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.476 ' O ' HD21 ' A' ' 44' ' ' LEU . 0.3 OUTLIER 61.33 45.29 8.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.428 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.481 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -124.03 -2.72 8.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.974 179.021 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.809 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -142.54 110.62 5.97 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.429 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.68 ' HA ' ' O ' ' A' ' 65' ' ' THR . 0.6 OUTLIER -114.93 152.62 32.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.256 0.55 . . . . 0.0 112.064 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 1.1 mt-10 -118.11 102.85 9.34 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.689 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.692 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -99.44 126.44 52.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.712 HG13 ' HB2' ' A' ' 38' ' ' LYS . 3.1 mp -80.94 103.81 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.425 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.68 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -48.08 118.79 4.76 Favored Glycine 0 N--CA 1.453 -0.186 0 CA-C-N 116.017 -0.538 . . . . 0.0 114.136 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.572 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -63.77 -15.38 58.5 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.987 0.423 . . . . 0.0 110.357 178.552 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.59 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.02 -19.71 20.17 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.827 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.853 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -139.73 -150.22 5.47 Favored Glycine 0 C--O 1.224 -0.519 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.787 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 4.3 Cg_exo -77.57 170.08 19.85 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 CA-C-N 119.711 1.755 . . . . 0.0 108.828 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.756 ' HB3' HD21 ' A' ' 60' ' ' LEU . 4.3 mm? -68.43 89.59 0.35 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.787 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 34.1 m170 -83.44 118.34 23.68 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.012 -1.904 . . . . 0.0 112.333 -176.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.527 ' H ' ' HB3' ' A' ' 111' ' ' ASN . . . -143.27 107.65 4.79 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.773 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -106.88 89.33 2.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.733 0.302 . . . . 0.0 110.947 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.63 20.45 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.74 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.32 48.11 19.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.394 0.616 . . . . 0.0 110.263 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 3.9 tp -76.57 131.6 39.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.261 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.585 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 6.9 tt0 -110.64 128.26 55.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.261 0.553 . . . . 0.0 110.096 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.507 HD22 ' CB ' ' A' ' 59' ' ' ALA . 48.6 mt -110.69 156.99 20.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.118 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' A' ' 116' ' ' THR . 45.4 t80 -119.57 105.15 10.93 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.628 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.723 ' HG ' ' HA ' ' A' ' 99' ' ' MET . 2.8 mm? -91.47 8.17 37.68 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.798 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 121' ' ' MET . . . 39.72 -139.82 0.93 Allowed Glycine 0 CA--C 1.523 0.556 0 C-N-CA 121.327 -0.463 . . . . 0.0 113.781 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.655 ' OD1' ' HB3' ' A' ' 120' ' ' ARG . 0.7 OUTLIER -91.32 46.57 1.31 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.023 0.44 . . . . 0.0 111.084 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 92' ' ' LEU . . . -90.52 -77.44 0.41 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.47 ' O ' ' HG2' ' A' ' 171' ' ' GLN . . . 78.65 -14.36 13.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.99 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.56 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -96.29 -11.47 25.88 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 120.81 0.338 . . . . 0.0 110.429 178.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.467 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -125.05 -21.27 4.7 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.49 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.723 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 10.4 ttm -66.8 -52.02 48.86 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.263 0.554 . . . . 0.0 110.47 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.881 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -57.77 -55.39 45.4 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.156 -179.522 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.627 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 24.1 Cg_exo -63.45 -46.8 8.75 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.53 2.153 . . . . 0.0 112.886 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.625 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 2.9 tm? -61.3 -40.81 95.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.78 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.441 ' HB3' ' CD1' ' A' ' 115' ' ' LEU . . . -58.94 -48.48 81.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.65 0.738 . . . . 0.0 109.736 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.738 ' HB3' HD21 ' A' ' 133' ' ' LEU . . . -68.01 -40.11 83.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.779 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.435 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -56.16 -42.49 77.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.042 0.449 . . . . 0.0 111.315 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.763 HD21 HD22 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -71.74 -21.32 61.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.399 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 104' ' ' ALA . 82.6 m -58.36 -11.76 3.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.669 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.688 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 12.3 mt -84.43 167.68 16.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.716 0.293 . . . . 0.0 110.244 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 55.04 -110.75 1.86 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.076 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.474 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.9 OUTLIER -171.3 96.25 0.19 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.954 0.407 . . . . 0.0 111.207 179.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.579 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 0.5 OUTLIER -137.28 139.61 41.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.974 -179.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.0 OUTLIER -99.77 111.3 23.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.752 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.682 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 4.3 mp -141.02 139.85 33.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.224 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.723 HG11 ' HG ' ' A' ' 143' ' ' LEU . 21.3 t -112.2 113.41 44.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.541 HD23 HD22 ' A' ' 92' ' ' LEU . 18.1 mt -80.44 155.46 27.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.467 0.651 . . . . 0.0 112.215 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 11.2 m -162.72 156.88 20.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.294 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -147.58 -165.34 11.81 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 119.972 -1.109 . . . . 0.0 113.662 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.562 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 1.7 mt-10 -71.38 177.86 1.44 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.312 -0.444 . . . . 0.0 110.507 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.562 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 38.7 Cg_exo -61.74 -26.43 79.77 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.177 1.918 . . . . 0.0 112.52 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.655 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 11.7 tpt180 -87.25 -38.56 16.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.714 0.292 . . . . 0.0 110.483 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.705 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 8.7 tpt -59.6 -19.21 47.32 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.687 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 11.8 mttp -72.32 -4.5 30.19 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.82 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.673 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 5.4 pt-20 -126.62 25.06 6.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.981 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.419 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 33.2 mmt180 -100.15 87.23 0.71 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.271 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.616 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 1.3 Cg_endo -42.32 126.82 3.99 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.958 2.439 . . . . 0.0 112.449 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.566 ' O ' HG12 ' A' ' 126' ' ' ILE . 16.5 tt -131.6 31.71 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.818 0.818 . . . . 0.0 110.103 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -70.7 -52.64 14.63 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.517 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.527 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -54.3 -25.45 23.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.737 0.303 . . . . 0.0 110.686 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.693 HD13 HD21 ' A' ' 133' ' ' LEU . 26.5 tp -84.39 -66.21 0.92 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.885 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.571 ' HA ' ' CD1' ' A' ' 133' ' ' LEU . 48.0 t -52.82 -25.2 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.189 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.566 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 10.8 t0 -72.55 -46.58 53.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.388 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.903 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -65.07 -46.76 79.83 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.661 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.738 HD21 ' HB3' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -60.77 -42.27 97.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.362 0.601 . . . . 0.0 109.777 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.48 -34.8 74.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.056 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.903 HD12 ' HA ' ' A' ' 132' ' ' ALA . 3.4 mt -68.51 -30.58 69.43 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.253 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.21 -18.49 80.04 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.541 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.3 4.58 5.38 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.231 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.99 148.35 49.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.85 0.357 . . . . 0.0 111.406 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.57 87.47 2.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.402 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.661 HD13 HD11 ' A' ' 133' ' ' LEU . 6.8 mt -114.56 175.34 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.47 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.54 ' O ' HD23 ' A' ' 151' ' ' LEU . 1.0 OUTLIER -152.32 -167.22 2.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.232 0.539 . . . . 0.0 111.152 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.444 ' CD2' ' HA ' ' A' ' 146' ' ' GLU . 23.5 m-85 -133.64 105.98 7.14 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.723 ' HG ' HG11 ' A' ' 114' ' ' VAL . 2.0 mm? -81.04 -14.75 57.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.738 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.655 ' HB3' ' HG3' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -134.67 -68.31 0.54 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.996 0.427 . . . . 0.0 109.92 179.439 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.645 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -132.38 150.89 52.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.229 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.444 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 66.3 mt-10 -69.0 131.87 45.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.235 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 13.4 m-20 65.55 50.39 1.66 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.081 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.855 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.3 m-30 -143.03 -178.95 0.86 Allowed Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.855 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 11.9 Cg_endo -59.0 -36.59 96.52 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.599 2.199 . . . . 0.0 114.548 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 149' ' ' PRO . 39.0 Cg_endo -62.94 93.77 0.15 Allowed 'Trans proline' 0 CA--C 1.515 -0.465 0 C-N-CA 121.465 1.443 . . . . 0.0 111.221 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.54 HD23 ' O ' ' A' ' 141' ' ' THR . 72.0 mt -132.54 123.49 26.63 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.513 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -103.11 111.54 23.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 1.1 mt -94.07 159.35 15.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.458 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.579 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -147.2 23.62 1.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.662 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.498 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 55.84 -165.5 4.11 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.318 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.96 -2.38 35.59 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.64 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.688 ' HE1' ' HA ' ' A' ' 133' ' ' LEU . 40.9 t80 -63.44 111.92 2.53 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.029 0.442 . . . . 0.0 110.752 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 78.1 p -106.99 -47.64 3.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.462 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.597 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 140.09 -161.66 26.38 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.913 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.558 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 115.96 170.44 15.9 Favored Glycine 0 CA--C 1.519 0.289 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -66.51 123.26 19.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.056 0.428 . . . . 0.0 110.191 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.462 HG11 HD12 ' A' ' 135' ' ' LEU . 38.8 t -131.6 157.05 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 111.512 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.444 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 2.5 m-20 -120.97 115.24 22.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.606 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.516 HG22 ' HB2' ' A' ' 132' ' ' ALA . 0.5 OUTLIER -116.49 145.62 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 120.176 -0.609 . . . . 0.0 112.201 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.9 OUTLIER -82.9 132.86 35.14 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.925 179.3 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.661 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -74.61 -44.73 25.36 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.369 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.421 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 0.6 OUTLIER -52.02 165.71 0.19 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.879 0.371 . . . . 0.0 111.28 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 4.1 t 71.8 54.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.979 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.509 ' HA ' HG13 ' A' ' 196' ' ' VAL . 69.6 m 59.26 160.02 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.266 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.71 ' HB2' ' HB2' ' A' ' 197' ' ' SER . 34.8 t -80.55 -1.63 42.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.881 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 2.2 mp0 -51.34 -22.16 2.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.671 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.502 ' CD2' ' HB2' ' A' ' 128' ' ' HIS . 2.7 m-85 -78.5 -54.94 5.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.942 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.488 ' CD2' HG12 ' A' ' 201' ' ' ILE . 32.1 tp -73.18 -41.04 64.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.399 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.512 ' CG2' ' HA ' ' A' ' 171' ' ' GLN . 14.7 t -58.64 -32.71 69.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.433 0.635 . . . . 0.0 109.499 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.648 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -64.88 -52.27 57.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.021 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.58 ' CD2' ' HB1' ' A' ' 132' ' ' ALA . 1.9 mt -71.28 -36.09 71.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.187 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.63 HD13 ' CD2' ' A' ' 223' ' ' PHE . 9.8 mt -66.2 -29.83 70.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.123 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.651 ' HG2' HD21 ' A' ' 31' ' ' LEU . 23.6 mtp -93.98 -27.54 16.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.259 0.552 . . . . 0.0 110.64 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.624 ' O ' HD21 ' A' ' 108' ' ' LEU . 87.6 m -88.12 -46.83 8.96 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.141 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.648 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -62.28 -36.71 30.4 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.648 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.4 Cg_endo -54.46 -37.72 89.7 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 CA-C-N 120.297 1.142 . . . . 0.0 111.506 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -83.79 -5.74 59.27 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.229 -179.55 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.1 124.66 90.16 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.1 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -43.74 -29.88 2.61 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.95 2.433 . . . . 0.0 113.535 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -107.75 151.53 25.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.067 0.46 . . . . 0.0 111.652 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.561 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 20.6 t0 -64.55 118.03 8.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.655 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.743 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 41.1 m -102.26 133.85 46.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.817 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.43 HG23 ' CG1' ' A' ' 224' ' ' VAL . 33.3 t -126.0 99.16 5.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.273 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.58 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.2 mt -91.71 145.94 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.116 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.838 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.1 OUTLIER -118.19 171.04 8.39 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.594 ' N ' ' O ' ' A' ' 221' ' ' GLN . 1.6 mm -111.69 98.17 6.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-O 121.096 0.474 . . . . 0.0 111.467 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -60.14 -81.01 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.381 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -81.09 166.75 48.74 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.422 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -57.61 126.32 26.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.65 0.262 . . . . 0.0 111.168 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.853 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.4 OUTLIER -62.48 147.21 49.48 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.013 0.435 . . . . 0.0 110.711 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 169' ' ' SER . 11.6 p -104.21 -20.55 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.797 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.71 ' HB2' ' HB2' ' A' ' 170' ' ' SER . 0.4 OUTLIER -128.28 45.32 2.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.378 0.608 . . . . 0.0 109.589 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.853 ' HA ' HD23 ' A' ' 195' ' ' LEU . 0.0 OUTLIER -41.72 -63.9 0.76 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.541 -179.081 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 49.0 Cg_endo -68.42 -17.33 44.03 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 121.707 1.605 . . . . 0.0 111.479 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.615 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 17.2 m-85 -76.88 -26.74 54.55 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.264 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.56 HD11 HD12 ' A' ' 177' ' ' LEU . 6.3 tp -73.08 -33.61 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.847 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.1 OUTLIER -61.89 -35.0 77.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.226 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.519 ' O ' ' HB2' ' A' ' 207' ' ' LEU . 10.1 mt -66.7 -28.67 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.175 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.53 ' O ' ' HG3' ' A' ' 208' ' ' MET . 53.9 m -61.45 -55.16 34.29 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.639 HD22 HG12 ' A' ' 215' ' ' ILE . 41.3 mt -70.05 -34.28 73.02 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.549 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.59 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 8.8 t30 -64.84 -25.51 67.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.193 0.521 . . . . 0.0 109.839 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.571 HD22 ' CE1' ' A' ' 237' ' ' TYR . 0.2 OUTLIER -83.9 -40.32 18.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.308 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.566 ' HB3' ' CE1' ' A' ' 231' ' ' TYR . 11.2 mtp -69.24 -39.41 78.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.018 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.59 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.1 OUTLIER -65.91 -44.45 85.16 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.53 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 207' ' ' LEU . 1.3 t -59.02 -28.98 66.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.426 0.632 . . . . 0.0 109.39 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.666 ' CE2' ' HA ' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -71.33 -51.41 24.42 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.926 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 157.39 -5.85 0.18 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.531 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.669 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 54.9 t -118.84 137.33 53.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.972 0.415 . . . . 0.0 111.857 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.421 ' C ' HG21 ' A' ' 215' ' ' ILE . 5.8 mt-10 -135.05 156.13 49.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.629 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.639 HG12 HD22 ' A' ' 205' ' ' LEU . 2.0 pp -132.44 175.99 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.932 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.846 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 4.5 tt0 -88.02 122.94 32.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.161 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.61 100.88 10.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.274 0.559 . . . . 0.0 109.778 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.717 ' HB2' ' HG2' ' A' ' 222' ' ' GLN . 1.5 tm0? -72.92 -161.87 0.1 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.044 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -74.32 46.28 0.25 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.499 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.691 ' CE2' ' HD3' ' A' ' 198' ' ' LYS . 0.3 OUTLIER 58.45 22.37 9.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.143 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 191' ' ' ILE . 23.3 mt-30 -109.0 -37.39 5.84 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.021 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.838 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 5.0 pt20 -136.12 139.19 42.75 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.278 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.63 ' CD2' HD13 ' A' ' 177' ' ' LEU . 28.2 m-85 -108.93 95.57 5.73 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.846 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 81.3 t -86.11 112.94 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.265 -177.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.743 ' CG2' ' HB ' ' A' ' 187' ' ' THR . 6.3 m -101.1 115.78 43.43 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.555 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.568 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -64.41 101.47 0.44 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.956 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.561 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -53.51 156.43 5.74 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.256 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.26 10.85 67.86 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.236 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.568 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 60.3 mm-40 -75.84 -179.63 4.93 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.53 0.681 . . . . 0.0 111.657 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.487 ' HA ' HD23 ' A' ' 182' ' ' LEU . 3.9 m -170.68 105.9 0.27 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.863 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.679 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 21.9 m-85 -53.64 149.13 8.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.933 0.397 . . . . 0.0 111.079 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.608 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 60.8 mt-30 -115.15 163.49 15.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.024 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 15.2 t -82.61 98.88 0.53 Allowed Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.987 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 50.4 Cg_endo -66.52 -31.32 41.97 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.587 2.191 . . . . 0.0 112.384 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.86 -121.52 5.18 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.57 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -94.19 115.85 28.17 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.571 ' CE1' HD22 ' A' ' 207' ' ' LEU . 0.0 OUTLIER -130.12 146.87 51.8 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.508 -178.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.843 ' HA ' HG21 ' A' ' 42' ' ' THR . 6.7 tp -95.22 117.71 30.74 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.043 0.449 . . . . 0.0 110.716 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.663 ' CG2' ' HB2' ' A' ' 41' ' ' LEU . 8.3 t -64.71 -73.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.009 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.378 -0.82 . . . . 0.0 111.078 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.688 ' HB3' ' H ' ' A' ' 45' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 121.208 0.528 . . . . 0.0 110.863 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.568 ' OD1' ' HA ' ' A' ' 50' ' ' VAL . 59.1 m-20 -76.53 -21.86 55.16 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.735 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 -65.59 -46.68 78.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.835 0.35 . . . . 0.0 110.767 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.419 ' CB ' ' HB3' ' A' ' 41' ' ' LEU . . . -69.39 -35.84 76.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.401 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.817 HD23 HD21 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -59.96 -53.96 51.76 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.237 0.542 . . . . 0.0 110.705 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.643 ' HB2' ' HE3' ' A' ' 53' ' ' MET . 11.8 tp -63.54 -54.35 37.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.951 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.656 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 78.0 mt -52.73 -34.1 51.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.929 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.685 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -78.09 -29.28 49.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.658 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.612 ' O ' ' HB2' ' A' ' 78' ' ' ASN . . . -73.89 -31.66 63.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.422 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.853 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -88.98 -12.04 42.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.362 . . . . 0.0 110.955 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -80.4 169.46 17.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.735 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.554 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 75.4 m80 -102.64 97.35 7.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.171 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.53 141.77 6.55 Favored Glycine 0 C--N 1.317 -0.519 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.257 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.717 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 7.1 tttt -64.28 134.92 55.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.083 0.468 . . . . 0.0 111.745 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.619 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.8 OUTLIER -131.59 155.08 48.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.616 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.743 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 26.2 t -100.87 141.17 18.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.052 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -128.08 111.2 13.22 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.269 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.819 HG22 ' HA ' ' A' ' 238' ' ' LEU . 0.7 OUTLIER -103.79 164.73 11.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.323 0.582 . . . . 0.0 111.886 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.539 ' N ' ' O ' ' A' ' 71' ' ' THR . 27.9 t30 71.28 21.25 4.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.325 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.538 HD23 HG13 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -58.51 160.35 5.51 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.296 178.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.688 ' H ' ' HB3' ' A' ' 25' ' ' SER . 25.6 tp -92.86 114.2 26.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.008 0.432 . . . . 0.0 111.415 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -75.0 68.78 1.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.599 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 t -129.34 -163.4 1.29 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.052 0.454 . . . . 0.0 111.322 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.541 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 48.9 m-20 -98.27 -20.65 17.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.714 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.454 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 3.7 p-10 -72.43 -27.03 62.08 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.007 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.643 HG23 ' HB3' ' A' ' 45' ' ' LEU . 17.8 t -89.07 -51.7 11.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.708 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.541 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -51.25 -27.63 9.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.181 0.515 . . . . 0.0 110.015 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.442 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . 3.4 m-70 -73.35 -36.6 66.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.962 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.643 ' HE3' ' HB2' ' A' ' 30' ' ' LEU . 13.4 tpt -64.56 -50.62 66.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.817 HD21 HD23 ' A' ' 29' ' ' LEU . 1.4 mp -62.41 -48.93 77.53 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 17.7 t-20 -57.13 -22.35 39.28 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.99 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.604 ' HB3' HD12 ' A' ' 90' ' ' LEU . . . -75.08 -46.4 34.94 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.53 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.555 HD21 ' O ' ' A' ' 53' ' ' MET . 0.1 OUTLIER -69.28 -49.46 55.87 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.861 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.465 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 4.9 t -50.8 -30.41 14.15 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.273 0.559 . . . . 0.0 110.298 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.566 ' CB ' HD21 ' A' ' 90' ' ' LEU . . . -59.83 -51.13 71.04 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.077 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.831 HD22 ' HB3' ' A' ' 82' ' ' LEU . 3.8 mp -66.1 -27.92 68.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.878 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.16 -0.9 5.73 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 114.77 -1.105 . . . . 0.0 113.67 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.601 HG22 HD13 ' A' ' 82' ' ' LEU . 12.0 t -58.34 149.71 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 117.695 0.747 . . . . 0.0 110.359 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.581 ' N ' HG13 ' A' ' 62' ' ' VAL . 4.0 m -113.48 108.45 17.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.214 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.642 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 12.9 p90 -126.67 159.75 32.75 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.173 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.624 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 72.3 m -149.76 116.78 5.97 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.984 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.651 HD13 ' HB2' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -88.2 173.24 8.91 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.332 0.587 . . . . 0.0 112.142 -179.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.673 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -82.51 178.57 8.15 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.621 178.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.56 -12.59 46.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.705 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.14 1.38 11.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.239 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.507 ' O ' HD21 ' A' ' 44' ' ' LEU . 1.6 mmt180 63.54 44.51 5.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.59 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -123.08 -2.84 8.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.229 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.673 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.1 OUTLIER -141.65 112.32 7.16 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.651 ' HB2' HD13 ' A' ' 66' ' ' LEU . 2.3 t -116.38 147.25 41.81 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 1.6 mt-10 -112.51 103.07 11.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.717 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -96.8 126.68 49.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 8.5 mt -80.96 102.89 7.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.007 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.685 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -46.6 113.0 1.01 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.957 -0.565 . . . . 0.0 113.974 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.612 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -60.35 -16.81 38.59 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.969 0.414 . . . . 0.0 110.341 178.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.554 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.45 -20.64 16.79 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.348 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.853 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.46 -151.67 5.84 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.806 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 5.4 Cg_exo -75.88 170.73 19.55 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 CA-C-N 119.653 1.726 . . . . 0.0 109.167 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.831 ' HB3' HD22 ' A' ' 60' ' ' LEU . 4.3 mm? -67.84 89.68 0.28 Allowed 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.806 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 27.8 m170 -81.68 119.38 23.76 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.017 -1.901 . . . . 0.0 112.688 -176.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.475 ' HB2' ' CB ' ' A' ' 60' ' ' LEU . . . -145.9 111.2 5.37 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.952 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -112.46 88.79 2.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.511 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -176.18 20.16 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.701 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.45 49.99 15.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.412 0.625 . . . . 0.0 110.037 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.672 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 5.6 tp -79.01 133.14 36.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.09 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.677 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 1.4 tm-20 -112.11 128.66 56.28 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.636 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.604 HD12 ' HB3' ' A' ' 56' ' ' ALA . 39.0 mt -110.37 158.59 18.28 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.448 ' CE1' ' CA ' ' A' ' 93' ' ' GLY . 21.5 t80 -126.51 106.63 9.58 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.844 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.679 ' HB2' ' HE2' ' A' ' 99' ' ' MET . 2.1 mm? -95.82 8.28 43.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.184 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.448 ' CA ' ' CE1' ' A' ' 91' ' ' PHE . . . 46.95 -142.55 5.8 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.724 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.414 HD21 ' HB3' ' A' ' 120' ' ' ARG . 17.0 t-20 -93.15 49.61 1.43 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.892 0.377 . . . . 0.0 111.039 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 92' ' ' LEU . . . -86.77 -75.82 0.38 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.089 0.471 . . . . 0.0 111.156 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.34 -17.46 13.39 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.089 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.401 HG23 ' NE2' ' A' ' 171' ' ' GLN . 3.9 p -94.06 -9.73 35.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.862 0.363 . . . . 0.0 111.052 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -125.8 -22.45 4.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.524 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.679 ' HE2' ' HB2' ' A' ' 92' ' ' LEU . 5.5 tpp -66.11 -51.23 59.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.818 0.342 . . . . 0.0 110.75 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.75 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -61.48 -56.11 36.49 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.283 -179.319 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.672 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 38.5 Cg_exo -59.43 -46.01 23.45 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.308 2.005 . . . . 0.0 112.668 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.653 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 3.1 tm? -69.42 -35.28 75.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.481 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 99' ' ' MET . . . -61.92 -48.24 81.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.284 0.564 . . . . 0.0 110.79 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.523 ' CB ' HD21 ' A' ' 133' ' ' LEU . . . -72.17 -34.65 68.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.846 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.587 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -59.04 -44.12 91.72 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.95 0.405 . . . . 0.0 111.865 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 102' ' ' LEU . 0.6 OUTLIER -69.74 -22.44 63.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.373 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.582 ' SG ' HD12 ' A' ' 140' ' ' ILE . 23.1 m -60.26 -10.3 4.45 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.907 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.651 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 11.5 mt -82.86 169.68 15.82 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 51.87 -110.97 1.25 Allowed Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.406 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.438 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 62.7 m -162.73 99.42 1.0 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.753 0.311 . . . . 0.0 110.354 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 2.6 m-20 -138.18 135.33 35.54 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.554 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 2.8 m-20 -102.41 111.1 23.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.292 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 4.9 mp -144.39 142.74 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.202 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.721 HG12 ' HG ' ' A' ' 143' ' ' LEU . 21.7 t -113.87 112.51 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.844 0.354 . . . . 0.0 110.252 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 90' ' ' LEU . 28.7 mt -83.91 156.93 22.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.565 0.697 . . . . 0.0 112.14 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 m -160.55 174.89 13.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.813 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -160.65 -164.84 16.32 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.774 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.638 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 6.8 mt-10 -69.51 174.97 2.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.26 -0.47 . . . . 0.0 110.82 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.638 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 22.6 Cg_endo -61.81 -36.08 75.37 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.169 1.913 . . . . 0.0 112.077 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.535 ' O ' ' HG2' ' A' ' 123' ' ' GLU . 8.2 tpt180 -78.96 -31.08 44.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.815 0.341 . . . . 0.0 110.338 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.503 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 11.0 tpt -62.4 -16.12 52.94 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.261 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.634 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 10.3 mmtp -68.65 -8.98 47.16 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.645 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 0.3 OUTLIER -120.79 26.33 9.16 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.142 179.005 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.408 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 2.1 mmp_? -98.55 89.02 0.76 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.482 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.7 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.1 Cg_endo -47.85 135.72 22.82 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.582 2.188 . . . . 0.0 112.373 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.494 HD13 ' HG3' ' A' ' 100' ' ' ARG . 19.3 tt -142.21 32.42 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.735 0.779 . . . . 0.0 110.233 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.609 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -73.85 -51.13 9.54 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.889 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.687 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -52.15 -31.16 29.94 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.02 0.438 . . . . 0.0 110.653 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.74 HD11 HD21 ' A' ' 133' ' ' LEU . 22.8 tp -78.63 -62.93 1.53 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.455 HG11 ' CD1' ' A' ' 140' ' ' ILE . 67.2 t -52.33 -26.17 8.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.363 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.609 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -73.71 -43.81 58.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.675 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.886 ' HA ' HD13 ' A' ' 135' ' ' LEU . . . -65.87 -52.1 53.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.912 0.387 . . . . 0.0 111.322 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.74 HD21 HD11 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -56.3 -45.89 80.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.364 0.602 . . . . 0.0 109.641 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -58.91 -36.19 74.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.354 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.886 HD13 ' HA ' ' A' ' 132' ' ' ALA . 4.6 mt -65.76 -33.72 76.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.028 0.442 . . . . 0.0 110.077 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.483 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -74.6 -18.87 80.02 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.603 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 130.68 3.43 4.59 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.276 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.412 ' CB ' ' HB3' ' A' ' 107' ' ' CYS . . . -70.3 147.54 49.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.909 0.355 . . . . 0.0 111.225 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 9.2 mtmm -114.15 94.32 4.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.582 HD12 ' SG ' ' A' ' 107' ' ' CYS . 11.1 mt -118.18 175.35 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.966 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.528 ' H ' ' CG2' ' A' ' 140' ' ' ILE . 0.5 OUTLIER -150.31 -167.97 2.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.037 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.48 ' N ' ' CG2' ' A' ' 141' ' ' THR . 24.6 m-85 -136.16 100.85 4.52 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.721 ' HG ' HG12 ' A' ' 114' ' ' VAL . 2.2 mm? -71.67 -12.97 61.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.846 -177.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.787 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 2.5 mt-10 -140.19 -71.57 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.92 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.506 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -124.15 150.28 45.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.025 0.441 . . . . 0.0 111.426 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.451 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 61.3 mt-10 -69.38 130.4 42.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.809 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.7 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 6.6 m-20 67.49 50.04 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.418 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.69 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 2.8 m-30 -145.53 174.53 3.37 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.096 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.69 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 4.8 Cg_endo -45.7 -40.53 19.0 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.487 2.791 . . . . 0.0 114.904 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.787 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 36.9 Cg_endo -62.47 101.38 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.386 1.39 . . . . 0.0 111.26 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 141' ' ' THR . 79.1 mt -139.23 123.61 18.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.734 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -106.17 112.27 25.23 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 4.8 mt -94.18 158.92 15.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.33 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.57 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.6 mt-30 -146.12 24.67 1.29 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.508 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 58.26 -161.65 11.1 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.362 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.18 -3.94 55.17 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.742 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.678 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 3.4 t80 -61.39 107.48 0.78 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.984 0.421 . . . . 0.0 110.714 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 71.3 p -105.16 -50.83 3.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.173 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.551 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.08 -162.33 27.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.0 -1.095 . . . . 0.0 114.326 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.481 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 116.26 169.43 15.41 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.92 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -61.97 126.67 28.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.934 0.367 . . . . 0.0 110.034 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 47.9 t -136.57 154.49 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 120.903 0.382 . . . . 0.0 111.793 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.462 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.6 OUTLIER -120.93 117.14 26.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.491 HG11 HD13 ' A' ' 173' ' ' LEU . 0.3 OUTLIER -118.72 140.79 41.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.939 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.687 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.5 OUTLIER -78.6 135.39 37.25 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.114 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -76.4 -44.62 16.41 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.061 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.446 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 3.2 m -49.1 164.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.918 0.39 . . . . 0.0 111.611 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.0 t 70.26 54.58 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.074 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.45 ' HA ' HG12 ' A' ' 196' ' ' VAL . 6.4 m 59.86 154.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.934 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.462 ' HB3' ' CB ' ' A' ' 197' ' ' SER . 18.9 p -77.36 1.24 19.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.044 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.75 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 44.0 mm-40 -53.59 -23.27 10.37 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.874 0.368 . . . . 0.0 111.34 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.507 ' CG ' ' HB2' ' A' ' 129' ' ' LEU . 1.9 m-85 -76.43 -56.06 4.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.14 0.495 . . . . 0.0 110.572 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.567 ' HG ' HD11 ' A' ' 201' ' ' ILE . 37.4 tp -72.96 -41.04 64.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.309 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.416 HG21 ' SD ' ' A' ' 178' ' ' MET . 38.2 m -55.94 -34.51 65.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.753 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.529 ' CB ' ' HA ' ' A' ' 101' ' ' PRO . . . -70.86 -50.87 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.108 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.572 HD22 ' N ' ' A' ' 133' ' ' LEU . 1.4 mt -67.33 -38.07 84.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.609 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.499 ' O ' ' HG3' ' A' ' 181' ' ' PRO . 8.9 mt -65.57 -25.29 67.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.686 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.538 ' HG2' HD23 ' A' ' 31' ' ' LEU . 9.8 mtp -96.64 -28.79 14.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.166 0.508 . . . . 0.0 111.031 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.637 ' O ' HD12 ' A' ' 108' ' ' LEU . 55.4 m -89.12 -46.19 9.01 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.815 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.681 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -60.74 -37.13 42.25 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.8 Cg_endo -53.15 -37.36 79.75 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 121.101 1.2 . . . . 0.0 111.967 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.48 -7.01 59.42 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.955 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -67.54 119.5 66.21 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.881 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -37.47 -32.68 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.684 2.922 . . . . 0.0 114.417 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.81 151.8 23.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.056 0.455 . . . . 0.0 111.616 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.561 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 3.6 t0 -65.74 116.92 7.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.481 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.689 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 28.2 m -102.63 134.94 45.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.339 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 224' ' ' VAL . 41.1 t -125.45 99.3 5.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.091 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.605 ' O ' ' N ' ' A' ' 223' ' ' PHE . 4.0 mt -90.4 143.56 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.311 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.826 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -115.01 171.25 7.77 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 177.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.767 HG22 HD13 ' A' ' 195' ' ' LEU . 1.2 mm -110.9 97.27 5.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 120.969 0.414 . . . . 0.0 111.314 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 12.3 mtmt -61.14 -80.96 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.468 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -79.23 167.84 52.65 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.212 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.48 124.67 21.05 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.767 HD13 HG22 ' A' ' 191' ' ' ILE . 1.5 tp -59.35 146.36 40.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.105 0.478 . . . . 0.0 110.539 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 169' ' ' SER . 12.6 p -104.45 -18.66 6.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.203 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.684 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.6 OUTLIER -129.29 45.63 2.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.498 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.59 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . 3.8 ttpt -41.98 -60.87 1.75 Allowed Pre-proline 0 N--CA 1.466 0.338 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.784 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 12.1 Cg_exo -70.7 -16.44 33.61 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 121.871 1.714 . . . . 0.0 111.786 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.684 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 14.4 m-85 -76.36 -26.27 55.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.715 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.567 HD11 ' HG ' ' A' ' 173' ' ' LEU . 7.2 tp -75.19 -31.47 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.744 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 5.0 t70 -61.9 -34.25 75.69 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.618 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.8 mt -67.23 -27.35 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.259 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 42.1 m -60.86 -57.45 12.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.541 0.686 . . . . 0.0 109.615 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.636 HD12 ' CD1' ' A' ' 215' ' ' ILE . 19.2 mt -70.32 -32.04 69.61 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.539 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.68 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 1.5 m-20 -66.73 -30.62 70.89 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.656 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -75.72 -46.23 32.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.154 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.522 ' HG2' ' CZ ' ' A' ' 231' ' ' TYR . 18.6 mtp -62.67 -39.57 94.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.318 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.68 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -68.04 -41.89 81.39 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.003 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.539 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.4 OUTLIER -61.65 -28.15 69.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.126 0.489 . . . . 0.0 109.736 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.724 ' HA ' ' HG3' ' A' ' 234' ' ' PRO . 0.8 OUTLIER -76.04 -50.99 13.26 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.761 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 156.51 -1.59 0.14 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.283 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.522 ' HB ' ' CD1' ' A' ' 231' ' ' TYR . 61.1 t -117.54 139.05 46.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.968 0.413 . . . . 0.0 111.701 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -134.11 153.94 51.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.713 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.636 ' CD1' HD12 ' A' ' 205' ' ' LEU . 2.4 pp -131.81 175.16 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.611 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.965 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 30.5 tt0 -89.99 125.74 35.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.753 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -101.27 101.04 11.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.128 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.681 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -67.02 -166.18 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.472 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -76.14 48.36 0.5 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.888 0.375 . . . . 0.0 110.362 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.523 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.1 OUTLIER 57.28 21.21 6.45 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.135 -179.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 191' ' ' ILE . 22.5 tt0 -113.11 -22.77 10.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.517 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.826 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 42.1 mt-30 -147.37 140.26 24.99 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.605 ' N ' ' O ' ' A' ' 189' ' ' ILE . 24.6 m-85 -112.59 96.73 6.15 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.965 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 42.5 t -84.05 111.13 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.06 0.457 . . . . 0.0 111.199 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.689 ' CG2' ' HB ' ' A' ' 187' ' ' THR . 3.6 m -99.71 116.75 43.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.142 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.639 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 3.0 mptt -62.64 103.99 0.48 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.127 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.561 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.05 154.33 19.32 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.98 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.6 8.56 76.83 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.367 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.639 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 64.2 mm-40 -71.6 -179.57 2.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.421 0.629 . . . . 0.0 111.184 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.534 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.2 m -170.43 105.71 0.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.688 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.656 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 22.8 m-85 -53.58 146.03 13.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.085 0.469 . . . . 0.0 111.309 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.618 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 90.2 mt-30 -110.93 153.19 25.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.58 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 27.5 p -78.07 103.06 1.13 Allowed Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.231 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.724 ' HG3' ' HA ' ' A' ' 211' ' ' PHE . 10.5 Cg_exo -73.86 -37.16 3.04 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.849 2.366 . . . . 0.0 111.577 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 128.8 -120.24 3.24 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.418 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.743 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -91.08 116.52 28.87 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.593 ' OH ' HD23 ' A' ' 207' ' ' LEU . 67.1 t80 -124.08 141.49 52.01 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.644 -0.422 . . . . 0.0 112.085 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.819 ' HA ' HG22 ' A' ' 42' ' ' THR . 6.5 tp -95.49 118.69 32.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.134 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 42' ' ' THR . 21.8 t -59.3 -70.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.101 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . 0.404 ' HG2' HD21 ' A' ' 43' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.9 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.528 ' HB3' ' H ' ' A' ' 45' ' ' LEU . 1.4 p . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.6 0.238 . . . . 0.0 111.294 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.536 ' HA ' HD12 ' A' ' 29' ' ' LEU . 13.6 p30 -76.45 -22.34 54.72 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.93 0.395 . . . . 0.0 111.039 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.417 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 3.0 mtm105 -62.02 -51.06 69.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.399 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.569 ' HB1' ' CD2' ' A' ' 41' ' ' LEU . . . -65.87 -41.11 92.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.379 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.63 HD21 ' CD2' ' A' ' 54' ' ' LEU . 12.1 mt -59.8 -50.6 73.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 0.0 110.81 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.488 HD21 ' HE3' ' A' ' 53' ' ' MET . 9.4 tp -69.12 -46.15 68.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.976 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.601 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 65.2 mt -61.01 -28.68 69.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.736 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.637 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . . . -77.11 -28.72 54.53 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.552 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.681 ' HB1' ' CD2' ' A' ' 57' ' ' LEU . . . -68.57 -31.12 70.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.875 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.876 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.82 -11.67 41.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.016 0.436 . . . . 0.0 110.883 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -79.85 167.77 20.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.764 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.572 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 73.8 m80 -101.31 98.92 9.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.595 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 114.63 142.18 7.83 Favored Glycine 0 C--N 1.314 -0.643 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.568 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.83 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 3.3 tttt -64.27 128.7 36.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.248 0.547 . . . . 0.0 111.938 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.525 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -123.6 160.9 26.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.06 178.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 73' ' ' CYS . 91.9 t -110.99 140.78 28.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.32 . . . . 0.0 111.781 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.627 ' HA ' ' O ' ' A' ' 237' ' ' TYR . 0.0 OUTLIER -129.39 111.29 12.66 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.113 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.813 HG23 ' HA ' ' A' ' 238' ' ' LEU . 0.0 OUTLIER -96.04 172.14 8.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.188 0.518 . . . . 0.0 111.534 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 71' ' ' THR . 0.1 OUTLIER 66.77 18.79 10.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.729 -178.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.662 HD22 HG12 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -58.73 164.43 2.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.868 179.078 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.528 ' H ' ' HB3' ' A' ' 25' ' ' SER . 27.7 tp -99.37 112.7 24.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.892 0.377 . . . . 0.0 111.721 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -71.69 68.14 0.59 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.555 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.455 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 12.8 t -129.48 -163.54 1.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.212 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.551 ' HA ' ' HE ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -98.59 -22.87 15.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.768 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.577 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 2.1 p30 -69.05 -26.02 64.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.727 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.662 HG12 HD22 ' A' ' 44' ' ' LEU . 24.0 t -88.07 -56.59 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.295 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.567 ' O ' ' HB2' ' A' ' 55' ' ' ASN . 1.8 ptt180 -52.83 -24.41 8.95 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.197 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 55' ' ' ASN . 4.6 m-70 -75.52 -38.08 59.63 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.726 ' O ' HD11 ' A' ' 57' ' ' LEU . 8.6 tpt -60.27 -54.65 43.17 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.746 ' HA ' HD13 ' A' ' 57' ' ' LEU . 1.9 mp -59.34 -47.97 83.4 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.712 177.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.567 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -48.51 -30.71 5.49 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.639 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.633 ' CB ' ' HG ' ' A' ' 102' ' ' LEU . . . -69.17 -51.36 38.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.298 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.746 HD13 ' HA ' ' A' ' 54' ' ' LEU . 3.4 mp -60.12 -49.18 78.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.812 0.339 . . . . 0.0 110.636 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.584 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.8 t -53.8 -30.79 46.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.095 0.474 . . . . 0.0 110.24 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.657 ' HB1' HD13 ' A' ' 88' ' ' LEU . . . -60.37 -50.88 71.84 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.168 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 82' ' ' LEU . 3.9 mp -65.84 -27.75 68.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.484 0.659 . . . . 0.0 110.131 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.92 -0.0 7.13 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 114.725 -1.125 . . . . 0.0 113.03 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.593 HG11 ' N ' ' A' ' 63' ' ' SER . 13.5 t -55.19 159.99 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 117.216 0.508 . . . . 0.0 110.47 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.593 ' N ' HG11 ' A' ' 62' ' ' VAL . 3.3 m -122.22 109.52 14.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.623 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.677 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 10.1 p90 -126.57 158.98 34.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.607 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 25.1 m -150.64 116.83 5.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.658 0.266 . . . . 0.0 111.267 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.741 HD11 ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -86.38 178.09 7.24 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.216 0.532 . . . . 0.0 111.748 -179.651 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.702 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -90.1 178.58 6.15 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.811 179.122 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.24 -11.88 45.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.596 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.4 1.45 11.79 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.876 0.37 . . . . 0.0 110.462 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.5 ' O ' HD23 ' A' ' 44' ' ' LEU . 3.1 mtt85 61.57 43.27 10.25 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.84 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.477 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -124.05 -2.27 8.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.293 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.702 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -143.0 111.13 6.06 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.968 0.413 . . . . 0.0 109.937 179.001 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.741 ' HB2' HD11 ' A' ' 66' ' ' LEU . 1.6 t -113.17 155.92 24.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.677 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 5.9 mt-10 -119.76 102.94 8.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.964 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.83 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -102.32 129.26 54.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 10.3 mt -82.16 102.3 7.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.351 178.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.611 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -48.43 111.97 1.04 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.771 -0.65 . . . . 0.0 113.681 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.628 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -57.2 -17.58 11.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 110.616 178.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.572 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 88.12 -22.36 19.39 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.446 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.876 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -139.96 -145.15 4.63 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.734 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 4.1 Cg_exo -79.15 168.24 20.68 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 121.969 1.779 . . . . 0.0 108.984 177.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.869 ' HB3' HD23 ' A' ' 60' ' ' LEU . 4.4 mm? -66.55 91.04 0.17 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.734 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 27.8 m170 -83.93 118.88 24.29 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 113.44 -1.709 . . . . 0.0 113.133 -175.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.536 ' HB2' HD21 ' A' ' 60' ' ' LEU . . . -148.84 110.58 4.52 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.898 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.4 87.88 2.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.59 0.233 . . . . 0.0 111.557 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -174.45 22.83 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.873 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 56.76 53.76 7.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.492 0.663 . . . . 0.0 110.096 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.719 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 5.2 tp -85.92 135.37 33.71 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.939 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.66 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 4.0 tt0 -115.27 130.16 56.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.242 0.544 . . . . 0.0 110.689 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.541 HD22 HD22 ' A' ' 88' ' ' LEU . 3.5 mt -108.68 153.79 22.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.744 -178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.468 ' CE1' ' CA ' ' A' ' 93' ' ' GLY . 53.8 t80 -118.52 106.59 12.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.817 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.747 HD22 ' N ' ' A' ' 92' ' ' LEU . 1.8 mm? -91.61 3.56 54.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.251 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.569 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 43.12 -140.34 2.59 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 116.207 -0.451 . . . . 0.0 113.625 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -93.54 52.03 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.07 0.462 . . . . 0.0 111.1 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.577 ' HB3' ' HA ' ' A' ' 49' ' ' ASP . . . -94.05 -75.51 0.5 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.376 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.97 -19.78 9.27 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.392 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.479 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -96.59 -9.56 29.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.772 0.32 . . . . 0.0 110.862 179.175 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 53' ' ' MET . . . -123.04 -19.99 5.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.773 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.713 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 9.7 ttm -70.72 -54.18 12.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.982 0.42 . . . . 0.0 111.164 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.72 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.2 mpt_? -57.72 -53.53 64.68 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.091 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.584 ' HA ' ' CB ' ' A' ' 175' ' ' ALA . 31.3 Cg_exo -59.3 -47.34 17.44 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.84 2.36 . . . . 0.0 113.135 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.633 ' HG ' ' CB ' ' A' ' 56' ' ' ALA . 3.0 tm? -66.67 -33.97 76.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.554 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.66 -47.37 85.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.464 0.649 . . . . 0.0 110.215 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 107' ' ' CYS . . . -71.46 -37.33 71.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.749 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.511 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -57.14 -43.4 82.41 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.897 0.38 . . . . 0.0 111.393 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.564 ' CD2' HD23 ' A' ' 60' ' ' LEU . 1.7 mt -70.58 -23.11 62.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.41 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.491 ' SG ' HD13 ' A' ' 140' ' ' ILE . 87.7 m -59.33 -11.11 3.68 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.019 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.694 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 12.6 mt -83.33 166.11 18.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.67 0.271 . . . . 0.0 110.318 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 54.56 -112.1 2.52 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.272 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.5 97.74 0.99 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 2.8 m120 -138.32 138.35 38.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.775 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.656 ' O ' HD13 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -104.1 110.41 22.58 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.58 178.667 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.719 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 25.1 mm -136.66 143.38 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.528 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.66 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 19.4 t -115.33 113.42 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.454 HD22 HD21 ' A' ' 92' ' ' LEU . 17.6 mt -82.42 152.98 25.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.495 0.664 . . . . 0.0 112.325 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.509 HG21 ' O ' ' A' ' 90' ' ' LEU . 9.5 t -160.27 163.59 33.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.892 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -157.57 -167.54 18.72 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.647 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.569 ' HG2' ' HA2' ' A' ' 93' ' ' GLY . 8.4 mm-40 -67.67 172.98 3.29 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.846 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.469 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 33.0 Cg_exo -62.07 -23.8 75.99 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.364 2.043 . . . . 0.0 112.171 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.443 ' HD2' ' CG ' ' A' ' 123' ' ' GLU . 8.1 tpt180 -85.56 -39.47 17.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.836 0.35 . . . . 0.0 110.556 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.596 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 10.8 tpt -59.48 -20.18 53.34 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.635 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 20.6 mttt -68.8 -7.13 31.29 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.255 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.544 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 3.9 pt-20 -120.0 28.17 8.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.115 0.483 . . . . 0.0 110.728 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.415 ' HA ' ' NE ' ' A' ' 124' ' ' ARG . 6.5 mmp_? -103.51 112.97 65.94 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.582 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 24.8 Cg_exo -60.84 137.01 69.79 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.274 1.983 . . . . 0.0 112.023 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.605 HG12 HG21 ' A' ' 130' ' ' VAL . 17.3 tt -145.01 30.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.849 0.833 . . . . 0.0 109.966 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -77.0 -50.44 6.87 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 114.39 -1.277 . . . . 0.0 112.101 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.647 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -57.26 -28.4 62.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.865 0.364 . . . . 0.0 110.668 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.558 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 20.6 tp -79.14 -63.85 1.32 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.859 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.605 HG21 HG12 ' A' ' 126' ' ' ILE . 60.6 t -55.28 -24.61 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.337 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.4 OUTLIER -70.6 -45.2 65.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.352 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.918 ' HA ' HD13 ' A' ' 135' ' ' LEU . . . -65.81 -53.25 42.65 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.418 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.646 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -55.86 -44.23 77.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.101 0.477 . . . . 0.0 109.77 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.63 -38.99 75.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.449 179.267 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.918 HD13 ' HA ' ' A' ' 132' ' ' ALA . 2.4 mt -64.91 -30.6 71.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.436 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.482 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -78.22 -18.15 76.88 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.471 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.65 2.98 5.19 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.165 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.95 146.48 54.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.944 0.372 . . . . 0.0 111.248 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -114.75 88.72 2.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.241 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.575 HD12 HD11 ' A' ' 133' ' ' LEU . 6.3 mt -115.59 176.63 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.085 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.533 ' O ' HD22 ' A' ' 151' ' ' LEU . 0.5 OUTLIER -154.45 -174.92 5.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.919 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.475 ' CD2' ' HA ' ' A' ' 146' ' ' GLU . 20.1 m-85 -126.63 106.98 9.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.049 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.486 ' HG ' HG13 ' A' ' 114' ' ' VAL . 2.4 mm? -77.36 -18.65 57.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.389 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.624 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 1.7 mm-40 -134.71 -73.04 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.969 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.594 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -123.27 149.81 44.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.727 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.475 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 4.6 pt-20 -69.61 135.12 49.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.093 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 12.1 m-20 64.92 46.99 2.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.48 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.797 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 4.6 m-85 -144.08 176.64 2.15 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.111 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.797 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 10.3 Cg_endo -52.01 -39.89 68.78 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.131 2.554 . . . . 0.0 115.629 -177.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.624 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 19.7 Cg_endo -61.9 100.4 0.2 Allowed 'Trans proline' 0 CA--C 1.515 -0.458 0 C-N-CA 120.861 1.041 . . . . 0.0 110.944 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.533 HD22 ' O ' ' A' ' 141' ' ' THR . 84.1 mt -137.05 123.89 21.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.817 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 1.6 ttm180 -105.03 111.83 24.74 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 112' ' ' ASP . 1.5 mt -94.98 160.12 14.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.684 -178.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.585 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 4.1 mt-30 -148.86 25.69 0.92 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.906 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.475 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 54.5 -166.45 2.44 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.477 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 109.84 -4.87 30.66 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.946 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.646 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 2.3 t80 -60.89 106.99 0.64 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.783 0.325 . . . . 0.0 110.681 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' THR . . . . . . . . . . . . . 43.5 p -104.97 -48.65 3.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.614 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.53 -162.23 27.67 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 119.889 -1.148 . . . . 0.0 114.293 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.421 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 114.36 168.94 16.3 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 114.937 -0.632 . . . . 0.0 112.003 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -63.08 126.2 26.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.432 HG13 ' HB1' ' A' ' 132' ' ' ALA . 62.1 t -133.51 157.63 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.091 0.472 . . . . 0.0 111.578 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.442 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.7 OUTLIER -124.31 116.12 22.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.891 179.267 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.02 150.92 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.92 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.647 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 2.7 t0 -89.83 127.36 35.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.667 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.689 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -70.16 -44.68 59.4 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.651 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.423 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 1.4 m -50.91 164.76 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.837 0.351 . . . . 0.0 111.517 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 2.1 t 69.17 56.75 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 121.275 0.559 . . . . 0.0 111.112 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.418 ' HA ' HG11 ' A' ' 196' ' ' VAL . 2.0 m 58.3 159.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.458 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.429 ' HB3' ' CB ' ' A' ' 197' ' ' SER . 12.4 p -82.65 0.43 43.19 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.807 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.72 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 2.1 mp0 -51.12 -21.91 2.2 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.934 0.397 . . . . 0.0 111.049 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.472 ' HA ' HD13 ' A' ' 129' ' ' LEU . 1.4 m-85 -78.96 -53.95 6.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.765 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.506 HD21 ' CE1' ' A' ' 223' ' ' PHE . 22.7 tp -74.71 -40.5 61.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.441 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.48 ' CG2' ' HA ' ' A' ' 171' ' ' GLN . 13.6 t -57.96 -34.31 69.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' A' ' 101' ' ' PRO . . . -68.37 -51.12 47.83 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.497 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.5 ' HB3' HD13 ' A' ' 189' ' ' ILE . 2.6 mt -67.78 -37.0 81.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.541 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.508 ' O ' ' HG3' ' A' ' 181' ' ' PRO . 8.2 mt -67.88 -24.63 65.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.075 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.499 ' HA ' ' OH ' ' A' ' 231' ' ' TYR . 13.5 ptp -98.92 -28.48 13.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.12 0.486 . . . . 0.0 110.811 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.614 ' O ' HD11 ' A' ' 108' ' ' LEU . 27.4 m -86.37 -46.22 10.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.991 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.693 ' N ' ' HD2' ' A' ' 181' ' ' PRO . . . -60.94 -37.26 42.72 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.693 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 12.1 Cg_endo -54.54 -36.69 89.43 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 121.232 1.288 . . . . 0.0 111.797 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.592 HD22 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -85.16 -6.48 59.29 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.828 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -66.9 114.99 20.51 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.16 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -31.09 -36.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.073 3.182 . . . . 0.0 114.642 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -105.47 153.34 21.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.968 0.413 . . . . 0.0 111.797 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.573 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 1.3 t0 -63.92 118.27 8.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.568 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.677 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 61.4 m -104.16 133.75 48.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.056 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.555 HG12 HG21 ' A' ' 224' ' ' VAL . 35.3 t -125.43 99.63 6.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.252 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.1 mt -90.82 143.56 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.418 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.819 ' HA ' ' HA ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -114.33 171.07 7.84 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.572 HG21 ' CD1' ' A' ' 195' ' ' LEU . 1.1 mm -111.41 96.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 120.973 0.415 . . . . 0.0 111.17 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -60.83 -81.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.625 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.431 ' HA3' ' OD1' ' A' ' 165' ' ' ASP . . . -78.12 168.4 53.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.269 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -61.41 122.62 15.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.635 0.255 . . . . 0.0 110.856 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.689 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.8 OUTLIER -58.43 143.63 44.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.96 0.41 . . . . 0.0 110.577 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 167' ' ' SER . 13.1 p -103.58 -18.82 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.512 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.643 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.6 OUTLIER -126.6 45.62 2.64 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.489 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.62 ' HB3' ' HD3' ' A' ' 199' ' ' PRO . 0.4 OUTLIER -42.15 -60.44 2.07 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.196 -0.911 . . . . 0.0 113.122 -178.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 7.6 Cg_exo -72.68 -16.32 26.76 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 121.908 1.739 . . . . 0.0 111.987 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.643 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 16.5 m-85 -75.64 -29.91 59.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.255 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.464 HG12 ' CD2' ' A' ' 173' ' ' LEU . 6.2 tp -70.69 -35.64 61.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -59.35 -33.16 70.83 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.147 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.543 ' O ' ' HB2' ' A' ' 207' ' ' LEU . 15.1 mt -67.71 -32.86 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.238 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 52.4 m -57.44 -52.64 64.54 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.651 HD12 ' CD1' ' A' ' 215' ' ' ILE . 13.3 mt -73.82 -35.45 64.85 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.92 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 202' ' ' ASP . 0.7 OUTLIER -64.0 -28.03 69.53 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.171 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.601 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -79.17 -44.02 22.77 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.842 178.473 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 231' ' ' TYR . 22.4 mtp -65.0 -38.83 92.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.456 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.502 ' HG3' ' N ' ' A' ' 210' ' ' THR . 0.0 OUTLIER -65.21 -48.94 71.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.666 0.269 . . . . 0.0 110.64 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.502 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.5 OUTLIER -56.53 -29.28 61.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.278 0.561 . . . . 0.0 109.843 179.064 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.637 ' CE2' ' HA ' ' A' ' 32' ' ' ALA . 1.1 m-85 -71.48 -48.84 46.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.002 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.453 ' HA3' ' HG2' ' A' ' 232' ' ' GLN . . . 153.21 -4.84 0.36 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.114 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.618 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 73.4 t -120.19 140.78 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.09 0.472 . . . . 0.0 111.823 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -134.08 156.0 49.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.662 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.651 ' CD1' HD12 ' A' ' 205' ' ' LEU . 2.3 pp -132.75 175.72 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.891 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.948 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 41.3 tt0 -90.36 124.66 35.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.068 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.99 100.87 11.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.003 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.707 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 2.1 mm-40 -66.64 -166.72 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.612 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -74.74 48.58 0.37 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.884 0.373 . . . . 0.0 110.41 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.514 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 57.47 20.66 6.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 -179.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 191' ' ' ILE . 66.3 mt-30 -112.69 -21.55 11.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.738 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . 0.819 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 46.6 mt-30 -149.04 141.34 24.1 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.902 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.603 ' N ' ' O ' ' A' ' 189' ' ' ILE . 19.7 m-85 -113.32 96.53 5.95 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.948 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 48.4 t -83.9 111.15 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 120.797 0.332 . . . . 0.0 111.429 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.677 ' CG2' ' HB ' ' A' ' 187' ' ' THR . 5.5 m -99.68 117.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.931 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.806 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -61.71 103.07 0.3 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.009 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.573 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -55.96 156.0 11.36 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.738 -0.665 . . . . 0.0 113.044 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.48 8.46 84.91 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.559 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . 0.806 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 26.0 mm100 -71.05 -176.52 1.42 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.358 0.579 . . . . 0.0 110.781 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.592 ' HA ' HD22 ' A' ' 182' ' ' LEU . 2.5 m -177.1 104.91 0.06 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.39 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.618 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 21.2 m-85 -55.66 151.94 10.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.163 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . 0.657 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 9.2 pt20 -123.01 154.76 38.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 68.7 p -67.6 101.11 0.27 Allowed Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.657 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 59.5 Cg_endo -68.13 -27.94 34.97 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.656 2.237 . . . . 0.0 111.898 178.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.39 -125.26 6.53 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' THR . . . . . 0.508 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -92.0 116.54 29.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.627 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 63.5 t80 -124.73 143.2 50.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.331 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.813 ' HA ' HG23 ' A' ' 42' ' ' THR . 5.7 tp -96.6 118.23 32.65 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.145 0.498 . . . . 0.0 110.752 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.408 ' CG2' ' HB2' ' A' ' 41' ' ' LEU . 61.4 t -59.2 -83.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.038 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.927 179.891 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.464 0.236 0 N-CA-C 111.852 0.315 . . . . 2.1200000000000001 111.852 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -60.66 -47.17 87.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.078 0.466 . . . . 2.0299999999999998 110.214 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.87 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -69.46 -33.31 72.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.767 -0.651 . . . . 0.28000000000000003 110.768 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.733 HD21 HD23 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -61.23 -54.57 42.51 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.229 0.537 . . . . 0.96999999999999997 110.695 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' A' ' 105' ' ' ALA . 7.1 tp -66.79 -51.39 56.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.292 -0.867 . . . . 0.38 111.216 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 63.7 mt -54.64 -35.84 63.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.022 0.439 . . . . 0.39000000000000001 110.804 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.593 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -72.91 -29.97 63.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.673 -0.694 . . . . 0.16 110.787 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.649 ' CB ' HD21 ' A' ' 82' ' ' LEU . . . -71.48 -32.28 68.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.817 -0.628 . . . . 0.14000000000000001 111.592 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.812 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.74 -11.21 42.91 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.826 0.346 . . . . 0.13 111.111 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -80.93 163.19 23.52 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.041 -0.527 . . . . 0.14999999999999999 110.144 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -96.51 97.27 9.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.004 0.43 . . . . 0.17999999999999999 110.079 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.5 146.97 7.94 Favored Glycine 0 C--N 1.313 -0.712 0 C-N-CA 120.796 -0.716 . . . . 0.19 111.751 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -71.74 138.06 48.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.105 0.479 . . . . 2.29 111.654 -179.51 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.426 HG23 ' N ' ' A' ' 40' ' ' VAL . 0.6 OUTLIER -131.74 164.59 25.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.64 -0.709 . . . . 0.17000000000000001 110.165 179.316 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.813 HG22 ' CG ' ' A' ' 74' ' ' GLU . 88.9 t -110.43 142.7 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 111.911 0.337 . . . . 0.23000000000000001 111.911 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.87 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -130.18 110.67 11.76 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.834 -0.802 . . . . 0.45000000000000001 108.834 178.257 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.848 HG23 HD12 ' A' ' 238' ' ' LEU . 0.0 OUTLIER -100.55 169.56 8.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.112 0.482 . . . . 0.32000000000000001 111.568 -178.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.729 ' HB2' HD11 ' A' ' 238' ' ' LEU . 1.5 t30 67.24 21.09 10.02 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.629 -0.714 . . . . 1.04 110.703 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.78 HD22 HD11 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -60.14 154.69 18.94 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.555 -0.535 . . . . 0.28999999999999998 109.555 178.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.6 tp -91.27 114.3 26.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.93 0.395 . . . . 0.33000000000000002 111.418 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.414 ' OD2' ' HB2' ' A' ' 70' ' ' ARG . 9.6 t70 -73.72 77.74 1.55 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.973 -0.558 . . . . 2.0499999999999998 110.27 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -137.38 -163.88 1.5 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.875 -0.602 . . . . 1.1499999999999999 110.841 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.528 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 10.0 m-20 -96.91 -19.05 19.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.19 -0.459 . . . . 1.8600000000000001 111.076 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.457 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -73.01 -26.53 61.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.177 -0.465 . . . . 1.97 109.919 178.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.542 HG11 HD21 ' A' ' 44' ' ' LEU . 26.5 t -90.04 -52.42 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.813 -0.63 . . . . 0.22 111.45 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.528 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -53.07 -26.53 16.38 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.53 -0.468 . . . . 2.6000000000000001 110.558 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -73.4 -37.57 65.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.698 -0.683 . . . . 0.53000000000000003 109.637 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.448 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 5.4 tpt -65.0 -47.35 77.82 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.565 -0.902 . . . . 0.57999999999999996 108.565 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.733 HD23 HD21 ' A' ' 29' ' ' LEU . 1.1 mp -61.95 -47.13 86.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.611 -0.722 . . . . 0.33000000000000002 110.051 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.408 ' HA ' HG22 ' A' ' 58' ' ' THR . 0.9 OUTLIER -59.57 -28.17 66.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.111 0.481 . . . . 1.3899999999999999 109.979 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.701 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -68.73 -43.85 75.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.631 -0.713 . . . . 0.20999999999999999 111.965 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.59 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -71.87 -50.45 29.31 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.774 -0.37 . . . . 0.78000000000000003 110.768 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.473 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.9 t -52.16 -29.81 23.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.07 0.462 . . . . 0.23999999999999999 110.371 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.783 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.82 -45.0 93.73 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.57 -0.741 . . . . 0.20999999999999999 110.523 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.009 HD21 HD22 ' A' ' 106' ' ' LEU . 3.0 mp -74.87 -24.37 58.55 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.454 0.645 . . . . 0.22 109.952 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.4 0.24 5.85 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.004 -0.998 . . . . 0.23000000000000001 114.146 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.472 HG21 HD11 ' A' ' 82' ' ' LEU . 34.0 t -61.77 150.12 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 118.041 0.921 . . . . 0.20000000000000001 110.364 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.49 ' CB ' HG13 ' A' ' 76' ' ' ILE . 2.5 m -111.23 104.91 13.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.815 -0.629 . . . . 0.25 111.595 -178.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CE2' ' HB ' ' A' ' 58' ' ' THR . 6.7 p90 -117.83 159.14 23.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.148 -0.933 . . . . 0.37 110.946 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 3.5 m -152.65 114.84 4.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.39000000000000001 110.214 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.826 HD22 ' SG ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -84.19 178.7 7.7 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.997 0.427 . . . . 0.23000000000000001 110.735 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.0 t -94.33 -179.92 5.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.803 -0.635 . . . . 1.1100000000000001 110.946 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.02 -19.41 61.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.176 -0.466 . . . . 0.31 111.517 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.22 5.99 14.9 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.897 0.379 . . . . 1.5600000000000001 110.564 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.414 ' HB2' ' OD2' ' A' ' 46' ' ' ASP . 53.1 mtt-85 59.42 41.42 19.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.119 -0.491 . . . . 2.27 110.974 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.435 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -121.91 -0.03 9.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.651 -0.704 . . . . 0.28999999999999998 110.887 179.111 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.592 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -143.54 115.35 8.24 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.446 -0.576 . . . . 1.8999999999999999 109.446 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.826 ' SG ' HD22 ' A' ' 66' ' ' LEU . 1.4 t -120.99 150.2 41.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.7 -0.682 . . . . 0.26000000000000001 112.141 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.813 ' CG ' HG22 ' A' ' 40' ' ' VAL . 4.2 mt-10 -118.18 103.79 10.19 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.477 -0.934 . . . . 1.53 108.477 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.614 HG12 HD23 ' A' ' 29' ' ' LEU . 1.7 mp -99.19 126.74 52.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.567 0.699 . . . . 0.20000000000000001 112.661 -178.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.49 HG13 ' CB ' ' A' ' 63' ' ' SER . 0.9 OUTLIER -78.54 110.81 14.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.478 -1.237 . . . . 1.0700000000000001 111.233 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -54.32 112.8 2.86 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.799 -0.637 . . . . 0.17999999999999999 114.047 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.0 OUTLIER -61.86 -19.6 62.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.187 0.518 . . . . 1.3700000000000001 109.943 178.279 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.69 -23.21 20.84 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.611 -0.722 . . . . 0.16 112.671 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.812 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -136.92 -149.81 5.69 Favored Glycine 0 CA--C 1.507 -0.464 0 N-CA-C 109.998 -1.241 . . . . 0.14999999999999999 109.998 178.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.833 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 5.1 Cg_exo -78.71 164.43 25.67 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 CA-C-N 119.469 1.635 . . . . 0.13 109.163 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.84 HD12 HD13 ' A' ' 60' ' ' LEU . 3.7 mm? -63.36 93.95 0.08 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.816 1.294 . . . . 0.12 108.217 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.833 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 28.9 m170 -87.8 120.18 28.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 112.435 -2.166 . . . . 0.14999999999999999 112.928 -175.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.813 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -149.21 109.4 4.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.882 -0.599 . . . . 0.19 110.912 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -107.9 91.64 3.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.769 0.319 . . . . 1.51 111.139 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.98 19.94 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.544 -0.836 . . . . 0.28000000000000003 113.432 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.71 50.82 13.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.308 0.575 . . . . 0.28000000000000003 110.006 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.783 HD21 ' HB1' ' A' ' 59' ' ' ALA . 3.5 tp -77.12 136.03 38.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.315 -0.857 . . . . 0.37 110.959 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.778 ' N ' HD12 ' A' ' 88' ' ' LEU . 1.2 tt0 -116.6 127.46 54.49 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.158 0.504 . . . . 1.3500000000000001 110.395 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.701 HD13 ' HA ' ' A' ' 56' ' ' ALA . 50.8 mt -109.68 163.38 13.54 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.49 -0.777 . . . . 0.65000000000000002 112.655 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -125.56 106.68 9.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.897 -1.047 . . . . 0.47999999999999998 109.892 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.638 HD22 ' N ' ' A' ' 92' ' ' LEU . 1.2 mm? -93.2 6.05 49.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.176 -0.465 . . . . 0.83999999999999997 111.485 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 42.3 -141.42 1.7 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.051 -0.595 . . . . 0.28999999999999998 113.009 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -96.9 51.7 1.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.133 0.492 . . . . 1.5800000000000001 110.733 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -88.75 -73.71 0.49 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.811 -0.631 . . . . 0.33000000000000002 111.071 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.0 -18.93 13.61 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.002 -0.618 . . . . 0.33000000000000002 113.092 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.489 HG22 ' NE2' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -96.85 -9.21 29.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.807 0.337 . . . . 0.91000000000000003 110.658 179.09 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.63 -12.75 6.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.1 -0.5 . . . . 0.20999999999999999 111.523 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.526 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 4.6 ttm -79.36 -36.32 39.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.551 -0.295 . . . . 1.1200000000000001 111.458 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.526 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -77.95 -48.91 2.07 Favored Pre-proline 0 N--CA 1.45 -0.45 0 CA-C-O 120.503 0.192 . . . . 2.0 111.236 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 24.4 Cg_exo -64.18 -43.06 15.91 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.793 2.329 . . . . 0.27000000000000002 112.734 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.59 HD13 HD11 ' A' ' 106' ' ' LEU . 2.2 tm? -71.0 -30.37 66.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.996 -0.547 . . . . 0.19 111.168 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.62 -49.22 74.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.195 0.522 . . . . 0.17000000000000001 110.633 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.813 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -72.5 -34.75 67.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.366 0.876 . . . . 0.14000000000000001 113.366 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.646 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -57.76 -44.27 86.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.034 0.445 . . . . 0.12 111.968 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.009 HD22 HD21 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -71.0 -21.19 62.33 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.927 -0.579 . . . . 0.20999999999999999 112.01 -178.861 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.586 ' SG ' HD11 ' A' ' 140' ' ' ILE . 98.1 m -58.26 -12.56 3.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.938 -0.574 . . . . 0.25 111.73 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.689 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 9.8 mt -80.62 167.85 19.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.695 0.283 . . . . 0.20999999999999999 110.638 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 50.16 -110.83 0.96 Allowed Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.08 -0.581 . . . . 0.16 112.559 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.436 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.1 OUTLIER -162.37 102.47 1.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.797 0.332 . . . . 0.70999999999999996 110.3 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 1.4 m-20 -138.84 135.97 35.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 1.5900000000000001 111.243 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.508 ' C ' HD12 ' A' ' 113' ' ' ILE . 4.6 m-20 -102.79 109.48 21.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.052 -0.522 . . . . 1.26 109.813 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.701 HG23 ' O ' ' A' ' 88' ' ' LEU . 5.2 mp -143.39 140.85 26.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.499 -0.319 . . . . 0.56000000000000005 111.249 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 17.5 t -112.2 112.7 41.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.767 -0.457 . . . . 0.22 109.767 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.516 HD22 HD21 ' A' ' 92' ' ' LEU . 31.8 mt -81.02 158.62 25.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.383 0.611 . . . . 0.25 111.91 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.3 m -160.84 162.98 32.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.99 -1.005 . . . . 1.01 110.219 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.21 -165.39 13.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.885 -1.15 . . . . 0.25 113.7 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.515 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 0.8 OUTLIER -71.74 175.86 2.66 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.26 -0.47 . . . . 1.5700000000000001 111.134 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 32.1 Cg_exo -60.47 -37.29 82.03 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.337 2.025 . . . . 0.48999999999999999 112.436 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.531 HH11 ' CG ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -76.3 -36.98 58.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.765 0.317 . . . . 2.23 110.796 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.533 ' HA ' ' HG3' ' A' ' 124' ' ' ARG . 7.5 tpt -58.59 -22.31 55.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.80000000000000004 110.21 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.503 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 2.9 mmtt -63.64 -10.38 18.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.05 -0.523 . . . . 1.8100000000000001 111.97 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.597 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 4.4 pt-20 -121.22 28.2 7.96 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.638 -0.425 . . . . 1.9199999999999999 111.539 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.533 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 1.2 mmp_? -101.39 95.05 4.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.195 -0.457 . . . . 2.6299999999999999 110.725 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.7 Cg_endo -47.43 129.03 15.78 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.732 2.288 . . . . 0.44 112.2 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.649 HD11 HD23 ' A' ' 129' ' ' LEU . 19.9 tt -138.35 31.48 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.745 0.783 . . . . 0.26000000000000001 110.143 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -74.93 -49.49 9.9 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.633 -1.167 . . . . 0.20999999999999999 112.668 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.442 ' HB2' ' CD2' ' A' ' 172' ' ' PHE . 0.7 OUTLIER -53.65 -33.0 53.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.825 0.345 . . . . 0.25 110.5 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.823 ' CD1' HD21 ' A' ' 133' ' ' LEU . 25.9 tp -76.48 -62.84 1.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 0.17999999999999999 110.165 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.783 HG13 HD12 ' A' ' 140' ' ' ILE . 94.2 t -51.94 -26.89 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 0.17999999999999999 111.604 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 2.7 t0 -71.93 -45.46 61.08 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.27 0.47 . . . . 1.4299999999999999 112.27 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.857 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -63.82 -54.19 38.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.863 0.363 . . . . 0.14999999999999999 111.129 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.904 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -55.12 -44.78 75.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.343 0.592 . . . . 0.20999999999999999 109.547 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -57.76 -40.11 78.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.133 -0.94 . . . . 2.7799999999999998 110.314 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.857 HD12 ' HA ' ' A' ' 132' ' ' ALA . 3.1 mt -63.93 -32.93 74.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.23000000000000001 110.686 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.437 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -76.53 -13.81 83.08 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.489 -0.862 . . . . 0.14000000000000001 112.929 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 127.05 4.46 5.99 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.54 -0.838 . . . . 0.14999999999999999 113.192 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.98 150.41 45.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.878 0.371 . . . . 0.14999999999999999 111.51 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -116.35 96.76 5.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 2.3500000000000001 111.317 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.783 HD12 HG13 ' A' ' 130' ' ' VAL . 10.6 mt -124.41 168.39 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.088 0.47 . . . . 0.19 111.403 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.686 HG22 ' HB3' ' A' ' 152' ' ' ARG . 0.4 OUTLIER -150.36 174.4 12.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.699 -0.682 . . . . 0.31 110.603 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.543 ' CD2' ' HA ' ' A' ' 146' ' ' GLU . 23.6 m-85 -116.61 107.91 15.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.709 -0.849 . . . . 0.32000000000000001 108.709 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.632 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.3 mm? -75.25 -23.46 57.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.886 -0.597 . . . . 0.34000000000000002 112.074 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.7 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 2.5 mt-10 -129.53 -67.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.745 -0.382 . . . . 2.1899999999999999 110.977 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.75 ' HB2' ' HD2' ' A' ' 148' ' ' TYR . 53.6 mt-30 -125.63 157.82 36.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.091 0.472 . . . . 2.73 111.774 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.543 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 47.4 mt-10 -75.31 131.46 40.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.676 . . . . 2.0099999999999998 110.826 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 16.6 m-20 67.46 44.3 1.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 1.3400000000000001 111.822 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.75 ' HD2' ' HB2' ' A' ' 145' ' ' GLN . 7.8 m-30 -140.55 164.26 37.93 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.353 -0.385 . . . . 0.72999999999999998 110.65 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.549 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 6.3 Cg_exo -37.73 -44.12 1.57 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 124.146 3.231 . . . . 0.28000000000000003 115.38 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.7 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 24.3 Cg_endo -61.41 95.18 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 121.202 1.268 . . . . 0.23000000000000001 111.041 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 94.4 mt -132.41 123.29 26.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.534 -0.757 . . . . 0.19 111.71 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.686 ' HB3' HG22 ' A' ' 141' ' ' THR . 1.4 ttm180 -101.7 110.83 22.89 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.221 -1.029 . . . . 2.5899999999999999 108.221 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.727 ' CD1' HD12 ' A' ' 106' ' ' LEU . 2.0 mt -92.93 158.27 15.91 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.768 0.318 . . . . 0.17000000000000001 111.21 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 6.4 mt-30 -146.17 22.77 1.36 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.146 -0.479 . . . . 1.3400000000000001 110.712 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.471 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 56.35 -167.16 3.92 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.501 -0.856 . . . . 0.14999999999999999 112.193 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 158' ' ' THR . . . 110.94 -4.29 28.85 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.532 -0.842 . . . . 0.16 112.814 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.644 ' CD2' HG22 ' A' ' 179' ' ' THR . 2.0 t80 -62.43 110.54 1.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.922 0.391 . . . . 0.64000000000000001 111.141 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.547 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 71.5 p -109.49 -50.67 2.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.20000000000000001 110.573 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.475 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 145.98 -161.91 28.31 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.276 -0.964 . . . . 0.19 113.58 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 162' ' ' VAL . . . 113.88 168.82 16.62 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 111.738 -0.545 . . . . 0.16 111.738 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.9 129.71 43.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.88 0.34 . . . . 1.21 110.323 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.747 HG11 ' HB1' ' A' ' 132' ' ' ALA . 61.4 t -136.56 156.99 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 120.932 0.396 . . . . 0.16 111.131 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.447 ' N ' HG12 ' A' ' 162' ' ' VAL . 1.1 m-20 -127.9 116.51 20.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.421 -0.585 . . . . 1.1000000000000001 109.421 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.433 HG21 ' CD1' ' A' ' 176' ' ' LEU . 0.5 OUTLIER -118.73 145.86 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 120.392 -0.523 . . . . 0.17999999999999999 112.278 -178.415 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 1.8 t70 -85.07 130.28 34.64 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.87 -0.605 . . . . 1.25 110.215 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.626 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -72.1 -45.34 41.3 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.799 -0.715 . . . . 0.14999999999999999 113.507 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.35 160.97 0.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.116 0.484 . . . . 1.0900000000000001 112.06 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 9.4 t 71.73 59.59 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 115.649 -0.705 . . . . 0.23999999999999999 111.06 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.841 ' N ' HG11 ' A' ' 196' ' ' VAL . 15.3 m 60.81 154.03 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.871 -0.604 . . . . 0.70999999999999996 110.722 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 3.8 t -82.82 1.8 37.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 1.3200000000000001 111.007 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 66.5 mm-40 -56.92 -21.0 26.45 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.543 -0.299 . . . . 1.8999999999999999 110.816 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.448 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 3.9 m-85 -71.88 -61.83 1.64 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.107 0.479 . . . . 0.20999999999999999 110.332 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.764 HD23 HG12 ' A' ' 201' ' ' ILE . 64.4 tp -68.77 -33.32 73.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.664 -0.698 . . . . 0.20999999999999999 109.768 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.577 ' O ' ' CG ' ' A' ' 178' ' ' MET . 52.5 m -59.76 -33.56 71.83 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.593 -0.731 . . . . 1.02 109.951 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.813 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -71.64 -45.07 63.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.23999999999999999 111.692 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.904 ' CD2' HD23 ' A' ' 133' ' ' LEU . 1.6 mt -72.84 -31.11 64.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.145 -0.48 . . . . 0.19 110.435 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.855 HD21 ' HB3' ' A' ' 223' ' ' PHE . 10.4 mt -66.78 -28.13 68.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.957 -0.565 . . . . 0.16 111.553 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.577 ' CG ' ' O ' ' A' ' 174' ' ' THR . 0.0 OUTLIER -98.75 -29.44 13.0 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 120.13 -0.628 . . . . 1.4099999999999999 110.43 179.178 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.701 HG21 ' O ' ' A' ' 104' ' ' ALA . 83.0 m -81.79 -46.14 14.61 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.637 -0.711 . . . . 0.17999999999999999 111.521 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.856 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -60.17 -40.9 81.24 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 113.286 0.847 . . . . 0.14999999999999999 113.286 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.5 Cg_endo -54.39 -35.57 84.93 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.426 1.418 . . . . 0.14999999999999999 112.545 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.99 -11.74 54.79 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.862 0.363 . . . . 0.19 110.478 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.547 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -61.64 124.21 80.24 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.97 -0.559 . . . . 0.23999999999999999 109.788 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.1 -32.95 5.21 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.917 2.412 . . . . 0.28000000000000003 113.77 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -103.81 154.68 19.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.105 0.478 . . . . 1.75 111.431 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.488 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 12.4 t0 -67.39 122.54 18.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.603 -0.726 . . . . 1.3799999999999999 110.505 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.55 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 24.3 m -107.69 136.31 47.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.247 -0.433 . . . . 0.14999999999999999 111.435 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 1.055 HG22 HG13 ' A' ' 224' ' ' VAL . 45.4 t -126.5 97.93 4.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.979 -0.555 . . . . 0.13 110.053 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.561 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.4 mt -89.43 143.87 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-N 116.124 -0.489 . . . . 0.12 110.03 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.811 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -114.64 170.7 8.12 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.153 -1.054 . . . . 2.6800000000000002 108.153 177.775 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.811 HD13 ' C ' ' A' ' 190' ' ' ARG . 0.9 OUTLIER -111.05 96.44 4.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 C-N-CA 120.767 -0.373 . . . . 0.14999999999999999 111.126 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -59.09 -80.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.965 -0.561 . . . . 1.47 110.662 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -81.24 167.18 48.95 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.838 -0.696 . . . . 0.17000000000000001 112.567 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.15 126.22 26.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.641 0.258 . . . . 2.04 110.777 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.626 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.4 OUTLIER -61.49 144.1 54.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.987 0.423 . . . . 0.20000000000000001 110.18 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.841 HG11 ' N ' ' A' ' 169' ' ' SER . 14.5 p -100.48 -17.96 6.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.04 -0.527 . . . . 0.23000000000000001 111.541 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.555 ' CB ' ' HB2' ' A' ' 200' ' ' TYR . 0.1 OUTLIER -131.51 46.7 2.62 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.541 -0.754 . . . . 0.66000000000000003 109.847 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.734 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.3 OUTLIER -40.0 -59.58 1.74 Allowed Pre-proline 0 N--CA 1.466 0.37 0 CA-C-N 115.453 -0.794 . . . . 1.3700000000000001 113.051 -178.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 59.3 Cg_endo -71.24 -16.04 31.59 Favored 'Trans proline' 0 CA--C 1.516 -0.402 0 C-N-CA 121.987 1.791 . . . . 0.45000000000000001 112.762 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.555 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 28.3 m-85 -79.23 -27.77 42.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.416 -0.356 . . . . 0.77000000000000002 110.332 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.764 HG12 HD23 ' A' ' 173' ' ' LEU . 7.7 tp -69.96 -31.44 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.19 110.259 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.4 OUTLIER -63.05 -32.21 73.53 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.643 -0.503 . . . . 1.3200000000000001 109.643 178.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 200' ' ' TYR . 31.1 mt -67.76 -31.08 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.804 -0.634 . . . . 0.31 110.356 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.423 HG22 ' SD ' ' A' ' 208' ' ' MET . 42.0 m -60.65 -52.3 65.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.692 -0.485 . . . . 0.20999999999999999 109.692 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.841 HD22 HG12 ' A' ' 215' ' ' ILE . 41.1 mt -70.95 -35.12 72.07 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.958 -0.565 . . . . 0.22 110.557 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 202' ' ' ASP . 1.6 t30 -63.86 -30.7 71.77 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 109.529 -0.545 . . . . 1.22 109.529 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.672 HD21 ' OH ' ' A' ' 237' ' ' TYR . 0.3 OUTLIER -76.69 -42.79 40.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.59999999999999998 109.373 178.686 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.475 ' SD ' HD23 ' A' ' 205' ' ' LEU . 30.4 mtp -64.89 -45.95 83.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.16 -0.927 . . . . 0.63 111.255 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 210' ' ' THR . 0.0 OUTLIER -60.46 -44.17 96.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.438 -0.346 . . . . 2.23 110.759 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 207' ' ' LEU . 0.5 OUTLIER -57.89 -31.71 67.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.147 0.499 . . . . 0.56999999999999995 109.88 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.584 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 1.6 m-85 -71.86 -51.54 21.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.488 -0.778 . . . . 0.40999999999999998 110.857 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 158.27 -4.82 0.14 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.522 -0.846 . . . . 0.23999999999999999 113.497 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.483 HG13 ' CG ' ' A' ' 229' ' ' GLN . 78.1 t -120.31 139.11 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.429 0.529 . . . . 0.20000000000000001 112.429 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -131.14 156.28 45.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.649 -0.705 . . . . 1.3300000000000001 110.568 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.965 HG21 HG12 ' A' ' 225' ' ' VAL . 1.8 pp -129.23 177.17 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 115.485 -0.78 . . . . 0.23999999999999999 111.782 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.85 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 2.8 tt0 -92.38 126.2 37.36 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.827 0.346 . . . . 1.8400000000000001 110.479 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -101.9 99.65 9.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.162 0.506 . . . . 2.2599999999999998 110.403 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.666 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 1.4 mm-40 -66.85 -166.35 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.652 -0.704 . . . . 1.6000000000000001 109.419 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.29 49.16 0.35 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.407 -0.36 . . . . 2.3199999999999998 110.611 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.479 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 56.7 20.05 4.79 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.016 0.436 . . . . 0.34000000000000002 110.926 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 191' ' ' ILE . 54.6 mt-30 -111.66 -24.24 10.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 1.96 110.106 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.738 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 41.2 mt-30 -146.63 140.93 26.39 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 120.979 0.418 . . . . 1.6200000000000001 111.168 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.855 ' HB3' HD21 ' A' ' 177' ' ' LEU . 19.6 m-85 -111.31 96.17 5.96 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.616 -0.883 . . . . 0.17000000000000001 108.616 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 1.055 HG13 HG22 ' A' ' 188' ' ' VAL . 52.1 t -86.36 110.76 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.042 0.448 . . . . 0.14999999999999999 110.935 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.965 HG12 HG21 ' A' ' 215' ' ' ILE . 7.4 m -103.03 120.71 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.662 -0.699 . . . . 0.16 111.669 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -62.89 112.59 2.63 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.497 -0.774 . . . . 1.6100000000000001 109.797 178.833 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.488 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -66.55 151.3 52.24 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.159 -0.928 . . . . 0.20000000000000001 113.039 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.77 10.63 62.87 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.591 -0.814 . . . . 0.26000000000000001 113.473 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.483 ' CG ' HG13 ' A' ' 213' ' ' VAL . 75.0 mm-40 -73.2 -175.42 1.85 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.34 0.591 . . . . 1.1299999999999999 110.992 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.658 ' HA ' HD23 ' A' ' 182' ' ' LEU . 1.2 m -176.6 103.25 0.06 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.273 -0.876 . . . . 0.28000000000000003 109.813 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 27.4 m-85 -54.73 152.24 7.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.196 -0.457 . . . . 0.33000000000000002 111.261 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.62 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 16.6 pt20 -122.13 154.25 37.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.06 -0.719 . . . . 2.0 109.06 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 9.5 t -64.97 102.93 0.37 Allowed Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 112.404 0.52 . . . . 1.1599999999999999 112.404 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.62 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 58.2 Cg_endo -68.93 -33.15 20.59 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.284 1.989 . . . . 0.5 111.466 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 121.54 -123.7 5.57 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.697 -0.683 . . . . 0.23999999999999999 111.645 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.549 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -91.38 117.38 29.62 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.83 -0.433 . . . . 0.39000000000000001 109.83 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.672 ' OH ' HD21 ' A' ' 207' ' ' LEU . 62.5 t80 -122.75 144.65 49.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.859 0.361 . . . . 1.1100000000000001 111.674 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.848 HD12 HG23 ' A' ' 42' ' ' THR . 25.0 tp . . . . . 0 N--CA 1.451 -0.39 0 CA-C-N 116.293 -0.412 . . . . 1.1100000000000001 110.651 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.584 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 7.5 p30 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.981 0.419 . . . . 0.0 111.027 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -65.57 -40.3 92.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.789 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.799 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -79.04 -36.46 40.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.993 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.776 HD21 HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -60.39 -51.63 68.66 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.922 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.555 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 2.4 tp -70.07 -43.21 71.63 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.891 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.494 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 48.6 mt -61.02 -35.9 78.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.005 0.431 . . . . 0.0 110.738 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.692 ' HA ' ' CE1' ' A' ' 211' ' ' PHE . . . -71.06 -29.97 66.0 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.737 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.757 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -70.08 -30.62 67.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.542 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.912 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -89.39 -11.29 43.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.902 0.382 . . . . 0.0 111.102 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.627 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.45 165.57 20.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.212 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.412 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 80.2 m-70 -99.07 98.68 9.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.967 0.413 . . . . 0.0 110.079 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.6 141.51 6.88 Favored Glycine 0 C--N 1.315 -0.637 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.162 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.911 ' HB2' HD13 ' A' ' 76' ' ' ILE . 13.6 tttt -62.6 132.83 53.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.085 0.469 . . . . 0.0 111.78 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.484 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.7 OUTLIER -128.22 152.71 47.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.917 178.882 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.871 HG22 ' HG2' ' A' ' 74' ' ' GLU . 58.5 t -100.85 141.2 17.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.021 0.439 . . . . 0.0 111.925 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.799 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -126.93 110.95 13.55 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.039 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.741 HG23 HD12 ' A' ' 238' ' ' LEU . 0.2 OUTLIER -101.99 166.94 10.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.121 0.486 . . . . 0.0 111.467 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 71' ' ' THR . 2.1 t30 70.6 19.35 6.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.879 -177.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.982 HD22 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -60.89 156.52 17.24 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.414 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.546 ' HB3' HG21 ' A' ' 50' ' ' VAL . 16.8 tp -93.71 115.65 28.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.0 0.428 . . . . 0.0 111.617 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -76.37 64.49 2.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.439 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.515 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.3 OUTLIER -124.8 -159.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.063 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.731 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -97.39 -21.07 17.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.988 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.64 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 4.0 p-10 -72.77 -27.39 61.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.268 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.546 HG21 ' HB3' ' A' ' 45' ' ' LEU . 13.3 t -88.46 -51.99 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.368 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.731 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 2.1 ptm180 -51.21 -28.53 11.62 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.209 0.528 . . . . 0.0 109.924 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.531 ' CE1' ' HA3' ' A' ' 93' ' ' GLY . 25.0 m170 -71.5 -39.82 70.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.246 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.652 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 3.0 tpt -62.54 -50.1 72.67 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.776 HD23 HD21 ' A' ' 29' ' ' LEU . 1.1 mt -60.01 -52.98 63.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.785 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 3.3 m-80 -54.22 -22.86 12.65 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.851 178.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.747 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -74.4 -48.11 29.83 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.597 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.635 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -72.06 -49.9 32.82 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.145 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.545 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 7.2 t -50.85 -30.88 15.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.158 0.504 . . . . 0.0 110.286 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.771 ' HB1' HD11 ' A' ' 88' ' ' LEU . . . -59.61 -49.5 77.5 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.958 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.915 HD21 HD22 ' A' ' 106' ' ' LEU . 3.6 mp -67.47 -28.46 67.88 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.584 0.707 . . . . 0.0 109.825 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.53 -0.24 5.47 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.537 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.591 HG21 HD11 ' A' ' 82' ' ' LEU . 13.8 t -58.7 147.97 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 117.491 0.645 . . . . 0.0 110.343 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.44 ' CB ' HG13 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -111.69 107.65 16.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.636 -178.851 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.652 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 6.8 p90 -122.7 160.52 25.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.157 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -149.31 116.41 6.03 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.662 179.623 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.982 HD11 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -86.52 174.09 9.17 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.228 0.537 . . . . 0.0 111.735 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.512 ' CB ' ' HG3' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -85.16 178.55 7.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.634 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.23 -14.79 53.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.091 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.95 2.93 12.8 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.003 0.43 . . . . 0.0 110.239 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.516 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 1.3 mtm-85 62.51 47.5 5.0 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.121 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -127.05 -2.54 6.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.271 179.412 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -141.27 109.75 5.96 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.462 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.899 ' SG ' HD22 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -114.41 147.67 38.89 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.255 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.871 ' HG2' HG22 ' A' ' 40' ' ' VAL . 7.2 mt-10 -114.62 102.52 10.11 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.742 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -95.27 131.93 40.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.911 HD13 ' HB2' ' A' ' 38' ' ' LYS . 8.6 mm -80.53 104.34 8.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.807 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.659 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -51.31 112.85 1.94 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.512 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.614 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.2 m-20 -59.61 -17.18 31.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.969 0.414 . . . . 0.0 110.378 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.412 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 88.08 -22.49 18.54 Favored Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.281 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.912 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -139.13 -143.22 4.39 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.803 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 6.2 Cg_exo -80.52 171.12 15.09 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 121.95 1.767 . . . . 0.0 109.319 177.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.867 ' HB2' HD23 ' A' ' 106' ' ' LEU . 4.3 mm? -69.78 90.68 0.6 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.803 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 35.5 m170 -83.08 119.54 24.61 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.281 -1.781 . . . . 0.0 112.749 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.687 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -143.54 106.76 4.54 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.334 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -105.09 86.73 2.49 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.346 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.62 23.41 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.897 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 53.93 51.02 15.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.526 0.679 . . . . 0.0 109.75 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.771 HD11 ' HB1' ' A' ' 59' ' ' ALA . 3.1 tp -80.88 137.33 36.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.252 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.62 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 3.3 tt0 -115.68 129.93 56.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.272 0.558 . . . . 0.0 110.766 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.763 HD12 HD11 ' A' ' 102' ' ' LEU . 4.3 mt -105.99 154.75 20.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.378 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -120.21 107.26 12.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.862 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.643 HD23 ' HE2' ' A' ' 99' ' ' MET . 1.6 mm? -93.33 3.47 55.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.378 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.531 ' HA3' ' CE1' ' A' ' 52' ' ' HIS . . . 40.53 -143.57 0.6 Allowed Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.166 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.478 ' OD1' ' HB3' ' A' ' 120' ' ' ARG . 1.0 OUTLIER -92.04 50.58 1.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.985 0.421 . . . . 0.0 110.88 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.64 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -92.34 -73.79 0.54 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.923 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.51 -17.46 14.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.465 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.44 ' HA ' ' OE1' ' A' ' 171' ' ' GLN . 6.0 p -96.59 -9.16 29.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.845 0.355 . . . . 0.0 111.271 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.411 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -128.02 -13.64 5.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.695 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.643 ' HE2' HD23 ' A' ' 92' ' ' LEU . 3.4 ttm -73.7 -54.8 7.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.082 0.467 . . . . 0.0 111.033 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.781 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -58.98 -50.8 86.03 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.475 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.754 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 28.2 Cg_exo -63.14 -47.18 8.62 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.721 2.28 . . . . 0.0 112.863 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.027 HD13 HD11 ' A' ' 106' ' ' LEU . 2.0 tm? -65.24 -37.74 88.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.754 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.598 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -60.3 -48.35 82.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.441 0.638 . . . . 0.0 110.077 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.991 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -66.09 -41.47 90.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.519 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.517 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -59.1 -39.36 81.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.389 . . . . 0.0 112.041 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.027 HD11 HD13 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -73.3 -21.14 60.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.849 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.665 ' SG ' HD11 ' A' ' 140' ' ' ILE . 10.8 m -63.86 -6.37 5.81 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.453 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.727 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 7.2 mt -85.13 168.5 14.77 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.554 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 56.11 -113.44 4.06 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.607 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.418 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.1 OUTLIER -167.9 94.18 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.972 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.607 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER -138.54 145.21 40.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.833 -179.271 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.55 ' C ' HD12 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -102.83 111.65 24.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.808 179.361 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.686 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 5.0 mp -141.2 143.59 27.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.235 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 41.2 t -115.59 113.62 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 120.67 0.272 . . . . 0.0 110.615 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.598 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 25.2 mt -81.89 156.82 24.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.428 0.632 . . . . 0.0 111.767 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.418 ' O ' ' HE3' ' A' ' 99' ' ' MET . 1.6 m -163.76 166.66 21.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.587 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -154.36 -166.11 14.66 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 119.928 -1.13 . . . . 0.0 113.708 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.656 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 11.7 mm-40 -69.48 173.17 4.22 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.46 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.656 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 24.3 Cg_endo -61.56 -24.48 78.1 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.979 1.786 . . . . 0.0 112.173 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.57 ' HD3' ' HG2' ' A' ' 123' ' ' GLU . 4.1 tpp180 -88.05 -33.47 18.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.536 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.505 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 9.2 tpt -59.96 -17.68 39.82 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.613 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 12.2 mttm -68.93 -5.51 21.84 Favored 'General case' 0 C--N 1.334 -0.09 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.57 ' HG2' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -119.09 22.62 11.78 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.141 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.439 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 17.0 mmm180 -102.24 86.73 0.94 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.766 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.796 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 4.4 Cg_endo -47.02 134.42 18.37 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.918 2.412 . . . . 0.0 112.581 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.89 HD11 HD23 ' A' ' 129' ' ' LEU . 21.4 tt -135.78 32.22 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.79 0.805 . . . . 0.0 109.682 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -70.99 -51.6 17.95 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.612 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.676 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.4 OUTLIER -58.85 -29.55 67.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.767 0.318 . . . . 0.0 110.447 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.89 HD23 HD11 ' A' ' 126' ' ' ILE . 29.6 tp -76.76 -61.03 2.11 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.964 HG13 HD12 ' A' ' 140' ' ' ILE . 61.9 t -57.06 -25.62 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.653 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -70.42 -45.42 65.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.584 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.892 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -66.1 -46.89 76.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.915 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.832 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.1 OUTLIER -60.43 -46.33 90.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.97 -38.1 72.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.549 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.892 HD12 ' HA ' ' A' ' 132' ' ' ALA . 3.8 mt -66.71 -32.31 73.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.271 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.476 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -76.09 -16.82 80.42 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.555 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 127.6 5.47 5.43 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.309 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.44 148.48 41.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.83 0.348 . . . . 0.0 111.439 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -117.2 94.04 4.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.391 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.964 HD12 HG13 ' A' ' 130' ' ' VAL . 14.1 mt -116.95 174.73 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.93 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.752 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.6 OUTLIER -153.17 -175.19 5.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.043 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.581 ' N ' HG23 ' A' ' 141' ' ' THR . 25.8 m-85 -125.35 106.87 10.15 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.675 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.2 mm? -79.91 -13.58 59.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.751 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 45.8 mt-10 -142.98 -71.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.062 0.458 . . . . 0.0 110.896 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.751 ' HB3' ' CD2' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -113.48 147.37 37.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.647 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.472 ' O ' ' CD2' ' A' ' 148' ' ' TYR . 2.2 mt-10 -76.68 131.97 39.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.47 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.796 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 82.5 m-20 62.84 48.97 3.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.125 0.488 . . . . 0.0 109.72 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.805 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 50.5 m-85 -147.44 176.2 2.33 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.503 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.805 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 2.3 Cg_endo -44.25 -43.4 13.28 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.518 2.812 . . . . 0.0 115.461 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.751 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 30.5 Cg_endo -61.94 101.29 0.22 Allowed 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 121.539 1.493 . . . . 0.0 111.751 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.623 HD11 HG21 ' A' ' 126' ' ' ILE . 91.0 mt -138.72 123.62 18.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.622 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.744 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.0 OUTLIER -104.63 112.3 25.33 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 176.69 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.811 HD23 HG23 ' A' ' 140' ' ' ILE . 1.2 mt -94.49 156.15 16.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.434 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.607 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 10.4 mt-30 -142.91 27.22 1.65 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.752 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 107' ' ' CYS . . . 53.86 -165.29 2.34 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.595 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 158' ' ' THR . . . 106.77 -5.15 36.86 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.901 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.648 ' CD2' HG22 ' A' ' 179' ' ' THR . 3.2 t80 -60.53 108.01 0.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 0.0 110.668 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.502 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 68.3 p -107.53 -47.24 3.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.006 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.59 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 141.26 -159.91 26.74 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 119.976 -1.107 . . . . 0.0 114.175 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.528 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 114.82 175.47 18.6 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.47 128.01 34.85 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.579 HG11 ' HB1' ' A' ' 132' ' ' ALA . 59.4 t -137.34 151.26 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.966 0.412 . . . . 0.0 111.858 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.44 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 1.9 m-20 -118.27 116.51 26.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.113 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.678 HG11 HD13 ' A' ' 173' ' ' LEU . 0.3 OUTLIER -118.04 144.82 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.754 -179.319 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.676 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.2 OUTLIER -83.75 138.0 33.47 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.638 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -80.05 -44.84 8.68 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.355 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.14 164.04 0.08 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.808 0.337 . . . . 0.0 111.189 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 4.0 t 70.73 56.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.83 ' H ' HG11 ' A' ' 196' ' ' VAL . 53.2 m 59.25 156.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.192 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 48.5 p -80.28 -0.9 38.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.165 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.781 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 77.3 mm-40 -52.8 -23.72 7.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.759 0.314 . . . . 0.0 111.278 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.659 ' HA ' HD13 ' A' ' 129' ' ' LEU . 3.8 m-85 -71.55 -54.27 11.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.033 0.444 . . . . 0.0 110.447 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.937 HD23 HG12 ' A' ' 201' ' ' ILE . 18.8 tp -78.02 -35.86 49.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.391 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.531 HG23 ' OG1' ' A' ' 204' ' ' THR . 92.3 m -55.65 -37.01 67.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.165 0.507 . . . . 0.0 109.69 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.991 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -71.56 -51.44 23.45 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.411 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.832 ' CD2' HD23 ' A' ' 133' ' ' LEU . 3.1 mt -65.41 -35.8 82.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.458 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.915 HD12 HD11 ' A' ' 201' ' ' ILE . 10.6 mt -66.53 -28.8 68.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.115 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.497 ' HA ' ' OH ' ' A' ' 231' ' ' TYR . 5.9 ptp -95.32 -27.53 15.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.169 0.509 . . . . 0.0 110.958 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.712 HG21 ' O ' ' A' ' 104' ' ' ALA . 80.3 m -87.44 -46.44 9.61 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.131 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.897 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -63.02 -36.29 23.88 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.726 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.5 Cg_endo -53.24 -36.91 79.66 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 121.28 1.32 . . . . 0.0 111.8 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.716 HD23 ' HA ' ' A' ' 230' ' ' SER . 0.9 OUTLIER -84.22 -10.83 57.38 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.655 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -64.49 119.52 57.52 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.747 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 3.4 Cg_exo -41.09 -29.67 0.55 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.478 2.785 . . . . 0.0 114.291 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.32 153.36 22.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.17 0.51 . . . . 0.0 111.59 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.624 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 6.0 t70 -67.28 116.6 8.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.84 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.763 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 26.3 m -102.87 135.65 44.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.295 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.965 HG22 HG13 ' A' ' 224' ' ' VAL . 39.4 t -126.13 99.16 5.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.147 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.59 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.0 mt -90.87 142.0 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.238 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.807 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.3 OUTLIER -112.99 171.14 7.72 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.734 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.807 HD13 ' C ' ' A' ' 190' ' ' ARG . 1.0 OUTLIER -110.59 97.42 5.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.918 0.39 . . . . 0.0 111.339 -178.952 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.498 ' HG2' ' HE ' ' A' ' 190' ' ' ARG . 15.1 mtmt -57.15 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.651 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.428 ' O ' HG22 ' A' ' 191' ' ' ILE . . . -82.58 170.44 50.28 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.216 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.08 124.17 20.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.61 0.243 . . . . 0.0 110.604 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.687 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.4 OUTLIER -58.48 144.88 40.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.995 0.426 . . . . 0.0 110.461 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.83 HG11 ' H ' ' A' ' 169' ' ' SER . 14.8 p -101.13 -20.57 5.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.79 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.733 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -128.39 46.19 2.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.376 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.78 ' O ' HG22 ' A' ' 201' ' ' ILE . 5.5 ttpt -40.44 -62.11 1.02 Allowed Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.825 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 59.1 Cg_endo -70.21 -16.44 35.67 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 121.586 1.524 . . . . 0.0 112.209 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.733 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 14.6 m-85 -75.74 -30.11 59.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.234 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.937 HG12 HD23 ' A' ' 173' ' ' LEU . 7.3 tp -68.28 -33.83 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.026 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.24 -31.27 68.92 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.673 HD12 ' HA ' ' A' ' 200' ' ' TYR . 20.7 mt -70.44 -30.77 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.236 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.531 ' OG1' HG23 ' A' ' 174' ' ' THR . 24.2 m -59.25 -55.1 39.16 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.766 HD21 HD22 ' A' ' 177' ' ' LEU . 21.7 mt -71.26 -35.73 71.51 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.296 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.755 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 58.4 m-20 -64.35 -28.67 69.86 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.669 ' HB2' ' O ' ' A' ' 203' ' ' ILE . 0.1 OUTLIER -76.55 -44.41 34.96 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.862 177.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.488 ' HB3' ' HE1' ' A' ' 231' ' ' TYR . 9.5 mtp -66.8 -41.09 88.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.449 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.755 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 17.1 pttt -61.07 -43.79 98.36 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.712 0.291 . . . . 0.0 110.337 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.646 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.6 OUTLIER -59.59 -29.68 68.14 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.692 ' CE1' ' HA ' ' A' ' 32' ' ' ALA . 1.3 m-85 -72.94 -50.78 21.49 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.504 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.428 ' HA3' ' HG2' ' A' ' 232' ' ' GLN . . . 153.98 -7.69 0.4 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.53 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.638 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 65.4 t -118.92 140.34 43.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.434 ' HG2' ' HB3' ' A' ' 209' ' ' LYS . 37.6 mt-10 -135.58 156.65 48.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.625 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 1.064 HG21 HG12 ' A' ' 225' ' ' VAL . 1.8 pp -127.77 175.3 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.94 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.885 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 6.4 tp10 -88.8 126.33 35.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.645 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -102.87 101.17 11.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.033 0.444 . . . . 0.0 110.573 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.74 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.7 OUTLIER -65.33 -166.64 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.453 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -73.37 49.02 0.26 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.842 0.353 . . . . 0.0 110.537 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.576 ' CZ ' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 57.48 19.81 5.55 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.129 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 191' ' ' ILE . 2.2 mt-30 -112.98 -21.42 11.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.826 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.769 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 23.9 mt-30 -149.17 140.11 22.87 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.967 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.894 ' HB3' HD21 ' A' ' 177' ' ' LEU . 27.5 m-85 -112.36 98.53 7.35 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.965 HG13 HG22 ' A' ' 188' ' ' VAL . 58.6 t -84.55 110.79 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 121.222 0.534 . . . . 0.0 111.283 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 1.064 HG12 HG21 ' A' ' 215' ' ' ILE . 3.4 m -98.75 115.31 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.964 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.692 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -64.59 103.53 0.69 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.895 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.624 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.99 153.81 25.1 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.935 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.07 10.75 62.21 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.492 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.692 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 6.7 mm-40 -77.21 -179.15 5.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.223 0.535 . . . . 0.0 110.791 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.716 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.1 m -174.5 105.03 0.1 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.993 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.639 ' HD2' ' HB2' ' A' ' 34' ' ' LEU . 35.0 m-85 -55.52 151.85 9.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.706 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 16.7 pt20 -119.66 159.44 24.44 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.419 ' HA ' ' HD2' ' A' ' 234' ' ' PRO . 51.6 p -75.48 98.35 0.24 Allowed Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.706 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 52.8 Cg_endo -65.88 -32.73 44.93 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.497 2.131 . . . . 0.0 112.011 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 122.45 -121.14 4.56 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.678 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.3 OUTLIER -92.56 116.88 29.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.745 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 63.6 t80 -122.54 138.6 54.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.53 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.741 HD12 HG23 ' A' ' 42' ' ' THR . 3.6 tp . . . . . 0 CA--C 1.513 -0.461 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.173 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.456 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 18.5 p30 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.902 0.382 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.522 ' O ' HD12 ' A' ' 31' ' ' LEU . 3.0 mtt180 -62.48 -38.8 91.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.651 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.851 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -78.55 -34.76 46.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.241 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.838 HD21 HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -62.3 -53.24 58.03 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.996 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 4.7 tp -67.77 -45.3 75.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.521 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.684 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 38.6 mt -58.97 -34.82 72.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.325 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.674 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -75.41 -30.06 59.96 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.729 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.802 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -69.67 -32.57 71.27 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.611 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.893 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -87.77 -12.12 46.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.006 0.432 . . . . 0.0 110.804 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.624 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.0 163.71 21.94 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.73 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.428 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 82.9 m-70 -97.44 97.07 8.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.86 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.34 144.6 7.38 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.018 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.753 ' HB2' HD13 ' A' ' 76' ' ' ILE . 16.2 tttt -66.6 134.8 53.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.076 0.465 . . . . 0.0 111.975 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.548 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -128.85 154.87 46.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.766 178.534 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.034 HG22 ' HG2' ' A' ' 74' ' ' GLU . 54.5 t -101.87 141.64 17.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.789 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.851 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -127.12 111.45 14.02 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.751 HG23 HD12 ' A' ' 238' ' ' LEU . 0.5 OUTLIER -104.7 167.4 9.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.156 0.503 . . . . 0.0 111.719 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.614 ' HB2' HD11 ' A' ' 238' ' ' LEU . 0.3 OUTLIER 67.45 20.47 9.85 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.794 -177.248 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.78 HD22 HD11 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -59.08 157.24 10.54 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.565 178.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.567 ' HB3' HG21 ' A' ' 50' ' ' VAL . 28.9 tp -95.32 114.3 26.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.122 0.487 . . . . 0.0 111.704 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -73.6 59.34 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.13 0.49 . . . . 0.0 110.53 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.438 ' OG ' HD23 ' A' ' 45' ' ' LEU . 36.8 p -115.87 -162.69 0.85 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.087 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.685 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 42.5 m-20 -97.94 -22.8 16.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.491 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -73.34 -24.01 60.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.228 0.537 . . . . 0.0 110.0 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 45' ' ' LEU . 19.2 t -89.02 -55.2 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.103 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.685 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -51.3 -29.47 15.01 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 109.842 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -71.12 -37.87 72.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.892 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.605 ' HE1' HD22 ' A' ' 30' ' ' LEU . 9.3 tpt -63.83 -51.15 66.0 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.838 HD23 HD21 ' A' ' 29' ' ' LEU . 1.2 mp -62.04 -47.46 84.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.674 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -56.25 -26.1 50.28 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.336 179.076 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.826 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -74.18 -46.31 42.92 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.631 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.612 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -68.27 -49.6 59.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.818 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.545 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 7.2 t -49.74 -31.47 11.47 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.204 0.526 . . . . 0.0 109.888 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.755 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.7 -52.36 65.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.093 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.016 HD21 HD22 ' A' ' 106' ' ' LEU . 4.1 mp -65.42 -28.63 69.38 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.524 0.678 . . . . 0.0 110.035 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.92 -1.23 6.26 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.758 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.654 HG21 HD11 ' A' ' 82' ' ' LEU . 22.8 t -56.27 152.81 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 117.639 0.72 . . . . 0.0 110.069 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.515 ' CB ' HG13 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -114.28 108.68 17.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.005 -179.442 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.667 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 9.1 p90 -126.95 156.95 40.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 32.1 m -150.33 116.62 5.7 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.68 0.276 . . . . 0.0 111.078 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.78 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -85.62 177.44 7.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.197 0.522 . . . . 0.0 111.63 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.79 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 3.6 t -88.02 178.82 6.56 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.993 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.91 -12.72 39.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.584 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -117.71 2.61 12.29 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.866 0.365 . . . . 0.0 110.667 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.471 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 10.9 mtt180 61.35 44.5 9.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.355 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -126.56 -2.6 6.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.562 179.446 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.79 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -141.21 110.25 6.19 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.447 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.741 ' SG ' HD22 ' A' ' 66' ' ' LEU . 3.0 t -114.75 149.88 36.21 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 1.034 ' HG2' HG22 ' A' ' 40' ' ' VAL . 43.7 mt-10 -115.85 102.85 10.07 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.693 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.6 mp -96.11 132.61 39.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.1 0.476 . . . . 0.0 111.995 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.753 HD13 ' HB2' ' A' ' 38' ' ' LYS . 15.1 mm -82.12 107.5 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.944 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.674 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -54.07 112.61 2.67 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.684 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.615 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.0 OUTLIER -61.33 -17.06 51.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.973 0.416 . . . . 0.0 110.519 178.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.428 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 86.76 -21.63 17.98 Favored Glycine 0 C--O 1.228 -0.248 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.41 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.893 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.62 -144.88 4.7 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.809 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 6.2 Cg_exo -79.96 168.44 19.03 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 121.858 1.705 . . . . 0.0 109.289 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.802 HD21 ' HB3' ' A' ' 33' ' ' ALA . 4.2 mm? -66.89 90.56 0.18 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.809 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 29.7 m170 -82.48 118.75 23.47 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.073 -1.876 . . . . 0.0 112.858 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.69 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -144.42 111.29 5.77 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.793 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -114.02 90.8 3.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.77 0.319 . . . . 0.0 111.524 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.03 22.6 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.736 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.7 52.28 11.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.453 0.644 . . . . 0.0 109.777 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.755 HD21 ' HB1' ' A' ' 59' ' ' ALA . 4.5 tp -82.71 130.53 35.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.256 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.652 ' N ' HD12 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -111.87 129.85 56.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.915 0.388 . . . . 0.0 110.519 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.826 HD13 ' HA ' ' A' ' 56' ' ' ALA . 16.3 mt -114.04 154.39 27.78 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.478 ' CE1' ' HA2' ' A' ' 93' ' ' GLY . 43.9 t80 -121.01 102.26 8.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.642 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.921 HD23 ' HE1' ' A' ' 99' ' ' MET . 2.0 mm? -89.09 8.39 30.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.893 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.558 ' CA ' ' HG3' ' A' ' 118' ' ' GLU . . . 45.23 -142.91 3.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.898 -0.667 . . . . 0.0 113.203 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.05 51.58 1.53 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.866 0.365 . . . . 0.0 111.081 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.15 -73.13 0.53 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.115 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.45 -16.38 18.83 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.073 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.454 ' HA ' ' CD ' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -95.15 -8.23 36.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.328 . . . . 0.0 111.103 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.436 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -127.46 -17.6 4.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.708 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.921 ' HE1' HD23 ' A' ' 92' ' ' LEU . 41.4 tpp -67.65 -54.72 17.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.097 0.475 . . . . 0.0 110.76 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.815 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -59.22 -53.37 66.94 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.474 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.685 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 31.3 Cg_exo -60.35 -47.15 15.18 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.731 2.287 . . . . 0.0 112.831 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.745 ' CD1' HD11 ' A' ' 106' ' ' LEU . 3.4 tm? -69.34 -38.92 78.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.553 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.431 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -60.92 -47.79 84.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.485 0.66 . . . . 0.0 109.988 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.912 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -68.17 -36.42 79.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.847 -1.069 . . . . 0.0 113.23 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.554 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -61.75 -44.21 97.34 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.016 HD22 HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -69.74 -19.96 63.52 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.56 -179.178 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.543 ' SG ' HD11 ' A' ' 140' ' ' ILE . 56.6 m -60.06 -11.52 6.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.169 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.745 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 7.7 mt -84.17 168.92 15.34 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 52.66 -108.96 0.8 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.374 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.405 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 11.3 p -166.93 100.86 0.55 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.689 0.281 . . . . 0.0 110.497 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 9.7 m-20 -138.3 136.82 36.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.119 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.721 ' C ' HD12 ' A' ' 113' ' ' ILE . 4.5 m-20 -101.42 111.21 23.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.476 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.723 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.3 mp -142.55 141.76 27.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.324 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.931 HG22 ' HG2' ' A' ' 152' ' ' ARG . 10.5 t -112.31 114.15 46.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.59 HD22 HD21 ' A' ' 92' ' ' LEU . 59.5 mt -87.35 156.74 19.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.551 0.691 . . . . 0.0 112.288 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 117' ' ' GLY . 0.6 OUTLIER -159.03 175.25 13.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.071 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.413 ' H ' HG22 ' A' ' 116' ' ' THR . . . -164.15 -168.5 26.31 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 119.902 -1.142 . . . . 0.0 114.253 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.745 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 36.5 mt-10 -67.7 174.8 1.98 Allowed Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 122.877 0.471 . . . . 0.0 110.453 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.745 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 24.1 Cg_endo -61.39 -38.44 64.25 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.988 1.792 . . . . 0.0 112.267 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 123' ' ' GLU . 15.0 tpp85 -76.88 -30.07 56.05 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.276 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.682 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 11.2 tpt -65.0 -11.59 40.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.205 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.752 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 10.4 mttt -76.33 -6.53 51.96 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.661 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 9.9 pt-20 -121.62 23.37 10.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.973 0.416 . . . . 0.0 111.166 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.446 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 5.1 mmp_? -96.94 94.75 1.89 Allowed Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.541 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.675 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 10.3 Cg_endo -53.66 123.09 12.53 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.499 2.133 . . . . 0.0 112.572 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.653 ' O ' HG23 ' A' ' 130' ' ' VAL . 13.3 tt -127.82 32.07 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.617 0.723 . . . . 0.0 110.225 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -74.3 -49.98 11.04 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.479 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.829 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.9 OUTLIER -52.1 -28.42 17.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.047 0.451 . . . . 0.0 110.656 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.734 ' CD1' HD21 ' A' ' 133' ' ' LEU . 15.8 tp -82.37 -65.44 1.01 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.546 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 1.014 HG13 HD12 ' A' ' 140' ' ' ILE . 47.8 t -51.1 -28.23 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.179 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 13.0 t70 -68.43 -45.93 71.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.496 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 1.038 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -66.5 -48.78 68.72 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.817 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -58.34 -43.08 88.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.36 0.6 . . . . 0.0 109.684 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.53 -33.88 73.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.698 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 1.038 HD12 ' HA ' ' A' ' 132' ' ' ALA . 3.4 mt -69.79 -31.12 68.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.991 0.424 . . . . 0.0 110.266 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.558 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -77.79 -17.12 79.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.379 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.78 3.98 5.33 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.141 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.25 147.24 48.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 111.105 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 1.9 mmtp -113.94 91.22 3.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.454 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.014 HD12 HG13 ' A' ' 130' ' ' VAL . 8.1 mt -116.45 174.63 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.784 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -151.49 -167.15 2.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.144 0.497 . . . . 0.0 111.187 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.743 ' N ' HG23 ' A' ' 141' ' ' THR . 24.4 m-85 -136.17 99.1 4.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.929 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.585 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.4 mm? -68.25 -13.07 61.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.584 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.765 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 40.1 mm-40 -142.0 -73.8 0.31 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.069 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.5 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -120.43 150.09 41.34 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.145 0.498 . . . . 0.0 111.526 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.487 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 16.6 pt-20 -68.21 128.0 34.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.258 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.675 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 8.3 m-20 68.73 51.58 0.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.248 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.809 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.0 m-30 -145.17 177.29 1.82 Allowed Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.809 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 4.5 Cg_endo -48.08 -43.38 30.82 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.026 2.484 . . . . 0.0 114.974 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.765 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 27.8 Cg_endo -62.4 100.95 0.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 120.989 1.126 . . . . 0.0 111.276 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.598 HD11 HG21 ' A' ' 126' ' ' ILE . 61.8 mt -136.97 123.32 20.68 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.412 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.931 ' HG2' HG22 ' A' ' 114' ' ' VAL . 2.8 mtp180 -103.93 112.11 24.95 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.892 HD23 HG23 ' A' ' 140' ' ' ILE . 1.7 mt -93.83 158.75 15.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.318 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.588 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 28.2 mt-30 -149.44 22.66 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.079 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.503 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 53.68 -166.87 1.71 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.707 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 109.29 -2.23 31.15 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.957 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.677 ' CD2' HG22 ' A' ' 179' ' ' THR . 2.5 t80 -60.38 108.21 0.78 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.943 0.372 . . . . 0.0 110.949 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.516 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 68.5 p -105.09 -49.29 3.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.054 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.649 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 142.43 -163.58 27.13 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.168 -1.015 . . . . 0.0 114.019 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.509 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 116.7 172.56 16.42 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -65.29 128.32 35.36 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 117.245 0.523 . . . . 0.0 109.732 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.608 HG11 ' HB1' ' A' ' 132' ' ' ALA . 59.5 t -135.9 157.35 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.149 0.5 . . . . 0.0 111.31 -178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.478 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.7 OUTLIER -125.34 117.94 24.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.518 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.966 HG11 HD13 ' A' ' 173' ' ' LEU . 0.5 OUTLIER -117.91 147.19 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.945 -178.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.829 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.2 OUTLIER -85.77 133.04 34.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.613 178.792 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.713 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -74.52 -44.67 26.14 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.304 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.506 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 0.2 OUTLIER -49.8 163.15 0.14 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.915 0.388 . . . . 0.0 111.805 -179.56 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 169' ' ' SER . 8.2 t 71.27 61.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.844 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.709 ' N ' HG11 ' A' ' 196' ' ' VAL . 0.2 OUTLIER 54.56 156.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.468 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.491 ' HG ' ' HG1' ' A' ' 174' ' ' THR . 6.7 t -79.61 2.21 23.28 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.877 0.37 . . . . 0.0 110.891 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.815 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 82.6 mm-40 -54.05 -24.14 16.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.328 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.55 ' CD2' ' HB2' ' A' ' 128' ' ' HIS . 2.1 m-85 -73.71 -58.48 3.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.352 0.596 . . . . 0.0 110.587 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.966 HD13 HG11 ' A' ' 164' ' ' VAL . 18.0 tp -72.25 -37.29 69.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.861 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.617 HG23 ' OG1' ' A' ' 204' ' ' THR . 66.8 m -57.29 -36.47 71.09 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.241 0.543 . . . . 0.0 109.772 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.912 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -71.76 -51.28 23.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.25 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.817 ' CD2' HD23 ' A' ' 133' ' ' LEU . 3.2 mt -64.12 -38.53 91.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.466 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.07 HD12 HD11 ' A' ' 201' ' ' ILE . 12.5 mt -65.61 -26.55 67.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.07 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.497 ' HA ' ' HH ' ' A' ' 231' ' ' TYR . 20.2 ptp -96.16 -27.03 15.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.175 0.512 . . . . 0.0 110.637 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.677 HG22 ' CD2' ' A' ' 157' ' ' PHE . 65.5 m -86.26 -47.0 9.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.795 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 1.009 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -61.56 -38.49 52.04 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 9.2 Cg_endo -53.57 -35.98 78.9 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 121.28 1.32 . . . . 0.0 111.895 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.721 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.68 -9.25 58.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.676 -179.554 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -65.75 123.95 86.16 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.935 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 1.5 Cg_endo -43.58 -31.26 3.09 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.333 2.688 . . . . 0.0 113.993 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -106.02 153.46 21.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.137 0.494 . . . . 0.0 111.879 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.701 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 75.5 m-20 -67.03 113.15 4.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.78 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.797 ' HB ' HG23 ' A' ' 225' ' ' VAL . 41.1 m -99.6 135.18 41.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.167 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 1.042 HG22 HG13 ' A' ' 224' ' ' VAL . 35.3 t -125.83 99.0 5.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.324 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.576 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.5 mt -89.58 144.17 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.462 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.813 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -114.21 170.93 7.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.908 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.842 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.4 mm -110.65 96.35 4.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 120.858 0.361 . . . . 0.0 111.007 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -59.33 -81.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.483 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -81.43 167.8 49.29 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.164 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.94 122.97 16.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.555 0.217 . . . . 0.0 110.546 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.839 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.8 OUTLIER -56.24 148.2 19.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.228 0.537 . . . . 0.0 110.535 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.709 HG11 ' N ' ' A' ' 169' ' ' SER . 13.8 p -105.81 -21.78 5.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.225 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.698 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -126.65 47.42 2.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.848 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.1 OUTLIER -44.1 -65.15 0.64 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.904 -178.114 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.567 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 43.0 Cg_endo -65.6 -18.18 58.55 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 121.545 1.497 . . . . 0.0 111.542 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.82 ' HA ' HD12 ' A' ' 203' ' ' ILE . 13.3 m-85 -73.81 -30.03 62.49 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.561 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 1.07 HD11 HD12 ' A' ' 177' ' ' LEU . 8.0 tp -69.55 -33.32 56.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.422 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.3 OUTLIER -60.9 -35.5 76.84 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.82 HD12 ' HA ' ' A' ' 200' ' ' TYR . 15.8 mt -65.93 -30.27 49.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.62 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.617 ' OG1' HG23 ' A' ' 174' ' ' THR . 45.0 m -60.99 -55.76 29.14 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 1.038 HD21 HD22 ' A' ' 177' ' ' LEU . 35.5 mt -70.25 -33.71 71.96 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.473 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.537 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 1.0 OUTLIER -66.14 -29.44 69.74 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.724 HD23 HG22 ' A' ' 203' ' ' ILE . 0.7 OUTLIER -77.08 -44.92 28.81 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.115 178.371 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.498 ' SD ' HG22 ' A' ' 204' ' ' THR . 12.7 mtp -64.62 -42.61 95.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.2 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.619 ' HG3' ' N ' ' A' ' 210' ' ' THR . 4.4 ptmt -61.53 -46.08 91.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.64 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.619 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.3 OUTLIER -59.11 -29.57 67.47 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.807 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 0.8 OUTLIER -70.76 -49.67 44.22 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.485 179.277 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 155.63 -7.52 0.28 Allowed Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.337 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.724 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 49.3 t -119.18 141.82 37.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.409 ' HG3' ' HA ' ' A' ' 209' ' ' LYS . 9.6 mt-10 -135.59 155.67 50.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.401 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 1.011 HG21 HG12 ' A' ' 225' ' ' VAL . 2.3 pp -129.1 175.87 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.754 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.916 -177.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 1.014 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 7.2 tp10 -88.74 125.2 34.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.529 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -101.53 101.02 11.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.424 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.845 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.6 OUTLIER -66.77 -168.14 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.499 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -74.37 48.42 0.33 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.816 0.341 . . . . 0.0 110.427 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.625 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 58.14 20.13 6.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.036 0.446 . . . . 0.0 111.252 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 191' ' ' ILE . 3.8 mt-30 -112.23 -20.52 11.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.77 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.845 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 34.9 mt-30 -151.2 140.87 21.74 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.901 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.969 ' HB3' HD21 ' A' ' 177' ' ' LEU . 11.0 m-85 -113.19 98.99 7.48 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 1.042 HG13 HG22 ' A' ' 188' ' ' VAL . 45.9 t -84.71 110.89 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.143 0.497 . . . . 0.0 111.25 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 1.011 HG12 HG21 ' A' ' 215' ' ' ILE . 3.2 m -99.02 111.61 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.927 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.738 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.6 OUTLIER -62.02 101.21 0.2 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.035 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.701 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -55.94 155.85 11.56 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.402 -0.817 . . . . 0.0 113.029 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.34 10.92 63.35 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.326 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.738 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 81.6 mm-40 -78.06 -177.67 5.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.444 0.64 . . . . 0.0 111.327 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.721 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.7 m -175.87 104.75 0.08 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.212 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.724 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 24.8 m-85 -54.11 152.44 6.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.825 0.345 . . . . 0.0 111.118 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.807 ' HG2' ' O ' ' A' ' 211' ' ' PHE . 7.5 pt20 -122.68 155.7 35.87 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 35.2 t -69.26 100.42 0.26 Allowed Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 56.9 Cg_endo -67.8 -32.75 28.95 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.387 2.058 . . . . 0.0 111.76 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 123.4 -119.01 3.69 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.962 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.666 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.8 OUTLIER -96.69 117.32 30.75 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.564 ' CE2' HD11 ' A' ' 207' ' ' LEU . 52.7 t80 -121.53 135.3 55.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.013 -178.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.751 HD12 HG23 ' A' ' 42' ' ' THR . 8.7 tp . . . . . 0 CA--C 1.515 -0.366 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.582 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.691 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 4.4 p30 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.899 0.38 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.417 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 52.0 mtt180 -67.96 -42.05 81.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.868 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -74.68 -32.98 62.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.827 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -62.07 -48.82 78.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.186 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.561 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 17.0 tp -73.93 -43.93 56.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.453 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.759 HD21 ' HG2' ' A' ' 178' ' ' MET . 61.8 mt -59.89 -31.9 70.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.109 0.48 . . . . 0.0 110.899 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.686 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -78.6 -30.66 46.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.595 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.839 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -69.37 -32.12 70.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.62 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.913 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -88.74 -12.28 42.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.145 0.497 . . . . 0.0 110.966 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.642 ' HB2' ' HB2' ' A' ' 231' ' ' TYR . . . -80.43 166.17 21.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.409 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 87.3 m-70 -101.21 97.83 8.3 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.14 142.28 6.77 Favored Glycine 0 C--N 1.315 -0.611 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.828 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.663 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 17.4 ttpp -67.02 138.91 57.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.236 0.541 . . . . 0.0 112.027 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.716 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.7 OUTLIER -132.93 156.13 47.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.333 179.076 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.722 HG22 ' CG ' ' A' ' 74' ' ' GLU . 61.9 t -102.75 142.87 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.317 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.868 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -127.79 111.94 14.2 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.466 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 1.155 ' HB ' ' HD3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -97.65 167.85 10.71 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.02 0.438 . . . . 0.0 111.179 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.643 ' HB2' ' CD1' ' A' ' 238' ' ' LEU . 0.2 OUTLIER 61.55 21.35 12.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.065 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.909 HD22 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -58.88 159.35 7.06 Favored 'General case' 0 N--CA 1.46 0.069 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.786 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.623 ' HB3' HG21 ' A' ' 50' ' ' VAL . 31.4 tp -92.63 114.6 27.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.022 0.439 . . . . 0.0 111.659 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.41 ' CG ' ' HB2' ' A' ' 70' ' ' ARG . 62.0 t0 -76.1 65.46 2.11 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.179 0.514 . . . . 0.0 109.995 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.3 m -128.31 -162.41 1.18 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.284 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.722 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -96.97 -19.94 18.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.246 0.546 . . . . 0.0 110.841 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.617 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 30.1 m-20 -69.95 -28.63 65.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.123 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.785 HG12 HD11 ' A' ' 54' ' ' LEU . 25.8 t -89.74 -50.89 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.752 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.722 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -49.21 -29.08 5.17 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.116 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . 37.8 m170 -73.32 -37.56 66.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.298 178.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.691 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 3.2 tpt -64.73 -47.86 76.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.827 HD23 HD21 ' A' ' 29' ' ' LEU . 1.6 mp -68.43 -43.93 76.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.584 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.2 m-80 -58.5 -22.72 56.01 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.955 0.407 . . . . 0.0 110.319 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.711 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -75.82 -48.57 21.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.62 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.614 HD21 ' HE2' ' A' ' 53' ' ' MET . 0.1 OUTLIER -67.41 -48.13 68.24 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.593 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.692 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.0 t -52.39 -30.67 30.22 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.16 0.505 . . . . 0.0 110.247 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.723 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -61.77 -47.98 82.71 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.296 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.997 HD21 HD22 ' A' ' 106' ' ' LEU . 3.3 mp -71.22 -24.88 62.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.212 0.53 . . . . 0.0 110.184 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.71 0.65 7.16 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.434 -0.889 . . . . 0.0 114.067 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.73 HG21 HD11 ' A' ' 82' ' ' LEU . 11.3 t -56.73 156.49 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 117.58 0.69 . . . . 0.0 110.536 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.583 ' HB3' HD13 ' A' ' 76' ' ' ILE . 2.8 m -113.66 110.09 19.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.733 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.692 ' CE2' ' HB ' ' A' ' 58' ' ' THR . 20.7 p90 -132.58 152.45 51.61 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.552 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.712 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -147.94 116.17 6.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.715 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.909 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -84.24 175.35 9.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.152 0.501 . . . . 0.0 111.104 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.639 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -87.25 179.22 6.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.092 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.83 -14.55 34.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.225 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.87 8.04 11.05 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.856 0.36 . . . . 0.0 110.606 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.431 ' O ' HD23 ' A' ' 44' ' ' LEU . 1.4 mtp180 58.75 47.04 13.35 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.421 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -129.23 -2.05 5.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.601 179.157 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 1.155 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -138.78 109.07 6.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.929 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.755 ' SG ' HD22 ' A' ' 66' ' ' LEU . 3.4 t -120.04 146.81 45.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.259 0.552 . . . . 0.0 112.185 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.722 ' CG ' HG22 ' A' ' 40' ' ' VAL . 1.2 mp0 -115.69 102.56 9.85 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.104 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.663 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -95.95 124.34 48.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.583 HD13 ' HB3' ' A' ' 63' ' ' SER . 1.8 mp -79.22 104.25 7.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.215 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.686 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -48.8 118.53 5.01 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.877 -0.601 . . . . 0.0 114.346 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.66 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 2.3 m-20 -64.02 -15.94 60.54 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.093 0.473 . . . . 0.0 110.022 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.555 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.15 -20.73 14.84 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.218 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.913 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -137.44 -155.38 6.9 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.852 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 3.0 Cg_exo -74.35 166.37 29.63 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 121.865 1.71 . . . . 0.0 108.738 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.839 HD21 ' HB3' ' A' ' 33' ' ' ALA . 4.3 mm? -64.62 90.03 0.07 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.328 1.061 . . . . 0.0 108.293 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.852 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 31.3 m170 -82.55 118.59 23.38 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.675 -176.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.85 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -142.93 109.42 5.37 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.971 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -112.76 93.42 4.42 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.222 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.86 21.26 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.282 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 56.72 50.24 12.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.469 0.652 . . . . 0.0 110.302 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.76 HD12 ' N ' ' A' ' 89' ' ' GLU . 4.8 tp -79.77 137.94 37.13 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.189 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.76 ' N ' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -117.04 124.06 48.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.139 0.495 . . . . 0.0 110.733 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.711 HD13 ' HA ' ' A' ' 56' ' ' ALA . 10.1 mt -105.47 162.99 12.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.475 0.655 . . . . 0.0 112.274 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.612 ' HA ' ' O ' ' A' ' 116' ' ' THR . 30.2 t80 -127.22 106.86 9.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.466 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.934 ' HG ' ' HA ' ' A' ' 99' ' ' MET . 2.5 mm? -94.67 6.83 47.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 44.37 -137.89 5.08 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.791 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.54 ' N ' ' HG3' ' A' ' 118' ' ' GLU . 32.0 t30 -104.47 55.18 0.72 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.911 0.386 . . . . 0.0 110.671 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -98.65 -66.35 0.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.917 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.591 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 78.48 -17.09 6.87 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.867 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.46 ' HA ' ' CD ' ' A' ' 171' ' ' GLN . 1.7 p -92.71 -6.92 48.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.737 0.303 . . . . 0.0 111.238 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.501 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -131.97 -20.71 2.47 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.934 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 2.2 ttt -68.19 -51.48 45.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.941 0.401 . . . . 0.0 110.53 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.663 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 2.5 mpt_? -58.83 -53.68 63.98 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.561 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.66 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 24.3 Cg_exo -64.57 -46.74 6.6 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.853 2.369 . . . . 0.0 113.164 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.809 HD13 HD11 ' A' ' 106' ' ' LEU . 3.1 tm? -64.0 -37.78 88.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.23 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.639 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -62.15 -48.38 80.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.443 0.639 . . . . 0.0 110.285 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.927 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -67.3 -40.77 86.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.566 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -58.68 -42.98 89.78 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.997 HD22 HD21 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -68.78 -21.37 64.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.276 0.56 . . . . 0.0 110.884 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.577 ' SG ' HD11 ' A' ' 140' ' ' ILE . 99.6 m -61.65 -10.33 8.2 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.727 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.778 HD11 ' O ' ' A' ' 179' ' ' THR . 13.0 mt -81.08 167.4 19.77 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 52.65 -111.74 1.78 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.393 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.456 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 14.7 m -162.59 99.59 1.02 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.949 0.404 . . . . 0.0 110.287 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.581 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 20.5 m-20 -138.94 136.11 35.1 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.698 ' C ' HD12 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -100.2 111.23 23.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.015 178.468 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.699 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.6 mp -144.23 142.7 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.411 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.622 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 29.5 t -115.44 111.37 35.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.044 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.639 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 33.7 mt -79.75 156.95 27.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.567 0.698 . . . . 0.0 112.359 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.612 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 19.0 m -159.51 156.34 28.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.795 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.3 -166.78 11.33 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.448 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.588 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 3.3 mm-40 -70.89 176.97 1.65 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.588 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 38.7 Cg_exo -62.22 -35.47 74.23 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.208 1.939 . . . . 0.0 112.222 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.637 ' HD3' ' HG2' ' A' ' 123' ' ' GLU . 19.5 tpp85 -79.71 -33.91 40.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.943 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.623 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 11.1 tpt -60.19 -18.11 45.88 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.74 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 5.1 mmtp -69.61 -4.84 20.98 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.066 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.637 ' HG2' ' HD3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -120.17 27.14 8.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.836 0.351 . . . . 0.0 110.903 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 11.4 mmm-85 -107.22 87.08 2.9 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.513 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.825 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.9 Cg_endo -47.82 123.8 8.95 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.753 2.302 . . . . 0.0 111.698 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.813 HD11 HD23 ' A' ' 129' ' ' LEU . 19.1 tt -125.04 28.28 2.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.81 0.814 . . . . 0.0 110.31 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.64 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -67.04 -51.16 41.19 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.548 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.674 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.8 OUTLIER -52.63 -31.62 37.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.085 0.469 . . . . 0.0 110.88 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.813 HD23 HD11 ' A' ' 126' ' ' ILE . 31.9 tp -79.23 -65.08 1.04 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.808 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 1.038 HG13 HD12 ' A' ' 140' ' ' ILE . 54.1 t -52.33 -26.19 8.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.54 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.64 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.4 OUTLIER -72.04 -47.79 49.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.093 0.473 . . . . 0.0 111.048 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.924 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -60.58 -48.85 79.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.426 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.983 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -61.4 -43.26 99.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.548 0.689 . . . . 0.0 109.707 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -61.51 -33.38 73.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.643 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.924 HD12 ' HA ' ' A' ' 132' ' ' ALA . 2.8 mt -69.33 -30.03 67.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.83 0.348 . . . . 0.0 110.075 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.43 -18.39 79.19 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.585 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 131.37 1.38 4.79 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.023 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.456 ' CB ' ' HB3' ' A' ' 107' ' ' CYS . . . -71.39 146.87 48.46 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.937 0.399 . . . . 0.0 111.45 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.0 mttt -116.29 94.38 4.62 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.235 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.038 HD12 HG13 ' A' ' 130' ' ' VAL . 9.0 mt -116.85 178.69 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.93 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.802 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.7 OUTLIER -161.38 -174.79 4.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.008 0.432 . . . . 0.0 111.205 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.575 ' N ' HG23 ' A' ' 141' ' ' THR . 24.5 m-85 -123.94 108.86 12.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.869 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.701 HD21 ' N ' ' A' ' 152' ' ' ARG . 1.4 mm? -85.51 -14.46 45.91 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.499 ' HB3' ' CB ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -137.48 -69.79 0.45 Allowed 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.164 0.506 . . . . 0.0 109.705 179.368 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.772 ' HB3' ' CD2' ' A' ' 148' ' ' TYR . 2.8 mt-30 -118.2 145.63 44.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.675 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.503 ' HA ' ' CG ' ' A' ' 142' ' ' TYR . 12.3 mt-10 -76.8 128.82 35.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.787 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.825 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 31.1 m-20 65.22 49.47 1.96 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.856 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 42.6 m-85 -149.15 179.02 1.28 Allowed Pre-proline 0 CA--C 1.549 0.904 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.594 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.856 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -43.9 -44.41 11.9 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 123.965 3.11 . . . . 0.0 115.167 -178.398 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.736 ' HD3' ' HE3' ' A' ' 122' ' ' LYS . 46.5 Cg_endo -64.6 102.65 0.42 Allowed 'Trans proline' 0 CA--C 1.509 -0.73 0 C-N-CA 121.701 1.601 . . . . 0.0 111.937 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.521 HD11 HG21 ' A' ' 126' ' ' ILE . 88.0 mt -139.43 124.11 18.45 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.057 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.785 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.1 OUTLIER -104.24 112.57 25.64 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.411 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.967 HD23 HG23 ' A' ' 140' ' ' ILE . 2.3 mt -93.61 159.97 14.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.191 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -147.51 23.97 1.12 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.964 179.518 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.537 ' HA2' ' O ' ' A' ' 107' ' ' CYS . . . 55.48 -166.07 3.47 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.597 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.44 -5.47 38.1 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.798 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.702 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 42.1 t80 -62.95 109.06 1.34 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.92 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.582 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 69.0 p -106.93 -47.7 3.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.958 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.628 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.55 -168.58 26.25 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.845 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.643 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 122.98 170.56 13.52 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -64.69 124.91 23.13 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.543 HG13 HD13 ' A' ' 135' ' ' LEU . 48.8 t -136.66 153.8 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 111.653 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.613 ' HB2' ' HE2' ' A' ' 192' ' ' LYS . 1.2 m-20 -119.01 118.03 30.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.729 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.583 HG11 HD13 ' A' ' 173' ' ' LEU . 0.9 OUTLIER -117.6 147.03 21.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.006 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.674 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 3.6 t0 -82.86 134.88 35.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.932 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.676 ' CA ' HD12 ' A' ' 195' ' ' LEU . . . -77.9 -44.2 12.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.299 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.455 ' C ' HG23 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -54.21 166.51 0.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.611 0.243 . . . . 0.0 111.141 -179.511 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.455 HG23 ' C ' ' A' ' 167' ' ' SER . 2.2 t 68.5 54.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.106 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.84 ' N ' HG11 ' A' ' 196' ' ' VAL . 0.3 OUTLIER 61.53 141.23 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.1 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.562 ' CB ' ' HB2' ' A' ' 197' ' ' SER . 0.4 OUTLIER -69.63 -5.02 21.94 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.319 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.663 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 76.2 mm-40 -50.66 -23.69 2.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.849 0.357 . . . . 0.0 111.046 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.704 ' O ' HD13 ' A' ' 129' ' ' LEU . 3.0 m-85 -68.83 -54.72 14.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.494 0.664 . . . . 0.0 109.992 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.703 HD23 HG12 ' A' ' 201' ' ' ILE . 58.9 tp -76.75 -30.9 56.76 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.249 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.607 HG23 ' OG1' ' A' ' 204' ' ' THR . 33.2 m -61.06 -33.39 73.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.181 0.515 . . . . 0.0 109.849 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.927 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -70.02 -51.55 31.36 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.796 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.983 ' CD2' HD23 ' A' ' 133' ' ' LEU . 1.6 mt -67.1 -35.87 80.73 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.382 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.043 HD22 HD21 ' A' ' 205' ' ' LEU . 10.5 mt -69.02 -25.71 64.62 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.323 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.759 ' HG2' HD21 ' A' ' 31' ' ' LEU . 44.9 mtp -95.27 -27.05 15.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.265 0.555 . . . . 0.0 110.959 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.778 ' O ' HD11 ' A' ' 108' ' ' LEU . 88.7 m -91.93 -47.21 7.42 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.682 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.95 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -60.8 -36.21 32.83 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.752 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 13.0 Cg_endo -54.14 -37.92 87.48 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.154 1.236 . . . . 0.0 111.541 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.68 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.1 mp -83.56 -8.87 59.25 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.047 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -67.21 120.15 70.12 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.148 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 5.9 Cg_exo -38.8 -28.92 0.15 Allowed 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.456 2.77 . . . . 0.0 114.224 -178.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -107.55 151.44 25.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 111.807 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.67 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 32.2 t70 -66.53 117.05 8.18 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.451 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.848 ' HB ' HG23 ' A' ' 225' ' ' VAL . 28.3 m -103.38 135.48 44.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.249 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.985 HG22 HG13 ' A' ' 224' ' ' VAL . 31.7 t -125.65 98.84 5.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.337 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.605 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.0 mp -89.62 141.62 14.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.324 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.807 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.4 OUTLIER -112.17 171.11 7.7 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.584 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.845 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.6 mm -110.18 97.61 5.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 120.981 0.42 . . . . 0.0 111.52 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.613 ' HE2' ' HB2' ' A' ' 163' ' ' ASP . 17.2 mttt -59.85 -82.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.884 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -80.95 175.0 54.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.77 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.39 124.67 22.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.649 0.261 . . . . 0.0 110.569 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.85 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.9 OUTLIER -60.95 148.25 40.51 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.01 0.433 . . . . 0.0 109.975 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.84 HG11 ' N ' ' A' ' 169' ' ' SER . 12.1 p -104.91 -19.33 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.557 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.845 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 3.8 m -131.36 45.46 2.8 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.04 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.883 ' O ' HG22 ' A' ' 201' ' ' ILE . 2.8 tttt -42.0 -65.41 0.52 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 114.896 -1.047 . . . . 0.0 113.283 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.859 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 15.9 Cg_exo -68.04 -17.88 45.95 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.517 1.478 . . . . 0.0 111.841 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.845 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 45.4 m-85 -75.11 -29.28 60.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.405 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.883 HG22 ' O ' ' A' ' 198' ' ' LYS . 9.5 tp -69.68 -30.95 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.126 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.64 -32.59 74.11 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.569 ' O ' HD23 ' A' ' 207' ' ' LEU . 33.0 mt -64.93 -32.63 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.147 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.607 ' OG1' HG23 ' A' ' 174' ' ' THR . 54.7 m -60.06 -53.74 54.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.376 0.608 . . . . 0.0 109.772 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 1.043 HD21 HD22 ' A' ' 177' ' ' LEU . 44.4 mt -68.59 -37.56 79.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.792 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -62.05 -29.29 70.19 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.736 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 2.1 mm? -76.66 -42.06 43.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.793 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.666 ' SD ' ' HG3' ' A' ' 181' ' ' PRO . 9.3 mtm -59.53 -42.92 93.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.796 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.881 ' HG3' ' O ' ' A' ' 205' ' ' LEU . 10.1 mtpt -64.96 -55.55 18.44 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.222 0.534 . . . . 0.0 110.2 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -50.76 -27.43 7.17 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.129 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.934 ' HA ' ' HG3' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -78.85 -50.2 11.65 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.561 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 152.58 0.82 0.22 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.967 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.573 HG13 ' CG ' ' A' ' 229' ' ' GLN . 53.8 t -118.78 139.81 44.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.138 0.494 . . . . 0.0 112.062 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.631 ' HG2' ' HG2' ' A' ' 209' ' ' LYS . 62.6 mt-10 -132.05 157.68 43.53 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.024 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.98 HG12 HD22 ' A' ' 205' ' ' LEU . 2.8 pp -138.16 175.26 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.909 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 1.068 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 33.0 tt0 -92.03 123.15 35.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.328 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -99.56 100.82 11.88 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.708 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.824 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.5 OUTLIER -67.33 -168.77 0.08 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.801 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -73.63 47.66 0.25 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.863 0.363 . . . . 0.0 110.364 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.673 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 0.1 OUTLIER 58.44 19.77 6.79 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.933 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 191' ' ' ILE . 18.7 mt-30 -111.67 -22.34 11.24 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.824 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 41.4 mt-30 -148.15 141.84 25.59 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.986 ' HB3' HD21 ' A' ' 177' ' ' LEU . 7.3 m-85 -112.59 95.93 5.7 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 1.068 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 41.5 t -80.36 110.98 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.062 0.458 . . . . 0.0 111.174 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.95 HG21 ' CB ' ' A' ' 180' ' ' ALA . 2.6 m -96.96 107.72 20.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.931 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.683 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -57.41 100.96 0.06 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.592 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.67 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -55.66 154.52 12.7 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.51 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.34 9.13 65.46 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.088 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.683 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 1.9 mm-40 -77.16 176.97 8.24 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.812 0.815 . . . . 0.0 112.19 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.68 ' HA ' HD23 ' A' ' 182' ' ' LEU . 3.4 m -175.6 105.01 0.08 Allowed 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.614 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.642 ' HB2' ' HB2' ' A' ' 35' ' ' ALA . 17.5 m-85 -53.63 152.57 5.04 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.478 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.551 ' HG2' ' O ' ' A' ' 211' ' ' PHE . 15.0 pt20 -121.4 142.5 49.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.787 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 34.6 t -51.18 99.64 0.21 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.197 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.934 ' HG3' ' HA ' ' A' ' 211' ' ' PHE . 14.7 Cg_exo -68.79 -29.03 29.51 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.454 2.103 . . . . 0.0 111.635 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.18 -122.52 5.56 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.361 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.652 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -91.97 116.08 28.61 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.023 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.594 ' CE2' HD11 ' A' ' 207' ' ' LEU . 58.0 t80 -113.52 140.99 47.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.293 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.923 ' HA ' HG23 ' A' ' 42' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.317 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.618 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 13.0 m-20 . . . . . 0 N--CA 1.448 -0.536 0 CA-C-O 121.028 0.442 . . . . 0.0 110.454 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.26 -43.01 82.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.296 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.516 ' CB ' HD22 ' A' ' 41' ' ' LEU . . . -76.37 -32.19 58.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.836 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -61.39 -54.25 46.13 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.25 0.548 . . . . 0.0 110.276 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.685 HD21 ' HB2' ' A' ' 105' ' ' ALA . 9.4 tp -63.78 -55.28 24.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.448 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.724 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 29.6 mt -52.57 -34.89 52.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.134 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.671 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -76.21 -29.24 57.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.375 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.684 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -73.08 -32.99 65.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.538 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.883 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -87.55 -13.13 43.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.927 0.394 . . . . 0.0 110.907 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -81.9 164.34 21.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.737 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.44 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 89.4 m-70 -97.24 96.14 8.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.479 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.34 141.36 5.98 Favored Glycine 0 C--N 1.318 -0.442 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.936 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.758 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -62.12 129.18 39.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.491 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.7 OUTLIER -122.67 155.49 36.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.147 178.837 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.712 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 46.7 t -102.63 142.17 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.332 -0.394 . . . . 0.0 112.013 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 237' ' ' TYR . 0.0 OUTLIER -129.41 111.97 13.34 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.055 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.998 ' HB ' ' HD3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -103.4 170.76 7.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.072 0.463 . . . . 0.0 111.595 -179.578 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.559 ' HB2' HD11 ' A' ' 238' ' ' LEU . 29.0 t-20 62.11 20.28 11.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.056 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.754 HD22 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -58.76 158.34 8.19 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.595 ' HB3' HG21 ' A' ' 50' ' ' VAL . 24.7 tp -90.74 114.36 26.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.097 0.475 . . . . 0.0 111.551 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -76.01 65.0 1.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.235 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 74.6 m -125.2 -163.49 1.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.898 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.731 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 1.3 m-20 -96.77 -19.08 19.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.399 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.588 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 8.6 m-20 -70.98 -29.86 65.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.968 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.781 HG12 HD11 ' A' ' 54' ' ' LEU . 39.1 t -88.11 -53.36 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.377 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.731 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 9.5 ptp180 -50.62 -30.73 14.11 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.039 0.447 . . . . 0.0 110.005 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -72.94 -35.3 66.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.039 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.618 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 10.9 tpt -64.93 -49.87 68.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.836 HD23 HD21 ' A' ' 29' ' ' LEU . 1.2 mp -66.14 -45.86 79.52 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.61 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.7 m-20 -57.29 -22.67 43.29 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.022 0.439 . . . . 0.0 109.987 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.747 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -74.77 -48.76 23.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.599 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.622 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -68.2 -49.65 59.42 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.903 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.477 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 5.3 t -50.48 -33.81 22.62 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.339 0.59 . . . . 0.0 110.304 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.623 ' CB ' HD21 ' A' ' 90' ' ' LEU . . . -59.36 -48.89 79.92 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.213 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.999 HD21 HD22 ' A' ' 106' ' ' LEU . 3.9 mp -67.13 -29.12 68.76 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.483 0.658 . . . . 0.0 109.831 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.13 -1.65 4.59 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 114.81 -1.087 . . . . 0.0 113.815 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.7 HG21 HD11 ' A' ' 82' ' ' LEU . 13.0 t -58.96 153.92 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 117.644 0.722 . . . . 0.0 110.247 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.737 ' HB2' HD12 ' A' ' 76' ' ' ILE . 3.8 m -116.97 108.92 16.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.151 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 16.6 p90 -124.76 157.23 36.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.726 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -148.03 116.1 6.48 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.812 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.754 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -87.16 175.19 8.19 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.237 0.542 . . . . 0.0 111.38 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.607 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -89.48 179.4 6.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.859 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.35 -14.62 28.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.439 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.63 6.09 11.63 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.816 0.341 . . . . 0.0 110.656 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.583 ' HG2' ' HG ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER 59.07 45.59 14.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.503 -179.678 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -129.27 -2.16 5.04 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.999 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.998 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 1.2 mmm180 -136.58 109.34 7.54 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.694 ' HA ' ' O ' ' A' ' 65' ' ' THR . 5.4 t -120.62 154.04 36.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.376 0.607 . . . . 0.0 112.637 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.711 ' HG3' HG22 ' A' ' 40' ' ' VAL . 2.9 mt-10 -121.39 104.66 9.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.141 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.758 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -96.57 128.03 48.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.751 HG12 ' HG3' ' A' ' 38' ' ' LYS . 18.9 mt -81.67 103.06 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.112 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.671 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -47.9 113.78 1.54 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.695 -0.684 . . . . 0.0 114.197 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 25.0 t-20 -60.01 -17.36 38.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.112 0.482 . . . . 0.0 110.117 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.44 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 86.49 -22.96 10.92 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.363 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.883 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.65 -148.79 5.36 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.846 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 2.6 Cg_exo -77.09 169.01 22.3 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 CA-C-N 119.708 1.754 . . . . 0.0 109.261 177.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.7 HD11 HG21 ' A' ' 62' ' ' VAL . 4.5 mm? -67.43 90.51 0.24 Allowed 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 122.445 1.117 . . . . 0.0 108.078 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.846 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 30.3 m170 -82.26 118.67 23.29 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 112.877 -1.965 . . . . 0.0 112.671 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.708 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -144.87 113.07 6.49 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.644 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.15 86.35 2.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.795 0.331 . . . . 0.0 111.295 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -173.82 20.07 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.654 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.74 52.16 8.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.418 0.628 . . . . 0.0 109.852 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.704 ' O ' HG23 ' A' ' 113' ' ' ILE . 4.1 tp -80.73 134.37 35.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.221 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.694 ' N ' HD12 ' A' ' 88' ' ' LEU . 1.2 tt0 -113.87 128.94 56.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.228 0.537 . . . . 0.0 110.523 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.683 ' O ' HG22 ' A' ' 116' ' ' THR . 28.3 mt -112.4 154.09 26.32 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.46 ' CE1' ' HA2' ' A' ' 93' ' ' GLY . 52.6 t80 -116.39 105.35 12.42 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.663 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.976 HD23 ' HE1' ' A' ' 99' ' ' MET . 3.0 mm? -90.2 8.9 30.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.275 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.46 ' HA2' ' CE1' ' A' ' 91' ' ' PHE . . . 37.73 -143.93 0.2 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.249 -0.501 . . . . 0.0 113.216 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.422 HD22 ' HB3' ' A' ' 120' ' ' ARG . 0.9 OUTLIER -96.09 50.94 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.242 0.544 . . . . 0.0 110.025 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.588 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -90.0 -72.96 0.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.608 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.37 -19.44 8.54 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.444 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.439 HG23 ' NE2' ' A' ' 171' ' ' GLN . 19.0 m -93.92 -7.23 43.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.769 0.319 . . . . 0.0 111.099 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.582 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . . . -129.88 -17.09 3.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.355 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.976 ' HE1' HD23 ' A' ' 92' ' ' LEU . 21.9 tpp -70.23 -55.13 10.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.935 0.398 . . . . 0.0 111.009 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.896 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.6 mpt_? -60.07 -49.36 91.39 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.938 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 20.6 Cg_exo -66.79 -47.15 2.85 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.814 2.343 . . . . 0.0 112.95 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.796 HD13 HD11 ' A' ' 106' ' ' LEU . 3.3 tm? -68.55 -34.14 75.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.661 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.624 ' HA ' HD11 ' A' ' 115' ' ' LEU . . . -63.36 -47.98 79.86 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.645 0.736 . . . . 0.0 109.78 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.746 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -70.25 -39.18 75.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.094 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.685 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -56.6 -40.92 76.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 111.949 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.999 HD22 HD21 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -71.72 -21.48 61.76 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.568 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.514 ' SG ' HD11 ' A' ' 140' ' ' ILE . 89.6 m -60.8 -10.55 5.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.102 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 179' ' ' THR . 13.9 mt -83.3 168.48 16.63 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 53.95 -108.09 0.77 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.428 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.47 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.3 OUTLIER -167.68 99.6 0.48 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.843 0.354 . . . . 0.0 110.398 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 8.5 m-20 -138.5 135.79 35.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.134 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.628 ' C ' HD12 ' A' ' 113' ' ' ILE . 18.3 m-20 -99.42 111.0 23.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.841 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.704 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.8 mp -143.0 140.79 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 5.8 t -109.46 113.71 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.624 HD11 ' HA ' ' A' ' 103' ' ' ALA . 37.2 mt -89.71 154.61 19.81 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.125 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.683 HG22 ' O ' ' A' ' 90' ' ' LEU . 13.0 t -155.46 -170.27 3.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.296 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -173.45 -167.8 33.71 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 119.988 -1.101 . . . . 0.0 113.901 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.501 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 2.9 mm-40 -69.59 178.09 1.08 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.319 -0.441 . . . . 0.0 110.919 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.501 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 31.8 Cg_exo -61.88 -38.49 58.55 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.048 1.832 . . . . 0.0 112.214 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.844 HH11 ' HG3' ' A' ' 123' ' ' GLU . 3.2 tpt180 -79.55 -23.75 42.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.026 0.441 . . . . 0.0 110.204 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.62 ' HE3' ' HB2' ' A' ' 124' ' ' ARG . 10.8 tpt -69.17 -15.54 63.42 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.777 ' HE2' ' HD3' ' A' ' 150' ' ' PRO . 0.8 OUTLIER -74.44 -4.71 38.25 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.162 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.844 ' HG3' HH11 ' A' ' 120' ' ' ARG . 0.1 OUTLIER -127.65 26.02 5.96 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.293 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.62 ' HB2' ' HE3' ' A' ' 121' ' ' MET . 2.5 mmp_? -100.56 91.43 1.8 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.493 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.7 Cg_endo -47.87 127.06 13.89 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.593 2.195 . . . . 0.0 112.589 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.761 HD11 HD23 ' A' ' 129' ' ' LEU . 18.5 tt -130.88 31.24 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 121.732 0.777 . . . . 0.0 109.943 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.635 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -71.61 -51.98 14.16 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 114.772 -1.103 . . . . 0.0 112.735 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.538 ' HB2' ' CD2' ' A' ' 172' ' ' PHE . 0.8 OUTLIER -52.31 -26.49 12.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.927 0.394 . . . . 0.0 110.562 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.761 HD23 HD11 ' A' ' 126' ' ' ILE . 39.6 tp -84.69 -65.05 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.545 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.818 HG13 HD12 ' A' ' 140' ' ' ILE . 47.6 t -52.55 -26.02 9.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.49 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.635 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -73.23 -44.6 59.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.651 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.975 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -66.64 -47.98 70.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.571 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.876 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -58.26 -45.47 87.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.514 0.673 . . . . 0.0 109.52 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -33.79 71.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.816 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.975 HD12 ' HA ' ' A' ' 132' ' ' ALA . 5.1 mt -70.19 -31.99 69.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.977 0.417 . . . . 0.0 110.104 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.517 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -74.78 -17.99 80.09 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.514 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.81 2.9 5.13 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.596 -0.812 . . . . 0.0 113.114 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' A' ' 107' ' ' CYS . . . -70.11 146.73 50.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 111.027 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 46.3 mmtt -113.43 81.47 1.51 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.473 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.955 HG23 HD23 ' A' ' 153' ' ' LEU . 9.3 mt -107.44 176.12 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.847 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.5 OUTLIER -153.24 -169.03 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.028 0.442 . . . . 0.0 111.225 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.694 ' N ' HG23 ' A' ' 141' ' ' THR . 19.3 m-85 -131.72 104.18 6.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.014 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.637 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.4 mm? -75.02 -13.22 60.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.522 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.758 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 5.0 mt-10 -138.99 -73.23 0.39 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.209 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.631 ' HB2' ' HD2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -123.98 156.43 36.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.227 0.537 . . . . 0.0 111.735 -179.314 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.404 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 2.8 mt-10 -70.95 125.83 27.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.616 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.684 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 0.9 OUTLIER 70.41 50.43 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.044 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.704 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.0 m-30 -141.75 173.82 4.39 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.72 ' CG ' ' HA ' ' A' ' 122' ' ' LYS . 6.3 Cg_endo -49.18 -40.79 42.4 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.159 2.573 . . . . 0.0 115.068 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.777 ' HD3' ' HE2' ' A' ' 122' ' ' LYS . 18.7 Cg_endo -62.26 101.79 0.25 Allowed 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 120.849 1.033 . . . . 0.0 110.745 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.523 HD11 HG21 ' A' ' 126' ' ' ILE . 83.2 mt -137.11 123.17 20.31 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.549 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.847 ' HB2' HG22 ' A' ' 141' ' ' THR . 2.6 mtp85 -102.47 111.78 24.23 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.955 HD23 HG23 ' A' ' 140' ' ' ILE . 3.7 mt -93.88 158.05 15.83 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.053 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.57 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 33.0 mt-30 -148.39 25.24 0.99 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.683 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.492 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 53.69 -166.35 1.88 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.537 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 158' ' ' THR . . . 108.2 -4.07 33.42 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.9 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.636 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 2.5 t80 -60.46 105.45 0.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.887 0.375 . . . . 0.0 110.828 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.495 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 67.9 p -104.56 -51.04 3.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.562 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.7 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 144.44 -163.95 27.77 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.065 -1.064 . . . . 0.0 114.269 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.601 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 118.04 170.74 15.11 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -64.2 126.3 27.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.26 0.53 . . . . 0.0 109.866 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 59.0 t -136.99 152.65 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.966 0.412 . . . . 0.0 111.259 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.459 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.9 OUTLIER -119.05 119.05 33.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.861 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.665 HG11 HD13 ' A' ' 173' ' ' LEU . 0.3 OUTLIER -118.78 141.98 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.984 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 3.9 t70 -79.77 137.14 36.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.835 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.677 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -79.52 -44.54 9.36 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.899 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.464 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 8.0 m -51.66 164.76 0.21 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.716 0.293 . . . . 0.0 111.175 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.424 HG23 ' C ' ' A' ' 167' ' ' SER . 2.8 t 70.55 55.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.294 0.569 . . . . 0.0 110.227 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.731 ' N ' HG11 ' A' ' 196' ' ' VAL . 4.9 m 57.09 149.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.478 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.525 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 0.6 OUTLIER -72.67 -3.83 27.39 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.546 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.896 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 57.1 mm-40 -49.79 -24.34 2.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.67 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.698 ' HA ' HD13 ' A' ' 129' ' ' LEU . 2.0 m-85 -72.58 -55.01 7.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.412 0.625 . . . . 0.0 110.283 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.665 HD13 HG11 ' A' ' 164' ' ' VAL . 26.3 tp -73.71 -38.89 64.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.511 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.759 HG23 ' OG1' ' A' ' 204' ' ' THR . 20.5 m -59.02 -33.06 70.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.279 0.561 . . . . 0.0 109.678 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.746 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -72.84 -47.18 48.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.977 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.876 ' CD2' HD23 ' A' ' 133' ' ' LEU . 2.9 mt -69.88 -35.98 75.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.605 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.989 HD21 ' HB3' ' A' ' 223' ' ' PHE . 12.5 mt -68.47 -27.33 66.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.612 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.637 ' CE ' HG22 ' A' ' 174' ' ' THR . 39.5 mtm -95.56 -26.99 15.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.245 0.545 . . . . 0.0 110.489 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.718 ' O ' HD11 ' A' ' 108' ' ' LEU . 51.6 m -88.79 -46.92 8.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.759 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.823 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -60.58 -39.07 63.64 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -177.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.3 Cg_endo -53.13 -36.01 75.24 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.347 1.364 . . . . 0.0 111.892 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.663 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.1 mp -85.04 -6.82 59.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.767 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.495 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -67.26 121.26 77.8 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.817 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 6.0 Cg_exo -38.76 -32.58 0.29 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.47 2.78 . . . . 0.0 113.91 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.47 155.8 19.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.05 0.453 . . . . 0.0 111.7 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.631 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 1.8 t70 -69.57 117.44 11.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.748 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.803 ' HB ' HG23 ' A' ' 225' ' ' VAL . 40.8 m -102.48 135.31 44.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.147 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.999 HG22 HG13 ' A' ' 224' ' ' VAL . 36.0 t -124.87 99.15 5.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.922 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 223' ' ' PHE . 2.9 mp -90.01 142.53 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.391 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.798 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.2 OUTLIER -113.47 170.68 8.06 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.78 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.861 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.5 mm -110.61 97.91 6.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 121.002 0.429 . . . . 0.0 111.363 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.561 ' HA ' ' NH1' ' A' ' 190' ' ' ARG . 4.9 mtmt -59.69 -82.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.133 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -79.1 168.21 53.12 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.36 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -59.9 122.45 14.29 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.82 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.8 OUTLIER -56.89 146.57 26.15 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.355 0.598 . . . . 0.0 110.61 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.731 HG11 ' N ' ' A' ' 169' ' ' SER . 12.5 p -104.1 -21.59 5.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.089 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.71 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -126.78 45.24 2.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.197 -179.431 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.82 ' HA ' HD23 ' A' ' 195' ' ' LEU . 6.1 ttpt -41.53 -65.63 0.48 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.04 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 51.4 Cg_endo -68.11 -16.77 45.2 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 121.556 1.504 . . . . 0.0 112.308 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.71 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 88.6 m-85 -75.34 -27.57 59.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.39 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.817 HD11 HD12 ' A' ' 177' ' ' LEU . 6.1 tp -71.23 -33.14 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.762 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -32.5 71.99 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.761 HG22 HD23 ' A' ' 207' ' ' LEU . 28.4 mt -68.32 -29.8 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.605 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.759 ' OG1' HG23 ' A' ' 174' ' ' THR . 52.5 m -61.38 -52.55 64.15 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.262 0.553 . . . . 0.0 109.806 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.918 HD22 HG12 ' A' ' 215' ' ' ILE . 30.9 mt -70.44 -38.37 74.52 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.191 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.654 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 39.4 t30 -63.65 -28.04 69.63 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.761 HD23 HG22 ' A' ' 203' ' ' ILE . 1.0 OUTLIER -78.36 -40.62 35.81 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.489 178.546 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.512 ' SD ' HG22 ' A' ' 204' ' ' THR . 17.2 mtp -68.9 -39.42 79.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.857 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.654 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 17.7 ptpt -65.37 -45.24 84.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.099 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 207' ' ' LEU . 2.0 t -57.71 -29.31 64.62 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.217 0.532 . . . . 0.0 109.798 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.605 ' HE2' ' HA ' ' A' ' 32' ' ' ALA . 1.3 m-85 -74.75 -53.04 9.94 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.587 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 158.82 -2.55 0.1 Allowed Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.644 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.66 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 53.7 t -119.0 142.44 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 117.08 0.44 . . . . 0.0 112.028 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -135.46 155.15 51.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.811 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.918 HG12 HD22 ' A' ' 205' ' ' LEU . 2.3 pp -130.43 175.53 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.378 -178.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 1.05 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 6.3 tp10 -91.57 127.43 37.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -102.31 101.3 11.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.42 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.87 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 4.8 mm-40 -66.71 -168.06 0.06 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.858 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -74.12 48.0 0.3 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.802 0.334 . . . . 0.0 110.633 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.577 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.1 OUTLIER 58.82 19.69 7.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.018 0.437 . . . . 0.0 111.26 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 191' ' ' ILE . 7.1 mm-40 -112.7 -22.38 10.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.713 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.87 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 29.5 mt-30 -149.22 141.87 24.48 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.088 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.989 ' HB3' HD21 ' A' ' 177' ' ' LEU . 14.6 m-85 -112.91 97.77 6.75 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 1.05 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 39.1 t -81.9 110.9 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.334 0.588 . . . . 0.0 111.341 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.915 HG12 HG21 ' A' ' 215' ' ' ILE . 1.9 m -97.95 112.09 29.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.977 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.71 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 4.9 mptp? -63.26 104.37 0.59 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.807 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.631 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.93 158.69 14.83 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.114 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.07 9.44 80.38 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.474 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.71 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 19.5 mm-40 -76.28 178.76 6.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.441 0.639 . . . . 0.0 111.576 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.663 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.9 m -174.06 106.36 0.12 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.265 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.66 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 22.9 m-85 -55.24 152.23 8.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.511 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.535 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 7.7 pt20 -122.97 138.34 54.71 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 7.0 t -46.54 98.04 0.17 Allowed Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 39.5 Cg_endo -64.89 -29.33 58.3 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.331 2.021 . . . . 0.0 111.804 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 117.39 -123.77 5.89 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.884 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.712 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -91.0 116.96 29.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.039 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.642 ' CZ ' HD11 ' A' ' 207' ' ' LEU . 68.0 t80 -121.7 126.58 49.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.531 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.862 ' HA ' HG23 ' A' ' 42' ' ' THR . 3.9 tp . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 121.252 0.548 . . . . 0.0 111.206 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.809 ' ND2' ' HB2' ' A' ' 98' ' ' ALA . 43.1 m-20 . . . . . 0 C--O 1.233 0.207 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -67.65 -43.29 80.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.17 0.51 . . . . 0.0 110.491 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.503 ' CB ' ' HB3' ' A' ' 41' ' ' LEU . . . -75.17 -31.96 61.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.978 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.789 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -66.07 -52.22 50.89 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.115 0.483 . . . . 0.0 110.218 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.64 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 8.1 tp -64.94 -53.76 41.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.278 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.721 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 62.6 mt -53.5 -36.35 61.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.411 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.727 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -76.99 -29.94 55.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.448 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.649 ' CB ' HD21 ' A' ' 82' ' ' LEU . . . -70.29 -33.2 71.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.526 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.902 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -88.81 -12.61 41.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.813 0.339 . . . . 0.0 111.145 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.69 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -81.72 166.06 20.42 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.687 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.533 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 87.5 m-70 -99.89 97.7 8.56 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.042 0.449 . . . . 0.0 109.885 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.01 142.28 6.6 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.385 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.763 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 1.3 ttpm? -66.36 140.55 58.09 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.096 0.474 . . . . 0.0 112.035 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.29 154.33 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.289 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.813 HG22 ' HG2' ' A' ' 74' ' ' GLU . 55.8 t -100.72 142.78 15.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.122 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.749 HD21 HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -129.25 111.69 13.14 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.097 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.754 HG23 HD13 ' A' ' 238' ' ' LEU . 0.6 OUTLIER -97.98 164.63 12.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.333 0.587 . . . . 0.0 112.136 -178.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.408 ' HB2' HD11 ' A' ' 238' ' ' LEU . 19.4 t30 63.21 23.38 13.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.287 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.9 HD22 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -58.87 153.61 16.84 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.328 179.093 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.639 ' HB3' HG21 ' A' ' 50' ' ' VAL . 27.2 tp -83.35 114.26 21.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.059 0.457 . . . . 0.0 111.342 -178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.01 68.57 4.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.995 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.4 m -130.01 -163.91 1.36 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.893 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.608 ' HA ' ' CD ' ' A' ' 51' ' ' ARG . 25.1 t0 -97.11 -20.45 17.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.031 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -70.45 -30.06 66.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.713 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.643 HG12 HD11 ' A' ' 54' ' ' LEU . 12.4 t -83.1 -54.84 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.105 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.608 ' CD ' ' HA ' ' A' ' 48' ' ' ASP . 11.9 ptm180 -49.67 -27.18 4.39 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.004 0.43 . . . . 0.0 110.013 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -71.02 -39.86 72.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' VAL . 7.1 tpt -64.29 -50.93 65.95 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.789 HD23 HD21 ' A' ' 29' ' ' LEU . 1.5 mp -62.11 -47.49 84.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.004 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 11.8 t30 -58.43 -23.26 56.95 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.815 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.805 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -76.28 -49.0 18.18 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.138 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.57 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -64.72 -49.73 69.68 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.271 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.7 t -50.37 -30.52 12.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.245 0.545 . . . . 0.0 109.983 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 1.081 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.22 -44.2 92.3 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.618 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.097 HD21 HD22 ' A' ' 106' ' ' LEU . 2.7 mp -79.56 -19.53 49.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.211 0.529 . . . . 0.0 110.656 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.13 -0.87 7.72 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.852 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.679 HG21 HD11 ' A' ' 82' ' ' LEU . 15.2 t -58.88 155.66 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 117.586 0.693 . . . . 0.0 110.086 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.596 ' CB ' HG13 ' A' ' 76' ' ' ILE . 2.9 m -117.57 108.93 16.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.07 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.539 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 10.0 p90 -124.06 153.59 41.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.172 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.728 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 11.7 m -147.61 116.53 6.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.028 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.9 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -88.81 172.25 9.34 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.138 0.494 . . . . 0.0 111.088 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.692 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 65.1 p -88.04 179.57 6.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.781 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.19 -14.72 27.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.407 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.42 7.03 12.67 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.791 0.329 . . . . 0.0 110.68 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.476 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 10.0 mtm180 57.08 41.91 26.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.116 0.484 . . . . 0.0 110.943 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.45 -2.14 8.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.604 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.692 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 4.8 mmt180 -136.94 110.53 8.02 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.841 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.728 ' HA ' ' O ' ' A' ' 65' ' ' THR . 4.0 t -120.22 151.57 38.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.452 0.644 . . . . 0.0 112.405 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.813 ' HG2' HG22 ' A' ' 40' ' ' VAL . 55.0 mt-10 -118.63 102.93 9.24 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.108 178.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.763 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -95.34 128.2 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-O 121.375 0.607 . . . . 0.0 112.213 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.687 HD13 ' HB2' ' A' ' 38' ' ' LYS . 15.9 mm -80.51 103.32 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.871 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.727 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -49.73 114.66 2.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.958 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.558 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.3 t-20 -61.51 -16.78 50.71 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 110.194 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.533 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.27 -22.02 11.27 Favored Glycine 0 C--O 1.226 -0.384 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.427 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.902 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.53 -149.03 5.41 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.821 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 5.4 Cg_exo -78.77 168.3 21.19 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.853 1.702 . . . . 0.0 109.209 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.754 HD12 HD13 ' A' ' 60' ' ' LEU . 4.5 mm? -66.62 91.14 0.18 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.821 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 29.3 m170 -84.14 118.02 23.84 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 113.158 -1.837 . . . . 0.0 112.779 -176.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.802 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -144.21 108.26 4.75 Favored 'General case' 0 C--O 1.227 -0.08 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.354 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -109.83 90.69 3.38 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.541 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -175.69 17.35 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.742 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.58 ' H ' ' HB2' ' A' ' 112' ' ' ASP . . . 55.2 47.81 20.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.565 0.697 . . . . 0.0 109.794 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 1.081 HD21 ' HB1' ' A' ' 59' ' ' ALA . 1.0 OUTLIER -81.3 129.14 34.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.31 -178.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.834 ' N ' HD12 ' A' ' 88' ' ' LEU . 1.6 tt0 -105.7 127.76 53.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.122 0.487 . . . . 0.0 110.658 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.805 HD13 ' HA ' ' A' ' 56' ' ' ALA . 61.1 mt -111.97 157.5 20.63 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.6 ' C ' HD23 ' A' ' 92' ' ' LEU . 31.9 t80 -112.88 101.62 9.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.243 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.8 HD23 ' N ' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -96.47 18.23 14.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.922 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.514 ' O ' ' HE2' ' A' ' 121' ' ' MET . . . 36.53 -154.47 0.01 OUTLIER Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.923 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.527 ' HA ' ' HB2' ' A' ' 121' ' ' MET . 10.6 t30 -87.6 50.1 1.93 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.287 0.565 . . . . 0.0 110.062 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.25 -77.04 0.24 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.426 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . 82.32 -13.77 38.03 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.644 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.466 ' HA ' ' CD ' ' A' ' 171' ' ' GLN . 0.3 OUTLIER -97.02 -5.39 37.79 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.073 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.809 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . . . -133.7 -22.7 1.87 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.339 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.742 ' HA ' HD12 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -62.08 -58.73 6.72 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.235 0.541 . . . . 0.0 110.337 179.299 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.921 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.8 mpt_? -59.76 -52.13 76.01 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.075 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.694 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 36.8 Cg_exo -61.99 -45.13 17.24 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.457 2.105 . . . . 0.0 113.192 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.674 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 2.6 tm? -74.04 -31.55 62.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.814 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.438 ' HA ' HD11 ' A' ' 115' ' ' LEU . . . -60.98 -48.29 82.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.407 0.622 . . . . 0.0 110.474 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.749 ' O ' HG21 ' A' ' 179' ' ' THR . . . -71.94 -36.82 70.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.006 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.503 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -57.67 -43.24 84.87 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.724 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.097 HD22 HD21 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -69.72 -24.24 63.53 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.33 0.586 . . . . 0.0 111.116 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.754 ' SG ' HD11 ' A' ' 140' ' ' ILE . 86.5 m -59.11 -10.59 2.82 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.059 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.705 HD11 ' O ' ' A' ' 179' ' ' THR . 12.0 mt -82.06 169.03 17.18 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 50.84 -110.39 0.94 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.513 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.428 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 2.4 p -161.67 101.35 1.17 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.037 -0.356 . . . . 0.0 110.037 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 12.9 m-20 -138.95 135.15 34.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.692 ' C ' HD12 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -101.93 110.67 22.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.812 178.548 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.712 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.6 mp -145.9 140.66 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.58 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.774 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 27.0 t -111.03 112.4 40.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.248 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.679 HD13 HD11 ' A' ' 92' ' ' LEU . 13.2 mt -82.09 150.58 27.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.385 0.612 . . . . 0.0 111.587 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.56 HG22 ' H ' ' A' ' 117' ' ' GLY . 3.6 m -155.25 177.25 11.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.419 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.56 ' H ' HG22 ' A' ' 116' ' ' THR . . . -165.08 -165.37 22.27 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.251 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.564 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 2.3 mm-40 -70.92 176.07 2.25 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.564 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 37.2 Cg_exo -62.4 -28.95 78.69 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 121.793 1.662 . . . . 0.0 111.97 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.508 ' HD2' ' CG ' ' A' ' 123' ' ' GLU . 6.0 tpt180 -80.44 -37.29 32.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.958 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.634 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 34.8 tpp -59.56 -15.72 20.21 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.734 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 6.3 mttm -69.8 -5.79 27.88 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.564 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 2.0 pt-20 -120.98 26.97 8.73 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.066 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.604 ' HA ' ' HE ' ' A' ' 124' ' ' ARG . 1.6 mmp_? -105.91 94.16 8.67 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.062 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 10.6 Cg_endo -53.56 129.03 31.81 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.954 2.436 . . . . 0.0 112.559 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.666 HD11 HD23 ' A' ' 129' ' ' LEU . 18.1 tt -132.78 29.35 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.724 0.774 . . . . 0.0 110.127 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -68.35 -51.06 34.34 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.184 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.739 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.7 OUTLIER -54.29 -28.58 43.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.924 0.392 . . . . 0.0 110.668 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.786 ' CD1' HD21 ' A' ' 133' ' ' LEU . 23.6 tp -81.8 -61.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.885 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.776 HG13 HD12 ' A' ' 140' ' ' ILE . 59.8 t -53.35 -26.5 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.947 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.507 ' O ' HD12 ' A' ' 135' ' ' LEU . 20.0 t0 -71.63 -43.43 66.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.007 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.893 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -65.43 -51.86 57.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 121.074 0.464 . . . . 0.0 111.528 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.828 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -57.38 -43.78 83.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.818 179.65 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -33.91 73.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.803 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.893 HD12 ' HA ' ' A' ' 132' ' ' ALA . 2.7 mt -68.79 -30.14 68.66 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.235 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.47 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -78.42 -17.84 77.07 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.669 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 130.14 4.31 4.6 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.302 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.23 146.8 48.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.833 0.349 . . . . 0.0 111.557 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -114.75 94.57 4.83 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.075 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.968 HG23 HD23 ' A' ' 153' ' ' LEU . 11.5 mt -118.75 175.39 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.829 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.747 ' H ' HG22 ' A' ' 140' ' ' ILE . 1.0 OUTLIER -153.29 -166.15 2.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.267 0.556 . . . . 0.0 111.632 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.569 ' N ' HG23 ' A' ' 141' ' ' THR . 29.0 m-85 -135.92 101.51 4.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.921 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.641 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.4 mm? -72.86 -13.55 61.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.602 -177.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.766 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 4.8 mt-10 -139.52 -73.2 0.38 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.635 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.633 ' HB3' ' HD2' ' A' ' 148' ' ' TYR . 0.2 OUTLIER -121.35 147.23 45.98 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.217 0.532 . . . . 0.0 111.704 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.466 ' HA ' ' CG ' ' A' ' 142' ' ' TYR . 10.3 mt-10 -68.22 131.92 46.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.301 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.643 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 87.2 m-20 65.95 51.9 1.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.691 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.867 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.6 m-85 -148.03 -179.72 1.02 Allowed Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.129 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.867 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 5.7 Cg_endo -50.66 -43.1 47.53 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.969 2.446 . . . . 0.0 115.143 -177.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.766 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 32.8 Cg_endo -62.73 102.18 0.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.149 1.233 . . . . 0.0 111.425 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 150' ' ' PRO . 67.3 mt -138.58 122.92 18.26 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.848 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.664 ' HB2' HG22 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -105.51 112.33 25.39 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.129 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.968 HD23 HG23 ' A' ' 140' ' ' ILE . 4.5 mt -93.18 157.95 16.01 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.266 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.602 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -145.53 24.79 1.38 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.469 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.497 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 54.84 -166.05 2.83 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.535 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.483 ' O ' HG23 ' A' ' 158' ' ' THR . . . 108.72 -5.27 32.71 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.888 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.654 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 3.0 t80 -60.66 106.13 0.52 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.712 0.291 . . . . 0.0 110.721 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 156' ' ' GLY . 69.1 p -106.97 -46.12 4.0 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.098 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.718 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.39 -165.98 26.94 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.158 -1.02 . . . . 0.0 114.185 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.592 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 118.8 170.21 14.68 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.47 128.54 36.24 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.624 HG13 HD13 ' A' ' 135' ' ' LEU . 62.4 t -138.27 151.32 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 120.786 0.326 . . . . 0.0 111.733 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.505 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 2.4 m-20 -118.89 117.85 29.96 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.738 HG11 HD13 ' A' ' 173' ' ' LEU . 0.9 OUTLIER -118.63 147.86 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 120.574 -0.451 . . . . 0.0 112.018 -178.871 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.739 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.4 OUTLIER -85.4 133.59 34.11 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.338 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.724 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -76.03 -44.62 18.23 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.279 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.423 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 83.2 p -51.55 163.69 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.942 0.401 . . . . 0.0 111.593 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 169' ' ' SER . 3.7 t 71.59 60.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.242 0.544 . . . . 0.0 110.658 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.68 ' N ' HG11 ' A' ' 196' ' ' VAL . 0.7 OUTLIER 54.81 154.95 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.409 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.623 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 0.1 OUTLIER -76.71 3.01 12.62 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.966 0.412 . . . . 0.0 111.097 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.921 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 55.8 mm-40 -54.11 -22.72 11.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.726 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.713 ' O ' HD12 ' A' ' 176' ' ' LEU . 1.9 m-85 -78.21 -55.77 5.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.935 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.819 HD23 HG12 ' A' ' 201' ' ' ILE . 22.3 tp -73.51 -38.32 65.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.869 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.576 HG22 ' HE2' ' A' ' 178' ' ' MET . 91.4 m -60.31 -33.07 71.85 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.188 0.518 . . . . 0.0 109.706 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.661 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -72.79 -50.18 25.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.734 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.828 ' CD2' HD23 ' A' ' 133' ' ' LEU . 2.3 mt -66.96 -38.78 86.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.749 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.006 HD21 ' HB3' ' A' ' 223' ' ' PHE . 12.7 mt -68.47 -24.87 64.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.282 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.576 ' HE2' HG22 ' A' ' 174' ' ' THR . 46.5 mtm -94.52 -28.2 15.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.34 0.591 . . . . 0.0 110.779 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.749 HG21 ' O ' ' A' ' 104' ' ' ALA . 84.5 m -91.28 -46.84 7.83 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.068 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.92 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -59.21 -39.27 71.84 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 9.3 Cg_endo -53.33 -36.71 79.63 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 121.095 1.197 . . . . 0.0 111.706 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.668 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -85.12 -5.7 59.33 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.163 -179.734 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -67.09 120.9 75.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -37.12 -32.93 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.554 2.836 . . . . 0.0 114.018 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 158' ' ' THR . 0.3 OUTLIER -107.33 153.43 22.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.332 . . . . 0.0 111.562 -179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.663 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 0.4 OUTLIER -67.44 118.24 10.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.693 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.821 ' HB ' HG23 ' A' ' 225' ' ' VAL . 31.4 m -103.1 137.59 41.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.304 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 1.126 HG22 HG13 ' A' ' 224' ' ' VAL . 40.5 t -125.85 99.15 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.094 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.596 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.3 mt -90.55 141.98 13.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.395 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.791 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.3 OUTLIER -113.54 170.97 7.85 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.65 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.865 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.7 mm -110.38 97.26 5.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 120.985 0.421 . . . . 0.0 111.31 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.562 ' HG2' ' HE ' ' A' ' 190' ' ' ARG . 8.1 mtmp? -59.94 -81.37 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.464 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -78.85 168.44 53.53 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.309 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.45 122.3 15.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.54 0.209 . . . . 0.0 110.73 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.724 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.5 OUTLIER -57.26 146.64 27.84 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.985 0.422 . . . . 0.0 110.302 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.68 HG11 ' N ' ' A' ' 169' ' ' SER . 13.0 p -104.43 -19.75 6.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.384 0.611 . . . . 0.0 111.507 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.751 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.6 OUTLIER -127.74 45.31 2.76 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.627 -179.208 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.86 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.0 OUTLIER -41.19 -64.75 0.56 Allowed Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.702 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.672 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 55.2 Cg_endo -68.54 -16.92 43.37 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 121.603 1.535 . . . . 0.0 111.941 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.751 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 31.3 m-85 -76.0 -29.35 58.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.13 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.86 HG22 ' O ' ' A' ' 198' ' ' LYS . 8.4 tp -70.53 -31.63 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.622 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.516 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.1 OUTLIER -61.52 -33.74 74.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.63 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 207' ' ' LEU . 36.3 mt -66.21 -31.37 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.706 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.488 HG22 ' SD ' ' A' ' 208' ' ' MET . 54.0 m -60.26 -52.67 64.29 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.376 0.608 . . . . 0.0 109.823 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.923 HD21 HD22 ' A' ' 177' ' ' LEU . 44.9 mt -72.74 -35.48 67.54 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.59 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.717 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 4.9 t-20 -65.62 -24.81 67.14 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.721 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -82.68 -40.76 20.23 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.537 178.594 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.504 ' HG2' ' CZ ' ' A' ' 231' ' ' TYR . 12.0 mtp -69.0 -36.49 77.87 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.905 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.717 ' HE3' ' HA ' ' A' ' 206' ' ' ASN . 13.2 ptpt -66.56 -46.52 75.77 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.203 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.647 HG22 ' O ' ' A' ' 207' ' ' LEU . 5.2 t -57.55 -29.65 64.56 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.101 0.477 . . . . 0.0 109.862 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.612 ' HE2' ' HA ' ' A' ' 32' ' ' ALA . 1.8 m-85 -71.21 -54.1 12.12 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.301 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 155.78 -0.71 0.15 Allowed Glycine 0 CA--C 1.52 0.396 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.048 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.595 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 70.2 t -118.24 139.63 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.263 0.554 . . . . 0.0 111.679 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -135.95 156.12 49.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.994 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.894 HG21 HG12 ' A' ' 225' ' ' VAL . 2.0 pp -128.77 175.56 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.336 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 1.003 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 23.7 tt0 -89.88 125.15 35.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.156 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -100.71 101.04 11.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.016 0.436 . . . . 0.0 110.761 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.602 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -67.65 -166.52 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.589 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.64 47.69 0.42 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.084 0.468 . . . . 0.0 110.334 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.611 ' CZ ' ' HD3' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 58.22 19.39 6.15 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 -179.349 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 191' ' ' ILE . 14.2 mt-30 -110.6 -21.5 12.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.545 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.787 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 33.2 mt-30 -149.81 140.29 22.43 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.885 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 1.006 ' HB3' HD21 ' A' ' 177' ' ' LEU . 10.3 m-85 -112.35 96.39 5.98 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 1.126 HG13 HG22 ' A' ' 188' ' ' VAL . 27.6 t -80.54 111.27 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-O 121.06 0.457 . . . . 0.0 110.91 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.92 HG21 ' CB ' ' A' ' 180' ' ' ALA . 2.7 m -97.68 112.96 30.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.12 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.723 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 5.7 mptt -61.38 104.16 0.38 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.584 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.663 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -59.57 157.39 25.22 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.825 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.44 8.74 84.56 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.339 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.723 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 15.1 mm-40 -73.38 178.99 4.21 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.401 0.619 . . . . 0.0 111.439 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.668 ' HA ' HD23 ' A' ' 182' ' ' LEU . 18.1 m -167.93 106.26 0.51 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.362 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.69 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 24.4 m-85 -54.03 142.02 26.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.163 0.506 . . . . 0.0 111.573 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.692 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 66.7 mt-30 -107.62 149.92 27.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.77 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 18.9 t -68.4 98.56 0.18 Allowed Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.745 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 47.8 Cg_endo -64.72 -33.36 54.73 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.498 2.132 . . . . 0.0 112.219 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 117.43 -114.09 2.87 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.624 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.6 OUTLIER -95.94 117.55 30.84 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 178.481 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.718 ' CZ ' HD11 ' A' ' 207' ' ' LEU . 37.3 t80 -119.93 136.01 54.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.793 0.33 . . . . 0.0 111.251 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.754 HD13 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.433 0 CA-C-O 121.2 0.524 . . . . 0.0 110.679 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.636 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 9.0 m-20 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.961 0.41 . . . . 0.0 111.463 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -68.34 -38.19 81.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.565 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.678 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -79.06 -34.58 43.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.75 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.831 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -62.23 -53.72 51.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.459 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.633 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 4.9 tp -66.93 -47.93 70.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.194 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.613 HD11 ' HB3' ' A' ' 207' ' ' LEU . 33.1 mt -56.87 -33.88 67.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.459 . . . . 0.0 110.862 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.686 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -76.42 -28.87 56.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.923 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.8 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -73.55 -29.61 62.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.616 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.895 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.35 -12.39 40.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.012 0.434 . . . . 0.0 110.858 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.23 164.89 20.9 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.609 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.501 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 84.6 m-70 -98.21 97.7 9.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.065 0.459 . . . . 0.0 110.173 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.06 142.26 6.58 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.255 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.765 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 10.9 tttt -65.69 135.23 54.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.996 0.427 . . . . 0.0 111.788 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.504 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -129.98 159.32 37.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.468 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.791 HG22 ' HG3' ' A' ' 74' ' ' GLU . 61.7 t -103.82 142.44 17.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.678 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -128.38 111.75 13.68 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.561 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.9 HG23 ' HA ' ' A' ' 238' ' ' LEU . 0.0 OUTLIER -100.96 170.74 8.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.096 0.474 . . . . 0.0 111.767 -179.329 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.542 ' HB2' ' CD1' ' A' ' 238' ' ' LEU . 0.1 OUTLIER 64.99 21.29 12.29 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.384 -179.165 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.897 HD22 HD11 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -60.35 157.43 13.75 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.533 179.047 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.576 ' HB3' HG21 ' A' ' 50' ' ' VAL . 23.4 tp -93.13 113.78 26.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.129 0.49 . . . . 0.0 111.464 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 p-10 -72.82 62.93 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.438 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.506 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.5 OUTLIER -124.85 -162.25 1.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.147 -179.036 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.65 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 51.3 m-20 -97.63 -20.47 17.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.179 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 5.0 p-10 -71.25 -27.65 63.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.947 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.657 HG12 HD11 ' A' ' 54' ' ' LEU . 23.9 t -89.09 -53.26 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.595 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.665 ' O ' ' HB2' ' A' ' 55' ' ' ASN . 2.9 ptm180 -50.02 -30.29 10.4 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.678 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.421 ' CD2' ' O ' ' A' ' 48' ' ' ASP . 10.5 m-70 -72.63 -35.49 67.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.41 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.636 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 3.8 tpt -65.87 -47.85 73.49 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.831 HD23 HD21 ' A' ' 29' ' ' LEU . 1.6 mp -65.42 -48.84 71.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.665 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -53.17 -25.54 13.99 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.321 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.874 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -75.25 -44.21 47.31 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.652 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.554 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -69.74 -49.48 52.73 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.389 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.514 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 5.1 t -52.05 -32.35 34.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.203 0.525 . . . . 0.0 109.898 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.915 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.01 -46.01 89.26 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.127 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.007 HD21 HD22 ' A' ' 106' ' ' LEU . 3.6 mp -72.27 -26.8 62.13 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.498 0.666 . . . . 0.0 109.801 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.41 -0.35 5.11 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.713 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.664 HG21 HD11 ' A' ' 82' ' ' LEU . 18.6 t -58.34 152.42 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 117.718 0.759 . . . . 0.0 110.193 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.42 ' CB ' HD12 ' A' ' 76' ' ' ILE . 3.7 m -116.16 108.68 16.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.932 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.718 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 15.0 p90 -127.53 154.62 44.93 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.22 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.627 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.9 OUTLIER -145.54 116.49 7.79 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.903 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.897 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -85.11 176.09 8.6 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.097 0.475 . . . . 0.0 111.842 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.861 ' HB3' ' HG3' ' A' ' 72' ' ' ARG . 50.4 p -86.3 178.99 6.98 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.051 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.94 -13.53 26.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.617 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -119.38 3.79 11.27 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.591 0.234 . . . . 0.0 110.877 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.51 ' O ' HD23 ' A' ' 44' ' ' LEU . 37.5 mmt-85 61.84 45.82 7.35 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 110.416 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -125.76 -3.11 7.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.367 179.339 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.861 ' HG3' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER -142.04 112.67 7.23 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.041 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 6.9 t -116.34 152.46 33.85 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.919 -0.712 . . . . 0.0 112.294 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.791 ' HG3' HG22 ' A' ' 40' ' ' VAL . 0.8 OUTLIER -116.2 102.61 9.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.878 178.662 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.765 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -96.04 127.63 47.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.493 ' CG1' ' HE3' ' A' ' 38' ' ' LYS . 14.3 mt -82.32 102.76 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.077 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.686 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -45.4 115.57 1.6 Allowed Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.999 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -61.24 -16.97 50.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.979 0.419 . . . . 0.0 110.1 178.727 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.501 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 86.16 -20.06 23.31 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.404 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.895 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -140.84 -148.28 5.08 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.833 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 3.8 Cg_exo -77.18 170.88 18.81 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.052 1.835 . . . . 0.0 109.183 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.8 HD21 ' HB3' ' A' ' 33' ' ' ALA . 4.2 mm? -69.31 92.19 0.57 Allowed 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.833 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 31.0 m170 -83.67 118.06 23.61 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.23 -1.805 . . . . 0.0 112.784 -175.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.799 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -144.45 109.04 4.89 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.361 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -111.58 91.65 3.74 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.418 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.63 20.37 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.773 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 54.95 49.37 17.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.366 0.603 . . . . 0.0 109.779 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.915 HD21 ' HB1' ' A' ' 59' ' ' ALA . 4.0 tp -81.78 135.96 35.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.425 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.749 ' N ' HD12 ' A' ' 88' ' ' LEU . 1.2 tt0 -114.31 128.71 56.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.261 0.553 . . . . 0.0 110.605 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.874 HD13 ' HA ' ' A' ' 56' ' ' ALA . 18.0 mt -111.14 158.99 18.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.468 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.453 ' CE1' ' HA2' ' A' ' 93' ' ' GLY . 41.8 t80 -123.83 103.39 8.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.428 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.741 HD23 ' HE1' ' A' ' 99' ' ' MET . 0.9 OUTLIER -90.05 6.5 42.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.09 -179.49 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.57 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 45.52 -145.52 2.74 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.283 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -86.65 47.99 1.57 Allowed 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 120.764 0.316 . . . . 0.0 111.387 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -90.43 -76.35 0.43 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.948 0.404 . . . . 0.0 111.124 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.55 -14.04 31.96 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.232 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 101' ' ' PRO . 65.3 p -97.0 -7.89 31.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.665 0.269 . . . . 0.0 111.015 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.522 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -126.85 -21.65 4.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.174 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.741 ' HE1' HD23 ' A' ' 92' ' ' LEU . 23.5 tpp -66.43 -50.44 63.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 0.0 110.018 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.694 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -61.6 -53.86 57.34 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.481 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.694 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 34.7 Cg_exo -61.31 -45.33 19.09 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.703 2.269 . . . . 0.0 112.79 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.594 ' CD1' HD11 ' A' ' 106' ' ' LEU . 2.7 tm? -70.8 -34.41 71.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.321 -178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.4 -47.72 84.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.366 0.603 . . . . 0.0 110.564 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.827 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -71.97 -34.2 68.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.356 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.583 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.31 -45.16 94.38 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.878 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.007 HD22 HD21 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -69.35 -20.49 63.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.662 -179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.558 ' SG ' HD11 ' A' ' 140' ' ' ILE . 6.4 m -62.17 -8.12 5.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.976 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.754 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 15.8 mt -87.44 165.57 15.45 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 57.2 -109.76 1.87 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.083 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.416 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -165.8 99.48 0.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.765 0.317 . . . . 0.0 110.299 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.611 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 3.4 m120 -138.44 135.44 35.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.683 ' C ' HD12 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -102.78 110.65 22.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.381 178.895 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.733 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.5 mp -143.88 142.28 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.216 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.777 HG22 ' HB2' ' A' ' 152' ' ' ARG . 32.5 t -113.66 112.29 39.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.466 HD13 ' SD ' ' A' ' 99' ' ' MET . 39.0 mt -81.7 157.23 24.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.451 0.643 . . . . 0.0 112.194 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.6 m -163.2 166.93 22.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.165 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -154.68 -166.14 14.82 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.023 -1.084 . . . . 0.0 113.497 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.587 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 22.5 mm-40 -69.15 178.25 0.97 Allowed Pre-proline 0 C--N 1.33 -0.267 0 C-N-CA 122.674 0.39 . . . . 0.0 110.78 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 36.4 Cg_exo -61.8 -39.59 51.28 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.892 1.728 . . . . 0.0 112.524 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -76.2 -33.07 59.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.977 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.567 ' HA ' ' HG3' ' A' ' 124' ' ' ARG . 10.0 tpt -60.75 -17.24 47.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.278 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.714 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 6.2 mmtp -71.46 -4.9 29.1 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.639 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 0.1 OUTLIER -125.52 32.24 5.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.014 0.435 . . . . 0.0 111.03 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.567 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 2.2 mmp_? -103.95 87.43 1.55 Allowed Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.822 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.789 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 1.1 Cg_endo -43.92 129.79 7.7 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.075 2.517 . . . . 0.0 112.406 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.849 HD11 HD23 ' A' ' 129' ' ' LEU . 15.0 tt -140.63 30.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.703 0.763 . . . . 0.0 110.29 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -70.11 -49.52 33.34 Favored Glycine 0 C--N 1.317 -0.523 0 CA-C-N 114.814 -1.085 . . . . 0.0 113.25 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.4 OUTLIER -55.27 -25.31 33.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.819 -179.344 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.849 HD23 HD11 ' A' ' 126' ' ' ILE . 30.9 tp -83.88 -65.74 0.97 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.813 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.869 HG13 HD12 ' A' ' 140' ' ' ILE . 60.3 t -51.15 -26.53 5.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.223 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 1.7 m-20 -73.2 -46.37 50.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.667 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.944 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -63.48 -48.71 76.54 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.284 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.863 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -59.86 -44.36 94.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.385 0.612 . . . . 0.0 109.692 179.573 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -59.18 -34.92 72.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.421 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.944 HD12 ' HA ' ' A' ' 132' ' ' ALA . 2.2 mt -68.86 -28.0 66.32 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.21 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.5 -11.37 85.21 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.611 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 121.24 6.13 9.13 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.931 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.29 149.2 37.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 111.3 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.449 ' HA ' ' HE3' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -115.4 95.95 5.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.082 0.468 . . . . 0.0 111.594 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.964 HG23 HD23 ' A' ' 153' ' ' LEU . 12.1 mt -118.26 177.05 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.395 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.814 ' H ' HG22 ' A' ' 140' ' ' ILE . 1.0 OUTLIER -154.11 -167.69 2.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.18 0.514 . . . . 0.0 111.403 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.632 ' HE1' HD21 ' A' ' 151' ' ' LEU . 23.6 m-85 -135.56 102.66 5.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.641 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.2 mm? -75.7 -13.86 60.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.932 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.686 ' HG3' ' N ' ' A' ' 145' ' ' GLN . 0.0 OUTLIER -135.63 -69.75 0.49 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.357 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.686 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.4 OUTLIER -132.15 163.86 27.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.912 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.542 ' HG2' ' CD2' ' A' ' 142' ' ' TYR . 23.4 mt-10 -74.97 143.46 43.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.556 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.789 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 0.5 OUTLIER 51.54 42.32 29.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.012 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.686 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.4 m-30 -130.24 174.43 4.64 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.262 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.714 ' CG ' ' HA ' ' A' ' 122' ' ' LYS . 8.6 Cg_endo -50.76 -40.65 56.44 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.921 2.414 . . . . 0.0 114.316 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 149' ' ' PRO . 40.1 Cg_endo -60.97 100.28 0.16 Allowed 'Trans proline' 0 CA--C 1.511 -0.625 0 C-N-CA 121.797 1.665 . . . . 0.0 111.514 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.632 HD21 ' HE1' ' A' ' 142' ' ' TYR . 92.6 mt -137.89 123.02 19.2 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.24 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.777 ' HB2' HG22 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -105.63 112.07 25.01 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.59 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.964 HD23 HG23 ' A' ' 140' ' ' ILE . 1.4 mt -94.0 158.22 15.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.045 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.611 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 32.4 mt-30 -145.72 24.45 1.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.784 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.504 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 53.59 -165.71 1.99 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.679 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.85 -3.73 38.93 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.105 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.683 ' HE2' ' HA ' ' A' ' 133' ' ' LEU . 44.5 t80 -61.81 107.35 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.846 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.644 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 53.3 p -103.02 -50.47 3.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.697 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.627 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 146.24 -165.25 28.24 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.138 -1.03 . . . . 0.0 114.19 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.602 ' O ' HG23 ' A' ' 162' ' ' VAL . . . 119.23 168.37 14.0 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -62.43 125.87 25.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.004 0.402 . . . . 0.0 110.15 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 160' ' ' GLY . 44.3 t -135.02 153.02 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.756 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.554 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.4 OUTLIER -119.3 115.57 24.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.032 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.766 HG11 HD13 ' A' ' 173' ' ' LEU . 0.5 OUTLIER -113.87 147.4 17.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.677 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.9 OUTLIER -85.64 134.14 34.0 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.481 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.724 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -76.54 -44.7 15.5 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.759 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.9 t -50.39 163.02 0.18 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.055 0.455 . . . . 0.0 111.832 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.2 t 71.3 59.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.898 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.772 ' N ' HG11 ' A' ' 196' ' ' VAL . 75.7 m 57.68 153.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.262 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.444 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 0.5 OUTLIER -78.14 -2.4 37.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.249 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.652 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 90.6 mm-40 -51.55 -23.36 4.04 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.819 0.342 . . . . 0.0 111.365 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.639 ' HA ' HD13 ' A' ' 129' ' ' LEU . 2.8 m-85 -72.16 -58.94 3.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.252 0.549 . . . . 0.0 110.702 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.766 HD13 HG11 ' A' ' 164' ' ' VAL . 39.5 tp -73.49 -34.28 65.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.821 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.674 HG22 ' HE2' ' A' ' 178' ' ' MET . 89.8 m -60.01 -31.33 69.83 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.827 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -73.15 -52.23 14.95 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.059 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.863 ' CD2' HD23 ' A' ' 133' ' ' LEU . 2.6 mt -65.46 -38.19 89.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.741 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.995 HD21 ' HB3' ' A' ' 223' ' ' PHE . 11.7 mt -64.57 -28.28 69.53 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.225 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.674 ' HE2' HG22 ' A' ' 174' ' ' THR . 9.6 ptp -97.3 -27.52 14.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.193 0.521 . . . . 0.0 110.894 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.705 HG23 ' HG ' ' A' ' 108' ' ' LEU . 23.0 m -85.03 -46.75 10.89 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.929 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.94 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -61.44 -38.67 54.64 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.2 Cg_endo -53.73 -35.66 79.24 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.516 1.478 . . . . 0.0 112.016 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.698 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.75 -7.77 59.08 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.988 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.644 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -66.42 122.75 83.21 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.06 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 1.9 Cg_endo -43.12 -27.84 1.15 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.939 2.426 . . . . 0.0 113.614 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.417 ' O ' ' HA3' ' A' ' 227' ' ' GLY . 11.1 mt-10 -107.17 153.06 23.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.013 0.435 . . . . 0.0 111.292 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.674 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 52.1 t0 -70.33 115.1 9.13 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.289 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.822 ' HB ' HG23 ' A' ' 225' ' ' VAL . 45.0 m -100.57 136.66 40.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.365 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 1.036 HG22 HG13 ' A' ' 224' ' ' VAL . 26.0 t -125.52 99.43 5.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.763 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.576 ' O ' ' N ' ' A' ' 223' ' ' PHE . 4.7 mt -90.57 143.65 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.132 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.817 ' C ' HD13 ' A' ' 191' ' ' ILE . 2.2 ptm180 -115.28 170.95 8.0 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.882 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.4 mm -111.1 97.86 6.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-O 120.977 0.418 . . . . 0.0 111.267 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -62.31 -80.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.581 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -76.84 167.81 54.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.146 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -62.6 122.26 15.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.656 0.265 . . . . 0.0 110.952 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.827 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.7 OUTLIER -57.37 146.45 29.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.891 0.377 . . . . 0.0 110.395 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.772 HG11 ' N ' ' A' ' 169' ' ' SER . 11.6 p -103.34 -20.09 5.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.318 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.709 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -128.9 46.33 2.64 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.248 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.852 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.9 OUTLIER -41.96 -64.79 0.6 Allowed Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.039 -178.601 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 60.0 Cg_endo -70.73 -16.83 33.46 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 121.519 1.479 . . . . 0.0 111.457 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.709 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 21.5 m-85 -74.2 -30.02 62.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.204 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.852 HG22 ' O ' ' A' ' 198' ' ' LYS . 8.8 tp -68.54 -31.84 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.405 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.93 -29.64 67.26 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.742 HG22 HD23 ' A' ' 207' ' ' LEU . 33.4 mt -70.68 -29.91 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.253 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.502 HG21 ' HA ' ' A' ' 174' ' ' THR . 51.6 m -61.73 -55.22 32.56 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.16 0.505 . . . . 0.0 109.677 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.934 HD21 HD22 ' A' ' 177' ' ' LEU . 21.5 mt -69.19 -33.71 73.77 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.859 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.808 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 47.7 t30 -68.94 -24.74 64.31 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.742 HD23 HG22 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -78.96 -41.56 28.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.073 178.818 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.432 ' SD ' HG22 ' A' ' 204' ' ' THR . 12.0 mtp -70.26 -39.14 75.16 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.4 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.808 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -64.97 -42.35 94.64 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.398 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 207' ' ' LEU . 1.0 OUTLIER -59.61 -30.72 68.89 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.054 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.638 ' CE2' ' HA ' ' A' ' 32' ' ' ALA . 1.5 m-85 -71.18 -53.43 14.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.85 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 158.21 -3.45 0.13 Allowed Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.543 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.602 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 55.6 t -119.8 142.97 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.144 0.497 . . . . 0.0 112.231 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -135.52 156.03 49.54 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.442 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.901 HG12 HD22 ' A' ' 205' ' ' LEU . 2.4 pp -129.07 176.14 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.52 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 1.07 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 8.3 tp10 -90.4 126.27 35.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.135 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -101.47 101.25 11.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.632 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.694 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.7 OUTLIER -67.38 -168.87 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.611 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -73.9 48.44 0.29 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.811 0.339 . . . . 0.0 110.489 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.593 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 58.9 18.73 6.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.222 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 191' ' ' ILE . 11.6 pt20 -111.67 -22.57 11.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.761 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.779 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 27.8 mt-30 -148.0 139.86 23.96 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.13 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.995 ' HB3' HD21 ' A' ' 177' ' ' LEU . 13.6 m-85 -111.15 98.37 7.47 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 1.07 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 37.2 t -82.4 111.42 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-O 121.153 0.501 . . . . 0.0 111.068 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.94 HG21 ' CB ' ' A' ' 180' ' ' ALA . 2.4 m -98.43 113.57 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.789 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.545 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 2.0 mptp? -65.03 103.83 0.79 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.757 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.674 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -58.51 156.71 21.33 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.94 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.36 10.91 70.08 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.367 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.573 ' NE2' HG13 ' A' ' 213' ' ' VAL . 14.0 mm-40 -80.53 179.51 7.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.563 0.697 . . . . 0.0 111.901 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.698 ' HA ' HD23 ' A' ' 182' ' ' LEU . 4.0 m -173.69 106.88 0.13 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.448 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.658 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 22.9 m-85 -54.9 151.84 8.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.211 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.571 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 8.6 pt20 -122.11 142.46 50.36 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.6 t -48.6 98.74 0.19 Allowed Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.571 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 55.0 Cg_endo -67.22 -25.95 42.59 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.336 2.024 . . . . 0.0 111.976 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 112.49 -119.03 4.83 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.628 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -95.71 117.31 30.28 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.543 ' CE2' HD11 ' A' ' 207' ' ' LEU . 41.7 t80 -116.54 130.6 56.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.9 ' HA ' HG23 ' A' ' 42' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.647 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.597 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 5.2 p30 . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 120.933 0.397 . . . . 0.0 110.75 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 27' ' ' ARG . 1.4 mpp_? -67.58 -42.91 81.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.683 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.888 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -77.65 -34.33 53.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.937 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.92 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -58.32 -48.93 78.95 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.366 0.603 . . . . 0.0 110.504 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.613 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 3.2 tp -72.57 -49.29 33.44 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.225 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.695 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 31.7 mt -56.36 -33.07 65.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.732 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.674 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . . . -75.16 -29.88 60.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.695 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.762 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -71.67 -29.19 64.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.651 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.922 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.23 -13.23 38.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.046 0.451 . . . . 0.0 110.855 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.677 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.26 168.01 18.05 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.779 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.547 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 84.1 m-70 -101.98 97.74 8.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.079 0.466 . . . . 0.0 110.011 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.94 140.64 6.01 Favored Glycine 0 C--N 1.316 -0.579 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.436 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.816 ' HB2' HD13 ' A' ' 76' ' ' ILE . 2.1 ttmm -66.96 139.96 57.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.983 0.421 . . . . 0.0 112.028 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.814 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -130.71 156.47 44.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.7 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.682 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 57.4 t -102.64 142.27 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.994 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.888 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -127.76 111.94 14.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.573 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.98 ' HB ' ' HD3' ' A' ' 72' ' ' ARG . 0.7 OUTLIER -102.1 164.96 11.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.894 0.378 . . . . 0.0 110.838 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.481 ' HB2' ' CD1' ' A' ' 238' ' ' LEU . 0.1 OUTLIER 66.56 19.09 10.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.726 -178.281 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.895 HD22 HD11 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -58.78 152.72 18.42 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.327 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.621 ' HB3' HG21 ' A' ' 50' ' ' VAL . 18.1 tp -82.54 114.95 21.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.22 0.533 . . . . 0.0 111.235 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -78.95 69.7 5.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.464 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.9 m -133.68 -160.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.379 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.644 ' HA ' ' CG ' ' A' ' 51' ' ' ARG . 76.9 m-20 -98.0 -19.42 18.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.014 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.433 ' OD2' ' HA ' ' A' ' 95' ' ' ALA . 4.0 m-20 -70.25 -32.2 69.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.885 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.621 HG21 ' HB3' ' A' ' 45' ' ' LEU . 21.1 t -84.72 -52.85 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.237 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.644 ' CG ' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -50.51 -28.7 8.96 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.913 179.291 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -72.68 -35.95 67.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.198 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.597 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 7.8 tpt -65.33 -48.93 71.32 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.92 HD23 HD21 ' A' ' 29' ' ' LEU . 1.5 mp -64.78 -47.9 76.43 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.515 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -55.63 -24.09 31.55 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.451 179.39 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.822 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -75.72 -48.99 19.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.726 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -66.48 -49.97 64.85 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.878 -179.646 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.497 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.3 t -51.9 -32.29 31.92 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.302 0.572 . . . . 0.0 110.034 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.703 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.21 -48.05 83.07 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.106 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.012 HD21 HD22 ' A' ' 106' ' ' LEU . 3.7 mp -69.37 -27.38 65.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.394 0.616 . . . . 0.0 110.084 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.41 -1.97 4.93 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.6 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.605 HG21 HD11 ' A' ' 82' ' ' LEU . 13.6 t -59.59 155.79 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 117.641 0.72 . . . . 0.0 110.056 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.62 ' CB ' HG13 ' A' ' 76' ' ' ILE . 1.7 m -116.95 107.71 14.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.991 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.667 ' CE2' ' HB3' ' A' ' 54' ' ' LEU . 8.3 p90 -122.24 153.43 38.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.861 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 1.7 m -147.99 116.33 6.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.877 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.895 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -87.97 177.32 6.98 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.085 0.469 . . . . 0.0 111.198 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.476 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 12.9 p -93.97 179.68 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.479 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.94 -14.59 36.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.751 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -118.12 6.8 12.06 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.888 0.375 . . . . 0.0 110.74 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.572 ' O ' HD23 ' A' ' 44' ' ' LEU . 3.9 mmt180 57.14 43.85 23.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.817 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -126.49 -2.32 6.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.436 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.98 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -136.54 109.73 7.79 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.822 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.599 ' SG ' HD22 ' A' ' 66' ' ' LEU . 5.7 t -118.11 153.99 32.86 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.461 0.648 . . . . 0.0 112.669 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.775 ' HB3' ' HD3' ' A' ' 38' ' ' LYS . 0.6 OUTLIER -121.49 103.45 8.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.054 178.821 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -98.96 125.05 52.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.816 HD13 ' HB2' ' A' ' 38' ' ' LYS . 8.3 mm -78.97 104.16 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.308 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.659 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -51.82 115.77 4.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.882 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.616 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -63.56 -14.87 55.56 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.914 0.388 . . . . 0.0 110.439 178.656 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.547 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 83.6 -19.88 13.51 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.336 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.922 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.75 -151.28 5.73 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 178.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.836 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 3.8 Cg_exo -77.47 171.0 18.35 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 119.638 1.719 . . . . 0.0 109.222 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.805 ' HB2' HD23 ' A' ' 106' ' ' LEU . 4.1 mm? -68.09 90.99 0.34 Allowed 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.836 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 32.7 m170 -84.21 120.74 26.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 113.062 -1.881 . . . . 0.0 112.368 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.745 ' HB3' HD11 ' A' ' 113' ' ' ILE . . . -144.13 106.83 4.44 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.274 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.08 88.63 2.78 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.545 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.07 21.18 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.803 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.47 50.07 15.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.421 0.629 . . . . 0.0 109.904 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.8 HD12 ' N ' ' A' ' 89' ' ' GLU . 2.8 tp -78.4 135.87 37.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.041 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.8 ' N ' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -116.63 126.49 53.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.274 0.559 . . . . 0.0 110.286 179.157 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.822 HD13 ' HA ' ' A' ' 56' ' ' ALA . 19.7 mt -107.91 156.25 19.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.762 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 116' ' ' THR . 49.5 t80 -122.07 102.15 7.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.884 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.74 HD23 ' HE2' ' A' ' 99' ' ' MET . 1.9 mm? -91.74 6.86 44.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.275 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 43.5 -142.84 2.04 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.859 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -92.92 50.43 1.56 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.169 0.509 . . . . 0.0 110.824 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.433 ' HA ' ' OD2' ' A' ' 49' ' ' ASP . . . -84.23 -77.03 0.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.218 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.539 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.54 -16.43 19.06 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.36 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.22 -9.9 29.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.851 0.358 . . . . 0.0 110.474 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.453 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -130.8 -15.94 3.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.731 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.74 ' HE2' HD23 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -67.95 -54.42 18.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.074 0.464 . . . . 0.0 110.459 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.652 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -60.48 -53.13 67.58 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.383 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.804 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 33.4 Cg_exo -59.9 -47.05 16.73 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.86 2.373 . . . . 0.0 112.894 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.928 HD13 HD11 ' A' ' 106' ' ' LEU . 2.7 tm? -68.54 -34.42 75.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.504 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.68 -47.65 85.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.523 0.677 . . . . 0.0 110.542 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.916 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -72.45 -39.85 67.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.077 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.603 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -56.57 -39.77 74.04 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.214 0.531 . . . . 0.0 111.735 -177.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.012 HD22 HD21 ' A' ' 60' ' ' LEU . 1.3 mt -72.58 -22.01 61.05 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.039 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.762 ' SG ' HD11 ' A' ' 140' ' ' ILE . 84.9 m -61.92 -8.55 5.22 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.344 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.747 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 11.2 mt -85.6 165.05 17.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.04 -113.58 5.23 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.33 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.436 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 1.4 p -168.66 95.33 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.886 0.374 . . . . 0.0 111.242 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.715 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -138.99 143.25 38.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.039 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.5 m-20 -101.08 111.55 23.78 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.18 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.745 HD11 ' HB3' ' A' ' 84' ' ' ALA . 5.0 mp -141.49 142.4 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.023 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.622 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 22.5 t -116.09 112.06 38.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.744 0.307 . . . . 0.0 110.377 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.556 HD22 HD21 ' A' ' 92' ' ' LEU . 21.8 mt -79.08 157.14 28.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.415 0.626 . . . . 0.0 111.787 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 35.2 m -161.99 154.74 20.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.758 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.69 -167.1 10.94 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 119.897 -1.144 . . . . 0.0 113.425 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.621 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 2.3 mt-10 -70.65 173.03 5.12 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.387 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 20.2 Cg_endo -61.19 -24.39 78.98 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.598 1.532 . . . . 0.0 111.972 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.52 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 2.3 tpp180 -90.23 -33.14 16.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.261 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.599 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 6.0 tpt -60.12 -19.55 54.0 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.675 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 7.6 mttm -68.33 -4.92 16.09 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.122 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.617 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -121.29 30.48 6.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.886 0.374 . . . . 0.0 110.986 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.454 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 4.0 mmp_? -108.96 93.75 13.26 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.758 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.65 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 8.2 Cg_endo -50.1 128.62 22.83 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.559 2.173 . . . . 0.0 112.466 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.772 HD11 HD23 ' A' ' 129' ' ' LEU . 17.3 tt -133.83 31.12 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.766 0.793 . . . . 0.0 110.215 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.666 ' HA3' ' ND2' ' A' ' 147' ' ' ASN . . . -71.8 -51.57 14.88 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.202 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.809 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.9 OUTLIER -53.14 -26.9 18.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.962 0.41 . . . . 0.0 110.727 -179.299 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.799 HD13 ' HA ' ' A' ' 172' ' ' PHE . 35.4 tp -82.63 -66.5 0.88 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.749 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.872 HG13 HD12 ' A' ' 140' ' ' ILE . 61.1 t -52.13 -25.44 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.312 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 30.9 t0 -72.16 -45.31 60.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.585 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.979 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -64.89 -51.83 59.8 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.834 0.35 . . . . 0.0 111.513 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.748 HD21 ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -56.62 -43.01 79.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.221 0.534 . . . . 0.0 109.874 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -60.06 -32.67 71.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.048 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.979 HD12 ' HA ' ' A' ' 132' ' ' ALA . 2.2 mt -72.09 -26.75 62.27 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.462 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.526 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -80.82 -13.55 81.16 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.659 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.82 4.04 6.24 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.302 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.88 145.71 48.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.923 0.392 . . . . 0.0 111.53 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 0.2 OUTLIER -114.29 90.83 3.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.54 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.97 HG23 HD23 ' A' ' 153' ' ' LEU . 7.0 mt -117.48 174.54 3.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.957 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.763 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.8 OUTLIER -152.43 -168.08 2.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 111.39 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.591 ' N ' HG23 ' A' ' 141' ' ' THR . 25.7 m-85 -131.77 105.65 7.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.097 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.686 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.1 mm? -79.69 -8.88 59.5 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.812 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 27.5 mt-10 -141.33 -73.68 0.33 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.349 . . . . 0.0 110.379 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.647 ' HB3' ' HD2' ' A' ' 148' ' ' TYR . 0.1 OUTLIER -123.87 148.63 46.63 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.252 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.45 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 4.3 mt-10 -70.24 135.64 49.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.12 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.666 ' ND2' ' HA3' ' A' ' 127' ' ' GLY . 3.6 m120 64.59 49.59 2.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.319 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.868 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.8 m-85 -148.29 179.6 1.15 Allowed Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.734 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.868 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 8.0 Cg_endo -50.22 -40.36 51.77 Favored 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 123.331 2.687 . . . . 0.0 115.037 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.812 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 36.7 Cg_endo -62.05 100.94 0.22 Allowed 'Trans proline' 0 CA--C 1.516 -0.375 0 C-N-CA 121.513 1.475 . . . . 0.0 111.586 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.476 HD21 ' HE1' ' A' ' 142' ' ' TYR . 91.5 mt -139.56 122.95 17.14 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.802 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.686 ' N ' HD21 ' A' ' 143' ' ' LEU . 0.9 OUTLIER -104.49 112.55 25.65 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.97 HD23 HG23 ' A' ' 140' ' ' ILE . 1.2 mt -96.07 155.39 16.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.254 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 18.8 mt-30 -142.55 24.34 1.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.615 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 56.49 -165.91 4.66 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.433 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.97 -4.98 34.1 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.13 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.651 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 3.5 t80 -60.8 107.34 0.69 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.863 0.332 . . . . 0.0 110.494 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.465 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 76.4 p -105.61 -46.39 4.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.889 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.676 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 141.73 -162.3 27.02 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.136 -1.03 . . . . 0.0 113.981 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.592 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 115.71 172.67 17.04 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -65.16 126.76 29.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.613 HG11 ' HB1' ' A' ' 132' ' ' ALA . 58.0 t -135.5 157.54 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-O 121.132 0.491 . . . . 0.0 111.47 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.535 ' O ' ' HE2' ' A' ' 192' ' ' LYS . 3.2 m-20 -123.65 119.66 30.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.384 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.805 HG11 HD13 ' A' ' 173' ' ' LEU . 0.4 OUTLIER -121.74 139.13 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.548 -0.461 . . . . 0.0 112.101 -178.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.809 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.3 OUTLIER -78.93 133.5 36.91 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.267 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.715 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -75.43 -44.64 21.1 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.105 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.493 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 54.4 p -52.91 165.44 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.922 0.391 . . . . 0.0 111.359 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.6 t 72.61 50.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.01 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.825 ' H ' HG11 ' A' ' 196' ' ' VAL . 1.4 m 63.62 150.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.424 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.467 ' HG ' ' HG1' ' A' ' 174' ' ' THR . 12.2 t -77.68 3.65 13.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.711 0.291 . . . . 0.0 111.412 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.652 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 71.1 mm-40 -54.49 -20.68 8.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.983 0.42 . . . . 0.0 111.42 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.799 ' HA ' HD13 ' A' ' 129' ' ' LEU . 1.6 m-85 -76.09 -54.29 7.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.619 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.838 HD23 HG12 ' A' ' 201' ' ' ILE . 21.0 tp -77.33 -35.03 55.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.593 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.475 HG23 ' OG1' ' A' ' 204' ' ' THR . 79.8 m -58.99 -33.46 70.71 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.026 0.441 . . . . 0.0 110.029 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.916 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -76.33 -51.96 10.9 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.966 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.711 ' CD2' HD23 ' A' ' 133' ' ' LEU . 3.2 mt -61.99 -43.08 99.6 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.507 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.06 HD22 HD21 ' A' ' 205' ' ' LEU . 12.6 mt -60.75 -28.07 68.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.867 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.639 ' HA ' ' OH ' ' A' ' 231' ' ' TYR . 4.9 ptp -96.39 -26.24 15.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.325 0.583 . . . . 0.0 110.492 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.618 ' O ' HD11 ' A' ' 108' ' ' LEU . 74.1 m -85.17 -47.55 10.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.157 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.892 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -63.74 -35.84 18.44 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.719 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 9.7 Cg_endo -53.17 -37.77 80.35 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 121.129 1.219 . . . . 0.0 111.376 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.577 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.78 -8.06 58.96 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -67.43 115.8 30.4 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.057 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -33.58 -34.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.69 2.927 . . . . 0.0 114.33 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -103.65 152.92 21.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.005 0.431 . . . . 0.0 111.77 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.678 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 40.9 t0 -67.29 114.68 6.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.708 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.817 ' HB ' HG23 ' A' ' 225' ' ' VAL . 29.2 m -99.7 135.23 41.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.098 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 1.07 HG22 HG13 ' A' ' 224' ' ' VAL . 25.4 t -125.8 99.22 5.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.881 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.5 mt -91.11 144.49 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.267 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.822 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.2 OUTLIER -114.93 170.98 7.93 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.845 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.4 mm -111.54 97.15 5.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.269 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.599 ' HE3' ' N ' ' A' ' 165' ' ' ASP . 9.3 mtmt -57.0 -81.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.681 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -83.21 168.0 46.06 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.361 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -59.61 122.64 14.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.568 0.223 . . . . 0.0 110.84 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.715 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.4 OUTLIER -55.65 147.6 17.97 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.22 0.533 . . . . 0.0 110.841 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.825 HG11 ' H ' ' A' ' 169' ' ' SER . 11.8 p -103.81 -21.06 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.134 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.57 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.3 OUTLIER -128.11 46.15 2.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.125 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.807 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.6 OUTLIER -43.62 -61.64 1.81 Allowed Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 114.854 -1.066 . . . . 0.0 113.11 -178.635 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 15.0 Cg_exo -69.37 -17.28 39.44 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 121.476 1.451 . . . . 0.0 111.55 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.691 ' HA ' HD12 ' A' ' 203' ' ' ILE . 26.9 m-85 -75.08 -30.69 61.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.113 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 1.014 HD11 HD12 ' A' ' 177' ' ' LEU . 8.0 tp -67.95 -33.6 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.229 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.565 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 9.9 t70 -59.79 -33.71 72.07 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.691 HD12 ' HA ' ' A' ' 200' ' ' TYR . 13.1 mt -68.32 -29.86 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.622 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.505 HG22 ' SD ' ' A' ' 208' ' ' MET . 71.7 m -61.0 -54.71 41.6 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.124 0.488 . . . . 0.0 109.716 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 1.06 HD21 HD22 ' A' ' 177' ' ' LEU . 28.7 mt -70.4 -34.64 72.77 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.231 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.737 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 0.9 OUTLIER -63.6 -29.93 71.11 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.299 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.695 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -77.73 -40.82 39.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.613 178.717 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.505 ' SD ' HG22 ' A' ' 204' ' ' THR . 10.4 mtp -68.76 -38.56 80.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.966 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.737 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -66.7 -45.26 79.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.384 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.667 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 2.0 t -58.71 -26.08 63.53 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.317 0.58 . . . . 0.0 109.529 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.943 ' HA ' ' HG3' ' A' ' 234' ' ' PRO . 2.1 m-85 -74.92 -54.56 7.02 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.602 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 156.67 -1.56 0.13 Allowed Glycine 0 CA--C 1.52 0.351 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.883 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.626 ' HB ' ' CD1' ' A' ' 231' ' ' TYR . 53.0 t -117.75 138.22 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.046 0.451 . . . . 0.0 111.767 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -135.49 155.12 51.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.535 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.966 HG21 HG12 ' A' ' 225' ' ' VAL . 2.4 pp -129.31 175.5 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.956 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.317 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 1.01 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 18.7 tt0 -89.91 125.52 35.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.874 0.368 . . . . 0.0 110.37 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -101.14 100.95 11.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.248 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.723 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 2.1 mm-40 -66.74 -167.08 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.75 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.46 48.26 0.34 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.901 0.381 . . . . 0.0 110.341 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.588 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 57.88 19.65 5.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.254 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 191' ' ' ILE . 15.2 pt20 -112.94 -19.72 11.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.83 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.775 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 32.5 mt-30 -150.34 141.67 23.27 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.701 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 1.004 ' HB3' HD21 ' A' ' 177' ' ' LEU . 19.4 m-85 -114.14 96.76 5.97 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 1.07 HG13 HG22 ' A' ' 188' ' ' VAL . 31.1 t -82.8 110.97 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 121.167 0.508 . . . . 0.0 111.235 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.966 HG12 HG21 ' A' ' 215' ' ' ILE . 3.0 m -99.87 113.15 34.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.964 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.661 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 1.3 mptm? -62.74 103.82 0.47 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.998 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.678 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.25 155.86 16.36 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.947 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.97 8.77 75.23 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.445 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.661 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 69.8 mm-40 -73.16 178.54 4.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.473 0.654 . . . . 0.0 111.546 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.577 ' HA ' HD23 ' A' ' 182' ' ' LEU . 4.9 m -167.68 105.55 0.52 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.863 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.677 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 22.7 m-85 -55.15 142.53 30.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.108 0.48 . . . . 0.0 111.368 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.569 ' HB2' ' O ' ' A' ' 211' ' ' PHE . 78.9 mt-30 -108.21 148.58 29.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.673 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 56.6 p -64.13 103.05 0.37 Allowed Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.155 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.943 ' HG3' ' HA ' ' A' ' 211' ' ' PHE . 7.7 Cg_exo -71.36 -31.39 14.17 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.705 2.27 . . . . 0.0 111.966 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.01 -120.79 5.22 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.682 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -92.9 116.8 29.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.699 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 88.1 t80 -123.78 136.8 54.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.519 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.931 HD12 HG23 ' A' ' 42' ' ' THR . 4.0 tp . . . . . 0 CA--C 1.514 -0.408 0 CA-C-O 121.261 0.553 . . . . 0.0 111.707 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.719 ' OD1' ' HA ' ' A' ' 50' ' ' VAL . 64.3 m-20 . . . . . 0 CA--C 1.519 -0.229 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 35.0 mtt85 -62.19 -40.41 95.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.053 0.454 . . . . 0.0 110.293 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.843 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -74.32 -37.63 63.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.908 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.935 HD13 ' HG ' ' A' ' 54' ' ' LEU . 55.1 mt -58.36 -47.19 84.61 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.862 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.875 HD21 ' HB2' ' A' ' 105' ' ' ALA . 14.9 tp -77.82 -48.84 15.55 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.572 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 27.7 mt -55.05 -35.19 64.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.467 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.707 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -78.17 -29.7 48.74 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.675 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.766 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -70.26 -30.58 67.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.939 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.869 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.35 -12.54 40.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.996 0.427 . . . . 0.0 111.065 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.691 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -80.42 168.68 18.68 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.239 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 76.4 m-70 -103.19 98.42 8.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.217 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.71 141.06 6.95 Favored Glycine 0 C--N 1.314 -0.657 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.627 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.73 ' HB2' HG13 ' A' ' 76' ' ' ILE . 1.6 ttpm? -64.84 138.53 58.43 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.37 157.74 44.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.374 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.878 HG22 ' HG3' ' A' ' 74' ' ' GLU . 94.1 t -104.83 141.46 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.372 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.843 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -127.93 111.62 13.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.888 178.828 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.982 HG23 HD12 ' A' ' 238' ' ' LEU . 0.1 OUTLIER -98.31 171.03 8.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 111.783 -179.743 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.65 ' HB2' HD11 ' A' ' 238' ' ' LEU . 1.8 t30 66.03 18.17 10.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.233 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.847 HD22 HD11 ' A' ' 66' ' ' LEU . 1.2 tp -58.61 163.64 3.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.536 ' HB3' HG21 ' A' ' 50' ' ' VAL . 38.5 tp -97.64 116.63 30.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.009 0.433 . . . . 0.0 111.425 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -75.64 71.85 2.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.749 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.532 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 63.1 m -134.85 -162.98 1.31 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.899 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.624 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 1.5 t70 -98.19 -22.11 16.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.896 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.464 ' CG ' ' HA ' ' A' ' 95' ' ' ALA . 8.2 m-20 -66.61 -30.4 70.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.78 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.719 ' HA ' ' OD1' ' A' ' 26' ' ' ASN . 21.3 t -84.48 -56.02 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.058 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.624 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 1.1 ptm180 -49.99 -26.97 4.77 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -71.41 -40.77 70.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.296 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.485 ' SD ' ' HB1' ' A' ' 98' ' ' ALA . 7.1 tpt -64.87 -47.43 77.91 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.935 ' HG ' HD13 ' A' ' 29' ' ' LEU . 1.3 mp -65.33 -47.21 77.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.588 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 8.4 t-20 -57.39 -23.01 46.64 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.0 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.692 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -74.76 -48.1 27.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.056 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -68.18 -49.44 60.87 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.771 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.509 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.0 t -51.65 -30.23 20.86 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.281 0.562 . . . . 0.0 110.201 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.9 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.31 -52.49 65.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.962 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.967 HD21 HD22 ' A' ' 106' ' ' LEU . 3.8 mp -65.14 -28.38 69.38 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.83 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.76 0.61 5.23 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 114.834 -1.075 . . . . 0.0 113.494 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.681 HG21 HD11 ' A' ' 82' ' ' LEU . 22.9 t -56.55 154.2 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 117.609 0.705 . . . . 0.0 110.391 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.856 ' HB3' HD13 ' A' ' 76' ' ' ILE . 11.9 m -115.16 112.27 22.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.379 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 7.5 p90 -129.71 156.95 43.45 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.875 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.685 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -149.25 116.05 5.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.823 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.95 HD22 ' HG ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -90.32 175.55 7.07 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.232 0.539 . . . . 0.0 111.645 -179.424 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.842 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 1.3 t -87.85 179.42 6.47 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.709 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.33 -14.36 49.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.33 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.98 2.39 11.5 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.866 0.365 . . . . 0.0 110.705 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.503 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER 61.33 45.29 8.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.428 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -124.03 -2.72 8.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.974 179.021 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.842 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -142.54 110.62 5.97 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.429 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.95 ' HG ' HD22 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -114.93 152.62 32.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.256 0.55 . . . . 0.0 112.064 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.878 ' HG3' HG22 ' A' ' 40' ' ' VAL . 1.1 mt-10 -118.11 102.85 9.34 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.689 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.703 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -99.44 126.44 52.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.856 HD13 ' HB3' ' A' ' 63' ' ' SER . 3.1 mp -80.94 103.81 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.425 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.707 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -48.08 118.79 4.76 Favored Glycine 0 N--CA 1.453 -0.186 0 CA-C-N 116.017 -0.538 . . . . 0.0 114.136 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.592 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -63.77 -15.38 58.5 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.987 0.423 . . . . 0.0 110.357 178.552 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.517 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.02 -19.71 20.17 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.827 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.869 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -139.73 -150.22 5.47 Favored Glycine 0 C--O 1.224 -0.519 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.806 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 4.3 Cg_exo -77.57 170.08 19.85 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 CA-C-N 119.711 1.755 . . . . 0.0 108.828 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.809 HD12 HD13 ' A' ' 60' ' ' LEU . 4.3 mm? -68.43 89.59 0.35 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.806 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 34.1 m170 -83.44 118.34 23.68 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.012 -1.904 . . . . 0.0 112.333 -176.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.784 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -143.27 107.65 4.79 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.773 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -106.88 89.33 2.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.733 0.302 . . . . 0.0 110.947 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.63 20.45 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.74 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.32 48.11 19.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.394 0.616 . . . . 0.0 110.263 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.9 HD21 ' HB1' ' A' ' 59' ' ' ALA . 3.9 tp -76.57 131.6 39.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.261 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.706 ' N ' HD12 ' A' ' 88' ' ' LEU . 6.9 tt0 -110.64 128.26 55.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.261 0.553 . . . . 0.0 110.096 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.802 HD21 ' CB ' ' A' ' 59' ' ' ALA . 48.6 mt -110.69 156.99 20.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.118 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 116' ' ' THR . 45.4 t80 -119.57 105.15 10.93 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.628 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.853 HD23 ' HE2' ' A' ' 99' ' ' MET . 2.8 mm? -91.47 8.17 37.68 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.798 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 121' ' ' MET . . . 39.72 -139.82 0.93 Allowed Glycine 0 CA--C 1.523 0.556 0 C-N-CA 121.327 -0.463 . . . . 0.0 113.781 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.667 ' OD1' ' HB3' ' A' ' 120' ' ' ARG . 0.7 OUTLIER -91.32 46.57 1.31 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.023 0.44 . . . . 0.0 111.084 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.464 ' HA ' ' CG ' ' A' ' 49' ' ' ASP . . . -90.52 -77.44 0.41 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.461 ' O ' ' HG2' ' A' ' 171' ' ' GLN . . . 78.65 -14.36 13.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.99 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.58 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -96.29 -11.47 25.88 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 120.81 0.338 . . . . 0.0 110.429 178.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.485 ' HB1' ' SD ' ' A' ' 53' ' ' MET . . . -125.05 -21.27 4.7 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.49 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.853 ' HE2' HD23 ' A' ' 92' ' ' LEU . 10.4 ttm -66.8 -52.02 48.86 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.263 0.554 . . . . 0.0 110.47 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.918 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -57.77 -55.39 45.4 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.156 -179.522 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.671 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 24.1 Cg_exo -63.45 -46.8 8.75 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.53 2.153 . . . . 0.0 112.886 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.929 HD13 HD11 ' A' ' 106' ' ' LEU . 2.9 tm? -61.3 -40.81 95.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.78 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.701 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -58.94 -48.48 81.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.65 0.738 . . . . 0.0 109.736 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.691 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -68.01 -40.11 83.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.779 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.875 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -56.16 -42.49 77.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.042 0.449 . . . . 0.0 111.315 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.967 HD22 HD21 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -71.74 -21.32 61.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.399 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.671 ' SG ' HD11 ' A' ' 140' ' ' ILE . 82.6 m -58.36 -11.76 3.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.669 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.72 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 12.3 mt -84.43 167.68 16.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.716 0.293 . . . . 0.0 110.244 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 55.04 -110.75 1.86 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.076 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.486 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.9 OUTLIER -171.3 96.25 0.19 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.954 0.407 . . . . 0.0 111.207 179.478 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.686 ' HB2' HD11 ' A' ' 113' ' ' ILE . 15.2 p30 -137.28 139.61 41.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.974 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.677 ' C ' HD12 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -99.77 111.3 23.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.752 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.742 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.3 mp -141.02 139.85 33.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.224 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 21.3 t -112.2 113.41 44.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.701 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 18.1 mt -80.44 155.46 27.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.467 0.651 . . . . 0.0 112.215 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 11.2 m -162.72 156.88 20.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.294 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -147.58 -165.34 11.81 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 119.972 -1.109 . . . . 0.0 113.662 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.577 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 1.7 mt-10 -71.38 177.86 1.44 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.312 -0.444 . . . . 0.0 110.507 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.577 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 38.7 Cg_exo -61.74 -26.43 79.77 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.177 1.918 . . . . 0.0 112.52 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.667 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 11.7 tpt180 -87.25 -38.56 16.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.714 0.292 . . . . 0.0 110.483 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.718 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 8.7 tpt -59.6 -19.21 47.32 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.706 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 11.8 mttp -72.32 -4.5 30.19 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.82 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.683 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 5.4 pt-20 -126.62 25.06 6.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.981 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.426 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 33.2 mmt180 -100.15 87.23 0.71 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.271 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.639 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 1.3 Cg_endo -42.32 126.82 3.99 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.958 2.439 . . . . 0.0 112.449 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.729 HD11 HD23 ' A' ' 129' ' ' LEU . 16.5 tt -131.6 31.71 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.818 0.818 . . . . 0.0 110.103 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.592 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -70.7 -52.64 14.63 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.517 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.562 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.5 OUTLIER -54.3 -25.45 23.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.737 0.303 . . . . 0.0 110.686 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.863 ' CD1' HD21 ' A' ' 133' ' ' LEU . 26.5 tp -84.39 -66.21 0.92 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.885 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.877 HG13 HD12 ' A' ' 140' ' ' ILE . 48.0 t -52.82 -25.2 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.189 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.592 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 10.8 t0 -72.55 -46.58 53.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.388 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.945 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -65.07 -46.76 79.83 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.661 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.941 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -60.77 -42.27 97.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.362 0.601 . . . . 0.0 109.777 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.48 -34.8 74.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.056 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.945 HD12 ' HA ' ' A' ' 132' ' ' ALA . 3.4 mt -68.51 -30.58 69.43 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.253 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.21 -18.49 80.04 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.541 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.3 4.58 5.38 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.231 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.99 148.35 49.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.85 0.357 . . . . 0.0 111.406 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.57 87.47 2.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.402 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.986 HG23 HD23 ' A' ' 153' ' ' LEU . 6.8 mt -114.56 175.34 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.47 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.769 ' H ' HG22 ' A' ' 140' ' ' ILE . 1.0 OUTLIER -152.32 -167.22 2.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.232 0.539 . . . . 0.0 111.152 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.594 ' N ' HG23 ' A' ' 141' ' ' THR . 23.5 m-85 -133.64 105.98 7.14 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.671 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.0 mm? -81.04 -14.75 57.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.738 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.649 ' HG3' ' N ' ' A' ' 145' ' ' GLN . 0.1 OUTLIER -134.67 -68.31 0.54 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.996 0.427 . . . . 0.0 109.92 179.439 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.649 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -132.38 150.89 52.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.229 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.452 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 66.3 mt-10 -69.0 131.87 45.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.235 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.639 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 13.4 m-20 65.55 50.39 1.66 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.081 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.874 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.3 m-30 -143.03 -178.95 0.86 Allowed Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.874 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 11.9 Cg_endo -59.0 -36.59 96.52 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.599 2.199 . . . . 0.0 114.548 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.701 ' HD2' ' N ' ' A' ' 149' ' ' PRO . 39.0 Cg_endo -62.94 93.77 0.15 Allowed 'Trans proline' 0 CA--C 1.515 -0.465 0 C-N-CA 121.465 1.443 . . . . 0.0 111.221 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 150' ' ' PRO . 72.0 mt -132.54 123.49 26.63 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.513 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.709 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.0 OUTLIER -103.11 111.54 23.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.986 HD23 HG23 ' A' ' 140' ' ' ILE . 1.1 mt -94.07 159.35 15.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.458 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -147.2 23.62 1.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.662 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.514 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 55.84 -165.5 4.11 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.318 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.423 ' O ' HG23 ' A' ' 158' ' ' THR . . . 106.96 -2.38 35.59 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.64 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.698 ' HE1' ' HA ' ' A' ' 133' ' ' LEU . 40.9 t80 -63.44 111.92 2.53 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.029 0.442 . . . . 0.0 110.752 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.626 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 78.1 p -106.99 -47.64 3.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.462 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.62 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 140.09 -161.66 26.38 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.913 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.629 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 115.96 170.44 15.9 Favored Glycine 0 CA--C 1.519 0.289 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -66.51 123.26 19.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.056 0.428 . . . . 0.0 110.191 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.55 HG11 ' HB1' ' A' ' 132' ' ' ALA . 38.8 t -131.6 157.05 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 111.512 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.465 ' CG ' ' HG2' ' A' ' 190' ' ' ARG . 2.5 m-20 -120.97 115.24 22.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.606 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.594 HG21 ' CD1' ' A' ' 176' ' ' LEU . 0.5 OUTLIER -116.49 145.62 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 120.176 -0.609 . . . . 0.0 112.201 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.562 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.9 OUTLIER -82.9 132.86 35.14 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.925 179.3 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.684 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -74.61 -44.73 25.36 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.369 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.438 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 0.6 OUTLIER -52.02 165.71 0.19 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.879 0.371 . . . . 0.0 111.28 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 4.1 t 71.8 54.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.979 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.857 ' N ' HG11 ' A' ' 196' ' ' VAL . 69.6 m 59.26 160.02 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.266 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.726 ' HB2' ' HB2' ' A' ' 197' ' ' SER . 34.8 t -80.55 -1.63 42.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.918 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 2.2 mp0 -51.34 -22.16 2.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.671 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.666 ' HA ' HD13 ' A' ' 129' ' ' LEU . 2.7 m-85 -78.5 -54.94 5.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.942 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.748 HD23 HG12 ' A' ' 201' ' ' ILE . 32.1 tp -73.18 -41.04 64.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.399 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 170' ' ' SER . 14.7 t -58.64 -32.71 69.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.433 0.635 . . . . 0.0 109.499 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.691 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -64.88 -52.27 57.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.021 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.941 ' CD2' HD23 ' A' ' 133' ' ' LEU . 1.9 mt -71.28 -36.09 71.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.187 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.054 HD22 HD21 ' A' ' 205' ' ' LEU . 9.8 mt -66.2 -29.83 70.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.123 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.662 ' CE ' HD23 ' A' ' 30' ' ' LEU . 23.6 mtp -93.98 -27.54 16.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.259 0.552 . . . . 0.0 110.64 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.662 HG23 ' HG ' ' A' ' 108' ' ' LEU . 87.6 m -88.12 -46.83 8.96 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.141 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.954 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -62.28 -36.71 30.4 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.4 Cg_endo -54.46 -37.72 89.7 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 CA-C-N 120.297 1.142 . . . . 0.0 111.506 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.703 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -83.79 -5.74 59.27 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.229 -179.55 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.626 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -68.1 124.66 90.16 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.1 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 1.5 Cg_endo -43.74 -29.88 2.61 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.95 2.433 . . . . 0.0 113.535 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -107.75 151.53 25.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.067 0.46 . . . . 0.0 111.652 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.655 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 20.6 t0 -64.55 118.03 8.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.655 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.774 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 41.1 m -102.26 133.85 46.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.817 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 1.016 HG22 HG13 ' A' ' 224' ' ' VAL . 33.3 t -126.0 99.16 5.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.273 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.58 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.2 mt -91.71 145.94 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.116 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.842 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.1 OUTLIER -118.19 171.04 8.39 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.866 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.6 mm -111.69 98.17 6.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-O 121.096 0.474 . . . . 0.0 111.467 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -60.14 -81.01 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.381 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -81.09 166.75 48.74 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.422 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -57.61 126.32 26.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.65 0.262 . . . . 0.0 111.168 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.684 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.4 OUTLIER -62.48 147.21 49.48 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.013 0.435 . . . . 0.0 110.711 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.857 HG11 ' N ' ' A' ' 169' ' ' SER . 11.6 p -104.21 -20.55 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.797 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.726 ' HB2' ' HB2' ' A' ' 170' ' ' SER . 0.4 OUTLIER -128.28 45.32 2.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.378 0.608 . . . . 0.0 109.589 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.842 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.0 OUTLIER -41.72 -63.9 0.76 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.541 -179.081 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 49.0 Cg_endo -68.42 -17.33 44.03 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 121.707 1.605 . . . . 0.0 111.479 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.87 ' HA ' HD12 ' A' ' 203' ' ' ILE . 17.2 m-85 -76.88 -26.74 54.55 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.264 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.905 HD11 HD12 ' A' ' 177' ' ' LEU . 6.3 tp -73.08 -33.61 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.847 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.1 OUTLIER -61.89 -35.0 77.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.226 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.87 HD12 ' HA ' ' A' ' 200' ' ' TYR . 10.1 mt -66.7 -28.67 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.175 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.582 HG22 ' SD ' ' A' ' 208' ' ' MET . 53.9 m -61.45 -55.16 34.29 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 1.054 HD21 HD22 ' A' ' 177' ' ' LEU . 41.3 mt -70.05 -34.28 73.02 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.549 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.62 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 8.8 t30 -64.84 -25.51 67.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.193 0.521 . . . . 0.0 109.839 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.779 HD11 ' CZ ' ' A' ' 237' ' ' TYR . 0.2 OUTLIER -83.9 -40.32 18.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.308 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.59 ' SD ' HD23 ' A' ' 205' ' ' LEU . 11.2 mtp -69.24 -39.41 78.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.018 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.62 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.1 OUTLIER -65.91 -44.45 85.16 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.53 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 207' ' ' LEU . 1.3 t -59.02 -28.98 66.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.426 0.632 . . . . 0.0 109.39 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.676 ' CE2' ' HA ' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -71.33 -51.41 24.42 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.926 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 157.39 -5.85 0.18 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.531 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.695 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 54.9 t -118.84 137.33 53.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.972 0.415 . . . . 0.0 111.857 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.405 ' HG3' ' HA ' ' A' ' 209' ' ' LYS . 5.8 mt-10 -135.05 156.13 49.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.629 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 1.07 HG21 HG12 ' A' ' 225' ' ' VAL . 2.0 pp -132.44 175.99 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.932 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.868 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 4.5 tt0 -88.02 122.94 32.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.161 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -103.61 100.88 10.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.274 0.559 . . . . 0.0 109.778 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.764 ' HB2' ' HG2' ' A' ' 222' ' ' GLN . 1.5 tm0? -72.92 -161.87 0.1 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.044 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.422 ' H ' ' CD ' ' A' ' 218' ' ' GLN . 18.7 m-70 -74.32 46.28 0.25 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.499 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.713 ' CE2' ' HD3' ' A' ' 198' ' ' LYS . 0.3 OUTLIER 58.45 22.37 9.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.143 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 191' ' ' ILE . 23.3 mt-30 -109.0 -37.39 5.84 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.021 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.797 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 5.0 pt20 -136.12 139.19 42.75 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.278 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.866 ' CD1' HD11 ' A' ' 191' ' ' ILE . 28.2 m-85 -108.93 95.57 5.73 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 1.016 HG13 HG22 ' A' ' 188' ' ' VAL . 81.3 t -86.11 112.94 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.265 -177.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 1.07 HG12 HG21 ' A' ' 215' ' ' ILE . 6.3 m -101.1 115.78 43.43 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.555 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.601 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -64.41 101.47 0.44 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.956 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.655 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -53.51 156.43 5.74 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.256 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.26 10.85 67.86 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.236 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 60.3 mm-40 -75.84 -179.63 4.93 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.53 0.681 . . . . 0.0 111.657 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.703 ' HA ' HD23 ' A' ' 182' ' ' LEU . 3.9 m -170.68 105.9 0.27 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.863 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.695 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 21.9 m-85 -53.64 149.13 8.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.933 0.397 . . . . 0.0 111.079 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.64 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 60.8 mt-30 -115.15 163.49 15.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.024 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 234' ' ' PRO . 15.2 t -82.61 98.88 0.53 Allowed Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.987 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.64 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 50.4 Cg_endo -66.52 -31.32 41.97 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.587 2.191 . . . . 0.0 112.384 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.86 -121.52 5.18 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.611 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -94.19 115.85 28.17 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.779 ' CZ ' HD11 ' A' ' 207' ' ' LEU . 0.0 OUTLIER -130.12 146.87 51.8 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.508 -178.809 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.982 HD12 HG23 ' A' ' 42' ' ' THR . 6.7 tp . . . . . 0 CA--C 1.514 -0.419 0 CA-C-O 121.043 0.449 . . . . 0.0 110.716 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.568 ' OD1' ' HA ' ' A' ' 50' ' ' VAL . 59.1 m-20 . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.675 0.274 . . . . 0.0 111.735 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 -65.59 -46.68 78.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.835 0.35 . . . . 0.0 110.767 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.982 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -69.39 -35.84 76.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.401 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.908 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -59.96 -53.96 51.76 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.237 0.542 . . . . 0.0 110.705 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.751 HD21 ' HB2' ' A' ' 105' ' ' ALA . 11.8 tp -63.54 -54.35 37.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.951 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.803 HD21 ' HG2' ' A' ' 178' ' ' MET . 78.0 mt -52.73 -34.1 51.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.929 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.711 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -78.09 -29.28 49.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.658 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.781 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -73.89 -31.66 63.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.422 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.867 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -88.98 -12.04 42.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.362 . . . . 0.0 110.955 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -80.4 169.46 17.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.735 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -102.64 97.35 7.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.171 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.53 141.77 6.55 Favored Glycine 0 C--N 1.317 -0.519 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.257 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.73 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 7.1 tttt -64.28 134.92 55.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.083 0.468 . . . . 0.0 111.745 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.647 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.8 OUTLIER -131.59 155.08 48.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.616 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.778 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 26.2 t -100.87 141.17 18.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.052 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.982 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -128.08 111.2 13.22 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.269 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.937 HG23 HD12 ' A' ' 238' ' ' LEU . 0.7 OUTLIER -103.79 164.73 11.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.323 0.582 . . . . 0.0 111.886 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.623 ' HB2' HD11 ' A' ' 238' ' ' LEU . 27.9 t30 71.28 21.25 4.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.325 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.67 HD22 HD11 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -58.51 160.35 5.51 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.296 178.667 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.654 ' HB3' HG21 ' A' ' 50' ' ' VAL . 25.6 tp -92.86 114.2 26.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.008 0.432 . . . . 0.0 111.415 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -75.0 68.78 1.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.599 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 t -129.34 -163.4 1.29 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.052 0.454 . . . . 0.0 111.322 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.581 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 48.9 m-20 -98.27 -20.65 17.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.714 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 3.7 p-10 -72.43 -27.03 62.08 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.007 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.654 HG21 ' HB3' ' A' ' 45' ' ' LEU . 17.8 t -89.07 -51.7 11.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.708 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.581 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -51.25 -27.63 9.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.181 0.515 . . . . 0.0 110.015 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . 54.0 m170 -73.35 -36.6 66.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.962 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.618 ' SD ' ' HB1' ' A' ' 98' ' ' ALA . 13.4 tpt -64.56 -50.62 66.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.908 HD23 HD21 ' A' ' 29' ' ' LEU . 1.4 mp -62.41 -48.93 77.53 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 17.7 t-20 -57.13 -22.35 39.28 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.99 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.686 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -75.08 -46.4 34.94 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.53 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.601 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -69.28 -49.46 55.87 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.861 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.48 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 4.9 t -50.8 -30.41 14.15 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.273 0.559 . . . . 0.0 110.298 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.729 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.83 -51.13 71.04 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.077 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.127 HD21 HD22 ' A' ' 106' ' ' LEU . 3.8 mp -66.1 -27.92 68.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.878 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.16 -0.9 5.73 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 114.77 -1.105 . . . . 0.0 113.67 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.645 HG21 HD11 ' A' ' 82' ' ' LEU . 12.0 t -58.34 149.71 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 117.695 0.747 . . . . 0.0 110.359 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.417 ' HB2' HD12 ' A' ' 76' ' ' ILE . 4.0 m -113.48 108.45 17.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.214 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.664 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 12.9 p90 -126.67 159.75 32.75 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.173 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.634 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 72.3 m -149.76 116.78 5.97 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.984 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.829 HD22 ' SG ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -88.2 173.24 8.91 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.332 0.587 . . . . 0.0 112.142 -179.481 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.691 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -82.51 178.57 8.15 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.621 178.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.56 -12.59 46.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.705 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.14 1.38 11.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.239 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.43 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 1.6 mmt180 63.54 44.51 5.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.59 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -123.08 -2.84 8.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.229 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.691 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.1 OUTLIER -141.65 112.32 7.16 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.429 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.829 ' SG ' HD22 ' A' ' 66' ' ' LEU . 2.3 t -116.38 147.25 41.81 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.653 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 1.6 mt-10 -112.51 103.07 11.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -96.8 126.68 49.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 8.5 mt -80.96 102.89 7.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.007 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.711 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -46.6 113.0 1.01 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.957 -0.565 . . . . 0.0 113.974 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.632 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -60.35 -16.81 38.59 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.969 0.414 . . . . 0.0 110.341 178.735 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.45 -20.64 16.79 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.348 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.867 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.46 -151.67 5.84 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.827 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 5.4 Cg_exo -75.88 170.73 19.55 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 CA-C-N 119.653 1.726 . . . . 0.0 109.167 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.781 HD21 ' HB3' ' A' ' 33' ' ' ALA . 4.3 mm? -67.84 89.68 0.28 Allowed 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.827 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 27.8 m170 -81.68 119.38 23.76 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.017 -1.901 . . . . 0.0 112.688 -176.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.73 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -145.9 111.2 5.37 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.952 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -112.46 88.79 2.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.511 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -176.18 20.16 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.701 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.45 49.99 15.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.412 0.625 . . . . 0.0 110.037 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.778 ' O ' HG23 ' A' ' 113' ' ' ILE . 5.6 tp -79.01 133.14 36.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.09 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.684 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 1.4 tm-20 -112.11 128.66 56.28 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.636 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.625 HD21 ' CB ' ' A' ' 59' ' ' ALA . 39.0 mt -110.37 158.59 18.28 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.448 ' CE1' ' CA ' ' A' ' 93' ' ' GLY . 21.5 t80 -126.51 106.63 9.58 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.844 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 1.074 HD23 ' HE1' ' A' ' 99' ' ' MET . 2.1 mm? -95.82 8.28 43.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.184 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.448 ' CA ' ' CE1' ' A' ' 91' ' ' PHE . . . 46.95 -142.55 5.8 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.724 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.482 ' O ' ' ND2' ' A' ' 94' ' ' ASN . 0.6 OUTLIER -93.15 49.61 1.43 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.892 0.377 . . . . 0.0 111.039 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -86.77 -75.82 0.38 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.089 0.471 . . . . 0.0 111.156 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.34 -17.46 13.39 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.089 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.531 HG22 ' NE2' ' A' ' 171' ' ' GLN . 3.9 p -94.06 -9.73 35.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.862 0.363 . . . . 0.0 111.052 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.618 ' HB1' ' SD ' ' A' ' 53' ' ' MET . . . -125.8 -22.45 4.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.524 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . 1.074 ' HE1' HD23 ' A' ' 92' ' ' LEU . 5.5 tpp -66.11 -51.23 59.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.818 0.342 . . . . 0.0 110.75 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.804 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -61.48 -56.11 36.49 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.283 -179.319 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.7 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 38.5 Cg_exo -59.43 -46.01 23.45 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.308 2.005 . . . . 0.0 112.668 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.666 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 3.1 tm? -69.42 -35.28 75.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.481 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.92 -48.24 81.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.284 0.564 . . . . 0.0 110.79 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.826 ' O ' HG21 ' A' ' 179' ' ' THR . . . -72.17 -34.65 68.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.846 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.751 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -59.04 -44.12 91.72 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.95 0.405 . . . . 0.0 111.865 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.127 HD22 HD21 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -69.74 -22.44 63.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.373 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.576 ' SG ' HD11 ' A' ' 140' ' ' ILE . 23.1 m -60.26 -10.3 4.45 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.907 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.689 HD11 ' O ' ' A' ' 179' ' ' THR . 11.5 mt -82.86 169.68 15.82 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 51.87 -110.97 1.25 Allowed Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.406 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.437 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 62.7 m -162.73 99.42 1.0 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.753 0.311 . . . . 0.0 110.354 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 2.6 m-20 -138.18 135.33 35.54 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.625 ' C ' HD12 ' A' ' 113' ' ' ILE . 2.8 m-20 -102.41 111.1 23.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.292 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.9 mp -144.39 142.74 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.202 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 21.7 t -113.87 112.51 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.844 0.354 . . . . 0.0 110.252 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.439 ' CD2' ' HB2' ' A' ' 90' ' ' LEU . 28.7 mt -83.91 156.93 22.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.565 0.697 . . . . 0.0 112.14 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 117' ' ' GLY . 1.9 m -160.55 174.89 13.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.813 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.474 ' H ' HG22 ' A' ' 116' ' ' THR . . . -160.65 -164.84 16.32 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.774 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.64 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 6.8 mt-10 -69.51 174.97 2.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.26 -0.47 . . . . 0.0 110.82 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 22.6 Cg_endo -61.81 -36.08 75.37 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.169 1.913 . . . . 0.0 112.077 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.542 ' O ' ' HG2' ' A' ' 123' ' ' GLU . 8.2 tpt180 -78.96 -31.08 44.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.815 0.341 . . . . 0.0 110.338 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.513 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 11.0 tpt -62.4 -16.12 52.94 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.261 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.658 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 10.3 mmtp -68.65 -8.98 47.16 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.649 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 0.3 OUTLIER -120.79 26.33 9.16 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.142 179.005 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.419 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 2.1 mmp_? -98.55 89.02 0.76 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.482 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.726 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.1 Cg_endo -47.85 135.72 22.82 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.582 2.188 . . . . 0.0 112.373 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.775 HD11 HD23 ' A' ' 129' ' ' LEU . 19.3 tt -142.21 32.42 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.735 0.779 . . . . 0.0 110.233 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.622 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -73.85 -51.13 9.54 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.889 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.709 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.6 OUTLIER -52.15 -31.16 29.94 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.02 0.438 . . . . 0.0 110.653 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.778 ' CD1' HD21 ' A' ' 133' ' ' LEU . 22.8 tp -78.63 -62.93 1.53 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.798 HG13 HD12 ' A' ' 140' ' ' ILE . 67.2 t -52.33 -26.17 8.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.363 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.622 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -73.71 -43.81 58.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.675 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.957 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -65.87 -52.1 53.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.912 0.387 . . . . 0.0 111.322 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.914 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -56.3 -45.89 80.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.364 0.602 . . . . 0.0 109.641 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.411 ' CD ' HG12 ' A' ' 130' ' ' VAL . 9.9 mtp180 -58.91 -36.19 74.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.354 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.957 HD12 ' HA ' ' A' ' 132' ' ' ALA . 4.6 mt -65.76 -33.72 76.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.028 0.442 . . . . 0.0 110.077 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.491 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -74.6 -18.87 80.02 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.603 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 130.68 3.43 4.59 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.276 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.408 ' CB ' ' HB3' ' A' ' 107' ' ' CYS . . . -70.3 147.54 49.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.909 0.355 . . . . 0.0 111.225 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 9.2 mtmm -114.15 94.32 4.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.962 HG23 HD23 ' A' ' 153' ' ' LEU . 11.1 mt -118.18 175.35 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.966 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.781 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -150.31 -167.97 2.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.037 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.698 ' N ' HG23 ' A' ' 141' ' ' THR . 24.6 m-85 -136.16 100.85 4.52 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.589 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.2 mm? -71.67 -12.97 61.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.846 -177.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.815 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 2.5 mt-10 -140.19 -71.57 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.92 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.515 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -124.15 150.28 45.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.025 0.441 . . . . 0.0 111.426 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.46 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 61.3 mt-10 -69.38 130.4 42.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.809 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.726 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 6.6 m-20 67.49 50.04 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.418 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.683 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 2.8 m-30 -145.53 174.53 3.37 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.096 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.683 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 4.8 Cg_endo -45.7 -40.53 19.0 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.487 2.791 . . . . 0.0 114.904 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.815 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 36.9 Cg_endo -62.47 101.38 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.386 1.39 . . . . 0.0 111.26 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.542 HD23 ' O ' ' A' ' 150' ' ' PRO . 79.1 mt -139.23 123.61 18.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.734 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.736 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.6 OUTLIER -106.17 112.27 25.23 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.962 HD23 HG23 ' A' ' 140' ' ' ILE . 4.8 mt -94.18 158.92 15.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.33 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 19.4 mt-30 -146.12 24.67 1.29 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.522 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 58.26 -161.65 11.1 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.362 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 158' ' ' THR . . . 101.18 -3.94 55.17 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.742 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.682 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 3.4 t80 -61.39 107.48 0.78 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.984 0.421 . . . . 0.0 110.714 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.567 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 71.3 p -105.16 -50.83 3.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.173 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.575 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.08 -162.33 27.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.0 -1.095 . . . . 0.0 114.326 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.594 ' O ' HG23 ' A' ' 162' ' ' VAL . . . 116.26 169.43 15.41 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.92 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -61.97 126.67 28.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.934 0.367 . . . . 0.0 110.034 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.63 HG13 HD13 ' A' ' 135' ' ' LEU . 47.9 t -136.57 154.49 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 120.903 0.382 . . . . 0.0 111.793 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.487 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.6 OUTLIER -120.93 117.14 26.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.607 HG21 ' CD1' ' A' ' 176' ' ' LEU . 0.3 OUTLIER -118.72 140.79 41.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.939 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.709 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.5 OUTLIER -78.6 135.39 37.25 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.114 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.717 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -76.4 -44.62 16.41 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.061 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.469 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 3.2 m -49.1 164.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.918 0.39 . . . . 0.0 111.611 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.0 t 70.26 54.58 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.074 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.822 ' H ' HG11 ' A' ' 196' ' ' VAL . 6.4 m 59.86 154.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.934 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.455 ' HB3' ' CB ' ' A' ' 197' ' ' SER . 18.9 p -77.36 1.24 19.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.044 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.804 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 44.0 mm-40 -53.59 -23.27 10.37 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.874 0.368 . . . . 0.0 111.34 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.703 ' HA ' HD13 ' A' ' 129' ' ' LEU . 1.9 m-85 -76.43 -56.06 4.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.14 0.495 . . . . 0.0 110.572 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.576 HD13 HG11 ' A' ' 164' ' ' VAL . 37.4 tp -72.96 -41.04 64.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.309 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 38.2 m -55.94 -34.51 65.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.753 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.654 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -70.86 -50.87 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.108 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.914 ' CD2' HD23 ' A' ' 133' ' ' LEU . 1.4 mt -67.33 -38.07 84.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.609 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.018 HD22 HD21 ' A' ' 205' ' ' LEU . 8.9 mt -65.57 -25.29 67.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.686 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.803 ' HG2' HD21 ' A' ' 31' ' ' LEU . 9.8 mtp -96.64 -28.79 14.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.166 0.508 . . . . 0.0 111.031 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.826 HG21 ' O ' ' A' ' 104' ' ' ALA . 55.4 m -89.12 -46.19 9.01 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.815 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.749 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -60.74 -37.13 42.25 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.701 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.8 Cg_endo -53.15 -37.36 79.75 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 121.101 1.2 . . . . 0.0 111.967 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.48 -7.01 59.42 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.955 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -67.54 119.5 66.21 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.881 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 2.7 Cg_exo -37.47 -32.68 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.684 2.922 . . . . 0.0 114.417 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.81 151.8 23.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.056 0.455 . . . . 0.0 111.616 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.67 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 3.6 t0 -65.74 116.92 7.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.481 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.724 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 28.2 m -102.63 134.94 45.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.339 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 1.104 HG22 HG13 ' A' ' 224' ' ' VAL . 41.1 t -125.45 99.3 5.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.091 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.605 ' O ' ' N ' ' A' ' 223' ' ' PHE . 4.0 mt -90.4 143.56 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.311 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.822 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -115.01 171.25 7.77 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 177.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.822 HD13 ' C ' ' A' ' 190' ' ' ARG . 1.2 mm -110.9 97.27 5.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 120.969 0.414 . . . . 0.0 111.314 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 12.3 mtmt -61.14 -80.96 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.468 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -79.23 167.84 52.65 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.212 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.48 124.67 21.05 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.879 HD23 ' HA ' ' A' ' 198' ' ' LYS . 1.5 tp -59.35 146.36 40.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.105 0.478 . . . . 0.0 110.539 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.822 HG11 ' H ' ' A' ' 169' ' ' SER . 12.6 p -104.45 -18.66 6.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.203 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.713 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.6 OUTLIER -129.29 45.63 2.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.498 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.879 ' HA ' HD23 ' A' ' 195' ' ' LEU . 3.8 ttpt -41.98 -60.87 1.75 Allowed Pre-proline 0 N--CA 1.466 0.338 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.784 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 12.1 Cg_exo -70.7 -16.44 33.61 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 121.871 1.714 . . . . 0.0 111.786 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.834 ' HA ' HD12 ' A' ' 203' ' ' ILE . 14.4 m-85 -76.36 -26.27 55.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.715 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.891 HD11 HD12 ' A' ' 177' ' ' LEU . 7.2 tp -75.19 -31.47 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.744 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 5.0 t70 -61.9 -34.25 75.69 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.8 mt -67.23 -27.35 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.259 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.62 HG22 ' SD ' ' A' ' 208' ' ' MET . 42.1 m -60.86 -57.45 12.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.541 0.686 . . . . 0.0 109.615 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 1.018 HD21 HD22 ' A' ' 177' ' ' LEU . 19.2 mt -70.32 -32.04 69.61 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.539 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.685 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 1.5 m-20 -66.73 -30.62 70.89 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.677 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -75.72 -46.23 32.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.154 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.62 ' SD ' HG22 ' A' ' 204' ' ' THR . 18.6 mtp -62.67 -39.57 94.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.318 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.685 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -68.04 -41.89 81.39 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.003 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.544 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.4 OUTLIER -61.65 -28.15 69.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.126 0.489 . . . . 0.0 109.736 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.781 ' HA ' ' HG3' ' A' ' 234' ' ' PRO . 0.8 OUTLIER -76.04 -50.99 13.26 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.761 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 156.51 -1.59 0.14 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.283 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.574 HG13 ' CG ' ' A' ' 229' ' ' GLN . 61.1 t -117.54 139.05 46.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.968 0.413 . . . . 0.0 111.701 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -134.11 153.94 51.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.713 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.94 HD11 HD13 ' A' ' 205' ' ' LEU . 2.4 pp -131.81 175.16 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.611 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 1.006 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 30.5 tt0 -89.99 125.74 35.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.753 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -101.27 101.04 11.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.128 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.707 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -67.02 -166.18 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.472 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -76.14 48.36 0.5 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.888 0.375 . . . . 0.0 110.362 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.547 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.1 OUTLIER 57.28 21.21 6.45 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.135 -179.468 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 191' ' ' ILE . 22.5 tt0 -113.11 -22.77 10.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.517 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.796 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 14.5 mt-30 -147.37 140.26 24.99 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 1.005 ' HB3' HD21 ' A' ' 177' ' ' LEU . 24.6 m-85 -112.59 96.73 6.15 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 1.104 HG13 HG22 ' A' ' 188' ' ' VAL . 42.5 t -84.05 111.13 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.06 0.457 . . . . 0.0 111.199 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.936 HG12 HG21 ' A' ' 215' ' ' ILE . 3.6 m -99.71 116.75 43.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.142 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.672 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 3.0 mptt -62.64 103.99 0.48 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.127 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.67 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.05 154.33 19.32 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.98 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.6 8.56 76.83 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.367 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.672 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 64.2 mm-40 -71.6 -179.57 2.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.421 0.629 . . . . 0.0 111.184 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.673 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.2 m -170.43 105.71 0.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.688 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.672 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 22.8 m-85 -53.58 146.03 13.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.085 0.469 . . . . 0.0 111.309 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.611 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 90.2 mt-30 -110.93 153.19 25.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.58 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 27.5 p -78.07 103.06 1.13 Allowed Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.231 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.781 ' HG3' ' HA ' ' A' ' 211' ' ' PHE . 10.5 Cg_exo -73.86 -37.16 3.04 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.849 2.366 . . . . 0.0 111.577 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 128.8 -120.24 3.24 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.418 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.778 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -91.08 116.52 28.87 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.588 ' CE2' HD11 ' A' ' 207' ' ' LEU . 67.1 t80 -124.08 141.49 52.01 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.644 -0.422 . . . . 0.0 112.085 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.937 HD12 HG23 ' A' ' 42' ' ' THR . 6.5 tp . . . . . 0 CA--C 1.514 -0.432 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.134 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.885 ' HA ' HD12 ' A' ' 29' ' ' LEU . 13.6 p30 . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 120.93 0.395 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.431 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 3.0 mtm105 -62.02 -51.06 69.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.399 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.937 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -65.87 -41.11 92.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.379 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.885 HD12 ' HA ' ' A' ' 26' ' ' ASN . 12.1 mt -59.8 -50.6 73.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 0.0 110.81 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.4 tp -69.12 -46.15 68.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.976 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.617 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 65.2 mt -61.01 -28.68 69.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.736 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.648 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . . . -77.11 -28.72 54.53 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.552 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.881 ' HB2' HD23 ' A' ' 57' ' ' LEU . . . -68.57 -31.12 70.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.875 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.893 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.82 -11.67 41.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.016 0.436 . . . . 0.0 110.883 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -79.85 167.77 20.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.764 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -101.31 98.92 9.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.595 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 114.63 142.18 7.83 Favored Glycine 0 C--N 1.314 -0.643 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.568 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.844 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 3.3 tttt -64.27 128.7 36.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.248 0.547 . . . . 0.0 111.938 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.51 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -123.6 160.9 26.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.06 178.773 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.705 HG22 ' HG3' ' A' ' 74' ' ' GLU . 91.9 t -110.99 140.78 28.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.32 . . . . 0.0 111.781 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.937 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -129.39 111.29 12.66 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.113 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.935 HG23 HD12 ' A' ' 238' ' ' LEU . 0.0 OUTLIER -96.04 172.14 8.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.188 0.518 . . . . 0.0 111.534 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 71' ' ' THR . 0.1 OUTLIER 66.77 18.79 10.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.729 -178.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.955 HD22 HD11 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -58.73 164.43 2.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.868 179.078 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.511 ' HB3' HG21 ' A' ' 50' ' ' VAL . 27.7 tp -99.37 112.7 24.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.892 0.377 . . . . 0.0 111.721 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -71.69 68.14 0.59 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.555 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.455 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 12.8 t -129.48 -163.54 1.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.212 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.576 ' HA ' ' HE ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -98.59 -22.87 15.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.768 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.649 ' OD1' HG23 ' A' ' 50' ' ' VAL . 2.1 p30 -69.05 -26.02 64.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.727 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.649 HG23 ' OD1' ' A' ' 49' ' ' ASP . 24.0 t -88.07 -56.59 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.295 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.576 ' HE ' ' HA ' ' A' ' 48' ' ' ASP . 1.8 ptt180 -52.83 -24.41 8.95 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.197 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 55' ' ' ASN . 4.6 m-70 -75.52 -38.08 59.63 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.748 ' O ' HD12 ' A' ' 57' ' ' LEU . 8.6 tpt -60.27 -54.65 43.17 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.788 ' HA ' HD13 ' A' ' 57' ' ' LEU . 1.9 mp -59.34 -47.97 83.4 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.712 177.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.565 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -48.51 -30.71 5.49 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.639 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.883 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -69.17 -51.36 38.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.298 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.881 HD23 ' HB2' ' A' ' 33' ' ' ALA . 3.4 mp -60.12 -49.18 78.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.812 0.339 . . . . 0.0 110.636 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.616 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.8 t -53.8 -30.79 46.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.095 0.474 . . . . 0.0 110.24 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.691 ' CB ' HD21 ' A' ' 88' ' ' LEU . . . -60.37 -50.88 71.84 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.168 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.97 HD21 HD22 ' A' ' 106' ' ' LEU . 3.9 mp -65.84 -27.75 68.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.484 0.659 . . . . 0.0 110.131 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.92 -0.0 7.13 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 114.725 -1.125 . . . . 0.0 113.03 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 13.5 t -55.19 159.99 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 117.216 0.508 . . . . 0.0 110.47 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.569 ' HB2' HD12 ' A' ' 76' ' ' ILE . 3.3 m -122.22 109.52 14.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.623 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.698 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 10.1 p90 -126.57 158.98 34.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.607 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 25.1 m -150.64 116.83 5.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.658 0.266 . . . . 0.0 111.267 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.955 HD11 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -86.38 178.09 7.24 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.216 0.532 . . . . 0.0 111.748 -179.651 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.723 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -90.1 178.58 6.15 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.811 179.122 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.24 -11.88 45.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.596 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.4 1.45 11.79 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.876 0.37 . . . . 0.0 110.462 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.451 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 3.1 mtt85 61.57 43.27 10.25 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.84 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.494 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -124.05 -2.27 8.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.293 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.723 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -143.0 111.13 6.06 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.968 0.413 . . . . 0.0 109.937 179.001 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.752 ' SG ' HD22 ' A' ' 66' ' ' LEU . 1.6 t -113.17 155.92 24.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.705 ' HG3' HG22 ' A' ' 40' ' ' VAL . 5.9 mt-10 -119.76 102.94 8.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.964 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.844 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -102.32 129.26 54.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.569 HD12 ' HB2' ' A' ' 63' ' ' SER . 10.3 mt -82.16 102.3 7.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.351 178.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.635 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -48.43 111.97 1.04 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.771 -0.65 . . . . 0.0 113.681 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.646 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -57.2 -17.58 11.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 110.616 178.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.12 -22.36 19.39 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.446 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.893 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -139.96 -145.15 4.63 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.754 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 4.1 Cg_exo -79.15 168.24 20.68 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 121.969 1.779 . . . . 0.0 108.984 177.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.795 HD12 HD13 ' A' ' 60' ' ' LEU . 4.4 mm? -66.55 91.04 0.17 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.754 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 27.8 m170 -83.93 118.88 24.29 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 113.44 -1.709 . . . . 0.0 113.133 -175.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.846 ' HB3' HD11 ' A' ' 113' ' ' ILE . . . -148.84 110.58 4.52 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.898 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.4 87.88 2.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.59 0.233 . . . . 0.0 111.557 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -174.45 22.83 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.873 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 56.76 53.76 7.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.492 0.663 . . . . 0.0 110.096 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.703 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 5.2 tp -85.92 135.37 33.71 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.939 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.673 ' C ' HD23 ' A' ' 90' ' ' LEU . 4.0 tt0 -115.27 130.16 56.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.242 0.544 . . . . 0.0 110.689 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.883 HD13 ' HA ' ' A' ' 56' ' ' ALA . 3.5 mt -108.68 153.79 22.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.744 -178.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.468 ' CE1' ' CA ' ' A' ' 93' ' ' GLY . 53.8 t80 -118.52 106.59 12.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.817 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.842 HD23 ' HE2' ' A' ' 99' ' ' MET . 1.8 mm? -91.61 3.56 54.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.251 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.611 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 43.12 -140.34 2.59 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 116.207 -0.451 . . . . 0.0 113.625 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -93.54 52.03 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.07 0.462 . . . . 0.0 111.1 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -94.05 -75.51 0.5 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.376 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.97 -19.78 9.27 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.392 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.508 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -96.59 -9.56 29.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.772 0.32 . . . . 0.0 110.862 179.175 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.04 -19.99 5.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.773 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.842 ' HE2' HD23 ' A' ' 92' ' ' LEU . 9.7 ttm -70.72 -54.18 12.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.982 0.42 . . . . 0.0 111.164 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.774 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.2 mpt_? -57.72 -53.53 64.68 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.091 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.656 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 31.3 Cg_exo -59.3 -47.34 17.44 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.84 2.36 . . . . 0.0 113.135 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.68 HD11 HD12 ' A' ' 90' ' ' LEU . 3.0 tm? -66.67 -33.97 76.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.554 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.548 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -61.66 -47.37 85.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.464 0.649 . . . . 0.0 110.215 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.709 ' O ' HG21 ' A' ' 179' ' ' THR . . . -71.46 -37.33 71.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.749 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.522 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -57.14 -43.4 82.41 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.897 0.38 . . . . 0.0 111.393 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.97 HD22 HD21 ' A' ' 60' ' ' LEU . 1.7 mt -70.58 -23.11 62.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.41 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.491 ' C ' ' HA2' ' A' ' 155' ' ' GLY . 87.7 m -59.33 -11.11 3.68 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.019 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.728 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 12.6 mt -83.33 166.11 18.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.67 0.271 . . . . 0.0 110.318 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 54.56 -112.1 2.52 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.272 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.5 97.74 0.99 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 2.8 m120 -138.32 138.35 38.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.775 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.899 ' O ' HD13 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -104.1 110.41 22.58 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.58 178.667 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.899 HD13 ' O ' ' A' ' 112' ' ' ASP . 25.1 mm -136.66 143.38 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.528 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.654 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 19.4 t -115.33 113.42 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.548 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 17.6 mt -82.42 152.98 25.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.495 0.664 . . . . 0.0 112.325 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.615 HG22 ' O ' ' A' ' 90' ' ' LEU . 9.5 t -160.27 163.59 33.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.892 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -157.57 -167.54 18.72 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.647 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.611 ' HG2' ' HA2' ' A' ' 93' ' ' GLY . 8.4 mm-40 -67.67 172.98 3.29 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.846 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 33.0 Cg_exo -62.07 -23.8 75.99 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.364 2.043 . . . . 0.0 112.171 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.455 ' HD2' ' CG ' ' A' ' 123' ' ' GLU . 8.1 tpt180 -85.56 -39.47 17.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.836 0.35 . . . . 0.0 110.556 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.605 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 10.8 tpt -59.48 -20.18 53.34 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.651 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 20.6 mttt -68.8 -7.13 31.29 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.255 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.548 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 3.9 pt-20 -120.0 28.17 8.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.115 0.483 . . . . 0.0 110.728 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.415 ' HA ' ' NE ' ' A' ' 124' ' ' ARG . 6.5 mmp_? -103.51 112.97 65.94 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.582 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 24.8 Cg_exo -60.84 137.01 69.79 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.274 1.983 . . . . 0.0 112.023 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.676 HD12 ' HD2' ' A' ' 100' ' ' ARG . 17.3 tt -145.01 30.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.849 0.833 . . . . 0.0 109.966 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -77.0 -50.44 6.87 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 114.39 -1.277 . . . . 0.0 112.101 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.68 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.7 OUTLIER -57.26 -28.4 62.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.865 0.364 . . . . 0.0 110.668 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.9 ' CD1' HD21 ' A' ' 133' ' ' LEU . 20.6 tp -79.14 -63.85 1.32 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.859 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 1.051 HG13 HD12 ' A' ' 140' ' ' ILE . 60.6 t -55.28 -24.61 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.337 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.593 ' O ' HD12 ' A' ' 135' ' ' LEU . 0.4 OUTLIER -70.6 -45.2 65.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.352 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.841 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -65.81 -53.25 42.65 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.418 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.994 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -55.86 -44.23 77.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.101 0.477 . . . . 0.0 109.77 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.63 -38.99 75.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.449 179.267 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.841 HD12 ' HA ' ' A' ' 132' ' ' ALA . 2.4 mt -64.91 -30.6 71.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.436 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.487 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -78.22 -18.15 76.88 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.471 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.65 2.98 5.19 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.165 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.95 146.48 54.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.944 0.372 . . . . 0.0 111.248 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -114.75 88.72 2.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.241 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.051 HD12 HG13 ' A' ' 130' ' ' VAL . 6.3 mt -115.59 176.63 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.085 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.796 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -154.45 -174.92 5.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.919 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.607 ' N ' HG23 ' A' ' 141' ' ' THR . 20.1 m-85 -126.63 106.98 9.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.049 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.67 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.4 mm? -77.36 -18.65 57.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.389 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.652 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 1.7 mm-40 -134.71 -73.04 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.969 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.603 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -123.27 149.81 44.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.727 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.484 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 4.6 pt-20 -69.61 135.12 49.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.093 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 12.1 m-20 64.92 46.99 2.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.48 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.828 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 4.6 m-85 -144.08 176.64 2.15 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.111 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.828 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 10.3 Cg_endo -52.01 -39.89 68.78 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.131 2.554 . . . . 0.0 115.629 -177.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.652 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 19.7 Cg_endo -61.9 100.4 0.2 Allowed 'Trans proline' 0 CA--C 1.515 -0.458 0 C-N-CA 120.861 1.041 . . . . 0.0 110.944 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 150' ' ' PRO . 84.1 mt -137.05 123.89 21.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.817 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.767 ' HB3' HG22 ' A' ' 141' ' ' THR . 1.6 ttm180 -105.03 111.83 24.74 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 1.028 HD23 HG23 ' A' ' 140' ' ' ILE . 1.5 mt -94.98 160.12 14.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.684 -178.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.588 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 4.1 mt-30 -148.86 25.69 0.92 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.906 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.491 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 54.5 -166.45 2.44 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.477 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 109.84 -4.87 30.66 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.946 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.676 ' CD2' HG22 ' A' ' 179' ' ' THR . 2.3 t80 -60.89 106.99 0.64 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.783 0.325 . . . . 0.0 110.681 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' THR . . . . . 0.457 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 43.5 p -104.97 -48.65 3.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.639 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.53 -162.23 27.67 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 119.889 -1.148 . . . . 0.0 114.293 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' ' 162' ' ' VAL . . . 114.36 168.94 16.3 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 114.937 -0.632 . . . . 0.0 112.003 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -63.08 126.2 26.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.626 HG11 ' HB1' ' A' ' 132' ' ' ALA . 62.1 t -133.51 157.63 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.091 0.472 . . . . 0.0 111.578 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.478 ' N ' HG12 ' A' ' 162' ' ' VAL . 0.7 OUTLIER -124.31 116.12 22.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.891 179.267 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.851 HG11 HD13 ' A' ' 173' ' ' LEU . 0.3 OUTLIER -115.02 150.92 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.92 -179.005 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.68 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 2.7 t0 -89.83 127.36 35.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.667 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.712 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -70.16 -44.68 59.4 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.651 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.491 ' C ' HG23 ' A' ' 168' ' ' VAL . 1.4 m -50.91 164.76 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.837 0.351 . . . . 0.0 111.517 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.491 HG23 ' C ' ' A' ' 167' ' ' SER . 2.1 t 69.17 56.75 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 121.275 0.559 . . . . 0.0 111.112 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.807 ' H ' HG11 ' A' ' 196' ' ' VAL . 2.0 m 58.3 159.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.458 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.466 ' O ' HG22 ' A' ' 174' ' ' THR . 12.4 p -82.65 0.43 43.19 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.807 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.774 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 2.1 mp0 -51.12 -21.91 2.2 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.934 0.397 . . . . 0.0 111.049 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.553 ' O ' HD12 ' A' ' 176' ' ' LEU . 1.4 m-85 -78.96 -53.95 6.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.765 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.851 HD13 HG11 ' A' ' 164' ' ' VAL . 22.7 tp -74.71 -40.5 61.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.441 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 171' ' ' GLN . 13.6 t -57.96 -34.31 69.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -68.37 -51.12 47.83 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.497 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.994 ' CD2' HD23 ' A' ' 133' ' ' LEU . 2.6 mt -67.78 -37.0 81.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.541 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.992 HD11 ' CD2' ' A' ' 223' ' ' PHE . 8.2 mt -67.88 -24.63 65.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.075 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.525 ' HA ' ' OH ' ' A' ' 231' ' ' TYR . 13.5 ptp -98.92 -28.48 13.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.12 0.486 . . . . 0.0 110.811 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.709 HG21 ' O ' ' A' ' 104' ' ' ALA . 27.4 m -86.37 -46.22 10.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.991 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.879 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -60.94 -37.26 42.72 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.711 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 12.1 Cg_endo -54.54 -36.69 89.43 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 121.232 1.288 . . . . 0.0 111.797 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.686 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -85.16 -6.48 59.29 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.828 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -66.9 114.99 20.51 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.16 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -31.09 -36.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.073 3.182 . . . . 0.0 114.642 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -105.47 153.34 21.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.968 0.413 . . . . 0.0 111.797 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.684 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 1.3 t0 -63.92 118.27 8.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.568 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.711 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 61.4 m -104.16 133.75 48.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.056 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 1.008 HG22 HG13 ' A' ' 224' ' ' VAL . 35.3 t -125.43 99.63 6.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.252 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.1 mt -90.82 143.56 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.418 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.84 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -114.33 171.07 7.84 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.888 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.84 HD13 ' C ' ' A' ' 190' ' ' ARG . 1.1 mm -111.41 96.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 120.973 0.415 . . . . 0.0 111.17 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -60.83 -81.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.625 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.429 ' HA3' ' OD1' ' A' ' 165' ' ' ASP . . . -78.12 168.4 53.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.269 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -61.41 122.62 15.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.635 0.255 . . . . 0.0 110.856 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.81 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.8 OUTLIER -58.43 143.63 44.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.96 0.41 . . . . 0.0 110.577 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.807 HG11 ' H ' ' A' ' 169' ' ' SER . 13.1 p -103.58 -18.82 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.512 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.673 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.6 OUTLIER -126.6 45.62 2.64 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.489 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.81 ' HA ' HD23 ' A' ' 195' ' ' LEU . 0.4 OUTLIER -42.15 -60.44 2.07 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.196 -0.911 . . . . 0.0 113.122 -178.52 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 7.6 Cg_exo -72.68 -16.32 26.76 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 121.908 1.739 . . . . 0.0 111.987 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.739 ' HA ' HD12 ' A' ' 203' ' ' ILE . 16.5 m-85 -75.64 -29.91 59.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.255 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.92 HD11 HD12 ' A' ' 177' ' ' LEU . 6.2 tp -70.69 -35.64 61.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -59.35 -33.16 70.83 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.147 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.739 HD12 ' HA ' ' A' ' 200' ' ' TYR . 15.1 mt -67.71 -32.86 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.238 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.489 HG22 ' SD ' ' A' ' 208' ' ' MET . 52.4 m -57.44 -52.64 64.54 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.944 HD21 HD22 ' A' ' 177' ' ' LEU . 13.3 mt -73.82 -35.45 64.85 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.92 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 202' ' ' ASP . 0.7 OUTLIER -64.0 -28.03 69.53 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.171 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.617 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -79.17 -44.02 22.77 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.842 178.473 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 208' ' ' MET . . . . . 0.514 ' HG2' ' CZ ' ' A' ' 231' ' ' TYR . 22.4 mtp -65.0 -38.83 92.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.456 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.518 ' HG3' ' N ' ' A' ' 210' ' ' THR . 0.0 OUTLIER -65.21 -48.94 71.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.666 0.269 . . . . 0.0 110.64 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.518 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.5 OUTLIER -56.53 -29.28 61.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.278 0.561 . . . . 0.0 109.843 179.064 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.648 ' CE2' ' HA ' ' A' ' 32' ' ' ALA . 1.1 m-85 -71.48 -48.84 46.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.002 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.474 ' HA3' ' HG2' ' A' ' 232' ' ' GLN . . . 153.21 -4.84 0.36 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.114 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.64 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 73.4 t -120.19 140.78 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.09 0.472 . . . . 0.0 111.823 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -134.08 156.0 49.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.662 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.925 HG21 HG12 ' A' ' 225' ' ' VAL . 2.3 pp -132.75 175.72 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.891 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.986 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 41.3 tt0 -90.36 124.66 35.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.068 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -100.99 100.87 11.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.003 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.733 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 2.1 mm-40 -66.64 -166.72 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.612 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -74.74 48.58 0.37 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.884 0.373 . . . . 0.0 110.41 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' TYR . . . . . 0.541 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 57.47 20.66 6.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 -179.515 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 191' ' ' ILE . 66.3 mt-30 -112.69 -21.55 11.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.738 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' GLN . . . . . 0.784 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 46.6 mt-30 -149.04 141.34 24.1 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.902 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.992 ' CD2' HD11 ' A' ' 177' ' ' LEU . 19.7 m-85 -113.32 96.53 5.95 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 1.008 HG13 HG22 ' A' ' 188' ' ' VAL . 48.4 t -83.9 111.15 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 120.797 0.332 . . . . 0.0 111.429 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.925 HG12 HG21 ' A' ' 215' ' ' ILE . 5.5 m -99.68 117.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.931 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.828 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -61.71 103.07 0.3 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.009 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.684 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -55.96 156.0 11.36 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.738 -0.665 . . . . 0.0 113.044 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.48 8.46 84.91 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.559 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' GLN . . . . . 0.828 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 97.5 mm-40 -71.05 -176.52 1.42 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.358 0.579 . . . . 0.0 110.781 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' SER . . . . . 0.686 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.5 m -177.1 104.91 0.06 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.39 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.64 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 21.2 m-85 -55.66 151.94 10.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.163 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' GLN . . . . . 0.673 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 9.2 pt20 -123.01 154.76 38.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.42 ' HA ' ' HD2' ' A' ' 234' ' ' PRO . 68.7 p -67.6 101.11 0.27 Allowed Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' PRO . . . . . 0.673 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 59.5 Cg_endo -68.13 -27.94 34.97 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.656 2.237 . . . . 0.0 111.898 178.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.39 -125.26 6.53 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' THR . . . . . 0.535 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -92.0 116.54 29.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.626 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 63.5 t80 -124.73 143.2 50.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.331 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.935 HD12 HG23 ' A' ' 42' ' ' THR . 5.7 tp . . . . . 0 CA--C 1.515 -0.386 0 CA-C-O 121.145 0.498 . . . . 0.0 110.752 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.6 ' HB3' ' H ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.218 0.532 . . . . 0.81000000000000005 110.726 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.24 -24.74 42.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.534 -0.757 . . . . 2.1200000000000001 111.852 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -60.66 -47.17 87.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.078 0.466 . . . . 2.0299999999999998 110.214 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.87 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -69.46 -33.31 72.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.767 -0.651 . . . . 0.28000000000000003 110.768 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.733 HD21 HD23 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -61.23 -54.57 42.51 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.229 0.537 . . . . 0.96999999999999997 110.695 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' A' ' 105' ' ' ALA . 7.1 tp -66.79 -51.39 56.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.292 -0.867 . . . . 0.38 111.216 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 63.7 mt -54.64 -35.84 63.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.022 0.439 . . . . 0.39000000000000001 110.804 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.593 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -72.91 -29.97 63.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.673 -0.694 . . . . 0.16 110.787 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.649 ' CB ' HD21 ' A' ' 82' ' ' LEU . . . -71.48 -32.28 68.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.817 -0.628 . . . . 0.14000000000000001 111.592 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.812 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.74 -11.21 42.91 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.826 0.346 . . . . 0.13 111.111 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -80.93 163.19 23.52 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.041 -0.527 . . . . 0.14999999999999999 110.144 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -96.51 97.27 9.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.004 0.43 . . . . 0.17999999999999999 110.079 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.5 146.97 7.94 Favored Glycine 0 C--N 1.313 -0.712 0 C-N-CA 120.796 -0.716 . . . . 0.19 111.751 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -71.74 138.06 48.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.105 0.479 . . . . 2.29 111.654 -179.51 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.426 HG23 ' N ' ' A' ' 40' ' ' VAL . 0.6 OUTLIER -131.74 164.59 25.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.64 -0.709 . . . . 0.17000000000000001 110.165 179.316 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.813 HG22 ' CG ' ' A' ' 74' ' ' GLU . 88.9 t -110.43 142.7 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 111.911 0.337 . . . . 0.23000000000000001 111.911 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.87 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -130.18 110.67 11.76 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.834 -0.802 . . . . 0.45000000000000001 108.834 178.257 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.848 HG23 HD12 ' A' ' 238' ' ' LEU . 0.0 OUTLIER -100.55 169.56 8.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.112 0.482 . . . . 0.32000000000000001 111.568 -178.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.729 ' HB2' HD11 ' A' ' 238' ' ' LEU . 1.5 t30 67.24 21.09 10.02 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.629 -0.714 . . . . 1.04 110.703 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.78 HD22 HD11 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -60.14 154.69 18.94 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.555 -0.535 . . . . 0.28999999999999998 109.555 178.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.6 ' H ' ' HB3' ' A' ' 25' ' ' SER . 17.6 tp -91.27 114.3 26.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.93 0.395 . . . . 0.33000000000000002 111.418 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.414 ' OD2' ' HB2' ' A' ' 70' ' ' ARG . 9.6 t70 -73.72 77.74 1.55 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.973 -0.558 . . . . 2.0499999999999998 110.27 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -137.38 -163.88 1.5 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.875 -0.602 . . . . 1.1499999999999999 110.841 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.528 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 10.0 m-20 -96.91 -19.05 19.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.19 -0.459 . . . . 1.8600000000000001 111.076 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.457 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -73.01 -26.53 61.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.177 -0.465 . . . . 1.97 109.919 178.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.542 HG11 HD21 ' A' ' 44' ' ' LEU . 26.5 t -90.04 -52.42 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.813 -0.63 . . . . 0.22 111.45 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.528 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -53.07 -26.53 16.38 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.53 -0.468 . . . . 2.6000000000000001 110.558 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -73.4 -37.57 65.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.698 -0.683 . . . . 0.53000000000000003 109.637 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.448 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 5.4 tpt -65.0 -47.35 77.82 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.565 -0.902 . . . . 0.57999999999999996 108.565 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.733 HD23 HD21 ' A' ' 29' ' ' LEU . 1.1 mp -61.95 -47.13 86.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.611 -0.722 . . . . 0.33000000000000002 110.051 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.408 ' HA ' HG22 ' A' ' 58' ' ' THR . 0.9 OUTLIER -59.57 -28.17 66.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.111 0.481 . . . . 1.3899999999999999 109.979 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.701 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -68.73 -43.85 75.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.631 -0.713 . . . . 0.20999999999999999 111.965 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.59 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -71.87 -50.45 29.31 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.774 -0.37 . . . . 0.78000000000000003 110.768 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.473 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.9 t -52.16 -29.81 23.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.07 0.462 . . . . 0.23999999999999999 110.371 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.783 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.82 -45.0 93.73 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.57 -0.741 . . . . 0.20999999999999999 110.523 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.009 HD21 HD22 ' A' ' 106' ' ' LEU . 3.0 mp -74.87 -24.37 58.55 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.454 0.645 . . . . 0.22 109.952 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.4 0.24 5.85 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.004 -0.998 . . . . 0.23000000000000001 114.146 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.472 HG21 HD11 ' A' ' 82' ' ' LEU . 34.0 t -61.77 150.12 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 118.041 0.921 . . . . 0.20000000000000001 110.364 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.49 ' CB ' HG13 ' A' ' 76' ' ' ILE . 2.5 m -111.23 104.91 13.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.815 -0.629 . . . . 0.25 111.595 -178.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CE2' ' HB ' ' A' ' 58' ' ' THR . 6.7 p90 -117.83 159.14 23.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.148 -0.933 . . . . 0.37 110.946 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 3.5 m -152.65 114.84 4.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.39000000000000001 110.214 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.826 HD22 ' SG ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -84.19 178.7 7.7 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.997 0.427 . . . . 0.23000000000000001 110.735 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.0 t -94.33 -179.92 5.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.803 -0.635 . . . . 1.1100000000000001 110.946 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.02 -19.41 61.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.176 -0.466 . . . . 0.31 111.517 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.22 5.99 14.9 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.897 0.379 . . . . 1.5600000000000001 110.564 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.414 ' HB2' ' OD2' ' A' ' 46' ' ' ASP . 53.1 mtt-85 59.42 41.42 19.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.119 -0.491 . . . . 2.27 110.974 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.435 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -121.91 -0.03 9.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.651 -0.704 . . . . 0.28999999999999998 110.887 179.111 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.592 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -143.54 115.35 8.24 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.446 -0.576 . . . . 1.8999999999999999 109.446 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.826 ' SG ' HD22 ' A' ' 66' ' ' LEU . 1.4 t -120.99 150.2 41.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.7 -0.682 . . . . 0.26000000000000001 112.141 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.813 ' CG ' HG22 ' A' ' 40' ' ' VAL . 4.2 mt-10 -118.18 103.79 10.19 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.477 -0.934 . . . . 1.53 108.477 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.614 HG12 HD23 ' A' ' 29' ' ' LEU . 1.7 mp -99.19 126.74 52.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.567 0.699 . . . . 0.20000000000000001 112.661 -178.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.49 HG13 ' CB ' ' A' ' 63' ' ' SER . 0.9 OUTLIER -78.54 110.81 14.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.478 -1.237 . . . . 1.0700000000000001 111.233 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -54.32 112.8 2.86 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.799 -0.637 . . . . 0.17999999999999999 114.047 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.0 OUTLIER -61.86 -19.6 62.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.187 0.518 . . . . 1.3700000000000001 109.943 178.279 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.69 -23.21 20.84 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.611 -0.722 . . . . 0.16 112.671 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.812 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -136.92 -149.81 5.69 Favored Glycine 0 CA--C 1.507 -0.464 0 N-CA-C 109.998 -1.241 . . . . 0.14999999999999999 109.998 178.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.833 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 5.1 Cg_exo -78.71 164.43 25.67 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 CA-C-N 119.469 1.635 . . . . 0.13 109.163 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.84 HD12 HD13 ' A' ' 60' ' ' LEU . 3.7 mm? -63.36 93.95 0.08 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.816 1.294 . . . . 0.12 108.217 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.833 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 28.9 m170 -87.8 120.18 28.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 112.435 -2.166 . . . . 0.14999999999999999 112.928 -175.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.813 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -149.21 109.4 4.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.882 -0.599 . . . . 0.19 110.912 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -107.9 91.64 3.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.769 0.319 . . . . 1.51 111.139 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.98 19.94 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.544 -0.836 . . . . 0.28000000000000003 113.432 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.71 50.82 13.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.308 0.575 . . . . 0.28000000000000003 110.006 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.783 HD21 ' HB1' ' A' ' 59' ' ' ALA . 3.5 tp -77.12 136.03 38.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.315 -0.857 . . . . 0.37 110.959 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.778 ' N ' HD12 ' A' ' 88' ' ' LEU . 1.2 tt0 -116.6 127.46 54.49 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.158 0.504 . . . . 1.3500000000000001 110.395 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.701 HD13 ' HA ' ' A' ' 56' ' ' ALA . 50.8 mt -109.68 163.38 13.54 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.49 -0.777 . . . . 0.65000000000000002 112.655 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -125.56 106.68 9.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.897 -1.047 . . . . 0.47999999999999998 109.892 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.638 HD22 ' N ' ' A' ' 92' ' ' LEU . 1.2 mm? -93.2 6.05 49.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.176 -0.465 . . . . 0.83999999999999997 111.485 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 42.3 -141.42 1.7 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.051 -0.595 . . . . 0.28999999999999998 113.009 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -96.9 51.7 1.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.133 0.492 . . . . 1.5800000000000001 110.733 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -88.75 -73.71 0.49 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.811 -0.631 . . . . 0.33000000000000002 111.071 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.0 -18.93 13.61 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.002 -0.618 . . . . 0.33000000000000002 113.092 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.489 HG22 ' NE2' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -96.85 -9.21 29.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.807 0.337 . . . . 0.91000000000000003 110.658 179.09 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.63 -12.75 6.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.1 -0.5 . . . . 0.20999999999999999 111.523 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.526 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 4.6 ttm -79.36 -36.32 39.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.551 -0.295 . . . . 1.1200000000000001 111.458 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.526 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -77.95 -48.91 2.07 Favored Pre-proline 0 N--CA 1.45 -0.45 0 CA-C-O 120.503 0.192 . . . . 2.0 111.236 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 24.4 Cg_exo -64.18 -43.06 15.91 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.793 2.329 . . . . 0.27000000000000002 112.734 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.59 HD13 HD11 ' A' ' 106' ' ' LEU . 2.2 tm? -71.0 -30.37 66.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.996 -0.547 . . . . 0.19 111.168 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.62 -49.22 74.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.195 0.522 . . . . 0.17000000000000001 110.633 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.813 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -72.5 -34.75 67.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.366 0.876 . . . . 0.14000000000000001 113.366 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.646 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -57.76 -44.27 86.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.034 0.445 . . . . 0.12 111.968 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.009 HD22 HD21 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -71.0 -21.19 62.33 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.927 -0.579 . . . . 0.20999999999999999 112.01 -178.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.586 ' SG ' HD11 ' A' ' 140' ' ' ILE . 98.1 m -58.26 -12.56 3.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.938 -0.574 . . . . 0.25 111.73 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.689 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 9.8 mt -80.62 167.85 19.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.695 0.283 . . . . 0.20999999999999999 110.638 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 50.16 -110.83 0.96 Allowed Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.08 -0.581 . . . . 0.16 112.559 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.436 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.1 OUTLIER -162.37 102.47 1.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.797 0.332 . . . . 0.70999999999999996 110.3 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 1.4 m-20 -138.84 135.97 35.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 1.5900000000000001 111.243 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.508 ' C ' HD12 ' A' ' 113' ' ' ILE . 4.6 m-20 -102.79 109.48 21.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.052 -0.522 . . . . 1.26 109.813 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.701 HG23 ' O ' ' A' ' 88' ' ' LEU . 5.2 mp -143.39 140.85 26.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.499 -0.319 . . . . 0.56000000000000005 111.249 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 17.5 t -112.2 112.7 41.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.767 -0.457 . . . . 0.22 109.767 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.516 HD22 HD21 ' A' ' 92' ' ' LEU . 31.8 mt -81.02 158.62 25.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.383 0.611 . . . . 0.25 111.91 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.3 m -160.84 162.98 32.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.99 -1.005 . . . . 1.01 110.219 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.21 -165.39 13.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.885 -1.15 . . . . 0.25 113.7 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.515 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 0.8 OUTLIER -71.74 175.86 2.66 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.26 -0.47 . . . . 1.5700000000000001 111.134 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 32.1 Cg_exo -60.47 -37.29 82.03 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.337 2.025 . . . . 0.48999999999999999 112.436 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.531 HH11 ' CG ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -76.3 -36.98 58.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.765 0.317 . . . . 2.23 110.796 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.533 ' HA ' ' HG3' ' A' ' 124' ' ' ARG . 7.5 tpt -58.59 -22.31 55.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.80000000000000004 110.21 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.503 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 2.9 mmtt -63.64 -10.38 18.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.05 -0.523 . . . . 1.8100000000000001 111.97 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.597 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 4.4 pt-20 -121.22 28.2 7.96 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.638 -0.425 . . . . 1.9199999999999999 111.539 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.533 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 1.2 mmp_? -101.39 95.05 4.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.195 -0.457 . . . . 2.6299999999999999 110.725 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.7 Cg_endo -47.43 129.03 15.78 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.732 2.288 . . . . 0.44 112.2 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.649 HD11 HD23 ' A' ' 129' ' ' LEU . 19.9 tt -138.35 31.48 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.745 0.783 . . . . 0.26000000000000001 110.143 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -74.93 -49.49 9.9 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.633 -1.167 . . . . 0.20999999999999999 112.668 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.442 ' HB2' ' CD2' ' A' ' 172' ' ' PHE . 0.7 OUTLIER -53.65 -33.0 53.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.825 0.345 . . . . 0.25 110.5 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.823 ' CD1' HD21 ' A' ' 133' ' ' LEU . 25.9 tp -76.48 -62.84 1.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 0.17999999999999999 110.165 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.783 HG13 HD12 ' A' ' 140' ' ' ILE . 94.2 t -51.94 -26.89 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 0.17999999999999999 111.604 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 2.7 t0 -71.93 -45.46 61.08 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.27 0.47 . . . . 1.4299999999999999 112.27 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.857 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -63.82 -54.19 38.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.863 0.363 . . . . 0.14999999999999999 111.129 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.904 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -55.12 -44.78 75.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.343 0.592 . . . . 0.20999999999999999 109.547 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -57.76 -40.11 78.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.133 -0.94 . . . . 2.7799999999999998 110.314 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.857 HD12 ' HA ' ' A' ' 132' ' ' ALA . 3.1 mt -63.93 -32.93 74.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.23000000000000001 110.686 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.437 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -76.53 -13.81 83.08 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.489 -0.862 . . . . 0.14000000000000001 112.929 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 127.05 4.46 5.99 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.54 -0.838 . . . . 0.14999999999999999 113.192 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.98 150.41 45.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.878 0.371 . . . . 0.14999999999999999 111.51 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -116.35 96.76 5.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 2.3500000000000001 111.317 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.783 HD12 HG13 ' A' ' 130' ' ' VAL . 10.6 mt -124.41 168.39 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.088 0.47 . . . . 0.19 111.403 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.686 HG22 ' HB3' ' A' ' 152' ' ' ARG . 0.4 OUTLIER -150.36 174.4 12.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.699 -0.682 . . . . 0.31 110.603 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.543 ' CD2' ' HA ' ' A' ' 146' ' ' GLU . 23.6 m-85 -116.61 107.91 15.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.709 -0.849 . . . . 0.32000000000000001 108.709 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.632 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.3 mm? -75.25 -23.46 57.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.886 -0.597 . . . . 0.34000000000000002 112.074 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.7 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 2.5 mt-10 -129.53 -67.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.745 -0.382 . . . . 2.1899999999999999 110.977 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.75 ' HB2' ' HD2' ' A' ' 148' ' ' TYR . 53.6 mt-30 -125.63 157.82 36.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.091 0.472 . . . . 2.73 111.774 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.543 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 47.4 mt-10 -75.31 131.46 40.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.676 . . . . 2.0099999999999998 110.826 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 16.6 m-20 67.46 44.3 1.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 1.3400000000000001 111.822 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.75 ' HD2' ' HB2' ' A' ' 145' ' ' GLN . 7.8 m-30 -140.55 164.26 37.93 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.353 -0.385 . . . . 0.72999999999999998 110.65 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.549 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 6.3 Cg_exo -37.73 -44.12 1.57 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 124.146 3.231 . . . . 0.28000000000000003 115.38 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.7 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 24.3 Cg_endo -61.41 95.18 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 121.202 1.268 . . . . 0.23000000000000001 111.041 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 94.4 mt -132.41 123.29 26.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.534 -0.757 . . . . 0.19 111.71 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.686 ' HB3' HG22 ' A' ' 141' ' ' THR . 1.4 ttm180 -101.7 110.83 22.89 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.221 -1.029 . . . . 2.5899999999999999 108.221 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.727 ' CD1' HD12 ' A' ' 106' ' ' LEU . 2.0 mt -92.93 158.27 15.91 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.768 0.318 . . . . 0.17000000000000001 111.21 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 6.4 mt-30 -146.17 22.77 1.36 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.146 -0.479 . . . . 1.3400000000000001 110.712 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.471 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 56.35 -167.16 3.92 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.501 -0.856 . . . . 0.14999999999999999 112.193 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 158' ' ' THR . . . 110.94 -4.29 28.85 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.532 -0.842 . . . . 0.16 112.814 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.644 ' CD2' HG22 ' A' ' 179' ' ' THR . 2.0 t80 -62.43 110.54 1.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.922 0.391 . . . . 0.64000000000000001 111.141 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.547 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 71.5 p -109.49 -50.67 2.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.20000000000000001 110.573 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.475 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 145.98 -161.91 28.31 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.276 -0.964 . . . . 0.19 113.58 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 162' ' ' VAL . . . 113.88 168.82 16.62 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 111.738 -0.545 . . . . 0.16 111.738 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.9 129.71 43.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.88 0.34 . . . . 1.21 110.323 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.747 HG11 ' HB1' ' A' ' 132' ' ' ALA . 61.4 t -136.56 156.99 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 120.932 0.396 . . . . 0.16 111.131 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.447 ' N ' HG12 ' A' ' 162' ' ' VAL . 1.1 m-20 -127.9 116.51 20.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.421 -0.585 . . . . 1.1000000000000001 109.421 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.433 HG21 ' CD1' ' A' ' 176' ' ' LEU . 0.5 OUTLIER -118.73 145.86 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 120.392 -0.523 . . . . 0.17999999999999999 112.278 -178.415 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 1.8 t70 -85.07 130.28 34.64 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.87 -0.605 . . . . 1.25 110.215 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.626 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -72.1 -45.34 41.3 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.799 -0.715 . . . . 0.14999999999999999 113.507 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.35 160.97 0.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.116 0.484 . . . . 1.0900000000000001 112.06 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 9.4 t 71.73 59.59 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 115.649 -0.705 . . . . 0.23999999999999999 111.06 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.841 ' N ' HG11 ' A' ' 196' ' ' VAL . 15.3 m 60.81 154.03 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.871 -0.604 . . . . 0.70999999999999996 110.722 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 3.8 t -82.82 1.8 37.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 1.3200000000000001 111.007 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 66.5 mm-40 -56.92 -21.0 26.45 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.543 -0.299 . . . . 1.8999999999999999 110.816 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.448 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 3.9 m-85 -71.88 -61.83 1.64 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.107 0.479 . . . . 0.20999999999999999 110.332 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.764 HD23 HG12 ' A' ' 201' ' ' ILE . 64.4 tp -68.77 -33.32 73.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.664 -0.698 . . . . 0.20999999999999999 109.768 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.577 ' O ' ' CG ' ' A' ' 178' ' ' MET . 52.5 m -59.76 -33.56 71.83 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.593 -0.731 . . . . 1.02 109.951 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.813 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -71.64 -45.07 63.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.23999999999999999 111.692 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.904 ' CD2' HD23 ' A' ' 133' ' ' LEU . 1.6 mt -72.84 -31.11 64.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.145 -0.48 . . . . 0.19 110.435 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.855 HD21 ' HB3' ' A' ' 223' ' ' PHE . 10.4 mt -66.78 -28.13 68.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.957 -0.565 . . . . 0.16 111.553 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.577 ' CG ' ' O ' ' A' ' 174' ' ' THR . 0.0 OUTLIER -98.75 -29.44 13.0 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 120.13 -0.628 . . . . 1.4099999999999999 110.43 179.178 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.701 HG21 ' O ' ' A' ' 104' ' ' ALA . 83.0 m -81.79 -46.14 14.61 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.637 -0.711 . . . . 0.17999999999999999 111.521 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.856 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -60.17 -40.9 81.24 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 113.286 0.847 . . . . 0.14999999999999999 113.286 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.5 Cg_endo -54.39 -35.57 84.93 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.426 1.418 . . . . 0.14999999999999999 112.545 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.99 -11.74 54.79 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.862 0.363 . . . . 0.19 110.478 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.547 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -61.64 124.21 80.24 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.97 -0.559 . . . . 0.23999999999999999 109.788 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.1 -32.95 5.21 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.917 2.412 . . . . 0.28000000000000003 113.77 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -103.81 154.68 19.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.105 0.478 . . . . 1.75 111.431 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.488 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 12.4 t0 -67.39 122.54 18.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.603 -0.726 . . . . 1.3799999999999999 110.505 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.55 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 24.3 m -107.69 136.31 47.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.247 -0.433 . . . . 0.14999999999999999 111.435 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 1.055 HG22 HG13 ' A' ' 224' ' ' VAL . 45.4 t -126.5 97.93 4.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.979 -0.555 . . . . 0.13 110.053 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.561 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.4 mt -89.43 143.87 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-N 116.124 -0.489 . . . . 0.12 110.03 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.811 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -114.64 170.7 8.12 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.153 -1.054 . . . . 2.6800000000000002 108.153 177.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.811 HD13 ' C ' ' A' ' 190' ' ' ARG . 0.9 OUTLIER -111.05 96.44 4.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 C-N-CA 120.767 -0.373 . . . . 0.14999999999999999 111.126 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -59.09 -80.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.965 -0.561 . . . . 1.47 110.662 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -81.24 167.18 48.95 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.838 -0.696 . . . . 0.17000000000000001 112.567 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.15 126.22 26.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.641 0.258 . . . . 2.04 110.777 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.626 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.4 OUTLIER -61.49 144.1 54.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.987 0.423 . . . . 0.20000000000000001 110.18 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.841 HG11 ' N ' ' A' ' 169' ' ' SER . 14.5 p -100.48 -17.96 6.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.04 -0.527 . . . . 0.23000000000000001 111.541 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.555 ' CB ' ' HB2' ' A' ' 200' ' ' TYR . 0.1 OUTLIER -131.51 46.7 2.62 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.541 -0.754 . . . . 0.66000000000000003 109.847 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.734 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.3 OUTLIER -40.0 -59.58 1.74 Allowed Pre-proline 0 N--CA 1.466 0.37 0 CA-C-N 115.453 -0.794 . . . . 1.3700000000000001 113.051 -178.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 59.3 Cg_endo -71.24 -16.04 31.59 Favored 'Trans proline' 0 CA--C 1.516 -0.402 0 C-N-CA 121.987 1.791 . . . . 0.45000000000000001 112.762 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.555 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 28.3 m-85 -79.23 -27.77 42.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.416 -0.356 . . . . 0.77000000000000002 110.332 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.764 HG12 HD23 ' A' ' 173' ' ' LEU . 7.7 tp -69.96 -31.44 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.19 110.259 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.4 OUTLIER -63.05 -32.21 73.53 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.643 -0.503 . . . . 1.3200000000000001 109.643 178.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 200' ' ' TYR . 31.1 mt -67.76 -31.08 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.804 -0.634 . . . . 0.31 110.356 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.423 HG22 ' SD ' ' A' ' 208' ' ' MET . 42.0 m -60.65 -52.3 65.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.692 -0.485 . . . . 0.20999999999999999 109.692 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.841 HD22 HG12 ' A' ' 215' ' ' ILE . 41.1 mt -70.95 -35.12 72.07 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.958 -0.565 . . . . 0.22 110.557 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 202' ' ' ASP . 1.6 t30 -63.86 -30.7 71.77 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 109.529 -0.545 . . . . 1.22 109.529 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.672 HD21 ' OH ' ' A' ' 237' ' ' TYR . 0.3 OUTLIER -76.69 -42.79 40.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.59999999999999998 109.373 178.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.475 ' SD ' HD23 ' A' ' 205' ' ' LEU . 30.4 mtp -64.89 -45.95 83.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.16 -0.927 . . . . 0.63 111.255 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 210' ' ' THR . 0.0 OUTLIER -60.46 -44.17 96.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.438 -0.346 . . . . 2.23 110.759 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 207' ' ' LEU . 0.5 OUTLIER -57.89 -31.71 67.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.147 0.499 . . . . 0.56999999999999995 109.88 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.584 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 1.6 m-85 -71.86 -51.54 21.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.488 -0.778 . . . . 0.40999999999999998 110.857 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 158.27 -4.82 0.14 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.522 -0.846 . . . . 0.23999999999999999 113.497 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.483 HG13 ' CG ' ' A' ' 229' ' ' GLN . 78.1 t -120.31 139.11 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.429 0.529 . . . . 0.20000000000000001 112.429 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -131.14 156.28 45.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.649 -0.705 . . . . 1.3300000000000001 110.568 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.965 HG21 HG12 ' A' ' 225' ' ' VAL . 1.8 pp -129.23 177.17 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 115.485 -0.78 . . . . 0.23999999999999999 111.782 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.85 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 2.8 tt0 -92.38 126.2 37.36 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.827 0.346 . . . . 1.8400000000000001 110.479 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -101.9 99.65 9.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.162 0.506 . . . . 2.2599999999999998 110.403 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.666 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 1.4 mm-40 -66.85 -166.35 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.652 -0.704 . . . . 1.6000000000000001 109.419 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.29 49.16 0.35 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.407 -0.36 . . . . 2.3199999999999998 110.611 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.479 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 56.7 20.05 4.79 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.016 0.436 . . . . 0.34000000000000002 110.926 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 191' ' ' ILE . 54.6 mt-30 -111.66 -24.24 10.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 1.96 110.106 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.738 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 41.2 mt-30 -146.63 140.93 26.39 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 120.979 0.418 . . . . 1.6200000000000001 111.168 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.855 ' HB3' HD21 ' A' ' 177' ' ' LEU . 19.6 m-85 -111.31 96.17 5.96 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.616 -0.883 . . . . 0.17000000000000001 108.616 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 1.055 HG13 HG22 ' A' ' 188' ' ' VAL . 52.1 t -86.36 110.76 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.042 0.448 . . . . 0.14999999999999999 110.935 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.965 HG12 HG21 ' A' ' 215' ' ' ILE . 7.4 m -103.03 120.71 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.662 -0.699 . . . . 0.16 111.669 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -62.89 112.59 2.63 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.497 -0.774 . . . . 1.6100000000000001 109.797 178.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.488 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -66.55 151.3 52.24 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.159 -0.928 . . . . 0.20000000000000001 113.039 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.77 10.63 62.87 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.591 -0.814 . . . . 0.26000000000000001 113.473 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.483 ' CG ' HG13 ' A' ' 213' ' ' VAL . 75.0 mm-40 -73.2 -175.42 1.85 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.34 0.591 . . . . 1.1299999999999999 110.992 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.658 ' HA ' HD23 ' A' ' 182' ' ' LEU . 1.2 m -176.6 103.25 0.06 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.273 -0.876 . . . . 0.28000000000000003 109.813 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 27.4 m-85 -54.73 152.24 7.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.196 -0.457 . . . . 0.33000000000000002 111.261 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.62 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 16.6 pt20 -122.13 154.25 37.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.06 -0.719 . . . . 2.0 109.06 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 9.5 t -64.97 102.93 0.37 Allowed Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 112.404 0.52 . . . . 1.1599999999999999 112.404 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.62 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 58.2 Cg_endo -68.93 -33.15 20.59 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.284 1.989 . . . . 0.5 111.466 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 121.54 -123.7 5.57 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.697 -0.683 . . . . 0.23999999999999999 111.645 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.549 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -91.38 117.38 29.62 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.83 -0.433 . . . . 0.39000000000000001 109.83 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.672 ' OH ' HD21 ' A' ' 207' ' ' LEU . 62.5 t80 -122.75 144.65 49.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.859 0.361 . . . . 1.1100000000000001 111.674 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.848 HD12 HG23 ' A' ' 42' ' ' THR . 25.0 tp -99.35 117.78 34.54 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.293 -0.412 . . . . 1.1100000000000001 110.651 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 42' ' ' THR . 57.9 t -56.78 -73.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.988 -0.551 . . . . 0.72999999999999998 111.07 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.533 ' H ' ' HB3' ' A' ' 43' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.235 -0.888 . . . . 2.6200000000000001 111.154 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.532 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . 2.6 m . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.49 0.662 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.584 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 7.5 p30 -81.61 -22.32 37.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.027 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -65.57 -40.3 92.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.789 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.799 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -79.04 -36.46 40.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.993 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.776 HD21 HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -60.39 -51.63 68.66 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.922 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.555 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 2.4 tp -70.07 -43.21 71.63 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.891 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.494 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 48.6 mt -61.02 -35.9 78.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.005 0.431 . . . . 0.0 110.738 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.692 ' HA ' ' CE1' ' A' ' 211' ' ' PHE . . . -71.06 -29.97 66.0 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.737 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.757 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -70.08 -30.62 67.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.542 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.912 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -89.39 -11.29 43.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.902 0.382 . . . . 0.0 111.102 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.627 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.45 165.57 20.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.212 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.412 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 80.2 m-70 -99.07 98.68 9.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.967 0.413 . . . . 0.0 110.079 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.6 141.51 6.88 Favored Glycine 0 C--N 1.315 -0.637 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.162 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.911 ' HB2' HD13 ' A' ' 76' ' ' ILE . 13.6 tttt -62.6 132.83 53.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.085 0.469 . . . . 0.0 111.78 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.484 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.7 OUTLIER -128.22 152.71 47.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.917 178.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.871 HG22 ' HG2' ' A' ' 74' ' ' GLU . 58.5 t -100.85 141.2 17.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.021 0.439 . . . . 0.0 111.925 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.799 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -126.93 110.95 13.55 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.039 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.741 HG23 HD12 ' A' ' 238' ' ' LEU . 0.2 OUTLIER -101.99 166.94 10.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.121 0.486 . . . . 0.0 111.467 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 71' ' ' THR . 5.8 t-20 70.6 19.35 6.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.879 -177.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.982 HD22 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -60.89 156.52 17.24 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.414 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.546 ' HB3' HG21 ' A' ' 50' ' ' VAL . 16.8 tp -93.71 115.65 28.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.0 0.428 . . . . 0.0 111.617 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -76.37 64.49 2.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.439 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.515 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.3 OUTLIER -124.8 -159.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.063 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.731 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -97.39 -21.07 17.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.988 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.64 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 4.0 p-10 -72.77 -27.39 61.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.268 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.546 HG21 ' HB3' ' A' ' 45' ' ' LEU . 13.3 t -88.46 -51.99 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.368 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.731 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 2.1 ptm180 -51.21 -28.53 11.62 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.209 0.528 . . . . 0.0 109.924 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.531 ' CE1' ' HA3' ' A' ' 93' ' ' GLY . 25.0 m170 -71.5 -39.82 70.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.246 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.652 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 3.0 tpt -62.54 -50.1 72.67 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.776 HD23 HD21 ' A' ' 29' ' ' LEU . 1.1 mt -60.01 -52.98 63.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.785 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 3.3 m-80 -54.22 -22.86 12.65 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.851 178.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.747 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -74.4 -48.11 29.83 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.597 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.635 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -72.06 -49.9 32.82 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.145 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.545 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 7.2 t -50.85 -30.88 15.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.158 0.504 . . . . 0.0 110.286 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.771 ' HB1' HD11 ' A' ' 88' ' ' LEU . . . -59.61 -49.5 77.5 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.958 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.915 HD21 HD22 ' A' ' 106' ' ' LEU . 3.6 mp -67.47 -28.46 67.88 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.584 0.707 . . . . 0.0 109.825 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.53 -0.24 5.47 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.537 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.591 HG21 HD11 ' A' ' 82' ' ' LEU . 13.8 t -58.7 147.97 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 117.491 0.645 . . . . 0.0 110.343 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.44 ' CB ' HG13 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -111.69 107.65 16.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.636 -178.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.652 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 6.8 p90 -122.7 160.52 25.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.157 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -149.31 116.41 6.03 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.662 179.623 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.982 HD11 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -86.52 174.09 9.17 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.228 0.537 . . . . 0.0 111.735 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.512 ' CB ' ' HG3' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -85.16 178.55 7.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.634 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.23 -14.79 53.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.091 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.95 2.93 12.8 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.003 0.43 . . . . 0.0 110.239 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.516 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 1.3 mtm-85 62.51 47.5 5.0 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.121 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -127.05 -2.54 6.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.271 179.412 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -141.27 109.75 5.96 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.462 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.899 ' SG ' HD22 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -114.41 147.67 38.89 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.255 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.871 ' HG2' HG22 ' A' ' 40' ' ' VAL . 7.2 mt-10 -114.62 102.52 10.11 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.742 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -95.27 131.93 40.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.911 HD13 ' HB2' ' A' ' 38' ' ' LYS . 8.6 mm -80.53 104.34 8.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.807 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.659 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -51.31 112.85 1.94 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.512 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.614 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.2 m-20 -59.61 -17.18 31.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.969 0.414 . . . . 0.0 110.378 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.412 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 88.08 -22.49 18.54 Favored Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.281 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.912 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -139.13 -143.22 4.39 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.803 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 6.2 Cg_exo -80.52 171.12 15.09 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 121.95 1.767 . . . . 0.0 109.319 177.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.867 ' HB2' HD23 ' A' ' 106' ' ' LEU . 4.3 mm? -69.78 90.68 0.6 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.803 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 35.5 m170 -83.08 119.54 24.61 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.281 -1.781 . . . . 0.0 112.749 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.687 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -143.54 106.76 4.54 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.334 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -105.09 86.73 2.49 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.346 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.62 23.41 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.897 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 53.93 51.02 15.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.526 0.679 . . . . 0.0 109.75 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.771 HD11 ' HB1' ' A' ' 59' ' ' ALA . 3.1 tp -80.88 137.33 36.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.252 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.62 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 3.3 tt0 -115.68 129.93 56.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.272 0.558 . . . . 0.0 110.766 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.763 HD12 HD11 ' A' ' 102' ' ' LEU . 4.3 mt -105.99 154.75 20.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.378 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -120.21 107.26 12.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.862 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.643 HD23 ' HE2' ' A' ' 99' ' ' MET . 1.6 mm? -93.33 3.47 55.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.378 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.531 ' HA3' ' CE1' ' A' ' 52' ' ' HIS . . . 40.53 -143.57 0.6 Allowed Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.166 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.478 ' OD1' ' HB3' ' A' ' 120' ' ' ARG . 1.0 OUTLIER -92.04 50.58 1.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.985 0.421 . . . . 0.0 110.88 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.64 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -92.34 -73.79 0.54 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.923 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.51 -17.46 14.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.465 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.44 ' HA ' ' OE1' ' A' ' 171' ' ' GLN . 6.0 p -96.59 -9.16 29.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.845 0.355 . . . . 0.0 111.271 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.411 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -128.02 -13.64 5.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.695 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.643 ' HE2' HD23 ' A' ' 92' ' ' LEU . 3.4 ttm -73.7 -54.8 7.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.082 0.467 . . . . 0.0 111.033 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.781 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -58.98 -50.8 86.03 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.475 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.754 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 28.2 Cg_exo -63.14 -47.18 8.62 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.721 2.28 . . . . 0.0 112.863 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.027 HD13 HD11 ' A' ' 106' ' ' LEU . 2.0 tm? -65.24 -37.74 88.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.754 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.598 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -60.3 -48.35 82.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.441 0.638 . . . . 0.0 110.077 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.991 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -66.09 -41.47 90.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.519 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.517 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -59.1 -39.36 81.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.389 . . . . 0.0 112.041 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.027 HD11 HD13 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -73.3 -21.14 60.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.849 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.665 ' SG ' HD11 ' A' ' 140' ' ' ILE . 10.8 m -63.86 -6.37 5.81 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.453 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.727 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 7.2 mt -85.13 168.5 14.77 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.554 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 56.11 -113.44 4.06 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.607 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.418 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.1 OUTLIER -167.9 94.18 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.972 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.607 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER -138.54 145.21 40.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.833 -179.271 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.55 ' C ' HD12 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -102.83 111.65 24.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.808 179.361 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.686 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 5.0 mp -141.2 143.59 27.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.235 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 41.2 t -115.59 113.62 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 120.67 0.272 . . . . 0.0 110.615 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.598 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 25.2 mt -81.89 156.82 24.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.428 0.632 . . . . 0.0 111.767 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.418 ' O ' ' HE3' ' A' ' 99' ' ' MET . 1.6 m -163.76 166.66 21.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.587 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -154.36 -166.11 14.66 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 119.928 -1.13 . . . . 0.0 113.708 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.656 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 11.7 mm-40 -69.48 173.17 4.22 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.46 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.656 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 24.3 Cg_endo -61.56 -24.48 78.1 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.979 1.786 . . . . 0.0 112.173 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.57 ' HD3' ' HG2' ' A' ' 123' ' ' GLU . 4.1 tpp180 -88.05 -33.47 18.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.536 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.505 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 9.2 tpt -59.96 -17.68 39.82 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.613 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 12.2 mttm -68.93 -5.51 21.84 Favored 'General case' 0 C--N 1.334 -0.09 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.57 ' HG2' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -119.09 22.62 11.78 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.141 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.439 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 17.0 mmm180 -102.24 86.73 0.94 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.766 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.796 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 4.4 Cg_endo -47.02 134.42 18.37 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.918 2.412 . . . . 0.0 112.581 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.89 HD11 HD23 ' A' ' 129' ' ' LEU . 21.4 tt -135.78 32.22 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.79 0.805 . . . . 0.0 109.682 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -70.99 -51.6 17.95 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.612 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.676 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.4 OUTLIER -58.85 -29.55 67.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.767 0.318 . . . . 0.0 110.447 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.89 HD23 HD11 ' A' ' 126' ' ' ILE . 29.6 tp -76.76 -61.03 2.11 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.964 HG13 HD12 ' A' ' 140' ' ' ILE . 61.9 t -57.06 -25.62 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.653 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -70.42 -45.42 65.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.584 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.892 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -66.1 -46.89 76.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.915 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.832 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.1 OUTLIER -60.43 -46.33 90.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.97 -38.1 72.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.549 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.892 HD12 ' HA ' ' A' ' 132' ' ' ALA . 3.8 mt -66.71 -32.31 73.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.271 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.476 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -76.09 -16.82 80.42 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.555 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 127.6 5.47 5.43 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.309 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.44 148.48 41.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.83 0.348 . . . . 0.0 111.439 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -117.2 94.04 4.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.391 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.964 HD12 HG13 ' A' ' 130' ' ' VAL . 14.1 mt -116.95 174.73 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.93 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.752 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.6 OUTLIER -153.17 -175.19 5.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.043 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.581 ' N ' HG23 ' A' ' 141' ' ' THR . 25.8 m-85 -125.35 106.87 10.15 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.675 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.2 mm? -79.91 -13.58 59.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.751 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 45.8 mt-10 -142.98 -71.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.062 0.458 . . . . 0.0 110.896 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.751 ' HB3' ' CD2' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -113.48 147.37 37.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.647 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.472 ' O ' ' CD2' ' A' ' 148' ' ' TYR . 2.2 mt-10 -76.68 131.97 39.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.47 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.796 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 82.5 m-20 62.84 48.97 3.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.125 0.488 . . . . 0.0 109.72 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.805 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 50.5 m-85 -147.44 176.2 2.33 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.503 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.805 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 2.3 Cg_endo -44.25 -43.4 13.28 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.518 2.812 . . . . 0.0 115.461 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.751 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 30.5 Cg_endo -61.94 101.29 0.22 Allowed 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 121.539 1.493 . . . . 0.0 111.751 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.623 HD11 HG21 ' A' ' 126' ' ' ILE . 91.0 mt -138.72 123.62 18.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.622 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.744 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.0 OUTLIER -104.63 112.3 25.33 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 176.69 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.811 HD23 HG23 ' A' ' 140' ' ' ILE . 1.2 mt -94.49 156.15 16.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.434 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.607 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 10.4 mt-30 -142.91 27.22 1.65 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.752 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 107' ' ' CYS . . . 53.86 -165.29 2.34 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.595 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 158' ' ' THR . . . 106.77 -5.15 36.86 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.901 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.648 ' CD2' HG22 ' A' ' 179' ' ' THR . 3.2 t80 -60.53 108.01 0.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 0.0 110.668 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.502 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 68.3 p -107.53 -47.24 3.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.006 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.59 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 141.26 -159.91 26.74 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 119.976 -1.107 . . . . 0.0 114.175 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.528 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 114.82 175.47 18.6 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.47 128.01 34.85 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.579 HG11 ' HB1' ' A' ' 132' ' ' ALA . 59.4 t -137.34 151.26 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.966 0.412 . . . . 0.0 111.858 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.44 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 1.9 m-20 -118.27 116.51 26.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.113 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.678 HG11 HD13 ' A' ' 173' ' ' LEU . 0.3 OUTLIER -118.04 144.82 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.754 -179.319 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.676 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.2 OUTLIER -83.75 138.0 33.47 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.638 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -80.05 -44.84 8.68 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.355 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.14 164.04 0.08 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.808 0.337 . . . . 0.0 111.189 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 4.0 t 70.73 56.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.83 ' H ' HG11 ' A' ' 196' ' ' VAL . 53.2 m 59.25 156.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.192 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 48.5 p -80.28 -0.9 38.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.165 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.781 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 77.3 mm-40 -52.8 -23.72 7.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.759 0.314 . . . . 0.0 111.278 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.659 ' HA ' HD13 ' A' ' 129' ' ' LEU . 3.8 m-85 -71.55 -54.27 11.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.033 0.444 . . . . 0.0 110.447 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.937 HD23 HG12 ' A' ' 201' ' ' ILE . 18.8 tp -78.02 -35.86 49.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.391 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.531 HG23 ' OG1' ' A' ' 204' ' ' THR . 92.3 m -55.65 -37.01 67.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.165 0.507 . . . . 0.0 109.69 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.991 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -71.56 -51.44 23.45 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.411 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.832 ' CD2' HD23 ' A' ' 133' ' ' LEU . 3.1 mt -65.41 -35.8 82.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.458 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.915 HD12 HD11 ' A' ' 201' ' ' ILE . 10.6 mt -66.53 -28.8 68.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.115 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.497 ' HA ' ' OH ' ' A' ' 231' ' ' TYR . 5.9 ptp -95.32 -27.53 15.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.169 0.509 . . . . 0.0 110.958 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.712 HG21 ' O ' ' A' ' 104' ' ' ALA . 80.3 m -87.44 -46.44 9.61 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.131 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.897 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -63.02 -36.29 23.88 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.726 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.5 Cg_endo -53.24 -36.91 79.66 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 121.28 1.32 . . . . 0.0 111.8 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.716 HD23 ' HA ' ' A' ' 230' ' ' SER . 0.9 OUTLIER -84.22 -10.83 57.38 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.655 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -64.49 119.52 57.52 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.747 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 3.4 Cg_exo -41.09 -29.67 0.55 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.478 2.785 . . . . 0.0 114.291 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.32 153.36 22.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.17 0.51 . . . . 0.0 111.59 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.624 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 6.0 t70 -67.28 116.6 8.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.84 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.763 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 26.3 m -102.87 135.65 44.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.295 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.965 HG22 HG13 ' A' ' 224' ' ' VAL . 39.4 t -126.13 99.16 5.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.147 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.59 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.0 mt -90.87 142.0 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.238 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.807 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.3 OUTLIER -112.99 171.14 7.72 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.734 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.807 HD13 ' C ' ' A' ' 190' ' ' ARG . 1.0 OUTLIER -110.59 97.42 5.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.918 0.39 . . . . 0.0 111.339 -178.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.498 ' HG2' ' HE ' ' A' ' 190' ' ' ARG . 15.1 mtmt -57.15 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.651 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.428 ' O ' HG22 ' A' ' 191' ' ' ILE . . . -82.58 170.44 50.28 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.216 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.08 124.17 20.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.61 0.243 . . . . 0.0 110.604 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.687 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.4 OUTLIER -58.48 144.88 40.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.995 0.426 . . . . 0.0 110.461 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.83 HG11 ' H ' ' A' ' 169' ' ' SER . 14.8 p -101.13 -20.57 5.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.79 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.733 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -128.39 46.19 2.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.376 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.78 ' O ' HG22 ' A' ' 201' ' ' ILE . 5.5 ttpt -40.44 -62.11 1.02 Allowed Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.825 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 59.1 Cg_endo -70.21 -16.44 35.67 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 121.586 1.524 . . . . 0.0 112.209 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.733 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 14.6 m-85 -75.74 -30.11 59.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.234 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.937 HG12 HD23 ' A' ' 173' ' ' LEU . 7.3 tp -68.28 -33.83 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.026 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.24 -31.27 68.92 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.673 HD12 ' HA ' ' A' ' 200' ' ' TYR . 20.7 mt -70.44 -30.77 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.236 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.531 ' OG1' HG23 ' A' ' 174' ' ' THR . 24.2 m -59.25 -55.1 39.16 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.766 HD21 HD22 ' A' ' 177' ' ' LEU . 21.7 mt -71.26 -35.73 71.51 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.296 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.755 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 58.4 m-20 -64.35 -28.67 69.86 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.669 ' HB2' ' O ' ' A' ' 203' ' ' ILE . 0.1 OUTLIER -76.55 -44.41 34.96 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.862 177.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.488 ' HB3' ' HE1' ' A' ' 231' ' ' TYR . 9.5 mtp -66.8 -41.09 88.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.449 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.755 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 17.1 pttt -61.07 -43.79 98.36 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.712 0.291 . . . . 0.0 110.337 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.646 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.6 OUTLIER -59.59 -29.68 68.14 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.692 ' CE1' ' HA ' ' A' ' 32' ' ' ALA . 1.3 m-85 -72.94 -50.78 21.49 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.504 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.428 ' HA3' ' HG2' ' A' ' 232' ' ' GLN . . . 153.98 -7.69 0.4 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.53 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.638 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 65.4 t -118.92 140.34 43.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.434 ' HG2' ' HB3' ' A' ' 209' ' ' LYS . 37.6 mt-10 -135.58 156.65 48.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.625 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 1.064 HG21 HG12 ' A' ' 225' ' ' VAL . 1.8 pp -127.77 175.3 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.94 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.885 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 6.4 tp10 -88.8 126.33 35.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.645 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -102.87 101.17 11.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.033 0.444 . . . . 0.0 110.573 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.74 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.7 OUTLIER -65.33 -166.64 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.453 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -73.37 49.02 0.26 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.842 0.353 . . . . 0.0 110.537 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.576 ' CZ ' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 57.48 19.81 5.55 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.129 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 191' ' ' ILE . 2.2 mt-30 -112.98 -21.42 11.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.826 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.769 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 23.9 mt-30 -149.17 140.11 22.87 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.967 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.894 ' HB3' HD21 ' A' ' 177' ' ' LEU . 27.5 m-85 -112.36 98.53 7.35 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.965 HG13 HG22 ' A' ' 188' ' ' VAL . 58.6 t -84.55 110.79 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 121.222 0.534 . . . . 0.0 111.283 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 1.064 HG12 HG21 ' A' ' 215' ' ' ILE . 3.4 m -98.75 115.31 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.964 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.692 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -64.59 103.53 0.69 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.895 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.624 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.99 153.81 25.1 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.935 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.07 10.75 62.21 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.492 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.692 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 6.7 mm-40 -77.21 -179.15 5.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.223 0.535 . . . . 0.0 110.791 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.716 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.1 m -174.5 105.03 0.1 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.993 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.639 ' HD2' ' HB2' ' A' ' 34' ' ' LEU . 35.0 m-85 -55.52 151.85 9.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.706 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 16.7 pt20 -119.66 159.44 24.44 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.419 ' HA ' ' HD2' ' A' ' 234' ' ' PRO . 51.6 p -75.48 98.35 0.24 Allowed Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.706 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 52.8 Cg_endo -65.88 -32.73 44.93 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.497 2.131 . . . . 0.0 112.011 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 122.45 -121.14 4.56 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.678 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.3 OUTLIER -92.56 116.88 29.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.745 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 63.6 t80 -122.54 138.6 54.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.53 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.741 HD12 HG23 ' A' ' 42' ' ' THR . 3.6 tp -93.57 120.42 33.82 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.173 178.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.452 HG11 ' N ' ' A' ' 25' ' ' SER . 40.7 t -61.5 -75.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.821 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.492 ' H ' ' HB3' ' A' ' 43' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.935 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.735 ' N ' HG11 ' A' ' 239' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 121.427 0.632 . . . . 0.0 110.399 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.456 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 18.5 p30 -78.76 -26.23 44.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.787 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.522 ' O ' HD12 ' A' ' 31' ' ' LEU . 3.0 mtt180 -62.48 -38.8 91.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.651 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.851 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -78.55 -34.76 46.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.241 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.838 HD21 HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -62.3 -53.24 58.03 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.996 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 4.7 tp -67.77 -45.3 75.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.521 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.684 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 38.6 mt -58.97 -34.82 72.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.325 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.674 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -75.41 -30.06 59.96 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.729 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.802 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -69.67 -32.57 71.27 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.611 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.893 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -87.77 -12.12 46.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.006 0.432 . . . . 0.0 110.804 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.624 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.0 163.71 21.94 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.73 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.428 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 82.9 m-70 -97.44 97.07 8.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.86 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.34 144.6 7.38 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.018 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.753 ' HB2' HD13 ' A' ' 76' ' ' ILE . 16.2 tttt -66.6 134.8 53.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.076 0.465 . . . . 0.0 111.975 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.548 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -128.85 154.87 46.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.766 178.534 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.034 HG22 ' HG2' ' A' ' 74' ' ' GLU . 54.5 t -101.87 141.64 17.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.789 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.851 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -127.12 111.45 14.02 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.751 HG23 HD12 ' A' ' 238' ' ' LEU . 0.5 OUTLIER -104.7 167.4 9.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.156 0.503 . . . . 0.0 111.719 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.71 ' HB3' ' H ' ' A' ' 240' ' ' GLU . 0.3 OUTLIER 67.45 20.47 9.85 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.794 -177.248 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.78 HD22 HD11 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -59.08 157.24 10.54 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.565 178.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.622 ' H ' ' HB3' ' A' ' 25' ' ' SER . 28.9 tp -95.32 114.3 26.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.122 0.487 . . . . 0.0 111.704 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -73.6 59.34 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.13 0.49 . . . . 0.0 110.53 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.438 ' OG ' HD23 ' A' ' 45' ' ' LEU . 36.8 p -115.87 -162.69 0.85 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.087 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.685 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 42.5 m-20 -97.94 -22.8 16.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.491 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -73.34 -24.01 60.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.228 0.537 . . . . 0.0 110.0 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 45' ' ' LEU . 19.2 t -89.02 -55.2 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.103 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.685 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -51.3 -29.47 15.01 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 109.842 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -71.12 -37.87 72.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.892 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.605 ' HE1' HD22 ' A' ' 30' ' ' LEU . 9.3 tpt -63.83 -51.15 66.0 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.838 HD23 HD21 ' A' ' 29' ' ' LEU . 1.2 mp -62.04 -47.46 84.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.674 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -56.25 -26.1 50.28 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.336 179.076 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.826 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -74.18 -46.31 42.92 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.631 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.612 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -68.27 -49.6 59.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.818 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.545 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 7.2 t -49.74 -31.47 11.47 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.204 0.526 . . . . 0.0 109.888 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.755 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.7 -52.36 65.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.093 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.016 HD21 HD22 ' A' ' 106' ' ' LEU . 4.1 mp -65.42 -28.63 69.38 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.524 0.678 . . . . 0.0 110.035 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.92 -1.23 6.26 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.758 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.654 HG21 HD11 ' A' ' 82' ' ' LEU . 22.8 t -56.27 152.81 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 117.639 0.72 . . . . 0.0 110.069 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.515 ' CB ' HG13 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -114.28 108.68 17.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.005 -179.442 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.667 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 9.1 p90 -126.95 156.95 40.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 32.1 m -150.33 116.62 5.7 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.68 0.276 . . . . 0.0 111.078 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.78 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -85.62 177.44 7.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.197 0.522 . . . . 0.0 111.63 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.79 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 3.6 t -88.02 178.82 6.56 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.993 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.91 -12.72 39.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.584 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -117.71 2.61 12.29 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.866 0.365 . . . . 0.0 110.667 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.471 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 10.9 mtt180 61.35 44.5 9.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.355 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -126.56 -2.6 6.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.562 179.446 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.79 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -141.21 110.25 6.19 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.447 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.741 ' SG ' HD22 ' A' ' 66' ' ' LEU . 3.0 t -114.75 149.88 36.21 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 1.034 ' HG2' HG22 ' A' ' 40' ' ' VAL . 43.7 mt-10 -115.85 102.85 10.07 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.693 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.6 mp -96.11 132.61 39.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.1 0.476 . . . . 0.0 111.995 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.753 HD13 ' HB2' ' A' ' 38' ' ' LYS . 15.1 mm -82.12 107.5 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.944 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.674 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -54.07 112.61 2.67 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.684 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.615 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.0 OUTLIER -61.33 -17.06 51.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.973 0.416 . . . . 0.0 110.519 178.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.428 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 86.76 -21.63 17.98 Favored Glycine 0 C--O 1.228 -0.248 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.41 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.893 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.62 -144.88 4.7 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.809 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 6.2 Cg_exo -79.96 168.44 19.03 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 121.858 1.705 . . . . 0.0 109.289 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.802 HD21 ' HB3' ' A' ' 33' ' ' ALA . 4.2 mm? -66.89 90.56 0.18 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.809 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 29.7 m170 -82.48 118.75 23.47 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.073 -1.876 . . . . 0.0 112.858 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.69 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -144.42 111.29 5.77 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.793 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -114.02 90.8 3.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.77 0.319 . . . . 0.0 111.524 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.03 22.6 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.736 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.7 52.28 11.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.453 0.644 . . . . 0.0 109.777 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.755 HD21 ' HB1' ' A' ' 59' ' ' ALA . 4.5 tp -82.71 130.53 35.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.256 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.652 ' N ' HD12 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -111.87 129.85 56.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.915 0.388 . . . . 0.0 110.519 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.826 HD13 ' HA ' ' A' ' 56' ' ' ALA . 16.3 mt -114.04 154.39 27.78 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.478 ' CE1' ' HA2' ' A' ' 93' ' ' GLY . 43.9 t80 -121.01 102.26 8.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.642 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.921 HD23 ' HE1' ' A' ' 99' ' ' MET . 2.0 mm? -89.09 8.39 30.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.893 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.558 ' CA ' ' HG3' ' A' ' 118' ' ' GLU . . . 45.23 -142.91 3.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.898 -0.667 . . . . 0.0 113.203 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.05 51.58 1.53 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.866 0.365 . . . . 0.0 111.081 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.15 -73.13 0.53 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.115 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.45 -16.38 18.83 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.073 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.454 ' HA ' ' CD ' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -95.15 -8.23 36.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.328 . . . . 0.0 111.103 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.436 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -127.46 -17.6 4.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.708 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.921 ' HE1' HD23 ' A' ' 92' ' ' LEU . 41.4 tpp -67.65 -54.72 17.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.097 0.475 . . . . 0.0 110.76 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.815 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -59.22 -53.37 66.94 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.474 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.685 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 31.3 Cg_exo -60.35 -47.15 15.18 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.731 2.287 . . . . 0.0 112.831 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.745 ' CD1' HD11 ' A' ' 106' ' ' LEU . 3.4 tm? -69.34 -38.92 78.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.553 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.431 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -60.92 -47.79 84.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.485 0.66 . . . . 0.0 109.988 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.912 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -68.17 -36.42 79.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.847 -1.069 . . . . 0.0 113.23 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.554 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -61.75 -44.21 97.34 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.016 HD22 HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -69.74 -19.96 63.52 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.56 -179.178 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.543 ' SG ' HD11 ' A' ' 140' ' ' ILE . 56.6 m -60.06 -11.52 6.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.169 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.745 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 7.7 mt -84.17 168.92 15.34 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 52.66 -108.96 0.8 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.374 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.405 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 11.3 p -166.93 100.86 0.55 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.689 0.281 . . . . 0.0 110.497 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 9.7 m-20 -138.3 136.82 36.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.119 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.721 ' C ' HD12 ' A' ' 113' ' ' ILE . 4.5 m-20 -101.42 111.21 23.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.476 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.723 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.3 mp -142.55 141.76 27.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.324 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.931 HG22 ' HG2' ' A' ' 152' ' ' ARG . 10.5 t -112.31 114.15 46.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.59 HD22 HD21 ' A' ' 92' ' ' LEU . 59.5 mt -87.35 156.74 19.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.551 0.691 . . . . 0.0 112.288 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 117' ' ' GLY . 0.6 OUTLIER -159.03 175.25 13.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.071 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.413 ' H ' HG22 ' A' ' 116' ' ' THR . . . -164.15 -168.5 26.31 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 119.902 -1.142 . . . . 0.0 114.253 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.745 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 36.5 mt-10 -67.7 174.8 1.98 Allowed Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 122.877 0.471 . . . . 0.0 110.453 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.745 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 24.1 Cg_endo -61.39 -38.44 64.25 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.988 1.792 . . . . 0.0 112.267 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 123' ' ' GLU . 15.0 tpp85 -76.88 -30.07 56.05 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.276 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.682 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 11.2 tpt -65.0 -11.59 40.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.205 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.752 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 10.4 mttt -76.33 -6.53 51.96 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.661 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 9.9 pt-20 -121.62 23.37 10.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.973 0.416 . . . . 0.0 111.166 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.446 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 5.1 mmp_? -96.94 94.75 1.89 Allowed Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.541 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.675 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 10.3 Cg_endo -53.66 123.09 12.53 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.499 2.133 . . . . 0.0 112.572 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.653 ' O ' HG23 ' A' ' 130' ' ' VAL . 13.3 tt -127.82 32.07 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.617 0.723 . . . . 0.0 110.225 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -74.3 -49.98 11.04 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.479 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.829 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.9 OUTLIER -52.1 -28.42 17.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.047 0.451 . . . . 0.0 110.656 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.734 ' CD1' HD21 ' A' ' 133' ' ' LEU . 15.8 tp -82.37 -65.44 1.01 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.546 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 1.014 HG13 HD12 ' A' ' 140' ' ' ILE . 47.8 t -51.1 -28.23 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.179 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 13.0 t70 -68.43 -45.93 71.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.496 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 1.038 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -66.5 -48.78 68.72 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.817 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -58.34 -43.08 88.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.36 0.6 . . . . 0.0 109.684 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.53 -33.88 73.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.698 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 1.038 HD12 ' HA ' ' A' ' 132' ' ' ALA . 3.4 mt -69.79 -31.12 68.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.991 0.424 . . . . 0.0 110.266 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.558 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -77.79 -17.12 79.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.379 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.78 3.98 5.33 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.141 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.25 147.24 48.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 111.105 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 1.9 mmtp -113.94 91.22 3.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.454 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.014 HD12 HG13 ' A' ' 130' ' ' VAL . 8.1 mt -116.45 174.63 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.784 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -151.49 -167.15 2.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.144 0.497 . . . . 0.0 111.187 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.743 ' N ' HG23 ' A' ' 141' ' ' THR . 24.4 m-85 -136.17 99.1 4.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.929 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.585 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.4 mm? -68.25 -13.07 61.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.584 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.765 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 40.1 mm-40 -142.0 -73.8 0.31 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.069 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.5 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -120.43 150.09 41.34 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.145 0.498 . . . . 0.0 111.526 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.487 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 16.6 pt-20 -68.21 128.0 34.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.258 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.675 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 8.3 m-20 68.73 51.58 0.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.248 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.809 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.0 m-30 -145.17 177.29 1.82 Allowed Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.809 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 4.5 Cg_endo -48.08 -43.38 30.82 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.026 2.484 . . . . 0.0 114.974 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.765 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 27.8 Cg_endo -62.4 100.95 0.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 120.989 1.126 . . . . 0.0 111.276 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.598 HD11 HG21 ' A' ' 126' ' ' ILE . 61.8 mt -136.97 123.32 20.68 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.412 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.931 ' HG2' HG22 ' A' ' 114' ' ' VAL . 2.8 mtp180 -103.93 112.11 24.95 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.892 HD23 HG23 ' A' ' 140' ' ' ILE . 1.7 mt -93.83 158.75 15.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.318 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.588 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 28.2 mt-30 -149.44 22.66 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.079 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.503 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 53.68 -166.87 1.71 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.707 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 109.29 -2.23 31.15 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.957 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.677 ' CD2' HG22 ' A' ' 179' ' ' THR . 2.5 t80 -60.38 108.21 0.78 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.943 0.372 . . . . 0.0 110.949 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.516 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 68.5 p -105.09 -49.29 3.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.054 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.649 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 142.43 -163.58 27.13 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.168 -1.015 . . . . 0.0 114.019 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.509 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 116.7 172.56 16.42 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -65.29 128.32 35.36 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 117.245 0.523 . . . . 0.0 109.732 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.608 HG11 ' HB1' ' A' ' 132' ' ' ALA . 59.5 t -135.9 157.35 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.149 0.5 . . . . 0.0 111.31 -178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.478 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.7 OUTLIER -125.34 117.94 24.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.518 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.966 HG11 HD13 ' A' ' 173' ' ' LEU . 0.5 OUTLIER -117.91 147.19 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.945 -178.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.829 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.2 OUTLIER -85.77 133.04 34.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.613 178.792 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.713 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -74.52 -44.67 26.14 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.304 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.506 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 0.2 OUTLIER -49.8 163.15 0.14 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.915 0.388 . . . . 0.0 111.805 -179.56 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 169' ' ' SER . 8.2 t 71.27 61.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.844 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.709 ' N ' HG11 ' A' ' 196' ' ' VAL . 0.2 OUTLIER 54.56 156.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.468 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.491 ' HG ' ' HG1' ' A' ' 174' ' ' THR . 6.7 t -79.61 2.21 23.28 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.877 0.37 . . . . 0.0 110.891 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.815 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 82.6 mm-40 -54.05 -24.14 16.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.328 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.55 ' CD2' ' HB2' ' A' ' 128' ' ' HIS . 2.1 m-85 -73.71 -58.48 3.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.352 0.596 . . . . 0.0 110.587 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.966 HD13 HG11 ' A' ' 164' ' ' VAL . 18.0 tp -72.25 -37.29 69.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.861 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.617 HG23 ' OG1' ' A' ' 204' ' ' THR . 66.8 m -57.29 -36.47 71.09 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.241 0.543 . . . . 0.0 109.772 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.912 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -71.76 -51.28 23.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.25 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.817 ' CD2' HD23 ' A' ' 133' ' ' LEU . 3.2 mt -64.12 -38.53 91.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.466 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.07 HD12 HD11 ' A' ' 201' ' ' ILE . 12.5 mt -65.61 -26.55 67.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.07 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.497 ' HA ' ' HH ' ' A' ' 231' ' ' TYR . 20.2 ptp -96.16 -27.03 15.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.175 0.512 . . . . 0.0 110.637 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.677 HG22 ' CD2' ' A' ' 157' ' ' PHE . 65.5 m -86.26 -47.0 9.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.795 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 1.009 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -61.56 -38.49 52.04 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 9.2 Cg_endo -53.57 -35.98 78.9 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 121.28 1.32 . . . . 0.0 111.895 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.721 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.68 -9.25 58.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.676 -179.554 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -65.75 123.95 86.16 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.935 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 1.5 Cg_endo -43.58 -31.26 3.09 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.333 2.688 . . . . 0.0 113.993 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -106.02 153.46 21.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.137 0.494 . . . . 0.0 111.879 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.701 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 75.5 m-20 -67.03 113.15 4.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.78 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.797 ' HB ' HG23 ' A' ' 225' ' ' VAL . 41.1 m -99.6 135.18 41.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.167 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 1.042 HG22 HG13 ' A' ' 224' ' ' VAL . 35.3 t -125.83 99.0 5.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.324 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.576 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.5 mt -89.58 144.17 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.462 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.813 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -114.21 170.93 7.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.842 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.4 mm -110.65 96.35 4.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 120.858 0.361 . . . . 0.0 111.007 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -59.33 -81.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.483 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -81.43 167.8 49.29 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.164 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.94 122.97 16.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.555 0.217 . . . . 0.0 110.546 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.839 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.8 OUTLIER -56.24 148.2 19.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.228 0.537 . . . . 0.0 110.535 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.709 HG11 ' N ' ' A' ' 169' ' ' SER . 13.8 p -105.81 -21.78 5.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.225 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.698 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -126.65 47.42 2.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.848 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.1 OUTLIER -44.1 -65.15 0.64 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.904 -178.114 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.567 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 43.0 Cg_endo -65.6 -18.18 58.55 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 121.545 1.497 . . . . 0.0 111.542 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.82 ' HA ' HD12 ' A' ' 203' ' ' ILE . 13.3 m-85 -73.81 -30.03 62.49 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.561 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 1.07 HD11 HD12 ' A' ' 177' ' ' LEU . 8.0 tp -69.55 -33.32 56.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.422 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.3 OUTLIER -60.9 -35.5 76.84 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.82 HD12 ' HA ' ' A' ' 200' ' ' TYR . 15.8 mt -65.93 -30.27 49.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.62 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.617 ' OG1' HG23 ' A' ' 174' ' ' THR . 45.0 m -60.99 -55.76 29.14 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 1.038 HD21 HD22 ' A' ' 177' ' ' LEU . 35.5 mt -70.25 -33.71 71.96 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.473 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.537 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 1.0 OUTLIER -66.14 -29.44 69.74 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.724 HD23 HG22 ' A' ' 203' ' ' ILE . 0.7 OUTLIER -77.08 -44.92 28.81 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.115 178.371 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.498 ' SD ' HG22 ' A' ' 204' ' ' THR . 12.7 mtp -64.62 -42.61 95.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.2 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.619 ' HG3' ' N ' ' A' ' 210' ' ' THR . 4.4 ptmt -61.53 -46.08 91.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.64 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.619 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.3 OUTLIER -59.11 -29.57 67.47 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.807 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 0.8 OUTLIER -70.76 -49.67 44.22 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.485 179.277 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 155.63 -7.52 0.28 Allowed Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.337 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.724 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 49.3 t -119.18 141.82 37.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.409 ' HG3' ' HA ' ' A' ' 209' ' ' LYS . 9.6 mt-10 -135.59 155.67 50.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.401 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 1.011 HG21 HG12 ' A' ' 225' ' ' VAL . 2.3 pp -129.1 175.87 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.754 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.916 -177.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 1.014 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 7.2 tp10 -88.74 125.2 34.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.529 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -101.53 101.02 11.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.424 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.845 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.6 OUTLIER -66.77 -168.14 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.499 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -74.37 48.42 0.33 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.816 0.341 . . . . 0.0 110.427 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.625 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 58.14 20.13 6.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.036 0.446 . . . . 0.0 111.252 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 191' ' ' ILE . 3.8 mt-30 -112.23 -20.52 11.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.77 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.845 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 34.9 mt-30 -151.2 140.87 21.74 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.901 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.969 ' HB3' HD21 ' A' ' 177' ' ' LEU . 11.0 m-85 -113.19 98.99 7.48 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 1.042 HG13 HG22 ' A' ' 188' ' ' VAL . 45.9 t -84.71 110.89 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.143 0.497 . . . . 0.0 111.25 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 1.011 HG12 HG21 ' A' ' 215' ' ' ILE . 3.2 m -99.02 111.61 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.927 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.738 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.6 OUTLIER -62.02 101.21 0.2 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.035 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.701 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -55.94 155.85 11.56 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.402 -0.817 . . . . 0.0 113.029 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.34 10.92 63.35 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.326 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.738 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 81.6 mm-40 -78.06 -177.67 5.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.444 0.64 . . . . 0.0 111.327 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.721 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.7 m -175.87 104.75 0.08 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.212 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.724 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 24.8 m-85 -54.11 152.44 6.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.825 0.345 . . . . 0.0 111.118 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.807 ' HG2' ' O ' ' A' ' 211' ' ' PHE . 7.5 pt20 -122.68 155.7 35.87 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 35.2 t -69.26 100.42 0.26 Allowed Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 56.9 Cg_endo -67.8 -32.75 28.95 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.387 2.058 . . . . 0.0 111.76 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 123.4 -119.01 3.69 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.962 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.666 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.8 OUTLIER -96.69 117.32 30.75 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.564 ' CE2' HD11 ' A' ' 207' ' ' LEU . 52.7 t80 -121.53 135.3 55.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.013 -178.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.751 HD12 HG23 ' A' ' 42' ' ' THR . 8.7 tp -95.51 111.35 23.28 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.582 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.735 HG11 ' N ' ' A' ' 25' ' ' SER . 21.5 t -58.9 -71.46 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.035 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.71 ' H ' ' HB3' ' A' ' 43' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.013 -0.994 . . . . 0.0 111.072 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.706 ' O ' HD12 ' A' ' 29' ' ' LEU . 19.2 p . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.68 0.276 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.691 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 4.4 p30 -84.87 -25.78 27.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.535 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.417 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 52.0 mtt180 -67.96 -42.05 81.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.868 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -74.68 -32.98 62.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.827 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -62.07 -48.82 78.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.186 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.561 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 17.0 tp -73.93 -43.93 56.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.453 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.759 HD21 ' HG2' ' A' ' 178' ' ' MET . 61.8 mt -59.89 -31.9 70.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.109 0.48 . . . . 0.0 110.899 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.686 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -78.6 -30.66 46.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.595 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.839 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -69.37 -32.12 70.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.62 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.913 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -88.74 -12.28 42.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.145 0.497 . . . . 0.0 110.966 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.642 ' HB2' ' HB2' ' A' ' 231' ' ' TYR . . . -80.43 166.17 21.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.409 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 87.3 m-70 -101.21 97.83 8.3 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.14 142.28 6.77 Favored Glycine 0 C--N 1.315 -0.611 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.828 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.663 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 17.4 ttpp -67.02 138.91 57.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.236 0.541 . . . . 0.0 112.027 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.716 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.7 OUTLIER -132.93 156.13 47.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.333 179.076 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.722 HG22 ' CG ' ' A' ' 74' ' ' GLU . 61.9 t -102.75 142.87 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.317 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.868 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -127.79 111.94 14.2 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.466 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 1.155 ' HB ' ' HD3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -97.65 167.85 10.71 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.02 0.438 . . . . 0.0 111.179 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.643 ' HB2' ' CD1' ' A' ' 238' ' ' LEU . 0.2 OUTLIER 61.55 21.35 12.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.065 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.909 HD22 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -58.88 159.35 7.06 Favored 'General case' 0 N--CA 1.46 0.069 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.786 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.623 ' HB3' HG21 ' A' ' 50' ' ' VAL . 31.4 tp -92.63 114.6 27.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.022 0.439 . . . . 0.0 111.659 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.41 ' CG ' ' HB2' ' A' ' 70' ' ' ARG . 62.0 t0 -76.1 65.46 2.11 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.179 0.514 . . . . 0.0 109.995 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.3 m -128.31 -162.41 1.18 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.284 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.722 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -96.97 -19.94 18.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.246 0.546 . . . . 0.0 110.841 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.617 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 30.1 m-20 -69.95 -28.63 65.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.123 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.785 HG12 HD11 ' A' ' 54' ' ' LEU . 25.8 t -89.74 -50.89 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.752 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.722 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -49.21 -29.08 5.17 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.116 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . 37.8 m170 -73.32 -37.56 66.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.298 178.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.691 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 3.2 tpt -64.73 -47.86 76.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.827 HD23 HD21 ' A' ' 29' ' ' LEU . 1.6 mp -68.43 -43.93 76.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.584 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.2 m-80 -58.5 -22.72 56.01 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.955 0.407 . . . . 0.0 110.319 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.711 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -75.82 -48.57 21.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.62 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.614 HD21 ' HE2' ' A' ' 53' ' ' MET . 0.1 OUTLIER -67.41 -48.13 68.24 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.593 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.692 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.0 t -52.39 -30.67 30.22 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.16 0.505 . . . . 0.0 110.247 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.723 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -61.77 -47.98 82.71 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.296 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.997 HD21 HD22 ' A' ' 106' ' ' LEU . 3.3 mp -71.22 -24.88 62.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.212 0.53 . . . . 0.0 110.184 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.71 0.65 7.16 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.434 -0.889 . . . . 0.0 114.067 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.73 HG21 HD11 ' A' ' 82' ' ' LEU . 11.3 t -56.73 156.49 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 117.58 0.69 . . . . 0.0 110.536 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.583 ' HB3' HD13 ' A' ' 76' ' ' ILE . 2.8 m -113.66 110.09 19.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.733 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.692 ' CE2' ' HB ' ' A' ' 58' ' ' THR . 20.7 p90 -132.58 152.45 51.61 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.552 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.712 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -147.94 116.17 6.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.715 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.909 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -84.24 175.35 9.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.152 0.501 . . . . 0.0 111.104 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.639 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -87.25 179.22 6.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.092 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.83 -14.55 34.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.225 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.87 8.04 11.05 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.856 0.36 . . . . 0.0 110.606 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.431 ' O ' HD23 ' A' ' 44' ' ' LEU . 1.4 mtp180 58.75 47.04 13.35 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.421 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -129.23 -2.05 5.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.601 179.157 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 1.155 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -138.78 109.07 6.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.929 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.755 ' SG ' HD22 ' A' ' 66' ' ' LEU . 3.4 t -120.04 146.81 45.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.259 0.552 . . . . 0.0 112.185 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.722 ' CG ' HG22 ' A' ' 40' ' ' VAL . 1.2 mp0 -115.69 102.56 9.85 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.104 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.663 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -95.95 124.34 48.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.583 HD13 ' HB3' ' A' ' 63' ' ' SER . 1.8 mp -79.22 104.25 7.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.215 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.686 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -48.8 118.53 5.01 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.877 -0.601 . . . . 0.0 114.346 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.66 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 2.3 m-20 -64.02 -15.94 60.54 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.093 0.473 . . . . 0.0 110.022 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.555 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.15 -20.73 14.84 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.218 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.913 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -137.44 -155.38 6.9 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.852 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 3.0 Cg_exo -74.35 166.37 29.63 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 121.865 1.71 . . . . 0.0 108.738 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.839 HD21 ' HB3' ' A' ' 33' ' ' ALA . 4.3 mm? -64.62 90.03 0.07 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.328 1.061 . . . . 0.0 108.293 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.852 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 31.3 m170 -82.55 118.59 23.38 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.675 -176.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.85 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -142.93 109.42 5.37 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.971 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -112.76 93.42 4.42 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.222 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.86 21.26 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.282 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 56.72 50.24 12.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.469 0.652 . . . . 0.0 110.302 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.76 HD12 ' N ' ' A' ' 89' ' ' GLU . 4.8 tp -79.77 137.94 37.13 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.189 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.76 ' N ' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -117.04 124.06 48.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.139 0.495 . . . . 0.0 110.733 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.711 HD13 ' HA ' ' A' ' 56' ' ' ALA . 10.1 mt -105.47 162.99 12.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.475 0.655 . . . . 0.0 112.274 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.612 ' HA ' ' O ' ' A' ' 116' ' ' THR . 30.2 t80 -127.22 106.86 9.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.466 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.934 ' HG ' ' HA ' ' A' ' 99' ' ' MET . 2.5 mm? -94.67 6.83 47.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 44.37 -137.89 5.08 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.791 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.54 ' N ' ' HG3' ' A' ' 118' ' ' GLU . 32.0 t30 -104.47 55.18 0.72 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.911 0.386 . . . . 0.0 110.671 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -98.65 -66.35 0.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.917 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.591 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 78.48 -17.09 6.87 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.867 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.46 ' HA ' ' CD ' ' A' ' 171' ' ' GLN . 1.7 p -92.71 -6.92 48.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.737 0.303 . . . . 0.0 111.238 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.501 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -131.97 -20.71 2.47 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.934 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 2.2 ttt -68.19 -51.48 45.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.941 0.401 . . . . 0.0 110.53 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.663 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 2.5 mpt_? -58.83 -53.68 63.98 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.561 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.66 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 24.3 Cg_exo -64.57 -46.74 6.6 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.853 2.369 . . . . 0.0 113.164 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.809 HD13 HD11 ' A' ' 106' ' ' LEU . 3.1 tm? -64.0 -37.78 88.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.23 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.639 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -62.15 -48.38 80.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.443 0.639 . . . . 0.0 110.285 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.927 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -67.3 -40.77 86.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.566 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -58.68 -42.98 89.78 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.997 HD22 HD21 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -68.78 -21.37 64.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.276 0.56 . . . . 0.0 110.884 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.577 ' SG ' HD11 ' A' ' 140' ' ' ILE . 99.6 m -61.65 -10.33 8.2 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.727 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.778 HD11 ' O ' ' A' ' 179' ' ' THR . 13.0 mt -81.08 167.4 19.77 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 52.65 -111.74 1.78 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.393 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.456 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 14.7 m -162.59 99.59 1.02 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.949 0.404 . . . . 0.0 110.287 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.581 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 20.5 m-20 -138.94 136.11 35.1 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.698 ' C ' HD12 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -100.2 111.23 23.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.015 178.468 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.699 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.6 mp -144.23 142.7 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.411 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.622 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 29.5 t -115.44 111.37 35.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.044 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.639 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 33.7 mt -79.75 156.95 27.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.567 0.698 . . . . 0.0 112.359 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.612 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 19.0 m -159.51 156.34 28.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.795 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.3 -166.78 11.33 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.448 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.588 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 3.3 mm-40 -70.89 176.97 1.65 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.588 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 38.7 Cg_exo -62.22 -35.47 74.23 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.208 1.939 . . . . 0.0 112.222 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.637 ' HD3' ' HG2' ' A' ' 123' ' ' GLU . 19.5 tpp85 -79.71 -33.91 40.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.943 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.623 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 11.1 tpt -60.19 -18.11 45.88 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.74 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 5.1 mmtp -69.61 -4.84 20.98 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.066 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.637 ' HG2' ' HD3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -120.17 27.14 8.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.836 0.351 . . . . 0.0 110.903 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 11.4 mmm-85 -107.22 87.08 2.9 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.513 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.825 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.9 Cg_endo -47.82 123.8 8.95 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.753 2.302 . . . . 0.0 111.698 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.813 HD11 HD23 ' A' ' 129' ' ' LEU . 19.1 tt -125.04 28.28 2.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.81 0.814 . . . . 0.0 110.31 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.64 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -67.04 -51.16 41.19 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.548 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.674 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.8 OUTLIER -52.63 -31.62 37.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.085 0.469 . . . . 0.0 110.88 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.813 HD23 HD11 ' A' ' 126' ' ' ILE . 31.9 tp -79.23 -65.08 1.04 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.808 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 1.038 HG13 HD12 ' A' ' 140' ' ' ILE . 54.1 t -52.33 -26.19 8.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.54 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.64 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.4 OUTLIER -72.04 -47.79 49.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.093 0.473 . . . . 0.0 111.048 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.924 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -60.58 -48.85 79.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.426 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.983 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -61.4 -43.26 99.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.548 0.689 . . . . 0.0 109.707 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -61.51 -33.38 73.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.643 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.924 HD12 ' HA ' ' A' ' 132' ' ' ALA . 2.8 mt -69.33 -30.03 67.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.83 0.348 . . . . 0.0 110.075 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.43 -18.39 79.19 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.585 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 131.37 1.38 4.79 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.023 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.456 ' CB ' ' HB3' ' A' ' 107' ' ' CYS . . . -71.39 146.87 48.46 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.937 0.399 . . . . 0.0 111.45 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.0 mttt -116.29 94.38 4.62 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.235 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.038 HD12 HG13 ' A' ' 130' ' ' VAL . 9.0 mt -116.85 178.69 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.93 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.802 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.7 OUTLIER -161.38 -174.79 4.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.008 0.432 . . . . 0.0 111.205 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.575 ' N ' HG23 ' A' ' 141' ' ' THR . 24.5 m-85 -123.94 108.86 12.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.869 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.701 HD21 ' N ' ' A' ' 152' ' ' ARG . 1.4 mm? -85.51 -14.46 45.91 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.499 ' HB3' ' CB ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -137.48 -69.79 0.45 Allowed 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.164 0.506 . . . . 0.0 109.705 179.368 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.772 ' HB3' ' CD2' ' A' ' 148' ' ' TYR . 2.8 mt-30 -118.2 145.63 44.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.675 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.503 ' HA ' ' CG ' ' A' ' 142' ' ' TYR . 12.3 mt-10 -76.8 128.82 35.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.787 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.825 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 31.1 m-20 65.22 49.47 1.96 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.856 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 42.6 m-85 -149.15 179.02 1.28 Allowed Pre-proline 0 CA--C 1.549 0.904 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.594 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.856 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -43.9 -44.41 11.9 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 123.965 3.11 . . . . 0.0 115.167 -178.398 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.736 ' HD3' ' HE3' ' A' ' 122' ' ' LYS . 46.5 Cg_endo -64.6 102.65 0.42 Allowed 'Trans proline' 0 CA--C 1.509 -0.73 0 C-N-CA 121.701 1.601 . . . . 0.0 111.937 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.521 HD11 HG21 ' A' ' 126' ' ' ILE . 88.0 mt -139.43 124.11 18.45 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.057 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.785 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.1 OUTLIER -104.24 112.57 25.64 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.411 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.967 HD23 HG23 ' A' ' 140' ' ' ILE . 2.3 mt -93.61 159.97 14.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.191 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER -147.51 23.97 1.12 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.964 179.518 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.537 ' HA2' ' O ' ' A' ' 107' ' ' CYS . . . 55.48 -166.07 3.47 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.597 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.44 -5.47 38.1 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.798 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.702 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 42.1 t80 -62.95 109.06 1.34 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.92 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.582 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 69.0 p -106.93 -47.7 3.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.958 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.628 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.55 -168.58 26.25 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.845 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.643 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 122.98 170.56 13.52 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -64.69 124.91 23.13 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.543 HG13 HD13 ' A' ' 135' ' ' LEU . 48.8 t -136.66 153.8 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 111.653 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.613 ' HB2' ' HE2' ' A' ' 192' ' ' LYS . 1.2 m-20 -119.01 118.03 30.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.729 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.583 HG11 HD13 ' A' ' 173' ' ' LEU . 0.9 OUTLIER -117.6 147.03 21.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.006 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.674 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 3.6 t0 -82.86 134.88 35.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.932 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.676 ' CA ' HD12 ' A' ' 195' ' ' LEU . . . -77.9 -44.2 12.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.299 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.455 ' C ' HG23 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -54.21 166.51 0.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.611 0.243 . . . . 0.0 111.141 -179.511 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.455 HG23 ' C ' ' A' ' 167' ' ' SER . 2.2 t 68.5 54.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.106 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.84 ' N ' HG11 ' A' ' 196' ' ' VAL . 0.3 OUTLIER 61.53 141.23 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.1 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.562 ' CB ' ' HB2' ' A' ' 197' ' ' SER . 0.4 OUTLIER -69.63 -5.02 21.94 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.319 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.663 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 76.2 mm-40 -50.66 -23.69 2.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.849 0.357 . . . . 0.0 111.046 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.704 ' O ' HD13 ' A' ' 129' ' ' LEU . 3.0 m-85 -68.83 -54.72 14.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.494 0.664 . . . . 0.0 109.992 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.703 HD23 HG12 ' A' ' 201' ' ' ILE . 58.9 tp -76.75 -30.9 56.76 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.249 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.607 HG23 ' OG1' ' A' ' 204' ' ' THR . 33.2 m -61.06 -33.39 73.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.181 0.515 . . . . 0.0 109.849 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.927 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -70.02 -51.55 31.36 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.796 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.983 ' CD2' HD23 ' A' ' 133' ' ' LEU . 1.6 mt -67.1 -35.87 80.73 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.382 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.043 HD22 HD21 ' A' ' 205' ' ' LEU . 10.5 mt -69.02 -25.71 64.62 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.323 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.759 ' HG2' HD21 ' A' ' 31' ' ' LEU . 44.9 mtp -95.27 -27.05 15.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.265 0.555 . . . . 0.0 110.959 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.778 ' O ' HD11 ' A' ' 108' ' ' LEU . 88.7 m -91.93 -47.21 7.42 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.682 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.95 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -60.8 -36.21 32.83 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.752 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 13.0 Cg_endo -54.14 -37.92 87.48 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.154 1.236 . . . . 0.0 111.541 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.68 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.1 mp -83.56 -8.87 59.25 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.047 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -67.21 120.15 70.12 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.148 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 5.9 Cg_exo -38.8 -28.92 0.15 Allowed 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.456 2.77 . . . . 0.0 114.224 -178.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -107.55 151.44 25.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 111.807 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.67 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 32.2 t70 -66.53 117.05 8.18 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.451 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.848 ' HB ' HG23 ' A' ' 225' ' ' VAL . 28.3 m -103.38 135.48 44.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.249 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.985 HG22 HG13 ' A' ' 224' ' ' VAL . 31.7 t -125.65 98.84 5.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.337 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.605 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.0 mp -89.62 141.62 14.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.324 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.807 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.4 OUTLIER -112.17 171.11 7.7 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.584 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.845 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.6 mm -110.18 97.61 5.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 120.981 0.42 . . . . 0.0 111.52 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.613 ' HE2' ' HB2' ' A' ' 163' ' ' ASP . 17.2 mttt -59.85 -82.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.884 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -80.95 175.0 54.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.77 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.39 124.67 22.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.649 0.261 . . . . 0.0 110.569 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.85 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.9 OUTLIER -60.95 148.25 40.51 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.01 0.433 . . . . 0.0 109.975 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.84 HG11 ' N ' ' A' ' 169' ' ' SER . 12.1 p -104.91 -19.33 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.557 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.845 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 3.8 m -131.36 45.46 2.8 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.04 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.883 ' O ' HG22 ' A' ' 201' ' ' ILE . 2.8 tttt -42.0 -65.41 0.52 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 114.896 -1.047 . . . . 0.0 113.283 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.859 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 15.9 Cg_exo -68.04 -17.88 45.95 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.517 1.478 . . . . 0.0 111.841 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.845 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 45.4 m-85 -75.11 -29.28 60.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.405 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.883 HG22 ' O ' ' A' ' 198' ' ' LYS . 9.5 tp -69.68 -30.95 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.126 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.64 -32.59 74.11 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.569 ' O ' HD23 ' A' ' 207' ' ' LEU . 33.0 mt -64.93 -32.63 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.147 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.607 ' OG1' HG23 ' A' ' 174' ' ' THR . 54.7 m -60.06 -53.74 54.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.376 0.608 . . . . 0.0 109.772 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 1.043 HD21 HD22 ' A' ' 177' ' ' LEU . 44.4 mt -68.59 -37.56 79.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.792 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -62.05 -29.29 70.19 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.736 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 2.1 mm? -76.66 -42.06 43.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.793 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.666 ' SD ' ' HG3' ' A' ' 181' ' ' PRO . 9.3 mtm -59.53 -42.92 93.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.796 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.881 ' HG3' ' O ' ' A' ' 205' ' ' LEU . 10.1 mtpt -64.96 -55.55 18.44 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.222 0.534 . . . . 0.0 110.2 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -50.76 -27.43 7.17 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.129 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.934 ' HA ' ' HG3' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -78.85 -50.2 11.65 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.561 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 152.58 0.82 0.22 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.967 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.573 HG13 ' CG ' ' A' ' 229' ' ' GLN . 53.8 t -118.78 139.81 44.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.138 0.494 . . . . 0.0 112.062 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.631 ' HG2' ' HG2' ' A' ' 209' ' ' LYS . 62.6 mt-10 -132.05 157.68 43.53 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.024 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.98 HG12 HD22 ' A' ' 205' ' ' LEU . 2.8 pp -138.16 175.26 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.909 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 1.068 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 33.0 tt0 -92.03 123.15 35.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.328 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -99.56 100.82 11.88 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.708 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.824 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.5 OUTLIER -67.33 -168.77 0.08 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.801 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -73.63 47.66 0.25 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.863 0.363 . . . . 0.0 110.364 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.673 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 0.1 OUTLIER 58.44 19.77 6.79 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.933 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 191' ' ' ILE . 18.7 mt-30 -111.67 -22.34 11.24 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.824 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 41.4 mt-30 -148.15 141.84 25.59 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.986 ' HB3' HD21 ' A' ' 177' ' ' LEU . 7.3 m-85 -112.59 95.93 5.7 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 1.068 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 41.5 t -80.36 110.98 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.062 0.458 . . . . 0.0 111.174 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.95 HG21 ' CB ' ' A' ' 180' ' ' ALA . 2.6 m -96.96 107.72 20.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.931 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.683 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -57.41 100.96 0.06 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.592 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.67 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -55.66 154.52 12.7 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.51 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.34 9.13 65.46 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.088 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.683 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 1.9 mm-40 -77.16 176.97 8.24 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.812 0.815 . . . . 0.0 112.19 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.68 ' HA ' HD23 ' A' ' 182' ' ' LEU . 3.4 m -175.6 105.01 0.08 Allowed 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.614 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.642 ' HB2' ' HB2' ' A' ' 35' ' ' ALA . 17.5 m-85 -53.63 152.57 5.04 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.478 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.551 ' HG2' ' O ' ' A' ' 211' ' ' PHE . 15.0 pt20 -121.4 142.5 49.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.787 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 34.6 t -51.18 99.64 0.21 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.197 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.934 ' HG3' ' HA ' ' A' ' 211' ' ' PHE . 14.7 Cg_exo -68.79 -29.03 29.51 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.454 2.103 . . . . 0.0 111.635 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.18 -122.52 5.56 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.361 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.652 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -91.97 116.08 28.61 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.023 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.594 ' CE2' HD11 ' A' ' 207' ' ' LEU . 58.0 t80 -113.52 140.99 47.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.293 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.923 ' HA ' HG23 ' A' ' 42' ' ' THR . 0.1 OUTLIER -99.71 108.07 20.32 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.317 179.325 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.721 ' O ' ' HG3' ' A' ' 240' ' ' GLU . 54.0 t -50.68 -44.53 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.247 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.722 ' H ' HD12 ' A' ' 238' ' ' LEU . 1.3 pt-20 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 117.971 -1.014 . . . . 0.0 111.597 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.65 ' O ' HD12 ' A' ' 29' ' ' LEU . 2.4 p . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 121.549 0.69 . . . . 0.0 109.688 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.618 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 13.0 m-20 -87.6 -22.93 24.47 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.454 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.26 -43.01 82.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.296 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.516 ' CB ' HD22 ' A' ' 41' ' ' LEU . . . -76.37 -32.19 58.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.836 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -61.39 -54.25 46.13 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.25 0.548 . . . . 0.0 110.276 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.685 HD21 ' HB2' ' A' ' 105' ' ' ALA . 9.4 tp -63.78 -55.28 24.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.448 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.724 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 29.6 mt -52.57 -34.89 52.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.134 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.671 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -76.21 -29.24 57.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.375 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.684 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -73.08 -32.99 65.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.538 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.883 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -87.55 -13.13 43.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.927 0.394 . . . . 0.0 110.907 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -81.9 164.34 21.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.737 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.44 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 89.4 m-70 -97.24 96.14 8.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.479 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.34 141.36 5.98 Favored Glycine 0 C--N 1.318 -0.442 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.936 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.758 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -62.12 129.18 39.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.491 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.7 OUTLIER -122.67 155.49 36.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.147 178.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.712 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 46.7 t -102.63 142.17 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.332 -0.394 . . . . 0.0 112.013 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 237' ' ' TYR . 0.0 OUTLIER -129.41 111.97 13.34 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.055 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.998 ' HB ' ' HD3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -103.4 170.76 7.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.072 0.463 . . . . 0.0 111.595 -179.578 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.559 ' HB2' HD11 ' A' ' 238' ' ' LEU . 29.0 t-20 62.11 20.28 11.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.056 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.754 HD22 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -58.76 158.34 8.19 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.595 ' HB3' HG21 ' A' ' 50' ' ' VAL . 24.7 tp -90.74 114.36 26.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.097 0.475 . . . . 0.0 111.551 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -76.01 65.0 1.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.235 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 74.6 m -125.2 -163.49 1.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.898 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.731 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 1.3 m-20 -96.77 -19.08 19.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.399 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.588 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 8.6 m-20 -70.98 -29.86 65.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.968 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.781 HG12 HD11 ' A' ' 54' ' ' LEU . 39.1 t -88.11 -53.36 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.377 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.731 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 9.5 ptp180 -50.62 -30.73 14.11 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.039 0.447 . . . . 0.0 110.005 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -72.94 -35.3 66.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.039 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.618 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 10.9 tpt -64.93 -49.87 68.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.836 HD23 HD21 ' A' ' 29' ' ' LEU . 1.2 mp -66.14 -45.86 79.52 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.61 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.7 m-20 -57.29 -22.67 43.29 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.022 0.439 . . . . 0.0 109.987 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.747 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -74.77 -48.76 23.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.599 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.622 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -68.2 -49.65 59.42 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.903 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.477 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 5.3 t -50.48 -33.81 22.62 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.339 0.59 . . . . 0.0 110.304 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.623 ' CB ' HD21 ' A' ' 90' ' ' LEU . . . -59.36 -48.89 79.92 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.213 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.999 HD21 HD22 ' A' ' 106' ' ' LEU . 3.9 mp -67.13 -29.12 68.76 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.483 0.658 . . . . 0.0 109.831 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.13 -1.65 4.59 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 114.81 -1.087 . . . . 0.0 113.815 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.7 HG21 HD11 ' A' ' 82' ' ' LEU . 13.0 t -58.96 153.92 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 117.644 0.722 . . . . 0.0 110.247 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.737 ' HB2' HD12 ' A' ' 76' ' ' ILE . 3.8 m -116.97 108.92 16.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.151 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 16.6 p90 -124.76 157.23 36.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.726 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -148.03 116.1 6.48 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.812 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.754 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -87.16 175.19 8.19 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.237 0.542 . . . . 0.0 111.38 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.607 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -89.48 179.4 6.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.859 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.35 -14.62 28.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.439 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.63 6.09 11.63 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.816 0.341 . . . . 0.0 110.656 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.583 ' HG2' ' HG ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER 59.07 45.59 14.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.503 -179.678 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -129.27 -2.16 5.04 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.999 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.998 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 1.2 mmm180 -136.58 109.34 7.54 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.694 ' HA ' ' O ' ' A' ' 65' ' ' THR . 5.4 t -120.62 154.04 36.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.376 0.607 . . . . 0.0 112.637 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.711 ' HG3' HG22 ' A' ' 40' ' ' VAL . 2.9 mt-10 -121.39 104.66 9.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.141 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.758 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -96.57 128.03 48.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.751 HG12 ' HG3' ' A' ' 38' ' ' LYS . 18.9 mt -81.67 103.06 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.112 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.671 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -47.9 113.78 1.54 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.695 -0.684 . . . . 0.0 114.197 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 25.0 t-20 -60.01 -17.36 38.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.112 0.482 . . . . 0.0 110.117 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.44 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 86.49 -22.96 10.92 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.363 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.883 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.65 -148.79 5.36 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.846 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 2.6 Cg_exo -77.09 169.01 22.3 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 CA-C-N 119.708 1.754 . . . . 0.0 109.261 177.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.7 HD11 HG21 ' A' ' 62' ' ' VAL . 4.5 mm? -67.43 90.51 0.24 Allowed 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 122.445 1.117 . . . . 0.0 108.078 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.846 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 30.3 m170 -82.26 118.67 23.29 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 112.877 -1.965 . . . . 0.0 112.671 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.708 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -144.87 113.07 6.49 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.644 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.15 86.35 2.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.795 0.331 . . . . 0.0 111.295 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -173.82 20.07 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.654 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.74 52.16 8.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.418 0.628 . . . . 0.0 109.852 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.704 ' O ' HG23 ' A' ' 113' ' ' ILE . 4.1 tp -80.73 134.37 35.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.221 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.694 ' N ' HD12 ' A' ' 88' ' ' LEU . 1.2 tt0 -113.87 128.94 56.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.228 0.537 . . . . 0.0 110.523 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.683 ' O ' HG22 ' A' ' 116' ' ' THR . 28.3 mt -112.4 154.09 26.32 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.46 ' CE1' ' HA2' ' A' ' 93' ' ' GLY . 52.6 t80 -116.39 105.35 12.42 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.663 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.976 HD23 ' HE1' ' A' ' 99' ' ' MET . 3.0 mm? -90.2 8.9 30.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.275 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.46 ' HA2' ' CE1' ' A' ' 91' ' ' PHE . . . 37.73 -143.93 0.2 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.249 -0.501 . . . . 0.0 113.216 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.422 HD22 ' HB3' ' A' ' 120' ' ' ARG . 0.9 OUTLIER -96.09 50.94 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.242 0.544 . . . . 0.0 110.025 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.588 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -90.0 -72.96 0.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.608 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.37 -19.44 8.54 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.444 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.439 HG23 ' NE2' ' A' ' 171' ' ' GLN . 19.0 m -93.92 -7.23 43.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.769 0.319 . . . . 0.0 111.099 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.582 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . . . -129.88 -17.09 3.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.355 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.976 ' HE1' HD23 ' A' ' 92' ' ' LEU . 21.9 tpp -70.23 -55.13 10.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.935 0.398 . . . . 0.0 111.009 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.896 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.6 mpt_? -60.07 -49.36 91.39 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.938 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 20.6 Cg_exo -66.79 -47.15 2.85 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.814 2.343 . . . . 0.0 112.95 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.796 HD13 HD11 ' A' ' 106' ' ' LEU . 3.3 tm? -68.55 -34.14 75.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.661 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.624 ' HA ' HD11 ' A' ' 115' ' ' LEU . . . -63.36 -47.98 79.86 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.645 0.736 . . . . 0.0 109.78 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.746 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -70.25 -39.18 75.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.094 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.685 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -56.6 -40.92 76.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 111.949 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.999 HD22 HD21 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -71.72 -21.48 61.76 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.568 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.514 ' SG ' HD11 ' A' ' 140' ' ' ILE . 89.6 m -60.8 -10.55 5.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.102 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 179' ' ' THR . 13.9 mt -83.3 168.48 16.63 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 53.95 -108.09 0.77 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.428 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.47 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.3 OUTLIER -167.68 99.6 0.48 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.843 0.354 . . . . 0.0 110.398 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 8.5 m-20 -138.5 135.79 35.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.134 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.628 ' C ' HD12 ' A' ' 113' ' ' ILE . 18.3 m-20 -99.42 111.0 23.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.841 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.704 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.8 mp -143.0 140.79 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 5.8 t -109.46 113.71 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.624 HD11 ' HA ' ' A' ' 103' ' ' ALA . 37.2 mt -89.71 154.61 19.81 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.125 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.683 HG22 ' O ' ' A' ' 90' ' ' LEU . 13.0 t -155.46 -170.27 3.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.296 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -173.45 -167.8 33.71 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 119.988 -1.101 . . . . 0.0 113.901 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.501 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 2.9 mm-40 -69.59 178.09 1.08 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.319 -0.441 . . . . 0.0 110.919 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.501 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 31.8 Cg_exo -61.88 -38.49 58.55 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.048 1.832 . . . . 0.0 112.214 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.844 HH11 ' HG3' ' A' ' 123' ' ' GLU . 3.2 tpt180 -79.55 -23.75 42.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.026 0.441 . . . . 0.0 110.204 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.62 ' HE3' ' HB2' ' A' ' 124' ' ' ARG . 10.8 tpt -69.17 -15.54 63.42 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.777 ' HE2' ' HD3' ' A' ' 150' ' ' PRO . 0.8 OUTLIER -74.44 -4.71 38.25 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.162 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.844 ' HG3' HH11 ' A' ' 120' ' ' ARG . 0.1 OUTLIER -127.65 26.02 5.96 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.293 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.62 ' HB2' ' HE3' ' A' ' 121' ' ' MET . 2.5 mmp_? -100.56 91.43 1.8 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.493 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.7 Cg_endo -47.87 127.06 13.89 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.593 2.195 . . . . 0.0 112.589 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.761 HD11 HD23 ' A' ' 129' ' ' LEU . 18.5 tt -130.88 31.24 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 121.732 0.777 . . . . 0.0 109.943 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.635 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -71.61 -51.98 14.16 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 114.772 -1.103 . . . . 0.0 112.735 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.538 ' HB2' ' CD2' ' A' ' 172' ' ' PHE . 0.8 OUTLIER -52.31 -26.49 12.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.927 0.394 . . . . 0.0 110.562 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.761 HD23 HD11 ' A' ' 126' ' ' ILE . 39.6 tp -84.69 -65.05 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.545 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.818 HG13 HD12 ' A' ' 140' ' ' ILE . 47.6 t -52.55 -26.02 9.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.49 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.635 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -73.23 -44.6 59.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.651 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.975 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -66.64 -47.98 70.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.571 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.876 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -58.26 -45.47 87.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.514 0.673 . . . . 0.0 109.52 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -33.79 71.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.816 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.975 HD12 ' HA ' ' A' ' 132' ' ' ALA . 5.1 mt -70.19 -31.99 69.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.977 0.417 . . . . 0.0 110.104 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.517 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -74.78 -17.99 80.09 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.514 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.81 2.9 5.13 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.596 -0.812 . . . . 0.0 113.114 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' A' ' 107' ' ' CYS . . . -70.11 146.73 50.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 111.027 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 46.3 mmtt -113.43 81.47 1.51 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.473 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.955 HG23 HD23 ' A' ' 153' ' ' LEU . 9.3 mt -107.44 176.12 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.847 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.5 OUTLIER -153.24 -169.03 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.028 0.442 . . . . 0.0 111.225 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.694 ' N ' HG23 ' A' ' 141' ' ' THR . 19.3 m-85 -131.72 104.18 6.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.014 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.637 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.4 mm? -75.02 -13.22 60.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.522 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.758 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 5.0 mt-10 -138.99 -73.23 0.39 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.209 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.631 ' HB2' ' HD2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -123.98 156.43 36.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.227 0.537 . . . . 0.0 111.735 -179.314 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.404 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 2.8 mt-10 -70.95 125.83 27.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.616 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.684 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 0.9 OUTLIER 70.41 50.43 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.044 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.704 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.0 m-30 -141.75 173.82 4.39 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.72 ' CG ' ' HA ' ' A' ' 122' ' ' LYS . 6.3 Cg_endo -49.18 -40.79 42.4 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.159 2.573 . . . . 0.0 115.068 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.777 ' HD3' ' HE2' ' A' ' 122' ' ' LYS . 18.7 Cg_endo -62.26 101.79 0.25 Allowed 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 120.849 1.033 . . . . 0.0 110.745 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.523 HD11 HG21 ' A' ' 126' ' ' ILE . 83.2 mt -137.11 123.17 20.31 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.549 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.847 ' HB2' HG22 ' A' ' 141' ' ' THR . 2.6 mtp85 -102.47 111.78 24.23 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.955 HD23 HG23 ' A' ' 140' ' ' ILE . 3.7 mt -93.88 158.05 15.83 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.053 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.57 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 33.0 mt-30 -148.39 25.24 0.99 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.683 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.492 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 53.69 -166.35 1.88 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.537 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 158' ' ' THR . . . 108.2 -4.07 33.42 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.9 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.636 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 2.5 t80 -60.46 105.45 0.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.887 0.375 . . . . 0.0 110.828 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.495 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 67.9 p -104.56 -51.04 3.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.562 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.7 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 144.44 -163.95 27.77 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.065 -1.064 . . . . 0.0 114.269 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.601 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 118.04 170.74 15.11 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -64.2 126.3 27.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.26 0.53 . . . . 0.0 109.866 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 59.0 t -136.99 152.65 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.966 0.412 . . . . 0.0 111.259 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.459 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.9 OUTLIER -119.05 119.05 33.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.861 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.665 HG11 HD13 ' A' ' 173' ' ' LEU . 0.3 OUTLIER -118.78 141.98 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.984 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 3.9 t70 -79.77 137.14 36.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.835 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.677 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -79.52 -44.54 9.36 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.899 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.464 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 8.0 m -51.66 164.76 0.21 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.716 0.293 . . . . 0.0 111.175 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.424 HG23 ' C ' ' A' ' 167' ' ' SER . 2.8 t 70.55 55.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.294 0.569 . . . . 0.0 110.227 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.731 ' N ' HG11 ' A' ' 196' ' ' VAL . 4.9 m 57.09 149.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.478 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.525 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 0.6 OUTLIER -72.67 -3.83 27.39 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.546 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.896 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 57.1 mm-40 -49.79 -24.34 2.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.67 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.698 ' HA ' HD13 ' A' ' 129' ' ' LEU . 2.0 m-85 -72.58 -55.01 7.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.412 0.625 . . . . 0.0 110.283 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.665 HD13 HG11 ' A' ' 164' ' ' VAL . 26.3 tp -73.71 -38.89 64.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.511 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.759 HG23 ' OG1' ' A' ' 204' ' ' THR . 20.5 m -59.02 -33.06 70.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.279 0.561 . . . . 0.0 109.678 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.746 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -72.84 -47.18 48.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.977 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.876 ' CD2' HD23 ' A' ' 133' ' ' LEU . 2.9 mt -69.88 -35.98 75.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.605 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.989 HD21 ' HB3' ' A' ' 223' ' ' PHE . 12.5 mt -68.47 -27.33 66.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.612 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.637 ' CE ' HG22 ' A' ' 174' ' ' THR . 39.5 mtm -95.56 -26.99 15.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.245 0.545 . . . . 0.0 110.489 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.718 ' O ' HD11 ' A' ' 108' ' ' LEU . 51.6 m -88.79 -46.92 8.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.759 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.823 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -60.58 -39.07 63.64 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -177.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.3 Cg_endo -53.13 -36.01 75.24 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.347 1.364 . . . . 0.0 111.892 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.663 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.1 mp -85.04 -6.82 59.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.767 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.495 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -67.26 121.26 77.8 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.817 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 6.0 Cg_exo -38.76 -32.58 0.29 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.47 2.78 . . . . 0.0 113.91 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.47 155.8 19.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.05 0.453 . . . . 0.0 111.7 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.631 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 1.8 t70 -69.57 117.44 11.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.748 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.803 ' HB ' HG23 ' A' ' 225' ' ' VAL . 40.8 m -102.48 135.31 44.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.147 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.999 HG22 HG13 ' A' ' 224' ' ' VAL . 36.0 t -124.87 99.15 5.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.922 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 223' ' ' PHE . 2.9 mp -90.01 142.53 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.391 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.798 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.2 OUTLIER -113.47 170.68 8.06 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.78 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.861 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.5 mm -110.61 97.91 6.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 121.002 0.429 . . . . 0.0 111.363 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.561 ' HA ' ' NH1' ' A' ' 190' ' ' ARG . 4.9 mtmt -59.69 -82.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.133 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -79.1 168.21 53.12 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.36 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -59.9 122.45 14.29 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.82 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.8 OUTLIER -56.89 146.57 26.15 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.355 0.598 . . . . 0.0 110.61 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.731 HG11 ' N ' ' A' ' 169' ' ' SER . 12.5 p -104.1 -21.59 5.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.089 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.71 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -126.78 45.24 2.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.197 -179.431 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.82 ' HA ' HD23 ' A' ' 195' ' ' LEU . 6.1 ttpt -41.53 -65.63 0.48 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.04 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 51.4 Cg_endo -68.11 -16.77 45.2 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 121.556 1.504 . . . . 0.0 112.308 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.71 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 88.6 m-85 -75.34 -27.57 59.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.39 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.817 HD11 HD12 ' A' ' 177' ' ' LEU . 6.1 tp -71.23 -33.14 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.762 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -32.5 71.99 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.761 HG22 HD23 ' A' ' 207' ' ' LEU . 28.4 mt -68.32 -29.8 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.605 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.759 ' OG1' HG23 ' A' ' 174' ' ' THR . 52.5 m -61.38 -52.55 64.15 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.262 0.553 . . . . 0.0 109.806 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.918 HD22 HG12 ' A' ' 215' ' ' ILE . 30.9 mt -70.44 -38.37 74.52 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.191 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.654 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 39.4 t30 -63.65 -28.04 69.63 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.761 HD23 HG22 ' A' ' 203' ' ' ILE . 1.0 OUTLIER -78.36 -40.62 35.81 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.489 178.546 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.512 ' SD ' HG22 ' A' ' 204' ' ' THR . 17.2 mtp -68.9 -39.42 79.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.857 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.654 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 17.7 ptpt -65.37 -45.24 84.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.099 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 207' ' ' LEU . 2.0 t -57.71 -29.31 64.62 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.217 0.532 . . . . 0.0 109.798 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.605 ' HE2' ' HA ' ' A' ' 32' ' ' ALA . 1.3 m-85 -74.75 -53.04 9.94 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.587 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 158.82 -2.55 0.1 Allowed Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.644 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.66 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 53.7 t -119.0 142.44 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 117.08 0.44 . . . . 0.0 112.028 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -135.46 155.15 51.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.811 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.918 HG12 HD22 ' A' ' 205' ' ' LEU . 2.3 pp -130.43 175.53 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.378 -178.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 1.05 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 6.3 tp10 -91.57 127.43 37.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -102.31 101.3 11.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.42 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.87 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 4.8 mm-40 -66.71 -168.06 0.06 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.858 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -74.12 48.0 0.3 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.802 0.334 . . . . 0.0 110.633 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.577 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.1 OUTLIER 58.82 19.69 7.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.018 0.437 . . . . 0.0 111.26 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 191' ' ' ILE . 7.1 mm-40 -112.7 -22.38 10.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.713 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.87 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 29.5 mt-30 -149.22 141.87 24.48 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.088 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.989 ' HB3' HD21 ' A' ' 177' ' ' LEU . 14.6 m-85 -112.91 97.77 6.75 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 1.05 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 39.1 t -81.9 110.9 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.334 0.588 . . . . 0.0 111.341 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.915 HG12 HG21 ' A' ' 215' ' ' ILE . 1.9 m -97.95 112.09 29.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.977 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.71 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 4.9 mptp? -63.26 104.37 0.59 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.807 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.631 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.93 158.69 14.83 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.114 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.07 9.44 80.38 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.474 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.71 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 19.5 mm-40 -76.28 178.76 6.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.441 0.639 . . . . 0.0 111.576 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.663 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.9 m -174.06 106.36 0.12 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.265 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.66 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 22.9 m-85 -55.24 152.23 8.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.511 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.535 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 7.7 pt20 -122.97 138.34 54.71 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 7.0 t -46.54 98.04 0.17 Allowed Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 39.5 Cg_endo -64.89 -29.33 58.3 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.331 2.021 . . . . 0.0 111.804 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 117.39 -123.77 5.89 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.884 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.712 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -91.0 116.96 29.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.039 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.642 ' CZ ' HD11 ' A' ' 207' ' ' LEU . 68.0 t80 -121.7 126.58 49.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.531 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.862 ' HA ' HG23 ' A' ' 42' ' ' THR . 3.9 tp -91.43 119.01 31.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.252 0.548 . . . . 0.0 111.206 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 42' ' ' THR . 78.2 t -51.29 -79.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.808 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.511 ' H ' ' HB3' ' A' ' 43' ' ' ASN . 2.6 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.639 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.708 ' HA ' HD12 ' A' ' 44' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.941 0.401 . . . . 0.0 111.623 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.809 ' ND2' ' HB2' ' A' ' 98' ' ' ALA . 43.1 m-20 -82.82 -23.15 33.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.899 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -67.65 -43.29 80.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.17 0.51 . . . . 0.0 110.491 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.503 ' CB ' ' HB3' ' A' ' 41' ' ' LEU . . . -75.17 -31.96 61.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.978 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.789 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -66.07 -52.22 50.89 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.115 0.483 . . . . 0.0 110.218 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.64 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 8.1 tp -64.94 -53.76 41.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.278 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.721 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 62.6 mt -53.5 -36.35 61.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.411 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.727 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -76.99 -29.94 55.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.448 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.649 ' CB ' HD21 ' A' ' 82' ' ' LEU . . . -70.29 -33.2 71.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.526 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.902 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -88.81 -12.61 41.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.813 0.339 . . . . 0.0 111.145 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.69 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -81.72 166.06 20.42 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.687 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.533 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 87.5 m-70 -99.89 97.7 8.56 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.042 0.449 . . . . 0.0 109.885 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.01 142.28 6.6 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.385 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.763 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 1.3 ttpm? -66.36 140.55 58.09 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.096 0.474 . . . . 0.0 112.035 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.29 154.33 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.289 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.813 HG22 ' HG2' ' A' ' 74' ' ' GLU . 55.8 t -100.72 142.78 15.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.122 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.749 HD21 HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -129.25 111.69 13.14 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.097 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.754 HG23 HD13 ' A' ' 238' ' ' LEU . 0.6 OUTLIER -97.98 164.63 12.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.333 0.587 . . . . 0.0 112.136 -178.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.421 ' HB3' ' H ' ' A' ' 240' ' ' GLU . 7.3 t-20 63.21 23.38 13.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.287 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.9 HD22 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -58.87 153.61 16.84 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.328 179.093 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.706 ' H ' ' HB3' ' A' ' 25' ' ' SER . 27.2 tp -83.35 114.26 21.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.059 0.457 . . . . 0.0 111.342 -178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.01 68.57 4.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.995 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.4 m -130.01 -163.91 1.36 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.893 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.608 ' HA ' ' CD ' ' A' ' 51' ' ' ARG . 25.1 t0 -97.11 -20.45 17.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.031 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -70.45 -30.06 66.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.713 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.643 HG12 HD11 ' A' ' 54' ' ' LEU . 12.4 t -83.1 -54.84 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.105 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.608 ' CD ' ' HA ' ' A' ' 48' ' ' ASP . 11.9 ptm180 -49.67 -27.18 4.39 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.004 0.43 . . . . 0.0 110.013 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -71.02 -39.86 72.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' VAL . 7.1 tpt -64.29 -50.93 65.95 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.789 HD23 HD21 ' A' ' 29' ' ' LEU . 1.5 mp -62.11 -47.49 84.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.004 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 11.8 t30 -58.43 -23.26 56.95 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.815 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.805 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -76.28 -49.0 18.18 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.138 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.57 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -64.72 -49.73 69.68 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.271 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.7 t -50.37 -30.52 12.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.245 0.545 . . . . 0.0 109.983 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 1.081 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.22 -44.2 92.3 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.618 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.097 HD21 HD22 ' A' ' 106' ' ' LEU . 2.7 mp -79.56 -19.53 49.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.211 0.529 . . . . 0.0 110.656 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.13 -0.87 7.72 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.852 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.679 HG21 HD11 ' A' ' 82' ' ' LEU . 15.2 t -58.88 155.66 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 117.586 0.693 . . . . 0.0 110.086 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.596 ' CB ' HG13 ' A' ' 76' ' ' ILE . 2.9 m -117.57 108.93 16.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.07 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.539 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 10.0 p90 -124.06 153.59 41.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.172 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.728 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 11.7 m -147.61 116.53 6.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.028 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.9 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -88.81 172.25 9.34 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.138 0.494 . . . . 0.0 111.088 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.692 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 65.1 p -88.04 179.57 6.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.781 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.19 -14.72 27.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.407 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.42 7.03 12.67 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.791 0.329 . . . . 0.0 110.68 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.476 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 10.0 mtm180 57.08 41.91 26.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.116 0.484 . . . . 0.0 110.943 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.45 -2.14 8.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.604 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.692 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 4.8 mmt180 -136.94 110.53 8.02 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.841 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.728 ' HA ' ' O ' ' A' ' 65' ' ' THR . 4.0 t -120.22 151.57 38.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.452 0.644 . . . . 0.0 112.405 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.813 ' HG2' HG22 ' A' ' 40' ' ' VAL . 55.0 mt-10 -118.63 102.93 9.24 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.108 178.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.763 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -95.34 128.2 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-O 121.375 0.607 . . . . 0.0 112.213 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.687 HD13 ' HB2' ' A' ' 38' ' ' LYS . 15.9 mm -80.51 103.32 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.871 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.727 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -49.73 114.66 2.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.958 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.558 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.3 t-20 -61.51 -16.78 50.71 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 110.194 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.533 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.27 -22.02 11.27 Favored Glycine 0 C--O 1.226 -0.384 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.427 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.902 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.53 -149.03 5.41 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.821 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 5.4 Cg_exo -78.77 168.3 21.19 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.853 1.702 . . . . 0.0 109.209 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.754 HD12 HD13 ' A' ' 60' ' ' LEU . 4.5 mm? -66.62 91.14 0.18 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.821 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 29.3 m170 -84.14 118.02 23.84 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 113.158 -1.837 . . . . 0.0 112.779 -176.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.802 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -144.21 108.26 4.75 Favored 'General case' 0 C--O 1.227 -0.08 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.354 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -109.83 90.69 3.38 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.541 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -175.69 17.35 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.742 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.58 ' H ' ' HB2' ' A' ' 112' ' ' ASP . . . 55.2 47.81 20.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.565 0.697 . . . . 0.0 109.794 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 1.081 HD21 ' HB1' ' A' ' 59' ' ' ALA . 1.0 OUTLIER -81.3 129.14 34.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.31 -178.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.834 ' N ' HD12 ' A' ' 88' ' ' LEU . 1.6 tt0 -105.7 127.76 53.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.122 0.487 . . . . 0.0 110.658 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.805 HD13 ' HA ' ' A' ' 56' ' ' ALA . 61.1 mt -111.97 157.5 20.63 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.6 ' C ' HD23 ' A' ' 92' ' ' LEU . 31.9 t80 -112.88 101.62 9.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.243 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.8 HD23 ' N ' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -96.47 18.23 14.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.922 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.514 ' O ' ' HE2' ' A' ' 121' ' ' MET . . . 36.53 -154.47 0.01 OUTLIER Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.923 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.527 ' HA ' ' HB2' ' A' ' 121' ' ' MET . 10.6 t30 -87.6 50.1 1.93 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.287 0.565 . . . . 0.0 110.062 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.25 -77.04 0.24 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.426 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . 82.32 -13.77 38.03 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.644 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.466 ' HA ' ' CD ' ' A' ' 171' ' ' GLN . 0.3 OUTLIER -97.02 -5.39 37.79 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.073 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.809 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . . . -133.7 -22.7 1.87 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.339 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.742 ' HA ' HD12 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -62.08 -58.73 6.72 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.235 0.541 . . . . 0.0 110.337 179.299 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.921 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.8 mpt_? -59.76 -52.13 76.01 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.075 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.694 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 36.8 Cg_exo -61.99 -45.13 17.24 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.457 2.105 . . . . 0.0 113.192 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.674 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 2.6 tm? -74.04 -31.55 62.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.814 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.438 ' HA ' HD11 ' A' ' 115' ' ' LEU . . . -60.98 -48.29 82.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.407 0.622 . . . . 0.0 110.474 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.749 ' O ' HG21 ' A' ' 179' ' ' THR . . . -71.94 -36.82 70.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.006 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.503 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -57.67 -43.24 84.87 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.724 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.097 HD22 HD21 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -69.72 -24.24 63.53 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.33 0.586 . . . . 0.0 111.116 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.754 ' SG ' HD11 ' A' ' 140' ' ' ILE . 86.5 m -59.11 -10.59 2.82 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.059 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.705 HD11 ' O ' ' A' ' 179' ' ' THR . 12.0 mt -82.06 169.03 17.18 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 50.84 -110.39 0.94 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.513 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.428 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 2.4 p -161.67 101.35 1.17 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.037 -0.356 . . . . 0.0 110.037 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 12.9 m-20 -138.95 135.15 34.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.692 ' C ' HD12 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -101.93 110.67 22.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.812 178.548 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.712 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.6 mp -145.9 140.66 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.58 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.774 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 27.0 t -111.03 112.4 40.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.248 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.679 HD13 HD11 ' A' ' 92' ' ' LEU . 13.2 mt -82.09 150.58 27.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.385 0.612 . . . . 0.0 111.587 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.56 HG22 ' H ' ' A' ' 117' ' ' GLY . 3.6 m -155.25 177.25 11.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.419 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.56 ' H ' HG22 ' A' ' 116' ' ' THR . . . -165.08 -165.37 22.27 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.251 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.564 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 2.3 mm-40 -70.92 176.07 2.25 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.564 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 37.2 Cg_exo -62.4 -28.95 78.69 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 121.793 1.662 . . . . 0.0 111.97 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.508 ' HD2' ' CG ' ' A' ' 123' ' ' GLU . 6.0 tpt180 -80.44 -37.29 32.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.958 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.634 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 34.8 tpp -59.56 -15.72 20.21 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.734 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 6.3 mttm -69.8 -5.79 27.88 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.564 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 2.0 pt-20 -120.98 26.97 8.73 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.066 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.604 ' HA ' ' HE ' ' A' ' 124' ' ' ARG . 1.6 mmp_? -105.91 94.16 8.67 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.062 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 10.6 Cg_endo -53.56 129.03 31.81 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.954 2.436 . . . . 0.0 112.559 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.666 HD11 HD23 ' A' ' 129' ' ' LEU . 18.1 tt -132.78 29.35 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.724 0.774 . . . . 0.0 110.127 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -68.35 -51.06 34.34 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.184 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.739 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.7 OUTLIER -54.29 -28.58 43.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.924 0.392 . . . . 0.0 110.668 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.786 ' CD1' HD21 ' A' ' 133' ' ' LEU . 23.6 tp -81.8 -61.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.885 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.776 HG13 HD12 ' A' ' 140' ' ' ILE . 59.8 t -53.35 -26.5 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.947 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.507 ' O ' HD12 ' A' ' 135' ' ' LEU . 20.0 t0 -71.63 -43.43 66.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.007 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.893 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -65.43 -51.86 57.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 121.074 0.464 . . . . 0.0 111.528 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.828 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -57.38 -43.78 83.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.818 179.65 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -33.91 73.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.803 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.893 HD12 ' HA ' ' A' ' 132' ' ' ALA . 2.7 mt -68.79 -30.14 68.66 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.235 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.47 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -78.42 -17.84 77.07 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.669 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 130.14 4.31 4.6 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.302 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.23 146.8 48.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.833 0.349 . . . . 0.0 111.557 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -114.75 94.57 4.83 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.075 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.968 HG23 HD23 ' A' ' 153' ' ' LEU . 11.5 mt -118.75 175.39 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.829 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.747 ' H ' HG22 ' A' ' 140' ' ' ILE . 1.0 OUTLIER -153.29 -166.15 2.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.267 0.556 . . . . 0.0 111.632 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.569 ' N ' HG23 ' A' ' 141' ' ' THR . 29.0 m-85 -135.92 101.51 4.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.921 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.641 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.4 mm? -72.86 -13.55 61.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.602 -177.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.766 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 4.8 mt-10 -139.52 -73.2 0.38 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.635 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.633 ' HB3' ' HD2' ' A' ' 148' ' ' TYR . 0.2 OUTLIER -121.35 147.23 45.98 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.217 0.532 . . . . 0.0 111.704 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.466 ' HA ' ' CG ' ' A' ' 142' ' ' TYR . 10.3 mt-10 -68.22 131.92 46.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.301 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.643 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 87.2 m-20 65.95 51.9 1.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.691 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.867 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.6 m-85 -148.03 -179.72 1.02 Allowed Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.129 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.867 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 5.7 Cg_endo -50.66 -43.1 47.53 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.969 2.446 . . . . 0.0 115.143 -177.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.766 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 32.8 Cg_endo -62.73 102.18 0.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.149 1.233 . . . . 0.0 111.425 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 150' ' ' PRO . 67.3 mt -138.58 122.92 18.26 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.848 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.664 ' HB2' HG22 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -105.51 112.33 25.39 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.129 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.968 HD23 HG23 ' A' ' 140' ' ' ILE . 4.5 mt -93.18 157.95 16.01 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.266 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.602 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -145.53 24.79 1.38 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.469 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.497 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 54.84 -166.05 2.83 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.535 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.483 ' O ' HG23 ' A' ' 158' ' ' THR . . . 108.72 -5.27 32.71 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.888 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.654 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 3.0 t80 -60.66 106.13 0.52 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.712 0.291 . . . . 0.0 110.721 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 156' ' ' GLY . 69.1 p -106.97 -46.12 4.0 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.098 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.718 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.39 -165.98 26.94 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.158 -1.02 . . . . 0.0 114.185 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.592 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 118.8 170.21 14.68 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.47 128.54 36.24 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.624 HG13 HD13 ' A' ' 135' ' ' LEU . 62.4 t -138.27 151.32 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 120.786 0.326 . . . . 0.0 111.733 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.505 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 2.4 m-20 -118.89 117.85 29.96 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.738 HG11 HD13 ' A' ' 173' ' ' LEU . 0.9 OUTLIER -118.63 147.86 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 120.574 -0.451 . . . . 0.0 112.018 -178.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.739 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.4 OUTLIER -85.4 133.59 34.11 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.338 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.724 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -76.03 -44.62 18.23 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.279 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.423 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 83.2 p -51.55 163.69 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.942 0.401 . . . . 0.0 111.593 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 169' ' ' SER . 3.7 t 71.59 60.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.242 0.544 . . . . 0.0 110.658 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.68 ' N ' HG11 ' A' ' 196' ' ' VAL . 0.7 OUTLIER 54.81 154.95 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.409 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.623 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 0.1 OUTLIER -76.71 3.01 12.62 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.966 0.412 . . . . 0.0 111.097 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.921 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 55.8 mm-40 -54.11 -22.72 11.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.726 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.713 ' O ' HD12 ' A' ' 176' ' ' LEU . 1.9 m-85 -78.21 -55.77 5.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.935 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.819 HD23 HG12 ' A' ' 201' ' ' ILE . 22.3 tp -73.51 -38.32 65.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.869 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.576 HG22 ' HE2' ' A' ' 178' ' ' MET . 91.4 m -60.31 -33.07 71.85 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.188 0.518 . . . . 0.0 109.706 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.661 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -72.79 -50.18 25.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.734 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.828 ' CD2' HD23 ' A' ' 133' ' ' LEU . 2.3 mt -66.96 -38.78 86.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.749 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.006 HD21 ' HB3' ' A' ' 223' ' ' PHE . 12.7 mt -68.47 -24.87 64.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.282 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.576 ' HE2' HG22 ' A' ' 174' ' ' THR . 46.5 mtm -94.52 -28.2 15.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.34 0.591 . . . . 0.0 110.779 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.749 HG21 ' O ' ' A' ' 104' ' ' ALA . 84.5 m -91.28 -46.84 7.83 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.068 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.92 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -59.21 -39.27 71.84 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 9.3 Cg_endo -53.33 -36.71 79.63 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 121.095 1.197 . . . . 0.0 111.706 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.668 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -85.12 -5.7 59.33 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.163 -179.734 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -67.09 120.9 75.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -37.12 -32.93 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.554 2.836 . . . . 0.0 114.018 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 158' ' ' THR . 0.3 OUTLIER -107.33 153.43 22.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.332 . . . . 0.0 111.562 -179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.663 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 0.4 OUTLIER -67.44 118.24 10.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.693 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.821 ' HB ' HG23 ' A' ' 225' ' ' VAL . 31.4 m -103.1 137.59 41.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.304 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 1.126 HG22 HG13 ' A' ' 224' ' ' VAL . 40.5 t -125.85 99.15 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.094 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.596 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.3 mt -90.55 141.98 13.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.395 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.791 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.3 OUTLIER -113.54 170.97 7.85 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.65 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.865 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.7 mm -110.38 97.26 5.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 120.985 0.421 . . . . 0.0 111.31 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.562 ' HG2' ' HE ' ' A' ' 190' ' ' ARG . 8.1 mtmp? -59.94 -81.37 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.464 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -78.85 168.44 53.53 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.309 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.45 122.3 15.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.54 0.209 . . . . 0.0 110.73 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.724 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.5 OUTLIER -57.26 146.64 27.84 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.985 0.422 . . . . 0.0 110.302 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.68 HG11 ' N ' ' A' ' 169' ' ' SER . 13.0 p -104.43 -19.75 6.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.384 0.611 . . . . 0.0 111.507 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.751 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.6 OUTLIER -127.74 45.31 2.76 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.627 -179.208 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.86 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.0 OUTLIER -41.19 -64.75 0.56 Allowed Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.702 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.672 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 55.2 Cg_endo -68.54 -16.92 43.37 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 121.603 1.535 . . . . 0.0 111.941 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.751 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 31.3 m-85 -76.0 -29.35 58.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.13 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.86 HG22 ' O ' ' A' ' 198' ' ' LYS . 8.4 tp -70.53 -31.63 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.622 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.516 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.1 OUTLIER -61.52 -33.74 74.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.63 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 207' ' ' LEU . 36.3 mt -66.21 -31.37 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.706 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.488 HG22 ' SD ' ' A' ' 208' ' ' MET . 54.0 m -60.26 -52.67 64.29 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.376 0.608 . . . . 0.0 109.823 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.923 HD21 HD22 ' A' ' 177' ' ' LEU . 44.9 mt -72.74 -35.48 67.54 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.59 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.717 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 4.9 t-20 -65.62 -24.81 67.14 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.721 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -82.68 -40.76 20.23 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.537 178.594 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.504 ' HG2' ' CZ ' ' A' ' 231' ' ' TYR . 12.0 mtp -69.0 -36.49 77.87 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.905 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.717 ' HE3' ' HA ' ' A' ' 206' ' ' ASN . 13.2 ptpt -66.56 -46.52 75.77 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.203 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.647 HG22 ' O ' ' A' ' 207' ' ' LEU . 5.2 t -57.55 -29.65 64.56 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.101 0.477 . . . . 0.0 109.862 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.612 ' HE2' ' HA ' ' A' ' 32' ' ' ALA . 1.8 m-85 -71.21 -54.1 12.12 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.301 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 155.78 -0.71 0.15 Allowed Glycine 0 CA--C 1.52 0.396 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.048 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.595 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 70.2 t -118.24 139.63 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.263 0.554 . . . . 0.0 111.679 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -135.95 156.12 49.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.994 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.894 HG21 HG12 ' A' ' 225' ' ' VAL . 2.0 pp -128.77 175.56 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.336 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 1.003 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 23.7 tt0 -89.88 125.15 35.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.156 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -100.71 101.04 11.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.016 0.436 . . . . 0.0 110.761 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.602 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -67.65 -166.52 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.589 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.64 47.69 0.42 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.084 0.468 . . . . 0.0 110.334 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.611 ' CZ ' ' HD3' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 58.22 19.39 6.15 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 -179.349 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 191' ' ' ILE . 14.2 mt-30 -110.6 -21.5 12.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.545 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.787 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 33.2 mt-30 -149.81 140.29 22.43 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.885 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 1.006 ' HB3' HD21 ' A' ' 177' ' ' LEU . 10.3 m-85 -112.35 96.39 5.98 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 1.126 HG13 HG22 ' A' ' 188' ' ' VAL . 27.6 t -80.54 111.27 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-O 121.06 0.457 . . . . 0.0 110.91 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.92 HG21 ' CB ' ' A' ' 180' ' ' ALA . 2.7 m -97.68 112.96 30.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.12 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.723 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 5.7 mptt -61.38 104.16 0.38 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.584 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.663 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -59.57 157.39 25.22 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.825 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.44 8.74 84.56 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.339 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.723 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 15.1 mm-40 -73.38 178.99 4.21 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.401 0.619 . . . . 0.0 111.439 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.668 ' HA ' HD23 ' A' ' 182' ' ' LEU . 18.1 m -167.93 106.26 0.51 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.362 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.69 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 24.4 m-85 -54.03 142.02 26.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.163 0.506 . . . . 0.0 111.573 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.692 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 66.7 mt-30 -107.62 149.92 27.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.77 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 18.9 t -68.4 98.56 0.18 Allowed Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.745 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 47.8 Cg_endo -64.72 -33.36 54.73 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.498 2.132 . . . . 0.0 112.219 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 117.43 -114.09 2.87 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.624 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.6 OUTLIER -95.94 117.55 30.84 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 178.481 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.718 ' CZ ' HD11 ' A' ' 207' ' ' LEU . 37.3 t80 -119.93 136.01 54.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.793 0.33 . . . . 0.0 111.251 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.754 HD13 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER -102.28 111.43 23.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.2 0.524 . . . . 0.0 110.679 178.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.67 ' N ' HD12 ' A' ' 238' ' ' LEU . 46.0 t -52.09 -61.74 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.771 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.421 ' H ' ' HB3' ' A' ' 43' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.457 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.792 ' HA ' HD12 ' A' ' 44' ' ' LEU . 47.0 m . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.906 0.384 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.636 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 9.0 m-20 -87.96 -27.08 22.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.463 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -68.34 -38.19 81.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.565 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.678 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -79.06 -34.58 43.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.75 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.831 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -62.23 -53.72 51.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.459 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.633 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 4.9 tp -66.93 -47.93 70.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.194 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.613 HD11 ' HB3' ' A' ' 207' ' ' LEU . 33.1 mt -56.87 -33.88 67.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.459 . . . . 0.0 110.862 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.686 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -76.42 -28.87 56.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.923 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.8 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -73.55 -29.61 62.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.616 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.895 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.35 -12.39 40.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.012 0.434 . . . . 0.0 110.858 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.23 164.89 20.9 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.609 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.501 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 84.6 m-70 -98.21 97.7 9.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.065 0.459 . . . . 0.0 110.173 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.06 142.26 6.58 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.255 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.765 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 10.9 tttt -65.69 135.23 54.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.996 0.427 . . . . 0.0 111.788 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.504 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -129.98 159.32 37.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.468 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.791 HG22 ' HG3' ' A' ' 74' ' ' GLU . 61.7 t -103.82 142.44 17.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.678 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -128.38 111.75 13.68 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.561 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.9 HG23 ' HA ' ' A' ' 238' ' ' LEU . 0.0 OUTLIER -100.96 170.74 8.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.096 0.474 . . . . 0.0 111.767 -179.329 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.542 ' HB2' ' CD1' ' A' ' 238' ' ' LEU . 0.1 OUTLIER 64.99 21.29 12.29 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.384 -179.165 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.897 HD22 HD11 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -60.35 157.43 13.75 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.533 179.047 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.576 ' HB3' HG21 ' A' ' 50' ' ' VAL . 23.4 tp -93.13 113.78 26.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.129 0.49 . . . . 0.0 111.464 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 p-10 -72.82 62.93 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.438 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.506 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.5 OUTLIER -124.85 -162.25 1.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.147 -179.036 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.65 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 51.3 m-20 -97.63 -20.47 17.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.179 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 5.0 p-10 -71.25 -27.65 63.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.947 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.657 HG12 HD11 ' A' ' 54' ' ' LEU . 23.9 t -89.09 -53.26 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.595 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.665 ' O ' ' HB2' ' A' ' 55' ' ' ASN . 2.9 ptm180 -50.02 -30.29 10.4 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.678 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.421 ' CD2' ' O ' ' A' ' 48' ' ' ASP . 10.5 m-70 -72.63 -35.49 67.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.41 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.636 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 3.8 tpt -65.87 -47.85 73.49 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.831 HD23 HD21 ' A' ' 29' ' ' LEU . 1.6 mp -65.42 -48.84 71.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.665 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -53.17 -25.54 13.99 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.321 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.874 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -75.25 -44.21 47.31 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.652 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.554 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -69.74 -49.48 52.73 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.389 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.514 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 5.1 t -52.05 -32.35 34.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.203 0.525 . . . . 0.0 109.898 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.915 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.01 -46.01 89.26 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.127 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.007 HD21 HD22 ' A' ' 106' ' ' LEU . 3.6 mp -72.27 -26.8 62.13 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.498 0.666 . . . . 0.0 109.801 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.41 -0.35 5.11 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.713 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.664 HG21 HD11 ' A' ' 82' ' ' LEU . 18.6 t -58.34 152.42 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 117.718 0.759 . . . . 0.0 110.193 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.42 ' CB ' HD12 ' A' ' 76' ' ' ILE . 3.7 m -116.16 108.68 16.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.932 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.718 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 15.0 p90 -127.53 154.62 44.93 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.22 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.627 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.9 OUTLIER -145.54 116.49 7.79 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.903 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.897 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -85.11 176.09 8.6 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.097 0.475 . . . . 0.0 111.842 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.861 ' HB3' ' HG3' ' A' ' 72' ' ' ARG . 50.4 p -86.3 178.99 6.98 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.051 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.94 -13.53 26.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.617 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -119.38 3.79 11.27 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.591 0.234 . . . . 0.0 110.877 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.51 ' O ' HD23 ' A' ' 44' ' ' LEU . 37.5 mmt-85 61.84 45.82 7.35 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 110.416 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -125.76 -3.11 7.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.367 179.339 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.861 ' HG3' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER -142.04 112.67 7.23 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.041 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 6.9 t -116.34 152.46 33.85 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.919 -0.712 . . . . 0.0 112.294 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.791 ' HG3' HG22 ' A' ' 40' ' ' VAL . 0.8 OUTLIER -116.2 102.61 9.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.878 178.662 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.765 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -96.04 127.63 47.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.493 ' CG1' ' HE3' ' A' ' 38' ' ' LYS . 14.3 mt -82.32 102.76 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.077 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.686 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -45.4 115.57 1.6 Allowed Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.999 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -61.24 -16.97 50.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.979 0.419 . . . . 0.0 110.1 178.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.501 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 86.16 -20.06 23.31 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.404 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.895 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -140.84 -148.28 5.08 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.833 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 3.8 Cg_exo -77.18 170.88 18.81 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.052 1.835 . . . . 0.0 109.183 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.8 HD21 ' HB3' ' A' ' 33' ' ' ALA . 4.2 mm? -69.31 92.19 0.57 Allowed 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.833 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 31.0 m170 -83.67 118.06 23.61 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.23 -1.805 . . . . 0.0 112.784 -175.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.799 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -144.45 109.04 4.89 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.361 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -111.58 91.65 3.74 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.418 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.63 20.37 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.773 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 54.95 49.37 17.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.366 0.603 . . . . 0.0 109.779 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.915 HD21 ' HB1' ' A' ' 59' ' ' ALA . 4.0 tp -81.78 135.96 35.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.425 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.749 ' N ' HD12 ' A' ' 88' ' ' LEU . 1.2 tt0 -114.31 128.71 56.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.261 0.553 . . . . 0.0 110.605 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.874 HD13 ' HA ' ' A' ' 56' ' ' ALA . 18.0 mt -111.14 158.99 18.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.468 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.453 ' CE1' ' HA2' ' A' ' 93' ' ' GLY . 41.8 t80 -123.83 103.39 8.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.428 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.741 HD23 ' HE1' ' A' ' 99' ' ' MET . 0.9 OUTLIER -90.05 6.5 42.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.09 -179.49 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.57 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 45.52 -145.52 2.74 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.283 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -86.65 47.99 1.57 Allowed 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 120.764 0.316 . . . . 0.0 111.387 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -90.43 -76.35 0.43 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.948 0.404 . . . . 0.0 111.124 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.55 -14.04 31.96 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.232 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 101' ' ' PRO . 65.3 p -97.0 -7.89 31.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.665 0.269 . . . . 0.0 111.015 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.522 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -126.85 -21.65 4.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.174 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.741 ' HE1' HD23 ' A' ' 92' ' ' LEU . 23.5 tpp -66.43 -50.44 63.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 0.0 110.018 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.694 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -61.6 -53.86 57.34 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.481 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.694 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 34.7 Cg_exo -61.31 -45.33 19.09 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.703 2.269 . . . . 0.0 112.79 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.594 ' CD1' HD11 ' A' ' 106' ' ' LEU . 2.7 tm? -70.8 -34.41 71.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.321 -178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.4 -47.72 84.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.366 0.603 . . . . 0.0 110.564 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.827 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -71.97 -34.2 68.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.356 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.583 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.31 -45.16 94.38 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.878 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.007 HD22 HD21 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -69.35 -20.49 63.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.662 -179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.558 ' SG ' HD11 ' A' ' 140' ' ' ILE . 6.4 m -62.17 -8.12 5.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.976 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.754 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 15.8 mt -87.44 165.57 15.45 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 57.2 -109.76 1.87 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.083 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.416 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -165.8 99.48 0.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.765 0.317 . . . . 0.0 110.299 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.611 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 3.4 m120 -138.44 135.44 35.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.683 ' C ' HD12 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -102.78 110.65 22.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.381 178.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.733 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.5 mp -143.88 142.28 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.216 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.777 HG22 ' HB2' ' A' ' 152' ' ' ARG . 32.5 t -113.66 112.29 39.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.466 HD13 ' SD ' ' A' ' 99' ' ' MET . 39.0 mt -81.7 157.23 24.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.451 0.643 . . . . 0.0 112.194 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.6 m -163.2 166.93 22.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.165 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -154.68 -166.14 14.82 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.023 -1.084 . . . . 0.0 113.497 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.587 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 22.5 mm-40 -69.15 178.25 0.97 Allowed Pre-proline 0 C--N 1.33 -0.267 0 C-N-CA 122.674 0.39 . . . . 0.0 110.78 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 36.4 Cg_exo -61.8 -39.59 51.28 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.892 1.728 . . . . 0.0 112.524 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -76.2 -33.07 59.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.977 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.567 ' HA ' ' HG3' ' A' ' 124' ' ' ARG . 10.0 tpt -60.75 -17.24 47.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.278 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.714 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 6.2 mmtp -71.46 -4.9 29.1 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.639 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 0.1 OUTLIER -125.52 32.24 5.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.014 0.435 . . . . 0.0 111.03 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.567 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 2.2 mmp_? -103.95 87.43 1.55 Allowed Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.822 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.789 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 1.1 Cg_endo -43.92 129.79 7.7 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.075 2.517 . . . . 0.0 112.406 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.849 HD11 HD23 ' A' ' 129' ' ' LEU . 15.0 tt -140.63 30.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.703 0.763 . . . . 0.0 110.29 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -70.11 -49.52 33.34 Favored Glycine 0 C--N 1.317 -0.523 0 CA-C-N 114.814 -1.085 . . . . 0.0 113.25 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.4 OUTLIER -55.27 -25.31 33.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.819 -179.344 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.849 HD23 HD11 ' A' ' 126' ' ' ILE . 30.9 tp -83.88 -65.74 0.97 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.813 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.869 HG13 HD12 ' A' ' 140' ' ' ILE . 60.3 t -51.15 -26.53 5.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.223 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 1.7 m-20 -73.2 -46.37 50.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.667 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.944 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -63.48 -48.71 76.54 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.284 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.863 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -59.86 -44.36 94.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.385 0.612 . . . . 0.0 109.692 179.573 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -59.18 -34.92 72.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.421 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.944 HD12 ' HA ' ' A' ' 132' ' ' ALA . 2.2 mt -68.86 -28.0 66.32 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.21 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.5 -11.37 85.21 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.611 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 121.24 6.13 9.13 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.931 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.29 149.2 37.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 111.3 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.449 ' HA ' ' HE3' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -115.4 95.95 5.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.082 0.468 . . . . 0.0 111.594 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.964 HG23 HD23 ' A' ' 153' ' ' LEU . 12.1 mt -118.26 177.05 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.395 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.814 ' H ' HG22 ' A' ' 140' ' ' ILE . 1.0 OUTLIER -154.11 -167.69 2.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.18 0.514 . . . . 0.0 111.403 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.632 ' HE1' HD21 ' A' ' 151' ' ' LEU . 23.6 m-85 -135.56 102.66 5.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.641 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.2 mm? -75.7 -13.86 60.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.932 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.686 ' HG3' ' N ' ' A' ' 145' ' ' GLN . 0.0 OUTLIER -135.63 -69.75 0.49 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.357 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.686 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.4 OUTLIER -132.15 163.86 27.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.912 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.542 ' HG2' ' CD2' ' A' ' 142' ' ' TYR . 23.4 mt-10 -74.97 143.46 43.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.556 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.789 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 0.5 OUTLIER 51.54 42.32 29.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.012 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.686 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.4 m-30 -130.24 174.43 4.64 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.262 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.714 ' CG ' ' HA ' ' A' ' 122' ' ' LYS . 8.6 Cg_endo -50.76 -40.65 56.44 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.921 2.414 . . . . 0.0 114.316 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 149' ' ' PRO . 40.1 Cg_endo -60.97 100.28 0.16 Allowed 'Trans proline' 0 CA--C 1.511 -0.625 0 C-N-CA 121.797 1.665 . . . . 0.0 111.514 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.632 HD21 ' HE1' ' A' ' 142' ' ' TYR . 92.6 mt -137.89 123.02 19.2 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.24 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.777 ' HB2' HG22 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -105.63 112.07 25.01 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.59 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.964 HD23 HG23 ' A' ' 140' ' ' ILE . 1.4 mt -94.0 158.22 15.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.045 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.611 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 32.4 mt-30 -145.72 24.45 1.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.784 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.504 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 53.59 -165.71 1.99 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.679 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.85 -3.73 38.93 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.105 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.683 ' HE2' ' HA ' ' A' ' 133' ' ' LEU . 44.5 t80 -61.81 107.35 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.846 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.644 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 53.3 p -103.02 -50.47 3.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.697 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.627 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 146.24 -165.25 28.24 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.138 -1.03 . . . . 0.0 114.19 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.602 ' O ' HG23 ' A' ' 162' ' ' VAL . . . 119.23 168.37 14.0 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -62.43 125.87 25.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.004 0.402 . . . . 0.0 110.15 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 160' ' ' GLY . 44.3 t -135.02 153.02 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.756 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.554 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.4 OUTLIER -119.3 115.57 24.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.032 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.766 HG11 HD13 ' A' ' 173' ' ' LEU . 0.5 OUTLIER -113.87 147.4 17.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.677 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.9 OUTLIER -85.64 134.14 34.0 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.481 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.724 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -76.54 -44.7 15.5 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.759 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.9 t -50.39 163.02 0.18 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.055 0.455 . . . . 0.0 111.832 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.2 t 71.3 59.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.898 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.772 ' N ' HG11 ' A' ' 196' ' ' VAL . 75.7 m 57.68 153.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.262 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.444 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 0.5 OUTLIER -78.14 -2.4 37.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.249 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.652 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 90.6 mm-40 -51.55 -23.36 4.04 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.819 0.342 . . . . 0.0 111.365 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.639 ' HA ' HD13 ' A' ' 129' ' ' LEU . 2.8 m-85 -72.16 -58.94 3.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.252 0.549 . . . . 0.0 110.702 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.766 HD13 HG11 ' A' ' 164' ' ' VAL . 39.5 tp -73.49 -34.28 65.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.821 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.674 HG22 ' HE2' ' A' ' 178' ' ' MET . 89.8 m -60.01 -31.33 69.83 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.827 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -73.15 -52.23 14.95 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.059 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.863 ' CD2' HD23 ' A' ' 133' ' ' LEU . 2.6 mt -65.46 -38.19 89.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.741 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.995 HD21 ' HB3' ' A' ' 223' ' ' PHE . 11.7 mt -64.57 -28.28 69.53 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.225 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.674 ' HE2' HG22 ' A' ' 174' ' ' THR . 9.6 ptp -97.3 -27.52 14.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.193 0.521 . . . . 0.0 110.894 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.705 HG23 ' HG ' ' A' ' 108' ' ' LEU . 23.0 m -85.03 -46.75 10.89 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.929 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.94 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -61.44 -38.67 54.64 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.2 Cg_endo -53.73 -35.66 79.24 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.516 1.478 . . . . 0.0 112.016 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.698 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.75 -7.77 59.08 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.988 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.644 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -66.42 122.75 83.21 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.06 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 1.9 Cg_endo -43.12 -27.84 1.15 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.939 2.426 . . . . 0.0 113.614 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.417 ' O ' ' HA3' ' A' ' 227' ' ' GLY . 11.1 mt-10 -107.17 153.06 23.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.013 0.435 . . . . 0.0 111.292 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.674 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 52.1 t0 -70.33 115.1 9.13 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.289 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.822 ' HB ' HG23 ' A' ' 225' ' ' VAL . 45.0 m -100.57 136.66 40.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.365 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 1.036 HG22 HG13 ' A' ' 224' ' ' VAL . 26.0 t -125.52 99.43 5.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.763 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.576 ' O ' ' N ' ' A' ' 223' ' ' PHE . 4.7 mt -90.57 143.65 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.132 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.817 ' C ' HD13 ' A' ' 191' ' ' ILE . 2.2 ptm180 -115.28 170.95 8.0 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.882 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.4 mm -111.1 97.86 6.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-O 120.977 0.418 . . . . 0.0 111.267 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -62.31 -80.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.581 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -76.84 167.81 54.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.146 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -62.6 122.26 15.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.656 0.265 . . . . 0.0 110.952 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.827 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.7 OUTLIER -57.37 146.45 29.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.891 0.377 . . . . 0.0 110.395 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.772 HG11 ' N ' ' A' ' 169' ' ' SER . 11.6 p -103.34 -20.09 5.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.318 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.709 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -128.9 46.33 2.64 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.248 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.852 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.9 OUTLIER -41.96 -64.79 0.6 Allowed Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.039 -178.601 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 60.0 Cg_endo -70.73 -16.83 33.46 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 121.519 1.479 . . . . 0.0 111.457 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.709 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 21.5 m-85 -74.2 -30.02 62.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.204 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.852 HG22 ' O ' ' A' ' 198' ' ' LYS . 8.8 tp -68.54 -31.84 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.405 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.93 -29.64 67.26 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.742 HG22 HD23 ' A' ' 207' ' ' LEU . 33.4 mt -70.68 -29.91 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.253 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.502 HG21 ' HA ' ' A' ' 174' ' ' THR . 51.6 m -61.73 -55.22 32.56 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.16 0.505 . . . . 0.0 109.677 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.934 HD21 HD22 ' A' ' 177' ' ' LEU . 21.5 mt -69.19 -33.71 73.77 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.859 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.808 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 47.7 t30 -68.94 -24.74 64.31 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.742 HD23 HG22 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -78.96 -41.56 28.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.073 178.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.432 ' SD ' HG22 ' A' ' 204' ' ' THR . 12.0 mtp -70.26 -39.14 75.16 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.4 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.808 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -64.97 -42.35 94.64 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.398 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 207' ' ' LEU . 1.0 OUTLIER -59.61 -30.72 68.89 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.054 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.638 ' CE2' ' HA ' ' A' ' 32' ' ' ALA . 1.5 m-85 -71.18 -53.43 14.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.85 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 158.21 -3.45 0.13 Allowed Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.543 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.602 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 55.6 t -119.8 142.97 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.144 0.497 . . . . 0.0 112.231 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -135.52 156.03 49.54 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.442 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.901 HG12 HD22 ' A' ' 205' ' ' LEU . 2.4 pp -129.07 176.14 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.52 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 1.07 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 8.3 tp10 -90.4 126.27 35.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.135 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -101.47 101.25 11.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.632 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.694 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.7 OUTLIER -67.38 -168.87 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.611 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -73.9 48.44 0.29 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.811 0.339 . . . . 0.0 110.489 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.593 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 58.9 18.73 6.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.222 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 191' ' ' ILE . 11.6 pt20 -111.67 -22.57 11.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.761 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.779 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 27.8 mt-30 -148.0 139.86 23.96 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.13 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.995 ' HB3' HD21 ' A' ' 177' ' ' LEU . 13.6 m-85 -111.15 98.37 7.47 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 1.07 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 37.2 t -82.4 111.42 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-O 121.153 0.501 . . . . 0.0 111.068 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.94 HG21 ' CB ' ' A' ' 180' ' ' ALA . 2.4 m -98.43 113.57 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.789 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.545 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 2.0 mptp? -65.03 103.83 0.79 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.757 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.674 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -58.51 156.71 21.33 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.94 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.36 10.91 70.08 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.367 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.573 ' NE2' HG13 ' A' ' 213' ' ' VAL . 14.0 mm-40 -80.53 179.51 7.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.563 0.697 . . . . 0.0 111.901 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.698 ' HA ' HD23 ' A' ' 182' ' ' LEU . 4.0 m -173.69 106.88 0.13 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.448 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.658 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 22.9 m-85 -54.9 151.84 8.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.211 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.571 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 8.6 pt20 -122.11 142.46 50.36 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.6 t -48.6 98.74 0.19 Allowed Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.571 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 55.0 Cg_endo -67.22 -25.95 42.59 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.336 2.024 . . . . 0.0 111.976 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 112.49 -119.03 4.83 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.628 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -95.71 117.31 30.28 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.543 ' CE2' HD11 ' A' ' 207' ' ' LEU . 41.7 t80 -116.54 130.6 56.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.9 ' HA ' HG23 ' A' ' 42' ' ' THR . 0.1 OUTLIER -93.39 106.08 18.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.647 179.229 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 42' ' ' THR . 78.3 t -48.78 -52.9 8.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.125 0.488 . . . . 0.0 110.512 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.56 ' N ' HD12 ' A' ' 238' ' ' LEU . 24.0 tt0 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.069 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.748 ' O ' HD12 ' A' ' 29' ' ' LEU . 79.5 p . . . . . 0 N--CA 1.484 1.237 0 CA-C-O 121.25 0.548 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.597 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 5.2 p30 -86.91 -23.83 25.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.75 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 27' ' ' ARG . 1.4 mpp_? -67.58 -42.91 81.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.683 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.888 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -77.65 -34.33 53.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.937 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.92 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -58.32 -48.93 78.95 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.366 0.603 . . . . 0.0 110.504 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.613 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 3.2 tp -72.57 -49.29 33.44 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.225 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.695 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 31.7 mt -56.36 -33.07 65.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.732 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.674 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . . . -75.16 -29.88 60.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.695 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.762 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -71.67 -29.19 64.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.651 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.922 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.23 -13.23 38.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.046 0.451 . . . . 0.0 110.855 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.677 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.26 168.01 18.05 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.779 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.547 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 84.1 m-70 -101.98 97.74 8.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.079 0.466 . . . . 0.0 110.011 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.94 140.64 6.01 Favored Glycine 0 C--N 1.316 -0.579 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.436 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.816 ' HB2' HD13 ' A' ' 76' ' ' ILE . 2.1 ttmm -66.96 139.96 57.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.983 0.421 . . . . 0.0 112.028 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.814 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -130.71 156.47 44.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.7 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.682 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 57.4 t -102.64 142.27 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.994 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.888 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -127.76 111.94 14.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.573 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.98 ' HB ' ' HD3' ' A' ' 72' ' ' ARG . 0.7 OUTLIER -102.1 164.96 11.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.894 0.378 . . . . 0.0 110.838 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.504 ' HB3' ' H ' ' A' ' 240' ' ' GLU . 0.1 OUTLIER 66.56 19.09 10.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.726 -178.281 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.895 HD22 HD11 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -58.78 152.72 18.42 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.327 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.621 ' HB3' HG21 ' A' ' 50' ' ' VAL . 18.1 tp -82.54 114.95 21.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.22 0.533 . . . . 0.0 111.235 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -78.95 69.7 5.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.464 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.9 m -133.68 -160.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.379 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.644 ' HA ' ' CG ' ' A' ' 51' ' ' ARG . 76.9 m-20 -98.0 -19.42 18.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.014 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.433 ' OD2' ' HA ' ' A' ' 95' ' ' ALA . 4.0 m-20 -70.25 -32.2 69.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.885 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.621 HG21 ' HB3' ' A' ' 45' ' ' LEU . 21.1 t -84.72 -52.85 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.237 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.644 ' CG ' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -50.51 -28.7 8.96 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.913 179.291 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -72.68 -35.95 67.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.198 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.597 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 7.8 tpt -65.33 -48.93 71.32 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.92 HD23 HD21 ' A' ' 29' ' ' LEU . 1.5 mp -64.78 -47.9 76.43 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.515 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -55.63 -24.09 31.55 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.451 179.39 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.822 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -75.72 -48.99 19.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.726 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -66.48 -49.97 64.85 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.878 -179.646 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.497 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.3 t -51.9 -32.29 31.92 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.302 0.572 . . . . 0.0 110.034 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.703 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.21 -48.05 83.07 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.106 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.012 HD21 HD22 ' A' ' 106' ' ' LEU . 3.7 mp -69.37 -27.38 65.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.394 0.616 . . . . 0.0 110.084 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.41 -1.97 4.93 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.6 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.605 HG21 HD11 ' A' ' 82' ' ' LEU . 13.6 t -59.59 155.79 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 117.641 0.72 . . . . 0.0 110.056 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.62 ' CB ' HG13 ' A' ' 76' ' ' ILE . 1.7 m -116.95 107.71 14.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.991 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.667 ' CE2' ' HB3' ' A' ' 54' ' ' LEU . 8.3 p90 -122.24 153.43 38.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.861 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 1.7 m -147.99 116.33 6.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.877 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.895 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -87.97 177.32 6.98 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.085 0.469 . . . . 0.0 111.198 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.476 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 12.9 p -93.97 179.68 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.479 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.94 -14.59 36.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.751 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -118.12 6.8 12.06 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.888 0.375 . . . . 0.0 110.74 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.572 ' O ' HD23 ' A' ' 44' ' ' LEU . 3.9 mmt180 57.14 43.85 23.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.817 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -126.49 -2.32 6.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.436 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.98 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -136.54 109.73 7.79 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.822 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.599 ' SG ' HD22 ' A' ' 66' ' ' LEU . 5.7 t -118.11 153.99 32.86 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.461 0.648 . . . . 0.0 112.669 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.775 ' HB3' ' HD3' ' A' ' 38' ' ' LYS . 0.6 OUTLIER -121.49 103.45 8.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.054 178.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -98.96 125.05 52.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.816 HD13 ' HB2' ' A' ' 38' ' ' LYS . 8.3 mm -78.97 104.16 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.308 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.659 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -51.82 115.77 4.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.882 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.616 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -63.56 -14.87 55.56 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.914 0.388 . . . . 0.0 110.439 178.656 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.547 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 83.6 -19.88 13.51 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.336 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.922 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.75 -151.28 5.73 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 178.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.836 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 3.8 Cg_exo -77.47 171.0 18.35 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 119.638 1.719 . . . . 0.0 109.222 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.805 ' HB2' HD23 ' A' ' 106' ' ' LEU . 4.1 mm? -68.09 90.99 0.34 Allowed 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.836 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 32.7 m170 -84.21 120.74 26.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 113.062 -1.881 . . . . 0.0 112.368 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.745 ' HB3' HD11 ' A' ' 113' ' ' ILE . . . -144.13 106.83 4.44 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.274 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.08 88.63 2.78 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.545 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.07 21.18 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.803 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.47 50.07 15.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.421 0.629 . . . . 0.0 109.904 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.8 HD12 ' N ' ' A' ' 89' ' ' GLU . 2.8 tp -78.4 135.87 37.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.041 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.8 ' N ' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -116.63 126.49 53.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.274 0.559 . . . . 0.0 110.286 179.157 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.822 HD13 ' HA ' ' A' ' 56' ' ' ALA . 19.7 mt -107.91 156.25 19.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.762 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 116' ' ' THR . 49.5 t80 -122.07 102.15 7.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.884 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.74 HD23 ' HE2' ' A' ' 99' ' ' MET . 1.9 mm? -91.74 6.86 44.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.275 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 43.5 -142.84 2.04 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.859 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -92.92 50.43 1.56 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.169 0.509 . . . . 0.0 110.824 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.433 ' HA ' ' OD2' ' A' ' 49' ' ' ASP . . . -84.23 -77.03 0.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.218 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.539 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.54 -16.43 19.06 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.36 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.22 -9.9 29.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.851 0.358 . . . . 0.0 110.474 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.453 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -130.8 -15.94 3.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.731 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.74 ' HE2' HD23 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -67.95 -54.42 18.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.074 0.464 . . . . 0.0 110.459 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.652 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -60.48 -53.13 67.58 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.383 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.804 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 33.4 Cg_exo -59.9 -47.05 16.73 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.86 2.373 . . . . 0.0 112.894 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.928 HD13 HD11 ' A' ' 106' ' ' LEU . 2.7 tm? -68.54 -34.42 75.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.504 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.68 -47.65 85.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.523 0.677 . . . . 0.0 110.542 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.916 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -72.45 -39.85 67.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.077 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.603 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -56.57 -39.77 74.04 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.214 0.531 . . . . 0.0 111.735 -177.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.012 HD22 HD21 ' A' ' 60' ' ' LEU . 1.3 mt -72.58 -22.01 61.05 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.039 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.762 ' SG ' HD11 ' A' ' 140' ' ' ILE . 84.9 m -61.92 -8.55 5.22 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.344 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.747 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 11.2 mt -85.6 165.05 17.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.04 -113.58 5.23 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.33 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.436 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 1.4 p -168.66 95.33 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.886 0.374 . . . . 0.0 111.242 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.715 ' HB2' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -138.99 143.25 38.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.039 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.5 m-20 -101.08 111.55 23.78 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.18 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.745 HD11 ' HB3' ' A' ' 84' ' ' ALA . 5.0 mp -141.49 142.4 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.023 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.622 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 22.5 t -116.09 112.06 38.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.744 0.307 . . . . 0.0 110.377 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.556 HD22 HD21 ' A' ' 92' ' ' LEU . 21.8 mt -79.08 157.14 28.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.415 0.626 . . . . 0.0 111.787 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 35.2 m -161.99 154.74 20.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.758 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.69 -167.1 10.94 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 119.897 -1.144 . . . . 0.0 113.425 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.621 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 2.3 mt-10 -70.65 173.03 5.12 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.387 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 20.2 Cg_endo -61.19 -24.39 78.98 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.598 1.532 . . . . 0.0 111.972 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.52 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 2.3 tpp180 -90.23 -33.14 16.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.261 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.599 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 6.0 tpt -60.12 -19.55 54.0 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.675 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 7.6 mttm -68.33 -4.92 16.09 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.122 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.617 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -121.29 30.48 6.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.886 0.374 . . . . 0.0 110.986 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.454 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 4.0 mmp_? -108.96 93.75 13.26 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.758 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.65 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 8.2 Cg_endo -50.1 128.62 22.83 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.559 2.173 . . . . 0.0 112.466 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.772 HD11 HD23 ' A' ' 129' ' ' LEU . 17.3 tt -133.83 31.12 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.766 0.793 . . . . 0.0 110.215 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.666 ' HA3' ' ND2' ' A' ' 147' ' ' ASN . . . -71.8 -51.57 14.88 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.202 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.809 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.9 OUTLIER -53.14 -26.9 18.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.962 0.41 . . . . 0.0 110.727 -179.299 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.799 HD13 ' HA ' ' A' ' 172' ' ' PHE . 35.4 tp -82.63 -66.5 0.88 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.749 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.872 HG13 HD12 ' A' ' 140' ' ' ILE . 61.1 t -52.13 -25.44 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.312 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 30.9 t0 -72.16 -45.31 60.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.585 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.979 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -64.89 -51.83 59.8 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.834 0.35 . . . . 0.0 111.513 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.748 HD21 ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -56.62 -43.01 79.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.221 0.534 . . . . 0.0 109.874 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -60.06 -32.67 71.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.048 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.979 HD12 ' HA ' ' A' ' 132' ' ' ALA . 2.2 mt -72.09 -26.75 62.27 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.462 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.526 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -80.82 -13.55 81.16 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.659 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.82 4.04 6.24 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.302 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.88 145.71 48.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.923 0.392 . . . . 0.0 111.53 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 0.2 OUTLIER -114.29 90.83 3.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.54 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.97 HG23 HD23 ' A' ' 153' ' ' LEU . 7.0 mt -117.48 174.54 3.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.957 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.763 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.8 OUTLIER -152.43 -168.08 2.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 111.39 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.591 ' N ' HG23 ' A' ' 141' ' ' THR . 25.7 m-85 -131.77 105.65 7.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.097 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.686 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.1 mm? -79.69 -8.88 59.5 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.812 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 27.5 mt-10 -141.33 -73.68 0.33 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.349 . . . . 0.0 110.379 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.647 ' HB3' ' HD2' ' A' ' 148' ' ' TYR . 0.1 OUTLIER -123.87 148.63 46.63 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.252 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.45 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 4.3 mt-10 -70.24 135.64 49.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.12 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.666 ' ND2' ' HA3' ' A' ' 127' ' ' GLY . 3.6 m120 64.59 49.59 2.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.319 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.868 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.8 m-85 -148.29 179.6 1.15 Allowed Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.734 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.868 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 8.0 Cg_endo -50.22 -40.36 51.77 Favored 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 123.331 2.687 . . . . 0.0 115.037 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.812 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 36.7 Cg_endo -62.05 100.94 0.22 Allowed 'Trans proline' 0 CA--C 1.516 -0.375 0 C-N-CA 121.513 1.475 . . . . 0.0 111.586 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.476 HD21 ' HE1' ' A' ' 142' ' ' TYR . 91.5 mt -139.56 122.95 17.14 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.802 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.686 ' N ' HD21 ' A' ' 143' ' ' LEU . 0.9 OUTLIER -104.49 112.55 25.65 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.97 HD23 HG23 ' A' ' 140' ' ' ILE . 1.2 mt -96.07 155.39 16.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.254 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 18.8 mt-30 -142.55 24.34 1.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.615 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 56.49 -165.91 4.66 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.433 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.97 -4.98 34.1 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.13 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.651 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 3.5 t80 -60.8 107.34 0.69 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.863 0.332 . . . . 0.0 110.494 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.465 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 76.4 p -105.61 -46.39 4.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.889 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.676 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 141.73 -162.3 27.02 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.136 -1.03 . . . . 0.0 113.981 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.592 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 115.71 172.67 17.04 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -65.16 126.76 29.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.613 HG11 ' HB1' ' A' ' 132' ' ' ALA . 58.0 t -135.5 157.54 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-O 121.132 0.491 . . . . 0.0 111.47 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.535 ' O ' ' HE2' ' A' ' 192' ' ' LYS . 3.2 m-20 -123.65 119.66 30.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.384 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.805 HG11 HD13 ' A' ' 173' ' ' LEU . 0.4 OUTLIER -121.74 139.13 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.548 -0.461 . . . . 0.0 112.101 -178.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.809 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.3 OUTLIER -78.93 133.5 36.91 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.267 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.715 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -75.43 -44.64 21.1 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.105 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.493 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 54.4 p -52.91 165.44 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.922 0.391 . . . . 0.0 111.359 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.6 t 72.61 50.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.01 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.825 ' H ' HG11 ' A' ' 196' ' ' VAL . 1.4 m 63.62 150.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.424 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.467 ' HG ' ' HG1' ' A' ' 174' ' ' THR . 12.2 t -77.68 3.65 13.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.711 0.291 . . . . 0.0 111.412 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.652 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 71.1 mm-40 -54.49 -20.68 8.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.983 0.42 . . . . 0.0 111.42 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.799 ' HA ' HD13 ' A' ' 129' ' ' LEU . 1.6 m-85 -76.09 -54.29 7.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.619 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.838 HD23 HG12 ' A' ' 201' ' ' ILE . 21.0 tp -77.33 -35.03 55.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.593 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.475 HG23 ' OG1' ' A' ' 204' ' ' THR . 79.8 m -58.99 -33.46 70.71 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.026 0.441 . . . . 0.0 110.029 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.916 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -76.33 -51.96 10.9 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.966 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.711 ' CD2' HD23 ' A' ' 133' ' ' LEU . 3.2 mt -61.99 -43.08 99.6 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.507 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.06 HD22 HD21 ' A' ' 205' ' ' LEU . 12.6 mt -60.75 -28.07 68.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.867 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.639 ' HA ' ' OH ' ' A' ' 231' ' ' TYR . 4.9 ptp -96.39 -26.24 15.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.325 0.583 . . . . 0.0 110.492 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.618 ' O ' HD11 ' A' ' 108' ' ' LEU . 74.1 m -85.17 -47.55 10.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.157 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.892 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -63.74 -35.84 18.44 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.719 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 9.7 Cg_endo -53.17 -37.77 80.35 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 121.129 1.219 . . . . 0.0 111.376 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.577 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.78 -8.06 58.96 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -67.43 115.8 30.4 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.057 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -33.58 -34.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.69 2.927 . . . . 0.0 114.33 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -103.65 152.92 21.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.005 0.431 . . . . 0.0 111.77 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.678 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 40.9 t0 -67.29 114.68 6.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.708 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.817 ' HB ' HG23 ' A' ' 225' ' ' VAL . 29.2 m -99.7 135.23 41.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.098 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 1.07 HG22 HG13 ' A' ' 224' ' ' VAL . 25.4 t -125.8 99.22 5.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.881 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.5 mt -91.11 144.49 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.267 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.822 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.2 OUTLIER -114.93 170.98 7.93 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.845 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.4 mm -111.54 97.15 5.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.269 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.599 ' HE3' ' N ' ' A' ' 165' ' ' ASP . 9.3 mtmt -57.0 -81.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.681 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -83.21 168.0 46.06 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.361 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -59.61 122.64 14.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.568 0.223 . . . . 0.0 110.84 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.715 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.4 OUTLIER -55.65 147.6 17.97 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.22 0.533 . . . . 0.0 110.841 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.825 HG11 ' H ' ' A' ' 169' ' ' SER . 11.8 p -103.81 -21.06 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.134 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.57 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.3 OUTLIER -128.11 46.15 2.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.125 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.807 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.6 OUTLIER -43.62 -61.64 1.81 Allowed Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 114.854 -1.066 . . . . 0.0 113.11 -178.635 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 15.0 Cg_exo -69.37 -17.28 39.44 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 121.476 1.451 . . . . 0.0 111.55 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.691 ' HA ' HD12 ' A' ' 203' ' ' ILE . 26.9 m-85 -75.08 -30.69 61.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.113 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 1.014 HD11 HD12 ' A' ' 177' ' ' LEU . 8.0 tp -67.95 -33.6 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.229 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.565 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 9.9 t70 -59.79 -33.71 72.07 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.691 HD12 ' HA ' ' A' ' 200' ' ' TYR . 13.1 mt -68.32 -29.86 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.622 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.505 HG22 ' SD ' ' A' ' 208' ' ' MET . 71.7 m -61.0 -54.71 41.6 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.124 0.488 . . . . 0.0 109.716 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 1.06 HD21 HD22 ' A' ' 177' ' ' LEU . 28.7 mt -70.4 -34.64 72.77 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.231 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.737 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 0.9 OUTLIER -63.6 -29.93 71.11 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.299 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.695 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -77.73 -40.82 39.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.613 178.717 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.505 ' SD ' HG22 ' A' ' 204' ' ' THR . 10.4 mtp -68.76 -38.56 80.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.966 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.737 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -66.7 -45.26 79.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.384 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.667 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 2.0 t -58.71 -26.08 63.53 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.317 0.58 . . . . 0.0 109.529 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.943 ' HA ' ' HG3' ' A' ' 234' ' ' PRO . 2.1 m-85 -74.92 -54.56 7.02 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.602 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 156.67 -1.56 0.13 Allowed Glycine 0 CA--C 1.52 0.351 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.883 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.626 ' HB ' ' CD1' ' A' ' 231' ' ' TYR . 53.0 t -117.75 138.22 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.046 0.451 . . . . 0.0 111.767 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -135.49 155.12 51.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.535 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.966 HG21 HG12 ' A' ' 225' ' ' VAL . 2.4 pp -129.31 175.5 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.956 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.317 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 1.01 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 18.7 tt0 -89.91 125.52 35.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.874 0.368 . . . . 0.0 110.37 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -101.14 100.95 11.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.248 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.723 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 2.1 mm-40 -66.74 -167.08 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.75 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.46 48.26 0.34 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.901 0.381 . . . . 0.0 110.341 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.588 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 57.88 19.65 5.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.254 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 191' ' ' ILE . 15.2 pt20 -112.94 -19.72 11.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.83 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.775 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 32.5 mt-30 -150.34 141.67 23.27 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.701 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 1.004 ' HB3' HD21 ' A' ' 177' ' ' LEU . 19.4 m-85 -114.14 96.76 5.97 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 1.07 HG13 HG22 ' A' ' 188' ' ' VAL . 31.1 t -82.8 110.97 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 121.167 0.508 . . . . 0.0 111.235 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.966 HG12 HG21 ' A' ' 215' ' ' ILE . 3.0 m -99.87 113.15 34.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.964 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.661 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 1.3 mptm? -62.74 103.82 0.47 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.998 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.678 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.25 155.86 16.36 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.947 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.97 8.77 75.23 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.445 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.661 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 69.8 mm-40 -73.16 178.54 4.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.473 0.654 . . . . 0.0 111.546 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.577 ' HA ' HD23 ' A' ' 182' ' ' LEU . 4.9 m -167.68 105.55 0.52 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.863 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.677 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 22.7 m-85 -55.15 142.53 30.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.108 0.48 . . . . 0.0 111.368 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.569 ' HB2' ' O ' ' A' ' 211' ' ' PHE . 78.9 mt-30 -108.21 148.58 29.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.673 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 56.6 p -64.13 103.05 0.37 Allowed Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.155 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.943 ' HG3' ' HA ' ' A' ' 211' ' ' PHE . 7.7 Cg_exo -71.36 -31.39 14.17 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.705 2.27 . . . . 0.0 111.966 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.01 -120.79 5.22 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.682 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -92.9 116.8 29.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.699 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 88.1 t80 -123.78 136.8 54.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.519 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.931 HD12 HG23 ' A' ' 42' ' ' THR . 4.0 tp -98.18 119.46 36.87 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.261 0.553 . . . . 0.0 111.707 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 42' ' ' THR . 92.8 t -52.84 -81.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.052 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.504 ' H ' ' HB3' ' A' ' 43' ' ' ASN . 2.8 tt0 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.712 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.664 ' HB3' ' H ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.902 0.382 . . . . 0.0 111.054 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.719 ' OD1' ' HA ' ' A' ' 50' ' ' VAL . 64.3 m-20 -74.83 -22.39 58.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.964 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 35.0 mtt85 -62.19 -40.41 95.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.053 0.454 . . . . 0.0 110.293 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.843 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -74.32 -37.63 63.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.908 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.935 HD13 ' HG ' ' A' ' 54' ' ' LEU . 55.1 mt -58.36 -47.19 84.61 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.862 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.875 HD21 ' HB2' ' A' ' 105' ' ' ALA . 14.9 tp -77.82 -48.84 15.55 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.572 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 27.7 mt -55.05 -35.19 64.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.467 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.707 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -78.17 -29.7 48.74 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.675 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.766 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -70.26 -30.58 67.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.939 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.869 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.35 -12.54 40.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.996 0.427 . . . . 0.0 111.065 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.691 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -80.42 168.68 18.68 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.239 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 76.4 m-70 -103.19 98.42 8.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.217 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.71 141.06 6.95 Favored Glycine 0 C--N 1.314 -0.657 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.627 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.73 ' HB2' HG13 ' A' ' 76' ' ' ILE . 1.6 ttpm? -64.84 138.53 58.43 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.37 157.74 44.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.374 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.878 HG22 ' HG3' ' A' ' 74' ' ' GLU . 94.1 t -104.83 141.46 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.372 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.843 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -127.93 111.62 13.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.888 178.828 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.982 HG23 HD12 ' A' ' 238' ' ' LEU . 0.1 OUTLIER -98.31 171.03 8.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 111.783 -179.743 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.65 ' HB2' HD11 ' A' ' 238' ' ' LEU . 2.3 t-20 66.03 18.17 10.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.233 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.847 HD22 HD11 ' A' ' 66' ' ' LEU . 1.2 tp -58.61 163.64 3.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.664 ' H ' ' HB3' ' A' ' 25' ' ' SER . 38.5 tp -97.64 116.63 30.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.009 0.433 . . . . 0.0 111.425 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -75.64 71.85 2.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.749 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.532 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 63.1 m -134.85 -162.98 1.31 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.899 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.624 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 1.5 t70 -98.19 -22.11 16.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.896 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.464 ' CG ' ' HA ' ' A' ' 95' ' ' ALA . 8.2 m-20 -66.61 -30.4 70.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.78 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.719 ' HA ' ' OD1' ' A' ' 26' ' ' ASN . 21.3 t -84.48 -56.02 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.058 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.624 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 1.1 ptm180 -49.99 -26.97 4.77 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -71.41 -40.77 70.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.296 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.485 ' SD ' ' HB1' ' A' ' 98' ' ' ALA . 7.1 tpt -64.87 -47.43 77.91 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.935 ' HG ' HD13 ' A' ' 29' ' ' LEU . 1.3 mp -65.33 -47.21 77.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.588 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 8.4 t-20 -57.39 -23.01 46.64 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.0 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.692 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -74.76 -48.1 27.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.056 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -68.18 -49.44 60.87 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.771 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.509 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.0 t -51.65 -30.23 20.86 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.281 0.562 . . . . 0.0 110.201 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.9 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.31 -52.49 65.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.962 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.967 HD21 HD22 ' A' ' 106' ' ' LEU . 3.8 mp -65.14 -28.38 69.38 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.83 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.76 0.61 5.23 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 114.834 -1.075 . . . . 0.0 113.494 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.681 HG21 HD11 ' A' ' 82' ' ' LEU . 22.9 t -56.55 154.2 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 117.609 0.705 . . . . 0.0 110.391 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.856 ' HB3' HD13 ' A' ' 76' ' ' ILE . 11.9 m -115.16 112.27 22.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.379 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 7.5 p90 -129.71 156.95 43.45 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.875 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.685 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -149.25 116.05 5.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.823 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.95 HD22 ' HG ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -90.32 175.55 7.07 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.232 0.539 . . . . 0.0 111.645 -179.424 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.842 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 1.3 t -87.85 179.42 6.47 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.709 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.33 -14.36 49.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.33 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.98 2.39 11.5 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.866 0.365 . . . . 0.0 110.705 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.503 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER 61.33 45.29 8.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.428 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -124.03 -2.72 8.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.974 179.021 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.842 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -142.54 110.62 5.97 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.429 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.95 ' HG ' HD22 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -114.93 152.62 32.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.256 0.55 . . . . 0.0 112.064 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.878 ' HG3' HG22 ' A' ' 40' ' ' VAL . 1.1 mt-10 -118.11 102.85 9.34 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.689 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.703 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -99.44 126.44 52.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.856 HD13 ' HB3' ' A' ' 63' ' ' SER . 3.1 mp -80.94 103.81 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.425 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.707 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -48.08 118.79 4.76 Favored Glycine 0 N--CA 1.453 -0.186 0 CA-C-N 116.017 -0.538 . . . . 0.0 114.136 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.592 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -63.77 -15.38 58.5 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.987 0.423 . . . . 0.0 110.357 178.552 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.517 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.02 -19.71 20.17 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.827 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.869 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -139.73 -150.22 5.47 Favored Glycine 0 C--O 1.224 -0.519 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.806 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 4.3 Cg_exo -77.57 170.08 19.85 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 CA-C-N 119.711 1.755 . . . . 0.0 108.828 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.809 HD12 HD13 ' A' ' 60' ' ' LEU . 4.3 mm? -68.43 89.59 0.35 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.806 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 34.1 m170 -83.44 118.34 23.68 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.012 -1.904 . . . . 0.0 112.333 -176.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.784 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -143.27 107.65 4.79 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.773 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -106.88 89.33 2.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.733 0.302 . . . . 0.0 110.947 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.63 20.45 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.74 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.32 48.11 19.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.394 0.616 . . . . 0.0 110.263 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.9 HD21 ' HB1' ' A' ' 59' ' ' ALA . 3.9 tp -76.57 131.6 39.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.261 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.706 ' N ' HD12 ' A' ' 88' ' ' LEU . 6.9 tt0 -110.64 128.26 55.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.261 0.553 . . . . 0.0 110.096 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.802 HD21 ' CB ' ' A' ' 59' ' ' ALA . 48.6 mt -110.69 156.99 20.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.118 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 116' ' ' THR . 45.4 t80 -119.57 105.15 10.93 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.628 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.853 HD23 ' HE2' ' A' ' 99' ' ' MET . 2.8 mm? -91.47 8.17 37.68 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.798 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 121' ' ' MET . . . 39.72 -139.82 0.93 Allowed Glycine 0 CA--C 1.523 0.556 0 C-N-CA 121.327 -0.463 . . . . 0.0 113.781 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.667 ' OD1' ' HB3' ' A' ' 120' ' ' ARG . 0.7 OUTLIER -91.32 46.57 1.31 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.023 0.44 . . . . 0.0 111.084 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.464 ' HA ' ' CG ' ' A' ' 49' ' ' ASP . . . -90.52 -77.44 0.41 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.461 ' O ' ' HG2' ' A' ' 171' ' ' GLN . . . 78.65 -14.36 13.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.99 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.58 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -96.29 -11.47 25.88 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 120.81 0.338 . . . . 0.0 110.429 178.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.485 ' HB1' ' SD ' ' A' ' 53' ' ' MET . . . -125.05 -21.27 4.7 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.49 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.853 ' HE2' HD23 ' A' ' 92' ' ' LEU . 10.4 ttm -66.8 -52.02 48.86 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.263 0.554 . . . . 0.0 110.47 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.918 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -57.77 -55.39 45.4 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.156 -179.522 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.671 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 24.1 Cg_exo -63.45 -46.8 8.75 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.53 2.153 . . . . 0.0 112.886 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.929 HD13 HD11 ' A' ' 106' ' ' LEU . 2.9 tm? -61.3 -40.81 95.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.78 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.701 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -58.94 -48.48 81.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.65 0.738 . . . . 0.0 109.736 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.691 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -68.01 -40.11 83.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.779 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.875 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -56.16 -42.49 77.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.042 0.449 . . . . 0.0 111.315 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.967 HD22 HD21 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -71.74 -21.32 61.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.399 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.671 ' SG ' HD11 ' A' ' 140' ' ' ILE . 82.6 m -58.36 -11.76 3.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.669 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.72 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 12.3 mt -84.43 167.68 16.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.716 0.293 . . . . 0.0 110.244 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 55.04 -110.75 1.86 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.076 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.486 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.9 OUTLIER -171.3 96.25 0.19 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.954 0.407 . . . . 0.0 111.207 179.478 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.686 ' HB2' HD11 ' A' ' 113' ' ' ILE . 15.2 p30 -137.28 139.61 41.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.974 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.677 ' C ' HD12 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -99.77 111.3 23.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.752 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.742 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.3 mp -141.02 139.85 33.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.224 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 21.3 t -112.2 113.41 44.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.701 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 18.1 mt -80.44 155.46 27.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.467 0.651 . . . . 0.0 112.215 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 11.2 m -162.72 156.88 20.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.294 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -147.58 -165.34 11.81 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 119.972 -1.109 . . . . 0.0 113.662 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.577 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 1.7 mt-10 -71.38 177.86 1.44 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.312 -0.444 . . . . 0.0 110.507 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.577 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 38.7 Cg_exo -61.74 -26.43 79.77 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.177 1.918 . . . . 0.0 112.52 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.667 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 11.7 tpt180 -87.25 -38.56 16.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.714 0.292 . . . . 0.0 110.483 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.718 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 8.7 tpt -59.6 -19.21 47.32 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.706 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 11.8 mttp -72.32 -4.5 30.19 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.82 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.683 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 5.4 pt-20 -126.62 25.06 6.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.981 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.426 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 33.2 mmt180 -100.15 87.23 0.71 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.271 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.639 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 1.3 Cg_endo -42.32 126.82 3.99 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.958 2.439 . . . . 0.0 112.449 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.729 HD11 HD23 ' A' ' 129' ' ' LEU . 16.5 tt -131.6 31.71 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.818 0.818 . . . . 0.0 110.103 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.592 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -70.7 -52.64 14.63 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.517 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.562 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.5 OUTLIER -54.3 -25.45 23.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.737 0.303 . . . . 0.0 110.686 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.863 ' CD1' HD21 ' A' ' 133' ' ' LEU . 26.5 tp -84.39 -66.21 0.92 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.885 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.877 HG13 HD12 ' A' ' 140' ' ' ILE . 48.0 t -52.82 -25.2 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.189 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.592 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 10.8 t0 -72.55 -46.58 53.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.388 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.945 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -65.07 -46.76 79.83 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.661 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.941 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -60.77 -42.27 97.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.362 0.601 . . . . 0.0 109.777 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.48 -34.8 74.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.056 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.945 HD12 ' HA ' ' A' ' 132' ' ' ALA . 3.4 mt -68.51 -30.58 69.43 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.253 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.21 -18.49 80.04 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.541 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.3 4.58 5.38 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.231 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.99 148.35 49.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.85 0.357 . . . . 0.0 111.406 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.57 87.47 2.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.402 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.986 HG23 HD23 ' A' ' 153' ' ' LEU . 6.8 mt -114.56 175.34 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.47 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.769 ' H ' HG22 ' A' ' 140' ' ' ILE . 1.0 OUTLIER -152.32 -167.22 2.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.232 0.539 . . . . 0.0 111.152 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.594 ' N ' HG23 ' A' ' 141' ' ' THR . 23.5 m-85 -133.64 105.98 7.14 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.671 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.0 mm? -81.04 -14.75 57.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.738 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.649 ' HG3' ' N ' ' A' ' 145' ' ' GLN . 0.1 OUTLIER -134.67 -68.31 0.54 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.996 0.427 . . . . 0.0 109.92 179.439 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.649 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -132.38 150.89 52.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.229 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.452 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 66.3 mt-10 -69.0 131.87 45.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.235 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.639 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 13.4 m-20 65.55 50.39 1.66 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.081 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.874 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.3 m-30 -143.03 -178.95 0.86 Allowed Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.874 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 11.9 Cg_endo -59.0 -36.59 96.52 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.599 2.199 . . . . 0.0 114.548 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.701 ' HD2' ' N ' ' A' ' 149' ' ' PRO . 39.0 Cg_endo -62.94 93.77 0.15 Allowed 'Trans proline' 0 CA--C 1.515 -0.465 0 C-N-CA 121.465 1.443 . . . . 0.0 111.221 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 150' ' ' PRO . 72.0 mt -132.54 123.49 26.63 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.513 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.709 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.0 OUTLIER -103.11 111.54 23.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.986 HD23 HG23 ' A' ' 140' ' ' ILE . 1.1 mt -94.07 159.35 15.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.458 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -147.2 23.62 1.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.662 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.514 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 55.84 -165.5 4.11 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.318 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.423 ' O ' HG23 ' A' ' 158' ' ' THR . . . 106.96 -2.38 35.59 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.64 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.698 ' HE1' ' HA ' ' A' ' 133' ' ' LEU . 40.9 t80 -63.44 111.92 2.53 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.029 0.442 . . . . 0.0 110.752 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.626 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 78.1 p -106.99 -47.64 3.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.462 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.62 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 140.09 -161.66 26.38 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.913 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.629 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 115.96 170.44 15.9 Favored Glycine 0 CA--C 1.519 0.289 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -66.51 123.26 19.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.056 0.428 . . . . 0.0 110.191 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.55 HG11 ' HB1' ' A' ' 132' ' ' ALA . 38.8 t -131.6 157.05 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 111.512 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.465 ' CG ' ' HG2' ' A' ' 190' ' ' ARG . 2.5 m-20 -120.97 115.24 22.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.606 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.594 HG21 ' CD1' ' A' ' 176' ' ' LEU . 0.5 OUTLIER -116.49 145.62 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 120.176 -0.609 . . . . 0.0 112.201 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.562 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.9 OUTLIER -82.9 132.86 35.14 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.925 179.3 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.684 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -74.61 -44.73 25.36 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.369 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.438 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 0.6 OUTLIER -52.02 165.71 0.19 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.879 0.371 . . . . 0.0 111.28 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 4.1 t 71.8 54.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.979 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.857 ' N ' HG11 ' A' ' 196' ' ' VAL . 69.6 m 59.26 160.02 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.266 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.726 ' HB2' ' HB2' ' A' ' 197' ' ' SER . 34.8 t -80.55 -1.63 42.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.918 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 2.2 mp0 -51.34 -22.16 2.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.671 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.666 ' HA ' HD13 ' A' ' 129' ' ' LEU . 2.7 m-85 -78.5 -54.94 5.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.942 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.748 HD23 HG12 ' A' ' 201' ' ' ILE . 32.1 tp -73.18 -41.04 64.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.399 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 170' ' ' SER . 14.7 t -58.64 -32.71 69.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.433 0.635 . . . . 0.0 109.499 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.691 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -64.88 -52.27 57.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.021 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.941 ' CD2' HD23 ' A' ' 133' ' ' LEU . 1.9 mt -71.28 -36.09 71.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.187 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.054 HD22 HD21 ' A' ' 205' ' ' LEU . 9.8 mt -66.2 -29.83 70.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.123 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.662 ' CE ' HD23 ' A' ' 30' ' ' LEU . 23.6 mtp -93.98 -27.54 16.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.259 0.552 . . . . 0.0 110.64 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.662 HG23 ' HG ' ' A' ' 108' ' ' LEU . 87.6 m -88.12 -46.83 8.96 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.141 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.954 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -62.28 -36.71 30.4 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.4 Cg_endo -54.46 -37.72 89.7 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 CA-C-N 120.297 1.142 . . . . 0.0 111.506 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.703 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -83.79 -5.74 59.27 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.229 -179.55 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.626 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -68.1 124.66 90.16 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.1 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 1.5 Cg_endo -43.74 -29.88 2.61 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.95 2.433 . . . . 0.0 113.535 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -107.75 151.53 25.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.067 0.46 . . . . 0.0 111.652 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.655 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 20.6 t0 -64.55 118.03 8.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.655 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.774 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 41.1 m -102.26 133.85 46.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.817 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 1.016 HG22 HG13 ' A' ' 224' ' ' VAL . 33.3 t -126.0 99.16 5.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.273 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.58 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.2 mt -91.71 145.94 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.116 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.842 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.1 OUTLIER -118.19 171.04 8.39 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.866 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.6 mm -111.69 98.17 6.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-O 121.096 0.474 . . . . 0.0 111.467 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -60.14 -81.01 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.381 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -81.09 166.75 48.74 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.422 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -57.61 126.32 26.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.65 0.262 . . . . 0.0 111.168 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.684 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.4 OUTLIER -62.48 147.21 49.48 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.013 0.435 . . . . 0.0 110.711 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.857 HG11 ' N ' ' A' ' 169' ' ' SER . 11.6 p -104.21 -20.55 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.797 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.726 ' HB2' ' HB2' ' A' ' 170' ' ' SER . 0.4 OUTLIER -128.28 45.32 2.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.378 0.608 . . . . 0.0 109.589 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.842 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.0 OUTLIER -41.72 -63.9 0.76 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.541 -179.081 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 49.0 Cg_endo -68.42 -17.33 44.03 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 121.707 1.605 . . . . 0.0 111.479 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.87 ' HA ' HD12 ' A' ' 203' ' ' ILE . 17.2 m-85 -76.88 -26.74 54.55 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.264 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.905 HD11 HD12 ' A' ' 177' ' ' LEU . 6.3 tp -73.08 -33.61 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.847 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.1 OUTLIER -61.89 -35.0 77.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.226 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.87 HD12 ' HA ' ' A' ' 200' ' ' TYR . 10.1 mt -66.7 -28.67 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.175 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.582 HG22 ' SD ' ' A' ' 208' ' ' MET . 53.9 m -61.45 -55.16 34.29 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 1.054 HD21 HD22 ' A' ' 177' ' ' LEU . 41.3 mt -70.05 -34.28 73.02 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.549 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.62 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 8.8 t30 -64.84 -25.51 67.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.193 0.521 . . . . 0.0 109.839 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.779 HD11 ' CZ ' ' A' ' 237' ' ' TYR . 0.2 OUTLIER -83.9 -40.32 18.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.308 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.59 ' SD ' HD23 ' A' ' 205' ' ' LEU . 11.2 mtp -69.24 -39.41 78.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.018 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.62 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.1 OUTLIER -65.91 -44.45 85.16 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.53 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 207' ' ' LEU . 1.3 t -59.02 -28.98 66.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.426 0.632 . . . . 0.0 109.39 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.676 ' CE2' ' HA ' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -71.33 -51.41 24.42 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.926 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 157.39 -5.85 0.18 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.531 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.695 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 54.9 t -118.84 137.33 53.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.972 0.415 . . . . 0.0 111.857 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.405 ' HG3' ' HA ' ' A' ' 209' ' ' LYS . 5.8 mt-10 -135.05 156.13 49.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.629 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 1.07 HG21 HG12 ' A' ' 225' ' ' VAL . 2.0 pp -132.44 175.99 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.932 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.868 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 4.5 tt0 -88.02 122.94 32.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.161 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -103.61 100.88 10.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.274 0.559 . . . . 0.0 109.778 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.764 ' HB2' ' HG2' ' A' ' 222' ' ' GLN . 1.5 tm0? -72.92 -161.87 0.1 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.044 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.422 ' H ' ' CD ' ' A' ' 218' ' ' GLN . 18.7 m-70 -74.32 46.28 0.25 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.499 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.713 ' CE2' ' HD3' ' A' ' 198' ' ' LYS . 0.3 OUTLIER 58.45 22.37 9.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.143 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 191' ' ' ILE . 23.3 mt-30 -109.0 -37.39 5.84 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.021 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.797 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 5.0 pt20 -136.12 139.19 42.75 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.278 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.866 ' CD1' HD11 ' A' ' 191' ' ' ILE . 28.2 m-85 -108.93 95.57 5.73 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 1.016 HG13 HG22 ' A' ' 188' ' ' VAL . 81.3 t -86.11 112.94 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.265 -177.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 1.07 HG12 HG21 ' A' ' 215' ' ' ILE . 6.3 m -101.1 115.78 43.43 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.555 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.601 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -64.41 101.47 0.44 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.956 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.655 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -53.51 156.43 5.74 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.256 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.26 10.85 67.86 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.236 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 60.3 mm-40 -75.84 -179.63 4.93 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.53 0.681 . . . . 0.0 111.657 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.703 ' HA ' HD23 ' A' ' 182' ' ' LEU . 3.9 m -170.68 105.9 0.27 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.863 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.695 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 21.9 m-85 -53.64 149.13 8.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.933 0.397 . . . . 0.0 111.079 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.64 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 60.8 mt-30 -115.15 163.49 15.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.024 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 234' ' ' PRO . 15.2 t -82.61 98.88 0.53 Allowed Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.987 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.64 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 50.4 Cg_endo -66.52 -31.32 41.97 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.587 2.191 . . . . 0.0 112.384 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.86 -121.52 5.18 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.611 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -94.19 115.85 28.17 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.779 ' CZ ' HD11 ' A' ' 207' ' ' LEU . 0.0 OUTLIER -130.12 146.87 51.8 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.508 -178.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.982 HD12 HG23 ' A' ' 42' ' ' THR . 6.7 tp -95.22 117.71 30.74 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.043 0.449 . . . . 0.0 110.716 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.686 ' CG2' ' HB2' ' A' ' 41' ' ' LEU . 8.3 t -64.71 -73.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.009 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.427 ' H ' ' HB3' ' A' ' 43' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.378 -0.82 . . . . 0.0 111.078 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.731 ' HB3' ' H ' ' A' ' 45' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 121.208 0.528 . . . . 0.0 110.863 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.568 ' OD1' ' HA ' ' A' ' 50' ' ' VAL . 59.1 m-20 -76.53 -21.86 55.16 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.735 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 -65.59 -46.68 78.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.835 0.35 . . . . 0.0 110.767 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.982 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -69.39 -35.84 76.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.401 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.908 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -59.96 -53.96 51.76 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.237 0.542 . . . . 0.0 110.705 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.751 HD21 ' HB2' ' A' ' 105' ' ' ALA . 11.8 tp -63.54 -54.35 37.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.951 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.803 HD21 ' HG2' ' A' ' 178' ' ' MET . 78.0 mt -52.73 -34.1 51.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.929 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.711 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -78.09 -29.28 49.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.658 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.781 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -73.89 -31.66 63.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.422 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.867 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -88.98 -12.04 42.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.362 . . . . 0.0 110.955 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -80.4 169.46 17.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.735 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -102.64 97.35 7.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.171 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.53 141.77 6.55 Favored Glycine 0 C--N 1.317 -0.519 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.257 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.73 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 7.1 tttt -64.28 134.92 55.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.083 0.468 . . . . 0.0 111.745 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.647 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.8 OUTLIER -131.59 155.08 48.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.616 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.778 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 26.2 t -100.87 141.17 18.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.052 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.982 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -128.08 111.2 13.22 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.269 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.937 HG23 HD12 ' A' ' 238' ' ' LEU . 0.7 OUTLIER -103.79 164.73 11.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.323 0.582 . . . . 0.0 111.886 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.623 ' HB2' HD11 ' A' ' 238' ' ' LEU . 27.9 t30 71.28 21.25 4.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.325 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.67 HD22 HD11 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -58.51 160.35 5.51 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.296 178.667 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.731 ' H ' ' HB3' ' A' ' 25' ' ' SER . 25.6 tp -92.86 114.2 26.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.008 0.432 . . . . 0.0 111.415 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -75.0 68.78 1.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.599 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 t -129.34 -163.4 1.29 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.052 0.454 . . . . 0.0 111.322 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.581 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 48.9 m-20 -98.27 -20.65 17.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.714 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 3.7 p-10 -72.43 -27.03 62.08 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.007 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.654 HG21 ' HB3' ' A' ' 45' ' ' LEU . 17.8 t -89.07 -51.7 11.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.708 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.581 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -51.25 -27.63 9.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.181 0.515 . . . . 0.0 110.015 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . 54.0 m170 -73.35 -36.6 66.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.962 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.618 ' SD ' ' HB1' ' A' ' 98' ' ' ALA . 13.4 tpt -64.56 -50.62 66.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.908 HD23 HD21 ' A' ' 29' ' ' LEU . 1.4 mp -62.41 -48.93 77.53 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 17.7 t-20 -57.13 -22.35 39.28 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.99 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.686 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -75.08 -46.4 34.94 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.53 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.601 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -69.28 -49.46 55.87 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.861 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.48 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 4.9 t -50.8 -30.41 14.15 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.273 0.559 . . . . 0.0 110.298 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.729 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.83 -51.13 71.04 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.077 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.127 HD21 HD22 ' A' ' 106' ' ' LEU . 3.8 mp -66.1 -27.92 68.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.878 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.16 -0.9 5.73 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 114.77 -1.105 . . . . 0.0 113.67 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.645 HG21 HD11 ' A' ' 82' ' ' LEU . 12.0 t -58.34 149.71 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 117.695 0.747 . . . . 0.0 110.359 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.417 ' HB2' HD12 ' A' ' 76' ' ' ILE . 4.0 m -113.48 108.45 17.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.214 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.664 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 12.9 p90 -126.67 159.75 32.75 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.173 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.634 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 72.3 m -149.76 116.78 5.97 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.984 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.829 HD22 ' SG ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -88.2 173.24 8.91 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.332 0.587 . . . . 0.0 112.142 -179.481 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.691 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -82.51 178.57 8.15 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.621 178.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.56 -12.59 46.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.705 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.14 1.38 11.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.239 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.43 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 1.6 mmt180 63.54 44.51 5.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.59 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -123.08 -2.84 8.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.229 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.691 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.1 OUTLIER -141.65 112.32 7.16 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.429 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.829 ' SG ' HD22 ' A' ' 66' ' ' LEU . 2.3 t -116.38 147.25 41.81 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.653 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 1.6 mt-10 -112.51 103.07 11.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -96.8 126.68 49.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 8.5 mt -80.96 102.89 7.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.007 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.711 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -46.6 113.0 1.01 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.957 -0.565 . . . . 0.0 113.974 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.632 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -60.35 -16.81 38.59 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.969 0.414 . . . . 0.0 110.341 178.735 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.45 -20.64 16.79 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.348 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.867 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.46 -151.67 5.84 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.827 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 5.4 Cg_exo -75.88 170.73 19.55 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 CA-C-N 119.653 1.726 . . . . 0.0 109.167 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.781 HD21 ' HB3' ' A' ' 33' ' ' ALA . 4.3 mm? -67.84 89.68 0.28 Allowed 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.827 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 27.8 m170 -81.68 119.38 23.76 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.017 -1.901 . . . . 0.0 112.688 -176.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.73 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -145.9 111.2 5.37 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.952 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -112.46 88.79 2.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.511 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -176.18 20.16 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.701 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.45 49.99 15.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.412 0.625 . . . . 0.0 110.037 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.778 ' O ' HG23 ' A' ' 113' ' ' ILE . 5.6 tp -79.01 133.14 36.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.09 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.684 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 1.4 tm-20 -112.11 128.66 56.28 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.636 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.625 HD21 ' CB ' ' A' ' 59' ' ' ALA . 39.0 mt -110.37 158.59 18.28 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.448 ' CE1' ' CA ' ' A' ' 93' ' ' GLY . 21.5 t80 -126.51 106.63 9.58 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.844 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.074 HD23 ' HE1' ' A' ' 99' ' ' MET . 2.1 mm? -95.82 8.28 43.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.184 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.448 ' CA ' ' CE1' ' A' ' 91' ' ' PHE . . . 46.95 -142.55 5.8 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.724 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.482 ' O ' ' ND2' ' A' ' 94' ' ' ASN . 0.6 OUTLIER -93.15 49.61 1.43 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.892 0.377 . . . . 0.0 111.039 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -86.77 -75.82 0.38 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.089 0.471 . . . . 0.0 111.156 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.34 -17.46 13.39 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.089 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.531 HG22 ' NE2' ' A' ' 171' ' ' GLN . 3.9 p -94.06 -9.73 35.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.862 0.363 . . . . 0.0 111.052 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.618 ' HB1' ' SD ' ' A' ' 53' ' ' MET . . . -125.8 -22.45 4.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.524 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.074 ' HE1' HD23 ' A' ' 92' ' ' LEU . 5.5 tpp -66.11 -51.23 59.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.818 0.342 . . . . 0.0 110.75 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.804 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -61.48 -56.11 36.49 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.283 -179.319 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.7 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 38.5 Cg_exo -59.43 -46.01 23.45 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.308 2.005 . . . . 0.0 112.668 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.666 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 3.1 tm? -69.42 -35.28 75.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.481 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.92 -48.24 81.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.284 0.564 . . . . 0.0 110.79 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.826 ' O ' HG21 ' A' ' 179' ' ' THR . . . -72.17 -34.65 68.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.846 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.751 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -59.04 -44.12 91.72 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.95 0.405 . . . . 0.0 111.865 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.127 HD22 HD21 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -69.74 -22.44 63.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.373 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.576 ' SG ' HD11 ' A' ' 140' ' ' ILE . 23.1 m -60.26 -10.3 4.45 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.907 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.689 HD11 ' O ' ' A' ' 179' ' ' THR . 11.5 mt -82.86 169.68 15.82 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 51.87 -110.97 1.25 Allowed Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.406 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.437 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 62.7 m -162.73 99.42 1.0 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.753 0.311 . . . . 0.0 110.354 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 2.6 m-20 -138.18 135.33 35.54 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.625 ' C ' HD12 ' A' ' 113' ' ' ILE . 2.8 m-20 -102.41 111.1 23.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.292 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.9 mp -144.39 142.74 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.202 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 21.7 t -113.87 112.51 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.844 0.354 . . . . 0.0 110.252 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.439 ' CD2' ' HB2' ' A' ' 90' ' ' LEU . 28.7 mt -83.91 156.93 22.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.565 0.697 . . . . 0.0 112.14 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 117' ' ' GLY . 1.9 m -160.55 174.89 13.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.813 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.474 ' H ' HG22 ' A' ' 116' ' ' THR . . . -160.65 -164.84 16.32 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.774 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.64 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 6.8 mt-10 -69.51 174.97 2.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.26 -0.47 . . . . 0.0 110.82 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 22.6 Cg_endo -61.81 -36.08 75.37 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.169 1.913 . . . . 0.0 112.077 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.542 ' O ' ' HG2' ' A' ' 123' ' ' GLU . 8.2 tpt180 -78.96 -31.08 44.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.815 0.341 . . . . 0.0 110.338 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.513 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 11.0 tpt -62.4 -16.12 52.94 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.261 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.658 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 10.3 mmtp -68.65 -8.98 47.16 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.649 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 0.3 OUTLIER -120.79 26.33 9.16 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.142 179.005 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.419 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 2.1 mmp_? -98.55 89.02 0.76 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.482 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.726 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.1 Cg_endo -47.85 135.72 22.82 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.582 2.188 . . . . 0.0 112.373 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.775 HD11 HD23 ' A' ' 129' ' ' LEU . 19.3 tt -142.21 32.42 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.735 0.779 . . . . 0.0 110.233 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.622 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -73.85 -51.13 9.54 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.889 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.709 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.6 OUTLIER -52.15 -31.16 29.94 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.02 0.438 . . . . 0.0 110.653 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.778 ' CD1' HD21 ' A' ' 133' ' ' LEU . 22.8 tp -78.63 -62.93 1.53 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.798 HG13 HD12 ' A' ' 140' ' ' ILE . 67.2 t -52.33 -26.17 8.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.363 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.622 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -73.71 -43.81 58.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.675 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.957 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -65.87 -52.1 53.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.912 0.387 . . . . 0.0 111.322 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.914 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -56.3 -45.89 80.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.364 0.602 . . . . 0.0 109.641 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.411 ' CD ' HG12 ' A' ' 130' ' ' VAL . 9.9 mtp180 -58.91 -36.19 74.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.354 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.957 HD12 ' HA ' ' A' ' 132' ' ' ALA . 4.6 mt -65.76 -33.72 76.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.028 0.442 . . . . 0.0 110.077 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.491 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -74.6 -18.87 80.02 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.603 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 130.68 3.43 4.59 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.276 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.408 ' CB ' ' HB3' ' A' ' 107' ' ' CYS . . . -70.3 147.54 49.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.909 0.355 . . . . 0.0 111.225 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 9.2 mtmm -114.15 94.32 4.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.962 HG23 HD23 ' A' ' 153' ' ' LEU . 11.1 mt -118.18 175.35 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.966 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.781 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -150.31 -167.97 2.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.037 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.698 ' N ' HG23 ' A' ' 141' ' ' THR . 24.6 m-85 -136.16 100.85 4.52 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.589 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.2 mm? -71.67 -12.97 61.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.846 -177.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.815 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 2.5 mt-10 -140.19 -71.57 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.92 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.515 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -124.15 150.28 45.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.025 0.441 . . . . 0.0 111.426 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.46 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 61.3 mt-10 -69.38 130.4 42.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.809 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.726 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 6.6 m-20 67.49 50.04 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.418 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.683 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 2.8 m-30 -145.53 174.53 3.37 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.096 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.683 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 4.8 Cg_endo -45.7 -40.53 19.0 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.487 2.791 . . . . 0.0 114.904 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.815 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 36.9 Cg_endo -62.47 101.38 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.386 1.39 . . . . 0.0 111.26 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.542 HD23 ' O ' ' A' ' 150' ' ' PRO . 79.1 mt -139.23 123.61 18.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.734 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.736 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.6 OUTLIER -106.17 112.27 25.23 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.962 HD23 HG23 ' A' ' 140' ' ' ILE . 4.8 mt -94.18 158.92 15.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.33 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 19.4 mt-30 -146.12 24.67 1.29 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.522 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 58.26 -161.65 11.1 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.362 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 158' ' ' THR . . . 101.18 -3.94 55.17 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.742 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.682 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 3.4 t80 -61.39 107.48 0.78 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.984 0.421 . . . . 0.0 110.714 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.567 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 71.3 p -105.16 -50.83 3.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.173 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.575 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.08 -162.33 27.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.0 -1.095 . . . . 0.0 114.326 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.594 ' O ' HG23 ' A' ' 162' ' ' VAL . . . 116.26 169.43 15.41 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.92 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -61.97 126.67 28.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.934 0.367 . . . . 0.0 110.034 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.63 HG13 HD13 ' A' ' 135' ' ' LEU . 47.9 t -136.57 154.49 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 120.903 0.382 . . . . 0.0 111.793 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.487 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.6 OUTLIER -120.93 117.14 26.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.607 HG21 ' CD1' ' A' ' 176' ' ' LEU . 0.3 OUTLIER -118.72 140.79 41.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.939 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.709 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.5 OUTLIER -78.6 135.39 37.25 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.114 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.717 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -76.4 -44.62 16.41 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.061 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.469 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 3.2 m -49.1 164.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.918 0.39 . . . . 0.0 111.611 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.0 t 70.26 54.58 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.074 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.822 ' H ' HG11 ' A' ' 196' ' ' VAL . 6.4 m 59.86 154.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.934 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.455 ' HB3' ' CB ' ' A' ' 197' ' ' SER . 18.9 p -77.36 1.24 19.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.044 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.804 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 44.0 mm-40 -53.59 -23.27 10.37 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.874 0.368 . . . . 0.0 111.34 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.703 ' HA ' HD13 ' A' ' 129' ' ' LEU . 1.9 m-85 -76.43 -56.06 4.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.14 0.495 . . . . 0.0 110.572 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.576 HD13 HG11 ' A' ' 164' ' ' VAL . 37.4 tp -72.96 -41.04 64.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.309 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 38.2 m -55.94 -34.51 65.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.753 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.654 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -70.86 -50.87 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.108 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.914 ' CD2' HD23 ' A' ' 133' ' ' LEU . 1.4 mt -67.33 -38.07 84.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.609 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.018 HD22 HD21 ' A' ' 205' ' ' LEU . 8.9 mt -65.57 -25.29 67.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.686 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.803 ' HG2' HD21 ' A' ' 31' ' ' LEU . 9.8 mtp -96.64 -28.79 14.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.166 0.508 . . . . 0.0 111.031 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.826 HG21 ' O ' ' A' ' 104' ' ' ALA . 55.4 m -89.12 -46.19 9.01 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.815 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.749 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -60.74 -37.13 42.25 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.701 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.8 Cg_endo -53.15 -37.36 79.75 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 121.101 1.2 . . . . 0.0 111.967 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.48 -7.01 59.42 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.955 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -67.54 119.5 66.21 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.881 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 2.7 Cg_exo -37.47 -32.68 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.684 2.922 . . . . 0.0 114.417 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.81 151.8 23.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.056 0.455 . . . . 0.0 111.616 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.67 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 3.6 t0 -65.74 116.92 7.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.481 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.724 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 28.2 m -102.63 134.94 45.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.339 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 1.104 HG22 HG13 ' A' ' 224' ' ' VAL . 41.1 t -125.45 99.3 5.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.091 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.605 ' O ' ' N ' ' A' ' 223' ' ' PHE . 4.0 mt -90.4 143.56 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.311 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.822 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -115.01 171.25 7.77 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 177.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.822 HD13 ' C ' ' A' ' 190' ' ' ARG . 1.2 mm -110.9 97.27 5.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 120.969 0.414 . . . . 0.0 111.314 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 12.3 mtmt -61.14 -80.96 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.468 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -79.23 167.84 52.65 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.212 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.48 124.67 21.05 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.879 HD23 ' HA ' ' A' ' 198' ' ' LYS . 1.5 tp -59.35 146.36 40.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.105 0.478 . . . . 0.0 110.539 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.822 HG11 ' H ' ' A' ' 169' ' ' SER . 12.6 p -104.45 -18.66 6.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.203 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.713 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.6 OUTLIER -129.29 45.63 2.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.498 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.879 ' HA ' HD23 ' A' ' 195' ' ' LEU . 3.8 ttpt -41.98 -60.87 1.75 Allowed Pre-proline 0 N--CA 1.466 0.338 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.784 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 12.1 Cg_exo -70.7 -16.44 33.61 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 121.871 1.714 . . . . 0.0 111.786 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.834 ' HA ' HD12 ' A' ' 203' ' ' ILE . 14.4 m-85 -76.36 -26.27 55.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.715 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.891 HD11 HD12 ' A' ' 177' ' ' LEU . 7.2 tp -75.19 -31.47 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.744 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 5.0 t70 -61.9 -34.25 75.69 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.8 mt -67.23 -27.35 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.259 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.62 HG22 ' SD ' ' A' ' 208' ' ' MET . 42.1 m -60.86 -57.45 12.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.541 0.686 . . . . 0.0 109.615 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 1.018 HD21 HD22 ' A' ' 177' ' ' LEU . 19.2 mt -70.32 -32.04 69.61 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.539 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.685 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 1.5 m-20 -66.73 -30.62 70.89 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.677 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -75.72 -46.23 32.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.154 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.62 ' SD ' HG22 ' A' ' 204' ' ' THR . 18.6 mtp -62.67 -39.57 94.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.318 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.685 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -68.04 -41.89 81.39 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.003 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.544 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.4 OUTLIER -61.65 -28.15 69.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.126 0.489 . . . . 0.0 109.736 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.781 ' HA ' ' HG3' ' A' ' 234' ' ' PRO . 0.8 OUTLIER -76.04 -50.99 13.26 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.761 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 156.51 -1.59 0.14 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.283 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.574 HG13 ' CG ' ' A' ' 229' ' ' GLN . 61.1 t -117.54 139.05 46.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.968 0.413 . . . . 0.0 111.701 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -134.11 153.94 51.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.713 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.94 HD11 HD13 ' A' ' 205' ' ' LEU . 2.4 pp -131.81 175.16 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.611 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 1.006 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 30.5 tt0 -89.99 125.74 35.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.753 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -101.27 101.04 11.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.128 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.707 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -67.02 -166.18 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.472 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -76.14 48.36 0.5 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.888 0.375 . . . . 0.0 110.362 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.547 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.1 OUTLIER 57.28 21.21 6.45 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.135 -179.468 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 191' ' ' ILE . 22.5 tt0 -113.11 -22.77 10.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.517 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.796 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 14.5 mt-30 -147.37 140.26 24.99 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 1.005 ' HB3' HD21 ' A' ' 177' ' ' LEU . 24.6 m-85 -112.59 96.73 6.15 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 1.104 HG13 HG22 ' A' ' 188' ' ' VAL . 42.5 t -84.05 111.13 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.06 0.457 . . . . 0.0 111.199 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.936 HG12 HG21 ' A' ' 215' ' ' ILE . 3.6 m -99.71 116.75 43.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.142 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.672 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 3.0 mptt -62.64 103.99 0.48 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.127 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.67 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.05 154.33 19.32 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.98 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.6 8.56 76.83 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.367 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.672 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 64.2 mm-40 -71.6 -179.57 2.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.421 0.629 . . . . 0.0 111.184 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.673 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.2 m -170.43 105.71 0.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.688 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.672 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 22.8 m-85 -53.58 146.03 13.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.085 0.469 . . . . 0.0 111.309 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.611 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 90.2 mt-30 -110.93 153.19 25.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.58 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 27.5 p -78.07 103.06 1.13 Allowed Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.231 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.781 ' HG3' ' HA ' ' A' ' 211' ' ' PHE . 10.5 Cg_exo -73.86 -37.16 3.04 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.849 2.366 . . . . 0.0 111.577 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 128.8 -120.24 3.24 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.418 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.778 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -91.08 116.52 28.87 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.588 ' CE2' HD11 ' A' ' 207' ' ' LEU . 67.1 t80 -124.08 141.49 52.01 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.644 -0.422 . . . . 0.0 112.085 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.937 HD12 HG23 ' A' ' 42' ' ' THR . 6.5 tp -95.49 118.69 32.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.134 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.555 HG11 ' N ' ' A' ' 25' ' ' SER . 21.8 t -59.3 -70.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.101 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.464 ' HG2' HD22 ' A' ' 43' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.9 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.572 ' HB3' ' H ' ' A' ' 45' ' ' LEU . 1.4 p . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.6 0.238 . . . . 0.0 111.294 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.885 ' HA ' HD12 ' A' ' 29' ' ' LEU . 13.6 p30 -76.45 -22.34 54.72 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.93 0.395 . . . . 0.0 111.039 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.431 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 3.0 mtm105 -62.02 -51.06 69.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.399 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.937 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -65.87 -41.11 92.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.379 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.885 HD12 ' HA ' ' A' ' 26' ' ' ASN . 12.1 mt -59.8 -50.6 73.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 0.0 110.81 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.4 tp -69.12 -46.15 68.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.976 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.617 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 65.2 mt -61.01 -28.68 69.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.736 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.648 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . . . -77.11 -28.72 54.53 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.552 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.881 ' HB2' HD23 ' A' ' 57' ' ' LEU . . . -68.57 -31.12 70.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.875 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.893 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.82 -11.67 41.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.016 0.436 . . . . 0.0 110.883 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -79.85 167.77 20.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.764 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -101.31 98.92 9.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.595 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 114.63 142.18 7.83 Favored Glycine 0 C--N 1.314 -0.643 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.568 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.844 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 3.3 tttt -64.27 128.7 36.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.248 0.547 . . . . 0.0 111.938 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.51 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -123.6 160.9 26.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.06 178.773 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.705 HG22 ' HG3' ' A' ' 74' ' ' GLU . 91.9 t -110.99 140.78 28.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.32 . . . . 0.0 111.781 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.937 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -129.39 111.29 12.66 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.113 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.935 HG23 HD12 ' A' ' 238' ' ' LEU . 0.0 OUTLIER -96.04 172.14 8.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.188 0.518 . . . . 0.0 111.534 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.444 ' HB3' ' H ' ' A' ' 240' ' ' GLU . 0.1 OUTLIER 66.77 18.79 10.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.729 -178.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.955 HD22 HD11 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -58.73 164.43 2.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.868 179.078 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.572 ' H ' ' HB3' ' A' ' 25' ' ' SER . 27.7 tp -99.37 112.7 24.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.892 0.377 . . . . 0.0 111.721 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -71.69 68.14 0.59 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.555 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.455 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 12.8 t -129.48 -163.54 1.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.212 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.576 ' HA ' ' HE ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -98.59 -22.87 15.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.768 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.649 ' OD1' HG23 ' A' ' 50' ' ' VAL . 2.1 p30 -69.05 -26.02 64.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.727 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.649 HG23 ' OD1' ' A' ' 49' ' ' ASP . 24.0 t -88.07 -56.59 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.295 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.576 ' HE ' ' HA ' ' A' ' 48' ' ' ASP . 1.8 ptt180 -52.83 -24.41 8.95 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.197 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 55' ' ' ASN . 4.6 m-70 -75.52 -38.08 59.63 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.748 ' O ' HD12 ' A' ' 57' ' ' LEU . 8.6 tpt -60.27 -54.65 43.17 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.788 ' HA ' HD13 ' A' ' 57' ' ' LEU . 1.9 mp -59.34 -47.97 83.4 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.712 177.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.565 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -48.51 -30.71 5.49 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.639 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.883 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -69.17 -51.36 38.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.298 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.881 HD23 ' HB2' ' A' ' 33' ' ' ALA . 3.4 mp -60.12 -49.18 78.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.812 0.339 . . . . 0.0 110.636 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.616 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.8 t -53.8 -30.79 46.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.095 0.474 . . . . 0.0 110.24 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.691 ' CB ' HD21 ' A' ' 88' ' ' LEU . . . -60.37 -50.88 71.84 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.168 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.97 HD21 HD22 ' A' ' 106' ' ' LEU . 3.9 mp -65.84 -27.75 68.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.484 0.659 . . . . 0.0 110.131 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.92 -0.0 7.13 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 114.725 -1.125 . . . . 0.0 113.03 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 13.5 t -55.19 159.99 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 117.216 0.508 . . . . 0.0 110.47 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.569 ' HB2' HD12 ' A' ' 76' ' ' ILE . 3.3 m -122.22 109.52 14.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.623 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.698 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 10.1 p90 -126.57 158.98 34.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.607 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 25.1 m -150.64 116.83 5.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.658 0.266 . . . . 0.0 111.267 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.955 HD11 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -86.38 178.09 7.24 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.216 0.532 . . . . 0.0 111.748 -179.651 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.723 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -90.1 178.58 6.15 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.811 179.122 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.24 -11.88 45.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.596 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.4 1.45 11.79 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.876 0.37 . . . . 0.0 110.462 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.451 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 3.1 mtt85 61.57 43.27 10.25 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.84 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.494 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -124.05 -2.27 8.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.293 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.723 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -143.0 111.13 6.06 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.968 0.413 . . . . 0.0 109.937 179.001 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.752 ' SG ' HD22 ' A' ' 66' ' ' LEU . 1.6 t -113.17 155.92 24.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.705 ' HG3' HG22 ' A' ' 40' ' ' VAL . 5.9 mt-10 -119.76 102.94 8.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.964 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.844 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -102.32 129.26 54.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.569 HD12 ' HB2' ' A' ' 63' ' ' SER . 10.3 mt -82.16 102.3 7.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.351 178.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.635 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -48.43 111.97 1.04 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.771 -0.65 . . . . 0.0 113.681 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.646 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -57.2 -17.58 11.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 110.616 178.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.12 -22.36 19.39 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.446 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.893 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -139.96 -145.15 4.63 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.754 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 4.1 Cg_exo -79.15 168.24 20.68 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 121.969 1.779 . . . . 0.0 108.984 177.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.795 HD12 HD13 ' A' ' 60' ' ' LEU . 4.4 mm? -66.55 91.04 0.17 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.754 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 27.8 m170 -83.93 118.88 24.29 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 113.44 -1.709 . . . . 0.0 113.133 -175.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.846 ' HB3' HD11 ' A' ' 113' ' ' ILE . . . -148.84 110.58 4.52 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.898 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.4 87.88 2.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.59 0.233 . . . . 0.0 111.557 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -174.45 22.83 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.873 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 56.76 53.76 7.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.492 0.663 . . . . 0.0 110.096 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.703 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 5.2 tp -85.92 135.37 33.71 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.939 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.673 ' C ' HD23 ' A' ' 90' ' ' LEU . 4.0 tt0 -115.27 130.16 56.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.242 0.544 . . . . 0.0 110.689 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.883 HD13 ' HA ' ' A' ' 56' ' ' ALA . 3.5 mt -108.68 153.79 22.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.744 -178.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.468 ' CE1' ' CA ' ' A' ' 93' ' ' GLY . 53.8 t80 -118.52 106.59 12.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.817 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.842 HD23 ' HE2' ' A' ' 99' ' ' MET . 1.8 mm? -91.61 3.56 54.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.251 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.611 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 43.12 -140.34 2.59 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 116.207 -0.451 . . . . 0.0 113.625 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -93.54 52.03 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.07 0.462 . . . . 0.0 111.1 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -94.05 -75.51 0.5 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.376 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.97 -19.78 9.27 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.392 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.508 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -96.59 -9.56 29.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.772 0.32 . . . . 0.0 110.862 179.175 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.04 -19.99 5.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.773 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.842 ' HE2' HD23 ' A' ' 92' ' ' LEU . 9.7 ttm -70.72 -54.18 12.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.982 0.42 . . . . 0.0 111.164 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.774 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.2 mpt_? -57.72 -53.53 64.68 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.091 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.656 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 31.3 Cg_exo -59.3 -47.34 17.44 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.84 2.36 . . . . 0.0 113.135 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.68 HD11 HD12 ' A' ' 90' ' ' LEU . 3.0 tm? -66.67 -33.97 76.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.554 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.548 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -61.66 -47.37 85.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.464 0.649 . . . . 0.0 110.215 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.709 ' O ' HG21 ' A' ' 179' ' ' THR . . . -71.46 -37.33 71.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.749 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.522 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -57.14 -43.4 82.41 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.897 0.38 . . . . 0.0 111.393 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.97 HD22 HD21 ' A' ' 60' ' ' LEU . 1.7 mt -70.58 -23.11 62.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.41 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.491 ' C ' ' HA2' ' A' ' 155' ' ' GLY . 87.7 m -59.33 -11.11 3.68 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.019 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.728 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 12.6 mt -83.33 166.11 18.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.67 0.271 . . . . 0.0 110.318 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 54.56 -112.1 2.52 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.272 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.5 97.74 0.99 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 2.8 m120 -138.32 138.35 38.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.775 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.899 ' O ' HD13 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -104.1 110.41 22.58 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.58 178.667 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.899 HD13 ' O ' ' A' ' 112' ' ' ASP . 25.1 mm -136.66 143.38 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.528 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.654 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 19.4 t -115.33 113.42 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.548 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 17.6 mt -82.42 152.98 25.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.495 0.664 . . . . 0.0 112.325 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.615 HG22 ' O ' ' A' ' 90' ' ' LEU . 9.5 t -160.27 163.59 33.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.892 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -157.57 -167.54 18.72 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.647 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.611 ' HG2' ' HA2' ' A' ' 93' ' ' GLY . 8.4 mm-40 -67.67 172.98 3.29 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.846 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 33.0 Cg_exo -62.07 -23.8 75.99 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.364 2.043 . . . . 0.0 112.171 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.455 ' HD2' ' CG ' ' A' ' 123' ' ' GLU . 8.1 tpt180 -85.56 -39.47 17.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.836 0.35 . . . . 0.0 110.556 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.605 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 10.8 tpt -59.48 -20.18 53.34 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.651 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 20.6 mttt -68.8 -7.13 31.29 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.255 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.548 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 3.9 pt-20 -120.0 28.17 8.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.115 0.483 . . . . 0.0 110.728 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.415 ' HA ' ' NE ' ' A' ' 124' ' ' ARG . 6.5 mmp_? -103.51 112.97 65.94 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.582 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 24.8 Cg_exo -60.84 137.01 69.79 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.274 1.983 . . . . 0.0 112.023 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.676 HD12 ' HD2' ' A' ' 100' ' ' ARG . 17.3 tt -145.01 30.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.849 0.833 . . . . 0.0 109.966 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -77.0 -50.44 6.87 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 114.39 -1.277 . . . . 0.0 112.101 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.68 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.7 OUTLIER -57.26 -28.4 62.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.865 0.364 . . . . 0.0 110.668 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.9 ' CD1' HD21 ' A' ' 133' ' ' LEU . 20.6 tp -79.14 -63.85 1.32 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.859 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 1.051 HG13 HD12 ' A' ' 140' ' ' ILE . 60.6 t -55.28 -24.61 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.337 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.593 ' O ' HD12 ' A' ' 135' ' ' LEU . 0.4 OUTLIER -70.6 -45.2 65.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.352 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.841 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -65.81 -53.25 42.65 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.418 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.994 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -55.86 -44.23 77.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.101 0.477 . . . . 0.0 109.77 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.63 -38.99 75.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.449 179.267 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.841 HD12 ' HA ' ' A' ' 132' ' ' ALA . 2.4 mt -64.91 -30.6 71.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.436 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.487 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -78.22 -18.15 76.88 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.471 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.65 2.98 5.19 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.165 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.95 146.48 54.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.944 0.372 . . . . 0.0 111.248 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -114.75 88.72 2.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.241 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.051 HD12 HG13 ' A' ' 130' ' ' VAL . 6.3 mt -115.59 176.63 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.085 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.796 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -154.45 -174.92 5.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.919 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.607 ' N ' HG23 ' A' ' 141' ' ' THR . 20.1 m-85 -126.63 106.98 9.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.049 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.67 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.4 mm? -77.36 -18.65 57.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.389 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.652 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 1.7 mm-40 -134.71 -73.04 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.969 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.603 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -123.27 149.81 44.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.727 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.484 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 4.6 pt-20 -69.61 135.12 49.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.093 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 12.1 m-20 64.92 46.99 2.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.48 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.828 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 4.6 m-85 -144.08 176.64 2.15 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.111 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.828 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 10.3 Cg_endo -52.01 -39.89 68.78 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.131 2.554 . . . . 0.0 115.629 -177.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.652 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 19.7 Cg_endo -61.9 100.4 0.2 Allowed 'Trans proline' 0 CA--C 1.515 -0.458 0 C-N-CA 120.861 1.041 . . . . 0.0 110.944 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 150' ' ' PRO . 84.1 mt -137.05 123.89 21.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.817 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.767 ' HB3' HG22 ' A' ' 141' ' ' THR . 1.6 ttm180 -105.03 111.83 24.74 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 1.028 HD23 HG23 ' A' ' 140' ' ' ILE . 1.5 mt -94.98 160.12 14.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.684 -178.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.588 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 4.1 mt-30 -148.86 25.69 0.92 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.906 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.491 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 54.5 -166.45 2.44 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.477 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 109.84 -4.87 30.66 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.946 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.676 ' CD2' HG22 ' A' ' 179' ' ' THR . 2.3 t80 -60.89 106.99 0.64 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.783 0.325 . . . . 0.0 110.681 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' THR . . . . . 0.457 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 43.5 p -104.97 -48.65 3.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.639 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.53 -162.23 27.67 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 119.889 -1.148 . . . . 0.0 114.293 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' ' 162' ' ' VAL . . . 114.36 168.94 16.3 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 114.937 -0.632 . . . . 0.0 112.003 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -63.08 126.2 26.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.626 HG11 ' HB1' ' A' ' 132' ' ' ALA . 62.1 t -133.51 157.63 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.091 0.472 . . . . 0.0 111.578 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.478 ' N ' HG12 ' A' ' 162' ' ' VAL . 0.7 OUTLIER -124.31 116.12 22.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.891 179.267 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.851 HG11 HD13 ' A' ' 173' ' ' LEU . 0.3 OUTLIER -115.02 150.92 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.92 -179.005 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.68 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 2.7 t0 -89.83 127.36 35.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.667 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.712 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -70.16 -44.68 59.4 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.651 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.491 ' C ' HG23 ' A' ' 168' ' ' VAL . 1.4 m -50.91 164.76 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.837 0.351 . . . . 0.0 111.517 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.491 HG23 ' C ' ' A' ' 167' ' ' SER . 2.1 t 69.17 56.75 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 121.275 0.559 . . . . 0.0 111.112 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.807 ' H ' HG11 ' A' ' 196' ' ' VAL . 2.0 m 58.3 159.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.458 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.466 ' O ' HG22 ' A' ' 174' ' ' THR . 12.4 p -82.65 0.43 43.19 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.807 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.774 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 2.1 mp0 -51.12 -21.91 2.2 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.934 0.397 . . . . 0.0 111.049 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.553 ' O ' HD12 ' A' ' 176' ' ' LEU . 1.4 m-85 -78.96 -53.95 6.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.765 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.851 HD13 HG11 ' A' ' 164' ' ' VAL . 22.7 tp -74.71 -40.5 61.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.441 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 171' ' ' GLN . 13.6 t -57.96 -34.31 69.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -68.37 -51.12 47.83 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.497 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.994 ' CD2' HD23 ' A' ' 133' ' ' LEU . 2.6 mt -67.78 -37.0 81.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.541 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.992 HD11 ' CD2' ' A' ' 223' ' ' PHE . 8.2 mt -67.88 -24.63 65.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.075 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.525 ' HA ' ' OH ' ' A' ' 231' ' ' TYR . 13.5 ptp -98.92 -28.48 13.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.12 0.486 . . . . 0.0 110.811 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.709 HG21 ' O ' ' A' ' 104' ' ' ALA . 27.4 m -86.37 -46.22 10.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.991 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.879 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -60.94 -37.26 42.72 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.711 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 12.1 Cg_endo -54.54 -36.69 89.43 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 121.232 1.288 . . . . 0.0 111.797 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.686 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -85.16 -6.48 59.29 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.828 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -66.9 114.99 20.51 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.16 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -31.09 -36.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.073 3.182 . . . . 0.0 114.642 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -105.47 153.34 21.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.968 0.413 . . . . 0.0 111.797 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.684 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 1.3 t0 -63.92 118.27 8.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.568 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.711 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 61.4 m -104.16 133.75 48.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.056 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 1.008 HG22 HG13 ' A' ' 224' ' ' VAL . 35.3 t -125.43 99.63 6.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.252 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.1 mt -90.82 143.56 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.418 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.84 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -114.33 171.07 7.84 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.84 HD13 ' C ' ' A' ' 190' ' ' ARG . 1.1 mm -111.41 96.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 120.973 0.415 . . . . 0.0 111.17 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -60.83 -81.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.625 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.429 ' HA3' ' OD1' ' A' ' 165' ' ' ASP . . . -78.12 168.4 53.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.269 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -61.41 122.62 15.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.635 0.255 . . . . 0.0 110.856 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.81 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.8 OUTLIER -58.43 143.63 44.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.96 0.41 . . . . 0.0 110.577 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.807 HG11 ' H ' ' A' ' 169' ' ' SER . 13.1 p -103.58 -18.82 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.512 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.673 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.6 OUTLIER -126.6 45.62 2.64 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.489 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.81 ' HA ' HD23 ' A' ' 195' ' ' LEU . 0.4 OUTLIER -42.15 -60.44 2.07 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.196 -0.911 . . . . 0.0 113.122 -178.52 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 7.6 Cg_exo -72.68 -16.32 26.76 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 121.908 1.739 . . . . 0.0 111.987 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.739 ' HA ' HD12 ' A' ' 203' ' ' ILE . 16.5 m-85 -75.64 -29.91 59.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.255 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.92 HD11 HD12 ' A' ' 177' ' ' LEU . 6.2 tp -70.69 -35.64 61.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -59.35 -33.16 70.83 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.147 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.739 HD12 ' HA ' ' A' ' 200' ' ' TYR . 15.1 mt -67.71 -32.86 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.238 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.489 HG22 ' SD ' ' A' ' 208' ' ' MET . 52.4 m -57.44 -52.64 64.54 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.944 HD21 HD22 ' A' ' 177' ' ' LEU . 13.3 mt -73.82 -35.45 64.85 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.92 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 202' ' ' ASP . 0.7 OUTLIER -64.0 -28.03 69.53 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.171 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.617 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -79.17 -44.02 22.77 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.842 178.473 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.514 ' HG2' ' CZ ' ' A' ' 231' ' ' TYR . 22.4 mtp -65.0 -38.83 92.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.456 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.518 ' HG3' ' N ' ' A' ' 210' ' ' THR . 0.0 OUTLIER -65.21 -48.94 71.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.666 0.269 . . . . 0.0 110.64 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.518 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.5 OUTLIER -56.53 -29.28 61.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.278 0.561 . . . . 0.0 109.843 179.064 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.648 ' CE2' ' HA ' ' A' ' 32' ' ' ALA . 1.1 m-85 -71.48 -48.84 46.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.002 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.474 ' HA3' ' HG2' ' A' ' 232' ' ' GLN . . . 153.21 -4.84 0.36 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.114 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.64 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 73.4 t -120.19 140.78 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.09 0.472 . . . . 0.0 111.823 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -134.08 156.0 49.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.662 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.925 HG21 HG12 ' A' ' 225' ' ' VAL . 2.3 pp -132.75 175.72 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.891 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.986 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 41.3 tt0 -90.36 124.66 35.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.068 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -100.99 100.87 11.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.003 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.733 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 2.1 mm-40 -66.64 -166.72 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.612 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -74.74 48.58 0.37 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.884 0.373 . . . . 0.0 110.41 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.541 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 57.47 20.66 6.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 -179.515 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 191' ' ' ILE . 66.3 mt-30 -112.69 -21.55 11.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.738 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLN . . . . . 0.784 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 46.6 mt-30 -149.04 141.34 24.1 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.902 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.992 ' CD2' HD11 ' A' ' 177' ' ' LEU . 19.7 m-85 -113.32 96.53 5.95 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 1.008 HG13 HG22 ' A' ' 188' ' ' VAL . 48.4 t -83.9 111.15 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 120.797 0.332 . . . . 0.0 111.429 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.925 HG12 HG21 ' A' ' 215' ' ' ILE . 5.5 m -99.68 117.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.931 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.828 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -61.71 103.07 0.3 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.009 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.684 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -55.96 156.0 11.36 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.738 -0.665 . . . . 0.0 113.044 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.48 8.46 84.91 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.559 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' GLN . . . . . 0.828 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 97.5 mm-40 -71.05 -176.52 1.42 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.358 0.579 . . . . 0.0 110.781 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.686 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.5 m -177.1 104.91 0.06 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.39 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.64 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 21.2 m-85 -55.66 151.94 10.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.163 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' GLN . . . . . 0.673 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 9.2 pt20 -123.01 154.76 38.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.42 ' HA ' ' HD2' ' A' ' 234' ' ' PRO . 68.7 p -67.6 101.11 0.27 Allowed Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.673 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 59.5 Cg_endo -68.13 -27.94 34.97 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.656 2.237 . . . . 0.0 111.898 178.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.39 -125.26 6.53 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' THR . . . . . 0.535 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -92.0 116.54 29.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.626 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 63.5 t80 -124.73 143.2 50.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.331 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.935 HD12 HG23 ' A' ' 42' ' ' THR . 5.7 tp -96.6 118.23 32.65 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.145 0.498 . . . . 0.0 110.752 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 25' ' ' SER . 61.4 t -59.2 -83.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.038 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLU . . . . . 0.444 ' H ' ' HB3' ' A' ' 43' ' ' ASN . 4.0 tp10 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.927 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.464 0.236 0 N-CA-C 111.852 0.315 . . . . 2.1200000000000001 111.852 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -60.66 -47.17 87.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.078 0.466 . . . . 2.0299999999999998 110.214 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.87 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -69.46 -33.31 72.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.767 -0.651 . . . . 0.28000000000000003 110.768 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.733 HD21 HD23 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -61.23 -54.57 42.51 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.229 0.537 . . . . 0.96999999999999997 110.695 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' A' ' 105' ' ' ALA . 7.1 tp -66.79 -51.39 56.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.292 -0.867 . . . . 0.38 111.216 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 63.7 mt -54.64 -35.84 63.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.022 0.439 . . . . 0.39000000000000001 110.804 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.593 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -72.91 -29.97 63.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.673 -0.694 . . . . 0.16 110.787 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.649 ' CB ' HD21 ' A' ' 82' ' ' LEU . . . -71.48 -32.28 68.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.817 -0.628 . . . . 0.14000000000000001 111.592 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.812 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.74 -11.21 42.91 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.826 0.346 . . . . 0.13 111.111 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -80.93 163.19 23.52 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.041 -0.527 . . . . 0.14999999999999999 110.144 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.486 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 70.9 m80 -96.51 97.27 9.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.004 0.43 . . . . 0.17999999999999999 110.079 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.5 146.97 7.94 Favored Glycine 0 C--N 1.313 -0.712 0 C-N-CA 120.796 -0.716 . . . . 0.19 111.751 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -71.74 138.06 48.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.105 0.479 . . . . 2.29 111.654 -179.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.426 HG23 ' N ' ' A' ' 40' ' ' VAL . 0.6 OUTLIER -131.74 164.59 25.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.64 -0.709 . . . . 0.17000000000000001 110.165 179.316 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.813 HG22 ' CG ' ' A' ' 74' ' ' GLU . 88.9 t -110.43 142.7 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 111.911 0.337 . . . . 0.23000000000000001 111.911 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.87 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -130.18 110.67 11.76 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.834 -0.802 . . . . 0.45000000000000001 108.834 178.257 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.848 HG23 HD12 ' A' ' 238' ' ' LEU . 0.0 OUTLIER -100.55 169.56 8.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.112 0.482 . . . . 0.32000000000000001 111.568 -178.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.729 ' HB2' HD11 ' A' ' 238' ' ' LEU . 1.5 t30 67.24 21.09 10.02 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.629 -0.714 . . . . 1.04 110.703 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.78 HD22 HD11 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -60.14 154.69 18.94 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.555 -0.535 . . . . 0.28999999999999998 109.555 178.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.6 tp -91.27 114.3 26.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.93 0.395 . . . . 0.33000000000000002 111.418 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.414 ' OD2' ' HB2' ' A' ' 70' ' ' ARG . 9.6 t70 -73.72 77.74 1.55 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.973 -0.558 . . . . 2.0499999999999998 110.27 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -137.38 -163.88 1.5 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.875 -0.602 . . . . 1.1499999999999999 110.841 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.528 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 10.0 m-20 -96.91 -19.05 19.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.19 -0.459 . . . . 1.8600000000000001 111.076 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.457 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -73.01 -26.53 61.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.177 -0.465 . . . . 1.97 109.919 178.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.542 HG11 HD21 ' A' ' 44' ' ' LEU . 26.5 t -90.04 -52.42 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.813 -0.63 . . . . 0.22 111.45 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.528 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -53.07 -26.53 16.38 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.53 -0.468 . . . . 2.6000000000000001 110.558 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -73.4 -37.57 65.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.698 -0.683 . . . . 0.53000000000000003 109.637 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.448 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 5.4 tpt -65.0 -47.35 77.82 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.565 -0.902 . . . . 0.57999999999999996 108.565 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.733 HD23 HD21 ' A' ' 29' ' ' LEU . 1.1 mp -61.95 -47.13 86.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.611 -0.722 . . . . 0.33000000000000002 110.051 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.408 ' HA ' HG22 ' A' ' 58' ' ' THR . 0.9 OUTLIER -59.57 -28.17 66.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.111 0.481 . . . . 1.3899999999999999 109.979 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.701 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -68.73 -43.85 75.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.631 -0.713 . . . . 0.20999999999999999 111.965 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.59 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -71.87 -50.45 29.31 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.774 -0.37 . . . . 0.78000000000000003 110.768 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.473 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.9 t -52.16 -29.81 23.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.07 0.462 . . . . 0.23999999999999999 110.371 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.783 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.82 -45.0 93.73 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.57 -0.741 . . . . 0.20999999999999999 110.523 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.009 HD21 HD22 ' A' ' 106' ' ' LEU . 3.0 mp -74.87 -24.37 58.55 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.454 0.645 . . . . 0.22 109.952 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.4 0.24 5.85 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.004 -0.998 . . . . 0.23000000000000001 114.146 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.472 HG21 HD11 ' A' ' 82' ' ' LEU . 34.0 t -61.77 150.12 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 118.041 0.921 . . . . 0.20000000000000001 110.364 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.49 ' CB ' HG13 ' A' ' 76' ' ' ILE . 2.5 m -111.23 104.91 13.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.815 -0.629 . . . . 0.25 111.595 -178.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CE2' ' HB ' ' A' ' 58' ' ' THR . 6.7 p90 -117.83 159.14 23.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.148 -0.933 . . . . 0.37 110.946 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 3.5 m -152.65 114.84 4.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.39000000000000001 110.214 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.826 HD22 ' SG ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -84.19 178.7 7.7 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.997 0.427 . . . . 0.23000000000000001 110.735 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.0 t -94.33 -179.92 5.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.803 -0.635 . . . . 1.1100000000000001 110.946 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.02 -19.41 61.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.176 -0.466 . . . . 0.31 111.517 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.22 5.99 14.9 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.897 0.379 . . . . 1.5600000000000001 110.564 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.414 ' HB2' ' OD2' ' A' ' 46' ' ' ASP . 53.1 mtt-85 59.42 41.42 19.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.119 -0.491 . . . . 2.27 110.974 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.435 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -121.91 -0.03 9.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.651 -0.704 . . . . 0.28999999999999998 110.887 179.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.592 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -143.54 115.35 8.24 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.446 -0.576 . . . . 1.8999999999999999 109.446 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.826 ' SG ' HD22 ' A' ' 66' ' ' LEU . 1.4 t -120.99 150.2 41.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.7 -0.682 . . . . 0.26000000000000001 112.141 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.813 ' CG ' HG22 ' A' ' 40' ' ' VAL . 4.2 mt-10 -118.18 103.79 10.19 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.477 -0.934 . . . . 1.53 108.477 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.614 HG12 HD23 ' A' ' 29' ' ' LEU . 1.7 mp -99.19 126.74 52.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.567 0.699 . . . . 0.20000000000000001 112.661 -178.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.49 HG13 ' CB ' ' A' ' 63' ' ' SER . 0.9 OUTLIER -78.54 110.81 14.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.478 -1.237 . . . . 1.0700000000000001 111.233 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -54.32 112.8 2.86 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.799 -0.637 . . . . 0.17999999999999999 114.047 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.0 OUTLIER -61.86 -19.6 62.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.187 0.518 . . . . 1.3700000000000001 109.943 178.279 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.486 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 89.69 -23.21 20.84 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.611 -0.722 . . . . 0.16 112.671 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.812 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -136.92 -149.81 5.69 Favored Glycine 0 CA--C 1.507 -0.464 0 N-CA-C 109.998 -1.241 . . . . 0.14999999999999999 109.998 178.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.833 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 5.1 Cg_exo -78.71 164.43 25.67 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 CA-C-N 119.469 1.635 . . . . 0.13 109.163 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.84 HD12 HD13 ' A' ' 60' ' ' LEU . 3.7 mm? -63.36 93.95 0.08 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.816 1.294 . . . . 0.12 108.217 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.833 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 28.9 m170 -87.8 120.18 28.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 112.435 -2.166 . . . . 0.14999999999999999 112.928 -175.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.813 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -149.21 109.4 4.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.882 -0.599 . . . . 0.19 110.912 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -107.9 91.64 3.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.769 0.319 . . . . 1.51 111.139 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.98 19.94 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.544 -0.836 . . . . 0.28000000000000003 113.432 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.71 50.82 13.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.308 0.575 . . . . 0.28000000000000003 110.006 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.783 HD21 ' HB1' ' A' ' 59' ' ' ALA . 3.5 tp -77.12 136.03 38.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.315 -0.857 . . . . 0.37 110.959 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.778 ' N ' HD12 ' A' ' 88' ' ' LEU . 1.2 tt0 -116.6 127.46 54.49 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.158 0.504 . . . . 1.3500000000000001 110.395 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.701 HD13 ' HA ' ' A' ' 56' ' ' ALA . 50.8 mt -109.68 163.38 13.54 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.49 -0.777 . . . . 0.65000000000000002 112.655 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -125.56 106.68 9.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.897 -1.047 . . . . 0.47999999999999998 109.892 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.638 HD22 ' N ' ' A' ' 92' ' ' LEU . 1.2 mm? -93.2 6.05 49.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.176 -0.465 . . . . 0.83999999999999997 111.485 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 42.3 -141.42 1.7 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.051 -0.595 . . . . 0.28999999999999998 113.009 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -96.9 51.7 1.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.133 0.492 . . . . 1.5800000000000001 110.733 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -88.75 -73.71 0.49 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.811 -0.631 . . . . 0.33000000000000002 111.071 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.0 -18.93 13.61 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.002 -0.618 . . . . 0.33000000000000002 113.092 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.489 HG22 ' NE2' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -96.85 -9.21 29.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.807 0.337 . . . . 0.91000000000000003 110.658 179.09 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.63 -12.75 6.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.1 -0.5 . . . . 0.20999999999999999 111.523 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.526 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 4.6 ttm -79.36 -36.32 39.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.551 -0.295 . . . . 1.1200000000000001 111.458 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.526 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -77.95 -48.91 2.07 Favored Pre-proline 0 N--CA 1.45 -0.45 0 CA-C-O 120.503 0.192 . . . . 2.0 111.236 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 24.4 Cg_exo -64.18 -43.06 15.91 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.793 2.329 . . . . 0.27000000000000002 112.734 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.59 HD13 HD11 ' A' ' 106' ' ' LEU . 2.2 tm? -71.0 -30.37 66.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.996 -0.547 . . . . 0.19 111.168 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.62 -49.22 74.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.195 0.522 . . . . 0.17000000000000001 110.633 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.813 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -72.5 -34.75 67.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.366 0.876 . . . . 0.14000000000000001 113.366 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.646 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -57.76 -44.27 86.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.034 0.445 . . . . 0.12 111.968 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.009 HD22 HD21 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -71.0 -21.19 62.33 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.927 -0.579 . . . . 0.20999999999999999 112.01 -178.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.586 ' SG ' HD11 ' A' ' 140' ' ' ILE . 98.1 m -58.26 -12.56 3.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.938 -0.574 . . . . 0.25 111.73 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.689 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 9.8 mt -80.62 167.85 19.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.695 0.283 . . . . 0.20999999999999999 110.638 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 50.16 -110.83 0.96 Allowed Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.08 -0.581 . . . . 0.16 112.559 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.436 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.1 OUTLIER -162.37 102.47 1.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.797 0.332 . . . . 0.70999999999999996 110.3 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 1.4 m-20 -138.84 135.97 35.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 1.5900000000000001 111.243 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.508 ' C ' HD12 ' A' ' 113' ' ' ILE . 4.6 m-20 -102.79 109.48 21.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.052 -0.522 . . . . 1.26 109.813 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.701 HG23 ' O ' ' A' ' 88' ' ' LEU . 5.2 mp -143.39 140.85 26.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.499 -0.319 . . . . 0.56000000000000005 111.249 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 17.5 t -112.2 112.7 41.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.767 -0.457 . . . . 0.22 109.767 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.516 HD22 HD21 ' A' ' 92' ' ' LEU . 31.8 mt -81.02 158.62 25.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.383 0.611 . . . . 0.25 111.91 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.3 m -160.84 162.98 32.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.99 -1.005 . . . . 1.01 110.219 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.21 -165.39 13.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.885 -1.15 . . . . 0.25 113.7 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.515 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 0.8 OUTLIER -71.74 175.86 2.66 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.26 -0.47 . . . . 1.5700000000000001 111.134 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 32.1 Cg_exo -60.47 -37.29 82.03 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.337 2.025 . . . . 0.48999999999999999 112.436 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.531 HH11 ' CG ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -76.3 -36.98 58.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.765 0.317 . . . . 2.23 110.796 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.533 ' HA ' ' HG3' ' A' ' 124' ' ' ARG . 7.5 tpt -58.59 -22.31 55.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.80000000000000004 110.21 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.503 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 2.9 mmtt -63.64 -10.38 18.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.05 -0.523 . . . . 1.8100000000000001 111.97 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.597 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 4.4 pt-20 -121.22 28.2 7.96 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.638 -0.425 . . . . 1.9199999999999999 111.539 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.533 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 1.2 mmp_? -101.39 95.05 4.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.195 -0.457 . . . . 2.6299999999999999 110.725 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.7 Cg_endo -47.43 129.03 15.78 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.732 2.288 . . . . 0.44 112.2 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.649 HD11 HD23 ' A' ' 129' ' ' LEU . 19.9 tt -138.35 31.48 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.745 0.783 . . . . 0.26000000000000001 110.143 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -74.93 -49.49 9.9 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.633 -1.167 . . . . 0.20999999999999999 112.668 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.486 ' HE1' HG21 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -53.65 -33.0 53.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.825 0.345 . . . . 0.25 110.5 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.823 ' CD1' HD21 ' A' ' 133' ' ' LEU . 25.9 tp -76.48 -62.84 1.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 0.17999999999999999 110.165 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.783 HG13 HD12 ' A' ' 140' ' ' ILE . 94.2 t -51.94 -26.89 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 0.17999999999999999 111.604 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 2.7 t0 -71.93 -45.46 61.08 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.27 0.47 . . . . 1.4299999999999999 112.27 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.857 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -63.82 -54.19 38.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.863 0.363 . . . . 0.14999999999999999 111.129 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.904 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -55.12 -44.78 75.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.343 0.592 . . . . 0.20999999999999999 109.547 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -57.76 -40.11 78.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.133 -0.94 . . . . 2.7799999999999998 110.314 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.857 HD12 ' HA ' ' A' ' 132' ' ' ALA . 3.1 mt -63.93 -32.93 74.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.23000000000000001 110.686 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.437 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -76.53 -13.81 83.08 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.489 -0.862 . . . . 0.14000000000000001 112.929 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 127.05 4.46 5.99 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.54 -0.838 . . . . 0.14999999999999999 113.192 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.98 150.41 45.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.878 0.371 . . . . 0.14999999999999999 111.51 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -116.35 96.76 5.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 2.3500000000000001 111.317 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.783 HD12 HG13 ' A' ' 130' ' ' VAL . 10.6 mt -124.41 168.39 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.088 0.47 . . . . 0.19 111.403 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.686 HG22 ' HB3' ' A' ' 152' ' ' ARG . 0.4 OUTLIER -150.36 174.4 12.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.699 -0.682 . . . . 0.31 110.603 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.543 ' CD2' ' HA ' ' A' ' 146' ' ' GLU . 23.6 m-85 -116.61 107.91 15.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.709 -0.849 . . . . 0.32000000000000001 108.709 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.632 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.3 mm? -75.25 -23.46 57.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.886 -0.597 . . . . 0.34000000000000002 112.074 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.7 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 2.5 mt-10 -129.53 -67.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.745 -0.382 . . . . 2.1899999999999999 110.977 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.75 ' HB2' ' HD2' ' A' ' 148' ' ' TYR . 53.6 mt-30 -125.63 157.82 36.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.091 0.472 . . . . 2.73 111.774 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.543 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 47.4 mt-10 -75.31 131.46 40.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.676 . . . . 2.0099999999999998 110.826 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 16.6 m-20 67.46 44.3 1.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 1.3400000000000001 111.822 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.75 ' HD2' ' HB2' ' A' ' 145' ' ' GLN . 7.8 m-30 -140.55 164.26 37.93 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.353 -0.385 . . . . 0.72999999999999998 110.65 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.549 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 6.3 Cg_exo -37.73 -44.12 1.57 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 124.146 3.231 . . . . 0.28000000000000003 115.38 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.7 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 24.3 Cg_endo -61.41 95.18 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 121.202 1.268 . . . . 0.23000000000000001 111.041 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 94.4 mt -132.41 123.29 26.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.534 -0.757 . . . . 0.19 111.71 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.686 ' HB3' HG22 ' A' ' 141' ' ' THR . 1.4 ttm180 -101.7 110.83 22.89 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.221 -1.029 . . . . 2.5899999999999999 108.221 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.727 ' CD1' HD12 ' A' ' 106' ' ' LEU . 2.0 mt -92.93 158.27 15.91 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.768 0.318 . . . . 0.17000000000000001 111.21 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 6.4 mt-30 -146.17 22.77 1.36 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.146 -0.479 . . . . 1.3400000000000001 110.712 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.471 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 56.35 -167.16 3.92 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.501 -0.856 . . . . 0.14999999999999999 112.193 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 158' ' ' THR . . . 110.94 -4.29 28.85 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.532 -0.842 . . . . 0.16 112.814 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.644 ' CD2' HG22 ' A' ' 179' ' ' THR . 2.0 t80 -62.43 110.54 1.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.922 0.391 . . . . 0.64000000000000001 111.141 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.547 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 71.5 p -109.49 -50.67 2.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.20000000000000001 110.573 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.475 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 145.98 -161.91 28.31 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.276 -0.964 . . . . 0.19 113.58 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 162' ' ' VAL . . . 113.88 168.82 16.62 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 111.738 -0.545 . . . . 0.16 111.738 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.9 129.71 43.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.88 0.34 . . . . 1.21 110.323 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.747 HG11 ' HB1' ' A' ' 132' ' ' ALA . 61.4 t -136.56 156.99 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 120.932 0.396 . . . . 0.16 111.131 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.447 ' N ' HG12 ' A' ' 162' ' ' VAL . 1.1 m-20 -127.9 116.51 20.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.421 -0.585 . . . . 1.1000000000000001 109.421 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.433 HG21 ' CD1' ' A' ' 176' ' ' LEU . 0.5 OUTLIER -118.73 145.86 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 120.392 -0.523 . . . . 0.17999999999999999 112.278 -178.415 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 1.8 t70 -85.07 130.28 34.64 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.87 -0.605 . . . . 1.25 110.215 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.626 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -72.1 -45.34 41.3 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.799 -0.715 . . . . 0.14999999999999999 113.507 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.35 160.97 0.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.116 0.484 . . . . 1.0900000000000001 112.06 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.486 HG21 ' HE1' ' A' ' 128' ' ' HIS . 9.4 t 71.73 59.59 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 115.649 -0.705 . . . . 0.23999999999999999 111.06 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.841 ' N ' HG11 ' A' ' 196' ' ' VAL . 15.3 m 60.81 154.03 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.871 -0.604 . . . . 0.70999999999999996 110.722 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 3.8 t -82.82 1.8 37.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 1.3200000000000001 111.007 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 66.5 mm-40 -56.92 -21.0 26.45 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.543 -0.299 . . . . 1.8999999999999999 110.816 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.448 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 3.9 m-85 -71.88 -61.83 1.64 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.107 0.479 . . . . 0.20999999999999999 110.332 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.764 HD23 HG12 ' A' ' 201' ' ' ILE . 64.4 tp -68.77 -33.32 73.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.664 -0.698 . . . . 0.20999999999999999 109.768 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.577 ' O ' ' CG ' ' A' ' 178' ' ' MET . 52.5 m -59.76 -33.56 71.83 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.593 -0.731 . . . . 1.02 109.951 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.813 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -71.64 -45.07 63.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.23999999999999999 111.692 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.904 ' CD2' HD23 ' A' ' 133' ' ' LEU . 1.6 mt -72.84 -31.11 64.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.145 -0.48 . . . . 0.19 110.435 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.855 HD21 ' HB3' ' A' ' 223' ' ' PHE . 10.4 mt -66.78 -28.13 68.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.957 -0.565 . . . . 0.16 111.553 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.577 ' CG ' ' O ' ' A' ' 174' ' ' THR . 0.0 OUTLIER -98.75 -29.44 13.0 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 120.13 -0.628 . . . . 1.4099999999999999 110.43 179.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.701 HG21 ' O ' ' A' ' 104' ' ' ALA . 83.0 m -81.79 -46.14 14.61 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.637 -0.711 . . . . 0.17999999999999999 111.521 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.856 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -60.17 -40.9 81.24 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 113.286 0.847 . . . . 0.14999999999999999 113.286 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.5 Cg_endo -54.39 -35.57 84.93 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.426 1.418 . . . . 0.14999999999999999 112.545 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.99 -11.74 54.79 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.862 0.363 . . . . 0.19 110.478 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.547 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -61.64 124.21 80.24 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.97 -0.559 . . . . 0.23999999999999999 109.788 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.1 -32.95 5.21 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.917 2.412 . . . . 0.28000000000000003 113.77 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -103.81 154.68 19.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.105 0.478 . . . . 1.75 111.431 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.488 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 12.4 t0 -67.39 122.54 18.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.603 -0.726 . . . . 1.3799999999999999 110.505 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.55 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 24.3 m -107.69 136.31 47.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.247 -0.433 . . . . 0.14999999999999999 111.435 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 1.055 HG22 HG13 ' A' ' 224' ' ' VAL . 45.4 t -126.5 97.93 4.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.979 -0.555 . . . . 0.13 110.053 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.561 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.4 mt -89.43 143.87 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-N 116.124 -0.489 . . . . 0.12 110.03 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.811 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -114.64 170.7 8.12 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.153 -1.054 . . . . 2.6800000000000002 108.153 177.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.811 HD13 ' C ' ' A' ' 190' ' ' ARG . 0.9 OUTLIER -111.05 96.44 4.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 C-N-CA 120.767 -0.373 . . . . 0.14999999999999999 111.126 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -59.09 -80.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.965 -0.561 . . . . 1.47 110.662 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -81.24 167.18 48.95 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.838 -0.696 . . . . 0.17000000000000001 112.567 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.15 126.22 26.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.641 0.258 . . . . 2.04 110.777 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.626 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.4 OUTLIER -61.49 144.1 54.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.987 0.423 . . . . 0.20000000000000001 110.18 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.841 HG11 ' N ' ' A' ' 169' ' ' SER . 14.5 p -100.48 -17.96 6.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.04 -0.527 . . . . 0.23000000000000001 111.541 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.555 ' CB ' ' HB2' ' A' ' 200' ' ' TYR . 0.1 OUTLIER -131.51 46.7 2.62 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.541 -0.754 . . . . 0.66000000000000003 109.847 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.734 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.3 OUTLIER -40.0 -59.58 1.74 Allowed Pre-proline 0 N--CA 1.466 0.37 0 CA-C-N 115.453 -0.794 . . . . 1.3700000000000001 113.051 -178.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 59.3 Cg_endo -71.24 -16.04 31.59 Favored 'Trans proline' 0 CA--C 1.516 -0.402 0 C-N-CA 121.987 1.791 . . . . 0.45000000000000001 112.762 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.555 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 28.3 m-85 -79.23 -27.77 42.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.416 -0.356 . . . . 0.77000000000000002 110.332 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.764 HG12 HD23 ' A' ' 173' ' ' LEU . 7.7 tp -69.96 -31.44 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.19 110.259 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.4 OUTLIER -63.05 -32.21 73.53 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.643 -0.503 . . . . 1.3200000000000001 109.643 178.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 200' ' ' TYR . 31.1 mt -67.76 -31.08 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.804 -0.634 . . . . 0.31 110.356 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.423 HG22 ' SD ' ' A' ' 208' ' ' MET . 42.0 m -60.65 -52.3 65.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.692 -0.485 . . . . 0.20999999999999999 109.692 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.841 HD22 HG12 ' A' ' 215' ' ' ILE . 41.1 mt -70.95 -35.12 72.07 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.958 -0.565 . . . . 0.22 110.557 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 202' ' ' ASP . 1.6 t30 -63.86 -30.7 71.77 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 109.529 -0.545 . . . . 1.22 109.529 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.672 HD21 ' OH ' ' A' ' 237' ' ' TYR . 0.3 OUTLIER -76.69 -42.79 40.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.59999999999999998 109.373 178.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.475 ' SD ' HD23 ' A' ' 205' ' ' LEU . 30.4 mtp -64.89 -45.95 83.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.16 -0.927 . . . . 0.63 111.255 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 210' ' ' THR . 0.0 OUTLIER -60.46 -44.17 96.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.438 -0.346 . . . . 2.23 110.759 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 207' ' ' LEU . 0.5 OUTLIER -57.89 -31.71 67.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.147 0.499 . . . . 0.56999999999999995 109.88 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.584 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 1.6 m-85 -71.86 -51.54 21.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.488 -0.778 . . . . 0.40999999999999998 110.857 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 158.27 -4.82 0.14 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.522 -0.846 . . . . 0.23999999999999999 113.497 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.483 HG13 ' CG ' ' A' ' 229' ' ' GLN . 78.1 t -120.31 139.11 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.429 0.529 . . . . 0.20000000000000001 112.429 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -131.14 156.28 45.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.649 -0.705 . . . . 1.3300000000000001 110.568 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.965 HG21 HG12 ' A' ' 225' ' ' VAL . 1.8 pp -129.23 177.17 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 115.485 -0.78 . . . . 0.23999999999999999 111.782 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.85 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 2.8 tt0 -92.38 126.2 37.36 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.827 0.346 . . . . 1.8400000000000001 110.479 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -101.9 99.65 9.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.162 0.506 . . . . 2.2599999999999998 110.403 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.666 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 1.4 mm-40 -66.85 -166.35 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.652 -0.704 . . . . 1.6000000000000001 109.419 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.29 49.16 0.35 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.407 -0.36 . . . . 2.3199999999999998 110.611 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.479 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 56.7 20.05 4.79 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.016 0.436 . . . . 0.34000000000000002 110.926 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 191' ' ' ILE . 54.6 mt-30 -111.66 -24.24 10.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 1.96 110.106 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.738 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 41.2 mt-30 -146.63 140.93 26.39 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 120.979 0.418 . . . . 1.6200000000000001 111.168 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.855 ' HB3' HD21 ' A' ' 177' ' ' LEU . 19.6 m-85 -111.31 96.17 5.96 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.616 -0.883 . . . . 0.17000000000000001 108.616 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 1.055 HG13 HG22 ' A' ' 188' ' ' VAL . 52.1 t -86.36 110.76 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.042 0.448 . . . . 0.14999999999999999 110.935 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.965 HG12 HG21 ' A' ' 215' ' ' ILE . 7.4 m -103.03 120.71 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.662 -0.699 . . . . 0.16 111.669 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -62.89 112.59 2.63 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.497 -0.774 . . . . 1.6100000000000001 109.797 178.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.488 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -66.55 151.3 52.24 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.159 -0.928 . . . . 0.20000000000000001 113.039 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.77 10.63 62.87 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.591 -0.814 . . . . 0.26000000000000001 113.473 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.483 ' CG ' HG13 ' A' ' 213' ' ' VAL . 75.0 mm-40 -73.2 -175.42 1.85 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.34 0.591 . . . . 1.1299999999999999 110.992 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.658 ' HA ' HD23 ' A' ' 182' ' ' LEU . 1.2 m -176.6 103.25 0.06 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.273 -0.876 . . . . 0.28000000000000003 109.813 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 27.4 m-85 -54.73 152.24 7.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.196 -0.457 . . . . 0.33000000000000002 111.261 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.62 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 16.6 pt20 -122.13 154.25 37.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.06 -0.719 . . . . 2.0 109.06 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 9.5 t -64.97 102.93 0.37 Allowed Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 112.404 0.52 . . . . 1.1599999999999999 112.404 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.62 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 58.2 Cg_endo -68.93 -33.15 20.59 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.284 1.989 . . . . 0.5 111.466 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 121.54 -123.7 5.57 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.697 -0.683 . . . . 0.23999999999999999 111.645 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.549 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -91.38 117.38 29.62 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.83 -0.433 . . . . 0.39000000000000001 109.83 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.672 ' OH ' HD21 ' A' ' 207' ' ' LEU . 62.5 t80 -122.75 144.65 49.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.859 0.361 . . . . 1.1100000000000001 111.674 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.848 HD12 HG23 ' A' ' 42' ' ' THR . 25.0 tp . . . . . 0 N--CA 1.451 -0.39 0 CA-C-N 116.293 -0.412 . . . . 1.1100000000000001 110.651 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.584 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 7.5 p30 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.981 0.419 . . . . 0.0 111.027 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -65.57 -40.3 92.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.789 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.799 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -79.04 -36.46 40.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.993 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.776 HD21 HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -60.39 -51.63 68.66 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.922 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.555 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 2.4 tp -70.07 -43.21 71.63 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.891 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.494 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 48.6 mt -61.02 -35.9 78.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.005 0.431 . . . . 0.0 110.738 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.692 ' HA ' ' CE1' ' A' ' 211' ' ' PHE . . . -71.06 -29.97 66.0 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.737 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.757 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -70.08 -30.62 67.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.542 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.912 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -89.39 -11.29 43.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.902 0.382 . . . . 0.0 111.102 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.627 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.45 165.57 20.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.212 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.524 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 75.7 m80 -99.07 98.68 9.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.967 0.413 . . . . 0.0 110.079 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.6 141.51 6.88 Favored Glycine 0 C--N 1.315 -0.637 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.162 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.911 ' HB2' HD13 ' A' ' 76' ' ' ILE . 13.6 tttt -62.6 132.83 53.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.085 0.469 . . . . 0.0 111.78 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.484 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.7 OUTLIER -128.22 152.71 47.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.917 178.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.871 HG22 ' HG2' ' A' ' 74' ' ' GLU . 58.5 t -100.85 141.2 17.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.021 0.439 . . . . 0.0 111.925 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.799 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -126.93 110.95 13.55 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.039 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.741 HG23 HD12 ' A' ' 238' ' ' LEU . 0.2 OUTLIER -101.99 166.94 10.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.121 0.486 . . . . 0.0 111.467 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 71' ' ' THR . 2.1 t30 70.6 19.35 6.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.879 -177.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.982 HD22 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -60.89 156.52 17.24 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.414 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.546 ' HB3' HG21 ' A' ' 50' ' ' VAL . 16.8 tp -93.71 115.65 28.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.0 0.428 . . . . 0.0 111.617 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -76.37 64.49 2.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.439 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.515 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.3 OUTLIER -124.8 -159.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.063 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.731 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -97.39 -21.07 17.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.988 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.64 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 4.0 p-10 -72.77 -27.39 61.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.268 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.546 HG21 ' HB3' ' A' ' 45' ' ' LEU . 13.3 t -88.46 -51.99 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.368 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.731 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 2.1 ptm180 -51.21 -28.53 11.62 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.209 0.528 . . . . 0.0 109.924 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . 2.9 m-70 -71.5 -39.82 70.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.246 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.652 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 3.0 tpt -62.54 -50.1 72.67 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.776 HD23 HD21 ' A' ' 29' ' ' LEU . 1.1 mt -60.01 -52.98 63.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.785 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.8 m120 -54.22 -22.86 12.65 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.851 178.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.747 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -74.4 -48.11 29.83 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.597 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.635 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -72.06 -49.9 32.82 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.145 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.545 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 7.2 t -50.85 -30.88 15.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.158 0.504 . . . . 0.0 110.286 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.771 ' HB1' HD11 ' A' ' 88' ' ' LEU . . . -59.61 -49.5 77.5 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.958 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.915 HD21 HD22 ' A' ' 106' ' ' LEU . 3.6 mp -67.47 -28.46 67.88 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.584 0.707 . . . . 0.0 109.825 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.53 -0.24 5.47 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.537 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.591 HG21 HD11 ' A' ' 82' ' ' LEU . 13.8 t -58.7 147.97 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 117.491 0.645 . . . . 0.0 110.343 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.44 ' CB ' HG13 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -111.69 107.65 16.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.636 -178.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.652 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 6.8 p90 -122.7 160.52 25.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.157 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -149.31 116.41 6.03 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.662 179.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.982 HD11 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -86.52 174.09 9.17 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.228 0.537 . . . . 0.0 111.735 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.512 ' CB ' ' HG3' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -85.16 178.55 7.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.634 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.23 -14.79 53.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.091 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.95 2.93 12.8 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.003 0.43 . . . . 0.0 110.239 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.516 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 1.3 mtm-85 62.51 47.5 5.0 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.121 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -127.05 -2.54 6.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.271 179.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -141.27 109.75 5.96 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.899 ' SG ' HD22 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -114.41 147.67 38.89 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.255 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.871 ' HG2' HG22 ' A' ' 40' ' ' VAL . 7.2 mt-10 -114.62 102.52 10.11 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.742 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -95.27 131.93 40.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.911 HD13 ' HB2' ' A' ' 38' ' ' LYS . 8.6 mm -80.53 104.34 8.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.807 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.659 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -51.31 112.85 1.94 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.512 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.614 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.2 m-20 -59.61 -17.18 31.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.969 0.414 . . . . 0.0 110.378 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.524 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 88.08 -22.49 18.54 Favored Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.281 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.912 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -139.13 -143.22 4.39 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.803 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 6.2 Cg_exo -80.52 171.12 15.09 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 121.95 1.767 . . . . 0.0 109.319 177.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.867 ' HB2' HD23 ' A' ' 106' ' ' LEU . 4.3 mm? -69.78 90.68 0.6 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.803 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 35.5 m170 -83.08 119.54 24.61 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.281 -1.781 . . . . 0.0 112.749 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.687 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -143.54 106.76 4.54 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.334 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -105.09 86.73 2.49 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.346 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.62 23.41 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.897 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 53.93 51.02 15.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.526 0.679 . . . . 0.0 109.75 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.771 HD11 ' HB1' ' A' ' 59' ' ' ALA . 3.1 tp -80.88 137.33 36.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.252 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.62 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 3.3 tt0 -115.68 129.93 56.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.272 0.558 . . . . 0.0 110.766 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.763 HD12 HD11 ' A' ' 102' ' ' LEU . 4.3 mt -105.99 154.75 20.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.378 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -120.21 107.26 12.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.862 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.643 HD23 ' HE2' ' A' ' 99' ' ' MET . 1.6 mm? -93.33 3.47 55.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.378 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.461 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 40.53 -143.57 0.6 Allowed Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.166 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.478 ' OD1' ' HB3' ' A' ' 120' ' ' ARG . 1.0 OUTLIER -92.04 50.58 1.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.985 0.421 . . . . 0.0 110.88 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.64 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -92.34 -73.79 0.54 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.923 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.51 -17.46 14.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.465 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.44 ' HA ' ' OE1' ' A' ' 171' ' ' GLN . 6.0 p -96.59 -9.16 29.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.845 0.355 . . . . 0.0 111.271 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.411 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -128.02 -13.64 5.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.695 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.643 ' HE2' HD23 ' A' ' 92' ' ' LEU . 3.4 ttm -73.7 -54.8 7.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.082 0.467 . . . . 0.0 111.033 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.781 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -58.98 -50.8 86.03 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.475 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.754 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 28.2 Cg_exo -63.14 -47.18 8.62 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.721 2.28 . . . . 0.0 112.863 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.027 HD13 HD11 ' A' ' 106' ' ' LEU . 2.0 tm? -65.24 -37.74 88.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.754 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.598 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -60.3 -48.35 82.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.441 0.638 . . . . 0.0 110.077 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.991 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -66.09 -41.47 90.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.519 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.517 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -59.1 -39.36 81.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.389 . . . . 0.0 112.041 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.027 HD11 HD13 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -73.3 -21.14 60.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.849 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.665 ' SG ' HD11 ' A' ' 140' ' ' ILE . 10.8 m -63.86 -6.37 5.81 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.453 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.727 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 7.2 mt -85.13 168.5 14.77 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.554 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 56.11 -113.44 4.06 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.607 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.418 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.1 OUTLIER -167.9 94.18 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.972 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.607 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 44.4 p-10 -138.54 145.21 40.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.833 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.55 ' C ' HD12 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -102.83 111.65 24.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.808 179.361 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.686 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 5.0 mp -141.2 143.59 27.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.235 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 41.2 t -115.59 113.62 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 120.67 0.272 . . . . 0.0 110.615 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.598 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 25.2 mt -81.89 156.82 24.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.428 0.632 . . . . 0.0 111.767 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.418 ' O ' ' HE3' ' A' ' 99' ' ' MET . 1.6 m -163.76 166.66 21.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.587 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -154.36 -166.11 14.66 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 119.928 -1.13 . . . . 0.0 113.708 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.656 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 11.7 mm-40 -69.48 173.17 4.22 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.46 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.656 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 24.3 Cg_endo -61.56 -24.48 78.1 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.979 1.786 . . . . 0.0 112.173 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.57 ' HD3' ' HG2' ' A' ' 123' ' ' GLU . 4.1 tpp180 -88.05 -33.47 18.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.536 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.505 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 9.2 tpt -59.96 -17.68 39.82 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.613 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 12.2 mttm -68.93 -5.51 21.84 Favored 'General case' 0 C--N 1.334 -0.09 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.57 ' HG2' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -119.09 22.62 11.78 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.141 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.439 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 17.0 mmm180 -102.24 86.73 0.94 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.766 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.796 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 4.4 Cg_endo -47.02 134.42 18.37 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.918 2.412 . . . . 0.0 112.581 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.89 HD11 HD23 ' A' ' 129' ' ' LEU . 21.4 tt -135.78 32.22 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.79 0.805 . . . . 0.0 109.682 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -70.99 -51.6 17.95 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.612 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.676 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -58.85 -29.55 67.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.767 0.318 . . . . 0.0 110.447 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.89 HD23 HD11 ' A' ' 126' ' ' ILE . 29.6 tp -76.76 -61.03 2.11 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.964 HG13 HD12 ' A' ' 140' ' ' ILE . 61.9 t -57.06 -25.62 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.653 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -70.42 -45.42 65.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.584 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.892 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -66.1 -46.89 76.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.915 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.832 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.1 OUTLIER -60.43 -46.33 90.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.97 -38.1 72.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.549 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.892 HD12 ' HA ' ' A' ' 132' ' ' ALA . 3.8 mt -66.71 -32.31 73.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.271 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.476 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -76.09 -16.82 80.42 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.555 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 127.6 5.47 5.43 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.309 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.44 148.48 41.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.83 0.348 . . . . 0.0 111.439 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -117.2 94.04 4.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.391 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.964 HD12 HG13 ' A' ' 130' ' ' VAL . 14.1 mt -116.95 174.73 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.93 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.752 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.6 OUTLIER -153.17 -175.19 5.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.043 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.581 ' N ' HG23 ' A' ' 141' ' ' THR . 25.8 m-85 -125.35 106.87 10.15 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.675 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.2 mm? -79.91 -13.58 59.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.751 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 45.8 mt-10 -142.98 -71.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.062 0.458 . . . . 0.0 110.896 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.751 ' HB3' ' CD2' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -113.48 147.37 37.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.647 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.472 ' O ' ' CD2' ' A' ' 148' ' ' TYR . 2.2 mt-10 -76.68 131.97 39.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.47 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.796 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 82.5 m-20 62.84 48.97 3.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.125 0.488 . . . . 0.0 109.72 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.805 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 50.5 m-85 -147.44 176.2 2.33 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.503 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.805 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 2.3 Cg_endo -44.25 -43.4 13.28 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.518 2.812 . . . . 0.0 115.461 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.751 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 30.5 Cg_endo -61.94 101.29 0.22 Allowed 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 121.539 1.493 . . . . 0.0 111.751 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.623 HD11 HG21 ' A' ' 126' ' ' ILE . 91.0 mt -138.72 123.62 18.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.622 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.744 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.0 OUTLIER -104.63 112.3 25.33 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 176.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.811 HD23 HG23 ' A' ' 140' ' ' ILE . 1.2 mt -94.49 156.15 16.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.434 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.607 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 19.1 mt-30 -142.91 27.22 1.65 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.752 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 107' ' ' CYS . . . 53.86 -165.29 2.34 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.595 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 158' ' ' THR . . . 106.77 -5.15 36.86 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.901 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.648 ' CD2' HG22 ' A' ' 179' ' ' THR . 3.2 t80 -60.53 108.01 0.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 0.0 110.668 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.502 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 68.3 p -107.53 -47.24 3.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.006 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.59 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 141.26 -159.91 26.74 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 119.976 -1.107 . . . . 0.0 114.175 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.528 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 114.82 175.47 18.6 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.47 128.01 34.85 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.579 HG11 ' HB1' ' A' ' 132' ' ' ALA . 59.4 t -137.34 151.26 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.966 0.412 . . . . 0.0 111.858 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.44 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 1.9 m-20 -118.27 116.51 26.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.113 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.678 HG11 HD13 ' A' ' 173' ' ' LEU . 0.3 OUTLIER -118.04 144.82 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.754 -179.319 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.676 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.2 OUTLIER -83.75 138.0 33.47 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.638 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -80.05 -44.84 8.68 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.355 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.14 164.04 0.08 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.808 0.337 . . . . 0.0 111.189 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.552 HG21 ' HE1' ' A' ' 128' ' ' HIS . 4.0 t 70.73 56.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.83 ' H ' HG11 ' A' ' 196' ' ' VAL . 53.2 m 59.25 156.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.192 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 48.5 p -80.28 -0.9 38.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.165 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.781 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 77.3 mm-40 -52.8 -23.72 7.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.759 0.314 . . . . 0.0 111.278 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.659 ' HA ' HD13 ' A' ' 129' ' ' LEU . 3.8 m-85 -71.55 -54.27 11.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.033 0.444 . . . . 0.0 110.447 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.937 HD23 HG12 ' A' ' 201' ' ' ILE . 18.8 tp -78.02 -35.86 49.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.391 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.531 HG23 ' OG1' ' A' ' 204' ' ' THR . 92.3 m -55.65 -37.01 67.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.165 0.507 . . . . 0.0 109.69 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.991 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -71.56 -51.44 23.45 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.411 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.832 ' CD2' HD23 ' A' ' 133' ' ' LEU . 3.1 mt -65.41 -35.8 82.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.458 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.915 HD12 HD11 ' A' ' 201' ' ' ILE . 10.6 mt -66.53 -28.8 68.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.115 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.497 ' HA ' ' OH ' ' A' ' 231' ' ' TYR . 5.9 ptp -95.32 -27.53 15.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.169 0.509 . . . . 0.0 110.958 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.712 HG21 ' O ' ' A' ' 104' ' ' ALA . 80.3 m -87.44 -46.44 9.61 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.131 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.897 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -63.02 -36.29 23.88 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.726 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.5 Cg_endo -53.24 -36.91 79.66 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 121.28 1.32 . . . . 0.0 111.8 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.716 HD23 ' HA ' ' A' ' 230' ' ' SER . 0.9 OUTLIER -84.22 -10.83 57.38 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.655 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -64.49 119.52 57.52 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.747 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 3.4 Cg_exo -41.09 -29.67 0.55 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.478 2.785 . . . . 0.0 114.291 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.32 153.36 22.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.17 0.51 . . . . 0.0 111.59 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.624 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 6.0 t70 -67.28 116.6 8.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.84 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.763 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 26.3 m -102.87 135.65 44.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.295 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.965 HG22 HG13 ' A' ' 224' ' ' VAL . 39.4 t -126.13 99.16 5.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.147 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.59 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.0 mt -90.87 142.0 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.238 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.807 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.3 OUTLIER -112.99 171.14 7.72 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.807 HD13 ' C ' ' A' ' 190' ' ' ARG . 1.0 OUTLIER -110.59 97.42 5.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.918 0.39 . . . . 0.0 111.339 -178.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.498 ' HG2' ' HE ' ' A' ' 190' ' ' ARG . 15.1 mtmt -57.15 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.651 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.428 ' O ' HG22 ' A' ' 191' ' ' ILE . . . -82.58 170.44 50.28 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.216 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.08 124.17 20.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.61 0.243 . . . . 0.0 110.604 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.687 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.4 OUTLIER -58.48 144.88 40.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.995 0.426 . . . . 0.0 110.461 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.83 HG11 ' H ' ' A' ' 169' ' ' SER . 14.8 p -101.13 -20.57 5.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.79 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.733 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -128.39 46.19 2.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.376 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.78 ' O ' HG22 ' A' ' 201' ' ' ILE . 5.5 ttpt -40.44 -62.11 1.02 Allowed Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.825 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 59.1 Cg_endo -70.21 -16.44 35.67 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 121.586 1.524 . . . . 0.0 112.209 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.733 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 14.6 m-85 -75.74 -30.11 59.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.234 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.937 HG12 HD23 ' A' ' 173' ' ' LEU . 7.3 tp -68.28 -33.83 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.026 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.24 -31.27 68.92 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.673 HD12 ' HA ' ' A' ' 200' ' ' TYR . 20.7 mt -70.44 -30.77 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.236 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.531 ' OG1' HG23 ' A' ' 174' ' ' THR . 24.2 m -59.25 -55.1 39.16 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.766 HD21 HD22 ' A' ' 177' ' ' LEU . 21.7 mt -71.26 -35.73 71.51 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.296 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.755 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 58.4 m-20 -64.35 -28.67 69.86 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.669 ' HB2' ' O ' ' A' ' 203' ' ' ILE . 0.1 OUTLIER -76.55 -44.41 34.96 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.862 177.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.488 ' HB3' ' HE1' ' A' ' 231' ' ' TYR . 9.5 mtp -66.8 -41.09 88.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.449 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.755 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 17.1 pttt -61.07 -43.79 98.36 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.712 0.291 . . . . 0.0 110.337 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.646 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.6 OUTLIER -59.59 -29.68 68.14 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.692 ' CE1' ' HA ' ' A' ' 32' ' ' ALA . 1.3 m-85 -72.94 -50.78 21.49 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.504 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.428 ' HA3' ' HG2' ' A' ' 232' ' ' GLN . . . 153.98 -7.69 0.4 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.53 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.638 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 65.4 t -118.92 140.34 43.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.434 ' HG2' ' HB3' ' A' ' 209' ' ' LYS . 37.6 mt-10 -135.58 156.65 48.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.625 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 1.064 HG21 HG12 ' A' ' 225' ' ' VAL . 1.8 pp -127.77 175.3 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.94 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.885 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 6.4 tp10 -88.8 126.33 35.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.645 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -102.87 101.17 11.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.033 0.444 . . . . 0.0 110.573 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.74 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.7 OUTLIER -65.33 -166.64 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.453 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -73.37 49.02 0.26 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.842 0.353 . . . . 0.0 110.537 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.576 ' CZ ' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 57.48 19.81 5.55 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.129 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 191' ' ' ILE . 2.2 mt-30 -112.98 -21.42 11.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.826 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.769 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 23.9 mt-30 -149.17 140.11 22.87 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.967 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.894 ' HB3' HD21 ' A' ' 177' ' ' LEU . 27.5 m-85 -112.36 98.53 7.35 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.965 HG13 HG22 ' A' ' 188' ' ' VAL . 58.6 t -84.55 110.79 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 121.222 0.534 . . . . 0.0 111.283 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 1.064 HG12 HG21 ' A' ' 215' ' ' ILE . 3.4 m -98.75 115.31 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.964 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.692 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -64.59 103.53 0.69 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.895 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.624 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.99 153.81 25.1 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.935 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.07 10.75 62.21 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.492 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.692 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 6.7 mm-40 -77.21 -179.15 5.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.223 0.535 . . . . 0.0 110.791 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.716 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.1 m -174.5 105.03 0.1 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.993 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.639 ' HD2' ' HB2' ' A' ' 34' ' ' LEU . 35.0 m-85 -55.52 151.85 9.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.706 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 16.7 pt20 -119.66 159.44 24.44 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.419 ' HA ' ' HD2' ' A' ' 234' ' ' PRO . 51.6 p -75.48 98.35 0.24 Allowed Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.706 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 52.8 Cg_endo -65.88 -32.73 44.93 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.497 2.131 . . . . 0.0 112.011 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 122.45 -121.14 4.56 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.678 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.3 OUTLIER -92.56 116.88 29.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 63.6 t80 -122.54 138.6 54.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.53 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.741 HD12 HG23 ' A' ' 42' ' ' THR . 3.6 tp . . . . . 0 CA--C 1.513 -0.461 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.173 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.456 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 18.5 p30 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.902 0.382 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.522 ' O ' HD12 ' A' ' 31' ' ' LEU . 3.0 mtt180 -62.48 -38.8 91.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.651 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.851 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -78.55 -34.76 46.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.241 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.838 HD21 HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -62.3 -53.24 58.03 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.996 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 4.7 tp -67.77 -45.3 75.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.521 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.684 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 38.6 mt -58.97 -34.82 72.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.325 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.674 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -75.41 -30.06 59.96 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.729 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.802 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -69.67 -32.57 71.27 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.611 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.893 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -87.77 -12.12 46.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.006 0.432 . . . . 0.0 110.804 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.624 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.0 163.71 21.94 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.73 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.538 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 75.0 m80 -97.44 97.07 8.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.86 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.34 144.6 7.38 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.018 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.753 ' HB2' HD13 ' A' ' 76' ' ' ILE . 16.2 tttt -66.6 134.8 53.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.076 0.465 . . . . 0.0 111.975 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.548 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -128.85 154.87 46.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.766 178.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.034 HG22 ' HG2' ' A' ' 74' ' ' GLU . 54.5 t -101.87 141.64 17.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.789 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.851 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -127.12 111.45 14.02 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.751 HG23 HD12 ' A' ' 238' ' ' LEU . 0.5 OUTLIER -104.7 167.4 9.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.156 0.503 . . . . 0.0 111.719 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.614 ' HB2' HD11 ' A' ' 238' ' ' LEU . 0.3 OUTLIER 67.45 20.47 9.85 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.794 -177.248 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.78 HD22 HD11 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -59.08 157.24 10.54 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.565 178.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.567 ' HB3' HG21 ' A' ' 50' ' ' VAL . 28.9 tp -95.32 114.3 26.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.122 0.487 . . . . 0.0 111.704 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -73.6 59.34 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.13 0.49 . . . . 0.0 110.53 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.438 ' OG ' HD23 ' A' ' 45' ' ' LEU . 36.8 p -115.87 -162.69 0.85 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.087 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.685 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 42.5 m-20 -97.94 -22.8 16.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.491 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -73.34 -24.01 60.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.228 0.537 . . . . 0.0 110.0 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 45' ' ' LEU . 19.2 t -89.02 -55.2 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.103 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.685 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -51.3 -29.47 15.01 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 109.842 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -71.12 -37.87 72.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.892 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.605 ' HE1' HD22 ' A' ' 30' ' ' LEU . 9.3 tpt -63.83 -51.15 66.0 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.838 HD23 HD21 ' A' ' 29' ' ' LEU . 1.2 mp -62.04 -47.46 84.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.674 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -56.25 -26.1 50.28 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.336 179.076 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.826 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -74.18 -46.31 42.92 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.631 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.612 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -68.27 -49.6 59.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.818 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.545 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 7.2 t -49.74 -31.47 11.47 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.204 0.526 . . . . 0.0 109.888 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.755 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.7 -52.36 65.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.093 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.016 HD21 HD22 ' A' ' 106' ' ' LEU . 4.1 mp -65.42 -28.63 69.38 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.524 0.678 . . . . 0.0 110.035 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.92 -1.23 6.26 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.758 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.654 HG21 HD11 ' A' ' 82' ' ' LEU . 22.8 t -56.27 152.81 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 117.639 0.72 . . . . 0.0 110.069 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.515 ' CB ' HG13 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -114.28 108.68 17.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.005 -179.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.667 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 9.1 p90 -126.95 156.95 40.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 32.1 m -150.33 116.62 5.7 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.68 0.276 . . . . 0.0 111.078 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.78 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -85.62 177.44 7.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.197 0.522 . . . . 0.0 111.63 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.79 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 3.6 t -88.02 178.82 6.56 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.993 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.91 -12.72 39.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.584 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -117.71 2.61 12.29 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.866 0.365 . . . . 0.0 110.667 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.471 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 10.9 mtt180 61.35 44.5 9.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.355 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -126.56 -2.6 6.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.562 179.446 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.79 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -141.21 110.25 6.19 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.741 ' SG ' HD22 ' A' ' 66' ' ' LEU . 3.0 t -114.75 149.88 36.21 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 1.034 ' HG2' HG22 ' A' ' 40' ' ' VAL . 43.7 mt-10 -115.85 102.85 10.07 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.693 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.6 mp -96.11 132.61 39.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.1 0.476 . . . . 0.0 111.995 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.753 HD13 ' HB2' ' A' ' 38' ' ' LYS . 15.1 mm -82.12 107.5 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.944 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.674 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -54.07 112.61 2.67 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.684 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.615 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -61.33 -17.06 51.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.973 0.416 . . . . 0.0 110.519 178.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.538 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 86.76 -21.63 17.98 Favored Glycine 0 C--O 1.228 -0.248 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.41 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.893 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.62 -144.88 4.7 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.809 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 6.2 Cg_exo -79.96 168.44 19.03 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 121.858 1.705 . . . . 0.0 109.289 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.802 HD21 ' HB3' ' A' ' 33' ' ' ALA . 4.2 mm? -66.89 90.56 0.18 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.809 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 29.7 m170 -82.48 118.75 23.47 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.073 -1.876 . . . . 0.0 112.858 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.69 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -144.42 111.29 5.77 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.793 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -114.02 90.8 3.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.77 0.319 . . . . 0.0 111.524 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.03 22.6 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.736 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.7 52.28 11.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.453 0.644 . . . . 0.0 109.777 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.755 HD21 ' HB1' ' A' ' 59' ' ' ALA . 4.5 tp -82.71 130.53 35.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.256 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.652 ' N ' HD12 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -111.87 129.85 56.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.915 0.388 . . . . 0.0 110.519 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.826 HD13 ' HA ' ' A' ' 56' ' ' ALA . 16.3 mt -114.04 154.39 27.78 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.478 ' CE1' ' HA2' ' A' ' 93' ' ' GLY . 43.9 t80 -121.01 102.26 8.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.642 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.921 HD23 ' HE1' ' A' ' 99' ' ' MET . 2.0 mm? -89.09 8.39 30.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.893 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.558 ' CA ' ' HG3' ' A' ' 118' ' ' GLU . . . 45.23 -142.91 3.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.898 -0.667 . . . . 0.0 113.203 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.488 ' ND2' ' HB3' ' A' ' 120' ' ' ARG . 16.6 t-20 -94.05 51.58 1.53 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.866 0.365 . . . . 0.0 111.081 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.15 -73.13 0.53 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.115 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.45 -16.38 18.83 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.073 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.454 ' HA ' ' CD ' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -95.15 -8.23 36.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.328 . . . . 0.0 111.103 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.436 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -127.46 -17.6 4.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.708 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.921 ' HE1' HD23 ' A' ' 92' ' ' LEU . 41.4 tpp -67.65 -54.72 17.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.097 0.475 . . . . 0.0 110.76 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.815 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -59.22 -53.37 66.94 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.474 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.685 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 31.3 Cg_exo -60.35 -47.15 15.18 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.731 2.287 . . . . 0.0 112.831 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.745 ' CD1' HD11 ' A' ' 106' ' ' LEU . 3.4 tm? -69.34 -38.92 78.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.553 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.431 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -60.92 -47.79 84.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.485 0.66 . . . . 0.0 109.988 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.912 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -68.17 -36.42 79.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.847 -1.069 . . . . 0.0 113.23 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.554 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -61.75 -44.21 97.34 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.016 HD22 HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -69.74 -19.96 63.52 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.56 -179.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.543 ' SG ' HD11 ' A' ' 140' ' ' ILE . 56.6 m -60.06 -11.52 6.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.169 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.745 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 7.7 mt -84.17 168.92 15.34 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 52.66 -108.96 0.8 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.374 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.405 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 11.3 p -166.93 100.86 0.55 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.689 0.281 . . . . 0.0 110.497 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 9.7 m-20 -138.3 136.82 36.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.119 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.721 ' C ' HD12 ' A' ' 113' ' ' ILE . 4.5 m-20 -101.42 111.21 23.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.476 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.723 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.3 mp -142.55 141.76 27.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.324 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.931 HG22 ' HG2' ' A' ' 152' ' ' ARG . 10.5 t -112.31 114.15 46.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.59 HD22 HD21 ' A' ' 92' ' ' LEU . 59.5 mt -87.35 156.74 19.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.551 0.691 . . . . 0.0 112.288 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 117' ' ' GLY . 0.6 OUTLIER -159.03 175.25 13.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.071 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.413 ' H ' HG22 ' A' ' 116' ' ' THR . . . -164.15 -168.5 26.31 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 119.902 -1.142 . . . . 0.0 114.253 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.745 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 36.5 mt-10 -67.7 174.8 1.98 Allowed Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 122.877 0.471 . . . . 0.0 110.453 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.745 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 24.1 Cg_endo -61.39 -38.44 64.25 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.988 1.792 . . . . 0.0 112.267 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 123' ' ' GLU . 15.0 tpp85 -76.88 -30.07 56.05 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.276 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.682 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 11.2 tpt -65.0 -11.59 40.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.205 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.752 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 10.4 mttt -76.33 -6.53 51.96 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.661 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 9.9 pt-20 -121.62 23.37 10.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.973 0.416 . . . . 0.0 111.166 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.446 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 5.1 mmp_? -96.94 94.75 1.89 Allowed Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.541 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.675 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 10.3 Cg_endo -53.66 123.09 12.53 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.499 2.133 . . . . 0.0 112.572 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.653 ' O ' HG23 ' A' ' 130' ' ' VAL . 13.3 tt -127.82 32.07 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.617 0.723 . . . . 0.0 110.225 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -74.3 -49.98 11.04 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.479 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.829 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -52.1 -28.42 17.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.047 0.451 . . . . 0.0 110.656 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.734 ' CD1' HD21 ' A' ' 133' ' ' LEU . 15.8 tp -82.37 -65.44 1.01 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.546 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 1.014 HG13 HD12 ' A' ' 140' ' ' ILE . 47.8 t -51.1 -28.23 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.179 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 13.0 t70 -68.43 -45.93 71.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.496 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 1.038 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -66.5 -48.78 68.72 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.817 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -58.34 -43.08 88.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.36 0.6 . . . . 0.0 109.684 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.53 -33.88 73.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.698 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 1.038 HD12 ' HA ' ' A' ' 132' ' ' ALA . 3.4 mt -69.79 -31.12 68.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.991 0.424 . . . . 0.0 110.266 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.558 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -77.79 -17.12 79.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.379 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.78 3.98 5.33 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.141 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.25 147.24 48.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 111.105 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 1.9 mmtp -113.94 91.22 3.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.454 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.014 HD12 HG13 ' A' ' 130' ' ' VAL . 8.1 mt -116.45 174.63 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.784 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -151.49 -167.15 2.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.144 0.497 . . . . 0.0 111.187 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.743 ' N ' HG23 ' A' ' 141' ' ' THR . 24.4 m-85 -136.17 99.1 4.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.929 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.585 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.4 mm? -68.25 -13.07 61.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.584 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.765 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 40.1 mm-40 -142.0 -73.8 0.31 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.069 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.5 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -120.43 150.09 41.34 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.145 0.498 . . . . 0.0 111.526 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.487 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 16.6 pt-20 -68.21 128.0 34.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.258 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.675 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 8.3 m-20 68.73 51.58 0.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.248 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.809 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.0 m-30 -145.17 177.29 1.82 Allowed Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.809 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 4.5 Cg_endo -48.08 -43.38 30.82 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.026 2.484 . . . . 0.0 114.974 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.765 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 27.8 Cg_endo -62.4 100.95 0.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 120.989 1.126 . . . . 0.0 111.276 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.598 HD11 HG21 ' A' ' 126' ' ' ILE . 61.8 mt -136.97 123.32 20.68 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.412 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.931 ' HG2' HG22 ' A' ' 114' ' ' VAL . 2.8 mtp180 -103.93 112.11 24.95 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.892 HD23 HG23 ' A' ' 140' ' ' ILE . 1.7 mt -93.83 158.75 15.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.318 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.588 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 28.2 mt-30 -149.44 22.66 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.079 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.503 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 53.68 -166.87 1.71 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.707 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 109.29 -2.23 31.15 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.957 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.677 ' CD2' HG22 ' A' ' 179' ' ' THR . 2.5 t80 -60.38 108.21 0.78 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.943 0.372 . . . . 0.0 110.949 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.516 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 68.5 p -105.09 -49.29 3.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.054 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.649 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 142.43 -163.58 27.13 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.168 -1.015 . . . . 0.0 114.019 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.509 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 116.7 172.56 16.42 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -65.29 128.32 35.36 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 117.245 0.523 . . . . 0.0 109.732 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.608 HG11 ' HB1' ' A' ' 132' ' ' ALA . 59.5 t -135.9 157.35 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.149 0.5 . . . . 0.0 111.31 -178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.478 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.7 OUTLIER -125.34 117.94 24.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.518 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.966 HG11 HD13 ' A' ' 173' ' ' LEU . 0.5 OUTLIER -117.91 147.19 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.945 -178.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.829 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.2 OUTLIER -85.77 133.04 34.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.613 178.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.713 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -74.52 -44.67 26.14 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.304 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.506 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 0.2 OUTLIER -49.8 163.15 0.14 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.915 0.388 . . . . 0.0 111.805 -179.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.655 HG21 ' HE1' ' A' ' 128' ' ' HIS . 8.2 t 71.27 61.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.844 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.709 ' N ' HG11 ' A' ' 196' ' ' VAL . 0.2 OUTLIER 54.56 156.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.468 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.491 ' HG ' ' HG1' ' A' ' 174' ' ' THR . 6.7 t -79.61 2.21 23.28 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.877 0.37 . . . . 0.0 110.891 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.815 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 82.6 mm-40 -54.05 -24.14 16.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.328 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.55 ' CD2' ' HB2' ' A' ' 128' ' ' HIS . 2.1 m-85 -73.71 -58.48 3.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.352 0.596 . . . . 0.0 110.587 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.966 HD13 HG11 ' A' ' 164' ' ' VAL . 18.0 tp -72.25 -37.29 69.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.861 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.617 HG23 ' OG1' ' A' ' 204' ' ' THR . 66.8 m -57.29 -36.47 71.09 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.241 0.543 . . . . 0.0 109.772 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.912 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -71.76 -51.28 23.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.25 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.817 ' CD2' HD23 ' A' ' 133' ' ' LEU . 3.2 mt -64.12 -38.53 91.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.466 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.07 HD12 HD11 ' A' ' 201' ' ' ILE . 12.5 mt -65.61 -26.55 67.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.07 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.497 ' HA ' ' HH ' ' A' ' 231' ' ' TYR . 20.2 ptp -96.16 -27.03 15.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.175 0.512 . . . . 0.0 110.637 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.677 HG22 ' CD2' ' A' ' 157' ' ' PHE . 65.5 m -86.26 -47.0 9.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.795 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 1.009 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -61.56 -38.49 52.04 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 9.2 Cg_endo -53.57 -35.98 78.9 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 121.28 1.32 . . . . 0.0 111.895 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.721 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.68 -9.25 58.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.676 -179.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -65.75 123.95 86.16 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.935 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 1.5 Cg_endo -43.58 -31.26 3.09 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.333 2.688 . . . . 0.0 113.993 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -106.02 153.46 21.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.137 0.494 . . . . 0.0 111.879 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.701 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 75.5 m-20 -67.03 113.15 4.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.78 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.797 ' HB ' HG23 ' A' ' 225' ' ' VAL . 41.1 m -99.6 135.18 41.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.167 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 1.042 HG22 HG13 ' A' ' 224' ' ' VAL . 35.3 t -125.83 99.0 5.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.324 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.576 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.5 mt -89.58 144.17 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.462 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.813 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -114.21 170.93 7.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.842 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.4 mm -110.65 96.35 4.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 120.858 0.361 . . . . 0.0 111.007 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -59.33 -81.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.483 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -81.43 167.8 49.29 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.164 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.94 122.97 16.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.555 0.217 . . . . 0.0 110.546 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.839 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.8 OUTLIER -56.24 148.2 19.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.228 0.537 . . . . 0.0 110.535 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.709 HG11 ' N ' ' A' ' 169' ' ' SER . 13.8 p -105.81 -21.78 5.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.225 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.698 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -126.65 47.42 2.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.848 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.1 OUTLIER -44.1 -65.15 0.64 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.904 -178.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.567 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 43.0 Cg_endo -65.6 -18.18 58.55 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 121.545 1.497 . . . . 0.0 111.542 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.82 ' HA ' HD12 ' A' ' 203' ' ' ILE . 13.3 m-85 -73.81 -30.03 62.49 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.561 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 1.07 HD11 HD12 ' A' ' 177' ' ' LEU . 8.0 tp -69.55 -33.32 56.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.422 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.3 OUTLIER -60.9 -35.5 76.84 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.82 HD12 ' HA ' ' A' ' 200' ' ' TYR . 15.8 mt -65.93 -30.27 49.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.62 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.617 ' OG1' HG23 ' A' ' 174' ' ' THR . 45.0 m -60.99 -55.76 29.14 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 1.038 HD21 HD22 ' A' ' 177' ' ' LEU . 35.5 mt -70.25 -33.71 71.96 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.473 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.537 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -66.14 -29.44 69.74 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.724 HD23 HG22 ' A' ' 203' ' ' ILE . 0.7 OUTLIER -77.08 -44.92 28.81 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.115 178.371 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.498 ' SD ' HG22 ' A' ' 204' ' ' THR . 12.7 mtp -64.62 -42.61 95.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.2 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.619 ' HG3' ' N ' ' A' ' 210' ' ' THR . 4.4 ptmt -61.53 -46.08 91.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.64 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.619 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.3 OUTLIER -59.11 -29.57 67.47 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.807 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 0.8 OUTLIER -70.76 -49.67 44.22 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.485 179.277 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 155.63 -7.52 0.28 Allowed Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.337 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.724 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 49.3 t -119.18 141.82 37.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.409 ' HG3' ' HA ' ' A' ' 209' ' ' LYS . 9.6 mt-10 -135.59 155.67 50.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.401 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 1.011 HG21 HG12 ' A' ' 225' ' ' VAL . 2.3 pp -129.1 175.87 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.754 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.916 -177.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 1.014 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 7.2 tp10 -88.74 125.2 34.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.529 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -101.53 101.02 11.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.424 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.845 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.6 OUTLIER -66.77 -168.14 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.499 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -74.37 48.42 0.33 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.816 0.341 . . . . 0.0 110.427 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.625 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 58.14 20.13 6.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.036 0.446 . . . . 0.0 111.252 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 191' ' ' ILE . 3.8 mt-30 -112.23 -20.52 11.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.77 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.845 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 17.6 mt-30 -151.2 140.87 21.74 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.901 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.969 ' HB3' HD21 ' A' ' 177' ' ' LEU . 11.0 m-85 -113.19 98.99 7.48 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 1.042 HG13 HG22 ' A' ' 188' ' ' VAL . 45.9 t -84.71 110.89 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.143 0.497 . . . . 0.0 111.25 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 1.011 HG12 HG21 ' A' ' 215' ' ' ILE . 3.2 m -99.02 111.61 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.927 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.738 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.6 OUTLIER -62.02 101.21 0.2 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.035 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.701 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -55.94 155.85 11.56 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.402 -0.817 . . . . 0.0 113.029 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.34 10.92 63.35 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.326 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.738 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 81.6 mm-40 -78.06 -177.67 5.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.444 0.64 . . . . 0.0 111.327 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.721 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.7 m -175.87 104.75 0.08 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.212 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.724 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 24.8 m-85 -54.11 152.44 6.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.825 0.345 . . . . 0.0 111.118 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.807 ' HG2' ' O ' ' A' ' 211' ' ' PHE . 7.5 pt20 -122.68 155.7 35.87 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 35.2 t -69.26 100.42 0.26 Allowed Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 56.9 Cg_endo -67.8 -32.75 28.95 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.387 2.058 . . . . 0.0 111.76 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 123.4 -119.01 3.69 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.962 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.666 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.8 OUTLIER -96.69 117.32 30.75 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.564 ' CE2' HD11 ' A' ' 207' ' ' LEU . 52.7 t80 -121.53 135.3 55.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.013 -178.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.751 HD12 HG23 ' A' ' 42' ' ' THR . 8.7 tp . . . . . 0 CA--C 1.515 -0.366 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.582 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.691 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 4.4 p30 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.899 0.38 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.417 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 52.0 mtt180 -67.96 -42.05 81.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.868 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -74.68 -32.98 62.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.827 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -62.07 -48.82 78.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.186 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.561 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 17.0 tp -73.93 -43.93 56.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.453 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.759 HD21 ' HG2' ' A' ' 178' ' ' MET . 61.8 mt -59.89 -31.9 70.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.109 0.48 . . . . 0.0 110.899 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.686 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -78.6 -30.66 46.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.595 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.839 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -69.37 -32.12 70.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.62 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.913 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -88.74 -12.28 42.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.145 0.497 . . . . 0.0 110.966 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.642 ' HB2' ' HB2' ' A' ' 231' ' ' TYR . . . -80.43 166.17 21.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.409 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.494 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 78.6 m80 -101.21 97.83 8.3 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.14 142.28 6.77 Favored Glycine 0 C--N 1.315 -0.611 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.828 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.663 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 17.4 ttpp -67.02 138.91 57.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.236 0.541 . . . . 0.0 112.027 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.716 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.7 OUTLIER -132.93 156.13 47.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.333 179.076 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.722 HG22 ' CG ' ' A' ' 74' ' ' GLU . 61.9 t -102.75 142.87 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.317 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.868 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -127.79 111.94 14.2 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 1.155 ' HB ' ' HD3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -97.65 167.85 10.71 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.02 0.438 . . . . 0.0 111.179 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.643 ' HB2' ' CD1' ' A' ' 238' ' ' LEU . 0.2 OUTLIER 61.55 21.35 12.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.065 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.909 HD22 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -58.88 159.35 7.06 Favored 'General case' 0 N--CA 1.46 0.069 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.623 ' HB3' HG21 ' A' ' 50' ' ' VAL . 31.4 tp -92.63 114.6 27.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.022 0.439 . . . . 0.0 111.659 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.41 ' CG ' ' HB2' ' A' ' 70' ' ' ARG . 62.0 t0 -76.1 65.46 2.11 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.179 0.514 . . . . 0.0 109.995 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.3 m -128.31 -162.41 1.18 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.284 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.722 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -96.97 -19.94 18.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.246 0.546 . . . . 0.0 110.841 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.617 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 30.1 m-20 -69.95 -28.63 65.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.123 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.785 HG12 HD11 ' A' ' 54' ' ' LEU . 25.8 t -89.74 -50.89 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.752 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.722 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -49.21 -29.08 5.17 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.116 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . 8.4 m-70 -73.32 -37.56 66.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.298 178.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.691 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 3.2 tpt -64.73 -47.86 76.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.827 HD23 HD21 ' A' ' 29' ' ' LEU . 1.6 mp -68.43 -43.93 76.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.584 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.2 m-80 -58.5 -22.72 56.01 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.955 0.407 . . . . 0.0 110.319 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.711 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -75.82 -48.57 21.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.62 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.614 HD21 ' HE2' ' A' ' 53' ' ' MET . 0.1 OUTLIER -67.41 -48.13 68.24 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.593 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.692 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.0 t -52.39 -30.67 30.22 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.16 0.505 . . . . 0.0 110.247 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.723 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -61.77 -47.98 82.71 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.296 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.997 HD21 HD22 ' A' ' 106' ' ' LEU . 3.3 mp -71.22 -24.88 62.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.212 0.53 . . . . 0.0 110.184 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.71 0.65 7.16 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.434 -0.889 . . . . 0.0 114.067 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.73 HG21 HD11 ' A' ' 82' ' ' LEU . 11.3 t -56.73 156.49 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 117.58 0.69 . . . . 0.0 110.536 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.583 ' HB3' HD13 ' A' ' 76' ' ' ILE . 2.8 m -113.66 110.09 19.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.733 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.692 ' CE2' ' HB ' ' A' ' 58' ' ' THR . 20.7 p90 -132.58 152.45 51.61 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.552 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.712 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -147.94 116.17 6.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.715 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.909 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -84.24 175.35 9.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.152 0.501 . . . . 0.0 111.104 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.639 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -87.25 179.22 6.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.092 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.83 -14.55 34.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.225 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.87 8.04 11.05 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.856 0.36 . . . . 0.0 110.606 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.431 ' O ' HD23 ' A' ' 44' ' ' LEU . 1.4 mtp180 58.75 47.04 13.35 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.421 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -129.23 -2.05 5.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.601 179.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 1.155 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -138.78 109.07 6.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.929 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.755 ' SG ' HD22 ' A' ' 66' ' ' LEU . 3.4 t -120.04 146.81 45.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.259 0.552 . . . . 0.0 112.185 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.722 ' CG ' HG22 ' A' ' 40' ' ' VAL . 1.2 mp0 -115.69 102.56 9.85 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.104 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.663 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -95.95 124.34 48.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.583 HD13 ' HB3' ' A' ' 63' ' ' SER . 1.8 mp -79.22 104.25 7.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.215 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.686 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -48.8 118.53 5.01 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.877 -0.601 . . . . 0.0 114.346 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.66 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 2.3 m-20 -64.02 -15.94 60.54 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.093 0.473 . . . . 0.0 110.022 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.494 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.15 -20.73 14.84 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.218 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.913 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -137.44 -155.38 6.9 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.852 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 3.0 Cg_exo -74.35 166.37 29.63 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 121.865 1.71 . . . . 0.0 108.738 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.839 HD21 ' HB3' ' A' ' 33' ' ' ALA . 4.3 mm? -64.62 90.03 0.07 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.328 1.061 . . . . 0.0 108.293 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.852 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 31.3 m170 -82.55 118.59 23.38 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.675 -176.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.85 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -142.93 109.42 5.37 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.971 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -112.76 93.42 4.42 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.222 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.86 21.26 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.282 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 56.72 50.24 12.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.469 0.652 . . . . 0.0 110.302 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.76 HD12 ' N ' ' A' ' 89' ' ' GLU . 4.8 tp -79.77 137.94 37.13 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.189 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.76 ' N ' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -117.04 124.06 48.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.139 0.495 . . . . 0.0 110.733 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.711 HD13 ' HA ' ' A' ' 56' ' ' ALA . 10.1 mt -105.47 162.99 12.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.475 0.655 . . . . 0.0 112.274 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.612 ' HA ' ' O ' ' A' ' 116' ' ' THR . 30.2 t80 -127.22 106.86 9.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.466 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.934 ' HG ' ' HA ' ' A' ' 99' ' ' MET . 2.5 mm? -94.67 6.83 47.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 44.37 -137.89 5.08 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.791 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.54 ' N ' ' HG3' ' A' ' 118' ' ' GLU . 9.8 t-20 -104.47 55.18 0.72 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.911 0.386 . . . . 0.0 110.671 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -98.65 -66.35 0.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.917 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.591 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 78.48 -17.09 6.87 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.867 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.46 ' HA ' ' CD ' ' A' ' 171' ' ' GLN . 1.7 p -92.71 -6.92 48.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.737 0.303 . . . . 0.0 111.238 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.501 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -131.97 -20.71 2.47 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.934 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 2.2 ttt -68.19 -51.48 45.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.941 0.401 . . . . 0.0 110.53 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.663 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 2.5 mpt_? -58.83 -53.68 63.98 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.561 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.66 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 24.3 Cg_exo -64.57 -46.74 6.6 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.853 2.369 . . . . 0.0 113.164 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.809 HD13 HD11 ' A' ' 106' ' ' LEU . 3.1 tm? -64.0 -37.78 88.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.23 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.639 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -62.15 -48.38 80.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.443 0.639 . . . . 0.0 110.285 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.927 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -67.3 -40.77 86.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.566 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -58.68 -42.98 89.78 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.997 HD22 HD21 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -68.78 -21.37 64.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.276 0.56 . . . . 0.0 110.884 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.577 ' SG ' HD11 ' A' ' 140' ' ' ILE . 99.6 m -61.65 -10.33 8.2 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.727 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.778 HD11 ' O ' ' A' ' 179' ' ' THR . 13.0 mt -81.08 167.4 19.77 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 52.65 -111.74 1.78 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.393 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.456 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 14.7 m -162.59 99.59 1.02 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.949 0.404 . . . . 0.0 110.287 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.581 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 20.5 m-20 -138.94 136.11 35.1 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.698 ' C ' HD12 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -100.2 111.23 23.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.015 178.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.699 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.6 mp -144.23 142.7 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.411 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.622 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 29.5 t -115.44 111.37 35.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.044 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.639 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 33.7 mt -79.75 156.95 27.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.567 0.698 . . . . 0.0 112.359 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.612 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 19.0 m -159.51 156.34 28.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.795 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.3 -166.78 11.33 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.448 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.588 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 3.3 mm-40 -70.89 176.97 1.65 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.588 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 38.7 Cg_exo -62.22 -35.47 74.23 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.208 1.939 . . . . 0.0 112.222 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.637 ' HD3' ' HG2' ' A' ' 123' ' ' GLU . 19.5 tpp85 -79.71 -33.91 40.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.943 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.623 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 11.1 tpt -60.19 -18.11 45.88 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.74 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 5.1 mmtp -69.61 -4.84 20.98 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.066 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.637 ' HG2' ' HD3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -120.17 27.14 8.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.836 0.351 . . . . 0.0 110.903 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 11.4 mmm-85 -107.22 87.08 2.9 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.513 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.825 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.9 Cg_endo -47.82 123.8 8.95 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.753 2.302 . . . . 0.0 111.698 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.813 HD11 HD23 ' A' ' 129' ' ' LEU . 19.1 tt -125.04 28.28 2.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.81 0.814 . . . . 0.0 110.31 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.64 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -67.04 -51.16 41.19 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.548 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.767 ' HE1' HG21 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -52.63 -31.62 37.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.085 0.469 . . . . 0.0 110.88 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.813 HD23 HD11 ' A' ' 126' ' ' ILE . 31.9 tp -79.23 -65.08 1.04 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.808 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 1.038 HG13 HD12 ' A' ' 140' ' ' ILE . 54.1 t -52.33 -26.19 8.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.54 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.64 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.4 OUTLIER -72.04 -47.79 49.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.093 0.473 . . . . 0.0 111.048 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.924 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -60.58 -48.85 79.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.426 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.983 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -61.4 -43.26 99.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.548 0.689 . . . . 0.0 109.707 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -61.51 -33.38 73.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.643 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.924 HD12 ' HA ' ' A' ' 132' ' ' ALA . 2.8 mt -69.33 -30.03 67.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.83 0.348 . . . . 0.0 110.075 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.43 -18.39 79.19 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.585 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 131.37 1.38 4.79 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.023 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.456 ' CB ' ' HB3' ' A' ' 107' ' ' CYS . . . -71.39 146.87 48.46 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.937 0.399 . . . . 0.0 111.45 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.0 mttt -116.29 94.38 4.62 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.235 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.038 HD12 HG13 ' A' ' 130' ' ' VAL . 9.0 mt -116.85 178.69 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.93 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.802 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.7 OUTLIER -161.38 -174.79 4.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.008 0.432 . . . . 0.0 111.205 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.575 ' N ' HG23 ' A' ' 141' ' ' THR . 24.5 m-85 -123.94 108.86 12.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.869 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.701 HD21 ' N ' ' A' ' 152' ' ' ARG . 1.4 mm? -85.51 -14.46 45.91 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.499 ' HB3' ' CB ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -137.48 -69.79 0.45 Allowed 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.164 0.506 . . . . 0.0 109.705 179.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.772 ' HB3' ' CD2' ' A' ' 148' ' ' TYR . 2.8 mt-30 -118.2 145.63 44.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.675 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.503 ' HA ' ' CG ' ' A' ' 142' ' ' TYR . 12.3 mt-10 -76.8 128.82 35.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.787 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.825 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 31.1 m-20 65.22 49.47 1.96 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.856 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 42.6 m-85 -149.15 179.02 1.28 Allowed Pre-proline 0 CA--C 1.549 0.904 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.594 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.856 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -43.9 -44.41 11.9 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 123.965 3.11 . . . . 0.0 115.167 -178.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.736 ' HD3' ' HE3' ' A' ' 122' ' ' LYS . 46.5 Cg_endo -64.6 102.65 0.42 Allowed 'Trans proline' 0 CA--C 1.509 -0.73 0 C-N-CA 121.701 1.601 . . . . 0.0 111.937 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.521 HD11 HG21 ' A' ' 126' ' ' ILE . 88.0 mt -139.43 124.11 18.45 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.057 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.785 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.1 OUTLIER -104.24 112.57 25.64 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.967 HD23 HG23 ' A' ' 140' ' ' ILE . 2.3 mt -93.61 159.97 14.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.191 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 2.0 mt-30 -147.51 23.97 1.12 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.964 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.537 ' HA2' ' O ' ' A' ' 107' ' ' CYS . . . 55.48 -166.07 3.47 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.597 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.44 -5.47 38.1 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.798 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.702 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 42.1 t80 -62.95 109.06 1.34 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.92 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.582 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 69.0 p -106.93 -47.7 3.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.958 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.628 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.55 -168.58 26.25 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.845 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.643 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 122.98 170.56 13.52 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -64.69 124.91 23.13 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.543 HG13 HD13 ' A' ' 135' ' ' LEU . 48.8 t -136.66 153.8 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 111.653 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.613 ' HB2' ' HE2' ' A' ' 192' ' ' LYS . 1.2 m-20 -119.01 118.03 30.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.729 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.583 HG11 HD13 ' A' ' 173' ' ' LEU . 0.9 OUTLIER -117.6 147.03 21.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.006 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.674 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 3.6 t0 -82.86 134.88 35.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.932 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.676 ' CA ' HD12 ' A' ' 195' ' ' LEU . . . -77.9 -44.2 12.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.299 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.455 ' C ' HG23 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -54.21 166.51 0.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.611 0.243 . . . . 0.0 111.141 -179.511 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.767 HG21 ' HE1' ' A' ' 128' ' ' HIS . 2.2 t 68.5 54.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.106 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.84 ' N ' HG11 ' A' ' 196' ' ' VAL . 0.3 OUTLIER 61.53 141.23 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.1 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.562 ' CB ' ' HB2' ' A' ' 197' ' ' SER . 0.4 OUTLIER -69.63 -5.02 21.94 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.319 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.663 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 18.2 mm100 -50.66 -23.69 2.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.849 0.357 . . . . 0.0 111.046 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.704 ' O ' HD13 ' A' ' 129' ' ' LEU . 3.0 m-85 -68.83 -54.72 14.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.494 0.664 . . . . 0.0 109.992 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.703 HD23 HG12 ' A' ' 201' ' ' ILE . 58.9 tp -76.75 -30.9 56.76 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.249 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.607 HG23 ' OG1' ' A' ' 204' ' ' THR . 33.2 m -61.06 -33.39 73.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.181 0.515 . . . . 0.0 109.849 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.927 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -70.02 -51.55 31.36 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.796 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.983 ' CD2' HD23 ' A' ' 133' ' ' LEU . 1.6 mt -67.1 -35.87 80.73 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.382 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.043 HD22 HD21 ' A' ' 205' ' ' LEU . 10.5 mt -69.02 -25.71 64.62 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.323 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.759 ' HG2' HD21 ' A' ' 31' ' ' LEU . 44.9 mtp -95.27 -27.05 15.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.265 0.555 . . . . 0.0 110.959 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.778 ' O ' HD11 ' A' ' 108' ' ' LEU . 88.7 m -91.93 -47.21 7.42 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.682 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.95 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -60.8 -36.21 32.83 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.752 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 13.0 Cg_endo -54.14 -37.92 87.48 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.154 1.236 . . . . 0.0 111.541 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.68 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.1 mp -83.56 -8.87 59.25 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.047 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -67.21 120.15 70.12 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.148 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 5.9 Cg_exo -38.8 -28.92 0.15 Allowed 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.456 2.77 . . . . 0.0 114.224 -178.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -107.55 151.44 25.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 111.807 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.67 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 32.2 t70 -66.53 117.05 8.18 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.451 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.848 ' HB ' HG23 ' A' ' 225' ' ' VAL . 28.3 m -103.38 135.48 44.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.249 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.985 HG22 HG13 ' A' ' 224' ' ' VAL . 31.7 t -125.65 98.84 5.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.337 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.605 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.0 mp -89.62 141.62 14.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.324 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.807 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.4 OUTLIER -112.17 171.11 7.7 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.845 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.6 mm -110.18 97.61 5.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 120.981 0.42 . . . . 0.0 111.52 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.613 ' HE2' ' HB2' ' A' ' 163' ' ' ASP . 17.2 mttt -59.85 -82.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.884 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -80.95 175.0 54.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.77 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.39 124.67 22.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.649 0.261 . . . . 0.0 110.569 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.85 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.9 OUTLIER -60.95 148.25 40.51 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.01 0.433 . . . . 0.0 109.975 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.84 HG11 ' N ' ' A' ' 169' ' ' SER . 12.1 p -104.91 -19.33 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.557 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.845 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 3.8 m -131.36 45.46 2.8 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.04 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.883 ' O ' HG22 ' A' ' 201' ' ' ILE . 2.8 tttt -42.0 -65.41 0.52 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 114.896 -1.047 . . . . 0.0 113.283 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.859 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 15.9 Cg_exo -68.04 -17.88 45.95 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.517 1.478 . . . . 0.0 111.841 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.845 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 45.4 m-85 -75.11 -29.28 60.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.405 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.883 HG22 ' O ' ' A' ' 198' ' ' LYS . 9.5 tp -69.68 -30.95 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.126 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.64 -32.59 74.11 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.569 ' O ' HD23 ' A' ' 207' ' ' LEU . 33.0 mt -64.93 -32.63 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.147 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.607 ' OG1' HG23 ' A' ' 174' ' ' THR . 54.7 m -60.06 -53.74 54.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.376 0.608 . . . . 0.0 109.772 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 1.043 HD21 HD22 ' A' ' 177' ' ' LEU . 44.4 mt -68.59 -37.56 79.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.792 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -62.05 -29.29 70.19 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.736 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 2.1 mm? -76.66 -42.06 43.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.793 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.666 ' SD ' ' HG3' ' A' ' 181' ' ' PRO . 9.3 mtm -59.53 -42.92 93.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.796 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.881 ' HG3' ' O ' ' A' ' 205' ' ' LEU . 10.1 mtpt -64.96 -55.55 18.44 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.222 0.534 . . . . 0.0 110.2 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -50.76 -27.43 7.17 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.129 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.934 ' HA ' ' HG3' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -78.85 -50.2 11.65 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.561 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 152.58 0.82 0.22 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.967 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.573 HG13 ' CG ' ' A' ' 229' ' ' GLN . 53.8 t -118.78 139.81 44.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.138 0.494 . . . . 0.0 112.062 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.631 ' HG2' ' HG2' ' A' ' 209' ' ' LYS . 62.6 mt-10 -132.05 157.68 43.53 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.024 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.98 HG12 HD22 ' A' ' 205' ' ' LEU . 2.8 pp -138.16 175.26 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.909 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 1.068 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 33.0 tt0 -92.03 123.15 35.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.328 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -99.56 100.82 11.88 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.708 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.824 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.5 OUTLIER -67.33 -168.77 0.08 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.801 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -73.63 47.66 0.25 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.863 0.363 . . . . 0.0 110.364 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.673 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 0.1 OUTLIER 58.44 19.77 6.79 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.933 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 191' ' ' ILE . 18.7 mt-30 -111.67 -22.34 11.24 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.824 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 41.4 mt-30 -148.15 141.84 25.59 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.986 ' HB3' HD21 ' A' ' 177' ' ' LEU . 7.3 m-85 -112.59 95.93 5.7 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 1.068 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 41.5 t -80.36 110.98 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.062 0.458 . . . . 0.0 111.174 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.95 HG21 ' CB ' ' A' ' 180' ' ' ALA . 2.6 m -96.96 107.72 20.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.931 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.683 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -57.41 100.96 0.06 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.592 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.67 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -55.66 154.52 12.7 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.51 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.34 9.13 65.46 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.088 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.683 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 1.9 mm-40 -77.16 176.97 8.24 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.812 0.815 . . . . 0.0 112.19 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.68 ' HA ' HD23 ' A' ' 182' ' ' LEU . 3.4 m -175.6 105.01 0.08 Allowed 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.614 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.642 ' HB2' ' HB2' ' A' ' 35' ' ' ALA . 17.5 m-85 -53.63 152.57 5.04 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.478 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.551 ' HG2' ' O ' ' A' ' 211' ' ' PHE . 15.0 pt20 -121.4 142.5 49.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.787 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 34.6 t -51.18 99.64 0.21 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.197 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.934 ' HG3' ' HA ' ' A' ' 211' ' ' PHE . 14.7 Cg_exo -68.79 -29.03 29.51 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.454 2.103 . . . . 0.0 111.635 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.18 -122.52 5.56 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.361 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.652 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -91.97 116.08 28.61 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.023 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.594 ' CE2' HD11 ' A' ' 207' ' ' LEU . 58.0 t80 -113.52 140.99 47.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.293 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.923 ' HA ' HG23 ' A' ' 42' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.317 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.618 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 13.0 m-20 . . . . . 0 N--CA 1.448 -0.536 0 CA-C-O 121.028 0.442 . . . . 0.0 110.454 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.26 -43.01 82.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.296 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.516 ' CB ' HD22 ' A' ' 41' ' ' LEU . . . -76.37 -32.19 58.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.836 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -61.39 -54.25 46.13 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.25 0.548 . . . . 0.0 110.276 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.685 HD21 ' HB2' ' A' ' 105' ' ' ALA . 9.4 tp -63.78 -55.28 24.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.448 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.724 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 29.6 mt -52.57 -34.89 52.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.134 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.671 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -76.21 -29.24 57.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.375 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.684 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -73.08 -32.99 65.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.538 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.883 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -87.55 -13.13 43.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.927 0.394 . . . . 0.0 110.907 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -81.9 164.34 21.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.737 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.504 ' CE1' ' HB3' ' A' ' 230' ' ' SER . 75.4 m80 -97.24 96.14 8.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.479 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.34 141.36 5.98 Favored Glycine 0 C--N 1.318 -0.442 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.936 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.758 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -62.12 129.18 39.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.491 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.7 OUTLIER -122.67 155.49 36.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.147 178.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.712 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 46.7 t -102.63 142.17 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.332 -0.394 . . . . 0.0 112.013 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 237' ' ' TYR . 0.0 OUTLIER -129.41 111.97 13.34 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.055 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.998 ' HB ' ' HD3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -103.4 170.76 7.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.072 0.463 . . . . 0.0 111.595 -179.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.559 ' HB2' HD11 ' A' ' 238' ' ' LEU . 29.0 t-20 62.11 20.28 11.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.056 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.754 HD22 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -58.76 158.34 8.19 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.595 ' HB3' HG21 ' A' ' 50' ' ' VAL . 24.7 tp -90.74 114.36 26.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.097 0.475 . . . . 0.0 111.551 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -76.01 65.0 1.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.235 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 74.6 m -125.2 -163.49 1.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.898 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.731 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 1.3 m-20 -96.77 -19.08 19.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.399 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.588 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 8.6 m-20 -70.98 -29.86 65.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.968 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.781 HG12 HD11 ' A' ' 54' ' ' LEU . 39.1 t -88.11 -53.36 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.377 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.731 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 9.5 ptp180 -50.62 -30.73 14.11 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.039 0.447 . . . . 0.0 110.005 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -72.94 -35.3 66.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.039 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.618 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 10.9 tpt -64.93 -49.87 68.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.836 HD23 HD21 ' A' ' 29' ' ' LEU . 1.2 mp -66.14 -45.86 79.52 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.61 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.7 m-20 -57.29 -22.67 43.29 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.022 0.439 . . . . 0.0 109.987 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.747 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -74.77 -48.76 23.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.599 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.622 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -68.2 -49.65 59.42 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.903 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.477 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 5.3 t -50.48 -33.81 22.62 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.339 0.59 . . . . 0.0 110.304 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.623 ' CB ' HD21 ' A' ' 90' ' ' LEU . . . -59.36 -48.89 79.92 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.213 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.999 HD21 HD22 ' A' ' 106' ' ' LEU . 3.9 mp -67.13 -29.12 68.76 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.483 0.658 . . . . 0.0 109.831 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.13 -1.65 4.59 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 114.81 -1.087 . . . . 0.0 113.815 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.7 HG21 HD11 ' A' ' 82' ' ' LEU . 13.0 t -58.96 153.92 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 117.644 0.722 . . . . 0.0 110.247 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.737 ' HB2' HD12 ' A' ' 76' ' ' ILE . 3.8 m -116.97 108.92 16.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.151 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 16.6 p90 -124.76 157.23 36.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.726 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -148.03 116.1 6.48 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.812 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.754 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -87.16 175.19 8.19 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.237 0.542 . . . . 0.0 111.38 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.607 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -89.48 179.4 6.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.859 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.35 -14.62 28.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.439 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.63 6.09 11.63 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.816 0.341 . . . . 0.0 110.656 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.583 ' HG2' ' HG ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER 59.07 45.59 14.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.503 -179.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -129.27 -2.16 5.04 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.999 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.998 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 1.2 mmm180 -136.58 109.34 7.54 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.694 ' HA ' ' O ' ' A' ' 65' ' ' THR . 5.4 t -120.62 154.04 36.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.376 0.607 . . . . 0.0 112.637 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.711 ' HG3' HG22 ' A' ' 40' ' ' VAL . 2.9 mt-10 -121.39 104.66 9.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.141 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.758 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -96.57 128.03 48.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.751 HG12 ' HG3' ' A' ' 38' ' ' LYS . 18.9 mt -81.67 103.06 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.112 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.671 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -47.9 113.78 1.54 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.695 -0.684 . . . . 0.0 114.197 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 25.0 t-20 -60.01 -17.36 38.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.112 0.482 . . . . 0.0 110.117 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.436 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 86.49 -22.96 10.92 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.363 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.883 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.65 -148.79 5.36 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.846 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 2.6 Cg_exo -77.09 169.01 22.3 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 CA-C-N 119.708 1.754 . . . . 0.0 109.261 177.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.7 HD11 HG21 ' A' ' 62' ' ' VAL . 4.5 mm? -67.43 90.51 0.24 Allowed 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 122.445 1.117 . . . . 0.0 108.078 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.846 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 30.3 m170 -82.26 118.67 23.29 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 112.877 -1.965 . . . . 0.0 112.671 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.708 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -144.87 113.07 6.49 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.644 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.15 86.35 2.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.795 0.331 . . . . 0.0 111.295 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -173.82 20.07 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.654 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.74 52.16 8.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.418 0.628 . . . . 0.0 109.852 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.704 ' O ' HG23 ' A' ' 113' ' ' ILE . 4.1 tp -80.73 134.37 35.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.221 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.694 ' N ' HD12 ' A' ' 88' ' ' LEU . 1.2 tt0 -113.87 128.94 56.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.228 0.537 . . . . 0.0 110.523 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.683 ' O ' HG22 ' A' ' 116' ' ' THR . 28.3 mt -112.4 154.09 26.32 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.46 ' CE1' ' HA2' ' A' ' 93' ' ' GLY . 52.6 t80 -116.39 105.35 12.42 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.663 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.976 HD23 ' HE1' ' A' ' 99' ' ' MET . 3.0 mm? -90.2 8.9 30.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.275 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.46 ' HA2' ' CE1' ' A' ' 91' ' ' PHE . . . 37.73 -143.93 0.2 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.249 -0.501 . . . . 0.0 113.216 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.418 HD21 ' HB3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -96.09 50.94 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.242 0.544 . . . . 0.0 110.025 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.588 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -90.0 -72.96 0.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.608 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.37 -19.44 8.54 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.444 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.439 HG23 ' NE2' ' A' ' 171' ' ' GLN . 19.0 m -93.92 -7.23 43.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.769 0.319 . . . . 0.0 111.099 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.582 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . . . -129.88 -17.09 3.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.355 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.976 ' HE1' HD23 ' A' ' 92' ' ' LEU . 21.9 tpp -70.23 -55.13 10.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.935 0.398 . . . . 0.0 111.009 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.896 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.6 mpt_? -60.07 -49.36 91.39 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.938 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 20.6 Cg_exo -66.79 -47.15 2.85 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.814 2.343 . . . . 0.0 112.95 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.796 HD13 HD11 ' A' ' 106' ' ' LEU . 3.3 tm? -68.55 -34.14 75.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.661 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.624 ' HA ' HD11 ' A' ' 115' ' ' LEU . . . -63.36 -47.98 79.86 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.645 0.736 . . . . 0.0 109.78 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.746 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -70.25 -39.18 75.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.094 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.685 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -56.6 -40.92 76.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 111.949 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.999 HD22 HD21 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -71.72 -21.48 61.76 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.568 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.514 ' SG ' HD11 ' A' ' 140' ' ' ILE . 89.6 m -60.8 -10.55 5.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.102 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 179' ' ' THR . 13.9 mt -83.3 168.48 16.63 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 53.95 -108.09 0.77 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.428 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.47 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.3 OUTLIER -167.68 99.6 0.48 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.843 0.354 . . . . 0.0 110.398 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 8.5 m-20 -138.5 135.79 35.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.134 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.628 ' C ' HD12 ' A' ' 113' ' ' ILE . 18.3 m-20 -99.42 111.0 23.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.841 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.704 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.8 mp -143.0 140.79 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 5.8 t -109.46 113.71 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.624 HD11 ' HA ' ' A' ' 103' ' ' ALA . 37.2 mt -89.71 154.61 19.81 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.125 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.683 HG22 ' O ' ' A' ' 90' ' ' LEU . 13.0 t -155.46 -170.27 3.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.296 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -173.45 -167.8 33.71 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 119.988 -1.101 . . . . 0.0 113.901 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.501 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 2.9 mm-40 -69.59 178.09 1.08 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.319 -0.441 . . . . 0.0 110.919 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.501 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 31.8 Cg_exo -61.88 -38.49 58.55 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.048 1.832 . . . . 0.0 112.214 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.844 HH11 ' HG3' ' A' ' 123' ' ' GLU . 3.2 tpt180 -79.55 -23.75 42.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.026 0.441 . . . . 0.0 110.204 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.62 ' HE3' ' HB2' ' A' ' 124' ' ' ARG . 10.8 tpt -69.17 -15.54 63.42 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.777 ' HE2' ' HD3' ' A' ' 150' ' ' PRO . 0.8 OUTLIER -74.44 -4.71 38.25 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.162 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.844 ' HG3' HH11 ' A' ' 120' ' ' ARG . 0.1 OUTLIER -127.65 26.02 5.96 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.293 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.62 ' HB2' ' HE3' ' A' ' 121' ' ' MET . 2.5 mmp_? -100.56 91.43 1.8 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.493 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.7 Cg_endo -47.87 127.06 13.89 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.593 2.195 . . . . 0.0 112.589 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.761 HD11 HD23 ' A' ' 129' ' ' LEU . 18.5 tt -130.88 31.24 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 121.732 0.777 . . . . 0.0 109.943 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.635 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -71.61 -51.98 14.16 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 114.772 -1.103 . . . . 0.0 112.735 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.775 ' HE1' HG21 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -52.31 -26.49 12.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.927 0.394 . . . . 0.0 110.562 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.761 HD23 HD11 ' A' ' 126' ' ' ILE . 39.6 tp -84.69 -65.05 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.545 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.818 HG13 HD12 ' A' ' 140' ' ' ILE . 47.6 t -52.55 -26.02 9.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.49 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.635 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -73.23 -44.6 59.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.651 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.975 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -66.64 -47.98 70.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.571 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.876 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -58.26 -45.47 87.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.514 0.673 . . . . 0.0 109.52 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -33.79 71.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.816 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.975 HD12 ' HA ' ' A' ' 132' ' ' ALA . 5.1 mt -70.19 -31.99 69.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.977 0.417 . . . . 0.0 110.104 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.517 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -74.78 -17.99 80.09 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.514 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.81 2.9 5.13 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.596 -0.812 . . . . 0.0 113.114 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' A' ' 107' ' ' CYS . . . -70.11 146.73 50.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 111.027 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 46.3 mmtt -113.43 81.47 1.51 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.473 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.955 HG23 HD23 ' A' ' 153' ' ' LEU . 9.3 mt -107.44 176.12 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.847 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.5 OUTLIER -153.24 -169.03 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.028 0.442 . . . . 0.0 111.225 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.694 ' N ' HG23 ' A' ' 141' ' ' THR . 19.3 m-85 -131.72 104.18 6.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.014 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.637 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.4 mm? -75.02 -13.22 60.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.522 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.758 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 5.0 mt-10 -138.99 -73.23 0.39 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.209 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.631 ' HB2' ' HD2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -123.98 156.43 36.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.227 0.537 . . . . 0.0 111.735 -179.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.404 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 2.8 mt-10 -70.95 125.83 27.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.616 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.684 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 0.9 OUTLIER 70.41 50.43 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.044 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.704 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.0 m-30 -141.75 173.82 4.39 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.72 ' CG ' ' HA ' ' A' ' 122' ' ' LYS . 6.3 Cg_endo -49.18 -40.79 42.4 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.159 2.573 . . . . 0.0 115.068 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.777 ' HD3' ' HE2' ' A' ' 122' ' ' LYS . 18.7 Cg_endo -62.26 101.79 0.25 Allowed 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 120.849 1.033 . . . . 0.0 110.745 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.523 HD11 HG21 ' A' ' 126' ' ' ILE . 83.2 mt -137.11 123.17 20.31 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.549 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.847 ' HB2' HG22 ' A' ' 141' ' ' THR . 2.6 mtp85 -102.47 111.78 24.23 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.955 HD23 HG23 ' A' ' 140' ' ' ILE . 3.7 mt -93.88 158.05 15.83 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.053 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.57 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 13.8 mt-30 -148.39 25.24 0.99 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.683 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.492 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 53.69 -166.35 1.88 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.537 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 158' ' ' THR . . . 108.2 -4.07 33.42 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.9 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.636 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 2.5 t80 -60.46 105.45 0.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.887 0.375 . . . . 0.0 110.828 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.495 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 67.9 p -104.56 -51.04 3.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.562 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.7 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 144.44 -163.95 27.77 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.065 -1.064 . . . . 0.0 114.269 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.601 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 118.04 170.74 15.11 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -64.2 126.3 27.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.26 0.53 . . . . 0.0 109.866 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 59.0 t -136.99 152.65 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.966 0.412 . . . . 0.0 111.259 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.459 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.9 OUTLIER -119.05 119.05 33.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.861 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.665 HG11 HD13 ' A' ' 173' ' ' LEU . 0.3 OUTLIER -118.78 141.98 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.984 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 3.9 t70 -79.77 137.14 36.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.835 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.677 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -79.52 -44.54 9.36 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.899 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.464 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 8.0 m -51.66 164.76 0.21 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.716 0.293 . . . . 0.0 111.175 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.775 HG21 ' HE1' ' A' ' 128' ' ' HIS . 2.8 t 70.55 55.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.294 0.569 . . . . 0.0 110.227 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.731 ' N ' HG11 ' A' ' 196' ' ' VAL . 4.9 m 57.09 149.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.478 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.525 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 0.6 OUTLIER -72.67 -3.83 27.39 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.546 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.896 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 57.1 mm-40 -49.79 -24.34 2.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.67 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.698 ' HA ' HD13 ' A' ' 129' ' ' LEU . 2.0 m-85 -72.58 -55.01 7.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.412 0.625 . . . . 0.0 110.283 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.665 HD13 HG11 ' A' ' 164' ' ' VAL . 26.3 tp -73.71 -38.89 64.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.511 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.759 HG23 ' OG1' ' A' ' 204' ' ' THR . 20.5 m -59.02 -33.06 70.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.279 0.561 . . . . 0.0 109.678 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.746 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -72.84 -47.18 48.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.977 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.876 ' CD2' HD23 ' A' ' 133' ' ' LEU . 2.9 mt -69.88 -35.98 75.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.605 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.989 HD21 ' HB3' ' A' ' 223' ' ' PHE . 12.5 mt -68.47 -27.33 66.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.612 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.637 ' CE ' HG22 ' A' ' 174' ' ' THR . 39.5 mtm -95.56 -26.99 15.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.245 0.545 . . . . 0.0 110.489 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.718 ' O ' HD11 ' A' ' 108' ' ' LEU . 51.6 m -88.79 -46.92 8.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.759 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.823 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -60.58 -39.07 63.64 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -177.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.3 Cg_endo -53.13 -36.01 75.24 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.347 1.364 . . . . 0.0 111.892 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.663 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.1 mp -85.04 -6.82 59.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.767 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.495 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -67.26 121.26 77.8 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.817 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 6.0 Cg_exo -38.76 -32.58 0.29 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.47 2.78 . . . . 0.0 113.91 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.47 155.8 19.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.05 0.453 . . . . 0.0 111.7 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.631 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 1.8 t70 -69.57 117.44 11.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.748 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.803 ' HB ' HG23 ' A' ' 225' ' ' VAL . 40.8 m -102.48 135.31 44.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.147 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.999 HG22 HG13 ' A' ' 224' ' ' VAL . 36.0 t -124.87 99.15 5.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.922 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 223' ' ' PHE . 2.9 mp -90.01 142.53 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.391 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.798 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.2 OUTLIER -113.47 170.68 8.06 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.861 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.5 mm -110.61 97.91 6.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 121.002 0.429 . . . . 0.0 111.363 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.561 ' HA ' ' NH1' ' A' ' 190' ' ' ARG . 4.9 mtmt -59.69 -82.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.133 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -79.1 168.21 53.12 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.36 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -59.9 122.45 14.29 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.82 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.8 OUTLIER -56.89 146.57 26.15 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.355 0.598 . . . . 0.0 110.61 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.731 HG11 ' N ' ' A' ' 169' ' ' SER . 12.5 p -104.1 -21.59 5.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.089 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.71 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -126.78 45.24 2.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.197 -179.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.82 ' HA ' HD23 ' A' ' 195' ' ' LEU . 6.1 ttpt -41.53 -65.63 0.48 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.04 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 51.4 Cg_endo -68.11 -16.77 45.2 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 121.556 1.504 . . . . 0.0 112.308 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.71 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 88.6 m-85 -75.34 -27.57 59.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.39 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.817 HD11 HD12 ' A' ' 177' ' ' LEU . 6.1 tp -71.23 -33.14 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.762 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -32.5 71.99 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.761 HG22 HD23 ' A' ' 207' ' ' LEU . 28.4 mt -68.32 -29.8 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.605 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.759 ' OG1' HG23 ' A' ' 174' ' ' THR . 52.5 m -61.38 -52.55 64.15 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.262 0.553 . . . . 0.0 109.806 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.918 HD22 HG12 ' A' ' 215' ' ' ILE . 30.9 mt -70.44 -38.37 74.52 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.191 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.654 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 39.4 t30 -63.65 -28.04 69.63 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.761 HD23 HG22 ' A' ' 203' ' ' ILE . 1.0 OUTLIER -78.36 -40.62 35.81 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.489 178.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.512 ' SD ' HG22 ' A' ' 204' ' ' THR . 17.2 mtp -68.9 -39.42 79.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.857 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.654 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 17.7 ptpt -65.37 -45.24 84.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.099 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 207' ' ' LEU . 2.0 t -57.71 -29.31 64.62 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.217 0.532 . . . . 0.0 109.798 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.605 ' HE2' ' HA ' ' A' ' 32' ' ' ALA . 1.3 m-85 -74.75 -53.04 9.94 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.587 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 158.82 -2.55 0.1 Allowed Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.644 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.66 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 53.7 t -119.0 142.44 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 117.08 0.44 . . . . 0.0 112.028 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -135.46 155.15 51.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.811 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.918 HG12 HD22 ' A' ' 205' ' ' LEU . 2.3 pp -130.43 175.53 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.378 -178.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 1.05 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 6.3 tp10 -91.57 127.43 37.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . 0.76 HD22 ' H ' ' A' ' 217' ' ' ASN . 0.1 OUTLIER -102.31 101.3 11.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.42 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.87 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 4.8 mm-40 -66.71 -168.06 0.06 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.858 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -74.12 48.0 0.3 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.802 0.334 . . . . 0.0 110.633 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.577 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.1 OUTLIER 58.82 19.69 7.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.018 0.437 . . . . 0.0 111.26 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 191' ' ' ILE . 7.1 mm-40 -112.7 -22.38 10.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.713 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.87 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 29.5 mt-30 -149.22 141.87 24.48 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.088 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.989 ' HB3' HD21 ' A' ' 177' ' ' LEU . 14.6 m-85 -112.91 97.77 6.75 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 1.05 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 39.1 t -81.9 110.9 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.334 0.588 . . . . 0.0 111.341 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.915 HG12 HG21 ' A' ' 215' ' ' ILE . 1.9 m -97.95 112.09 29.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.977 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.71 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 4.9 mptp? -63.26 104.37 0.59 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.807 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.631 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.93 158.69 14.83 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.114 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.07 9.44 80.38 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.474 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.71 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 19.5 mm-40 -76.28 178.76 6.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.441 0.639 . . . . 0.0 111.576 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.663 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.9 m -174.06 106.36 0.12 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.265 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.66 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 22.9 m-85 -55.24 152.23 8.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.511 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.535 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 7.7 pt20 -122.97 138.34 54.71 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 7.0 t -46.54 98.04 0.17 Allowed Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 39.5 Cg_endo -64.89 -29.33 58.3 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.331 2.021 . . . . 0.0 111.804 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 117.39 -123.77 5.89 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.884 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.712 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -91.0 116.96 29.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.039 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.642 ' CZ ' HD11 ' A' ' 207' ' ' LEU . 68.0 t80 -121.7 126.58 49.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.531 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.862 ' HA ' HG23 ' A' ' 42' ' ' THR . 3.9 tp . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 121.252 0.548 . . . . 0.0 111.206 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.809 ' ND2' ' HB2' ' A' ' 98' ' ' ALA . 43.1 m-20 . . . . . 0 C--O 1.233 0.207 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -67.65 -43.29 80.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.17 0.51 . . . . 0.0 110.491 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.503 ' CB ' ' HB3' ' A' ' 41' ' ' LEU . . . -75.17 -31.96 61.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.978 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.789 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -66.07 -52.22 50.89 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.115 0.483 . . . . 0.0 110.218 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.64 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 8.1 tp -64.94 -53.76 41.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.278 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.721 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 62.6 mt -53.5 -36.35 61.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.411 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.727 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -76.99 -29.94 55.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.448 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.649 ' CB ' HD21 ' A' ' 82' ' ' LEU . . . -70.29 -33.2 71.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.526 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.902 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -88.81 -12.61 41.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.813 0.339 . . . . 0.0 111.145 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.69 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -81.72 166.06 20.42 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.687 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.521 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 77.5 m80 -99.89 97.7 8.56 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.042 0.449 . . . . 0.0 109.885 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.01 142.28 6.6 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.385 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.763 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 1.3 ttpm? -66.36 140.55 58.09 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.096 0.474 . . . . 0.0 112.035 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.29 154.33 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.289 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.813 HG22 ' HG2' ' A' ' 74' ' ' GLU . 55.8 t -100.72 142.78 15.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.122 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.749 HD21 HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -129.25 111.69 13.14 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.754 HG23 HD13 ' A' ' 238' ' ' LEU . 0.6 OUTLIER -97.98 164.63 12.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.333 0.587 . . . . 0.0 112.136 -178.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.408 ' HB2' HD11 ' A' ' 238' ' ' LEU . 19.4 t30 63.21 23.38 13.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.287 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.9 HD22 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -58.87 153.61 16.84 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.328 179.093 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.639 ' HB3' HG21 ' A' ' 50' ' ' VAL . 27.2 tp -83.35 114.26 21.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.059 0.457 . . . . 0.0 111.342 -178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.01 68.57 4.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.995 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.4 m -130.01 -163.91 1.36 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.893 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.608 ' HA ' ' CD ' ' A' ' 51' ' ' ARG . 25.1 t0 -97.11 -20.45 17.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.031 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -70.45 -30.06 66.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.713 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.643 HG12 HD11 ' A' ' 54' ' ' LEU . 12.4 t -83.1 -54.84 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.105 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.608 ' CD ' ' HA ' ' A' ' 48' ' ' ASP . 11.9 ptm180 -49.67 -27.18 4.39 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.004 0.43 . . . . 0.0 110.013 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -71.02 -39.86 72.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' VAL . 7.1 tpt -64.29 -50.93 65.95 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.789 HD23 HD21 ' A' ' 29' ' ' LEU . 1.5 mp -62.11 -47.49 84.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.004 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 11.8 t30 -58.43 -23.26 56.95 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.815 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.805 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -76.28 -49.0 18.18 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.138 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.57 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -64.72 -49.73 69.68 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.271 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.7 t -50.37 -30.52 12.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.245 0.545 . . . . 0.0 109.983 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 1.081 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.22 -44.2 92.3 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.618 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.097 HD21 HD22 ' A' ' 106' ' ' LEU . 2.7 mp -79.56 -19.53 49.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.211 0.529 . . . . 0.0 110.656 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.13 -0.87 7.72 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.852 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.679 HG21 HD11 ' A' ' 82' ' ' LEU . 15.2 t -58.88 155.66 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 117.586 0.693 . . . . 0.0 110.086 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.596 ' CB ' HG13 ' A' ' 76' ' ' ILE . 2.9 m -117.57 108.93 16.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.07 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.539 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 10.0 p90 -124.06 153.59 41.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.172 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.728 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 11.7 m -147.61 116.53 6.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.028 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.9 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -88.81 172.25 9.34 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.138 0.494 . . . . 0.0 111.088 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.692 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 65.1 p -88.04 179.57 6.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.781 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.19 -14.72 27.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.407 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.42 7.03 12.67 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.791 0.329 . . . . 0.0 110.68 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.476 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 10.0 mtm180 57.08 41.91 26.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.116 0.484 . . . . 0.0 110.943 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.45 -2.14 8.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.604 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.692 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 4.8 mmt180 -136.94 110.53 8.02 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.841 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.728 ' HA ' ' O ' ' A' ' 65' ' ' THR . 4.0 t -120.22 151.57 38.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.452 0.644 . . . . 0.0 112.405 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.813 ' HG2' HG22 ' A' ' 40' ' ' VAL . 55.0 mt-10 -118.63 102.93 9.24 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.108 178.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.763 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -95.34 128.2 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-O 121.375 0.607 . . . . 0.0 112.213 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.687 HD13 ' HB2' ' A' ' 38' ' ' LYS . 15.9 mm -80.51 103.32 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.871 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.727 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -49.73 114.66 2.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.958 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.558 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.3 t-20 -61.51 -16.78 50.71 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 110.194 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.521 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.27 -22.02 11.27 Favored Glycine 0 C--O 1.226 -0.384 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.427 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.902 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.53 -149.03 5.41 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.821 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 5.4 Cg_exo -78.77 168.3 21.19 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.853 1.702 . . . . 0.0 109.209 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.754 HD12 HD13 ' A' ' 60' ' ' LEU . 4.5 mm? -66.62 91.14 0.18 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.821 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 29.3 m170 -84.14 118.02 23.84 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 113.158 -1.837 . . . . 0.0 112.779 -176.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.802 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -144.21 108.26 4.75 Favored 'General case' 0 C--O 1.227 -0.08 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.354 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -109.83 90.69 3.38 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.541 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -175.69 17.35 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.742 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.58 ' H ' ' HB2' ' A' ' 112' ' ' ASP . . . 55.2 47.81 20.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.565 0.697 . . . . 0.0 109.794 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 1.081 HD21 ' HB1' ' A' ' 59' ' ' ALA . 1.0 OUTLIER -81.3 129.14 34.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.31 -178.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.834 ' N ' HD12 ' A' ' 88' ' ' LEU . 1.6 tt0 -105.7 127.76 53.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.122 0.487 . . . . 0.0 110.658 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.805 HD13 ' HA ' ' A' ' 56' ' ' ALA . 61.1 mt -111.97 157.5 20.63 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.6 ' C ' HD23 ' A' ' 92' ' ' LEU . 31.9 t80 -112.88 101.62 9.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.243 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.8 HD23 ' N ' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -96.47 18.23 14.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.922 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.514 ' O ' ' HE2' ' A' ' 121' ' ' MET . . . 36.53 -154.47 0.01 OUTLIER Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.923 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.527 ' HA ' ' HB2' ' A' ' 121' ' ' MET . 10.6 t30 -87.6 50.1 1.93 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.287 0.565 . . . . 0.0 110.062 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.25 -77.04 0.24 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.426 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . 82.32 -13.77 38.03 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.644 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.466 ' HA ' ' CD ' ' A' ' 171' ' ' GLN . 0.3 OUTLIER -97.02 -5.39 37.79 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.073 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.809 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . . . -133.7 -22.7 1.87 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.339 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.742 ' HA ' HD12 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -62.08 -58.73 6.72 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.235 0.541 . . . . 0.0 110.337 179.299 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.921 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.8 mpt_? -59.76 -52.13 76.01 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.075 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.694 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 36.8 Cg_exo -61.99 -45.13 17.24 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.457 2.105 . . . . 0.0 113.192 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.674 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 2.6 tm? -74.04 -31.55 62.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.814 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.438 ' HA ' HD11 ' A' ' 115' ' ' LEU . . . -60.98 -48.29 82.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.407 0.622 . . . . 0.0 110.474 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.749 ' O ' HG21 ' A' ' 179' ' ' THR . . . -71.94 -36.82 70.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.006 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.503 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -57.67 -43.24 84.87 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.724 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.097 HD22 HD21 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -69.72 -24.24 63.53 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.33 0.586 . . . . 0.0 111.116 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.754 ' SG ' HD11 ' A' ' 140' ' ' ILE . 86.5 m -59.11 -10.59 2.82 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.059 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.705 HD11 ' O ' ' A' ' 179' ' ' THR . 12.0 mt -82.06 169.03 17.18 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 50.84 -110.39 0.94 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.513 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.428 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 2.4 p -161.67 101.35 1.17 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.037 -0.356 . . . . 0.0 110.037 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 12.9 m-20 -138.95 135.15 34.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.692 ' C ' HD12 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -101.93 110.67 22.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.812 178.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.712 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.6 mp -145.9 140.66 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.58 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.774 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 27.0 t -111.03 112.4 40.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.248 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.679 HD13 HD11 ' A' ' 92' ' ' LEU . 13.2 mt -82.09 150.58 27.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.385 0.612 . . . . 0.0 111.587 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.56 HG22 ' H ' ' A' ' 117' ' ' GLY . 3.6 m -155.25 177.25 11.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.419 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.56 ' H ' HG22 ' A' ' 116' ' ' THR . . . -165.08 -165.37 22.27 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.251 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.564 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 2.3 mm-40 -70.92 176.07 2.25 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.564 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 37.2 Cg_exo -62.4 -28.95 78.69 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 121.793 1.662 . . . . 0.0 111.97 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.508 ' HD2' ' CG ' ' A' ' 123' ' ' GLU . 6.0 tpt180 -80.44 -37.29 32.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.958 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.634 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 34.8 tpp -59.56 -15.72 20.21 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.734 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 6.3 mttm -69.8 -5.79 27.88 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.564 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 2.0 pt-20 -120.98 26.97 8.73 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.066 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.604 ' HA ' ' HE ' ' A' ' 124' ' ' ARG . 1.6 mmp_? -105.91 94.16 8.67 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.062 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 10.6 Cg_endo -53.56 129.03 31.81 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.954 2.436 . . . . 0.0 112.559 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.666 HD11 HD23 ' A' ' 129' ' ' LEU . 18.1 tt -132.78 29.35 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.724 0.774 . . . . 0.0 110.127 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -68.35 -51.06 34.34 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.184 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.739 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -54.29 -28.58 43.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.924 0.392 . . . . 0.0 110.668 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.786 ' CD1' HD21 ' A' ' 133' ' ' LEU . 23.6 tp -81.8 -61.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.885 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.776 HG13 HD12 ' A' ' 140' ' ' ILE . 59.8 t -53.35 -26.5 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.947 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.507 ' O ' HD12 ' A' ' 135' ' ' LEU . 20.0 t0 -71.63 -43.43 66.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.007 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.893 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -65.43 -51.86 57.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 121.074 0.464 . . . . 0.0 111.528 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.828 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -57.38 -43.78 83.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.818 179.65 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -33.91 73.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.803 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.893 HD12 ' HA ' ' A' ' 132' ' ' ALA . 2.7 mt -68.79 -30.14 68.66 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.235 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.47 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -78.42 -17.84 77.07 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.669 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 130.14 4.31 4.6 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.302 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.23 146.8 48.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.833 0.349 . . . . 0.0 111.557 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -114.75 94.57 4.83 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.075 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.968 HG23 HD23 ' A' ' 153' ' ' LEU . 11.5 mt -118.75 175.39 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.829 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.747 ' H ' HG22 ' A' ' 140' ' ' ILE . 1.0 OUTLIER -153.29 -166.15 2.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.267 0.556 . . . . 0.0 111.632 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.569 ' N ' HG23 ' A' ' 141' ' ' THR . 29.0 m-85 -135.92 101.51 4.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.921 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.641 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.4 mm? -72.86 -13.55 61.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.602 -177.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.766 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 4.8 mt-10 -139.52 -73.2 0.38 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.635 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.633 ' HB3' ' HD2' ' A' ' 148' ' ' TYR . 0.2 OUTLIER -121.35 147.23 45.98 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.217 0.532 . . . . 0.0 111.704 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.466 ' HA ' ' CG ' ' A' ' 142' ' ' TYR . 10.3 mt-10 -68.22 131.92 46.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.301 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.643 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 87.2 m-20 65.95 51.9 1.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.691 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.867 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.6 m-85 -148.03 -179.72 1.02 Allowed Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.129 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.867 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 5.7 Cg_endo -50.66 -43.1 47.53 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.969 2.446 . . . . 0.0 115.143 -177.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.766 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 32.8 Cg_endo -62.73 102.18 0.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.149 1.233 . . . . 0.0 111.425 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 150' ' ' PRO . 67.3 mt -138.58 122.92 18.26 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.848 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.664 ' HB2' HG22 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -105.51 112.33 25.39 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.968 HD23 HG23 ' A' ' 140' ' ' ILE . 4.5 mt -93.18 157.95 16.01 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.266 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.602 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -145.53 24.79 1.38 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.469 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.497 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 54.84 -166.05 2.83 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.535 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.483 ' O ' HG23 ' A' ' 158' ' ' THR . . . 108.72 -5.27 32.71 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.888 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.654 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 3.0 t80 -60.66 106.13 0.52 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.712 0.291 . . . . 0.0 110.721 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 156' ' ' GLY . 69.1 p -106.97 -46.12 4.0 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.098 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.718 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.39 -165.98 26.94 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.158 -1.02 . . . . 0.0 114.185 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.592 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 118.8 170.21 14.68 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.47 128.54 36.24 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.624 HG13 HD13 ' A' ' 135' ' ' LEU . 62.4 t -138.27 151.32 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 120.786 0.326 . . . . 0.0 111.733 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.505 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 2.4 m-20 -118.89 117.85 29.96 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.738 HG11 HD13 ' A' ' 173' ' ' LEU . 0.9 OUTLIER -118.63 147.86 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 120.574 -0.451 . . . . 0.0 112.018 -178.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.739 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.4 OUTLIER -85.4 133.59 34.11 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.338 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.724 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -76.03 -44.62 18.23 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.279 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.423 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 83.2 p -51.55 163.69 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.942 0.401 . . . . 0.0 111.593 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.727 HG21 ' HE1' ' A' ' 128' ' ' HIS . 3.7 t 71.59 60.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.242 0.544 . . . . 0.0 110.658 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.68 ' N ' HG11 ' A' ' 196' ' ' VAL . 0.7 OUTLIER 54.81 154.95 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.409 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.623 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 0.1 OUTLIER -76.71 3.01 12.62 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.966 0.412 . . . . 0.0 111.097 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.921 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 55.8 mm-40 -54.11 -22.72 11.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.726 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.713 ' O ' HD12 ' A' ' 176' ' ' LEU . 1.9 m-85 -78.21 -55.77 5.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.935 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.819 HD23 HG12 ' A' ' 201' ' ' ILE . 22.3 tp -73.51 -38.32 65.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.869 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.576 HG22 ' HE2' ' A' ' 178' ' ' MET . 91.4 m -60.31 -33.07 71.85 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.188 0.518 . . . . 0.0 109.706 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.661 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -72.79 -50.18 25.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.734 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.828 ' CD2' HD23 ' A' ' 133' ' ' LEU . 2.3 mt -66.96 -38.78 86.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.749 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.006 HD21 ' HB3' ' A' ' 223' ' ' PHE . 12.7 mt -68.47 -24.87 64.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.282 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.576 ' HE2' HG22 ' A' ' 174' ' ' THR . 46.5 mtm -94.52 -28.2 15.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.34 0.591 . . . . 0.0 110.779 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.749 HG21 ' O ' ' A' ' 104' ' ' ALA . 84.5 m -91.28 -46.84 7.83 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.068 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.92 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -59.21 -39.27 71.84 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 9.3 Cg_endo -53.33 -36.71 79.63 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 121.095 1.197 . . . . 0.0 111.706 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.668 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -85.12 -5.7 59.33 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.163 -179.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -67.09 120.9 75.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -37.12 -32.93 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.554 2.836 . . . . 0.0 114.018 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 158' ' ' THR . 0.3 OUTLIER -107.33 153.43 22.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.332 . . . . 0.0 111.562 -179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.663 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 0.4 OUTLIER -67.44 118.24 10.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.693 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.821 ' HB ' HG23 ' A' ' 225' ' ' VAL . 31.4 m -103.1 137.59 41.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.304 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 1.126 HG22 HG13 ' A' ' 224' ' ' VAL . 40.5 t -125.85 99.15 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.094 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.596 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.3 mt -90.55 141.98 13.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.395 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.791 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.3 OUTLIER -113.54 170.97 7.85 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.65 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.865 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.7 mm -110.38 97.26 5.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 120.985 0.421 . . . . 0.0 111.31 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.562 ' HG2' ' HE ' ' A' ' 190' ' ' ARG . 8.1 mtmp? -59.94 -81.37 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.464 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -78.85 168.44 53.53 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.309 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.45 122.3 15.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.54 0.209 . . . . 0.0 110.73 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.724 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.5 OUTLIER -57.26 146.64 27.84 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.985 0.422 . . . . 0.0 110.302 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.68 HG11 ' N ' ' A' ' 169' ' ' SER . 13.0 p -104.43 -19.75 6.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.384 0.611 . . . . 0.0 111.507 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.751 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.6 OUTLIER -127.74 45.31 2.76 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.627 -179.208 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.86 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.0 OUTLIER -41.19 -64.75 0.56 Allowed Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.702 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.672 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 55.2 Cg_endo -68.54 -16.92 43.37 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 121.603 1.535 . . . . 0.0 111.941 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.751 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 31.3 m-85 -76.0 -29.35 58.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.13 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.86 HG22 ' O ' ' A' ' 198' ' ' LYS . 8.4 tp -70.53 -31.63 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.622 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.516 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.1 OUTLIER -61.52 -33.74 74.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 207' ' ' LEU . 36.3 mt -66.21 -31.37 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.706 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.488 HG22 ' SD ' ' A' ' 208' ' ' MET . 54.0 m -60.26 -52.67 64.29 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.376 0.608 . . . . 0.0 109.823 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.923 HD21 HD22 ' A' ' 177' ' ' LEU . 44.9 mt -72.74 -35.48 67.54 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.59 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.717 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 4.9 t-20 -65.62 -24.81 67.14 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.721 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -82.68 -40.76 20.23 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.537 178.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.504 ' HG2' ' CZ ' ' A' ' 231' ' ' TYR . 12.0 mtp -69.0 -36.49 77.87 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.905 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.717 ' HE3' ' HA ' ' A' ' 206' ' ' ASN . 13.2 ptpt -66.56 -46.52 75.77 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.203 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.647 HG22 ' O ' ' A' ' 207' ' ' LEU . 5.2 t -57.55 -29.65 64.56 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.101 0.477 . . . . 0.0 109.862 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.612 ' HE2' ' HA ' ' A' ' 32' ' ' ALA . 1.8 m-85 -71.21 -54.1 12.12 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.301 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 155.78 -0.71 0.15 Allowed Glycine 0 CA--C 1.52 0.396 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.048 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.595 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 70.2 t -118.24 139.63 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.263 0.554 . . . . 0.0 111.679 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -135.95 156.12 49.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.994 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.894 HG21 HG12 ' A' ' 225' ' ' VAL . 2.0 pp -128.77 175.56 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.336 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 1.003 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 23.7 tt0 -89.88 125.15 35.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.156 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . 0.429 ' C ' HD22 ' A' ' 217' ' ' ASN . 0.2 OUTLIER -100.71 101.04 11.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.016 0.436 . . . . 0.0 110.761 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.602 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -67.65 -166.52 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.589 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.64 47.69 0.42 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.084 0.468 . . . . 0.0 110.334 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.611 ' CZ ' ' HD3' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 58.22 19.39 6.15 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 -179.349 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 191' ' ' ILE . 14.2 mt-30 -110.6 -21.5 12.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.545 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.787 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 16.8 mt-30 -149.81 140.29 22.43 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.885 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 1.006 ' HB3' HD21 ' A' ' 177' ' ' LEU . 10.3 m-85 -112.35 96.39 5.98 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 1.126 HG13 HG22 ' A' ' 188' ' ' VAL . 27.6 t -80.54 111.27 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-O 121.06 0.457 . . . . 0.0 110.91 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.92 HG21 ' CB ' ' A' ' 180' ' ' ALA . 2.7 m -97.68 112.96 30.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.12 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.723 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 5.7 mptt -61.38 104.16 0.38 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.584 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.663 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -59.57 157.39 25.22 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.825 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.44 8.74 84.56 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.339 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.723 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 15.1 mm-40 -73.38 178.99 4.21 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.401 0.619 . . . . 0.0 111.439 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.668 ' HA ' HD23 ' A' ' 182' ' ' LEU . 18.1 m -167.93 106.26 0.51 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.362 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.69 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 24.4 m-85 -54.03 142.02 26.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.163 0.506 . . . . 0.0 111.573 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.692 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 66.7 mt-30 -107.62 149.92 27.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.77 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 18.9 t -68.4 98.56 0.18 Allowed Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.745 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 47.8 Cg_endo -64.72 -33.36 54.73 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.498 2.132 . . . . 0.0 112.219 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 117.43 -114.09 2.87 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.624 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.6 OUTLIER -95.94 117.55 30.84 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 178.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.718 ' CZ ' HD11 ' A' ' 207' ' ' LEU . 37.3 t80 -119.93 136.01 54.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.793 0.33 . . . . 0.0 111.251 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.754 HD13 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.433 0 CA-C-O 121.2 0.524 . . . . 0.0 110.679 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.652 HD21 ' HA ' ' A' ' 50' ' ' VAL . 2.9 m120 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.961 0.41 . . . . 0.0 111.463 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -68.34 -38.19 81.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.565 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.678 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -79.06 -34.58 43.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.75 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.831 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -62.23 -53.72 51.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.459 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.633 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 4.9 tp -66.93 -47.93 70.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.194 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.613 HD11 ' HB3' ' A' ' 207' ' ' LEU . 33.1 mt -56.87 -33.88 67.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.459 . . . . 0.0 110.862 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.686 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -76.42 -28.87 56.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.923 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.8 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -73.55 -29.61 62.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.616 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.895 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.35 -12.39 40.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.012 0.434 . . . . 0.0 110.858 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.23 164.89 20.9 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.609 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.515 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 75.2 m80 -98.21 97.7 9.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.065 0.459 . . . . 0.0 110.173 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.06 142.26 6.58 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.255 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.765 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 10.9 tttt -65.69 135.23 54.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.996 0.427 . . . . 0.0 111.788 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.504 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -129.98 159.32 37.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.468 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.791 HG22 ' HG3' ' A' ' 74' ' ' GLU . 61.7 t -103.82 142.44 17.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.678 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -128.38 111.75 13.68 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.9 HG23 ' HA ' ' A' ' 238' ' ' LEU . 0.0 OUTLIER -100.96 170.74 8.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.096 0.474 . . . . 0.0 111.767 -179.329 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.542 ' HB2' ' CD1' ' A' ' 238' ' ' LEU . 0.1 OUTLIER 64.99 21.29 12.29 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.384 -179.165 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.897 HD22 HD11 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -60.35 157.43 13.75 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.533 179.047 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.576 ' HB3' HG21 ' A' ' 50' ' ' VAL . 23.4 tp -93.13 113.78 26.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.129 0.49 . . . . 0.0 111.464 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 p-10 -72.82 62.93 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.438 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.506 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.5 OUTLIER -124.85 -162.25 1.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.147 -179.036 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.65 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 51.3 m-20 -97.63 -20.47 17.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.179 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 5.0 p-10 -71.25 -27.65 63.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.947 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.657 HG12 HD11 ' A' ' 54' ' ' LEU . 23.9 t -89.09 -53.26 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.595 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.665 ' O ' ' HB2' ' A' ' 55' ' ' ASN . 2.9 ptm180 -50.02 -30.29 10.4 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.678 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.421 ' CD2' ' O ' ' A' ' 48' ' ' ASP . 10.5 m-70 -72.63 -35.49 67.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.41 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.636 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 3.8 tpt -65.87 -47.85 73.49 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.831 HD23 HD21 ' A' ' 29' ' ' LEU . 1.6 mp -65.42 -48.84 71.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.665 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -53.17 -25.54 13.99 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.321 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.874 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -75.25 -44.21 47.31 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.652 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.554 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -69.74 -49.48 52.73 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.389 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.514 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 5.1 t -52.05 -32.35 34.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.203 0.525 . . . . 0.0 109.898 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.915 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.01 -46.01 89.26 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.127 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.007 HD21 HD22 ' A' ' 106' ' ' LEU . 3.6 mp -72.27 -26.8 62.13 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.498 0.666 . . . . 0.0 109.801 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.41 -0.35 5.11 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.713 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.664 HG21 HD11 ' A' ' 82' ' ' LEU . 18.6 t -58.34 152.42 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 117.718 0.759 . . . . 0.0 110.193 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.42 ' CB ' HD12 ' A' ' 76' ' ' ILE . 3.7 m -116.16 108.68 16.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.932 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.718 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 15.0 p90 -127.53 154.62 44.93 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.22 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.627 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.9 OUTLIER -145.54 116.49 7.79 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.903 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.897 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -85.11 176.09 8.6 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.097 0.475 . . . . 0.0 111.842 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.861 ' HB3' ' HG3' ' A' ' 72' ' ' ARG . 50.4 p -86.3 178.99 6.98 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.051 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.94 -13.53 26.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.617 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -119.38 3.79 11.27 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.591 0.234 . . . . 0.0 110.877 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.51 ' O ' HD23 ' A' ' 44' ' ' LEU . 37.5 mmt-85 61.84 45.82 7.35 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 110.416 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -125.76 -3.11 7.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.367 179.339 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.861 ' HG3' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER -142.04 112.67 7.23 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.041 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 6.9 t -116.34 152.46 33.85 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.919 -0.712 . . . . 0.0 112.294 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.791 ' HG3' HG22 ' A' ' 40' ' ' VAL . 0.8 OUTLIER -116.2 102.61 9.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.878 178.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.765 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -96.04 127.63 47.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.493 ' CG1' ' HE3' ' A' ' 38' ' ' LYS . 14.3 mt -82.32 102.76 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.077 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.686 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -45.4 115.57 1.6 Allowed Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.999 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -61.24 -16.97 50.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.979 0.419 . . . . 0.0 110.1 178.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.515 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 86.16 -20.06 23.31 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.404 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.895 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -140.84 -148.28 5.08 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.833 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 3.8 Cg_exo -77.18 170.88 18.81 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.052 1.835 . . . . 0.0 109.183 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.8 HD21 ' HB3' ' A' ' 33' ' ' ALA . 4.2 mm? -69.31 92.19 0.57 Allowed 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.833 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 31.0 m170 -83.67 118.06 23.61 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.23 -1.805 . . . . 0.0 112.784 -175.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.799 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -144.45 109.04 4.89 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.361 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -111.58 91.65 3.74 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.418 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.63 20.37 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.773 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 54.95 49.37 17.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.366 0.603 . . . . 0.0 109.779 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.915 HD21 ' HB1' ' A' ' 59' ' ' ALA . 4.0 tp -81.78 135.96 35.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.425 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.749 ' N ' HD12 ' A' ' 88' ' ' LEU . 1.2 tt0 -114.31 128.71 56.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.261 0.553 . . . . 0.0 110.605 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.874 HD13 ' HA ' ' A' ' 56' ' ' ALA . 18.0 mt -111.14 158.99 18.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.468 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.453 ' CE1' ' HA2' ' A' ' 93' ' ' GLY . 41.8 t80 -123.83 103.39 8.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.428 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.741 HD23 ' HE1' ' A' ' 99' ' ' MET . 0.9 OUTLIER -90.05 6.5 42.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.09 -179.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.57 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 45.52 -145.52 2.74 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.283 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -86.65 47.99 1.57 Allowed 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 120.764 0.316 . . . . 0.0 111.387 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -90.43 -76.35 0.43 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.948 0.404 . . . . 0.0 111.124 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.55 -14.04 31.96 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.232 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 101' ' ' PRO . 65.3 p -97.0 -7.89 31.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.665 0.269 . . . . 0.0 111.015 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.522 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -126.85 -21.65 4.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.174 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.741 ' HE1' HD23 ' A' ' 92' ' ' LEU . 23.5 tpp -66.43 -50.44 63.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 0.0 110.018 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.694 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -61.6 -53.86 57.34 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.481 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.694 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 34.7 Cg_exo -61.31 -45.33 19.09 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.703 2.269 . . . . 0.0 112.79 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.594 ' CD1' HD11 ' A' ' 106' ' ' LEU . 2.7 tm? -70.8 -34.41 71.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.321 -178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.4 -47.72 84.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.366 0.603 . . . . 0.0 110.564 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.827 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -71.97 -34.2 68.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.356 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.583 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.31 -45.16 94.38 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.878 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.007 HD22 HD21 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -69.35 -20.49 63.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.662 -179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.558 ' SG ' HD11 ' A' ' 140' ' ' ILE . 6.4 m -62.17 -8.12 5.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.976 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.754 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 15.8 mt -87.44 165.57 15.45 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 57.2 -109.76 1.87 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.083 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.416 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -165.8 99.48 0.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.765 0.317 . . . . 0.0 110.299 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.611 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 3.4 m120 -138.44 135.44 35.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.683 ' C ' HD12 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -102.78 110.65 22.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.381 178.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.733 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.5 mp -143.88 142.28 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.216 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.777 HG22 ' HB2' ' A' ' 152' ' ' ARG . 32.5 t -113.66 112.29 39.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.466 HD13 ' SD ' ' A' ' 99' ' ' MET . 39.0 mt -81.7 157.23 24.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.451 0.643 . . . . 0.0 112.194 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.6 m -163.2 166.93 22.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.165 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -154.68 -166.14 14.82 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.023 -1.084 . . . . 0.0 113.497 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.587 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 22.5 mm-40 -69.15 178.25 0.97 Allowed Pre-proline 0 C--N 1.33 -0.267 0 C-N-CA 122.674 0.39 . . . . 0.0 110.78 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 36.4 Cg_exo -61.8 -39.59 51.28 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.892 1.728 . . . . 0.0 112.524 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -76.2 -33.07 59.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.977 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.567 ' HA ' ' HG3' ' A' ' 124' ' ' ARG . 10.0 tpt -60.75 -17.24 47.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.278 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.714 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 6.2 mmtp -71.46 -4.9 29.1 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.639 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 0.1 OUTLIER -125.52 32.24 5.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.014 0.435 . . . . 0.0 111.03 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.567 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 2.2 mmp_? -103.95 87.43 1.55 Allowed Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.822 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.789 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 1.1 Cg_endo -43.92 129.79 7.7 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.075 2.517 . . . . 0.0 112.406 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.849 HD11 HD23 ' A' ' 129' ' ' LEU . 15.0 tt -140.63 30.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.703 0.763 . . . . 0.0 110.29 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -70.11 -49.52 33.34 Favored Glycine 0 C--N 1.317 -0.523 0 CA-C-N 114.814 -1.085 . . . . 0.0 113.25 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -55.27 -25.31 33.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.819 -179.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.849 HD23 HD11 ' A' ' 126' ' ' ILE . 30.9 tp -83.88 -65.74 0.97 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.813 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.869 HG13 HD12 ' A' ' 140' ' ' ILE . 60.3 t -51.15 -26.53 5.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.223 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 1.7 m-20 -73.2 -46.37 50.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.667 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.944 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -63.48 -48.71 76.54 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.284 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.863 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -59.86 -44.36 94.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.385 0.612 . . . . 0.0 109.692 179.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -59.18 -34.92 72.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.421 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.944 HD12 ' HA ' ' A' ' 132' ' ' ALA . 2.2 mt -68.86 -28.0 66.32 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.21 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.5 -11.37 85.21 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.611 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 121.24 6.13 9.13 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.931 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.29 149.2 37.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 111.3 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.449 ' HA ' ' HE3' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -115.4 95.95 5.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.082 0.468 . . . . 0.0 111.594 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.964 HG23 HD23 ' A' ' 153' ' ' LEU . 12.1 mt -118.26 177.05 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.395 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.814 ' H ' HG22 ' A' ' 140' ' ' ILE . 1.0 OUTLIER -154.11 -167.69 2.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.18 0.514 . . . . 0.0 111.403 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.632 ' HE1' HD21 ' A' ' 151' ' ' LEU . 23.6 m-85 -135.56 102.66 5.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.641 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.2 mm? -75.7 -13.86 60.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.932 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.686 ' HG3' ' N ' ' A' ' 145' ' ' GLN . 0.0 OUTLIER -135.63 -69.75 0.49 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.357 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.686 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.4 OUTLIER -132.15 163.86 27.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.912 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.542 ' HG2' ' CD2' ' A' ' 142' ' ' TYR . 23.4 mt-10 -74.97 143.46 43.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.556 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.789 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 0.5 OUTLIER 51.54 42.32 29.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.012 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.686 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.4 m-30 -130.24 174.43 4.64 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.262 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.714 ' CG ' ' HA ' ' A' ' 122' ' ' LYS . 8.6 Cg_endo -50.76 -40.65 56.44 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.921 2.414 . . . . 0.0 114.316 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 149' ' ' PRO . 40.1 Cg_endo -60.97 100.28 0.16 Allowed 'Trans proline' 0 CA--C 1.511 -0.625 0 C-N-CA 121.797 1.665 . . . . 0.0 111.514 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.632 HD21 ' HE1' ' A' ' 142' ' ' TYR . 92.6 mt -137.89 123.02 19.2 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.24 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.777 ' HB2' HG22 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -105.63 112.07 25.01 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.964 HD23 HG23 ' A' ' 140' ' ' ILE . 1.4 mt -94.0 158.22 15.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.045 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.611 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 32.4 mt-30 -145.72 24.45 1.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.784 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.504 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 53.59 -165.71 1.99 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.679 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.85 -3.73 38.93 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.105 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.683 ' HE2' ' HA ' ' A' ' 133' ' ' LEU . 44.5 t80 -61.81 107.35 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.846 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.644 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 53.3 p -103.02 -50.47 3.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.697 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.627 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 146.24 -165.25 28.24 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.138 -1.03 . . . . 0.0 114.19 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.602 ' O ' HG23 ' A' ' 162' ' ' VAL . . . 119.23 168.37 14.0 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -62.43 125.87 25.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.004 0.402 . . . . 0.0 110.15 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 160' ' ' GLY . 44.3 t -135.02 153.02 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.756 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.554 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.4 OUTLIER -119.3 115.57 24.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.032 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.766 HG11 HD13 ' A' ' 173' ' ' LEU . 0.5 OUTLIER -113.87 147.4 17.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.677 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.9 OUTLIER -85.64 134.14 34.0 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.481 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.724 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -76.54 -44.7 15.5 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.759 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.9 t -50.39 163.02 0.18 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.055 0.455 . . . . 0.0 111.832 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.569 HG21 ' HE1' ' A' ' 128' ' ' HIS . 3.2 t 71.3 59.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.898 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.772 ' N ' HG11 ' A' ' 196' ' ' VAL . 75.7 m 57.68 153.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.262 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.444 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 0.5 OUTLIER -78.14 -2.4 37.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.249 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.652 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 90.6 mm-40 -51.55 -23.36 4.04 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.819 0.342 . . . . 0.0 111.365 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.639 ' HA ' HD13 ' A' ' 129' ' ' LEU . 2.8 m-85 -72.16 -58.94 3.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.252 0.549 . . . . 0.0 110.702 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.766 HD13 HG11 ' A' ' 164' ' ' VAL . 39.5 tp -73.49 -34.28 65.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.821 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.674 HG22 ' HE2' ' A' ' 178' ' ' MET . 89.8 m -60.01 -31.33 69.83 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.827 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -73.15 -52.23 14.95 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.059 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.863 ' CD2' HD23 ' A' ' 133' ' ' LEU . 2.6 mt -65.46 -38.19 89.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.741 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.995 HD21 ' HB3' ' A' ' 223' ' ' PHE . 11.7 mt -64.57 -28.28 69.53 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.225 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.674 ' HE2' HG22 ' A' ' 174' ' ' THR . 9.6 ptp -97.3 -27.52 14.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.193 0.521 . . . . 0.0 110.894 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.705 HG23 ' HG ' ' A' ' 108' ' ' LEU . 23.0 m -85.03 -46.75 10.89 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.929 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.94 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -61.44 -38.67 54.64 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.2 Cg_endo -53.73 -35.66 79.24 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.516 1.478 . . . . 0.0 112.016 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.698 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.75 -7.77 59.08 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.988 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.644 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -66.42 122.75 83.21 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.06 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 1.9 Cg_endo -43.12 -27.84 1.15 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.939 2.426 . . . . 0.0 113.614 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.417 ' O ' ' HA3' ' A' ' 227' ' ' GLY . 11.1 mt-10 -107.17 153.06 23.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.013 0.435 . . . . 0.0 111.292 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.674 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 52.1 t0 -70.33 115.1 9.13 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.289 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.822 ' HB ' HG23 ' A' ' 225' ' ' VAL . 45.0 m -100.57 136.66 40.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.365 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 1.036 HG22 HG13 ' A' ' 224' ' ' VAL . 26.0 t -125.52 99.43 5.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.763 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.576 ' O ' ' N ' ' A' ' 223' ' ' PHE . 4.7 mt -90.57 143.65 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.132 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.817 ' C ' HD13 ' A' ' 191' ' ' ILE . 2.2 ptm180 -115.28 170.95 8.0 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.882 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.4 mm -111.1 97.86 6.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-O 120.977 0.418 . . . . 0.0 111.267 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -62.31 -80.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.581 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -76.84 167.81 54.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.146 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -62.6 122.26 15.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.656 0.265 . . . . 0.0 110.952 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.827 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.7 OUTLIER -57.37 146.45 29.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.891 0.377 . . . . 0.0 110.395 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.772 HG11 ' N ' ' A' ' 169' ' ' SER . 11.6 p -103.34 -20.09 5.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.318 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.709 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -128.9 46.33 2.64 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.248 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.852 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.9 OUTLIER -41.96 -64.79 0.6 Allowed Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.039 -178.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 60.0 Cg_endo -70.73 -16.83 33.46 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 121.519 1.479 . . . . 0.0 111.457 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.709 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 21.5 m-85 -74.2 -30.02 62.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.204 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.852 HG22 ' O ' ' A' ' 198' ' ' LYS . 8.8 tp -68.54 -31.84 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.405 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.93 -29.64 67.26 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.742 HG22 HD23 ' A' ' 207' ' ' LEU . 33.4 mt -70.68 -29.91 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.253 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.502 HG21 ' HA ' ' A' ' 174' ' ' THR . 51.6 m -61.73 -55.22 32.56 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.16 0.505 . . . . 0.0 109.677 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.934 HD21 HD22 ' A' ' 177' ' ' LEU . 21.5 mt -69.19 -33.71 73.77 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.859 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.808 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 47.7 t30 -68.94 -24.74 64.31 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.742 HD23 HG22 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -78.96 -41.56 28.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.073 178.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.432 ' SD ' HG22 ' A' ' 204' ' ' THR . 12.0 mtp -70.26 -39.14 75.16 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.4 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.808 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -64.97 -42.35 94.64 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.398 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 207' ' ' LEU . 1.0 OUTLIER -59.61 -30.72 68.89 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.054 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.638 ' CE2' ' HA ' ' A' ' 32' ' ' ALA . 1.5 m-85 -71.18 -53.43 14.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.85 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 158.21 -3.45 0.13 Allowed Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.543 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.602 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 55.6 t -119.8 142.97 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.144 0.497 . . . . 0.0 112.231 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -135.52 156.03 49.54 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.442 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.901 HG12 HD22 ' A' ' 205' ' ' LEU . 2.4 pp -129.07 176.14 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.52 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 1.07 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 8.3 tp10 -90.4 126.27 35.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.135 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -101.47 101.25 11.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.632 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.694 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.7 OUTLIER -67.38 -168.87 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.611 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -73.9 48.44 0.29 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.811 0.339 . . . . 0.0 110.489 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.593 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 58.9 18.73 6.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.222 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 191' ' ' ILE . 11.6 pt20 -111.67 -22.57 11.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.761 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.779 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 27.8 mt-30 -148.0 139.86 23.96 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.13 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.995 ' HB3' HD21 ' A' ' 177' ' ' LEU . 13.6 m-85 -111.15 98.37 7.47 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 1.07 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 37.2 t -82.4 111.42 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-O 121.153 0.501 . . . . 0.0 111.068 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.94 HG21 ' CB ' ' A' ' 180' ' ' ALA . 2.4 m -98.43 113.57 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.789 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.545 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 2.0 mptp? -65.03 103.83 0.79 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.757 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.674 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -58.51 156.71 21.33 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.94 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.36 10.91 70.08 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.367 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.572 HE21 ' HA ' ' A' ' 229' ' ' GLN . 1.3 mm-40 -80.53 179.51 7.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.563 0.697 . . . . 0.0 111.901 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.698 ' HA ' HD23 ' A' ' 182' ' ' LEU . 4.0 m -173.69 106.88 0.13 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.448 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.658 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 22.9 m-85 -54.9 151.84 8.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.211 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.571 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 8.6 pt20 -122.11 142.46 50.36 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.6 t -48.6 98.74 0.19 Allowed Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.571 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 55.0 Cg_endo -67.22 -25.95 42.59 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.336 2.024 . . . . 0.0 111.976 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 112.49 -119.03 4.83 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.628 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -95.71 117.31 30.28 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.543 ' CE2' HD11 ' A' ' 207' ' ' LEU . 41.7 t80 -116.54 130.6 56.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.9 ' HA ' HG23 ' A' ' 42' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.647 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.597 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 5.2 p30 . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 120.933 0.397 . . . . 0.0 110.75 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 27' ' ' ARG . 1.4 mpp_? -67.58 -42.91 81.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.683 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.888 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -77.65 -34.33 53.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.937 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.92 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -58.32 -48.93 78.95 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.366 0.603 . . . . 0.0 110.504 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.613 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 3.2 tp -72.57 -49.29 33.44 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.225 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.695 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 31.7 mt -56.36 -33.07 65.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.732 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.674 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . . . -75.16 -29.88 60.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.695 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.762 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -71.67 -29.19 64.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.651 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.922 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.23 -13.23 38.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.046 0.451 . . . . 0.0 110.855 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.677 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.26 168.01 18.05 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.779 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.53 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 80.4 m80 -101.98 97.74 8.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.079 0.466 . . . . 0.0 110.011 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.94 140.64 6.01 Favored Glycine 0 C--N 1.316 -0.579 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.436 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.816 ' HB2' HD13 ' A' ' 76' ' ' ILE . 2.1 ttmm -66.96 139.96 57.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.983 0.421 . . . . 0.0 112.028 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.814 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -130.71 156.47 44.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.7 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.682 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 57.4 t -102.64 142.27 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.994 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.888 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -127.76 111.94 14.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.98 ' HB ' ' HD3' ' A' ' 72' ' ' ARG . 0.7 OUTLIER -102.1 164.96 11.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.894 0.378 . . . . 0.0 110.838 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.481 ' HB2' ' CD1' ' A' ' 238' ' ' LEU . 0.1 OUTLIER 66.56 19.09 10.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.726 -178.281 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.895 HD22 HD11 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -58.78 152.72 18.42 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.327 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.621 ' HB3' HG21 ' A' ' 50' ' ' VAL . 18.1 tp -82.54 114.95 21.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.22 0.533 . . . . 0.0 111.235 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -78.95 69.7 5.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.464 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.9 m -133.68 -160.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.379 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.644 ' HA ' ' CG ' ' A' ' 51' ' ' ARG . 76.9 m-20 -98.0 -19.42 18.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.014 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.433 ' OD2' ' HA ' ' A' ' 95' ' ' ALA . 4.0 m-20 -70.25 -32.2 69.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.885 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.621 HG21 ' HB3' ' A' ' 45' ' ' LEU . 21.1 t -84.72 -52.85 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.237 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.644 ' CG ' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -50.51 -28.7 8.96 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.913 179.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -72.68 -35.95 67.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.198 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.597 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 7.8 tpt -65.33 -48.93 71.32 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.92 HD23 HD21 ' A' ' 29' ' ' LEU . 1.5 mp -64.78 -47.9 76.43 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.515 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -55.63 -24.09 31.55 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.451 179.39 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.822 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -75.72 -48.99 19.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.726 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -66.48 -49.97 64.85 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.878 -179.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.497 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.3 t -51.9 -32.29 31.92 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.302 0.572 . . . . 0.0 110.034 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.703 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.21 -48.05 83.07 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.106 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.012 HD21 HD22 ' A' ' 106' ' ' LEU . 3.7 mp -69.37 -27.38 65.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.394 0.616 . . . . 0.0 110.084 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.41 -1.97 4.93 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.6 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.605 HG21 HD11 ' A' ' 82' ' ' LEU . 13.6 t -59.59 155.79 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 117.641 0.72 . . . . 0.0 110.056 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.62 ' CB ' HG13 ' A' ' 76' ' ' ILE . 1.7 m -116.95 107.71 14.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.991 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.667 ' CE2' ' HB3' ' A' ' 54' ' ' LEU . 8.3 p90 -122.24 153.43 38.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.861 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 1.7 m -147.99 116.33 6.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.877 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.895 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -87.97 177.32 6.98 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.085 0.469 . . . . 0.0 111.198 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.476 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 12.9 p -93.97 179.68 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.479 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.94 -14.59 36.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.751 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -118.12 6.8 12.06 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.888 0.375 . . . . 0.0 110.74 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.572 ' O ' HD23 ' A' ' 44' ' ' LEU . 3.9 mmt180 57.14 43.85 23.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.817 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -126.49 -2.32 6.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.436 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.98 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -136.54 109.73 7.79 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.822 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.599 ' SG ' HD22 ' A' ' 66' ' ' LEU . 5.7 t -118.11 153.99 32.86 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.461 0.648 . . . . 0.0 112.669 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.775 ' HB3' ' HD3' ' A' ' 38' ' ' LYS . 0.6 OUTLIER -121.49 103.45 8.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.054 178.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -98.96 125.05 52.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.816 HD13 ' HB2' ' A' ' 38' ' ' LYS . 8.3 mm -78.97 104.16 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.308 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.659 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -51.82 115.77 4.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.882 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.616 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -63.56 -14.87 55.56 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.914 0.388 . . . . 0.0 110.439 178.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.53 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 83.6 -19.88 13.51 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.336 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.922 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.75 -151.28 5.73 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 178.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.836 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 3.8 Cg_exo -77.47 171.0 18.35 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 119.638 1.719 . . . . 0.0 109.222 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.805 ' HB2' HD23 ' A' ' 106' ' ' LEU . 4.1 mm? -68.09 90.99 0.34 Allowed 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.836 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 32.7 m170 -84.21 120.74 26.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 113.062 -1.881 . . . . 0.0 112.368 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.745 ' HB3' HD11 ' A' ' 113' ' ' ILE . . . -144.13 106.83 4.44 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.274 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.08 88.63 2.78 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.545 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.07 21.18 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.803 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.47 50.07 15.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.421 0.629 . . . . 0.0 109.904 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.8 HD12 ' N ' ' A' ' 89' ' ' GLU . 2.8 tp -78.4 135.87 37.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.041 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.8 ' N ' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -116.63 126.49 53.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.274 0.559 . . . . 0.0 110.286 179.157 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.822 HD13 ' HA ' ' A' ' 56' ' ' ALA . 19.7 mt -107.91 156.25 19.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.762 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 116' ' ' THR . 49.5 t80 -122.07 102.15 7.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.884 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.74 HD23 ' HE2' ' A' ' 99' ' ' MET . 1.9 mm? -91.74 6.86 44.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.275 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 43.5 -142.84 2.04 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.859 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -92.92 50.43 1.56 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.169 0.509 . . . . 0.0 110.824 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.433 ' HA ' ' OD2' ' A' ' 49' ' ' ASP . . . -84.23 -77.03 0.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.218 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.539 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.54 -16.43 19.06 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.36 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.437 ' HA ' ' NE2' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -96.22 -9.9 29.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.851 0.358 . . . . 0.0 110.474 179.013 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.453 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -130.8 -15.94 3.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.731 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.74 ' HE2' HD23 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -67.95 -54.42 18.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.074 0.464 . . . . 0.0 110.459 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.652 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -60.48 -53.13 67.58 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.383 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.804 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 33.4 Cg_exo -59.9 -47.05 16.73 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.86 2.373 . . . . 0.0 112.894 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.928 HD13 HD11 ' A' ' 106' ' ' LEU . 2.7 tm? -68.54 -34.42 75.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.504 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.68 -47.65 85.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.523 0.677 . . . . 0.0 110.542 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.916 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -72.45 -39.85 67.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.077 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.603 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -56.57 -39.77 74.04 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.214 0.531 . . . . 0.0 111.735 -177.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.012 HD22 HD21 ' A' ' 60' ' ' LEU . 1.3 mt -72.58 -22.01 61.05 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.039 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.762 ' SG ' HD11 ' A' ' 140' ' ' ILE . 84.9 m -61.92 -8.55 5.22 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.344 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.747 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 11.2 mt -85.6 165.05 17.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.04 -113.58 5.23 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.33 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.436 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 1.4 p -168.66 95.33 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.886 0.374 . . . . 0.0 111.242 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.958 HD21 ' HB3' ' A' ' 106' ' ' LEU . 51.1 p-10 -138.99 143.25 38.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.039 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.5 m-20 -101.08 111.55 23.78 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.18 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.745 HD11 ' HB3' ' A' ' 84' ' ' ALA . 5.0 mp -141.49 142.4 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.023 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.622 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 22.5 t -116.09 112.06 38.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.744 0.307 . . . . 0.0 110.377 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.556 HD22 HD21 ' A' ' 92' ' ' LEU . 21.8 mt -79.08 157.14 28.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.415 0.626 . . . . 0.0 111.787 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 35.2 m -161.99 154.74 20.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.758 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.69 -167.1 10.94 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 119.897 -1.144 . . . . 0.0 113.425 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.621 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 2.3 mt-10 -70.65 173.03 5.12 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.387 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 20.2 Cg_endo -61.19 -24.39 78.98 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.598 1.532 . . . . 0.0 111.972 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.52 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 2.3 tpp180 -90.23 -33.14 16.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.261 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.599 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 6.0 tpt -60.12 -19.55 54.0 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.675 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 7.6 mttm -68.33 -4.92 16.09 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.122 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.617 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -121.29 30.48 6.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.886 0.374 . . . . 0.0 110.986 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.454 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 4.0 mmp_? -108.96 93.75 13.26 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.758 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.65 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 8.2 Cg_endo -50.1 128.62 22.83 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.559 2.173 . . . . 0.0 112.466 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.772 HD11 HD23 ' A' ' 129' ' ' LEU . 17.3 tt -133.83 31.12 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.766 0.793 . . . . 0.0 110.215 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -71.8 -51.57 14.88 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.202 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.809 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.2 OUTLIER -53.14 -26.9 18.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.962 0.41 . . . . 0.0 110.727 -179.299 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.799 HD13 ' HA ' ' A' ' 172' ' ' PHE . 35.4 tp -82.63 -66.5 0.88 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.749 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.872 HG13 HD12 ' A' ' 140' ' ' ILE . 61.1 t -52.13 -25.44 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.312 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 30.9 t0 -72.16 -45.31 60.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.585 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.979 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -64.89 -51.83 59.8 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.834 0.35 . . . . 0.0 111.513 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.748 HD21 ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -56.62 -43.01 79.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.221 0.534 . . . . 0.0 109.874 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -60.06 -32.67 71.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.048 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.979 HD12 ' HA ' ' A' ' 132' ' ' ALA . 2.2 mt -72.09 -26.75 62.27 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.462 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.526 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -80.82 -13.55 81.16 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.659 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.82 4.04 6.24 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.302 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.88 145.71 48.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.923 0.392 . . . . 0.0 111.53 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 0.2 OUTLIER -114.29 90.83 3.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.54 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.97 HG23 HD23 ' A' ' 153' ' ' LEU . 7.0 mt -117.48 174.54 3.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.957 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.763 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.8 OUTLIER -152.43 -168.08 2.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 111.39 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.591 ' N ' HG23 ' A' ' 141' ' ' THR . 25.7 m-85 -131.77 105.65 7.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.097 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.686 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.1 mm? -79.69 -8.88 59.5 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.812 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 27.5 mt-10 -141.33 -73.68 0.33 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.349 . . . . 0.0 110.379 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.647 ' HB3' ' HD2' ' A' ' 148' ' ' TYR . 0.1 OUTLIER -123.87 148.63 46.63 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.252 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.45 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 4.3 mt-10 -70.24 135.64 49.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.12 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.65 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 1.3 m-80 64.59 49.59 2.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.319 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.868 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.8 m-85 -148.29 179.6 1.15 Allowed Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.734 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.868 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 8.0 Cg_endo -50.22 -40.36 51.77 Favored 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 123.331 2.687 . . . . 0.0 115.037 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.812 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 36.7 Cg_endo -62.05 100.94 0.22 Allowed 'Trans proline' 0 CA--C 1.516 -0.375 0 C-N-CA 121.513 1.475 . . . . 0.0 111.586 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.476 HD21 ' HE1' ' A' ' 142' ' ' TYR . 91.5 mt -139.56 122.95 17.14 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.802 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.686 ' N ' HD21 ' A' ' 143' ' ' LEU . 0.9 OUTLIER -104.49 112.55 25.65 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.97 HD23 HG23 ' A' ' 140' ' ' ILE . 1.2 mt -96.07 155.39 16.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.254 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 18.8 mt-30 -142.55 24.34 1.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.615 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 56.49 -165.91 4.66 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.433 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.97 -4.98 34.1 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.13 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.651 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 3.5 t80 -60.8 107.34 0.69 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.863 0.332 . . . . 0.0 110.494 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.465 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 76.4 p -105.61 -46.39 4.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.889 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.676 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 141.73 -162.3 27.02 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.136 -1.03 . . . . 0.0 113.981 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.592 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 115.71 172.67 17.04 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -65.16 126.76 29.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.613 HG11 ' HB1' ' A' ' 132' ' ' ALA . 58.0 t -135.5 157.54 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-O 121.132 0.491 . . . . 0.0 111.47 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.535 ' O ' ' HE2' ' A' ' 192' ' ' LYS . 3.2 m-20 -123.65 119.66 30.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.384 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.805 HG11 HD13 ' A' ' 173' ' ' LEU . 0.4 OUTLIER -121.74 139.13 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.548 -0.461 . . . . 0.0 112.101 -178.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.809 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.3 OUTLIER -78.93 133.5 36.91 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.267 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.715 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -75.43 -44.64 21.1 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.105 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.493 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 54.4 p -52.91 165.44 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.922 0.391 . . . . 0.0 111.359 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.777 HG21 ' HE1' ' A' ' 128' ' ' HIS . 6.6 t 72.61 50.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.01 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.825 ' H ' HG11 ' A' ' 196' ' ' VAL . 1.4 m 63.62 150.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.424 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.467 ' HG ' ' HG1' ' A' ' 174' ' ' THR . 12.2 t -77.68 3.65 13.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.711 0.291 . . . . 0.0 111.412 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.652 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 18.9 mm100 -54.49 -20.68 8.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.983 0.42 . . . . 0.0 111.42 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.799 ' HA ' HD13 ' A' ' 129' ' ' LEU . 1.6 m-85 -76.09 -54.29 7.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.619 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.838 HD23 HG12 ' A' ' 201' ' ' ILE . 21.0 tp -77.33 -35.03 55.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.593 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.475 HG23 ' OG1' ' A' ' 204' ' ' THR . 79.8 m -58.99 -33.46 70.71 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.026 0.441 . . . . 0.0 110.029 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.916 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -76.33 -51.96 10.9 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.966 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.711 ' CD2' HD23 ' A' ' 133' ' ' LEU . 3.2 mt -61.99 -43.08 99.6 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.507 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.06 HD22 HD21 ' A' ' 205' ' ' LEU . 12.6 mt -60.75 -28.07 68.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.867 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.639 ' HA ' ' OH ' ' A' ' 231' ' ' TYR . 4.9 ptp -96.39 -26.24 15.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.325 0.583 . . . . 0.0 110.492 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.618 ' O ' HD11 ' A' ' 108' ' ' LEU . 74.1 m -85.17 -47.55 10.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.157 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.892 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -63.74 -35.84 18.44 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.719 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 9.7 Cg_endo -53.17 -37.77 80.35 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 121.129 1.219 . . . . 0.0 111.376 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.577 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.78 -8.06 58.96 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -67.43 115.8 30.4 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.057 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -33.58 -34.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.69 2.927 . . . . 0.0 114.33 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -103.65 152.92 21.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.005 0.431 . . . . 0.0 111.77 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.678 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 40.9 t0 -67.29 114.68 6.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.708 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.817 ' HB ' HG23 ' A' ' 225' ' ' VAL . 29.2 m -99.7 135.23 41.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.098 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 1.07 HG22 HG13 ' A' ' 224' ' ' VAL . 25.4 t -125.8 99.22 5.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.881 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.5 mt -91.11 144.49 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.267 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.822 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.2 OUTLIER -114.93 170.98 7.93 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.845 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.4 mm -111.54 97.15 5.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.269 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.599 ' HE3' ' N ' ' A' ' 165' ' ' ASP . 9.3 mtmt -57.0 -81.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.681 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -83.21 168.0 46.06 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.361 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -59.61 122.64 14.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.568 0.223 . . . . 0.0 110.84 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.715 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.4 OUTLIER -55.65 147.6 17.97 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.22 0.533 . . . . 0.0 110.841 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.825 HG11 ' H ' ' A' ' 169' ' ' SER . 11.8 p -103.81 -21.06 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.134 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.57 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.3 OUTLIER -128.11 46.15 2.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.125 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.807 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.6 OUTLIER -43.62 -61.64 1.81 Allowed Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 114.854 -1.066 . . . . 0.0 113.11 -178.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 15.0 Cg_exo -69.37 -17.28 39.44 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 121.476 1.451 . . . . 0.0 111.55 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.691 ' HA ' HD12 ' A' ' 203' ' ' ILE . 26.9 m-85 -75.08 -30.69 61.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.113 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 1.014 HD11 HD12 ' A' ' 177' ' ' LEU . 8.0 tp -67.95 -33.6 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.229 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.565 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 9.9 t70 -59.79 -33.71 72.07 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.691 HD12 ' HA ' ' A' ' 200' ' ' TYR . 13.1 mt -68.32 -29.86 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.622 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.505 HG22 ' SD ' ' A' ' 208' ' ' MET . 71.7 m -61.0 -54.71 41.6 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.124 0.488 . . . . 0.0 109.716 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 1.06 HD21 HD22 ' A' ' 177' ' ' LEU . 28.7 mt -70.4 -34.64 72.77 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.231 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.737 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 0.9 OUTLIER -63.6 -29.93 71.11 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.299 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.695 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -77.73 -40.82 39.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.613 178.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.505 ' SD ' HG22 ' A' ' 204' ' ' THR . 10.4 mtp -68.76 -38.56 80.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.966 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.737 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -66.7 -45.26 79.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.384 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.667 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 2.0 t -58.71 -26.08 63.53 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.317 0.58 . . . . 0.0 109.529 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.943 ' HA ' ' HG3' ' A' ' 234' ' ' PRO . 2.1 m-85 -74.92 -54.56 7.02 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.602 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 156.67 -1.56 0.13 Allowed Glycine 0 CA--C 1.52 0.351 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.883 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.626 ' HB ' ' CD1' ' A' ' 231' ' ' TYR . 53.0 t -117.75 138.22 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.046 0.451 . . . . 0.0 111.767 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -135.49 155.12 51.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.535 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.966 HG21 HG12 ' A' ' 225' ' ' VAL . 2.4 pp -129.31 175.5 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.956 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.317 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 1.01 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 18.7 tt0 -89.91 125.52 35.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.874 0.368 . . . . 0.0 110.37 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -101.14 100.95 11.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.248 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.723 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 2.1 mm-40 -66.74 -167.08 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.75 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.46 48.26 0.34 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.901 0.381 . . . . 0.0 110.341 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.588 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 57.88 19.65 5.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.254 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 191' ' ' ILE . 3.1 pt20 -112.94 -19.72 11.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.83 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.775 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 32.5 mt-30 -150.34 141.67 23.27 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.701 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 1.004 ' HB3' HD21 ' A' ' 177' ' ' LEU . 19.4 m-85 -114.14 96.76 5.97 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 1.07 HG13 HG22 ' A' ' 188' ' ' VAL . 31.1 t -82.8 110.97 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 121.167 0.508 . . . . 0.0 111.235 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.966 HG12 HG21 ' A' ' 215' ' ' ILE . 3.0 m -99.87 113.15 34.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.964 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.661 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 1.3 mptm? -62.74 103.82 0.47 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.998 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.678 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.25 155.86 16.36 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.947 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.97 8.77 75.23 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.445 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.661 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 69.8 mm-40 -73.16 178.54 4.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.473 0.654 . . . . 0.0 111.546 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.577 ' HA ' HD23 ' A' ' 182' ' ' LEU . 4.9 m -167.68 105.55 0.52 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.863 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.677 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 22.7 m-85 -55.15 142.53 30.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.108 0.48 . . . . 0.0 111.368 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.569 ' HB2' ' O ' ' A' ' 211' ' ' PHE . 78.9 mt-30 -108.21 148.58 29.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.673 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 56.6 p -64.13 103.05 0.37 Allowed Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.155 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.943 ' HG3' ' HA ' ' A' ' 211' ' ' PHE . 7.7 Cg_exo -71.36 -31.39 14.17 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.705 2.27 . . . . 0.0 111.966 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.01 -120.79 5.22 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.682 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -92.9 116.8 29.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 88.1 t80 -123.78 136.8 54.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.519 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.931 HD12 HG23 ' A' ' 42' ' ' THR . 4.0 tp . . . . . 0 CA--C 1.514 -0.408 0 CA-C-O 121.261 0.553 . . . . 0.0 111.707 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.719 ' OD1' ' HA ' ' A' ' 50' ' ' VAL . 64.3 m-20 . . . . . 0 CA--C 1.519 -0.229 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 35.0 mtt85 -62.19 -40.41 95.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.053 0.454 . . . . 0.0 110.293 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.843 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -74.32 -37.63 63.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.908 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.935 HD13 ' HG ' ' A' ' 54' ' ' LEU . 55.1 mt -58.36 -47.19 84.61 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.862 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.875 HD21 ' HB2' ' A' ' 105' ' ' ALA . 14.9 tp -77.82 -48.84 15.55 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.572 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 27.7 mt -55.05 -35.19 64.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.467 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.707 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -78.17 -29.7 48.74 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.675 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.766 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -70.26 -30.58 67.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.939 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.869 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.35 -12.54 40.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.996 0.427 . . . . 0.0 111.065 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.691 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -80.42 168.68 18.68 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.239 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.59 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 76.9 m80 -103.19 98.42 8.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.217 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.71 141.06 6.95 Favored Glycine 0 C--N 1.314 -0.657 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.627 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.73 ' HB2' HG13 ' A' ' 76' ' ' ILE . 1.6 ttpm? -64.84 138.53 58.43 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.37 157.74 44.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.374 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.878 HG22 ' HG3' ' A' ' 74' ' ' GLU . 94.1 t -104.83 141.46 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.372 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.843 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -127.93 111.62 13.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.888 178.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.982 HG23 HD12 ' A' ' 238' ' ' LEU . 0.1 OUTLIER -98.31 171.03 8.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 111.783 -179.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.65 ' HB2' HD11 ' A' ' 238' ' ' LEU . 1.8 t30 66.03 18.17 10.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.233 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.847 HD22 HD11 ' A' ' 66' ' ' LEU . 1.2 tp -58.61 163.64 3.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.536 ' HB3' HG21 ' A' ' 50' ' ' VAL . 38.5 tp -97.64 116.63 30.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.009 0.433 . . . . 0.0 111.425 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -75.64 71.85 2.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.749 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.532 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 63.1 m -134.85 -162.98 1.31 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.899 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.624 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 1.5 t70 -98.19 -22.11 16.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.896 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.464 ' CG ' ' HA ' ' A' ' 95' ' ' ALA . 8.2 m-20 -66.61 -30.4 70.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.78 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.719 ' HA ' ' OD1' ' A' ' 26' ' ' ASN . 21.3 t -84.48 -56.02 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.058 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.624 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 1.1 ptm180 -49.99 -26.97 4.77 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -71.41 -40.77 70.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.296 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.485 ' SD ' ' HB1' ' A' ' 98' ' ' ALA . 7.1 tpt -64.87 -47.43 77.91 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.935 ' HG ' HD13 ' A' ' 29' ' ' LEU . 1.3 mp -65.33 -47.21 77.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.588 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 8.4 t-20 -57.39 -23.01 46.64 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.0 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.692 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -74.76 -48.1 27.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.056 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -68.18 -49.44 60.87 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.771 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.509 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.0 t -51.65 -30.23 20.86 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.281 0.562 . . . . 0.0 110.201 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.9 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.31 -52.49 65.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.962 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.967 HD21 HD22 ' A' ' 106' ' ' LEU . 3.8 mp -65.14 -28.38 69.38 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.83 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.76 0.61 5.23 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 114.834 -1.075 . . . . 0.0 113.494 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.681 HG21 HD11 ' A' ' 82' ' ' LEU . 22.9 t -56.55 154.2 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 117.609 0.705 . . . . 0.0 110.391 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.856 ' HB3' HD13 ' A' ' 76' ' ' ILE . 11.9 m -115.16 112.27 22.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.379 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 7.5 p90 -129.71 156.95 43.45 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.875 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.685 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -149.25 116.05 5.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.823 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.95 HD22 ' HG ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -90.32 175.55 7.07 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.232 0.539 . . . . 0.0 111.645 -179.424 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.842 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 1.3 t -87.85 179.42 6.47 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.709 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.33 -14.36 49.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.33 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.98 2.39 11.5 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.866 0.365 . . . . 0.0 110.705 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.503 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER 61.33 45.29 8.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.428 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -124.03 -2.72 8.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.974 179.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.842 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -142.54 110.62 5.97 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.95 ' HG ' HD22 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -114.93 152.62 32.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.256 0.55 . . . . 0.0 112.064 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.878 ' HG3' HG22 ' A' ' 40' ' ' VAL . 1.1 mt-10 -118.11 102.85 9.34 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.689 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.703 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -99.44 126.44 52.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.856 HD13 ' HB3' ' A' ' 63' ' ' SER . 3.1 mp -80.94 103.81 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.425 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.707 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -48.08 118.79 4.76 Favored Glycine 0 N--CA 1.453 -0.186 0 CA-C-N 116.017 -0.538 . . . . 0.0 114.136 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.592 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -63.77 -15.38 58.5 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.987 0.423 . . . . 0.0 110.357 178.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.59 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.02 -19.71 20.17 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.827 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.869 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -139.73 -150.22 5.47 Favored Glycine 0 C--O 1.224 -0.519 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.806 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 4.3 Cg_exo -77.57 170.08 19.85 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 CA-C-N 119.711 1.755 . . . . 0.0 108.828 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.809 HD12 HD13 ' A' ' 60' ' ' LEU . 4.3 mm? -68.43 89.59 0.35 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.806 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 34.1 m170 -83.44 118.34 23.68 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.012 -1.904 . . . . 0.0 112.333 -176.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.784 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -143.27 107.65 4.79 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.773 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -106.88 89.33 2.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.733 0.302 . . . . 0.0 110.947 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.63 20.45 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.74 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.32 48.11 19.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.394 0.616 . . . . 0.0 110.263 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.9 HD21 ' HB1' ' A' ' 59' ' ' ALA . 3.9 tp -76.57 131.6 39.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.261 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.706 ' N ' HD12 ' A' ' 88' ' ' LEU . 6.9 tt0 -110.64 128.26 55.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.261 0.553 . . . . 0.0 110.096 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.802 HD21 ' CB ' ' A' ' 59' ' ' ALA . 48.6 mt -110.69 156.99 20.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.118 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 116' ' ' THR . 45.4 t80 -119.57 105.15 10.93 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.628 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.853 HD23 ' HE2' ' A' ' 99' ' ' MET . 2.8 mm? -91.47 8.17 37.68 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.798 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 121' ' ' MET . . . 39.72 -139.82 0.93 Allowed Glycine 0 CA--C 1.523 0.556 0 C-N-CA 121.327 -0.463 . . . . 0.0 113.781 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.667 ' OD1' ' HB3' ' A' ' 120' ' ' ARG . 0.7 OUTLIER -91.32 46.57 1.31 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.023 0.44 . . . . 0.0 111.084 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.464 ' HA ' ' CG ' ' A' ' 49' ' ' ASP . . . -90.52 -77.44 0.41 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.461 ' O ' ' HG2' ' A' ' 171' ' ' GLN . . . 78.65 -14.36 13.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.99 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.58 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -96.29 -11.47 25.88 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 120.81 0.338 . . . . 0.0 110.429 178.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.485 ' HB1' ' SD ' ' A' ' 53' ' ' MET . . . -125.05 -21.27 4.7 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.49 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.853 ' HE2' HD23 ' A' ' 92' ' ' LEU . 10.4 ttm -66.8 -52.02 48.86 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.263 0.554 . . . . 0.0 110.47 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.918 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -57.77 -55.39 45.4 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.156 -179.522 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.671 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 24.1 Cg_exo -63.45 -46.8 8.75 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.53 2.153 . . . . 0.0 112.886 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.929 HD13 HD11 ' A' ' 106' ' ' LEU . 2.9 tm? -61.3 -40.81 95.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.78 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.701 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -58.94 -48.48 81.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.65 0.738 . . . . 0.0 109.736 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.691 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -68.01 -40.11 83.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.779 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.875 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -56.16 -42.49 77.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.042 0.449 . . . . 0.0 111.315 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.967 HD22 HD21 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -71.74 -21.32 61.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.399 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.671 ' SG ' HD11 ' A' ' 140' ' ' ILE . 82.6 m -58.36 -11.76 3.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.669 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.72 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 12.3 mt -84.43 167.68 16.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.716 0.293 . . . . 0.0 110.244 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 55.04 -110.75 1.86 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.076 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.486 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.9 OUTLIER -171.3 96.25 0.19 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.954 0.407 . . . . 0.0 111.207 179.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.686 ' HB2' HD11 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -137.28 139.61 41.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.974 -179.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.677 ' C ' HD12 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -99.77 111.3 23.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.752 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.742 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.3 mp -141.02 139.85 33.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.224 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 21.3 t -112.2 113.41 44.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.701 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 18.1 mt -80.44 155.46 27.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.467 0.651 . . . . 0.0 112.215 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 11.2 m -162.72 156.88 20.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.294 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -147.58 -165.34 11.81 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 119.972 -1.109 . . . . 0.0 113.662 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.577 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 1.7 mt-10 -71.38 177.86 1.44 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.312 -0.444 . . . . 0.0 110.507 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.577 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 38.7 Cg_exo -61.74 -26.43 79.77 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.177 1.918 . . . . 0.0 112.52 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.667 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 11.7 tpt180 -87.25 -38.56 16.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.714 0.292 . . . . 0.0 110.483 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.718 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 8.7 tpt -59.6 -19.21 47.32 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.706 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 11.8 mttp -72.32 -4.5 30.19 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.82 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.683 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 5.4 pt-20 -126.62 25.06 6.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.981 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.426 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 33.2 mmt180 -100.15 87.23 0.71 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.271 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.639 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 1.3 Cg_endo -42.32 126.82 3.99 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.958 2.439 . . . . 0.0 112.449 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.729 HD11 HD23 ' A' ' 129' ' ' LEU . 16.5 tt -131.6 31.71 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.818 0.818 . . . . 0.0 110.103 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.592 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -70.7 -52.64 14.63 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.517 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.778 ' HE1' HG21 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -54.3 -25.45 23.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.737 0.303 . . . . 0.0 110.686 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.863 ' CD1' HD21 ' A' ' 133' ' ' LEU . 26.5 tp -84.39 -66.21 0.92 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.885 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.877 HG13 HD12 ' A' ' 140' ' ' ILE . 48.0 t -52.82 -25.2 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.189 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.592 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 10.8 t0 -72.55 -46.58 53.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.388 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.945 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -65.07 -46.76 79.83 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.661 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.941 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -60.77 -42.27 97.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.362 0.601 . . . . 0.0 109.777 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.48 -34.8 74.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.056 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.945 HD12 ' HA ' ' A' ' 132' ' ' ALA . 3.4 mt -68.51 -30.58 69.43 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.253 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.21 -18.49 80.04 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.541 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.3 4.58 5.38 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.231 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.99 148.35 49.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.85 0.357 . . . . 0.0 111.406 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.57 87.47 2.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.402 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.986 HG23 HD23 ' A' ' 153' ' ' LEU . 6.8 mt -114.56 175.34 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.47 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.769 ' H ' HG22 ' A' ' 140' ' ' ILE . 1.0 OUTLIER -152.32 -167.22 2.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.232 0.539 . . . . 0.0 111.152 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.594 ' N ' HG23 ' A' ' 141' ' ' THR . 23.5 m-85 -133.64 105.98 7.14 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.671 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.0 mm? -81.04 -14.75 57.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.738 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.649 ' HG3' ' N ' ' A' ' 145' ' ' GLN . 0.1 OUTLIER -134.67 -68.31 0.54 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.996 0.427 . . . . 0.0 109.92 179.439 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.649 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -132.38 150.89 52.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.229 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.452 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 66.3 mt-10 -69.0 131.87 45.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.235 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.639 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 13.4 m-20 65.55 50.39 1.66 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.081 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.874 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.3 m-30 -143.03 -178.95 0.86 Allowed Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.874 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 11.9 Cg_endo -59.0 -36.59 96.52 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.599 2.199 . . . . 0.0 114.548 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.701 ' HD2' ' N ' ' A' ' 149' ' ' PRO . 39.0 Cg_endo -62.94 93.77 0.15 Allowed 'Trans proline' 0 CA--C 1.515 -0.465 0 C-N-CA 121.465 1.443 . . . . 0.0 111.221 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 150' ' ' PRO . 72.0 mt -132.54 123.49 26.63 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.513 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.709 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.0 OUTLIER -103.11 111.54 23.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.986 HD23 HG23 ' A' ' 140' ' ' ILE . 1.1 mt -94.07 159.35 15.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.458 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -147.2 23.62 1.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.662 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.514 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 55.84 -165.5 4.11 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.318 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.423 ' O ' HG23 ' A' ' 158' ' ' THR . . . 106.96 -2.38 35.59 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.64 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.698 ' HE1' ' HA ' ' A' ' 133' ' ' LEU . 40.9 t80 -63.44 111.92 2.53 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.029 0.442 . . . . 0.0 110.752 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.626 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 78.1 p -106.99 -47.64 3.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.462 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.62 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 140.09 -161.66 26.38 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.913 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.629 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 115.96 170.44 15.9 Favored Glycine 0 CA--C 1.519 0.289 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -66.51 123.26 19.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.056 0.428 . . . . 0.0 110.191 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.55 HG11 ' HB1' ' A' ' 132' ' ' ALA . 38.8 t -131.6 157.05 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 111.512 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.465 ' CG ' ' HG2' ' A' ' 190' ' ' ARG . 2.5 m-20 -120.97 115.24 22.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.606 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.594 HG21 ' CD1' ' A' ' 176' ' ' LEU . 0.5 OUTLIER -116.49 145.62 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 120.176 -0.609 . . . . 0.0 112.201 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.562 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.9 OUTLIER -82.9 132.86 35.14 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.925 179.3 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.684 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -74.61 -44.73 25.36 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.369 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.438 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 0.6 OUTLIER -52.02 165.71 0.19 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.879 0.371 . . . . 0.0 111.28 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.778 HG21 ' HE1' ' A' ' 128' ' ' HIS . 4.1 t 71.8 54.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.979 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.857 ' N ' HG11 ' A' ' 196' ' ' VAL . 69.6 m 59.26 160.02 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.266 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.726 ' HB2' ' HB2' ' A' ' 197' ' ' SER . 34.8 t -80.55 -1.63 42.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.918 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 2.2 mp0 -51.34 -22.16 2.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.671 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.666 ' HA ' HD13 ' A' ' 129' ' ' LEU . 2.7 m-85 -78.5 -54.94 5.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.942 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.748 HD23 HG12 ' A' ' 201' ' ' ILE . 32.1 tp -73.18 -41.04 64.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.399 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 170' ' ' SER . 14.7 t -58.64 -32.71 69.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.433 0.635 . . . . 0.0 109.499 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.691 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -64.88 -52.27 57.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.021 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.941 ' CD2' HD23 ' A' ' 133' ' ' LEU . 1.9 mt -71.28 -36.09 71.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.187 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.054 HD22 HD21 ' A' ' 205' ' ' LEU . 9.8 mt -66.2 -29.83 70.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.123 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.662 ' CE ' HD23 ' A' ' 30' ' ' LEU . 23.6 mtp -93.98 -27.54 16.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.259 0.552 . . . . 0.0 110.64 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.662 HG23 ' HG ' ' A' ' 108' ' ' LEU . 87.6 m -88.12 -46.83 8.96 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.141 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.954 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -62.28 -36.71 30.4 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.4 Cg_endo -54.46 -37.72 89.7 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 CA-C-N 120.297 1.142 . . . . 0.0 111.506 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.703 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -83.79 -5.74 59.27 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.229 -179.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.626 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -68.1 124.66 90.16 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.1 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 1.5 Cg_endo -43.74 -29.88 2.61 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.95 2.433 . . . . 0.0 113.535 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -107.75 151.53 25.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.067 0.46 . . . . 0.0 111.652 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.655 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 20.6 t0 -64.55 118.03 8.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.655 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.774 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 41.1 m -102.26 133.85 46.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.817 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 1.016 HG22 HG13 ' A' ' 224' ' ' VAL . 33.3 t -126.0 99.16 5.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.273 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.58 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.2 mt -91.71 145.94 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.116 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.842 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.1 OUTLIER -118.19 171.04 8.39 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.866 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.6 mm -111.69 98.17 6.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-O 121.096 0.474 . . . . 0.0 111.467 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -60.14 -81.01 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.381 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -81.09 166.75 48.74 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.422 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -57.61 126.32 26.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.65 0.262 . . . . 0.0 111.168 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.684 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.4 OUTLIER -62.48 147.21 49.48 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.013 0.435 . . . . 0.0 110.711 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.857 HG11 ' N ' ' A' ' 169' ' ' SER . 11.6 p -104.21 -20.55 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.797 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.726 ' HB2' ' HB2' ' A' ' 170' ' ' SER . 0.4 OUTLIER -128.28 45.32 2.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.378 0.608 . . . . 0.0 109.589 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.842 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.0 OUTLIER -41.72 -63.9 0.76 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.541 -179.081 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 49.0 Cg_endo -68.42 -17.33 44.03 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 121.707 1.605 . . . . 0.0 111.479 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.87 ' HA ' HD12 ' A' ' 203' ' ' ILE . 17.2 m-85 -76.88 -26.74 54.55 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.264 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.905 HD11 HD12 ' A' ' 177' ' ' LEU . 6.3 tp -73.08 -33.61 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.847 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.1 OUTLIER -61.89 -35.0 77.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.226 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.87 HD12 ' HA ' ' A' ' 200' ' ' TYR . 10.1 mt -66.7 -28.67 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.175 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.582 HG22 ' SD ' ' A' ' 208' ' ' MET . 53.9 m -61.45 -55.16 34.29 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 1.054 HD21 HD22 ' A' ' 177' ' ' LEU . 41.3 mt -70.05 -34.28 73.02 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.549 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.62 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 8.8 t30 -64.84 -25.51 67.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.193 0.521 . . . . 0.0 109.839 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.779 HD11 ' CZ ' ' A' ' 237' ' ' TYR . 0.2 OUTLIER -83.9 -40.32 18.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.308 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.59 ' SD ' HD23 ' A' ' 205' ' ' LEU . 11.2 mtp -69.24 -39.41 78.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.018 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.62 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.1 OUTLIER -65.91 -44.45 85.16 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.53 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 207' ' ' LEU . 1.3 t -59.02 -28.98 66.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.426 0.632 . . . . 0.0 109.39 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.676 ' CE2' ' HA ' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -71.33 -51.41 24.42 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.926 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 157.39 -5.85 0.18 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.531 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.695 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 54.9 t -118.84 137.33 53.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.972 0.415 . . . . 0.0 111.857 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.405 ' HG3' ' HA ' ' A' ' 209' ' ' LYS . 5.8 mt-10 -135.05 156.13 49.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.629 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 1.07 HG21 HG12 ' A' ' 225' ' ' VAL . 2.0 pp -132.44 175.99 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.932 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.868 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 4.5 tt0 -88.02 122.94 32.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.161 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.61 100.88 10.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.274 0.559 . . . . 0.0 109.778 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.764 ' HB2' ' HG2' ' A' ' 222' ' ' GLN . 1.5 tm0? -72.92 -161.87 0.1 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.044 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.422 ' H ' ' CD ' ' A' ' 218' ' ' GLN . 18.7 m-70 -74.32 46.28 0.25 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.499 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.713 ' CE2' ' HD3' ' A' ' 198' ' ' LYS . 0.3 OUTLIER 58.45 22.37 9.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.143 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 191' ' ' ILE . 23.3 mt-30 -109.0 -37.39 5.84 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.021 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.797 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 5.0 pt20 -136.12 139.19 42.75 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.278 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.866 ' CD1' HD11 ' A' ' 191' ' ' ILE . 28.2 m-85 -108.93 95.57 5.73 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 1.016 HG13 HG22 ' A' ' 188' ' ' VAL . 81.3 t -86.11 112.94 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.265 -177.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 1.07 HG12 HG21 ' A' ' 215' ' ' ILE . 6.3 m -101.1 115.78 43.43 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.555 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.601 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -64.41 101.47 0.44 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.956 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.655 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -53.51 156.43 5.74 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.256 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.26 10.85 67.86 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.236 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 60.3 mm-40 -75.84 -179.63 4.93 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.53 0.681 . . . . 0.0 111.657 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.703 ' HA ' HD23 ' A' ' 182' ' ' LEU . 3.9 m -170.68 105.9 0.27 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.863 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.695 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 21.9 m-85 -53.64 149.13 8.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.933 0.397 . . . . 0.0 111.079 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.64 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 60.8 mt-30 -115.15 163.49 15.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.024 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 234' ' ' PRO . 15.2 t -82.61 98.88 0.53 Allowed Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.987 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.64 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 50.4 Cg_endo -66.52 -31.32 41.97 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.587 2.191 . . . . 0.0 112.384 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.86 -121.52 5.18 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.611 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -94.19 115.85 28.17 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.779 ' CZ ' HD11 ' A' ' 207' ' ' LEU . 0.0 OUTLIER -130.12 146.87 51.8 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.508 -178.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.982 HD12 HG23 ' A' ' 42' ' ' THR . 6.7 tp . . . . . 0 CA--C 1.514 -0.419 0 CA-C-O 121.043 0.449 . . . . 0.0 110.716 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.568 ' OD1' ' HA ' ' A' ' 50' ' ' VAL . 59.1 m-20 . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.675 0.274 . . . . 0.0 111.735 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 -65.59 -46.68 78.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.835 0.35 . . . . 0.0 110.767 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.982 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -69.39 -35.84 76.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.401 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.908 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -59.96 -53.96 51.76 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.237 0.542 . . . . 0.0 110.705 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.751 HD21 ' HB2' ' A' ' 105' ' ' ALA . 11.8 tp -63.54 -54.35 37.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.951 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.803 HD21 ' HG2' ' A' ' 178' ' ' MET . 78.0 mt -52.73 -34.1 51.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.929 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.711 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -78.09 -29.28 49.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.658 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.781 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -73.89 -31.66 63.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.422 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.867 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -88.98 -12.04 42.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.362 . . . . 0.0 110.955 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -80.4 169.46 17.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.735 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.554 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 75.4 m80 -102.64 97.35 7.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.171 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.53 141.77 6.55 Favored Glycine 0 C--N 1.317 -0.519 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.257 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.73 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 7.1 tttt -64.28 134.92 55.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.083 0.468 . . . . 0.0 111.745 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.647 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.8 OUTLIER -131.59 155.08 48.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.616 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.778 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 26.2 t -100.87 141.17 18.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.052 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.982 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -128.08 111.2 13.22 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.269 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.937 HG23 HD12 ' A' ' 238' ' ' LEU . 0.7 OUTLIER -103.79 164.73 11.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.323 0.582 . . . . 0.0 111.886 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.623 ' HB2' HD11 ' A' ' 238' ' ' LEU . 27.9 t30 71.28 21.25 4.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.325 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.67 HD22 HD11 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -58.51 160.35 5.51 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.296 178.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.654 ' HB3' HG21 ' A' ' 50' ' ' VAL . 25.6 tp -92.86 114.2 26.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.008 0.432 . . . . 0.0 111.415 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -75.0 68.78 1.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.599 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 t -129.34 -163.4 1.29 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.052 0.454 . . . . 0.0 111.322 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.581 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 48.9 m-20 -98.27 -20.65 17.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.714 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 3.7 p-10 -72.43 -27.03 62.08 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.007 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.654 HG21 ' HB3' ' A' ' 45' ' ' LEU . 17.8 t -89.07 -51.7 11.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.708 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.581 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -51.25 -27.63 9.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.181 0.515 . . . . 0.0 110.015 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . 3.4 m-70 -73.35 -36.6 66.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.962 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.618 ' SD ' ' HB1' ' A' ' 98' ' ' ALA . 13.4 tpt -64.56 -50.62 66.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.908 HD23 HD21 ' A' ' 29' ' ' LEU . 1.4 mp -62.41 -48.93 77.53 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 17.7 t-20 -57.13 -22.35 39.28 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.99 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.686 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -75.08 -46.4 34.94 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.53 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.601 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -69.28 -49.46 55.87 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.861 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.48 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 4.9 t -50.8 -30.41 14.15 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.273 0.559 . . . . 0.0 110.298 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.729 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.83 -51.13 71.04 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.077 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.127 HD21 HD22 ' A' ' 106' ' ' LEU . 3.8 mp -66.1 -27.92 68.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.878 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.16 -0.9 5.73 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 114.77 -1.105 . . . . 0.0 113.67 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.645 HG21 HD11 ' A' ' 82' ' ' LEU . 12.0 t -58.34 149.71 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 117.695 0.747 . . . . 0.0 110.359 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.417 ' HB2' HD12 ' A' ' 76' ' ' ILE . 4.0 m -113.48 108.45 17.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.214 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.664 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 12.9 p90 -126.67 159.75 32.75 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.173 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.634 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 72.3 m -149.76 116.78 5.97 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.984 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.829 HD22 ' SG ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -88.2 173.24 8.91 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.332 0.587 . . . . 0.0 112.142 -179.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.691 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -82.51 178.57 8.15 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.621 178.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.56 -12.59 46.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.705 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.14 1.38 11.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.239 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.43 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 1.6 mmt180 63.54 44.51 5.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.59 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -123.08 -2.84 8.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.229 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.691 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.1 OUTLIER -141.65 112.32 7.16 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.829 ' SG ' HD22 ' A' ' 66' ' ' LEU . 2.3 t -116.38 147.25 41.81 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.653 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 1.6 mt-10 -112.51 103.07 11.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -96.8 126.68 49.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 8.5 mt -80.96 102.89 7.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.007 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.711 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -46.6 113.0 1.01 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.957 -0.565 . . . . 0.0 113.974 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.632 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -60.35 -16.81 38.59 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.969 0.414 . . . . 0.0 110.341 178.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.554 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.45 -20.64 16.79 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.348 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.867 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.46 -151.67 5.84 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.827 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 5.4 Cg_exo -75.88 170.73 19.55 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 CA-C-N 119.653 1.726 . . . . 0.0 109.167 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.781 HD21 ' HB3' ' A' ' 33' ' ' ALA . 4.3 mm? -67.84 89.68 0.28 Allowed 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.827 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 27.8 m170 -81.68 119.38 23.76 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.017 -1.901 . . . . 0.0 112.688 -176.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.73 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -145.9 111.2 5.37 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.952 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -112.46 88.79 2.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.511 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -176.18 20.16 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.701 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.45 49.99 15.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.412 0.625 . . . . 0.0 110.037 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.778 ' O ' HG23 ' A' ' 113' ' ' ILE . 5.6 tp -79.01 133.14 36.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.09 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.684 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 1.4 tm-20 -112.11 128.66 56.28 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.636 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.625 HD21 ' CB ' ' A' ' 59' ' ' ALA . 39.0 mt -110.37 158.59 18.28 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.448 ' CE1' ' CA ' ' A' ' 93' ' ' GLY . 21.5 t80 -126.51 106.63 9.58 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.844 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 1.074 HD23 ' HE1' ' A' ' 99' ' ' MET . 2.1 mm? -95.82 8.28 43.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.184 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.448 ' CA ' ' CE1' ' A' ' 91' ' ' PHE . . . 46.95 -142.55 5.8 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.724 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.467 HD22 ' HB3' ' A' ' 120' ' ' ARG . 17.0 t-20 -93.15 49.61 1.43 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.892 0.377 . . . . 0.0 111.039 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -86.77 -75.82 0.38 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.089 0.471 . . . . 0.0 111.156 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.34 -17.46 13.39 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.089 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.531 HG22 ' NE2' ' A' ' 171' ' ' GLN . 3.9 p -94.06 -9.73 35.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.862 0.363 . . . . 0.0 111.052 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.618 ' HB1' ' SD ' ' A' ' 53' ' ' MET . . . -125.8 -22.45 4.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.524 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 1.074 ' HE1' HD23 ' A' ' 92' ' ' LEU . 5.5 tpp -66.11 -51.23 59.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.818 0.342 . . . . 0.0 110.75 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.804 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -61.48 -56.11 36.49 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.283 -179.319 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.7 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 38.5 Cg_exo -59.43 -46.01 23.45 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.308 2.005 . . . . 0.0 112.668 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.666 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 3.1 tm? -69.42 -35.28 75.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.481 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.92 -48.24 81.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.284 0.564 . . . . 0.0 110.79 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.826 ' O ' HG21 ' A' ' 179' ' ' THR . . . -72.17 -34.65 68.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.846 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.751 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -59.04 -44.12 91.72 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.95 0.405 . . . . 0.0 111.865 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.127 HD22 HD21 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -69.74 -22.44 63.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.373 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.576 ' SG ' HD11 ' A' ' 140' ' ' ILE . 23.1 m -60.26 -10.3 4.45 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.907 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.689 HD11 ' O ' ' A' ' 179' ' ' THR . 11.5 mt -82.86 169.68 15.82 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 51.87 -110.97 1.25 Allowed Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.406 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.437 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 62.7 m -162.73 99.42 1.0 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.753 0.311 . . . . 0.0 110.354 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 2.6 m-20 -138.18 135.33 35.54 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.625 ' C ' HD12 ' A' ' 113' ' ' ILE . 2.8 m-20 -102.41 111.1 23.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.292 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.9 mp -144.39 142.74 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.202 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 21.7 t -113.87 112.51 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.844 0.354 . . . . 0.0 110.252 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.439 ' CD2' ' HB2' ' A' ' 90' ' ' LEU . 28.7 mt -83.91 156.93 22.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.565 0.697 . . . . 0.0 112.14 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 117' ' ' GLY . 1.9 m -160.55 174.89 13.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.813 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.474 ' H ' HG22 ' A' ' 116' ' ' THR . . . -160.65 -164.84 16.32 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.774 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.64 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 6.8 mt-10 -69.51 174.97 2.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.26 -0.47 . . . . 0.0 110.82 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 22.6 Cg_endo -61.81 -36.08 75.37 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.169 1.913 . . . . 0.0 112.077 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.542 ' O ' ' HG2' ' A' ' 123' ' ' GLU . 8.2 tpt180 -78.96 -31.08 44.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.815 0.341 . . . . 0.0 110.338 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.513 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 11.0 tpt -62.4 -16.12 52.94 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.261 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.658 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 10.3 mmtp -68.65 -8.98 47.16 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.649 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 0.3 OUTLIER -120.79 26.33 9.16 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.142 179.005 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.419 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 2.1 mmp_? -98.55 89.02 0.76 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.482 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.726 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.1 Cg_endo -47.85 135.72 22.82 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.582 2.188 . . . . 0.0 112.373 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.775 HD11 HD23 ' A' ' 129' ' ' LEU . 19.3 tt -142.21 32.42 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.735 0.779 . . . . 0.0 110.233 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.622 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -73.85 -51.13 9.54 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.889 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.715 ' HE1' HG21 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -52.15 -31.16 29.94 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.02 0.438 . . . . 0.0 110.653 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.778 ' CD1' HD21 ' A' ' 133' ' ' LEU . 22.8 tp -78.63 -62.93 1.53 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.798 HG13 HD12 ' A' ' 140' ' ' ILE . 67.2 t -52.33 -26.17 8.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.363 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.622 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -73.71 -43.81 58.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.675 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.957 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -65.87 -52.1 53.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.912 0.387 . . . . 0.0 111.322 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.914 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -56.3 -45.89 80.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.364 0.602 . . . . 0.0 109.641 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.411 ' CD ' HG12 ' A' ' 130' ' ' VAL . 9.9 mtp180 -58.91 -36.19 74.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.354 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.957 HD12 ' HA ' ' A' ' 132' ' ' ALA . 4.6 mt -65.76 -33.72 76.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.028 0.442 . . . . 0.0 110.077 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.491 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -74.6 -18.87 80.02 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.603 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 130.68 3.43 4.59 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.276 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.408 ' CB ' ' HB3' ' A' ' 107' ' ' CYS . . . -70.3 147.54 49.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.909 0.355 . . . . 0.0 111.225 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 9.2 mtmm -114.15 94.32 4.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.962 HG23 HD23 ' A' ' 153' ' ' LEU . 11.1 mt -118.18 175.35 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.966 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.781 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -150.31 -167.97 2.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.037 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.698 ' N ' HG23 ' A' ' 141' ' ' THR . 24.6 m-85 -136.16 100.85 4.52 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.589 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.2 mm? -71.67 -12.97 61.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.846 -177.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.815 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 2.5 mt-10 -140.19 -71.57 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.92 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.515 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -124.15 150.28 45.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.025 0.441 . . . . 0.0 111.426 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.46 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 61.3 mt-10 -69.38 130.4 42.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.809 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.726 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 6.6 m-20 67.49 50.04 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.418 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.683 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 2.8 m-30 -145.53 174.53 3.37 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.096 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.683 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 4.8 Cg_endo -45.7 -40.53 19.0 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.487 2.791 . . . . 0.0 114.904 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.815 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 36.9 Cg_endo -62.47 101.38 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.386 1.39 . . . . 0.0 111.26 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.542 HD23 ' O ' ' A' ' 150' ' ' PRO . 79.1 mt -139.23 123.61 18.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.734 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.736 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.6 OUTLIER -106.17 112.27 25.23 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.962 HD23 HG23 ' A' ' 140' ' ' ILE . 4.8 mt -94.18 158.92 15.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.33 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.6 mt-30 -146.12 24.67 1.29 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.522 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 58.26 -161.65 11.1 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.362 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 158' ' ' THR . . . 101.18 -3.94 55.17 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.742 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.682 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 3.4 t80 -61.39 107.48 0.78 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.984 0.421 . . . . 0.0 110.714 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.567 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 71.3 p -105.16 -50.83 3.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.173 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.575 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.08 -162.33 27.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.0 -1.095 . . . . 0.0 114.326 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.594 ' O ' HG23 ' A' ' 162' ' ' VAL . . . 116.26 169.43 15.41 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.92 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -61.97 126.67 28.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.934 0.367 . . . . 0.0 110.034 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.63 HG13 HD13 ' A' ' 135' ' ' LEU . 47.9 t -136.57 154.49 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 120.903 0.382 . . . . 0.0 111.793 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.487 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.6 OUTLIER -120.93 117.14 26.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.607 HG21 ' CD1' ' A' ' 176' ' ' LEU . 0.3 OUTLIER -118.72 140.79 41.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.939 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.709 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.5 OUTLIER -78.6 135.39 37.25 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.114 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.717 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -76.4 -44.62 16.41 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.061 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.469 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 3.2 m -49.1 164.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.918 0.39 . . . . 0.0 111.611 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.715 HG21 ' HE1' ' A' ' 128' ' ' HIS . 3.0 t 70.26 54.58 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.074 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.822 ' H ' HG11 ' A' ' 196' ' ' VAL . 6.4 m 59.86 154.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.934 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.455 ' HB3' ' CB ' ' A' ' 197' ' ' SER . 18.9 p -77.36 1.24 19.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.044 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.804 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 44.0 mm-40 -53.59 -23.27 10.37 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.874 0.368 . . . . 0.0 111.34 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.703 ' HA ' HD13 ' A' ' 129' ' ' LEU . 1.9 m-85 -76.43 -56.06 4.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.14 0.495 . . . . 0.0 110.572 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.576 HD13 HG11 ' A' ' 164' ' ' VAL . 37.4 tp -72.96 -41.04 64.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.309 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 38.2 m -55.94 -34.51 65.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.753 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.654 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -70.86 -50.87 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.108 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.914 ' CD2' HD23 ' A' ' 133' ' ' LEU . 1.4 mt -67.33 -38.07 84.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.609 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.018 HD22 HD21 ' A' ' 205' ' ' LEU . 8.9 mt -65.57 -25.29 67.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.686 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.803 ' HG2' HD21 ' A' ' 31' ' ' LEU . 9.8 mtp -96.64 -28.79 14.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.166 0.508 . . . . 0.0 111.031 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.826 HG21 ' O ' ' A' ' 104' ' ' ALA . 55.4 m -89.12 -46.19 9.01 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.815 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.749 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -60.74 -37.13 42.25 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.701 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.8 Cg_endo -53.15 -37.36 79.75 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 121.101 1.2 . . . . 0.0 111.967 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.48 -7.01 59.42 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.955 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -67.54 119.5 66.21 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.881 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 2.7 Cg_exo -37.47 -32.68 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.684 2.922 . . . . 0.0 114.417 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.81 151.8 23.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.056 0.455 . . . . 0.0 111.616 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.67 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 3.6 t0 -65.74 116.92 7.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.481 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.724 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 28.2 m -102.63 134.94 45.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.339 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 1.104 HG22 HG13 ' A' ' 224' ' ' VAL . 41.1 t -125.45 99.3 5.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.091 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.605 ' O ' ' N ' ' A' ' 223' ' ' PHE . 4.0 mt -90.4 143.56 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.311 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.822 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -115.01 171.25 7.77 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 177.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.822 HD13 ' C ' ' A' ' 190' ' ' ARG . 1.2 mm -110.9 97.27 5.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 120.969 0.414 . . . . 0.0 111.314 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 12.3 mtmt -61.14 -80.96 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.468 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -79.23 167.84 52.65 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.212 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.48 124.67 21.05 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.879 HD23 ' HA ' ' A' ' 198' ' ' LYS . 1.5 tp -59.35 146.36 40.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.105 0.478 . . . . 0.0 110.539 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.822 HG11 ' H ' ' A' ' 169' ' ' SER . 12.6 p -104.45 -18.66 6.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.203 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.713 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.6 OUTLIER -129.29 45.63 2.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.498 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.879 ' HA ' HD23 ' A' ' 195' ' ' LEU . 3.8 ttpt -41.98 -60.87 1.75 Allowed Pre-proline 0 N--CA 1.466 0.338 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.784 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 12.1 Cg_exo -70.7 -16.44 33.61 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 121.871 1.714 . . . . 0.0 111.786 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.834 ' HA ' HD12 ' A' ' 203' ' ' ILE . 14.4 m-85 -76.36 -26.27 55.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.715 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.891 HD11 HD12 ' A' ' 177' ' ' LEU . 7.2 tp -75.19 -31.47 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.744 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 5.0 t70 -61.9 -34.25 75.69 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.8 mt -67.23 -27.35 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.259 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.62 HG22 ' SD ' ' A' ' 208' ' ' MET . 42.1 m -60.86 -57.45 12.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.541 0.686 . . . . 0.0 109.615 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 1.018 HD21 HD22 ' A' ' 177' ' ' LEU . 19.2 mt -70.32 -32.04 69.61 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.539 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.685 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 1.5 m-20 -66.73 -30.62 70.89 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.677 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -75.72 -46.23 32.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.154 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.62 ' SD ' HG22 ' A' ' 204' ' ' THR . 18.6 mtp -62.67 -39.57 94.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.318 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.685 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -68.04 -41.89 81.39 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.003 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.544 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.4 OUTLIER -61.65 -28.15 69.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.126 0.489 . . . . 0.0 109.736 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.781 ' HA ' ' HG3' ' A' ' 234' ' ' PRO . 0.8 OUTLIER -76.04 -50.99 13.26 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.761 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 156.51 -1.59 0.14 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.283 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.574 HG13 ' CG ' ' A' ' 229' ' ' GLN . 61.1 t -117.54 139.05 46.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.968 0.413 . . . . 0.0 111.701 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -134.11 153.94 51.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.713 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.94 HD11 HD13 ' A' ' 205' ' ' LEU . 2.4 pp -131.81 175.16 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.611 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 1.006 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 30.5 tt0 -89.99 125.74 35.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.753 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -101.27 101.04 11.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.128 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.707 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -67.02 -166.18 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.472 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -76.14 48.36 0.5 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.888 0.375 . . . . 0.0 110.362 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.547 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.1 OUTLIER 57.28 21.21 6.45 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.135 -179.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 191' ' ' ILE . 22.5 tt0 -113.11 -22.77 10.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.517 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.796 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 42.1 mt-30 -147.37 140.26 24.99 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 1.005 ' HB3' HD21 ' A' ' 177' ' ' LEU . 24.6 m-85 -112.59 96.73 6.15 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 1.104 HG13 HG22 ' A' ' 188' ' ' VAL . 42.5 t -84.05 111.13 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.06 0.457 . . . . 0.0 111.199 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.936 HG12 HG21 ' A' ' 215' ' ' ILE . 3.6 m -99.71 116.75 43.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.142 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.672 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 3.0 mptt -62.64 103.99 0.48 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.127 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.67 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.05 154.33 19.32 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.98 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.6 8.56 76.83 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.367 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.672 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 64.2 mm-40 -71.6 -179.57 2.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.421 0.629 . . . . 0.0 111.184 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.673 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.2 m -170.43 105.71 0.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.688 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.672 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 22.8 m-85 -53.58 146.03 13.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.085 0.469 . . . . 0.0 111.309 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.611 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 90.2 mt-30 -110.93 153.19 25.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.58 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 27.5 p -78.07 103.06 1.13 Allowed Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.231 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.781 ' HG3' ' HA ' ' A' ' 211' ' ' PHE . 10.5 Cg_exo -73.86 -37.16 3.04 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.849 2.366 . . . . 0.0 111.577 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 128.8 -120.24 3.24 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.418 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.778 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -91.08 116.52 28.87 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.588 ' CE2' HD11 ' A' ' 207' ' ' LEU . 67.1 t80 -124.08 141.49 52.01 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.644 -0.422 . . . . 0.0 112.085 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.937 HD12 HG23 ' A' ' 42' ' ' THR . 6.5 tp . . . . . 0 CA--C 1.514 -0.432 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.134 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.885 ' HA ' HD12 ' A' ' 29' ' ' LEU . 13.6 p30 . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 120.93 0.395 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.431 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 3.0 mtm105 -62.02 -51.06 69.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.399 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.937 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -65.87 -41.11 92.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.379 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.885 HD12 ' HA ' ' A' ' 26' ' ' ASN . 12.1 mt -59.8 -50.6 73.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 0.0 110.81 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.4 tp -69.12 -46.15 68.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.976 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.617 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 65.2 mt -61.01 -28.68 69.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.736 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.648 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . . . -77.11 -28.72 54.53 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.552 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.881 ' HB2' HD23 ' A' ' 57' ' ' LEU . . . -68.57 -31.12 70.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.875 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.893 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.82 -11.67 41.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.016 0.436 . . . . 0.0 110.883 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -79.85 167.77 20.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.764 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.572 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 73.8 m80 -101.31 98.92 9.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.595 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 114.63 142.18 7.83 Favored Glycine 0 C--N 1.314 -0.643 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.568 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.844 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 3.3 tttt -64.27 128.7 36.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.248 0.547 . . . . 0.0 111.938 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.51 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -123.6 160.9 26.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.06 178.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.705 HG22 ' HG3' ' A' ' 74' ' ' GLU . 91.9 t -110.99 140.78 28.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.32 . . . . 0.0 111.781 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.937 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -129.39 111.29 12.66 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.113 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.935 HG23 HD12 ' A' ' 238' ' ' LEU . 0.0 OUTLIER -96.04 172.14 8.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.188 0.518 . . . . 0.0 111.534 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 71' ' ' THR . 0.1 OUTLIER 66.77 18.79 10.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.729 -178.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.955 HD22 HD11 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -58.73 164.43 2.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.868 179.078 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.511 ' HB3' HG21 ' A' ' 50' ' ' VAL . 27.7 tp -99.37 112.7 24.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.892 0.377 . . . . 0.0 111.721 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -71.69 68.14 0.59 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.555 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.455 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 12.8 t -129.48 -163.54 1.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.212 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.576 ' HA ' ' HE ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -98.59 -22.87 15.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.768 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.649 ' OD1' HG23 ' A' ' 50' ' ' VAL . 2.1 p30 -69.05 -26.02 64.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.727 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.649 HG23 ' OD1' ' A' ' 49' ' ' ASP . 24.0 t -88.07 -56.59 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.295 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.576 ' HE ' ' HA ' ' A' ' 48' ' ' ASP . 1.8 ptt180 -52.83 -24.41 8.95 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.197 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 55' ' ' ASN . 4.6 m-70 -75.52 -38.08 59.63 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.748 ' O ' HD12 ' A' ' 57' ' ' LEU . 8.6 tpt -60.27 -54.65 43.17 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.788 ' HA ' HD13 ' A' ' 57' ' ' LEU . 1.9 mp -59.34 -47.97 83.4 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.712 177.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.565 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -48.51 -30.71 5.49 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.639 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.883 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -69.17 -51.36 38.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.298 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.881 HD23 ' HB2' ' A' ' 33' ' ' ALA . 3.4 mp -60.12 -49.18 78.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.812 0.339 . . . . 0.0 110.636 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.616 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.8 t -53.8 -30.79 46.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.095 0.474 . . . . 0.0 110.24 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.691 ' CB ' HD21 ' A' ' 88' ' ' LEU . . . -60.37 -50.88 71.84 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.168 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.97 HD21 HD22 ' A' ' 106' ' ' LEU . 3.9 mp -65.84 -27.75 68.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.484 0.659 . . . . 0.0 110.131 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.92 -0.0 7.13 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 114.725 -1.125 . . . . 0.0 113.03 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 13.5 t -55.19 159.99 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 117.216 0.508 . . . . 0.0 110.47 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.569 ' HB2' HD12 ' A' ' 76' ' ' ILE . 3.3 m -122.22 109.52 14.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.623 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.698 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 10.1 p90 -126.57 158.98 34.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.607 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 25.1 m -150.64 116.83 5.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.658 0.266 . . . . 0.0 111.267 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.955 HD11 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -86.38 178.09 7.24 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.216 0.532 . . . . 0.0 111.748 -179.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.723 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -90.1 178.58 6.15 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.811 179.122 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.24 -11.88 45.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.596 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.4 1.45 11.79 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.876 0.37 . . . . 0.0 110.462 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.451 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 3.1 mtt85 61.57 43.27 10.25 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.84 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.494 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -124.05 -2.27 8.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.293 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.723 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -143.0 111.13 6.06 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.968 0.413 . . . . 0.0 109.937 179.001 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.752 ' SG ' HD22 ' A' ' 66' ' ' LEU . 1.6 t -113.17 155.92 24.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.705 ' HG3' HG22 ' A' ' 40' ' ' VAL . 5.9 mt-10 -119.76 102.94 8.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.964 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.844 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -102.32 129.26 54.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.569 HD12 ' HB2' ' A' ' 63' ' ' SER . 10.3 mt -82.16 102.3 7.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.351 178.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.635 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -48.43 111.97 1.04 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.771 -0.65 . . . . 0.0 113.681 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.646 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -57.2 -17.58 11.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 110.616 178.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.572 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 88.12 -22.36 19.39 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.446 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.893 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -139.96 -145.15 4.63 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.754 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 4.1 Cg_exo -79.15 168.24 20.68 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 121.969 1.779 . . . . 0.0 108.984 177.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.795 HD12 HD13 ' A' ' 60' ' ' LEU . 4.4 mm? -66.55 91.04 0.17 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.754 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 27.8 m170 -83.93 118.88 24.29 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 113.44 -1.709 . . . . 0.0 113.133 -175.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.846 ' HB3' HD11 ' A' ' 113' ' ' ILE . . . -148.84 110.58 4.52 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.898 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.4 87.88 2.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.59 0.233 . . . . 0.0 111.557 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -174.45 22.83 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.873 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 56.76 53.76 7.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.492 0.663 . . . . 0.0 110.096 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.703 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 5.2 tp -85.92 135.37 33.71 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.939 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.673 ' C ' HD23 ' A' ' 90' ' ' LEU . 4.0 tt0 -115.27 130.16 56.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.242 0.544 . . . . 0.0 110.689 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.883 HD13 ' HA ' ' A' ' 56' ' ' ALA . 3.5 mt -108.68 153.79 22.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.744 -178.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.468 ' CE1' ' CA ' ' A' ' 93' ' ' GLY . 53.8 t80 -118.52 106.59 12.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.817 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.842 HD23 ' HE2' ' A' ' 99' ' ' MET . 1.8 mm? -91.61 3.56 54.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.251 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.611 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 43.12 -140.34 2.59 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 116.207 -0.451 . . . . 0.0 113.625 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -93.54 52.03 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.07 0.462 . . . . 0.0 111.1 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -94.05 -75.51 0.5 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.376 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.97 -19.78 9.27 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.392 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.508 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -96.59 -9.56 29.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.772 0.32 . . . . 0.0 110.862 179.175 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.04 -19.99 5.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.773 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.842 ' HE2' HD23 ' A' ' 92' ' ' LEU . 9.7 ttm -70.72 -54.18 12.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.982 0.42 . . . . 0.0 111.164 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.774 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.2 mpt_? -57.72 -53.53 64.68 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.091 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.656 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 31.3 Cg_exo -59.3 -47.34 17.44 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.84 2.36 . . . . 0.0 113.135 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.68 HD11 HD12 ' A' ' 90' ' ' LEU . 3.0 tm? -66.67 -33.97 76.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.554 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.548 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -61.66 -47.37 85.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.464 0.649 . . . . 0.0 110.215 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.709 ' O ' HG21 ' A' ' 179' ' ' THR . . . -71.46 -37.33 71.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.749 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.522 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -57.14 -43.4 82.41 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.897 0.38 . . . . 0.0 111.393 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.97 HD22 HD21 ' A' ' 60' ' ' LEU . 1.7 mt -70.58 -23.11 62.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.41 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.491 ' C ' ' HA2' ' A' ' 155' ' ' GLY . 87.7 m -59.33 -11.11 3.68 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.019 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.728 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 12.6 mt -83.33 166.11 18.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.67 0.271 . . . . 0.0 110.318 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 54.56 -112.1 2.52 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.272 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.5 97.74 0.99 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 2.8 m120 -138.32 138.35 38.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.775 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.899 ' O ' HD13 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -104.1 110.41 22.58 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.58 178.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.899 HD13 ' O ' ' A' ' 112' ' ' ASP . 25.1 mm -136.66 143.38 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.528 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.654 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 19.4 t -115.33 113.42 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.548 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 17.6 mt -82.42 152.98 25.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.495 0.664 . . . . 0.0 112.325 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.615 HG22 ' O ' ' A' ' 90' ' ' LEU . 9.5 t -160.27 163.59 33.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.892 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -157.57 -167.54 18.72 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.647 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.611 ' HG2' ' HA2' ' A' ' 93' ' ' GLY . 8.4 mm-40 -67.67 172.98 3.29 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.846 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 33.0 Cg_exo -62.07 -23.8 75.99 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.364 2.043 . . . . 0.0 112.171 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.455 ' HD2' ' CG ' ' A' ' 123' ' ' GLU . 8.1 tpt180 -85.56 -39.47 17.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.836 0.35 . . . . 0.0 110.556 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.605 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 10.8 tpt -59.48 -20.18 53.34 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.651 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 20.6 mttt -68.8 -7.13 31.29 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.255 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.548 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 3.9 pt-20 -120.0 28.17 8.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.115 0.483 . . . . 0.0 110.728 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.415 ' HA ' ' NE ' ' A' ' 124' ' ' ARG . 6.5 mmp_? -103.51 112.97 65.94 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.582 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 24.8 Cg_exo -60.84 137.01 69.79 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.274 1.983 . . . . 0.0 112.023 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.676 HD12 ' HD2' ' A' ' 100' ' ' ARG . 17.3 tt -145.01 30.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.849 0.833 . . . . 0.0 109.966 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -77.0 -50.44 6.87 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 114.39 -1.277 . . . . 0.0 112.101 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.746 ' HE1' HG21 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -57.26 -28.4 62.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.865 0.364 . . . . 0.0 110.668 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.9 ' CD1' HD21 ' A' ' 133' ' ' LEU . 20.6 tp -79.14 -63.85 1.32 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.859 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 1.051 HG13 HD12 ' A' ' 140' ' ' ILE . 60.6 t -55.28 -24.61 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.337 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.593 ' O ' HD12 ' A' ' 135' ' ' LEU . 0.4 OUTLIER -70.6 -45.2 65.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.352 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.841 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -65.81 -53.25 42.65 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.418 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.994 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -55.86 -44.23 77.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.101 0.477 . . . . 0.0 109.77 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.63 -38.99 75.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.449 179.267 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.841 HD12 ' HA ' ' A' ' 132' ' ' ALA . 2.4 mt -64.91 -30.6 71.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.436 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.487 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -78.22 -18.15 76.88 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.471 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.65 2.98 5.19 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.165 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.95 146.48 54.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.944 0.372 . . . . 0.0 111.248 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -114.75 88.72 2.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.241 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.051 HD12 HG13 ' A' ' 130' ' ' VAL . 6.3 mt -115.59 176.63 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.085 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.796 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -154.45 -174.92 5.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.919 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.607 ' N ' HG23 ' A' ' 141' ' ' THR . 20.1 m-85 -126.63 106.98 9.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.049 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.67 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.4 mm? -77.36 -18.65 57.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.389 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.652 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 1.7 mm-40 -134.71 -73.04 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.969 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.603 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -123.27 149.81 44.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.727 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.484 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 4.6 pt-20 -69.61 135.12 49.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.093 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 12.1 m-20 64.92 46.99 2.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.48 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.828 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 4.6 m-85 -144.08 176.64 2.15 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.111 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.828 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 10.3 Cg_endo -52.01 -39.89 68.78 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.131 2.554 . . . . 0.0 115.629 -177.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.652 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 19.7 Cg_endo -61.9 100.4 0.2 Allowed 'Trans proline' 0 CA--C 1.515 -0.458 0 C-N-CA 120.861 1.041 . . . . 0.0 110.944 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 150' ' ' PRO . 84.1 mt -137.05 123.89 21.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.817 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.767 ' HB3' HG22 ' A' ' 141' ' ' THR . 1.6 ttm180 -105.03 111.83 24.74 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 1.028 HD23 HG23 ' A' ' 140' ' ' ILE . 1.5 mt -94.98 160.12 14.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.684 -178.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.588 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 4.1 mt-30 -148.86 25.69 0.92 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.906 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.491 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 54.5 -166.45 2.44 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.477 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 109.84 -4.87 30.66 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.946 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.676 ' CD2' HG22 ' A' ' 179' ' ' THR . 2.3 t80 -60.89 106.99 0.64 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.783 0.325 . . . . 0.0 110.681 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' THR . . . . . 0.457 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 43.5 p -104.97 -48.65 3.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.639 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.53 -162.23 27.67 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 119.889 -1.148 . . . . 0.0 114.293 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' ' 162' ' ' VAL . . . 114.36 168.94 16.3 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 114.937 -0.632 . . . . 0.0 112.003 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -63.08 126.2 26.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.626 HG11 ' HB1' ' A' ' 132' ' ' ALA . 62.1 t -133.51 157.63 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.091 0.472 . . . . 0.0 111.578 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.478 ' N ' HG12 ' A' ' 162' ' ' VAL . 0.7 OUTLIER -124.31 116.12 22.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.891 179.267 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.851 HG11 HD13 ' A' ' 173' ' ' LEU . 0.3 OUTLIER -115.02 150.92 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.92 -179.005 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.68 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 2.7 t0 -89.83 127.36 35.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.667 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.712 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -70.16 -44.68 59.4 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.651 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.491 ' C ' HG23 ' A' ' 168' ' ' VAL . 1.4 m -50.91 164.76 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.837 0.351 . . . . 0.0 111.517 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.746 HG21 ' HE1' ' A' ' 128' ' ' HIS . 2.1 t 69.17 56.75 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 121.275 0.559 . . . . 0.0 111.112 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.807 ' H ' HG11 ' A' ' 196' ' ' VAL . 2.0 m 58.3 159.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.458 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.466 ' O ' HG22 ' A' ' 174' ' ' THR . 12.4 p -82.65 0.43 43.19 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.807 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.774 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 2.1 mp0 -51.12 -21.91 2.2 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.934 0.397 . . . . 0.0 111.049 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.553 ' O ' HD12 ' A' ' 176' ' ' LEU . 1.4 m-85 -78.96 -53.95 6.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.765 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.851 HD13 HG11 ' A' ' 164' ' ' VAL . 22.7 tp -74.71 -40.5 61.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.441 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 171' ' ' GLN . 13.6 t -57.96 -34.31 69.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -68.37 -51.12 47.83 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.497 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.994 ' CD2' HD23 ' A' ' 133' ' ' LEU . 2.6 mt -67.78 -37.0 81.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.541 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.992 HD11 ' CD2' ' A' ' 223' ' ' PHE . 8.2 mt -67.88 -24.63 65.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.075 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.525 ' HA ' ' OH ' ' A' ' 231' ' ' TYR . 13.5 ptp -98.92 -28.48 13.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.12 0.486 . . . . 0.0 110.811 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.709 HG21 ' O ' ' A' ' 104' ' ' ALA . 27.4 m -86.37 -46.22 10.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.991 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.879 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -60.94 -37.26 42.72 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.711 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 12.1 Cg_endo -54.54 -36.69 89.43 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 121.232 1.288 . . . . 0.0 111.797 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.686 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -85.16 -6.48 59.29 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.828 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -66.9 114.99 20.51 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.16 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -31.09 -36.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.073 3.182 . . . . 0.0 114.642 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -105.47 153.34 21.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.968 0.413 . . . . 0.0 111.797 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.684 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 1.3 t0 -63.92 118.27 8.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.568 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.711 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 61.4 m -104.16 133.75 48.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.056 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 1.008 HG22 HG13 ' A' ' 224' ' ' VAL . 35.3 t -125.43 99.63 6.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.252 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.1 mt -90.82 143.56 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.418 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.84 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -114.33 171.07 7.84 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.84 HD13 ' C ' ' A' ' 190' ' ' ARG . 1.1 mm -111.41 96.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 120.973 0.415 . . . . 0.0 111.17 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -60.83 -81.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.625 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.429 ' HA3' ' OD1' ' A' ' 165' ' ' ASP . . . -78.12 168.4 53.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.269 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -61.41 122.62 15.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.635 0.255 . . . . 0.0 110.856 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.81 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.8 OUTLIER -58.43 143.63 44.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.96 0.41 . . . . 0.0 110.577 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.807 HG11 ' H ' ' A' ' 169' ' ' SER . 13.1 p -103.58 -18.82 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.512 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.673 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.6 OUTLIER -126.6 45.62 2.64 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.489 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.81 ' HA ' HD23 ' A' ' 195' ' ' LEU . 0.4 OUTLIER -42.15 -60.44 2.07 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.196 -0.911 . . . . 0.0 113.122 -178.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 7.6 Cg_exo -72.68 -16.32 26.76 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 121.908 1.739 . . . . 0.0 111.987 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.739 ' HA ' HD12 ' A' ' 203' ' ' ILE . 16.5 m-85 -75.64 -29.91 59.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.255 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.92 HD11 HD12 ' A' ' 177' ' ' LEU . 6.2 tp -70.69 -35.64 61.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -59.35 -33.16 70.83 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.147 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.739 HD12 ' HA ' ' A' ' 200' ' ' TYR . 15.1 mt -67.71 -32.86 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.238 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.489 HG22 ' SD ' ' A' ' 208' ' ' MET . 52.4 m -57.44 -52.64 64.54 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.944 HD21 HD22 ' A' ' 177' ' ' LEU . 13.3 mt -73.82 -35.45 64.85 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.92 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 202' ' ' ASP . 0.7 OUTLIER -64.0 -28.03 69.53 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.171 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.617 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -79.17 -44.02 22.77 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.842 178.473 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' MET . . . . . 0.514 ' HG2' ' CZ ' ' A' ' 231' ' ' TYR . 22.4 mtp -65.0 -38.83 92.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.456 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.518 ' HG3' ' N ' ' A' ' 210' ' ' THR . 0.0 OUTLIER -65.21 -48.94 71.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.666 0.269 . . . . 0.0 110.64 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.518 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.5 OUTLIER -56.53 -29.28 61.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.278 0.561 . . . . 0.0 109.843 179.064 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.648 ' CE2' ' HA ' ' A' ' 32' ' ' ALA . 1.1 m-85 -71.48 -48.84 46.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.002 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.474 ' HA3' ' HG2' ' A' ' 232' ' ' GLN . . . 153.21 -4.84 0.36 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.114 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.64 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 73.4 t -120.19 140.78 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.09 0.472 . . . . 0.0 111.823 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -134.08 156.0 49.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.662 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.925 HG21 HG12 ' A' ' 225' ' ' VAL . 2.3 pp -132.75 175.72 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.891 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.986 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 41.3 tt0 -90.36 124.66 35.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.068 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' ASN . . . . . 0.437 HD22 ' HA ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER -100.99 100.87 11.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.003 178.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.733 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 2.1 mm-40 -66.64 -166.72 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.612 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -74.74 48.58 0.37 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.884 0.373 . . . . 0.0 110.41 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . 0.541 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 57.47 20.66 6.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 -179.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 191' ' ' ILE . 66.3 mt-30 -112.69 -21.55 11.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.738 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' GLN . . . . . 0.784 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 46.6 mt-30 -149.04 141.34 24.1 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.902 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.992 ' CD2' HD11 ' A' ' 177' ' ' LEU . 19.7 m-85 -113.32 96.53 5.95 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 1.008 HG13 HG22 ' A' ' 188' ' ' VAL . 48.4 t -83.9 111.15 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 120.797 0.332 . . . . 0.0 111.429 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.925 HG12 HG21 ' A' ' 215' ' ' ILE . 5.5 m -99.68 117.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.931 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.828 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -61.71 103.07 0.3 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.009 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.684 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -55.96 156.0 11.36 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.738 -0.665 . . . . 0.0 113.044 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.48 8.46 84.91 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.559 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . 0.828 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 26.0 mm100 -71.05 -176.52 1.42 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.358 0.579 . . . . 0.0 110.781 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . 0.686 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.5 m -177.1 104.91 0.06 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.39 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.64 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 21.2 m-85 -55.66 151.94 10.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.163 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . 0.673 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 9.2 pt20 -123.01 154.76 38.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.42 ' HA ' ' HD2' ' A' ' 234' ' ' PRO . 68.7 p -67.6 101.11 0.27 Allowed Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' PRO . . . . . 0.673 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 59.5 Cg_endo -68.13 -27.94 34.97 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.656 2.237 . . . . 0.0 111.898 178.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.39 -125.26 6.53 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' THR . . . . . 0.535 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -92.0 116.54 29.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.626 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 63.5 t80 -124.73 143.2 50.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.331 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.935 HD12 HG23 ' A' ' 42' ' ' THR . 5.7 tp . . . . . 0 CA--C 1.515 -0.386 0 CA-C-O 121.145 0.498 . . . . 0.0 110.752 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.6 ' HB3' ' H ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.218 0.532 . . . . 0.81000000000000005 110.726 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.24 -24.74 42.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.534 -0.757 . . . . 2.1200000000000001 111.852 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -60.66 -47.17 87.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.078 0.466 . . . . 2.0299999999999998 110.214 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.87 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -69.46 -33.31 72.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.767 -0.651 . . . . 0.28000000000000003 110.768 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.733 HD21 HD23 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -61.23 -54.57 42.51 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.229 0.537 . . . . 0.96999999999999997 110.695 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' A' ' 105' ' ' ALA . 7.1 tp -66.79 -51.39 56.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.292 -0.867 . . . . 0.38 111.216 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 63.7 mt -54.64 -35.84 63.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.022 0.439 . . . . 0.39000000000000001 110.804 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.593 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -72.91 -29.97 63.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.673 -0.694 . . . . 0.16 110.787 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.649 ' CB ' HD21 ' A' ' 82' ' ' LEU . . . -71.48 -32.28 68.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.817 -0.628 . . . . 0.14000000000000001 111.592 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.812 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.74 -11.21 42.91 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.826 0.346 . . . . 0.13 111.111 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -80.93 163.19 23.52 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.041 -0.527 . . . . 0.14999999999999999 110.144 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.486 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 70.9 m80 -96.51 97.27 9.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.004 0.43 . . . . 0.17999999999999999 110.079 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.5 146.97 7.94 Favored Glycine 0 C--N 1.313 -0.712 0 C-N-CA 120.796 -0.716 . . . . 0.19 111.751 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -71.74 138.06 48.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.105 0.479 . . . . 2.29 111.654 -179.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.426 HG23 ' N ' ' A' ' 40' ' ' VAL . 0.6 OUTLIER -131.74 164.59 25.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.64 -0.709 . . . . 0.17000000000000001 110.165 179.316 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.813 HG22 ' CG ' ' A' ' 74' ' ' GLU . 88.9 t -110.43 142.7 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 111.911 0.337 . . . . 0.23000000000000001 111.911 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.87 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -130.18 110.67 11.76 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.834 -0.802 . . . . 0.45000000000000001 108.834 178.257 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.848 HG23 HD12 ' A' ' 238' ' ' LEU . 0.0 OUTLIER -100.55 169.56 8.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.112 0.482 . . . . 0.32000000000000001 111.568 -178.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.729 ' HB2' HD11 ' A' ' 238' ' ' LEU . 1.5 t30 67.24 21.09 10.02 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.629 -0.714 . . . . 1.04 110.703 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.78 HD22 HD11 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -60.14 154.69 18.94 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 109.555 -0.535 . . . . 0.28999999999999998 109.555 178.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.6 ' H ' ' HB3' ' A' ' 25' ' ' SER . 17.6 tp -91.27 114.3 26.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.93 0.395 . . . . 0.33000000000000002 111.418 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.414 ' OD2' ' HB2' ' A' ' 70' ' ' ARG . 9.6 t70 -73.72 77.74 1.55 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.973 -0.558 . . . . 2.0499999999999998 110.27 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -137.38 -163.88 1.5 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.875 -0.602 . . . . 1.1499999999999999 110.841 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.528 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 10.0 m-20 -96.91 -19.05 19.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.19 -0.459 . . . . 1.8600000000000001 111.076 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.457 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -73.01 -26.53 61.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.177 -0.465 . . . . 1.97 109.919 178.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.542 HG11 HD21 ' A' ' 44' ' ' LEU . 26.5 t -90.04 -52.42 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.813 -0.63 . . . . 0.22 111.45 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.528 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -53.07 -26.53 16.38 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.53 -0.468 . . . . 2.6000000000000001 110.558 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -73.4 -37.57 65.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.698 -0.683 . . . . 0.53000000000000003 109.637 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.448 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 5.4 tpt -65.0 -47.35 77.82 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.565 -0.902 . . . . 0.57999999999999996 108.565 178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.733 HD23 HD21 ' A' ' 29' ' ' LEU . 1.1 mp -61.95 -47.13 86.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.611 -0.722 . . . . 0.33000000000000002 110.051 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.408 ' HA ' HG22 ' A' ' 58' ' ' THR . 0.9 OUTLIER -59.57 -28.17 66.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.111 0.481 . . . . 1.3899999999999999 109.979 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.701 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -68.73 -43.85 75.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.631 -0.713 . . . . 0.20999999999999999 111.965 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.59 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -71.87 -50.45 29.31 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 120.774 -0.37 . . . . 0.78000000000000003 110.768 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.473 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.9 t -52.16 -29.81 23.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.07 0.462 . . . . 0.23999999999999999 110.371 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.783 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.82 -45.0 93.73 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.57 -0.741 . . . . 0.20999999999999999 110.523 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.009 HD21 HD22 ' A' ' 106' ' ' LEU . 3.0 mp -74.87 -24.37 58.55 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.454 0.645 . . . . 0.22 109.952 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.4 0.24 5.85 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.004 -0.998 . . . . 0.23000000000000001 114.146 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.472 HG21 HD11 ' A' ' 82' ' ' LEU . 34.0 t -61.77 150.12 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 118.041 0.921 . . . . 0.20000000000000001 110.364 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.49 ' CB ' HG13 ' A' ' 76' ' ' ILE . 2.5 m -111.23 104.91 13.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.815 -0.629 . . . . 0.25 111.595 -178.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CE2' ' HB ' ' A' ' 58' ' ' THR . 6.7 p90 -117.83 159.14 23.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.148 -0.933 . . . . 0.37 110.946 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 3.5 m -152.65 114.84 4.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.216 -0.447 . . . . 0.39000000000000001 110.214 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.826 HD22 ' SG ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -84.19 178.7 7.7 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.997 0.427 . . . . 0.23000000000000001 110.735 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.0 t -94.33 -179.92 5.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.803 -0.635 . . . . 1.1100000000000001 110.946 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.02 -19.41 61.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.176 -0.466 . . . . 0.31 111.517 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.22 5.99 14.9 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.897 0.379 . . . . 1.5600000000000001 110.564 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.414 ' HB2' ' OD2' ' A' ' 46' ' ' ASP . 53.1 mtt-85 59.42 41.42 19.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.119 -0.491 . . . . 2.27 110.974 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.435 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -121.91 -0.03 9.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.651 -0.704 . . . . 0.28999999999999998 110.887 179.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.592 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -143.54 115.35 8.24 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.446 -0.576 . . . . 1.8999999999999999 109.446 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.826 ' SG ' HD22 ' A' ' 66' ' ' LEU . 1.4 t -120.99 150.2 41.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.7 -0.682 . . . . 0.26000000000000001 112.141 -178.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.813 ' CG ' HG22 ' A' ' 40' ' ' VAL . 4.2 mt-10 -118.18 103.79 10.19 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.477 -0.934 . . . . 1.53 108.477 178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.614 HG12 HD23 ' A' ' 29' ' ' LEU . 1.7 mp -99.19 126.74 52.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.567 0.699 . . . . 0.20000000000000001 112.661 -178.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.49 HG13 ' CB ' ' A' ' 63' ' ' SER . 0.9 OUTLIER -78.54 110.81 14.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.478 -1.237 . . . . 1.0700000000000001 111.233 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -54.32 112.8 2.86 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.799 -0.637 . . . . 0.17999999999999999 114.047 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.0 OUTLIER -61.86 -19.6 62.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.187 0.518 . . . . 1.3700000000000001 109.943 178.279 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.486 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 89.69 -23.21 20.84 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.611 -0.722 . . . . 0.16 112.671 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.812 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -136.92 -149.81 5.69 Favored Glycine 0 CA--C 1.507 -0.464 0 N-CA-C 109.998 -1.241 . . . . 0.14999999999999999 109.998 178.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.833 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 5.1 Cg_exo -78.71 164.43 25.67 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 CA-C-N 119.469 1.635 . . . . 0.13 109.163 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.84 HD12 HD13 ' A' ' 60' ' ' LEU . 3.7 mm? -63.36 93.95 0.08 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.816 1.294 . . . . 0.12 108.217 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.833 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 28.9 m170 -87.8 120.18 28.87 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 112.435 -2.166 . . . . 0.14999999999999999 112.928 -175.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.813 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -149.21 109.4 4.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.882 -0.599 . . . . 0.19 110.912 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -107.9 91.64 3.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.769 0.319 . . . . 1.51 111.139 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.98 19.94 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.544 -0.836 . . . . 0.28000000000000003 113.432 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.71 50.82 13.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.308 0.575 . . . . 0.28000000000000003 110.006 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.783 HD21 ' HB1' ' A' ' 59' ' ' ALA . 3.5 tp -77.12 136.03 38.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.315 -0.857 . . . . 0.37 110.959 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.778 ' N ' HD12 ' A' ' 88' ' ' LEU . 1.2 tt0 -116.6 127.46 54.49 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.158 0.504 . . . . 1.3500000000000001 110.395 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.701 HD13 ' HA ' ' A' ' 56' ' ' ALA . 50.8 mt -109.68 163.38 13.54 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.49 -0.777 . . . . 0.65000000000000002 112.655 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -125.56 106.68 9.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.897 -1.047 . . . . 0.47999999999999998 109.892 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.638 HD22 ' N ' ' A' ' 92' ' ' LEU . 1.2 mm? -93.2 6.05 49.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.176 -0.465 . . . . 0.83999999999999997 111.485 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 42.3 -141.42 1.7 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.051 -0.595 . . . . 0.28999999999999998 113.009 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -96.9 51.7 1.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.133 0.492 . . . . 1.5800000000000001 110.733 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -88.75 -73.71 0.49 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.811 -0.631 . . . . 0.33000000000000002 111.071 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.0 -18.93 13.61 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.002 -0.618 . . . . 0.33000000000000002 113.092 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.489 HG22 ' NE2' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -96.85 -9.21 29.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.807 0.337 . . . . 0.91000000000000003 110.658 179.09 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.63 -12.75 6.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.1 -0.5 . . . . 0.20999999999999999 111.523 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.526 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 4.6 ttm -79.36 -36.32 39.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.551 -0.295 . . . . 1.1200000000000001 111.458 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.526 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -77.95 -48.91 2.07 Favored Pre-proline 0 N--CA 1.45 -0.45 0 CA-C-O 120.503 0.192 . . . . 2.0 111.236 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 24.4 Cg_exo -64.18 -43.06 15.91 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.793 2.329 . . . . 0.27000000000000002 112.734 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.59 HD13 HD11 ' A' ' 106' ' ' LEU . 2.2 tm? -71.0 -30.37 66.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.996 -0.547 . . . . 0.19 111.168 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.62 -49.22 74.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.195 0.522 . . . . 0.17000000000000001 110.633 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.813 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -72.5 -34.75 67.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.366 0.876 . . . . 0.14000000000000001 113.366 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.646 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -57.76 -44.27 86.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.034 0.445 . . . . 0.12 111.968 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.009 HD22 HD21 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -71.0 -21.19 62.33 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.927 -0.579 . . . . 0.20999999999999999 112.01 -178.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.586 ' SG ' HD11 ' A' ' 140' ' ' ILE . 98.1 m -58.26 -12.56 3.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.938 -0.574 . . . . 0.25 111.73 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.689 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 9.8 mt -80.62 167.85 19.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.695 0.283 . . . . 0.20999999999999999 110.638 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 50.16 -110.83 0.96 Allowed Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.08 -0.581 . . . . 0.16 112.559 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.436 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.1 OUTLIER -162.37 102.47 1.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.797 0.332 . . . . 0.70999999999999996 110.3 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 1.4 m-20 -138.84 135.97 35.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 1.5900000000000001 111.243 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.508 ' C ' HD12 ' A' ' 113' ' ' ILE . 4.6 m-20 -102.79 109.48 21.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.052 -0.522 . . . . 1.26 109.813 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.701 HG23 ' O ' ' A' ' 88' ' ' LEU . 5.2 mp -143.39 140.85 26.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.499 -0.319 . . . . 0.56000000000000005 111.249 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 17.5 t -112.2 112.7 41.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.767 -0.457 . . . . 0.22 109.767 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.516 HD22 HD21 ' A' ' 92' ' ' LEU . 31.8 mt -81.02 158.62 25.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.383 0.611 . . . . 0.25 111.91 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.3 m -160.84 162.98 32.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.99 -1.005 . . . . 1.01 110.219 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.21 -165.39 13.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.885 -1.15 . . . . 0.25 113.7 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.515 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 0.8 OUTLIER -71.74 175.86 2.66 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.26 -0.47 . . . . 1.5700000000000001 111.134 -179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 32.1 Cg_exo -60.47 -37.29 82.03 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.337 2.025 . . . . 0.48999999999999999 112.436 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.531 HH11 ' CG ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -76.3 -36.98 58.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.765 0.317 . . . . 2.23 110.796 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.533 ' HA ' ' HG3' ' A' ' 124' ' ' ARG . 7.5 tpt -58.59 -22.31 55.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.80000000000000004 110.21 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.503 ' HA ' ' HG2' ' A' ' 149' ' ' PRO . 2.9 mmtt -63.64 -10.38 18.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.05 -0.523 . . . . 1.8100000000000001 111.97 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.597 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 4.4 pt-20 -121.22 28.2 7.96 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.638 -0.425 . . . . 1.9199999999999999 111.539 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.533 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 1.2 mmp_? -101.39 95.05 4.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.195 -0.457 . . . . 2.6299999999999999 110.725 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.7 Cg_endo -47.43 129.03 15.78 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.732 2.288 . . . . 0.44 112.2 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.649 HD11 HD23 ' A' ' 129' ' ' LEU . 19.9 tt -138.35 31.48 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.745 0.783 . . . . 0.26000000000000001 110.143 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -74.93 -49.49 9.9 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.633 -1.167 . . . . 0.20999999999999999 112.668 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.486 ' HE1' HG21 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -53.65 -33.0 53.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.825 0.345 . . . . 0.25 110.5 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.823 ' CD1' HD21 ' A' ' 133' ' ' LEU . 25.9 tp -76.48 -62.84 1.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.155 -0.475 . . . . 0.17999999999999999 110.165 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.783 HG13 HD12 ' A' ' 140' ' ' ILE . 94.2 t -51.94 -26.89 8.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 0.17999999999999999 111.604 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 2.7 t0 -71.93 -45.46 61.08 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.27 0.47 . . . . 1.4299999999999999 112.27 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.857 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -63.82 -54.19 38.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.863 0.363 . . . . 0.14999999999999999 111.129 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.904 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -55.12 -44.78 75.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.343 0.592 . . . . 0.20999999999999999 109.547 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -57.76 -40.11 78.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.133 -0.94 . . . . 2.7799999999999998 110.314 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.857 HD12 ' HA ' ' A' ' 132' ' ' ALA . 3.1 mt -63.93 -32.93 74.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.23000000000000001 110.686 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.437 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -76.53 -13.81 83.08 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.489 -0.862 . . . . 0.14000000000000001 112.929 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 127.05 4.46 5.99 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.54 -0.838 . . . . 0.14999999999999999 113.192 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.98 150.41 45.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.878 0.371 . . . . 0.14999999999999999 111.51 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -116.35 96.76 5.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 2.3500000000000001 111.317 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.783 HD12 HG13 ' A' ' 130' ' ' VAL . 10.6 mt -124.41 168.39 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.088 0.47 . . . . 0.19 111.403 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.686 HG22 ' HB3' ' A' ' 152' ' ' ARG . 0.4 OUTLIER -150.36 174.4 12.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.699 -0.682 . . . . 0.31 110.603 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.543 ' CD2' ' HA ' ' A' ' 146' ' ' GLU . 23.6 m-85 -116.61 107.91 15.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.709 -0.849 . . . . 0.32000000000000001 108.709 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.632 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.3 mm? -75.25 -23.46 57.51 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.886 -0.597 . . . . 0.34000000000000002 112.074 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.7 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 2.5 mt-10 -129.53 -67.59 0.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.745 -0.382 . . . . 2.1899999999999999 110.977 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.75 ' HB2' ' HD2' ' A' ' 148' ' ' TYR . 53.6 mt-30 -125.63 157.82 36.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.091 0.472 . . . . 2.73 111.774 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.543 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 47.4 mt-10 -75.31 131.46 40.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.676 . . . . 2.0099999999999998 110.826 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 16.6 m-20 67.46 44.3 1.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 1.3400000000000001 111.822 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.75 ' HD2' ' HB2' ' A' ' 145' ' ' GLN . 7.8 m-30 -140.55 164.26 37.93 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.353 -0.385 . . . . 0.72999999999999998 110.65 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.549 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 6.3 Cg_exo -37.73 -44.12 1.57 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 124.146 3.231 . . . . 0.28000000000000003 115.38 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.7 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 24.3 Cg_endo -61.41 95.18 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 121.202 1.268 . . . . 0.23000000000000001 111.041 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 94.4 mt -132.41 123.29 26.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.534 -0.757 . . . . 0.19 111.71 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.686 ' HB3' HG22 ' A' ' 141' ' ' THR . 1.4 ttm180 -101.7 110.83 22.89 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.221 -1.029 . . . . 2.5899999999999999 108.221 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.727 ' CD1' HD12 ' A' ' 106' ' ' LEU . 2.0 mt -92.93 158.27 15.91 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.768 0.318 . . . . 0.17000000000000001 111.21 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 6.4 mt-30 -146.17 22.77 1.36 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.146 -0.479 . . . . 1.3400000000000001 110.712 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.471 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 56.35 -167.16 3.92 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.501 -0.856 . . . . 0.14999999999999999 112.193 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 158' ' ' THR . . . 110.94 -4.29 28.85 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.532 -0.842 . . . . 0.16 112.814 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.644 ' CD2' HG22 ' A' ' 179' ' ' THR . 2.0 t80 -62.43 110.54 1.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.922 0.391 . . . . 0.64000000000000001 111.141 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.547 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 71.5 p -109.49 -50.67 2.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.20000000000000001 110.573 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.475 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 145.98 -161.91 28.31 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.276 -0.964 . . . . 0.19 113.58 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 162' ' ' VAL . . . 113.88 168.82 16.62 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 111.738 -0.545 . . . . 0.16 111.738 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.9 129.71 43.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.88 0.34 . . . . 1.21 110.323 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.747 HG11 ' HB1' ' A' ' 132' ' ' ALA . 61.4 t -136.56 156.99 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 120.932 0.396 . . . . 0.16 111.131 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.447 ' N ' HG12 ' A' ' 162' ' ' VAL . 1.1 m-20 -127.9 116.51 20.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.421 -0.585 . . . . 1.1000000000000001 109.421 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.433 HG21 ' CD1' ' A' ' 176' ' ' LEU . 0.5 OUTLIER -118.73 145.86 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 120.392 -0.523 . . . . 0.17999999999999999 112.278 -178.415 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 1.8 t70 -85.07 130.28 34.64 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.87 -0.605 . . . . 1.25 110.215 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.626 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -72.1 -45.34 41.3 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.799 -0.715 . . . . 0.14999999999999999 113.507 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.35 160.97 0.13 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.116 0.484 . . . . 1.0900000000000001 112.06 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.486 HG21 ' HE1' ' A' ' 128' ' ' HIS . 9.4 t 71.73 59.59 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 115.649 -0.705 . . . . 0.23999999999999999 111.06 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.841 ' N ' HG11 ' A' ' 196' ' ' VAL . 15.3 m 60.81 154.03 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.871 -0.604 . . . . 0.70999999999999996 110.722 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 3.8 t -82.82 1.8 37.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 1.3200000000000001 111.007 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 66.5 mm-40 -56.92 -21.0 26.45 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.543 -0.299 . . . . 1.8999999999999999 110.816 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.448 ' CD2' ' HB2' ' A' ' 129' ' ' LEU . 3.9 m-85 -71.88 -61.83 1.64 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.107 0.479 . . . . 0.20999999999999999 110.332 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.764 HD23 HG12 ' A' ' 201' ' ' ILE . 64.4 tp -68.77 -33.32 73.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.664 -0.698 . . . . 0.20999999999999999 109.768 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.577 ' O ' ' CG ' ' A' ' 178' ' ' MET . 52.5 m -59.76 -33.56 71.83 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.593 -0.731 . . . . 1.02 109.951 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.813 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -71.64 -45.07 63.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.23999999999999999 111.692 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.904 ' CD2' HD23 ' A' ' 133' ' ' LEU . 1.6 mt -72.84 -31.11 64.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.145 -0.48 . . . . 0.19 110.435 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.855 HD21 ' HB3' ' A' ' 223' ' ' PHE . 10.4 mt -66.78 -28.13 68.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.957 -0.565 . . . . 0.16 111.553 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.577 ' CG ' ' O ' ' A' ' 174' ' ' THR . 0.0 OUTLIER -98.75 -29.44 13.0 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 120.13 -0.628 . . . . 1.4099999999999999 110.43 179.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.701 HG21 ' O ' ' A' ' 104' ' ' ALA . 83.0 m -81.79 -46.14 14.61 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.637 -0.711 . . . . 0.17999999999999999 111.521 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.856 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -60.17 -40.9 81.24 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 113.286 0.847 . . . . 0.14999999999999999 113.286 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.5 Cg_endo -54.39 -35.57 84.93 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 121.426 1.418 . . . . 0.14999999999999999 112.545 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.99 -11.74 54.79 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.862 0.363 . . . . 0.19 110.478 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.547 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -61.64 124.21 80.24 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.97 -0.559 . . . . 0.23999999999999999 109.788 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.1 -32.95 5.21 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.917 2.412 . . . . 0.28000000000000003 113.77 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -103.81 154.68 19.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.105 0.478 . . . . 1.75 111.431 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.488 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 12.4 t0 -67.39 122.54 18.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.603 -0.726 . . . . 1.3799999999999999 110.505 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.55 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 24.3 m -107.69 136.31 47.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.247 -0.433 . . . . 0.14999999999999999 111.435 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 1.055 HG22 HG13 ' A' ' 224' ' ' VAL . 45.4 t -126.5 97.93 4.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.979 -0.555 . . . . 0.13 110.053 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.561 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.4 mt -89.43 143.87 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 CA-C-N 116.124 -0.489 . . . . 0.12 110.03 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.811 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -114.64 170.7 8.12 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.153 -1.054 . . . . 2.6800000000000002 108.153 177.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.811 HD13 ' C ' ' A' ' 190' ' ' ARG . 0.9 OUTLIER -111.05 96.44 4.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 C-N-CA 120.767 -0.373 . . . . 0.14999999999999999 111.126 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -59.09 -80.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.965 -0.561 . . . . 1.47 110.662 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -81.24 167.18 48.95 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.838 -0.696 . . . . 0.17000000000000001 112.567 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.15 126.22 26.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.641 0.258 . . . . 2.04 110.777 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.626 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.4 OUTLIER -61.49 144.1 54.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.987 0.423 . . . . 0.20000000000000001 110.18 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.841 HG11 ' N ' ' A' ' 169' ' ' SER . 14.5 p -100.48 -17.96 6.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.04 -0.527 . . . . 0.23000000000000001 111.541 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.555 ' CB ' ' HB2' ' A' ' 200' ' ' TYR . 0.1 OUTLIER -131.51 46.7 2.62 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.541 -0.754 . . . . 0.66000000000000003 109.847 179.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.734 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.3 OUTLIER -40.0 -59.58 1.74 Allowed Pre-proline 0 N--CA 1.466 0.37 0 CA-C-N 115.453 -0.794 . . . . 1.3700000000000001 113.051 -178.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 59.3 Cg_endo -71.24 -16.04 31.59 Favored 'Trans proline' 0 CA--C 1.516 -0.402 0 C-N-CA 121.987 1.791 . . . . 0.45000000000000001 112.762 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.555 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 28.3 m-85 -79.23 -27.77 42.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.416 -0.356 . . . . 0.77000000000000002 110.332 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.764 HG12 HD23 ' A' ' 173' ' ' LEU . 7.7 tp -69.96 -31.44 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.19 110.259 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.4 OUTLIER -63.05 -32.21 73.53 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 109.643 -0.503 . . . . 1.3200000000000001 109.643 178.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 200' ' ' TYR . 31.1 mt -67.76 -31.08 50.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.804 -0.634 . . . . 0.31 110.356 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.423 HG22 ' SD ' ' A' ' 208' ' ' MET . 42.0 m -60.65 -52.3 65.74 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.692 -0.485 . . . . 0.20999999999999999 109.692 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.841 HD22 HG12 ' A' ' 215' ' ' ILE . 41.1 mt -70.95 -35.12 72.07 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.958 -0.565 . . . . 0.22 110.557 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 202' ' ' ASP . 1.6 t30 -63.86 -30.7 71.77 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 109.529 -0.545 . . . . 1.22 109.529 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.672 HD21 ' OH ' ' A' ' 237' ' ' TYR . 0.3 OUTLIER -76.69 -42.79 40.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.59999999999999998 109.373 178.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.475 ' SD ' HD23 ' A' ' 205' ' ' LEU . 30.4 mtp -64.89 -45.95 83.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.16 -0.927 . . . . 0.63 111.255 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 210' ' ' THR . 0.0 OUTLIER -60.46 -44.17 96.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.438 -0.346 . . . . 2.23 110.759 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 207' ' ' LEU . 0.5 OUTLIER -57.89 -31.71 67.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.147 0.499 . . . . 0.56999999999999995 109.88 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.584 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 1.6 m-85 -71.86 -51.54 21.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.488 -0.778 . . . . 0.40999999999999998 110.857 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 158.27 -4.82 0.14 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.522 -0.846 . . . . 0.23999999999999999 113.497 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.483 HG13 ' CG ' ' A' ' 229' ' ' GLN . 78.1 t -120.31 139.11 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.429 0.529 . . . . 0.20000000000000001 112.429 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -131.14 156.28 45.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.649 -0.705 . . . . 1.3300000000000001 110.568 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.965 HG21 HG12 ' A' ' 225' ' ' VAL . 1.8 pp -129.23 177.17 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 115.485 -0.78 . . . . 0.23999999999999999 111.782 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.85 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 2.8 tt0 -92.38 126.2 37.36 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.827 0.346 . . . . 1.8400000000000001 110.479 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -101.9 99.65 9.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.162 0.506 . . . . 2.2599999999999998 110.403 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.666 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 1.4 mm-40 -66.85 -166.35 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.652 -0.704 . . . . 1.6000000000000001 109.419 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.29 49.16 0.35 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.407 -0.36 . . . . 2.3199999999999998 110.611 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.479 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 56.7 20.05 4.79 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.016 0.436 . . . . 0.34000000000000002 110.926 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 191' ' ' ILE . 54.6 mt-30 -111.66 -24.24 10.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 1.96 110.106 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.738 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 41.2 mt-30 -146.63 140.93 26.39 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 120.979 0.418 . . . . 1.6200000000000001 111.168 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.855 ' HB3' HD21 ' A' ' 177' ' ' LEU . 19.6 m-85 -111.31 96.17 5.96 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.616 -0.883 . . . . 0.17000000000000001 108.616 177.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 1.055 HG13 HG22 ' A' ' 188' ' ' VAL . 52.1 t -86.36 110.76 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.042 0.448 . . . . 0.14999999999999999 110.935 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.965 HG12 HG21 ' A' ' 215' ' ' ILE . 7.4 m -103.03 120.71 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.662 -0.699 . . . . 0.16 111.669 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -62.89 112.59 2.63 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.497 -0.774 . . . . 1.6100000000000001 109.797 178.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.488 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -66.55 151.3 52.24 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.159 -0.928 . . . . 0.20000000000000001 113.039 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.77 10.63 62.87 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.591 -0.814 . . . . 0.26000000000000001 113.473 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.483 ' CG ' HG13 ' A' ' 213' ' ' VAL . 75.0 mm-40 -73.2 -175.42 1.85 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.34 0.591 . . . . 1.1299999999999999 110.992 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.658 ' HA ' HD23 ' A' ' 182' ' ' LEU . 1.2 m -176.6 103.25 0.06 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.273 -0.876 . . . . 0.28000000000000003 109.813 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.567 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 27.4 m-85 -54.73 152.24 7.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.196 -0.457 . . . . 0.33000000000000002 111.261 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.62 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 16.6 pt20 -122.13 154.25 37.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.06 -0.719 . . . . 2.0 109.06 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 9.5 t -64.97 102.93 0.37 Allowed Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 112.404 0.52 . . . . 1.1599999999999999 112.404 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.62 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 58.2 Cg_endo -68.93 -33.15 20.59 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.284 1.989 . . . . 0.5 111.466 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 121.54 -123.7 5.57 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.697 -0.683 . . . . 0.23999999999999999 111.645 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.549 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -91.38 117.38 29.62 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.83 -0.433 . . . . 0.39000000000000001 109.83 179.197 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.672 ' OH ' HD21 ' A' ' 207' ' ' LEU . 62.5 t80 -122.75 144.65 49.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.859 0.361 . . . . 1.1100000000000001 111.674 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.848 HD12 HG23 ' A' ' 42' ' ' THR . 25.0 tp -99.35 117.78 34.54 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.293 -0.412 . . . . 1.1100000000000001 110.651 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 42' ' ' THR . 57.9 t -56.78 -73.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.988 -0.551 . . . . 0.72999999999999998 111.07 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.533 ' H ' ' HB3' ' A' ' 43' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.235 -0.888 . . . . 2.6200000000000001 111.154 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.532 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . 2.6 m . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.49 0.662 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.584 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 7.5 p30 -81.61 -22.32 37.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.027 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -65.57 -40.3 92.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.789 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.799 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -79.04 -36.46 40.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.993 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.776 HD21 HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -60.39 -51.63 68.66 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.922 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.555 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 2.4 tp -70.07 -43.21 71.63 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.891 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.494 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 48.6 mt -61.02 -35.9 78.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.005 0.431 . . . . 0.0 110.738 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.692 ' HA ' ' CE1' ' A' ' 211' ' ' PHE . . . -71.06 -29.97 66.0 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.737 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.757 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -70.08 -30.62 67.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.542 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.912 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -89.39 -11.29 43.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.902 0.382 . . . . 0.0 111.102 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.627 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.45 165.57 20.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.212 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.524 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 75.7 m80 -99.07 98.68 9.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.967 0.413 . . . . 0.0 110.079 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.6 141.51 6.88 Favored Glycine 0 C--N 1.315 -0.637 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.162 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.911 ' HB2' HD13 ' A' ' 76' ' ' ILE . 13.6 tttt -62.6 132.83 53.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.085 0.469 . . . . 0.0 111.78 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.484 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.7 OUTLIER -128.22 152.71 47.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.917 178.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.871 HG22 ' HG2' ' A' ' 74' ' ' GLU . 58.5 t -100.85 141.2 17.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.021 0.439 . . . . 0.0 111.925 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.799 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -126.93 110.95 13.55 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.039 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.741 HG23 HD12 ' A' ' 238' ' ' LEU . 0.2 OUTLIER -101.99 166.94 10.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.121 0.486 . . . . 0.0 111.467 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 71' ' ' THR . 2.1 t30 70.6 19.35 6.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.879 -177.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.982 HD22 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -60.89 156.52 17.24 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.414 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.546 ' HB3' HG21 ' A' ' 50' ' ' VAL . 16.8 tp -93.71 115.65 28.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.0 0.428 . . . . 0.0 111.617 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -76.37 64.49 2.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.439 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.515 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.3 OUTLIER -124.8 -159.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.063 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.731 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 0.5 OUTLIER -97.39 -21.07 17.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.988 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.64 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 4.0 p-10 -72.77 -27.39 61.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.268 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.546 HG21 ' HB3' ' A' ' 45' ' ' LEU . 13.3 t -88.46 -51.99 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.368 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.731 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 2.1 ptm180 -51.21 -28.53 11.62 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.209 0.528 . . . . 0.0 109.924 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . 2.9 m-70 -71.5 -39.82 70.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.246 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.652 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 3.0 tpt -62.54 -50.1 72.67 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.776 HD23 HD21 ' A' ' 29' ' ' LEU . 1.1 mt -60.01 -52.98 63.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.785 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.8 m120 -54.22 -22.86 12.65 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.851 178.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.747 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -74.4 -48.11 29.83 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.597 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.635 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -72.06 -49.9 32.82 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.145 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.545 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 7.2 t -50.85 -30.88 15.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.158 0.504 . . . . 0.0 110.286 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.771 ' HB1' HD11 ' A' ' 88' ' ' LEU . . . -59.61 -49.5 77.5 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.958 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.915 HD21 HD22 ' A' ' 106' ' ' LEU . 3.6 mp -67.47 -28.46 67.88 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.584 0.707 . . . . 0.0 109.825 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.53 -0.24 5.47 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.537 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.591 HG21 HD11 ' A' ' 82' ' ' LEU . 13.8 t -58.7 147.97 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 117.491 0.645 . . . . 0.0 110.343 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.44 ' CB ' HG13 ' A' ' 76' ' ' ILE . 1.0 OUTLIER -111.69 107.65 16.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.636 -178.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.652 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 6.8 p90 -122.7 160.52 25.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.157 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -149.31 116.41 6.03 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.662 179.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.982 HD11 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -86.52 174.09 9.17 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.228 0.537 . . . . 0.0 111.735 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.512 ' CB ' ' HG3' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -85.16 178.55 7.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.634 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.23 -14.79 53.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.091 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.95 2.93 12.8 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.003 0.43 . . . . 0.0 110.239 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.516 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 1.3 mtm-85 62.51 47.5 5.0 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.121 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -127.05 -2.54 6.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.271 179.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -141.27 109.75 5.96 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.899 ' SG ' HD22 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -114.41 147.67 38.89 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.255 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.871 ' HG2' HG22 ' A' ' 40' ' ' VAL . 7.2 mt-10 -114.62 102.52 10.11 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.742 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -95.27 131.93 40.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.911 HD13 ' HB2' ' A' ' 38' ' ' LYS . 8.6 mm -80.53 104.34 8.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.807 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.659 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -51.31 112.85 1.94 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.512 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.614 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.2 m-20 -59.61 -17.18 31.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.969 0.414 . . . . 0.0 110.378 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.524 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 88.08 -22.49 18.54 Favored Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.281 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.912 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -139.13 -143.22 4.39 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.803 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 6.2 Cg_exo -80.52 171.12 15.09 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 121.95 1.767 . . . . 0.0 109.319 177.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.867 ' HB2' HD23 ' A' ' 106' ' ' LEU . 4.3 mm? -69.78 90.68 0.6 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.803 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 35.5 m170 -83.08 119.54 24.61 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.281 -1.781 . . . . 0.0 112.749 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.687 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -143.54 106.76 4.54 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.334 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -105.09 86.73 2.49 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.346 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.62 23.41 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.897 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 53.93 51.02 15.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.526 0.679 . . . . 0.0 109.75 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.771 HD11 ' HB1' ' A' ' 59' ' ' ALA . 3.1 tp -80.88 137.33 36.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.252 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.62 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 3.3 tt0 -115.68 129.93 56.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.272 0.558 . . . . 0.0 110.766 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.763 HD12 HD11 ' A' ' 102' ' ' LEU . 4.3 mt -105.99 154.75 20.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.378 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -120.21 107.26 12.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.862 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.643 HD23 ' HE2' ' A' ' 99' ' ' MET . 1.6 mm? -93.33 3.47 55.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.378 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.461 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 40.53 -143.57 0.6 Allowed Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.166 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.478 ' OD1' ' HB3' ' A' ' 120' ' ' ARG . 1.0 OUTLIER -92.04 50.58 1.68 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.985 0.421 . . . . 0.0 110.88 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.64 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -92.34 -73.79 0.54 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.923 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.51 -17.46 14.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.465 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.44 ' HA ' ' OE1' ' A' ' 171' ' ' GLN . 6.0 p -96.59 -9.16 29.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.845 0.355 . . . . 0.0 111.271 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.411 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -128.02 -13.64 5.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.695 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.643 ' HE2' HD23 ' A' ' 92' ' ' LEU . 3.4 ttm -73.7 -54.8 7.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.082 0.467 . . . . 0.0 111.033 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.781 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -58.98 -50.8 86.03 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.475 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.754 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 28.2 Cg_exo -63.14 -47.18 8.62 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.721 2.28 . . . . 0.0 112.863 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.027 HD13 HD11 ' A' ' 106' ' ' LEU . 2.0 tm? -65.24 -37.74 88.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.754 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.598 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -60.3 -48.35 82.1 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.441 0.638 . . . . 0.0 110.077 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.991 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -66.09 -41.47 90.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.519 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.517 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -59.1 -39.36 81.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.389 . . . . 0.0 112.041 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.027 HD11 HD13 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -73.3 -21.14 60.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.849 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.665 ' SG ' HD11 ' A' ' 140' ' ' ILE . 10.8 m -63.86 -6.37 5.81 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.453 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.727 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 7.2 mt -85.13 168.5 14.77 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.554 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 56.11 -113.44 4.06 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.607 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.418 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.1 OUTLIER -167.9 94.18 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.972 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.607 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 44.4 p-10 -138.54 145.21 40.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.833 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.55 ' C ' HD12 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -102.83 111.65 24.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.808 179.361 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.686 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 5.0 mp -141.2 143.59 27.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.235 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 41.2 t -115.59 113.62 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 120.67 0.272 . . . . 0.0 110.615 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.598 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 25.2 mt -81.89 156.82 24.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.428 0.632 . . . . 0.0 111.767 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.418 ' O ' ' HE3' ' A' ' 99' ' ' MET . 1.6 m -163.76 166.66 21.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.587 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -154.36 -166.11 14.66 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 119.928 -1.13 . . . . 0.0 113.708 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.656 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 11.7 mm-40 -69.48 173.17 4.22 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.46 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.656 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 24.3 Cg_endo -61.56 -24.48 78.1 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.979 1.786 . . . . 0.0 112.173 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.57 ' HD3' ' HG2' ' A' ' 123' ' ' GLU . 4.1 tpp180 -88.05 -33.47 18.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.536 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.505 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 9.2 tpt -59.96 -17.68 39.82 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.613 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 12.2 mttm -68.93 -5.51 21.84 Favored 'General case' 0 C--N 1.334 -0.09 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.57 ' HG2' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -119.09 22.62 11.78 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.141 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.439 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 17.0 mmm180 -102.24 86.73 0.94 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.766 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.796 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 4.4 Cg_endo -47.02 134.42 18.37 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.918 2.412 . . . . 0.0 112.581 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.89 HD11 HD23 ' A' ' 129' ' ' LEU . 21.4 tt -135.78 32.22 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.79 0.805 . . . . 0.0 109.682 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -70.99 -51.6 17.95 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.612 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.676 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -58.85 -29.55 67.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.767 0.318 . . . . 0.0 110.447 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.89 HD23 HD11 ' A' ' 126' ' ' ILE . 29.6 tp -76.76 -61.03 2.11 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.964 HG13 HD12 ' A' ' 140' ' ' ILE . 61.9 t -57.06 -25.62 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.653 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -70.42 -45.42 65.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.584 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.892 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -66.1 -46.89 76.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.915 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.832 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.1 OUTLIER -60.43 -46.33 90.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -56.97 -38.1 72.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.549 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.892 HD12 ' HA ' ' A' ' 132' ' ' ALA . 3.8 mt -66.71 -32.31 73.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.271 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.476 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -76.09 -16.82 80.42 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.555 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 127.6 5.47 5.43 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.309 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.44 148.48 41.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.83 0.348 . . . . 0.0 111.439 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -117.2 94.04 4.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.391 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.964 HD12 HG13 ' A' ' 130' ' ' VAL . 14.1 mt -116.95 174.73 3.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.93 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.752 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.6 OUTLIER -153.17 -175.19 5.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.043 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.581 ' N ' HG23 ' A' ' 141' ' ' THR . 25.8 m-85 -125.35 106.87 10.15 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.675 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.2 mm? -79.91 -13.58 59.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -177.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.751 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 45.8 mt-10 -142.98 -71.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.062 0.458 . . . . 0.0 110.896 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.751 ' HB3' ' CD2' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -113.48 147.37 37.99 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.647 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.472 ' O ' ' CD2' ' A' ' 148' ' ' TYR . 2.2 mt-10 -76.68 131.97 39.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.47 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.796 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 82.5 m-20 62.84 48.97 3.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.125 0.488 . . . . 0.0 109.72 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.805 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 50.5 m-85 -147.44 176.2 2.33 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.503 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.805 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 2.3 Cg_endo -44.25 -43.4 13.28 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.518 2.812 . . . . 0.0 115.461 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.751 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 30.5 Cg_endo -61.94 101.29 0.22 Allowed 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 121.539 1.493 . . . . 0.0 111.751 -178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.623 HD11 HG21 ' A' ' 126' ' ' ILE . 91.0 mt -138.72 123.62 18.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.622 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.744 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.0 OUTLIER -104.63 112.3 25.33 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 176.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.811 HD23 HG23 ' A' ' 140' ' ' ILE . 1.2 mt -94.49 156.15 16.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.434 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.607 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 19.1 mt-30 -142.91 27.22 1.65 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.752 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 107' ' ' CYS . . . 53.86 -165.29 2.34 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.595 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 158' ' ' THR . . . 106.77 -5.15 36.86 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.901 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.648 ' CD2' HG22 ' A' ' 179' ' ' THR . 3.2 t80 -60.53 108.01 0.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 0.0 110.668 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.502 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 68.3 p -107.53 -47.24 3.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.006 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.59 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 141.26 -159.91 26.74 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 119.976 -1.107 . . . . 0.0 114.175 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.528 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 114.82 175.47 18.6 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.47 128.01 34.85 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.579 HG11 ' HB1' ' A' ' 132' ' ' ALA . 59.4 t -137.34 151.26 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.966 0.412 . . . . 0.0 111.858 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.44 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 1.9 m-20 -118.27 116.51 26.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.113 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.678 HG11 HD13 ' A' ' 173' ' ' LEU . 0.3 OUTLIER -118.04 144.82 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.754 -179.319 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.676 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.2 OUTLIER -83.75 138.0 33.47 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.638 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -80.05 -44.84 8.68 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.355 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.14 164.04 0.08 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.808 0.337 . . . . 0.0 111.189 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.552 HG21 ' HE1' ' A' ' 128' ' ' HIS . 4.0 t 70.73 56.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.83 ' H ' HG11 ' A' ' 196' ' ' VAL . 53.2 m 59.25 156.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.192 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 48.5 p -80.28 -0.9 38.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.165 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.781 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 77.3 mm-40 -52.8 -23.72 7.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.759 0.314 . . . . 0.0 111.278 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.659 ' HA ' HD13 ' A' ' 129' ' ' LEU . 3.8 m-85 -71.55 -54.27 11.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.033 0.444 . . . . 0.0 110.447 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.937 HD23 HG12 ' A' ' 201' ' ' ILE . 18.8 tp -78.02 -35.86 49.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.391 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.531 HG23 ' OG1' ' A' ' 204' ' ' THR . 92.3 m -55.65 -37.01 67.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.165 0.507 . . . . 0.0 109.69 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.991 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -71.56 -51.44 23.45 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.411 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.832 ' CD2' HD23 ' A' ' 133' ' ' LEU . 3.1 mt -65.41 -35.8 82.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.458 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.915 HD12 HD11 ' A' ' 201' ' ' ILE . 10.6 mt -66.53 -28.8 68.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.115 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.497 ' HA ' ' OH ' ' A' ' 231' ' ' TYR . 5.9 ptp -95.32 -27.53 15.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.169 0.509 . . . . 0.0 110.958 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.712 HG21 ' O ' ' A' ' 104' ' ' ALA . 80.3 m -87.44 -46.44 9.61 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.131 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.897 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -63.02 -36.29 23.88 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.726 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.5 Cg_endo -53.24 -36.91 79.66 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 121.28 1.32 . . . . 0.0 111.8 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.716 HD23 ' HA ' ' A' ' 230' ' ' SER . 0.9 OUTLIER -84.22 -10.83 57.38 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.655 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -64.49 119.52 57.52 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.747 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 3.4 Cg_exo -41.09 -29.67 0.55 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.478 2.785 . . . . 0.0 114.291 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.32 153.36 22.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.17 0.51 . . . . 0.0 111.59 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.624 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 6.0 t70 -67.28 116.6 8.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.84 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.763 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 26.3 m -102.87 135.65 44.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.295 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.965 HG22 HG13 ' A' ' 224' ' ' VAL . 39.4 t -126.13 99.16 5.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.147 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.59 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.0 mt -90.87 142.0 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.238 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.807 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.3 OUTLIER -112.99 171.14 7.72 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.807 HD13 ' C ' ' A' ' 190' ' ' ARG . 1.0 OUTLIER -110.59 97.42 5.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.918 0.39 . . . . 0.0 111.339 -178.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.498 ' HG2' ' HE ' ' A' ' 190' ' ' ARG . 15.1 mtmt -57.15 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.651 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.428 ' O ' HG22 ' A' ' 191' ' ' ILE . . . -82.58 170.44 50.28 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.216 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.08 124.17 20.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.61 0.243 . . . . 0.0 110.604 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.687 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.4 OUTLIER -58.48 144.88 40.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.995 0.426 . . . . 0.0 110.461 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.83 HG11 ' H ' ' A' ' 169' ' ' SER . 14.8 p -101.13 -20.57 5.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.79 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.733 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -128.39 46.19 2.64 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.376 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.78 ' O ' HG22 ' A' ' 201' ' ' ILE . 5.5 ttpt -40.44 -62.11 1.02 Allowed Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.825 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 59.1 Cg_endo -70.21 -16.44 35.67 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 121.586 1.524 . . . . 0.0 112.209 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.733 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 14.6 m-85 -75.74 -30.11 59.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.234 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.937 HG12 HD23 ' A' ' 173' ' ' LEU . 7.3 tp -68.28 -33.83 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.026 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.24 -31.27 68.92 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.673 HD12 ' HA ' ' A' ' 200' ' ' TYR . 20.7 mt -70.44 -30.77 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.236 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.531 ' OG1' HG23 ' A' ' 174' ' ' THR . 24.2 m -59.25 -55.1 39.16 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.766 HD21 HD22 ' A' ' 177' ' ' LEU . 21.7 mt -71.26 -35.73 71.51 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.296 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.755 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 58.4 m-20 -64.35 -28.67 69.86 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.669 ' HB2' ' O ' ' A' ' 203' ' ' ILE . 0.1 OUTLIER -76.55 -44.41 34.96 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.862 177.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.488 ' HB3' ' HE1' ' A' ' 231' ' ' TYR . 9.5 mtp -66.8 -41.09 88.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.449 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.755 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 17.1 pttt -61.07 -43.79 98.36 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.712 0.291 . . . . 0.0 110.337 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.646 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.6 OUTLIER -59.59 -29.68 68.14 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.692 ' CE1' ' HA ' ' A' ' 32' ' ' ALA . 1.3 m-85 -72.94 -50.78 21.49 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.504 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.428 ' HA3' ' HG2' ' A' ' 232' ' ' GLN . . . 153.98 -7.69 0.4 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.53 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.638 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 65.4 t -118.92 140.34 43.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.434 ' HG2' ' HB3' ' A' ' 209' ' ' LYS . 37.6 mt-10 -135.58 156.65 48.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.625 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 1.064 HG21 HG12 ' A' ' 225' ' ' VAL . 1.8 pp -127.77 175.3 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.94 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.885 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 6.4 tp10 -88.8 126.33 35.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.645 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -102.87 101.17 11.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.033 0.444 . . . . 0.0 110.573 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.74 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.7 OUTLIER -65.33 -166.64 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.453 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -73.37 49.02 0.26 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.842 0.353 . . . . 0.0 110.537 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.576 ' CZ ' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 57.48 19.81 5.55 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.129 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 191' ' ' ILE . 2.2 mt-30 -112.98 -21.42 11.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.826 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.769 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 23.9 mt-30 -149.17 140.11 22.87 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.967 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.894 ' HB3' HD21 ' A' ' 177' ' ' LEU . 27.5 m-85 -112.36 98.53 7.35 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.965 HG13 HG22 ' A' ' 188' ' ' VAL . 58.6 t -84.55 110.79 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 121.222 0.534 . . . . 0.0 111.283 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 1.064 HG12 HG21 ' A' ' 215' ' ' ILE . 3.4 m -98.75 115.31 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.964 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.692 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -64.59 103.53 0.69 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.895 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.624 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.99 153.81 25.1 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.935 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.07 10.75 62.21 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.492 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.692 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 6.7 mm-40 -77.21 -179.15 5.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.223 0.535 . . . . 0.0 110.791 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.716 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.1 m -174.5 105.03 0.1 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.993 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.639 ' HD2' ' HB2' ' A' ' 34' ' ' LEU . 35.0 m-85 -55.52 151.85 9.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.706 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 16.7 pt20 -119.66 159.44 24.44 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.419 ' HA ' ' HD2' ' A' ' 234' ' ' PRO . 51.6 p -75.48 98.35 0.24 Allowed Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.706 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 52.8 Cg_endo -65.88 -32.73 44.93 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.497 2.131 . . . . 0.0 112.011 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 122.45 -121.14 4.56 Favored Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.678 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.3 OUTLIER -92.56 116.88 29.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 63.6 t80 -122.54 138.6 54.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.53 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.741 HD12 HG23 ' A' ' 42' ' ' THR . 3.6 tp -93.57 120.42 33.82 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.173 178.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.452 HG11 ' N ' ' A' ' 25' ' ' SER . 40.7 t -61.5 -75.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.821 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.492 ' H ' ' HB3' ' A' ' 43' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.935 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.735 ' N ' HG11 ' A' ' 239' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 121.427 0.632 . . . . 0.0 110.399 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.456 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 18.5 p30 -78.76 -26.23 44.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.787 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.522 ' O ' HD12 ' A' ' 31' ' ' LEU . 3.0 mtt180 -62.48 -38.8 91.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.651 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.851 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -78.55 -34.76 46.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.241 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.838 HD21 HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -62.3 -53.24 58.03 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.996 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 4.7 tp -67.77 -45.3 75.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.521 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.684 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 38.6 mt -58.97 -34.82 72.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.325 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.674 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -75.41 -30.06 59.96 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.729 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.802 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -69.67 -32.57 71.27 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.611 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.893 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -87.77 -12.12 46.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.006 0.432 . . . . 0.0 110.804 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.624 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.0 163.71 21.94 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.73 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.538 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 75.0 m80 -97.44 97.07 8.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.86 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.34 144.6 7.38 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.018 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.753 ' HB2' HD13 ' A' ' 76' ' ' ILE . 16.2 tttt -66.6 134.8 53.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.076 0.465 . . . . 0.0 111.975 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.548 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -128.85 154.87 46.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.766 178.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.034 HG22 ' HG2' ' A' ' 74' ' ' GLU . 54.5 t -101.87 141.64 17.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.789 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.851 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -127.12 111.45 14.02 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.751 HG23 HD12 ' A' ' 238' ' ' LEU . 0.5 OUTLIER -104.7 167.4 9.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.156 0.503 . . . . 0.0 111.719 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.71 ' HB3' ' H ' ' A' ' 240' ' ' GLU . 0.3 OUTLIER 67.45 20.47 9.85 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.794 -177.248 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.78 HD22 HD11 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -59.08 157.24 10.54 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.565 178.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.622 ' H ' ' HB3' ' A' ' 25' ' ' SER . 28.9 tp -95.32 114.3 26.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.122 0.487 . . . . 0.0 111.704 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -73.6 59.34 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.13 0.49 . . . . 0.0 110.53 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.438 ' OG ' HD23 ' A' ' 45' ' ' LEU . 36.8 p -115.87 -162.69 0.85 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.087 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.685 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 42.5 m-20 -97.94 -22.8 16.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.491 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -73.34 -24.01 60.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.228 0.537 . . . . 0.0 110.0 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.567 HG21 ' HB3' ' A' ' 45' ' ' LEU . 19.2 t -89.02 -55.2 6.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.103 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.685 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -51.3 -29.47 15.01 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 109.842 179.43 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -71.12 -37.87 72.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.892 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.605 ' HE1' HD22 ' A' ' 30' ' ' LEU . 9.3 tpt -63.83 -51.15 66.0 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.838 HD23 HD21 ' A' ' 29' ' ' LEU . 1.2 mp -62.04 -47.46 84.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.674 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -56.25 -26.1 50.28 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.336 179.076 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.826 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -74.18 -46.31 42.92 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.631 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.612 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -68.27 -49.6 59.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.818 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.545 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 7.2 t -49.74 -31.47 11.47 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.204 0.526 . . . . 0.0 109.888 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.755 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.7 -52.36 65.85 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.093 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.016 HD21 HD22 ' A' ' 106' ' ' LEU . 4.1 mp -65.42 -28.63 69.38 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.524 0.678 . . . . 0.0 110.035 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.92 -1.23 6.26 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 114.852 -1.067 . . . . 0.0 113.758 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.654 HG21 HD11 ' A' ' 82' ' ' LEU . 22.8 t -56.27 152.81 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 117.639 0.72 . . . . 0.0 110.069 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.515 ' CB ' HG13 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -114.28 108.68 17.25 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.005 -179.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.667 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 9.1 p90 -126.95 156.95 40.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 32.1 m -150.33 116.62 5.7 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.68 0.276 . . . . 0.0 111.078 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.78 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -85.62 177.44 7.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.197 0.522 . . . . 0.0 111.63 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.79 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 3.6 t -88.02 178.82 6.56 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.993 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.91 -12.72 39.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.584 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -117.71 2.61 12.29 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.866 0.365 . . . . 0.0 110.667 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.471 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 10.9 mtt180 61.35 44.5 9.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.355 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -126.56 -2.6 6.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.562 179.446 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.79 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -141.21 110.25 6.19 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.741 ' SG ' HD22 ' A' ' 66' ' ' LEU . 3.0 t -114.75 149.88 36.21 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 1.034 ' HG2' HG22 ' A' ' 40' ' ' VAL . 43.7 mt-10 -115.85 102.85 10.07 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.693 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.6 mp -96.11 132.61 39.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.1 0.476 . . . . 0.0 111.995 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.753 HD13 ' HB2' ' A' ' 38' ' ' LYS . 15.1 mm -82.12 107.5 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.944 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.674 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -54.07 112.61 2.67 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.684 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.615 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -61.33 -17.06 51.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.973 0.416 . . . . 0.0 110.519 178.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.538 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 86.76 -21.63 17.98 Favored Glycine 0 C--O 1.228 -0.248 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.41 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.893 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.62 -144.88 4.7 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.809 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 6.2 Cg_exo -79.96 168.44 19.03 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 121.858 1.705 . . . . 0.0 109.289 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.802 HD21 ' HB3' ' A' ' 33' ' ' ALA . 4.2 mm? -66.89 90.56 0.18 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.809 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 29.7 m170 -82.48 118.75 23.47 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.073 -1.876 . . . . 0.0 112.858 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.69 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -144.42 111.29 5.77 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.793 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -114.02 90.8 3.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.77 0.319 . . . . 0.0 111.524 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.03 22.6 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.736 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.7 52.28 11.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.453 0.644 . . . . 0.0 109.777 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.755 HD21 ' HB1' ' A' ' 59' ' ' ALA . 4.5 tp -82.71 130.53 35.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.256 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.652 ' N ' HD12 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -111.87 129.85 56.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.915 0.388 . . . . 0.0 110.519 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.826 HD13 ' HA ' ' A' ' 56' ' ' ALA . 16.3 mt -114.04 154.39 27.78 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.478 ' CE1' ' HA2' ' A' ' 93' ' ' GLY . 43.9 t80 -121.01 102.26 8.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.642 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.921 HD23 ' HE1' ' A' ' 99' ' ' MET . 2.0 mm? -89.09 8.39 30.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.893 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.558 ' CA ' ' HG3' ' A' ' 118' ' ' GLU . . . 45.23 -142.91 3.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.898 -0.667 . . . . 0.0 113.203 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.488 ' ND2' ' HB3' ' A' ' 120' ' ' ARG . 16.6 t-20 -94.05 51.58 1.53 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.866 0.365 . . . . 0.0 111.081 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.15 -73.13 0.53 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.115 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.45 -16.38 18.83 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.073 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.454 ' HA ' ' CD ' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -95.15 -8.23 36.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.328 . . . . 0.0 111.103 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.436 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -127.46 -17.6 4.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.708 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.921 ' HE1' HD23 ' A' ' 92' ' ' LEU . 41.4 tpp -67.65 -54.72 17.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.097 0.475 . . . . 0.0 110.76 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.815 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -59.22 -53.37 66.94 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.474 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.685 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 31.3 Cg_exo -60.35 -47.15 15.18 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.731 2.287 . . . . 0.0 112.831 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.745 ' CD1' HD11 ' A' ' 106' ' ' LEU . 3.4 tm? -69.34 -38.92 78.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.553 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.431 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -60.92 -47.79 84.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.485 0.66 . . . . 0.0 109.988 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.912 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -68.17 -36.42 79.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.847 -1.069 . . . . 0.0 113.23 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.554 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -61.75 -44.21 97.34 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.016 HD22 HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -69.74 -19.96 63.52 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.56 -179.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.543 ' SG ' HD11 ' A' ' 140' ' ' ILE . 56.6 m -60.06 -11.52 6.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.169 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.745 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 7.7 mt -84.17 168.92 15.34 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 52.66 -108.96 0.8 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.374 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.405 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 11.3 p -166.93 100.86 0.55 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.689 0.281 . . . . 0.0 110.497 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 9.7 m-20 -138.3 136.82 36.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.277 -0.42 . . . . 0.0 112.119 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.721 ' C ' HD12 ' A' ' 113' ' ' ILE . 4.5 m-20 -101.42 111.21 23.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.476 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.723 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.3 mp -142.55 141.76 27.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.324 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.931 HG22 ' HG2' ' A' ' 152' ' ' ARG . 10.5 t -112.31 114.15 46.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.59 HD22 HD21 ' A' ' 92' ' ' LEU . 59.5 mt -87.35 156.74 19.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.551 0.691 . . . . 0.0 112.288 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 117' ' ' GLY . 0.6 OUTLIER -159.03 175.25 13.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.071 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.413 ' H ' HG22 ' A' ' 116' ' ' THR . . . -164.15 -168.5 26.31 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 119.902 -1.142 . . . . 0.0 114.253 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.745 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 36.5 mt-10 -67.7 174.8 1.98 Allowed Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 122.877 0.471 . . . . 0.0 110.453 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.745 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 24.1 Cg_endo -61.39 -38.44 64.25 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.988 1.792 . . . . 0.0 112.267 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 123' ' ' GLU . 15.0 tpp85 -76.88 -30.07 56.05 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.276 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.682 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 11.2 tpt -65.0 -11.59 40.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.205 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.752 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 10.4 mttt -76.33 -6.53 51.96 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.661 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 9.9 pt-20 -121.62 23.37 10.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.973 0.416 . . . . 0.0 111.166 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.446 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 5.1 mmp_? -96.94 94.75 1.89 Allowed Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.541 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.675 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 10.3 Cg_endo -53.66 123.09 12.53 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.499 2.133 . . . . 0.0 112.572 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.653 ' O ' HG23 ' A' ' 130' ' ' VAL . 13.3 tt -127.82 32.07 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.617 0.723 . . . . 0.0 110.225 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -74.3 -49.98 11.04 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.479 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.829 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -52.1 -28.42 17.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.047 0.451 . . . . 0.0 110.656 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.734 ' CD1' HD21 ' A' ' 133' ' ' LEU . 15.8 tp -82.37 -65.44 1.01 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.546 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 1.014 HG13 HD12 ' A' ' 140' ' ' ILE . 47.8 t -51.1 -28.23 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.179 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 13.0 t70 -68.43 -45.93 71.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.496 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 1.038 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -66.5 -48.78 68.72 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.817 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -58.34 -43.08 88.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.36 0.6 . . . . 0.0 109.684 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.53 -33.88 73.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.698 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 1.038 HD12 ' HA ' ' A' ' 132' ' ' ALA . 3.4 mt -69.79 -31.12 68.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.991 0.424 . . . . 0.0 110.266 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.558 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -77.79 -17.12 79.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.379 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.78 3.98 5.33 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.141 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.25 147.24 48.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 0.0 111.105 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 1.9 mmtp -113.94 91.22 3.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.454 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.014 HD12 HG13 ' A' ' 130' ' ' VAL . 8.1 mt -116.45 174.63 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.784 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -151.49 -167.15 2.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.144 0.497 . . . . 0.0 111.187 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.743 ' N ' HG23 ' A' ' 141' ' ' THR . 24.4 m-85 -136.17 99.1 4.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.929 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.585 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.4 mm? -68.25 -13.07 61.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.584 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.765 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 40.1 mm-40 -142.0 -73.8 0.31 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.069 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.5 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -120.43 150.09 41.34 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.145 0.498 . . . . 0.0 111.526 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.487 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 16.6 pt-20 -68.21 128.0 34.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.258 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.675 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 8.3 m-20 68.73 51.58 0.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.248 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.809 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.0 m-30 -145.17 177.29 1.82 Allowed Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.809 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 4.5 Cg_endo -48.08 -43.38 30.82 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.026 2.484 . . . . 0.0 114.974 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.765 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 27.8 Cg_endo -62.4 100.95 0.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 120.989 1.126 . . . . 0.0 111.276 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.598 HD11 HG21 ' A' ' 126' ' ' ILE . 61.8 mt -136.97 123.32 20.68 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.412 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.931 ' HG2' HG22 ' A' ' 114' ' ' VAL . 2.8 mtp180 -103.93 112.11 24.95 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.892 HD23 HG23 ' A' ' 140' ' ' ILE . 1.7 mt -93.83 158.75 15.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.318 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.588 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 28.2 mt-30 -149.44 22.66 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.079 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.503 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 53.68 -166.87 1.71 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.707 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 109.29 -2.23 31.15 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.957 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.677 ' CD2' HG22 ' A' ' 179' ' ' THR . 2.5 t80 -60.38 108.21 0.78 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.943 0.372 . . . . 0.0 110.949 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.516 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 68.5 p -105.09 -49.29 3.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.054 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.649 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 142.43 -163.58 27.13 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.168 -1.015 . . . . 0.0 114.019 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.509 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 116.7 172.56 16.42 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -65.29 128.32 35.36 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 117.245 0.523 . . . . 0.0 109.732 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.608 HG11 ' HB1' ' A' ' 132' ' ' ALA . 59.5 t -135.9 157.35 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-O 121.149 0.5 . . . . 0.0 111.31 -178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.478 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.7 OUTLIER -125.34 117.94 24.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.518 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.966 HG11 HD13 ' A' ' 173' ' ' LEU . 0.5 OUTLIER -117.91 147.19 21.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.945 -178.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.829 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.2 OUTLIER -85.77 133.04 34.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.613 178.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.713 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -74.52 -44.67 26.14 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.304 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.506 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 0.2 OUTLIER -49.8 163.15 0.14 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.915 0.388 . . . . 0.0 111.805 -179.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.655 HG21 ' HE1' ' A' ' 128' ' ' HIS . 8.2 t 71.27 61.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.844 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.709 ' N ' HG11 ' A' ' 196' ' ' VAL . 0.2 OUTLIER 54.56 156.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.468 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.491 ' HG ' ' HG1' ' A' ' 174' ' ' THR . 6.7 t -79.61 2.21 23.28 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.877 0.37 . . . . 0.0 110.891 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.815 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 82.6 mm-40 -54.05 -24.14 16.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.328 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.55 ' CD2' ' HB2' ' A' ' 128' ' ' HIS . 2.1 m-85 -73.71 -58.48 3.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.352 0.596 . . . . 0.0 110.587 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.966 HD13 HG11 ' A' ' 164' ' ' VAL . 18.0 tp -72.25 -37.29 69.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.861 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.617 HG23 ' OG1' ' A' ' 204' ' ' THR . 66.8 m -57.29 -36.47 71.09 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.241 0.543 . . . . 0.0 109.772 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.912 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -71.76 -51.28 23.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.25 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.817 ' CD2' HD23 ' A' ' 133' ' ' LEU . 3.2 mt -64.12 -38.53 91.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.466 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.07 HD12 HD11 ' A' ' 201' ' ' ILE . 12.5 mt -65.61 -26.55 67.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.07 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.497 ' HA ' ' HH ' ' A' ' 231' ' ' TYR . 20.2 ptp -96.16 -27.03 15.23 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.175 0.512 . . . . 0.0 110.637 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.677 HG22 ' CD2' ' A' ' 157' ' ' PHE . 65.5 m -86.26 -47.0 9.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.795 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 1.009 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -61.56 -38.49 52.04 Favored Pre-proline 0 C--N 1.316 -0.885 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 9.2 Cg_endo -53.57 -35.98 78.9 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 121.28 1.32 . . . . 0.0 111.895 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.721 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.68 -9.25 58.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.676 -179.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -65.75 123.95 86.16 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.935 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 1.5 Cg_endo -43.58 -31.26 3.09 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.333 2.688 . . . . 0.0 113.993 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -106.02 153.46 21.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.137 0.494 . . . . 0.0 111.879 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.701 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 75.5 m-20 -67.03 113.15 4.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.78 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.797 ' HB ' HG23 ' A' ' 225' ' ' VAL . 41.1 m -99.6 135.18 41.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.167 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 1.042 HG22 HG13 ' A' ' 224' ' ' VAL . 35.3 t -125.83 99.0 5.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.324 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.576 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.5 mt -89.58 144.17 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.462 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.813 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -114.21 170.93 7.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.842 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.4 mm -110.65 96.35 4.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 120.858 0.361 . . . . 0.0 111.007 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -59.33 -81.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.483 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -81.43 167.8 49.29 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.164 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.94 122.97 16.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.555 0.217 . . . . 0.0 110.546 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.839 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.8 OUTLIER -56.24 148.2 19.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.228 0.537 . . . . 0.0 110.535 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.709 HG11 ' N ' ' A' ' 169' ' ' SER . 13.8 p -105.81 -21.78 5.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.225 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.698 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -126.65 47.42 2.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.848 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.1 OUTLIER -44.1 -65.15 0.64 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.904 -178.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.567 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 43.0 Cg_endo -65.6 -18.18 58.55 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 121.545 1.497 . . . . 0.0 111.542 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.82 ' HA ' HD12 ' A' ' 203' ' ' ILE . 13.3 m-85 -73.81 -30.03 62.49 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.561 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 1.07 HD11 HD12 ' A' ' 177' ' ' LEU . 8.0 tp -69.55 -33.32 56.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.422 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.3 OUTLIER -60.9 -35.5 76.84 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.82 HD12 ' HA ' ' A' ' 200' ' ' TYR . 15.8 mt -65.93 -30.27 49.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.62 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.617 ' OG1' HG23 ' A' ' 174' ' ' THR . 45.0 m -60.99 -55.76 29.14 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 1.038 HD21 HD22 ' A' ' 177' ' ' LEU . 35.5 mt -70.25 -33.71 71.96 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.473 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.537 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -66.14 -29.44 69.74 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.724 HD23 HG22 ' A' ' 203' ' ' ILE . 0.7 OUTLIER -77.08 -44.92 28.81 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.115 178.371 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.498 ' SD ' HG22 ' A' ' 204' ' ' THR . 12.7 mtp -64.62 -42.61 95.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.2 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.619 ' HG3' ' N ' ' A' ' 210' ' ' THR . 4.4 ptmt -61.53 -46.08 91.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.64 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.619 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.3 OUTLIER -59.11 -29.57 67.47 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.807 ' O ' ' HG2' ' A' ' 232' ' ' GLN . 0.8 OUTLIER -70.76 -49.67 44.22 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.485 179.277 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 155.63 -7.52 0.28 Allowed Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.337 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.724 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 49.3 t -119.18 141.82 37.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.409 ' HG3' ' HA ' ' A' ' 209' ' ' LYS . 9.6 mt-10 -135.59 155.67 50.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.401 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 1.011 HG21 HG12 ' A' ' 225' ' ' VAL . 2.3 pp -129.1 175.87 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.754 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.916 -177.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 1.014 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 7.2 tp10 -88.74 125.2 34.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.529 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -101.53 101.02 11.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.424 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.845 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.6 OUTLIER -66.77 -168.14 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.499 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -74.37 48.42 0.33 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.816 0.341 . . . . 0.0 110.427 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.625 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 58.14 20.13 6.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.036 0.446 . . . . 0.0 111.252 -179.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 191' ' ' ILE . 3.8 mt-30 -112.23 -20.52 11.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.77 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.845 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 17.6 mt-30 -151.2 140.87 21.74 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.901 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.969 ' HB3' HD21 ' A' ' 177' ' ' LEU . 11.0 m-85 -113.19 98.99 7.48 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 1.042 HG13 HG22 ' A' ' 188' ' ' VAL . 45.9 t -84.71 110.89 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.143 0.497 . . . . 0.0 111.25 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 1.011 HG12 HG21 ' A' ' 215' ' ' ILE . 3.2 m -99.02 111.61 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.927 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.738 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.6 OUTLIER -62.02 101.21 0.2 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.035 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.701 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -55.94 155.85 11.56 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.402 -0.817 . . . . 0.0 113.029 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.34 10.92 63.35 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.326 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.738 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 81.6 mm-40 -78.06 -177.67 5.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.444 0.64 . . . . 0.0 111.327 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.721 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.7 m -175.87 104.75 0.08 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.212 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.724 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 24.8 m-85 -54.11 152.44 6.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.825 0.345 . . . . 0.0 111.118 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.807 ' HG2' ' O ' ' A' ' 211' ' ' PHE . 7.5 pt20 -122.68 155.7 35.87 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 35.2 t -69.26 100.42 0.26 Allowed Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 56.9 Cg_endo -67.8 -32.75 28.95 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.387 2.058 . . . . 0.0 111.76 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 123.4 -119.01 3.69 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.962 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.666 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.8 OUTLIER -96.69 117.32 30.75 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.564 ' CE2' HD11 ' A' ' 207' ' ' LEU . 52.7 t80 -121.53 135.3 55.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.013 -178.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.751 HD12 HG23 ' A' ' 42' ' ' THR . 8.7 tp -95.51 111.35 23.28 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.582 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.735 HG11 ' N ' ' A' ' 25' ' ' SER . 21.5 t -58.9 -71.46 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.035 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.71 ' H ' ' HB3' ' A' ' 43' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.013 -0.994 . . . . 0.0 111.072 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.706 ' O ' HD12 ' A' ' 29' ' ' LEU . 19.2 p . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.68 0.276 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.691 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 4.4 p30 -84.87 -25.78 27.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.535 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.417 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 52.0 mtt180 -67.96 -42.05 81.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.868 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -74.68 -32.98 62.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.827 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -62.07 -48.82 78.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.186 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.561 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 17.0 tp -73.93 -43.93 56.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.453 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.759 HD21 ' HG2' ' A' ' 178' ' ' MET . 61.8 mt -59.89 -31.9 70.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.109 0.48 . . . . 0.0 110.899 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.686 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -78.6 -30.66 46.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.595 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.839 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -69.37 -32.12 70.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.62 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.913 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -88.74 -12.28 42.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.145 0.497 . . . . 0.0 110.966 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.642 ' HB2' ' HB2' ' A' ' 231' ' ' TYR . . . -80.43 166.17 21.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.409 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.494 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 78.6 m80 -101.21 97.83 8.3 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.14 142.28 6.77 Favored Glycine 0 C--N 1.315 -0.611 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.828 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.663 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 17.4 ttpp -67.02 138.91 57.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.236 0.541 . . . . 0.0 112.027 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.716 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.7 OUTLIER -132.93 156.13 47.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.333 179.076 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.722 HG22 ' CG ' ' A' ' 74' ' ' GLU . 61.9 t -102.75 142.87 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.317 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.868 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -127.79 111.94 14.2 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 1.155 ' HB ' ' HD3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -97.65 167.85 10.71 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.02 0.438 . . . . 0.0 111.179 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.643 ' HB2' ' CD1' ' A' ' 238' ' ' LEU . 0.2 OUTLIER 61.55 21.35 12.01 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.065 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.909 HD22 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -58.88 159.35 7.06 Favored 'General case' 0 N--CA 1.46 0.069 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.623 ' HB3' HG21 ' A' ' 50' ' ' VAL . 31.4 tp -92.63 114.6 27.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.022 0.439 . . . . 0.0 111.659 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.41 ' CG ' ' HB2' ' A' ' 70' ' ' ARG . 62.0 t0 -76.1 65.46 2.11 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.179 0.514 . . . . 0.0 109.995 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.3 m -128.31 -162.41 1.18 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.284 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.722 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -96.97 -19.94 18.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.246 0.546 . . . . 0.0 110.841 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.617 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 30.1 m-20 -69.95 -28.63 65.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.123 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.785 HG12 HD11 ' A' ' 54' ' ' LEU . 25.8 t -89.74 -50.89 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.752 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.722 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -49.21 -29.08 5.17 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.116 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . 8.4 m-70 -73.32 -37.56 66.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.298 178.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.691 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 3.2 tpt -64.73 -47.86 76.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.827 HD23 HD21 ' A' ' 29' ' ' LEU . 1.6 mp -68.43 -43.93 76.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.584 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.2 m-80 -58.5 -22.72 56.01 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.955 0.407 . . . . 0.0 110.319 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.711 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -75.82 -48.57 21.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.62 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.614 HD21 ' HE2' ' A' ' 53' ' ' MET . 0.1 OUTLIER -67.41 -48.13 68.24 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.593 -179.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.692 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.0 t -52.39 -30.67 30.22 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.16 0.505 . . . . 0.0 110.247 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.723 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -61.77 -47.98 82.71 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.296 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.997 HD21 HD22 ' A' ' 106' ' ' LEU . 3.3 mp -71.22 -24.88 62.29 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.212 0.53 . . . . 0.0 110.184 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.71 0.65 7.16 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.434 -0.889 . . . . 0.0 114.067 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.73 HG21 HD11 ' A' ' 82' ' ' LEU . 11.3 t -56.73 156.49 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 117.58 0.69 . . . . 0.0 110.536 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.583 ' HB3' HD13 ' A' ' 76' ' ' ILE . 2.8 m -113.66 110.09 19.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.733 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.692 ' CE2' ' HB ' ' A' ' 58' ' ' THR . 20.7 p90 -132.58 152.45 51.61 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.552 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.712 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -147.94 116.17 6.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.715 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.909 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -84.24 175.35 9.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.152 0.501 . . . . 0.0 111.104 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.639 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -87.25 179.22 6.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.092 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.83 -14.55 34.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.225 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.87 8.04 11.05 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.856 0.36 . . . . 0.0 110.606 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.431 ' O ' HD23 ' A' ' 44' ' ' LEU . 1.4 mtp180 58.75 47.04 13.35 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.421 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -129.23 -2.05 5.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.601 179.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 1.155 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -138.78 109.07 6.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.929 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.755 ' SG ' HD22 ' A' ' 66' ' ' LEU . 3.4 t -120.04 146.81 45.54 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.259 0.552 . . . . 0.0 112.185 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.722 ' CG ' HG22 ' A' ' 40' ' ' VAL . 1.2 mp0 -115.69 102.56 9.85 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.104 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.663 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -95.95 124.34 48.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.583 HD13 ' HB3' ' A' ' 63' ' ' SER . 1.8 mp -79.22 104.25 7.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.215 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.686 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -48.8 118.53 5.01 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.877 -0.601 . . . . 0.0 114.346 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.66 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 2.3 m-20 -64.02 -15.94 60.54 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.093 0.473 . . . . 0.0 110.022 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.494 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.15 -20.73 14.84 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.218 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.913 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -137.44 -155.38 6.9 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.852 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 3.0 Cg_exo -74.35 166.37 29.63 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 121.865 1.71 . . . . 0.0 108.738 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.839 HD21 ' HB3' ' A' ' 33' ' ' ALA . 4.3 mm? -64.62 90.03 0.07 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.328 1.061 . . . . 0.0 108.293 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.852 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 31.3 m170 -82.55 118.59 23.38 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.675 -176.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.85 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -142.93 109.42 5.37 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.971 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -112.76 93.42 4.42 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.222 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 177.86 21.26 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.282 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 56.72 50.24 12.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.469 0.652 . . . . 0.0 110.302 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.76 HD12 ' N ' ' A' ' 89' ' ' GLU . 4.8 tp -79.77 137.94 37.13 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.189 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.76 ' N ' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -117.04 124.06 48.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.139 0.495 . . . . 0.0 110.733 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.711 HD13 ' HA ' ' A' ' 56' ' ' ALA . 10.1 mt -105.47 162.99 12.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.475 0.655 . . . . 0.0 112.274 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.612 ' HA ' ' O ' ' A' ' 116' ' ' THR . 30.2 t80 -127.22 106.86 9.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.466 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.934 ' HG ' ' HA ' ' A' ' 99' ' ' MET . 2.5 mm? -94.67 6.83 47.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 44.37 -137.89 5.08 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.791 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.54 ' N ' ' HG3' ' A' ' 118' ' ' GLU . 9.8 t-20 -104.47 55.18 0.72 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.911 0.386 . . . . 0.0 110.671 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -98.65 -66.35 0.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.917 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.591 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 78.48 -17.09 6.87 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.867 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.46 ' HA ' ' CD ' ' A' ' 171' ' ' GLN . 1.7 p -92.71 -6.92 48.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.737 0.303 . . . . 0.0 111.238 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.501 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -131.97 -20.71 2.47 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.934 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 2.2 ttt -68.19 -51.48 45.19 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 120.941 0.401 . . . . 0.0 110.53 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.663 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 2.5 mpt_? -58.83 -53.68 63.98 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.561 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.66 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 24.3 Cg_exo -64.57 -46.74 6.6 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.853 2.369 . . . . 0.0 113.164 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.809 HD13 HD11 ' A' ' 106' ' ' LEU . 3.1 tm? -64.0 -37.78 88.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.23 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.639 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -62.15 -48.38 80.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.443 0.639 . . . . 0.0 110.285 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.927 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -67.3 -40.77 86.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.566 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -58.68 -42.98 89.78 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.997 HD22 HD21 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -68.78 -21.37 64.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.276 0.56 . . . . 0.0 110.884 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.577 ' SG ' HD11 ' A' ' 140' ' ' ILE . 99.6 m -61.65 -10.33 8.2 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.727 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.778 HD11 ' O ' ' A' ' 179' ' ' THR . 13.0 mt -81.08 167.4 19.77 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 52.65 -111.74 1.78 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.393 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.456 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 14.7 m -162.59 99.59 1.02 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.949 0.404 . . . . 0.0 110.287 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.581 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 20.5 m-20 -138.94 136.11 35.1 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.698 ' C ' HD12 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -100.2 111.23 23.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.015 178.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.699 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.6 mp -144.23 142.7 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.411 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.622 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 29.5 t -115.44 111.37 35.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.044 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.639 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 33.7 mt -79.75 156.95 27.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.567 0.698 . . . . 0.0 112.359 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.612 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 19.0 m -159.51 156.34 28.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.795 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.3 -166.78 11.33 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.448 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.588 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 3.3 mm-40 -70.89 176.97 1.65 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.588 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 38.7 Cg_exo -62.22 -35.47 74.23 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.208 1.939 . . . . 0.0 112.222 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.637 ' HD3' ' HG2' ' A' ' 123' ' ' GLU . 19.5 tpp85 -79.71 -33.91 40.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.943 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.623 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 11.1 tpt -60.19 -18.11 45.88 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.74 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 5.1 mmtp -69.61 -4.84 20.98 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.066 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.637 ' HG2' ' HD3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -120.17 27.14 8.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.836 0.351 . . . . 0.0 110.903 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 11.4 mmm-85 -107.22 87.08 2.9 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.513 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.825 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.9 Cg_endo -47.82 123.8 8.95 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.753 2.302 . . . . 0.0 111.698 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.813 HD11 HD23 ' A' ' 129' ' ' LEU . 19.1 tt -125.04 28.28 2.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.81 0.814 . . . . 0.0 110.31 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.64 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -67.04 -51.16 41.19 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.484 -1.234 . . . . 0.0 112.548 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.767 ' HE1' HG21 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -52.63 -31.62 37.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.085 0.469 . . . . 0.0 110.88 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.813 HD23 HD11 ' A' ' 126' ' ' ILE . 31.9 tp -79.23 -65.08 1.04 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.808 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 1.038 HG13 HD12 ' A' ' 140' ' ' ILE . 54.1 t -52.33 -26.19 8.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.54 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.64 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.4 OUTLIER -72.04 -47.79 49.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.093 0.473 . . . . 0.0 111.048 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.924 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -60.58 -48.85 79.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.426 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.983 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -61.4 -43.26 99.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.548 0.689 . . . . 0.0 109.707 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -61.51 -33.38 73.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.643 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.924 HD12 ' HA ' ' A' ' 132' ' ' ALA . 2.8 mt -69.33 -30.03 67.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.83 0.348 . . . . 0.0 110.075 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.43 -18.39 79.19 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.585 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 131.37 1.38 4.79 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.023 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.456 ' CB ' ' HB3' ' A' ' 107' ' ' CYS . . . -71.39 146.87 48.46 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.937 0.399 . . . . 0.0 111.45 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 45.0 mttt -116.29 94.38 4.62 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.235 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.038 HD12 HG13 ' A' ' 130' ' ' VAL . 9.0 mt -116.85 178.69 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.93 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.802 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.7 OUTLIER -161.38 -174.79 4.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.008 0.432 . . . . 0.0 111.205 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.575 ' N ' HG23 ' A' ' 141' ' ' THR . 24.5 m-85 -123.94 108.86 12.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.869 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.701 HD21 ' N ' ' A' ' 152' ' ' ARG . 1.4 mm? -85.51 -14.46 45.91 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.499 ' HB3' ' CB ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -137.48 -69.79 0.45 Allowed 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.164 0.506 . . . . 0.0 109.705 179.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.772 ' HB3' ' CD2' ' A' ' 148' ' ' TYR . 2.8 mt-30 -118.2 145.63 44.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.675 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.503 ' HA ' ' CG ' ' A' ' 142' ' ' TYR . 12.3 mt-10 -76.8 128.82 35.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.787 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.825 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 31.1 m-20 65.22 49.47 1.96 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.856 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 42.6 m-85 -149.15 179.02 1.28 Allowed Pre-proline 0 CA--C 1.549 0.904 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.594 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.856 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -43.9 -44.41 11.9 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 123.965 3.11 . . . . 0.0 115.167 -178.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.736 ' HD3' ' HE3' ' A' ' 122' ' ' LYS . 46.5 Cg_endo -64.6 102.65 0.42 Allowed 'Trans proline' 0 CA--C 1.509 -0.73 0 C-N-CA 121.701 1.601 . . . . 0.0 111.937 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.521 HD11 HG21 ' A' ' 126' ' ' ILE . 88.0 mt -139.43 124.11 18.45 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.057 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.785 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.1 OUTLIER -104.24 112.57 25.64 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 177.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.967 HD23 HG23 ' A' ' 140' ' ' ILE . 2.3 mt -93.61 159.97 14.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.191 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 2.0 mt-30 -147.51 23.97 1.12 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.964 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.537 ' HA2' ' O ' ' A' ' 107' ' ' CYS . . . 55.48 -166.07 3.47 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.597 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.44 -5.47 38.1 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.798 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.702 ' HE2' ' HA ' ' A' ' 180' ' ' ALA . 42.1 t80 -62.95 109.06 1.34 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.92 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.582 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 69.0 p -106.93 -47.7 3.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.958 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.628 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.55 -168.58 26.25 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.219 -0.991 . . . . 0.0 113.845 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.643 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 122.98 170.56 13.52 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -64.69 124.91 23.13 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.543 HG13 HD13 ' A' ' 135' ' ' LEU . 48.8 t -136.66 153.8 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 120.944 0.402 . . . . 0.0 111.653 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.613 ' HB2' ' HE2' ' A' ' 192' ' ' LYS . 1.2 m-20 -119.01 118.03 30.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.729 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.583 HG11 HD13 ' A' ' 173' ' ' LEU . 0.9 OUTLIER -117.6 147.03 21.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.006 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.674 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 3.6 t0 -82.86 134.88 35.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.932 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.676 ' CA ' HD12 ' A' ' 195' ' ' LEU . . . -77.9 -44.2 12.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.299 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.455 ' C ' HG23 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -54.21 166.51 0.39 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.611 0.243 . . . . 0.0 111.141 -179.511 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.767 HG21 ' HE1' ' A' ' 128' ' ' HIS . 2.2 t 68.5 54.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.106 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.84 ' N ' HG11 ' A' ' 196' ' ' VAL . 0.3 OUTLIER 61.53 141.23 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.1 179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.562 ' CB ' ' HB2' ' A' ' 197' ' ' SER . 0.4 OUTLIER -69.63 -5.02 21.94 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.319 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.663 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 18.2 mm100 -50.66 -23.69 2.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.849 0.357 . . . . 0.0 111.046 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.704 ' O ' HD13 ' A' ' 129' ' ' LEU . 3.0 m-85 -68.83 -54.72 14.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.494 0.664 . . . . 0.0 109.992 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.703 HD23 HG12 ' A' ' 201' ' ' ILE . 58.9 tp -76.75 -30.9 56.76 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.249 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.607 HG23 ' OG1' ' A' ' 204' ' ' THR . 33.2 m -61.06 -33.39 73.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.181 0.515 . . . . 0.0 109.849 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.927 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -70.02 -51.55 31.36 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.796 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.983 ' CD2' HD23 ' A' ' 133' ' ' LEU . 1.6 mt -67.1 -35.87 80.73 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.382 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.043 HD22 HD21 ' A' ' 205' ' ' LEU . 10.5 mt -69.02 -25.71 64.62 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.323 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.759 ' HG2' HD21 ' A' ' 31' ' ' LEU . 44.9 mtp -95.27 -27.05 15.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.265 0.555 . . . . 0.0 110.959 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.778 ' O ' HD11 ' A' ' 108' ' ' LEU . 88.7 m -91.93 -47.21 7.42 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.682 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.95 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -60.8 -36.21 32.83 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -178.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.752 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 13.0 Cg_endo -54.14 -37.92 87.48 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.154 1.236 . . . . 0.0 111.541 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.68 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.1 mp -83.56 -8.87 59.25 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.047 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -67.21 120.15 70.12 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.148 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 5.9 Cg_exo -38.8 -28.92 0.15 Allowed 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.456 2.77 . . . . 0.0 114.224 -178.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -107.55 151.44 25.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 111.807 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.67 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 32.2 t70 -66.53 117.05 8.18 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.451 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.848 ' HB ' HG23 ' A' ' 225' ' ' VAL . 28.3 m -103.38 135.48 44.92 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.249 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.985 HG22 HG13 ' A' ' 224' ' ' VAL . 31.7 t -125.65 98.84 5.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.337 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.605 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.0 mp -89.62 141.62 14.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.324 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.807 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.4 OUTLIER -112.17 171.11 7.7 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.845 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.6 mm -110.18 97.61 5.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 120.981 0.42 . . . . 0.0 111.52 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.613 ' HE2' ' HB2' ' A' ' 163' ' ' ASP . 17.2 mttt -59.85 -82.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.884 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -80.95 175.0 54.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.77 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.39 124.67 22.37 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.649 0.261 . . . . 0.0 110.569 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.85 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.9 OUTLIER -60.95 148.25 40.51 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.01 0.433 . . . . 0.0 109.975 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.84 HG11 ' N ' ' A' ' 169' ' ' SER . 12.1 p -104.91 -19.33 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.557 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.845 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 3.8 m -131.36 45.46 2.8 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.04 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.883 ' O ' HG22 ' A' ' 201' ' ' ILE . 2.8 tttt -42.0 -65.41 0.52 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 114.896 -1.047 . . . . 0.0 113.283 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.859 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 15.9 Cg_exo -68.04 -17.88 45.95 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.517 1.478 . . . . 0.0 111.841 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.845 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 45.4 m-85 -75.11 -29.28 60.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.405 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.883 HG22 ' O ' ' A' ' 198' ' ' LYS . 9.5 tp -69.68 -30.95 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.126 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.64 -32.59 74.11 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.569 ' O ' HD23 ' A' ' 207' ' ' LEU . 33.0 mt -64.93 -32.63 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.147 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.607 ' OG1' HG23 ' A' ' 174' ' ' THR . 54.7 m -60.06 -53.74 54.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.376 0.608 . . . . 0.0 109.772 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 1.043 HD21 HD22 ' A' ' 177' ' ' LEU . 44.4 mt -68.59 -37.56 79.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.792 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -62.05 -29.29 70.19 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.736 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 2.1 mm? -76.66 -42.06 43.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.793 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.666 ' SD ' ' HG3' ' A' ' 181' ' ' PRO . 9.3 mtm -59.53 -42.92 93.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.796 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.881 ' HG3' ' O ' ' A' ' 205' ' ' LEU . 10.1 mtpt -64.96 -55.55 18.44 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.222 0.534 . . . . 0.0 110.2 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -50.76 -27.43 7.17 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.129 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.934 ' HA ' ' HG3' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -78.85 -50.2 11.65 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.561 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 152.58 0.82 0.22 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.967 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.573 HG13 ' CG ' ' A' ' 229' ' ' GLN . 53.8 t -118.78 139.81 44.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.138 0.494 . . . . 0.0 112.062 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.631 ' HG2' ' HG2' ' A' ' 209' ' ' LYS . 62.6 mt-10 -132.05 157.68 43.53 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.024 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.98 HG12 HD22 ' A' ' 205' ' ' LEU . 2.8 pp -138.16 175.26 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.909 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 1.068 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 33.0 tt0 -92.03 123.15 35.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.328 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -99.56 100.82 11.88 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.708 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.824 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.5 OUTLIER -67.33 -168.77 0.08 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.801 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 71.4 t60 -73.63 47.66 0.25 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.863 0.363 . . . . 0.0 110.364 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.673 ' CE1' ' HG3' ' A' ' 198' ' ' LYS . 0.1 OUTLIER 58.44 19.77 6.79 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.933 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.478 ' O ' ' N ' ' A' ' 191' ' ' ILE . 18.7 mt-30 -111.67 -22.34 11.24 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.824 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 41.4 mt-30 -148.15 141.84 25.59 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.987 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.986 ' HB3' HD21 ' A' ' 177' ' ' LEU . 7.3 m-85 -112.59 95.93 5.7 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 1.068 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 41.5 t -80.36 110.98 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.062 0.458 . . . . 0.0 111.174 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.95 HG21 ' CB ' ' A' ' 180' ' ' ALA . 2.6 m -96.96 107.72 20.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.931 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.683 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -57.41 100.96 0.06 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.592 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.67 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -55.66 154.52 12.7 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.51 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.34 9.13 65.46 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.088 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.683 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 1.9 mm-40 -77.16 176.97 8.24 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.812 0.815 . . . . 0.0 112.19 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.68 ' HA ' HD23 ' A' ' 182' ' ' LEU . 3.4 m -175.6 105.01 0.08 Allowed 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.614 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.642 ' HB2' ' HB2' ' A' ' 35' ' ' ALA . 17.5 m-85 -53.63 152.57 5.04 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.478 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.551 ' HG2' ' O ' ' A' ' 211' ' ' PHE . 15.0 pt20 -121.4 142.5 49.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.787 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 34.6 t -51.18 99.64 0.21 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.197 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.934 ' HG3' ' HA ' ' A' ' 211' ' ' PHE . 14.7 Cg_exo -68.79 -29.03 29.51 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.454 2.103 . . . . 0.0 111.635 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.18 -122.52 5.56 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.361 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.652 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -91.97 116.08 28.61 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.023 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.594 ' CE2' HD11 ' A' ' 207' ' ' LEU . 58.0 t80 -113.52 140.99 47.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.293 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.923 ' HA ' HG23 ' A' ' 42' ' ' THR . 0.1 OUTLIER -99.71 108.07 20.32 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.317 179.325 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.721 ' O ' ' HG3' ' A' ' 240' ' ' GLU . 54.0 t -50.68 -44.53 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.247 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.722 ' H ' HD12 ' A' ' 238' ' ' LEU . 1.3 pt-20 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 117.971 -1.014 . . . . 0.0 111.597 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.65 ' O ' HD12 ' A' ' 29' ' ' LEU . 2.4 p . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 121.549 0.69 . . . . 0.0 109.688 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.618 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 13.0 m-20 -87.6 -22.93 24.47 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.454 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.26 -43.01 82.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.296 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.516 ' CB ' HD22 ' A' ' 41' ' ' LEU . . . -76.37 -32.19 58.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.836 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -61.39 -54.25 46.13 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.25 0.548 . . . . 0.0 110.276 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.685 HD21 ' HB2' ' A' ' 105' ' ' ALA . 9.4 tp -63.78 -55.28 24.29 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.448 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.724 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 29.6 mt -52.57 -34.89 52.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.134 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.671 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -76.21 -29.24 57.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.375 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.684 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -73.08 -32.99 65.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.538 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.883 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -87.55 -13.13 43.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.927 0.394 . . . . 0.0 110.907 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.648 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -81.9 164.34 21.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.737 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.504 ' CE1' ' HB3' ' A' ' 230' ' ' SER . 75.4 m80 -97.24 96.14 8.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.479 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.34 141.36 5.98 Favored Glycine 0 C--N 1.318 -0.442 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.936 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.758 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 0.1 OUTLIER -62.12 129.18 39.63 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.491 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.7 OUTLIER -122.67 155.49 36.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.147 178.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.712 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 46.7 t -102.63 142.17 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.332 -0.394 . . . . 0.0 112.013 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 237' ' ' TYR . 0.0 OUTLIER -129.41 111.97 13.34 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.055 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.998 ' HB ' ' HD3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -103.4 170.76 7.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.072 0.463 . . . . 0.0 111.595 -179.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.559 ' HB2' HD11 ' A' ' 238' ' ' LEU . 29.0 t-20 62.11 20.28 11.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.056 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.754 HD22 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -58.76 158.34 8.19 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.595 ' HB3' HG21 ' A' ' 50' ' ' VAL . 24.7 tp -90.74 114.36 26.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.097 0.475 . . . . 0.0 111.551 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -76.01 65.0 1.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.235 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 74.6 m -125.2 -163.49 1.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.898 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.731 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 1.3 m-20 -96.77 -19.08 19.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.399 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.588 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 8.6 m-20 -70.98 -29.86 65.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.968 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.781 HG12 HD11 ' A' ' 54' ' ' LEU . 39.1 t -88.11 -53.36 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.377 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.731 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 9.5 ptp180 -50.62 -30.73 14.11 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.039 0.447 . . . . 0.0 110.005 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -72.94 -35.3 66.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.039 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.618 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 10.9 tpt -64.93 -49.87 68.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.836 HD23 HD21 ' A' ' 29' ' ' LEU . 1.2 mp -66.14 -45.86 79.52 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.61 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.7 m-20 -57.29 -22.67 43.29 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.022 0.439 . . . . 0.0 109.987 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.747 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -74.77 -48.76 23.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.599 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.622 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -68.2 -49.65 59.42 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.903 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.477 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 5.3 t -50.48 -33.81 22.62 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.339 0.59 . . . . 0.0 110.304 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.623 ' CB ' HD21 ' A' ' 90' ' ' LEU . . . -59.36 -48.89 79.92 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.213 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.999 HD21 HD22 ' A' ' 106' ' ' LEU . 3.9 mp -67.13 -29.12 68.76 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.483 0.658 . . . . 0.0 109.831 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.13 -1.65 4.59 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 114.81 -1.087 . . . . 0.0 113.815 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.7 HG21 HD11 ' A' ' 82' ' ' LEU . 13.0 t -58.96 153.92 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 117.644 0.722 . . . . 0.0 110.247 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.737 ' HB2' HD12 ' A' ' 76' ' ' ILE . 3.8 m -116.97 108.92 16.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.151 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 16.6 p90 -124.76 157.23 36.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.726 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -148.03 116.1 6.48 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.812 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.754 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -87.16 175.19 8.19 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.237 0.542 . . . . 0.0 111.38 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.607 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -89.48 179.4 6.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.859 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.35 -14.62 28.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.439 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.63 6.09 11.63 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.816 0.341 . . . . 0.0 110.656 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.583 ' HG2' ' HG ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER 59.07 45.59 14.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.503 -179.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -129.27 -2.16 5.04 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.999 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.998 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 1.2 mmm180 -136.58 109.34 7.54 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.694 ' HA ' ' O ' ' A' ' 65' ' ' THR . 5.4 t -120.62 154.04 36.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.376 0.607 . . . . 0.0 112.637 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.711 ' HG3' HG22 ' A' ' 40' ' ' VAL . 2.9 mt-10 -121.39 104.66 9.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.141 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.758 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -96.57 128.03 48.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.751 HG12 ' HG3' ' A' ' 38' ' ' LYS . 18.9 mt -81.67 103.06 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.112 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.671 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -47.9 113.78 1.54 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.695 -0.684 . . . . 0.0 114.197 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.578 ' HB3' ' O ' ' A' ' 33' ' ' ALA . 25.0 t-20 -60.01 -17.36 38.12 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.112 0.482 . . . . 0.0 110.117 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.436 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 86.49 -22.96 10.92 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.363 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.883 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.65 -148.79 5.36 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.846 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 2.6 Cg_exo -77.09 169.01 22.3 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 CA-C-N 119.708 1.754 . . . . 0.0 109.261 177.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.7 HD11 HG21 ' A' ' 62' ' ' VAL . 4.5 mm? -67.43 90.51 0.24 Allowed 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 122.445 1.117 . . . . 0.0 108.078 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.846 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 30.3 m170 -82.26 118.67 23.29 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 112.877 -1.965 . . . . 0.0 112.671 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.708 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -144.87 113.07 6.49 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.644 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.15 86.35 2.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.795 0.331 . . . . 0.0 111.295 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -173.82 20.07 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.654 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.74 52.16 8.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.418 0.628 . . . . 0.0 109.852 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.704 ' O ' HG23 ' A' ' 113' ' ' ILE . 4.1 tp -80.73 134.37 35.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.221 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.694 ' N ' HD12 ' A' ' 88' ' ' LEU . 1.2 tt0 -113.87 128.94 56.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.228 0.537 . . . . 0.0 110.523 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.683 ' O ' HG22 ' A' ' 116' ' ' THR . 28.3 mt -112.4 154.09 26.32 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.46 ' CE1' ' HA2' ' A' ' 93' ' ' GLY . 52.6 t80 -116.39 105.35 12.42 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.663 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.976 HD23 ' HE1' ' A' ' 99' ' ' MET . 3.0 mm? -90.2 8.9 30.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.275 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.46 ' HA2' ' CE1' ' A' ' 91' ' ' PHE . . . 37.73 -143.93 0.2 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.249 -0.501 . . . . 0.0 113.216 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.418 HD21 ' HB3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -96.09 50.94 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.242 0.544 . . . . 0.0 110.025 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.588 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -90.0 -72.96 0.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.608 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.37 -19.44 8.54 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.444 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.439 HG23 ' NE2' ' A' ' 171' ' ' GLN . 19.0 m -93.92 -7.23 43.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.769 0.319 . . . . 0.0 111.099 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.582 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . . . -129.88 -17.09 3.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.355 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.976 ' HE1' HD23 ' A' ' 92' ' ' LEU . 21.9 tpp -70.23 -55.13 10.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.935 0.398 . . . . 0.0 111.009 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.896 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.6 mpt_? -60.07 -49.36 91.39 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.938 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.611 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 20.6 Cg_exo -66.79 -47.15 2.85 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.814 2.343 . . . . 0.0 112.95 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.796 HD13 HD11 ' A' ' 106' ' ' LEU . 3.3 tm? -68.55 -34.14 75.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.661 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.624 ' HA ' HD11 ' A' ' 115' ' ' LEU . . . -63.36 -47.98 79.86 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.645 0.736 . . . . 0.0 109.78 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.746 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -70.25 -39.18 75.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.094 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.685 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -56.6 -40.92 76.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.943 0.401 . . . . 0.0 111.949 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.999 HD22 HD21 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -71.72 -21.48 61.76 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.568 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.514 ' SG ' HD11 ' A' ' 140' ' ' ILE . 89.6 m -60.8 -10.55 5.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.102 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 179' ' ' THR . 13.9 mt -83.3 168.48 16.63 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 53.95 -108.09 0.77 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.428 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.47 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.3 OUTLIER -167.68 99.6 0.48 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.843 0.354 . . . . 0.0 110.398 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 8.5 m-20 -138.5 135.79 35.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.134 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.628 ' C ' HD12 ' A' ' 113' ' ' ILE . 18.3 m-20 -99.42 111.0 23.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.841 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.704 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.8 mp -143.0 140.79 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 5.8 t -109.46 113.71 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.624 HD11 ' HA ' ' A' ' 103' ' ' ALA . 37.2 mt -89.71 154.61 19.81 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.076 -0.65 . . . . 0.0 112.125 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.683 HG22 ' O ' ' A' ' 90' ' ' LEU . 13.0 t -155.46 -170.27 3.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.296 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -173.45 -167.8 33.71 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 119.988 -1.101 . . . . 0.0 113.901 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.501 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 2.9 mm-40 -69.59 178.09 1.08 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.319 -0.441 . . . . 0.0 110.919 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.501 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 31.8 Cg_exo -61.88 -38.49 58.55 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.048 1.832 . . . . 0.0 112.214 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.844 HH11 ' HG3' ' A' ' 123' ' ' GLU . 3.2 tpt180 -79.55 -23.75 42.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.026 0.441 . . . . 0.0 110.204 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.62 ' HE3' ' HB2' ' A' ' 124' ' ' ARG . 10.8 tpt -69.17 -15.54 63.42 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.777 ' HE2' ' HD3' ' A' ' 150' ' ' PRO . 0.8 OUTLIER -74.44 -4.71 38.25 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.162 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.844 ' HG3' HH11 ' A' ' 120' ' ' ARG . 0.1 OUTLIER -127.65 26.02 5.96 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.293 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.62 ' HB2' ' HE3' ' A' ' 121' ' ' MET . 2.5 mmp_? -100.56 91.43 1.8 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.493 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.7 Cg_endo -47.87 127.06 13.89 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.593 2.195 . . . . 0.0 112.589 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.761 HD11 HD23 ' A' ' 129' ' ' LEU . 18.5 tt -130.88 31.24 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-O 121.732 0.777 . . . . 0.0 109.943 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.635 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -71.61 -51.98 14.16 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 114.772 -1.103 . . . . 0.0 112.735 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.775 ' HE1' HG21 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -52.31 -26.49 12.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.927 0.394 . . . . 0.0 110.562 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.761 HD23 HD11 ' A' ' 126' ' ' ILE . 39.6 tp -84.69 -65.05 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.545 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.818 HG13 HD12 ' A' ' 140' ' ' ILE . 47.6 t -52.55 -26.02 9.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.49 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.635 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -73.23 -44.6 59.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.651 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.975 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -66.64 -47.98 70.88 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.571 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.876 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -58.26 -45.47 87.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.514 0.673 . . . . 0.0 109.52 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.13 -33.79 71.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.816 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.975 HD12 ' HA ' ' A' ' 132' ' ' ALA . 5.1 mt -70.19 -31.99 69.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.977 0.417 . . . . 0.0 110.104 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.517 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -74.78 -17.99 80.09 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.514 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.81 2.9 5.13 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.596 -0.812 . . . . 0.0 113.114 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' A' ' 107' ' ' CYS . . . -70.11 146.73 50.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 111.027 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 46.3 mmtt -113.43 81.47 1.51 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.473 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.955 HG23 HD23 ' A' ' 153' ' ' LEU . 9.3 mt -107.44 176.12 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.855 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.847 HG22 ' HB2' ' A' ' 152' ' ' ARG . 0.5 OUTLIER -153.24 -169.03 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.028 0.442 . . . . 0.0 111.225 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.694 ' N ' HG23 ' A' ' 141' ' ' THR . 19.3 m-85 -131.72 104.18 6.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.014 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.637 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.4 mm? -75.02 -13.22 60.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.522 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.758 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 5.0 mt-10 -138.99 -73.23 0.39 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.209 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.631 ' HB2' ' HD2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -123.98 156.43 36.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.227 0.537 . . . . 0.0 111.735 -179.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.404 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 2.8 mt-10 -70.95 125.83 27.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.616 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.684 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 0.9 OUTLIER 70.41 50.43 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.044 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.704 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.0 m-30 -141.75 173.82 4.39 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.72 ' CG ' ' HA ' ' A' ' 122' ' ' LYS . 6.3 Cg_endo -49.18 -40.79 42.4 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.159 2.573 . . . . 0.0 115.068 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.777 ' HD3' ' HE2' ' A' ' 122' ' ' LYS . 18.7 Cg_endo -62.26 101.79 0.25 Allowed 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 120.849 1.033 . . . . 0.0 110.745 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.523 HD11 HG21 ' A' ' 126' ' ' ILE . 83.2 mt -137.11 123.17 20.31 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.549 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.847 ' HB2' HG22 ' A' ' 141' ' ' THR . 2.6 mtp85 -102.47 111.78 24.23 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.955 HD23 HG23 ' A' ' 140' ' ' ILE . 3.7 mt -93.88 158.05 15.83 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.053 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.57 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 13.8 mt-30 -148.39 25.24 0.99 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.683 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.492 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 53.69 -166.35 1.88 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.537 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 158' ' ' THR . . . 108.2 -4.07 33.42 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.9 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.636 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 2.5 t80 -60.46 105.45 0.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.887 0.375 . . . . 0.0 110.828 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.495 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 67.9 p -104.56 -51.04 3.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.562 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.7 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 144.44 -163.95 27.77 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.065 -1.064 . . . . 0.0 114.269 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.601 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 118.04 170.74 15.11 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -64.2 126.3 27.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.26 0.53 . . . . 0.0 109.866 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 189' ' ' ILE . 59.0 t -136.99 152.65 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.966 0.412 . . . . 0.0 111.259 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.459 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.9 OUTLIER -119.05 119.05 33.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.861 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.665 HG11 HD13 ' A' ' 173' ' ' LEU . 0.3 OUTLIER -118.78 141.98 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.984 -179.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 3.9 t70 -79.77 137.14 36.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.835 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.677 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -79.52 -44.54 9.36 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.899 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.464 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 8.0 m -51.66 164.76 0.21 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.716 0.293 . . . . 0.0 111.175 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.775 HG21 ' HE1' ' A' ' 128' ' ' HIS . 2.8 t 70.55 55.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.294 0.569 . . . . 0.0 110.227 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.731 ' N ' HG11 ' A' ' 196' ' ' VAL . 4.9 m 57.09 149.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.478 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.525 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 0.6 OUTLIER -72.67 -3.83 27.39 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.546 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.896 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 57.1 mm-40 -49.79 -24.34 2.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.67 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.698 ' HA ' HD13 ' A' ' 129' ' ' LEU . 2.0 m-85 -72.58 -55.01 7.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.412 0.625 . . . . 0.0 110.283 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.665 HD13 HG11 ' A' ' 164' ' ' VAL . 26.3 tp -73.71 -38.89 64.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.511 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.759 HG23 ' OG1' ' A' ' 204' ' ' THR . 20.5 m -59.02 -33.06 70.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.279 0.561 . . . . 0.0 109.678 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.746 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -72.84 -47.18 48.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.977 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.876 ' CD2' HD23 ' A' ' 133' ' ' LEU . 2.9 mt -69.88 -35.98 75.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.605 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.989 HD21 ' HB3' ' A' ' 223' ' ' PHE . 12.5 mt -68.47 -27.33 66.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.612 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.637 ' CE ' HG22 ' A' ' 174' ' ' THR . 39.5 mtm -95.56 -26.99 15.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.245 0.545 . . . . 0.0 110.489 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.718 ' O ' HD11 ' A' ' 108' ' ' LEU . 51.6 m -88.79 -46.92 8.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.759 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.823 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -60.58 -39.07 63.64 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -177.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.3 Cg_endo -53.13 -36.01 75.24 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.347 1.364 . . . . 0.0 111.892 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.663 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.1 mp -85.04 -6.82 59.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.767 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.495 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -67.26 121.26 77.8 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.817 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 6.0 Cg_exo -38.76 -32.58 0.29 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.47 2.78 . . . . 0.0 113.91 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.47 155.8 19.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.05 0.453 . . . . 0.0 111.7 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.631 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 1.8 t70 -69.57 117.44 11.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.748 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.803 ' HB ' HG23 ' A' ' 225' ' ' VAL . 40.8 m -102.48 135.31 44.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.147 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.999 HG22 HG13 ' A' ' 224' ' ' VAL . 36.0 t -124.87 99.15 5.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.922 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 223' ' ' PHE . 2.9 mp -90.01 142.53 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.391 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.798 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.2 OUTLIER -113.47 170.68 8.06 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 177.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.861 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.5 mm -110.61 97.91 6.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 121.002 0.429 . . . . 0.0 111.363 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.561 ' HA ' ' NH1' ' A' ' 190' ' ' ARG . 4.9 mtmt -59.69 -82.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.133 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -79.1 168.21 53.12 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.36 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -59.9 122.45 14.29 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.82 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.8 OUTLIER -56.89 146.57 26.15 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.355 0.598 . . . . 0.0 110.61 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.731 HG11 ' N ' ' A' ' 169' ' ' SER . 12.5 p -104.1 -21.59 5.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.089 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.71 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -126.78 45.24 2.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.197 -179.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.82 ' HA ' HD23 ' A' ' 195' ' ' LEU . 6.1 ttpt -41.53 -65.63 0.48 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.04 -178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 51.4 Cg_endo -68.11 -16.77 45.2 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 121.556 1.504 . . . . 0.0 112.308 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.71 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 88.6 m-85 -75.34 -27.57 59.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.39 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.817 HD11 HD12 ' A' ' 177' ' ' LEU . 6.1 tp -71.23 -33.14 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.762 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -32.5 71.99 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.761 HG22 HD23 ' A' ' 207' ' ' LEU . 28.4 mt -68.32 -29.8 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.605 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.759 ' OG1' HG23 ' A' ' 174' ' ' THR . 52.5 m -61.38 -52.55 64.15 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.262 0.553 . . . . 0.0 109.806 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.918 HD22 HG12 ' A' ' 215' ' ' ILE . 30.9 mt -70.44 -38.37 74.52 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.191 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.654 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 39.4 t30 -63.65 -28.04 69.63 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.761 HD23 HG22 ' A' ' 203' ' ' ILE . 1.0 OUTLIER -78.36 -40.62 35.81 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.489 178.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.512 ' SD ' HG22 ' A' ' 204' ' ' THR . 17.2 mtp -68.9 -39.42 79.71 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.857 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.654 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 17.7 ptpt -65.37 -45.24 84.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.099 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 207' ' ' LEU . 2.0 t -57.71 -29.31 64.62 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.217 0.532 . . . . 0.0 109.798 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.605 ' HE2' ' HA ' ' A' ' 32' ' ' ALA . 1.3 m-85 -74.75 -53.04 9.94 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.587 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 158.82 -2.55 0.1 Allowed Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.644 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.66 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 53.7 t -119.0 142.44 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 117.08 0.44 . . . . 0.0 112.028 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -135.46 155.15 51.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.811 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.918 HG12 HD22 ' A' ' 205' ' ' LEU . 2.3 pp -130.43 175.53 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.378 -178.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 1.05 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 6.3 tp10 -91.57 127.43 37.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.76 HD22 ' H ' ' A' ' 217' ' ' ASN . 0.1 OUTLIER -102.31 101.3 11.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.42 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.87 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 4.8 mm-40 -66.71 -168.06 0.06 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.858 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -74.12 48.0 0.3 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.802 0.334 . . . . 0.0 110.633 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.577 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.1 OUTLIER 58.82 19.69 7.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.018 0.437 . . . . 0.0 111.26 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 191' ' ' ILE . 7.1 mm-40 -112.7 -22.38 10.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.713 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.87 ' O ' ' HB2' ' A' ' 218' ' ' GLN . 29.5 mt-30 -149.22 141.87 24.48 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.088 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.989 ' HB3' HD21 ' A' ' 177' ' ' LEU . 14.6 m-85 -112.91 97.77 6.75 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 1.05 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 39.1 t -81.9 110.9 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.334 0.588 . . . . 0.0 111.341 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.915 HG12 HG21 ' A' ' 215' ' ' ILE . 1.9 m -97.95 112.09 29.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.977 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.71 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 4.9 mptp? -63.26 104.37 0.59 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.807 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.631 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.93 158.69 14.83 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.114 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 85.07 9.44 80.38 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.474 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.71 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 19.5 mm-40 -76.28 178.76 6.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.441 0.639 . . . . 0.0 111.576 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.663 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.9 m -174.06 106.36 0.12 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.265 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.66 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 22.9 m-85 -55.24 152.23 8.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.511 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.535 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 7.7 pt20 -122.97 138.34 54.71 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 7.0 t -46.54 98.04 0.17 Allowed Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 39.5 Cg_endo -64.89 -29.33 58.3 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.331 2.021 . . . . 0.0 111.804 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 117.39 -123.77 5.89 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.884 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.712 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -91.0 116.96 29.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.039 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.642 ' CZ ' HD11 ' A' ' 207' ' ' LEU . 68.0 t80 -121.7 126.58 49.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.531 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.862 ' HA ' HG23 ' A' ' 42' ' ' THR . 3.9 tp -91.43 119.01 31.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.252 0.548 . . . . 0.0 111.206 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 42' ' ' THR . 78.2 t -51.29 -79.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.808 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.511 ' H ' ' HB3' ' A' ' 43' ' ' ASN . 2.6 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.097 -0.954 . . . . 0.0 110.639 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.708 ' HA ' HD12 ' A' ' 44' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.941 0.401 . . . . 0.0 111.623 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.809 ' ND2' ' HB2' ' A' ' 98' ' ' ALA . 43.1 m-20 -82.82 -23.15 33.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.899 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -67.65 -43.29 80.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.17 0.51 . . . . 0.0 110.491 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.503 ' CB ' ' HB3' ' A' ' 41' ' ' LEU . . . -75.17 -31.96 61.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.978 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.789 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -66.07 -52.22 50.89 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.115 0.483 . . . . 0.0 110.218 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.64 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 8.1 tp -64.94 -53.76 41.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.278 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.721 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 62.6 mt -53.5 -36.35 61.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.411 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.727 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -76.99 -29.94 55.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.448 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.649 ' CB ' HD21 ' A' ' 82' ' ' LEU . . . -70.29 -33.2 71.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.526 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.902 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -88.81 -12.61 41.52 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.813 0.339 . . . . 0.0 111.145 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.69 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -81.72 166.06 20.42 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.687 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.521 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 77.5 m80 -99.89 97.7 8.56 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.042 0.449 . . . . 0.0 109.885 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.01 142.28 6.6 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.385 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.763 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 1.3 ttpm? -66.36 140.55 58.09 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.096 0.474 . . . . 0.0 112.035 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.29 154.33 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.289 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.813 HG22 ' HG2' ' A' ' 74' ' ' GLU . 55.8 t -100.72 142.78 15.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.122 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.749 HD21 HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -129.25 111.69 13.14 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.754 HG23 HD13 ' A' ' 238' ' ' LEU . 0.6 OUTLIER -97.98 164.63 12.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.333 0.587 . . . . 0.0 112.136 -178.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.421 ' HB3' ' H ' ' A' ' 240' ' ' GLU . 19.4 t30 63.21 23.38 13.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.287 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.9 HD22 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -58.87 153.61 16.84 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.328 179.093 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.706 ' H ' ' HB3' ' A' ' 25' ' ' SER . 27.2 tp -83.35 114.26 21.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.059 0.457 . . . . 0.0 111.342 -178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -79.01 68.57 4.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.995 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.4 m -130.01 -163.91 1.36 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.893 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.608 ' HA ' ' CD ' ' A' ' 51' ' ' ARG . 25.1 t0 -97.11 -20.45 17.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.031 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -70.45 -30.06 66.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.713 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.643 HG12 HD11 ' A' ' 54' ' ' LEU . 12.4 t -83.1 -54.84 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.105 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.608 ' CD ' ' HA ' ' A' ' 48' ' ' ASP . 11.9 ptm180 -49.67 -27.18 4.39 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.004 0.43 . . . . 0.0 110.013 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -71.02 -39.86 72.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' VAL . 7.1 tpt -64.29 -50.93 65.95 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.789 HD23 HD21 ' A' ' 29' ' ' LEU . 1.5 mp -62.11 -47.49 84.37 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.004 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 11.8 t30 -58.43 -23.26 56.95 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.815 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.805 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -76.28 -49.0 18.18 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.138 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.57 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -64.72 -49.73 69.68 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.271 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.7 t -50.37 -30.52 12.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.245 0.545 . . . . 0.0 109.983 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 1.081 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.22 -44.2 92.3 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.618 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.097 HD21 HD22 ' A' ' 106' ' ' LEU . 2.7 mp -79.56 -19.53 49.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.211 0.529 . . . . 0.0 110.656 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.13 -0.87 7.72 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.852 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.679 HG21 HD11 ' A' ' 82' ' ' LEU . 15.2 t -58.88 155.66 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 117.586 0.693 . . . . 0.0 110.086 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.596 ' CB ' HG13 ' A' ' 76' ' ' ILE . 2.9 m -117.57 108.93 16.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.07 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.539 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 10.0 p90 -124.06 153.59 41.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.172 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.728 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 11.7 m -147.61 116.53 6.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.028 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.9 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -88.81 172.25 9.34 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.138 0.494 . . . . 0.0 111.088 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.692 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 65.1 p -88.04 179.57 6.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.781 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.19 -14.72 27.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.407 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.42 7.03 12.67 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.791 0.329 . . . . 0.0 110.68 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.476 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 10.0 mtm180 57.08 41.91 26.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.116 0.484 . . . . 0.0 110.943 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.45 -2.14 8.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.604 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.692 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 4.8 mmt180 -136.94 110.53 8.02 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.841 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.728 ' HA ' ' O ' ' A' ' 65' ' ' THR . 4.0 t -120.22 151.57 38.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.452 0.644 . . . . 0.0 112.405 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.813 ' HG2' HG22 ' A' ' 40' ' ' VAL . 55.0 mt-10 -118.63 102.93 9.24 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.108 178.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.763 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -95.34 128.2 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-O 121.375 0.607 . . . . 0.0 112.213 -178.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.687 HD13 ' HB2' ' A' ' 38' ' ' LYS . 15.9 mm -80.51 103.32 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.871 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.727 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -49.73 114.66 2.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.958 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.558 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 1.3 t-20 -61.51 -16.78 50.71 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 110.194 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.521 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.27 -22.02 11.27 Favored Glycine 0 C--O 1.226 -0.384 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.427 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.902 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.53 -149.03 5.41 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.821 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 5.4 Cg_exo -78.77 168.3 21.19 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 121.853 1.702 . . . . 0.0 109.209 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.754 HD12 HD13 ' A' ' 60' ' ' LEU . 4.5 mm? -66.62 91.14 0.18 Allowed 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.821 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 29.3 m170 -84.14 118.02 23.84 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 113.158 -1.837 . . . . 0.0 112.779 -176.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.802 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -144.21 108.26 4.75 Favored 'General case' 0 C--O 1.227 -0.08 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.354 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -109.83 90.69 3.38 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.541 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -175.69 17.35 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.742 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.58 ' H ' ' HB2' ' A' ' 112' ' ' ASP . . . 55.2 47.81 20.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.565 0.697 . . . . 0.0 109.794 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 1.081 HD21 ' HB1' ' A' ' 59' ' ' ALA . 1.0 OUTLIER -81.3 129.14 34.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.31 -178.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.834 ' N ' HD12 ' A' ' 88' ' ' LEU . 1.6 tt0 -105.7 127.76 53.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.122 0.487 . . . . 0.0 110.658 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.805 HD13 ' HA ' ' A' ' 56' ' ' ALA . 61.1 mt -111.97 157.5 20.63 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.6 ' C ' HD23 ' A' ' 92' ' ' LEU . 31.9 t80 -112.88 101.62 9.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.243 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.8 HD23 ' N ' ' A' ' 92' ' ' LEU . 0.1 OUTLIER -96.47 18.23 14.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.922 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.514 ' O ' ' HE2' ' A' ' 121' ' ' MET . . . 36.53 -154.47 0.01 OUTLIER Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.923 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.527 ' HA ' ' HB2' ' A' ' 121' ' ' MET . 10.6 t30 -87.6 50.1 1.93 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.287 0.565 . . . . 0.0 110.062 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.25 -77.04 0.24 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.426 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 100' ' ' ARG . . . 82.32 -13.77 38.03 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.644 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.466 ' HA ' ' CD ' ' A' ' 171' ' ' GLN . 0.3 OUTLIER -97.02 -5.39 37.79 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.073 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.809 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . . . -133.7 -22.7 1.87 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.339 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.742 ' HA ' HD12 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -62.08 -58.73 6.72 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.235 0.541 . . . . 0.0 110.337 179.299 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.921 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.8 mpt_? -59.76 -52.13 76.01 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.075 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.694 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 36.8 Cg_exo -61.99 -45.13 17.24 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.457 2.105 . . . . 0.0 113.192 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.674 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 2.6 tm? -74.04 -31.55 62.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.814 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.438 ' HA ' HD11 ' A' ' 115' ' ' LEU . . . -60.98 -48.29 82.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.407 0.622 . . . . 0.0 110.474 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.749 ' O ' HG21 ' A' ' 179' ' ' THR . . . -71.94 -36.82 70.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.006 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.503 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -57.67 -43.24 84.87 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.724 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.097 HD22 HD21 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -69.72 -24.24 63.53 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.33 0.586 . . . . 0.0 111.116 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.754 ' SG ' HD11 ' A' ' 140' ' ' ILE . 86.5 m -59.11 -10.59 2.82 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.059 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.705 HD11 ' O ' ' A' ' 179' ' ' THR . 12.0 mt -82.06 169.03 17.18 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 50.84 -110.39 0.94 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.513 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.428 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 2.4 p -161.67 101.35 1.17 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.037 -0.356 . . . . 0.0 110.037 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 12.9 m-20 -138.95 135.15 34.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.692 ' C ' HD12 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -101.93 110.67 22.7 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.812 178.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.712 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.6 mp -145.9 140.66 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.58 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.774 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 27.0 t -111.03 112.4 40.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.248 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.679 HD13 HD11 ' A' ' 92' ' ' LEU . 13.2 mt -82.09 150.58 27.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.385 0.612 . . . . 0.0 111.587 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.56 HG22 ' H ' ' A' ' 117' ' ' GLY . 3.6 m -155.25 177.25 11.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.419 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.56 ' H ' HG22 ' A' ' 116' ' ' THR . . . -165.08 -165.37 22.27 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.251 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.564 ' HB3' ' CD ' ' A' ' 119' ' ' PRO . 2.3 mm-40 -70.92 176.07 2.25 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.564 ' CD ' ' HB3' ' A' ' 118' ' ' GLU . 37.2 Cg_exo -62.4 -28.95 78.69 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 121.793 1.662 . . . . 0.0 111.97 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.508 ' HD2' ' CG ' ' A' ' 123' ' ' GLU . 6.0 tpt180 -80.44 -37.29 32.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.958 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.634 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 34.8 tpp -59.56 -15.72 20.21 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.734 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 6.3 mttm -69.8 -5.79 27.88 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.564 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 2.0 pt-20 -120.98 26.97 8.73 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.066 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.604 ' HA ' ' HE ' ' A' ' 124' ' ' ARG . 1.6 mmp_? -105.91 94.16 8.67 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.062 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 10.6 Cg_endo -53.56 129.03 31.81 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.954 2.436 . . . . 0.0 112.559 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.666 HD11 HD23 ' A' ' 129' ' ' LEU . 18.1 tt -132.78 29.35 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.724 0.774 . . . . 0.0 110.127 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -68.35 -51.06 34.34 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.184 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.739 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -54.29 -28.58 43.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.924 0.392 . . . . 0.0 110.668 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.786 ' CD1' HD21 ' A' ' 133' ' ' LEU . 23.6 tp -81.8 -61.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.885 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.776 HG13 HD12 ' A' ' 140' ' ' ILE . 59.8 t -53.35 -26.5 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.947 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.507 ' O ' HD12 ' A' ' 135' ' ' LEU . 20.0 t0 -71.63 -43.43 66.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.007 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.893 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -65.43 -51.86 57.28 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 121.074 0.464 . . . . 0.0 111.528 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.828 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -57.38 -43.78 83.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.818 179.65 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -33.91 73.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.803 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.893 HD12 ' HA ' ' A' ' 132' ' ' ALA . 2.7 mt -68.79 -30.14 68.66 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.235 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.47 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -78.42 -17.84 77.07 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.669 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 130.14 4.31 4.6 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.302 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.23 146.8 48.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.833 0.349 . . . . 0.0 111.557 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -114.75 94.57 4.83 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.075 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.968 HG23 HD23 ' A' ' 153' ' ' LEU . 11.5 mt -118.75 175.39 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.829 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.747 ' H ' HG22 ' A' ' 140' ' ' ILE . 1.0 OUTLIER -153.29 -166.15 2.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.267 0.556 . . . . 0.0 111.632 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.569 ' N ' HG23 ' A' ' 141' ' ' THR . 29.0 m-85 -135.92 101.51 4.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.921 178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.641 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.4 mm? -72.86 -13.55 61.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.602 -177.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.766 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 4.8 mt-10 -139.52 -73.2 0.38 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.635 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.633 ' HB3' ' HD2' ' A' ' 148' ' ' TYR . 0.2 OUTLIER -121.35 147.23 45.98 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.217 0.532 . . . . 0.0 111.704 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.466 ' HA ' ' CG ' ' A' ' 142' ' ' TYR . 10.3 mt-10 -68.22 131.92 46.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.301 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.643 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 87.2 m-20 65.95 51.9 1.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.691 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.867 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.6 m-85 -148.03 -179.72 1.02 Allowed Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.129 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.867 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 5.7 Cg_endo -50.66 -43.1 47.53 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.969 2.446 . . . . 0.0 115.143 -177.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.766 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 32.8 Cg_endo -62.73 102.18 0.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.149 1.233 . . . . 0.0 111.425 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 150' ' ' PRO . 67.3 mt -138.58 122.92 18.26 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.848 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.664 ' HB2' HG22 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -105.51 112.33 25.39 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.968 HD23 HG23 ' A' ' 140' ' ' ILE . 4.5 mt -93.18 157.95 16.01 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.266 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.602 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -145.53 24.79 1.38 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.469 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.497 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 54.84 -166.05 2.83 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.535 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.483 ' O ' HG23 ' A' ' 158' ' ' THR . . . 108.72 -5.27 32.71 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.888 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.654 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 3.0 t80 -60.66 106.13 0.52 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.712 0.291 . . . . 0.0 110.721 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 156' ' ' GLY . 69.1 p -106.97 -46.12 4.0 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.098 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.718 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.39 -165.98 26.94 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.158 -1.02 . . . . 0.0 114.185 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.592 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 118.8 170.21 14.68 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.47 128.54 36.24 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.624 HG13 HD13 ' A' ' 135' ' ' LEU . 62.4 t -138.27 151.32 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 120.786 0.326 . . . . 0.0 111.733 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.505 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 2.4 m-20 -118.89 117.85 29.96 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.738 HG11 HD13 ' A' ' 173' ' ' LEU . 0.9 OUTLIER -118.63 147.86 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 120.574 -0.451 . . . . 0.0 112.018 -178.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.739 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.4 OUTLIER -85.4 133.59 34.11 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.338 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.724 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -76.03 -44.62 18.23 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.279 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.423 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 83.2 p -51.55 163.69 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.942 0.401 . . . . 0.0 111.593 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.727 HG21 ' HE1' ' A' ' 128' ' ' HIS . 3.7 t 71.59 60.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.242 0.544 . . . . 0.0 110.658 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.68 ' N ' HG11 ' A' ' 196' ' ' VAL . 0.7 OUTLIER 54.81 154.95 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.409 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.623 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 0.1 OUTLIER -76.71 3.01 12.62 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.966 0.412 . . . . 0.0 111.097 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.921 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 55.8 mm-40 -54.11 -22.72 11.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.726 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.713 ' O ' HD12 ' A' ' 176' ' ' LEU . 1.9 m-85 -78.21 -55.77 5.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.935 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.819 HD23 HG12 ' A' ' 201' ' ' ILE . 22.3 tp -73.51 -38.32 65.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.869 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.576 HG22 ' HE2' ' A' ' 178' ' ' MET . 91.4 m -60.31 -33.07 71.85 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.188 0.518 . . . . 0.0 109.706 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.661 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -72.79 -50.18 25.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.734 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.828 ' CD2' HD23 ' A' ' 133' ' ' LEU . 2.3 mt -66.96 -38.78 86.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.749 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.006 HD21 ' HB3' ' A' ' 223' ' ' PHE . 12.7 mt -68.47 -24.87 64.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.282 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.576 ' HE2' HG22 ' A' ' 174' ' ' THR . 46.5 mtm -94.52 -28.2 15.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.34 0.591 . . . . 0.0 110.779 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.749 HG21 ' O ' ' A' ' 104' ' ' ALA . 84.5 m -91.28 -46.84 7.83 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.068 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.92 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -59.21 -39.27 71.84 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 9.3 Cg_endo -53.33 -36.71 79.63 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 121.095 1.197 . . . . 0.0 111.706 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.668 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -85.12 -5.7 59.33 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.163 -179.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -67.09 120.9 75.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -37.12 -32.93 0.15 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.554 2.836 . . . . 0.0 114.018 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 158' ' ' THR . 0.3 OUTLIER -107.33 153.43 22.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.332 . . . . 0.0 111.562 -179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.663 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 0.4 OUTLIER -67.44 118.24 10.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.693 179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.821 ' HB ' HG23 ' A' ' 225' ' ' VAL . 31.4 m -103.1 137.59 41.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.304 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 1.126 HG22 HG13 ' A' ' 224' ' ' VAL . 40.5 t -125.85 99.15 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.094 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.596 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.3 mt -90.55 141.98 13.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.395 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.791 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.3 OUTLIER -113.54 170.97 7.85 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.65 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.865 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.7 mm -110.38 97.26 5.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 120.985 0.421 . . . . 0.0 111.31 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.562 ' HG2' ' HE ' ' A' ' 190' ' ' ARG . 8.1 mtmp? -59.94 -81.37 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.464 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -78.85 168.44 53.53 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.309 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.45 122.3 15.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.54 0.209 . . . . 0.0 110.73 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.724 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.5 OUTLIER -57.26 146.64 27.84 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.985 0.422 . . . . 0.0 110.302 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.68 HG11 ' N ' ' A' ' 169' ' ' SER . 13.0 p -104.43 -19.75 6.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.384 0.611 . . . . 0.0 111.507 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.751 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.6 OUTLIER -127.74 45.31 2.76 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.627 -179.208 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.86 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.0 OUTLIER -41.19 -64.75 0.56 Allowed Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.702 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.672 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 55.2 Cg_endo -68.54 -16.92 43.37 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 121.603 1.535 . . . . 0.0 111.941 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.751 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 31.3 m-85 -76.0 -29.35 58.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.13 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.86 HG22 ' O ' ' A' ' 198' ' ' LYS . 8.4 tp -70.53 -31.63 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.622 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.516 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.1 OUTLIER -61.52 -33.74 74.32 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 207' ' ' LEU . 36.3 mt -66.21 -31.37 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.706 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.488 HG22 ' SD ' ' A' ' 208' ' ' MET . 54.0 m -60.26 -52.67 64.29 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.376 0.608 . . . . 0.0 109.823 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.923 HD21 HD22 ' A' ' 177' ' ' LEU . 44.9 mt -72.74 -35.48 67.54 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.59 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.717 ' HA ' ' HE3' ' A' ' 209' ' ' LYS . 4.9 t-20 -65.62 -24.81 67.14 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.721 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -82.68 -40.76 20.23 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.537 178.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.504 ' HG2' ' CZ ' ' A' ' 231' ' ' TYR . 12.0 mtp -69.0 -36.49 77.87 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.905 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.717 ' HE3' ' HA ' ' A' ' 206' ' ' ASN . 13.2 ptpt -66.56 -46.52 75.77 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.203 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.647 HG22 ' O ' ' A' ' 207' ' ' LEU . 5.2 t -57.55 -29.65 64.56 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.101 0.477 . . . . 0.0 109.862 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.612 ' HE2' ' HA ' ' A' ' 32' ' ' ALA . 1.8 m-85 -71.21 -54.1 12.12 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.301 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 155.78 -0.71 0.15 Allowed Glycine 0 CA--C 1.52 0.396 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.048 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.595 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 70.2 t -118.24 139.63 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.263 0.554 . . . . 0.0 111.679 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -135.95 156.12 49.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.994 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.894 HG21 HG12 ' A' ' 225' ' ' VAL . 2.0 pp -128.77 175.56 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.336 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 1.003 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 23.7 tt0 -89.88 125.15 35.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.156 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.429 ' C ' HD22 ' A' ' 217' ' ' ASN . 0.2 OUTLIER -100.71 101.04 11.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.016 0.436 . . . . 0.0 110.761 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.602 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -67.65 -166.52 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.589 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.64 47.69 0.42 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.084 0.468 . . . . 0.0 110.334 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.611 ' CZ ' ' HD3' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 58.22 19.39 6.15 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 -179.349 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 191' ' ' ILE . 14.2 mt-30 -110.6 -21.5 12.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.545 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.787 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 16.8 mt-30 -149.81 140.29 22.43 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.885 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 1.006 ' HB3' HD21 ' A' ' 177' ' ' LEU . 10.3 m-85 -112.35 96.39 5.98 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 1.126 HG13 HG22 ' A' ' 188' ' ' VAL . 27.6 t -80.54 111.27 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-O 121.06 0.457 . . . . 0.0 110.91 -178.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.92 HG21 ' CB ' ' A' ' 180' ' ' ALA . 2.7 m -97.68 112.96 30.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.12 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.723 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 5.7 mptt -61.38 104.16 0.38 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.584 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.663 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -59.57 157.39 25.22 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.825 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.44 8.74 84.56 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.339 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.723 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 15.1 mm-40 -73.38 178.99 4.21 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.401 0.619 . . . . 0.0 111.439 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.668 ' HA ' HD23 ' A' ' 182' ' ' LEU . 18.1 m -167.93 106.26 0.51 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.362 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.69 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 24.4 m-85 -54.03 142.02 26.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.163 0.506 . . . . 0.0 111.573 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.692 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 66.7 mt-30 -107.62 149.92 27.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.77 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 18.9 t -68.4 98.56 0.18 Allowed Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.745 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 47.8 Cg_endo -64.72 -33.36 54.73 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.498 2.132 . . . . 0.0 112.219 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 117.43 -114.09 2.87 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.624 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.6 OUTLIER -95.94 117.55 30.84 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 178.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.718 ' CZ ' HD11 ' A' ' 207' ' ' LEU . 37.3 t80 -119.93 136.01 54.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.793 0.33 . . . . 0.0 111.251 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.754 HD13 HG23 ' A' ' 42' ' ' THR . 0.3 OUTLIER -102.28 111.43 23.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.2 0.524 . . . . 0.0 110.679 178.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.67 ' N ' HD12 ' A' ' 238' ' ' LEU . 46.0 t -52.09 -61.74 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.771 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.421 ' H ' ' HB3' ' A' ' 43' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.457 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.792 ' HA ' HD12 ' A' ' 44' ' ' LEU . 47.0 m . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.906 0.384 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.652 HD21 ' HA ' ' A' ' 50' ' ' VAL . 2.9 m120 -87.96 -27.08 22.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.463 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -68.34 -38.19 81.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.565 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.678 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -79.06 -34.58 43.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.75 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.831 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -62.23 -53.72 51.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.459 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.633 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 4.9 tp -66.93 -47.93 70.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.194 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.613 HD11 ' HB3' ' A' ' 207' ' ' LEU . 33.1 mt -56.87 -33.88 67.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.459 . . . . 0.0 110.862 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.686 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -76.42 -28.87 56.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.923 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.8 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -73.55 -29.61 62.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.616 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.895 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.35 -12.39 40.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.012 0.434 . . . . 0.0 110.858 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.23 164.89 20.9 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.609 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.515 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 75.2 m80 -98.21 97.7 9.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.065 0.459 . . . . 0.0 110.173 179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.06 142.26 6.58 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.255 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.765 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 10.9 tttt -65.69 135.23 54.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.996 0.427 . . . . 0.0 111.788 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.504 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -129.98 159.32 37.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.468 179.249 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.791 HG22 ' HG3' ' A' ' 74' ' ' GLU . 61.7 t -103.82 142.44 17.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.678 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -128.38 111.75 13.68 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.9 HG23 ' HA ' ' A' ' 238' ' ' LEU . 0.0 OUTLIER -100.96 170.74 8.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.096 0.474 . . . . 0.0 111.767 -179.329 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.542 ' HB2' ' CD1' ' A' ' 238' ' ' LEU . 0.1 OUTLIER 64.99 21.29 12.29 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.384 -179.165 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.897 HD22 HD11 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -60.35 157.43 13.75 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.533 179.047 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.576 ' HB3' HG21 ' A' ' 50' ' ' VAL . 23.4 tp -93.13 113.78 26.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.129 0.49 . . . . 0.0 111.464 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.2 p-10 -72.82 62.93 0.61 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.438 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.506 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.5 OUTLIER -124.85 -162.25 1.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.147 -179.036 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.65 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 51.3 m-20 -97.63 -20.47 17.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.179 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 5.0 p-10 -71.25 -27.65 63.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.947 178.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.657 HG12 HD11 ' A' ' 54' ' ' LEU . 23.9 t -89.09 -53.26 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.595 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.665 ' O ' ' HB2' ' A' ' 55' ' ' ASN . 2.9 ptm180 -50.02 -30.29 10.4 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.678 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.421 ' CD2' ' O ' ' A' ' 48' ' ' ASP . 10.5 m-70 -72.63 -35.49 67.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.41 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.636 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 3.8 tpt -65.87 -47.85 73.49 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.831 HD23 HD21 ' A' ' 29' ' ' LEU . 1.6 mp -65.42 -48.84 71.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.665 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -53.17 -25.54 13.99 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.321 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.874 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -75.25 -44.21 47.31 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.652 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.554 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -69.74 -49.48 52.73 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.389 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.514 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 5.1 t -52.05 -32.35 34.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.203 0.525 . . . . 0.0 109.898 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.915 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.01 -46.01 89.26 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.127 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.007 HD21 HD22 ' A' ' 106' ' ' LEU . 3.6 mp -72.27 -26.8 62.13 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.498 0.666 . . . . 0.0 109.801 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.41 -0.35 5.11 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.713 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.664 HG21 HD11 ' A' ' 82' ' ' LEU . 18.6 t -58.34 152.42 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 117.718 0.759 . . . . 0.0 110.193 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.42 ' CB ' HD12 ' A' ' 76' ' ' ILE . 3.7 m -116.16 108.68 16.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.932 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.718 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 15.0 p90 -127.53 154.62 44.93 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.22 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.627 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.9 OUTLIER -145.54 116.49 7.79 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.903 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.897 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -85.11 176.09 8.6 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.097 0.475 . . . . 0.0 111.842 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.861 ' HB3' ' HG3' ' A' ' 72' ' ' ARG . 50.4 p -86.3 178.99 6.98 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.051 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.94 -13.53 26.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.617 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -119.38 3.79 11.27 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.591 0.234 . . . . 0.0 110.877 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.51 ' O ' HD23 ' A' ' 44' ' ' LEU . 37.5 mmt-85 61.84 45.82 7.35 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 110.416 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -125.76 -3.11 7.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.367 179.339 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.861 ' HG3' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER -142.04 112.67 7.23 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.041 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 64' ' ' TYR . 6.9 t -116.34 152.46 33.85 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.919 -0.712 . . . . 0.0 112.294 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.791 ' HG3' HG22 ' A' ' 40' ' ' VAL . 0.8 OUTLIER -116.2 102.61 9.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.878 178.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.765 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -96.04 127.63 47.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.493 ' CG1' ' HE3' ' A' ' 38' ' ' LYS . 14.3 mt -82.32 102.76 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.077 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.686 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -45.4 115.57 1.6 Allowed Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.999 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -61.24 -16.97 50.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.979 0.419 . . . . 0.0 110.1 178.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.515 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 86.16 -20.06 23.31 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.404 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.895 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -140.84 -148.28 5.08 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.833 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 3.8 Cg_exo -77.18 170.88 18.81 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.052 1.835 . . . . 0.0 109.183 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.8 HD21 ' HB3' ' A' ' 33' ' ' ALA . 4.2 mm? -69.31 92.19 0.57 Allowed 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.833 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 31.0 m170 -83.67 118.06 23.61 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.23 -1.805 . . . . 0.0 112.784 -175.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.799 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -144.45 109.04 4.89 Favored 'General case' 0 C--O 1.23 0.079 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.361 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -111.58 91.65 3.74 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.418 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.63 20.37 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.773 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 54.95 49.37 17.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.366 0.603 . . . . 0.0 109.779 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.915 HD21 ' HB1' ' A' ' 59' ' ' ALA . 4.0 tp -81.78 135.96 35.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.425 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.749 ' N ' HD12 ' A' ' 88' ' ' LEU . 1.2 tt0 -114.31 128.71 56.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.261 0.553 . . . . 0.0 110.605 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.874 HD13 ' HA ' ' A' ' 56' ' ' ALA . 18.0 mt -111.14 158.99 18.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.468 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.453 ' CE1' ' HA2' ' A' ' 93' ' ' GLY . 41.8 t80 -123.83 103.39 8.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.428 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.741 HD23 ' HE1' ' A' ' 99' ' ' MET . 0.9 OUTLIER -90.05 6.5 42.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.09 -179.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.57 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 45.52 -145.52 2.74 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.283 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -86.65 47.99 1.57 Allowed 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 120.764 0.316 . . . . 0.0 111.387 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -90.43 -76.35 0.43 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.948 0.404 . . . . 0.0 111.124 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.55 -14.04 31.96 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.232 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 101' ' ' PRO . 65.3 p -97.0 -7.89 31.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.665 0.269 . . . . 0.0 111.015 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.522 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -126.85 -21.65 4.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.174 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.741 ' HE1' HD23 ' A' ' 92' ' ' LEU . 23.5 tpp -66.43 -50.44 63.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 0.0 110.018 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.694 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -61.6 -53.86 57.34 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.481 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.694 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 34.7 Cg_exo -61.31 -45.33 19.09 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.703 2.269 . . . . 0.0 112.79 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.594 ' CD1' HD11 ' A' ' 106' ' ' LEU . 2.7 tm? -70.8 -34.41 71.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.321 -178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.4 -47.72 84.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.366 0.603 . . . . 0.0 110.564 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.827 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -71.97 -34.2 68.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.356 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.583 ' CB ' HD11 ' A' ' 30' ' ' LEU . . . -60.31 -45.16 94.38 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.878 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.007 HD22 HD21 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -69.35 -20.49 63.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.662 -179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.558 ' SG ' HD11 ' A' ' 140' ' ' ILE . 6.4 m -62.17 -8.12 5.12 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.976 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.754 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 15.8 mt -87.44 165.57 15.45 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 57.2 -109.76 1.87 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.083 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.416 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -165.8 99.48 0.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.765 0.317 . . . . 0.0 110.299 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.611 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 3.4 m120 -138.44 135.44 35.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.683 ' C ' HD12 ' A' ' 113' ' ' ILE . 0.8 OUTLIER -102.78 110.65 22.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.381 178.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.733 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.5 mp -143.88 142.28 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.216 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.777 HG22 ' HB2' ' A' ' 152' ' ' ARG . 32.5 t -113.66 112.29 39.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.466 HD13 ' SD ' ' A' ' 99' ' ' MET . 39.0 mt -81.7 157.23 24.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.451 0.643 . . . . 0.0 112.194 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.6 m -163.2 166.93 22.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.165 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -154.68 -166.14 14.82 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.023 -1.084 . . . . 0.0 113.497 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.587 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 22.5 mm-40 -69.15 178.25 0.97 Allowed Pre-proline 0 C--N 1.33 -0.267 0 C-N-CA 122.674 0.39 . . . . 0.0 110.78 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 36.4 Cg_exo -61.8 -39.59 51.28 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.892 1.728 . . . . 0.0 112.524 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -76.2 -33.07 59.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 120.488 -0.485 . . . . 0.0 109.977 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.567 ' HA ' ' HG3' ' A' ' 124' ' ' ARG . 10.0 tpt -60.75 -17.24 47.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.278 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.714 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 6.2 mmtp -71.46 -4.9 29.1 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.639 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 0.1 OUTLIER -125.52 32.24 5.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.014 0.435 . . . . 0.0 111.03 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.567 ' HG3' ' HA ' ' A' ' 121' ' ' MET . 2.2 mmp_? -103.95 87.43 1.55 Allowed Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.822 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.789 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 1.1 Cg_endo -43.92 129.79 7.7 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.075 2.517 . . . . 0.0 112.406 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.849 HD11 HD23 ' A' ' 129' ' ' LEU . 15.0 tt -140.63 30.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.703 0.763 . . . . 0.0 110.29 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -70.11 -49.52 33.34 Favored Glycine 0 C--N 1.317 -0.523 0 CA-C-N 114.814 -1.085 . . . . 0.0 113.25 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.1 OUTLIER -55.27 -25.31 33.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.819 -179.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.849 HD23 HD11 ' A' ' 126' ' ' ILE . 30.9 tp -83.88 -65.74 0.97 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.813 179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.869 HG13 HD12 ' A' ' 140' ' ' ILE . 60.3 t -51.15 -26.53 5.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.223 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 1.7 m-20 -73.2 -46.37 50.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.667 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.944 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -63.48 -48.71 76.54 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.284 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.863 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -59.86 -44.36 94.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.385 0.612 . . . . 0.0 109.692 179.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -59.18 -34.92 72.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.421 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.944 HD12 ' HA ' ' A' ' 132' ' ' ALA . 2.2 mt -68.86 -28.0 66.32 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.21 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.5 -11.37 85.21 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.611 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 121.24 6.13 9.13 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.931 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.29 149.2 37.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.745 0.307 . . . . 0.0 111.3 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.449 ' HA ' ' HE3' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -115.4 95.95 5.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.082 0.468 . . . . 0.0 111.594 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.964 HG23 HD23 ' A' ' 153' ' ' LEU . 12.1 mt -118.26 177.05 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.395 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.814 ' H ' HG22 ' A' ' 140' ' ' ILE . 1.0 OUTLIER -154.11 -167.69 2.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.18 0.514 . . . . 0.0 111.403 179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.632 ' HE1' HD21 ' A' ' 151' ' ' LEU . 23.6 m-85 -135.56 102.66 5.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.641 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.2 mm? -75.7 -13.86 60.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.932 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.686 ' HG3' ' N ' ' A' ' 145' ' ' GLN . 0.0 OUTLIER -135.63 -69.75 0.49 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.357 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.686 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.4 OUTLIER -132.15 163.86 27.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.912 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.542 ' HG2' ' CD2' ' A' ' 142' ' ' TYR . 23.4 mt-10 -74.97 143.46 43.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.556 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.789 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 0.5 OUTLIER 51.54 42.32 29.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.012 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.686 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.4 m-30 -130.24 174.43 4.64 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.262 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.714 ' CG ' ' HA ' ' A' ' 122' ' ' LYS . 8.6 Cg_endo -50.76 -40.65 56.44 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.921 2.414 . . . . 0.0 114.316 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 149' ' ' PRO . 40.1 Cg_endo -60.97 100.28 0.16 Allowed 'Trans proline' 0 CA--C 1.511 -0.625 0 C-N-CA 121.797 1.665 . . . . 0.0 111.514 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.632 HD21 ' HE1' ' A' ' 142' ' ' TYR . 92.6 mt -137.89 123.02 19.2 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.24 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.777 ' HB2' HG22 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -105.63 112.07 25.01 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.964 HD23 HG23 ' A' ' 140' ' ' ILE . 1.4 mt -94.0 158.22 15.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.045 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.611 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 32.4 mt-30 -145.72 24.45 1.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.784 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.504 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 53.59 -165.71 1.99 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.679 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.85 -3.73 38.93 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.105 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.683 ' HE2' ' HA ' ' A' ' 133' ' ' LEU . 44.5 t80 -61.81 107.35 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.846 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.644 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 53.3 p -103.02 -50.47 3.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.697 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.627 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 146.24 -165.25 28.24 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.138 -1.03 . . . . 0.0 114.19 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.602 ' O ' HG23 ' A' ' 162' ' ' VAL . . . 119.23 168.37 14.0 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -62.43 125.87 25.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.004 0.402 . . . . 0.0 110.15 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 160' ' ' GLY . 44.3 t -135.02 153.02 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.756 -178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.554 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.4 OUTLIER -119.3 115.57 24.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.032 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.766 HG11 HD13 ' A' ' 173' ' ' LEU . 0.5 OUTLIER -113.87 147.4 17.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.677 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.9 OUTLIER -85.64 134.14 34.0 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.481 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.724 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -76.54 -44.7 15.5 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.759 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.9 t -50.39 163.02 0.18 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.055 0.455 . . . . 0.0 111.832 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.569 HG21 ' HE1' ' A' ' 128' ' ' HIS . 3.2 t 71.3 59.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.898 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.772 ' N ' HG11 ' A' ' 196' ' ' VAL . 75.7 m 57.68 153.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.262 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.444 ' HB2' ' CB ' ' A' ' 197' ' ' SER . 0.5 OUTLIER -78.14 -2.4 37.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.249 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.652 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 90.6 mm-40 -51.55 -23.36 4.04 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.819 0.342 . . . . 0.0 111.365 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.639 ' HA ' HD13 ' A' ' 129' ' ' LEU . 2.8 m-85 -72.16 -58.94 3.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.252 0.549 . . . . 0.0 110.702 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.766 HD13 HG11 ' A' ' 164' ' ' VAL . 39.5 tp -73.49 -34.28 65.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.821 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.674 HG22 ' HE2' ' A' ' 178' ' ' MET . 89.8 m -60.01 -31.33 69.83 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.827 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -73.15 -52.23 14.95 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.059 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.863 ' CD2' HD23 ' A' ' 133' ' ' LEU . 2.6 mt -65.46 -38.19 89.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.741 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.995 HD21 ' HB3' ' A' ' 223' ' ' PHE . 11.7 mt -64.57 -28.28 69.53 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.225 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.674 ' HE2' HG22 ' A' ' 174' ' ' THR . 9.6 ptp -97.3 -27.52 14.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.193 0.521 . . . . 0.0 110.894 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.705 HG23 ' HG ' ' A' ' 108' ' ' LEU . 23.0 m -85.03 -46.75 10.89 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.929 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.94 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -61.44 -38.67 54.64 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.2 Cg_endo -53.73 -35.66 79.24 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.516 1.478 . . . . 0.0 112.016 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.698 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.75 -7.77 59.08 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.988 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.644 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -66.42 122.75 83.21 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.06 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 1.9 Cg_endo -43.12 -27.84 1.15 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.939 2.426 . . . . 0.0 113.614 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.417 ' O ' ' HA3' ' A' ' 227' ' ' GLY . 11.1 mt-10 -107.17 153.06 23.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.013 0.435 . . . . 0.0 111.292 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.674 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 52.1 t0 -70.33 115.1 9.13 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.289 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.822 ' HB ' HG23 ' A' ' 225' ' ' VAL . 45.0 m -100.57 136.66 40.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.365 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 1.036 HG22 HG13 ' A' ' 224' ' ' VAL . 26.0 t -125.52 99.43 5.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.763 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.576 ' O ' ' N ' ' A' ' 223' ' ' PHE . 4.7 mt -90.57 143.65 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.132 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.817 ' C ' HD13 ' A' ' 191' ' ' ILE . 2.2 ptm180 -115.28 170.95 8.0 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.882 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.4 mm -111.1 97.86 6.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-O 120.977 0.418 . . . . 0.0 111.267 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -62.31 -80.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.581 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -76.84 167.81 54.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.146 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -62.6 122.26 15.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.656 0.265 . . . . 0.0 110.952 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.827 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.7 OUTLIER -57.37 146.45 29.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.891 0.377 . . . . 0.0 110.395 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.772 HG11 ' N ' ' A' ' 169' ' ' SER . 11.6 p -103.34 -20.09 5.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.318 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.709 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -128.9 46.33 2.64 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.248 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.852 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.9 OUTLIER -41.96 -64.79 0.6 Allowed Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.039 -178.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 60.0 Cg_endo -70.73 -16.83 33.46 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 121.519 1.479 . . . . 0.0 111.457 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.709 ' HB2' ' HB3' ' A' ' 197' ' ' SER . 21.5 m-85 -74.2 -30.02 62.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.204 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.852 HG22 ' O ' ' A' ' 198' ' ' LYS . 8.8 tp -68.54 -31.84 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.405 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.93 -29.64 67.26 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.742 HG22 HD23 ' A' ' 207' ' ' LEU . 33.4 mt -70.68 -29.91 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.253 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.502 HG21 ' HA ' ' A' ' 174' ' ' THR . 51.6 m -61.73 -55.22 32.56 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.16 0.505 . . . . 0.0 109.677 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.934 HD21 HD22 ' A' ' 177' ' ' LEU . 21.5 mt -69.19 -33.71 73.77 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.859 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.808 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 47.7 t30 -68.94 -24.74 64.31 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.742 HD23 HG22 ' A' ' 203' ' ' ILE . 0.2 OUTLIER -78.96 -41.56 28.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.073 178.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.432 ' SD ' HG22 ' A' ' 204' ' ' THR . 12.0 mtp -70.26 -39.14 75.16 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.4 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.808 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -64.97 -42.35 94.64 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.398 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 207' ' ' LEU . 1.0 OUTLIER -59.61 -30.72 68.89 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.054 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.638 ' CE2' ' HA ' ' A' ' 32' ' ' ALA . 1.5 m-85 -71.18 -53.43 14.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.85 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 158.21 -3.45 0.13 Allowed Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.543 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.602 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 55.6 t -119.8 142.97 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.144 0.497 . . . . 0.0 112.231 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -135.52 156.03 49.54 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.442 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.901 HG12 HD22 ' A' ' 205' ' ' LEU . 2.4 pp -129.07 176.14 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.52 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 1.07 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 8.3 tp10 -90.4 126.27 35.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.135 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -101.47 101.25 11.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.632 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.694 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.7 OUTLIER -67.38 -168.87 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.611 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -73.9 48.44 0.29 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.811 0.339 . . . . 0.0 110.489 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.593 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 58.9 18.73 6.41 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.222 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 191' ' ' ILE . 11.6 pt20 -111.67 -22.57 11.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.761 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.779 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 27.8 mt-30 -148.0 139.86 23.96 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.13 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.995 ' HB3' HD21 ' A' ' 177' ' ' LEU . 13.6 m-85 -111.15 98.37 7.47 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 1.07 ' HB ' ' HB3' ' A' ' 216' ' ' GLU . 37.2 t -82.4 111.42 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-O 121.153 0.501 . . . . 0.0 111.068 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.94 HG21 ' CB ' ' A' ' 180' ' ' ALA . 2.4 m -98.43 113.57 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.789 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.545 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 2.0 mptp? -65.03 103.83 0.79 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.757 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.674 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -58.51 156.71 21.33 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.94 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 87.36 10.91 70.08 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.367 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.572 HE21 ' HA ' ' A' ' 229' ' ' GLN . 1.3 mm-40 -80.53 179.51 7.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.563 0.697 . . . . 0.0 111.901 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.698 ' HA ' HD23 ' A' ' 182' ' ' LEU . 4.0 m -173.69 106.88 0.13 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.448 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.658 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 22.9 m-85 -54.9 151.84 8.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.211 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.571 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 8.6 pt20 -122.11 142.46 50.36 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.6 t -48.6 98.74 0.19 Allowed Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.571 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 55.0 Cg_endo -67.22 -25.95 42.59 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.336 2.024 . . . . 0.0 111.976 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 112.49 -119.03 4.83 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.628 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -95.71 117.31 30.28 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.543 ' CE2' HD11 ' A' ' 207' ' ' LEU . 41.7 t80 -116.54 130.6 56.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.9 ' HA ' HG23 ' A' ' 42' ' ' THR . 0.1 OUTLIER -93.39 106.08 18.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.647 179.229 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 42' ' ' THR . 78.3 t -48.78 -52.9 8.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.125 0.488 . . . . 0.0 110.512 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.56 ' N ' HD12 ' A' ' 238' ' ' LEU . 24.0 tt0 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.069 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.748 ' O ' HD12 ' A' ' 29' ' ' LEU . 79.5 p . . . . . 0 N--CA 1.484 1.237 0 CA-C-O 121.25 0.548 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.597 ' HA ' ' HG2' ' A' ' 53' ' ' MET . 5.2 p30 -86.91 -23.83 25.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.75 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 27' ' ' ARG . 1.4 mpp_? -67.58 -42.91 81.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.683 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.888 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -77.65 -34.33 53.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.937 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.92 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -58.32 -48.93 78.95 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.366 0.603 . . . . 0.0 110.504 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.613 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 3.2 tp -72.57 -49.29 33.44 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.225 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.695 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 31.7 mt -56.36 -33.07 65.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.732 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.674 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . . . -75.16 -29.88 60.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.695 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.762 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -71.67 -29.19 64.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.651 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.922 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.23 -13.23 38.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.046 0.451 . . . . 0.0 110.855 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.677 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -82.26 168.01 18.05 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.779 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.53 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 80.4 m80 -101.98 97.74 8.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.079 0.466 . . . . 0.0 110.011 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.94 140.64 6.01 Favored Glycine 0 C--N 1.316 -0.579 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.436 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.816 ' HB2' HD13 ' A' ' 76' ' ' ILE . 2.1 ttmm -66.96 139.96 57.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.983 0.421 . . . . 0.0 112.028 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.814 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -130.71 156.47 44.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.7 179.19 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.682 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 57.4 t -102.64 142.27 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.994 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.888 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -127.76 111.94 14.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.98 ' HB ' ' HD3' ' A' ' 72' ' ' ARG . 0.7 OUTLIER -102.1 164.96 11.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.894 0.378 . . . . 0.0 110.838 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.504 ' HB3' ' H ' ' A' ' 240' ' ' GLU . 0.1 OUTLIER 66.56 19.09 10.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.726 -178.281 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.895 HD22 HD11 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -58.78 152.72 18.42 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.327 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.621 ' HB3' HG21 ' A' ' 50' ' ' VAL . 18.1 tp -82.54 114.95 21.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.22 0.533 . . . . 0.0 111.235 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -78.95 69.7 5.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.464 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.9 m -133.68 -160.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.379 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.644 ' HA ' ' CG ' ' A' ' 51' ' ' ARG . 76.9 m-20 -98.0 -19.42 18.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.014 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.433 ' OD2' ' HA ' ' A' ' 95' ' ' ALA . 4.0 m-20 -70.25 -32.2 69.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.885 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.621 HG21 ' HB3' ' A' ' 45' ' ' LEU . 21.1 t -84.72 -52.85 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.237 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.644 ' CG ' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -50.51 -28.7 8.96 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.913 179.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -72.68 -35.95 67.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.198 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.597 ' HG2' ' HA ' ' A' ' 26' ' ' ASN . 7.8 tpt -65.33 -48.93 71.32 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.92 HD23 HD21 ' A' ' 29' ' ' LEU . 1.5 mp -64.78 -47.9 76.43 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.515 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -55.63 -24.09 31.55 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.451 179.39 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.822 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -75.72 -48.99 19.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.726 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -66.48 -49.97 64.85 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.878 -179.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.497 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.3 t -51.9 -32.29 31.92 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.302 0.572 . . . . 0.0 110.034 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.703 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.21 -48.05 83.07 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.106 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.012 HD21 HD22 ' A' ' 106' ' ' LEU . 3.7 mp -69.37 -27.38 65.27 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.394 0.616 . . . . 0.0 110.084 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.41 -1.97 4.93 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.6 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.605 HG21 HD11 ' A' ' 82' ' ' LEU . 13.6 t -59.59 155.79 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 117.641 0.72 . . . . 0.0 110.056 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.62 ' CB ' HG13 ' A' ' 76' ' ' ILE . 1.7 m -116.95 107.71 14.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.991 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.667 ' CE2' ' HB3' ' A' ' 54' ' ' LEU . 8.3 p90 -122.24 153.43 38.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.861 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 1.7 m -147.99 116.33 6.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.877 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.895 HD11 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -87.97 177.32 6.98 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.085 0.469 . . . . 0.0 111.198 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.476 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 12.9 p -93.97 179.68 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.479 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.94 -14.59 36.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.751 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -118.12 6.8 12.06 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.888 0.375 . . . . 0.0 110.74 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.572 ' O ' HD23 ' A' ' 44' ' ' LEU . 3.9 mmt180 57.14 43.85 23.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.817 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -126.49 -2.32 6.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.436 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.98 ' HD3' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -136.54 109.73 7.79 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.822 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.599 ' SG ' HD22 ' A' ' 66' ' ' LEU . 5.7 t -118.11 153.99 32.86 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.461 0.648 . . . . 0.0 112.669 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.775 ' HB3' ' HD3' ' A' ' 38' ' ' LYS . 0.6 OUTLIER -121.49 103.45 8.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.054 178.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -98.96 125.05 52.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.816 HD13 ' HB2' ' A' ' 38' ' ' LYS . 8.3 mm -78.97 104.16 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.308 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.659 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -51.82 115.77 4.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.882 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.616 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.4 OUTLIER -63.56 -14.87 55.56 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.914 0.388 . . . . 0.0 110.439 178.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.53 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 83.6 -19.88 13.51 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.336 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.922 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.75 -151.28 5.73 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 178.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.836 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 3.8 Cg_exo -77.47 171.0 18.35 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 119.638 1.719 . . . . 0.0 109.222 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.805 ' HB2' HD23 ' A' ' 106' ' ' LEU . 4.1 mm? -68.09 90.99 0.34 Allowed 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.836 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 32.7 m170 -84.21 120.74 26.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 113.062 -1.881 . . . . 0.0 112.368 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.745 ' HB3' HD11 ' A' ' 113' ' ' ILE . . . -144.13 106.83 4.44 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.274 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.08 88.63 2.78 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.545 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -178.07 21.18 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.803 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.47 50.07 15.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.421 0.629 . . . . 0.0 109.904 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.8 HD12 ' N ' ' A' ' 89' ' ' GLU . 2.8 tp -78.4 135.87 37.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.041 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.8 ' N ' HD12 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -116.63 126.49 53.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.274 0.559 . . . . 0.0 110.286 179.157 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.822 HD13 ' HA ' ' A' ' 56' ' ' ALA . 19.7 mt -107.91 156.25 19.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.762 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 116' ' ' THR . 49.5 t80 -122.07 102.15 7.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.884 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.74 HD23 ' HE2' ' A' ' 99' ' ' MET . 1.9 mm? -91.74 6.86 44.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.275 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 43.5 -142.84 2.04 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.859 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -92.92 50.43 1.56 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.169 0.509 . . . . 0.0 110.824 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.433 ' HA ' ' OD2' ' A' ' 49' ' ' ASP . . . -84.23 -77.03 0.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.218 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.539 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.54 -16.43 19.06 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.36 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.437 ' HA ' ' NE2' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -96.22 -9.9 29.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.851 0.358 . . . . 0.0 110.474 179.013 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.453 ' C ' ' HD2' ' A' ' 101' ' ' PRO . . . -130.8 -15.94 3.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.731 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.74 ' HE2' HD23 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -67.95 -54.42 18.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.074 0.464 . . . . 0.0 110.459 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.652 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -60.48 -53.13 67.58 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.383 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.804 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 33.4 Cg_exo -59.9 -47.05 16.73 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.86 2.373 . . . . 0.0 112.894 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.928 HD13 HD11 ' A' ' 106' ' ' LEU . 2.7 tm? -68.54 -34.42 75.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.504 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.68 -47.65 85.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.523 0.677 . . . . 0.0 110.542 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.916 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . . . -72.45 -39.85 67.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.077 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.603 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -56.57 -39.77 74.04 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.214 0.531 . . . . 0.0 111.735 -177.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.012 HD22 HD21 ' A' ' 60' ' ' LEU . 1.3 mt -72.58 -22.01 61.05 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.039 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.762 ' SG ' HD11 ' A' ' 140' ' ' ILE . 84.9 m -61.92 -8.55 5.22 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.344 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.747 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 11.2 mt -85.6 165.05 17.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.04 -113.58 5.23 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.33 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.436 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 1.4 p -168.66 95.33 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.886 0.374 . . . . 0.0 111.242 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.958 HD21 ' HB3' ' A' ' 106' ' ' LEU . 51.1 p-10 -138.99 143.25 38.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.039 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 153' ' ' LEU . 1.5 m-20 -101.08 111.55 23.78 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.18 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.745 HD11 ' HB3' ' A' ' 84' ' ' ALA . 5.0 mp -141.49 142.4 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.023 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.622 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 22.5 t -116.09 112.06 38.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.744 0.307 . . . . 0.0 110.377 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.556 HD22 HD21 ' A' ' 92' ' ' LEU . 21.8 mt -79.08 157.14 28.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.415 0.626 . . . . 0.0 111.787 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 35.2 m -161.99 154.74 20.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.758 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.69 -167.1 10.94 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 119.897 -1.144 . . . . 0.0 113.425 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.621 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 2.3 mt-10 -70.65 173.03 5.12 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.387 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 20.2 Cg_endo -61.19 -24.39 78.98 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.598 1.532 . . . . 0.0 111.972 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.52 ' O ' ' HG3' ' A' ' 123' ' ' GLU . 2.3 tpp180 -90.23 -33.14 16.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.261 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.599 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 6.0 tpt -60.12 -19.55 54.0 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.675 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 7.6 mttm -68.33 -4.92 16.09 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.122 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.617 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -121.29 30.48 6.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.886 0.374 . . . . 0.0 110.986 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.454 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 4.0 mmp_? -108.96 93.75 13.26 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.758 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.65 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 8.2 Cg_endo -50.1 128.62 22.83 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.559 2.173 . . . . 0.0 112.466 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.772 HD11 HD23 ' A' ' 129' ' ' LEU . 17.3 tt -133.83 31.12 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.766 0.793 . . . . 0.0 110.215 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -71.8 -51.57 14.88 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.202 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.809 ' HB3' ' HB2' ' A' ' 165' ' ' ASP . 0.2 OUTLIER -53.14 -26.9 18.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.962 0.41 . . . . 0.0 110.727 -179.299 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.799 HD13 ' HA ' ' A' ' 172' ' ' PHE . 35.4 tp -82.63 -66.5 0.88 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.749 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.872 HG13 HD12 ' A' ' 140' ' ' ILE . 61.1 t -52.13 -25.44 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.312 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 30.9 t0 -72.16 -45.31 60.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.585 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.979 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -64.89 -51.83 59.8 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.834 0.35 . . . . 0.0 111.513 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.748 HD21 ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -56.62 -43.01 79.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.221 0.534 . . . . 0.0 109.874 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -60.06 -32.67 71.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.048 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.979 HD12 ' HA ' ' A' ' 132' ' ' ALA . 2.2 mt -72.09 -26.75 62.27 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.462 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.526 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -80.82 -13.55 81.16 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.659 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.82 4.04 6.24 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.302 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.88 145.71 48.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.923 0.392 . . . . 0.0 111.53 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 154' ' ' GLN . 0.2 OUTLIER -114.29 90.83 3.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.54 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.97 HG23 HD23 ' A' ' 153' ' ' LEU . 7.0 mt -117.48 174.54 3.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.957 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.763 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.8 OUTLIER -152.43 -168.08 2.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 111.39 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.591 ' N ' HG23 ' A' ' 141' ' ' THR . 25.7 m-85 -131.77 105.65 7.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.097 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.686 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.1 mm? -79.69 -8.88 59.5 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.812 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 27.5 mt-10 -141.33 -73.68 0.33 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.349 . . . . 0.0 110.379 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.647 ' HB3' ' HD2' ' A' ' 148' ' ' TYR . 0.1 OUTLIER -123.87 148.63 46.63 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.252 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.45 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 4.3 mt-10 -70.24 135.64 49.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.12 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.65 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 1.3 m-80 64.59 49.59 2.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.319 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.868 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.8 m-85 -148.29 179.6 1.15 Allowed Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.734 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.868 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 8.0 Cg_endo -50.22 -40.36 51.77 Favored 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 123.331 2.687 . . . . 0.0 115.037 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.812 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 36.7 Cg_endo -62.05 100.94 0.22 Allowed 'Trans proline' 0 CA--C 1.516 -0.375 0 C-N-CA 121.513 1.475 . . . . 0.0 111.586 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.476 HD21 ' HE1' ' A' ' 142' ' ' TYR . 91.5 mt -139.56 122.95 17.14 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.802 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.686 ' N ' HD21 ' A' ' 143' ' ' LEU . 0.9 OUTLIER -104.49 112.55 25.65 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.97 HD23 HG23 ' A' ' 140' ' ' ILE . 1.2 mt -96.07 155.39 16.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.254 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 18.8 mt-30 -142.55 24.34 1.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.615 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 56.49 -165.91 4.66 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.433 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.97 -4.98 34.1 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.13 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.651 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 3.5 t80 -60.8 107.34 0.69 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.863 0.332 . . . . 0.0 110.494 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.465 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 76.4 p -105.61 -46.39 4.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.889 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.676 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 141.73 -162.3 27.02 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.136 -1.03 . . . . 0.0 113.981 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.592 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 115.71 172.67 17.04 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -65.16 126.76 29.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.613 HG11 ' HB1' ' A' ' 132' ' ' ALA . 58.0 t -135.5 157.54 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-O 121.132 0.491 . . . . 0.0 111.47 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.535 ' O ' ' HE2' ' A' ' 192' ' ' LYS . 3.2 m-20 -123.65 119.66 30.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.384 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.805 HG11 HD13 ' A' ' 173' ' ' LEU . 0.4 OUTLIER -121.74 139.13 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.548 -0.461 . . . . 0.0 112.101 -178.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.809 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.3 OUTLIER -78.93 133.5 36.91 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.267 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.715 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -75.43 -44.64 21.1 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.105 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.493 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 54.4 p -52.91 165.44 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.922 0.391 . . . . 0.0 111.359 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.777 HG21 ' HE1' ' A' ' 128' ' ' HIS . 6.6 t 72.61 50.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.01 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.825 ' H ' HG11 ' A' ' 196' ' ' VAL . 1.4 m 63.62 150.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.424 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.467 ' HG ' ' HG1' ' A' ' 174' ' ' THR . 12.2 t -77.68 3.65 13.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.711 0.291 . . . . 0.0 111.412 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.652 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 18.9 mm100 -54.49 -20.68 8.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.983 0.42 . . . . 0.0 111.42 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.799 ' HA ' HD13 ' A' ' 129' ' ' LEU . 1.6 m-85 -76.09 -54.29 7.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.619 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.838 HD23 HG12 ' A' ' 201' ' ' ILE . 21.0 tp -77.33 -35.03 55.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.593 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.475 HG23 ' OG1' ' A' ' 204' ' ' THR . 79.8 m -58.99 -33.46 70.71 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.026 0.441 . . . . 0.0 110.029 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.916 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -76.33 -51.96 10.9 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.966 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.711 ' CD2' HD23 ' A' ' 133' ' ' LEU . 3.2 mt -61.99 -43.08 99.6 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.507 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.06 HD22 HD21 ' A' ' 205' ' ' LEU . 12.6 mt -60.75 -28.07 68.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.867 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.639 ' HA ' ' OH ' ' A' ' 231' ' ' TYR . 4.9 ptp -96.39 -26.24 15.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.325 0.583 . . . . 0.0 110.492 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.618 ' O ' HD11 ' A' ' 108' ' ' LEU . 74.1 m -85.17 -47.55 10.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.157 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.892 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -63.74 -35.84 18.44 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.719 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 9.7 Cg_endo -53.17 -37.77 80.35 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 121.129 1.219 . . . . 0.0 111.376 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.577 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.78 -8.06 58.96 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -67.43 115.8 30.4 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.057 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -33.58 -34.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.69 2.927 . . . . 0.0 114.33 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -103.65 152.92 21.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.005 0.431 . . . . 0.0 111.77 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.678 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 40.9 t0 -67.29 114.68 6.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.708 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.817 ' HB ' HG23 ' A' ' 225' ' ' VAL . 29.2 m -99.7 135.23 41.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.098 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 1.07 HG22 HG13 ' A' ' 224' ' ' VAL . 25.4 t -125.8 99.22 5.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.881 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.5 mt -91.11 144.49 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.267 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.822 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.2 OUTLIER -114.93 170.98 7.93 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.845 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.4 mm -111.54 97.15 5.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.269 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.599 ' HE3' ' N ' ' A' ' 165' ' ' ASP . 9.3 mtmt -57.0 -81.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.681 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -83.21 168.0 46.06 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.361 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -59.61 122.64 14.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.568 0.223 . . . . 0.0 110.84 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.715 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.4 OUTLIER -55.65 147.6 17.97 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.22 0.533 . . . . 0.0 110.841 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.825 HG11 ' H ' ' A' ' 169' ' ' SER . 11.8 p -103.81 -21.06 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.134 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.57 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.3 OUTLIER -128.11 46.15 2.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.125 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.807 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.6 OUTLIER -43.62 -61.64 1.81 Allowed Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 114.854 -1.066 . . . . 0.0 113.11 -178.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 15.0 Cg_exo -69.37 -17.28 39.44 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 121.476 1.451 . . . . 0.0 111.55 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.691 ' HA ' HD12 ' A' ' 203' ' ' ILE . 26.9 m-85 -75.08 -30.69 61.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.113 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 1.014 HD11 HD12 ' A' ' 177' ' ' LEU . 8.0 tp -67.95 -33.6 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.229 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.565 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 9.9 t70 -59.79 -33.71 72.07 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.691 HD12 ' HA ' ' A' ' 200' ' ' TYR . 13.1 mt -68.32 -29.86 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.622 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.505 HG22 ' SD ' ' A' ' 208' ' ' MET . 71.7 m -61.0 -54.71 41.6 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.124 0.488 . . . . 0.0 109.716 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 1.06 HD21 HD22 ' A' ' 177' ' ' LEU . 28.7 mt -70.4 -34.64 72.77 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.231 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.737 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 0.9 OUTLIER -63.6 -29.93 71.11 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.299 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.695 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -77.73 -40.82 39.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.613 178.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.505 ' SD ' HG22 ' A' ' 204' ' ' THR . 10.4 mtp -68.76 -38.56 80.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.966 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.737 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -66.7 -45.26 79.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.384 179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.667 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 2.0 t -58.71 -26.08 63.53 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 121.317 0.58 . . . . 0.0 109.529 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.943 ' HA ' ' HG3' ' A' ' 234' ' ' PRO . 2.1 m-85 -74.92 -54.56 7.02 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.602 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 156.67 -1.56 0.13 Allowed Glycine 0 CA--C 1.52 0.351 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.883 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.626 ' HB ' ' CD1' ' A' ' 231' ' ' TYR . 53.0 t -117.75 138.22 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.046 0.451 . . . . 0.0 111.767 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -135.49 155.12 51.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.535 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.966 HG21 HG12 ' A' ' 225' ' ' VAL . 2.4 pp -129.31 175.5 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.956 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.317 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 1.01 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 18.7 tt0 -89.91 125.52 35.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.874 0.368 . . . . 0.0 110.37 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -101.14 100.95 11.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.248 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.723 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 2.1 mm-40 -66.74 -167.08 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.75 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.46 48.26 0.34 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.901 0.381 . . . . 0.0 110.341 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.588 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 57.88 19.65 5.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.254 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 191' ' ' ILE . 3.1 pt20 -112.94 -19.72 11.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.83 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.775 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 32.5 mt-30 -150.34 141.67 23.27 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.701 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 1.004 ' HB3' HD21 ' A' ' 177' ' ' LEU . 19.4 m-85 -114.14 96.76 5.97 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 1.07 HG13 HG22 ' A' ' 188' ' ' VAL . 31.1 t -82.8 110.97 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 121.167 0.508 . . . . 0.0 111.235 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.966 HG12 HG21 ' A' ' 215' ' ' ILE . 3.0 m -99.87 113.15 34.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.964 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.661 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 1.3 mptm? -62.74 103.82 0.47 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.998 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.678 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.25 155.86 16.36 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.947 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.97 8.77 75.23 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.445 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.661 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 69.8 mm-40 -73.16 178.54 4.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.473 0.654 . . . . 0.0 111.546 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.577 ' HA ' HD23 ' A' ' 182' ' ' LEU . 4.9 m -167.68 105.55 0.52 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.863 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.677 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 22.7 m-85 -55.15 142.53 30.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.108 0.48 . . . . 0.0 111.368 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.569 ' HB2' ' O ' ' A' ' 211' ' ' PHE . 78.9 mt-30 -108.21 148.58 29.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.673 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 56.6 p -64.13 103.05 0.37 Allowed Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.155 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.943 ' HG3' ' HA ' ' A' ' 211' ' ' PHE . 7.7 Cg_exo -71.36 -31.39 14.17 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.705 2.27 . . . . 0.0 111.966 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.01 -120.79 5.22 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.682 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -92.9 116.8 29.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 88.1 t80 -123.78 136.8 54.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.519 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.931 HD12 HG23 ' A' ' 42' ' ' THR . 4.0 tp -98.18 119.46 36.87 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.261 0.553 . . . . 0.0 111.707 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 42' ' ' THR . 92.8 t -52.84 -81.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.052 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.504 ' H ' ' HB3' ' A' ' 43' ' ' ASN . 2.8 tt0 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.712 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.664 ' HB3' ' H ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.902 0.382 . . . . 0.0 111.054 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.719 ' OD1' ' HA ' ' A' ' 50' ' ' VAL . 64.3 m-20 -74.83 -22.39 58.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.964 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 35.0 mtt85 -62.19 -40.41 95.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.053 0.454 . . . . 0.0 110.293 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.843 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -74.32 -37.63 63.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.908 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.935 HD13 ' HG ' ' A' ' 54' ' ' LEU . 55.1 mt -58.36 -47.19 84.61 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.862 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.875 HD21 ' HB2' ' A' ' 105' ' ' ALA . 14.9 tp -77.82 -48.84 15.55 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.572 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 27.7 mt -55.05 -35.19 64.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.467 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.707 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -78.17 -29.7 48.74 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.675 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.766 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -70.26 -30.58 67.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.939 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.869 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.35 -12.54 40.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.996 0.427 . . . . 0.0 111.065 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.691 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -80.42 168.68 18.68 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.239 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.59 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 76.9 m80 -103.19 98.42 8.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.217 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.71 141.06 6.95 Favored Glycine 0 C--N 1.314 -0.657 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.627 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.73 ' HB2' HG13 ' A' ' 76' ' ' ILE . 1.6 ttpm? -64.84 138.53 58.43 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.37 157.74 44.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.374 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.878 HG22 ' HG3' ' A' ' 74' ' ' GLU . 94.1 t -104.83 141.46 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.372 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.843 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -127.93 111.62 13.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.888 178.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.982 HG23 HD12 ' A' ' 238' ' ' LEU . 0.1 OUTLIER -98.31 171.03 8.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 111.783 -179.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.65 ' HB2' HD11 ' A' ' 238' ' ' LEU . 1.8 t30 66.03 18.17 10.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.233 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.847 HD22 HD11 ' A' ' 66' ' ' LEU . 1.2 tp -58.61 163.64 3.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.664 ' H ' ' HB3' ' A' ' 25' ' ' SER . 38.5 tp -97.64 116.63 30.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.009 0.433 . . . . 0.0 111.425 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -75.64 71.85 2.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.749 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.532 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 63.1 m -134.85 -162.98 1.31 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.899 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.624 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 1.5 t70 -98.19 -22.11 16.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.896 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.464 ' CG ' ' HA ' ' A' ' 95' ' ' ALA . 8.2 m-20 -66.61 -30.4 70.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.78 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.719 ' HA ' ' OD1' ' A' ' 26' ' ' ASN . 21.3 t -84.48 -56.02 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.058 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.624 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 1.1 ptm180 -49.99 -26.97 4.77 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -71.41 -40.77 70.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.296 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.485 ' SD ' ' HB1' ' A' ' 98' ' ' ALA . 7.1 tpt -64.87 -47.43 77.91 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.935 ' HG ' HD13 ' A' ' 29' ' ' LEU . 1.3 mp -65.33 -47.21 77.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.588 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 8.4 t-20 -57.39 -23.01 46.64 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.0 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.692 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -74.76 -48.1 27.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.056 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -68.18 -49.44 60.87 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.771 -179.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.509 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.0 t -51.65 -30.23 20.86 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.281 0.562 . . . . 0.0 110.201 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.9 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.31 -52.49 65.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.962 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.967 HD21 HD22 ' A' ' 106' ' ' LEU . 3.8 mp -65.14 -28.38 69.38 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.83 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.76 0.61 5.23 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 114.834 -1.075 . . . . 0.0 113.494 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.681 HG21 HD11 ' A' ' 82' ' ' LEU . 22.9 t -56.55 154.2 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 117.609 0.705 . . . . 0.0 110.391 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.856 ' HB3' HD13 ' A' ' 76' ' ' ILE . 11.9 m -115.16 112.27 22.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.379 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 7.5 p90 -129.71 156.95 43.45 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.875 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.685 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -149.25 116.05 5.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.823 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.95 HD22 ' HG ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -90.32 175.55 7.07 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.232 0.539 . . . . 0.0 111.645 -179.424 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.842 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 1.3 t -87.85 179.42 6.47 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.709 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.33 -14.36 49.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.33 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.98 2.39 11.5 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.866 0.365 . . . . 0.0 110.705 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.503 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER 61.33 45.29 8.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.428 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -124.03 -2.72 8.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.974 179.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.842 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -142.54 110.62 5.97 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.95 ' HG ' HD22 ' A' ' 66' ' ' LEU . 0.6 OUTLIER -114.93 152.62 32.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.256 0.55 . . . . 0.0 112.064 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.878 ' HG3' HG22 ' A' ' 40' ' ' VAL . 1.1 mt-10 -118.11 102.85 9.34 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.689 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.703 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -99.44 126.44 52.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.856 HD13 ' HB3' ' A' ' 63' ' ' SER . 3.1 mp -80.94 103.81 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.425 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.707 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -48.08 118.79 4.76 Favored Glycine 0 N--CA 1.453 -0.186 0 CA-C-N 116.017 -0.538 . . . . 0.0 114.136 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.592 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -63.77 -15.38 58.5 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.987 0.423 . . . . 0.0 110.357 178.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.59 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.02 -19.71 20.17 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.827 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.869 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -139.73 -150.22 5.47 Favored Glycine 0 C--O 1.224 -0.519 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.806 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 4.3 Cg_exo -77.57 170.08 19.85 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 CA-C-N 119.711 1.755 . . . . 0.0 108.828 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.809 HD12 HD13 ' A' ' 60' ' ' LEU . 4.3 mm? -68.43 89.59 0.35 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.806 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 34.1 m170 -83.44 118.34 23.68 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.012 -1.904 . . . . 0.0 112.333 -176.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.784 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -143.27 107.65 4.79 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.773 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -106.88 89.33 2.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.733 0.302 . . . . 0.0 110.947 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -177.63 20.45 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.74 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.32 48.11 19.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.394 0.616 . . . . 0.0 110.263 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.9 HD21 ' HB1' ' A' ' 59' ' ' ALA . 3.9 tp -76.57 131.6 39.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.261 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.706 ' N ' HD12 ' A' ' 88' ' ' LEU . 6.9 tt0 -110.64 128.26 55.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.261 0.553 . . . . 0.0 110.096 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.802 HD21 ' CB ' ' A' ' 59' ' ' ALA . 48.6 mt -110.69 156.99 20.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.118 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 116' ' ' THR . 45.4 t80 -119.57 105.15 10.93 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.628 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.853 HD23 ' HE2' ' A' ' 99' ' ' MET . 2.8 mm? -91.47 8.17 37.68 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.798 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 121' ' ' MET . . . 39.72 -139.82 0.93 Allowed Glycine 0 CA--C 1.523 0.556 0 C-N-CA 121.327 -0.463 . . . . 0.0 113.781 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.667 ' OD1' ' HB3' ' A' ' 120' ' ' ARG . 0.7 OUTLIER -91.32 46.57 1.31 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.023 0.44 . . . . 0.0 111.084 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.464 ' HA ' ' CG ' ' A' ' 49' ' ' ASP . . . -90.52 -77.44 0.41 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.216 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.461 ' O ' ' HG2' ' A' ' 171' ' ' GLN . . . 78.65 -14.36 13.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.99 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.58 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -96.29 -11.47 25.88 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 120.81 0.338 . . . . 0.0 110.429 178.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.485 ' HB1' ' SD ' ' A' ' 53' ' ' MET . . . -125.05 -21.27 4.7 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.49 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.853 ' HE2' HD23 ' A' ' 92' ' ' LEU . 10.4 ttm -66.8 -52.02 48.86 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.263 0.554 . . . . 0.0 110.47 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.918 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -57.77 -55.39 45.4 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.156 -179.522 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.671 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 24.1 Cg_exo -63.45 -46.8 8.75 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.53 2.153 . . . . 0.0 112.886 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.929 HD13 HD11 ' A' ' 106' ' ' LEU . 2.9 tm? -61.3 -40.81 95.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.78 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.701 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -58.94 -48.48 81.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.65 0.738 . . . . 0.0 109.736 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.691 ' CB ' ' HB1' ' A' ' 175' ' ' ALA . . . -68.01 -40.11 83.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.779 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.875 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -56.16 -42.49 77.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.042 0.449 . . . . 0.0 111.315 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.967 HD22 HD21 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -71.74 -21.32 61.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.399 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.671 ' SG ' HD11 ' A' ' 140' ' ' ILE . 82.6 m -58.36 -11.76 3.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.669 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.72 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 12.3 mt -84.43 167.68 16.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.716 0.293 . . . . 0.0 110.244 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 55.04 -110.75 1.86 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.076 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.486 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 0.9 OUTLIER -171.3 96.25 0.19 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.954 0.407 . . . . 0.0 111.207 179.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.686 ' HB2' HD11 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -137.28 139.61 41.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.974 -179.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.677 ' C ' HD12 ' A' ' 113' ' ' ILE . 1.0 OUTLIER -99.77 111.3 23.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.752 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.742 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.3 mp -141.02 139.85 33.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.224 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.593 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 21.3 t -112.2 113.41 44.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.701 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 18.1 mt -80.44 155.46 27.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.467 0.651 . . . . 0.0 112.215 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 11.2 m -162.72 156.88 20.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.294 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -147.58 -165.34 11.81 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 119.972 -1.109 . . . . 0.0 113.662 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.577 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 1.7 mt-10 -71.38 177.86 1.44 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.312 -0.444 . . . . 0.0 110.507 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.577 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 38.7 Cg_exo -61.74 -26.43 79.77 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.177 1.918 . . . . 0.0 112.52 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.667 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 11.7 tpt180 -87.25 -38.56 16.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.714 0.292 . . . . 0.0 110.483 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.718 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 8.7 tpt -59.6 -19.21 47.32 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.706 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 11.8 mttp -72.32 -4.5 30.19 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.82 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.683 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 5.4 pt-20 -126.62 25.06 6.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.981 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.426 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 33.2 mmt180 -100.15 87.23 0.71 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.271 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.639 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 1.3 Cg_endo -42.32 126.82 3.99 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.958 2.439 . . . . 0.0 112.449 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.729 HD11 HD23 ' A' ' 129' ' ' LEU . 16.5 tt -131.6 31.71 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.818 0.818 . . . . 0.0 110.103 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.592 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -70.7 -52.64 14.63 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.517 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.778 ' HE1' HG21 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -54.3 -25.45 23.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.737 0.303 . . . . 0.0 110.686 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.863 ' CD1' HD21 ' A' ' 133' ' ' LEU . 26.5 tp -84.39 -66.21 0.92 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.885 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.877 HG13 HD12 ' A' ' 140' ' ' ILE . 48.0 t -52.82 -25.2 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.189 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.592 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 10.8 t0 -72.55 -46.58 53.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.388 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.945 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -65.07 -46.76 79.83 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.661 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.941 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -60.77 -42.27 97.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.362 0.601 . . . . 0.0 109.777 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.48 -34.8 74.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.056 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.945 HD12 ' HA ' ' A' ' 132' ' ' ALA . 3.4 mt -68.51 -30.58 69.43 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.253 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.21 -18.49 80.04 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.541 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.3 4.58 5.38 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.231 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.99 148.35 49.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.85 0.357 . . . . 0.0 111.406 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.57 87.47 2.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.402 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.986 HG23 HD23 ' A' ' 153' ' ' LEU . 6.8 mt -114.56 175.34 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.47 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.769 ' H ' HG22 ' A' ' 140' ' ' ILE . 1.0 OUTLIER -152.32 -167.22 2.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.232 0.539 . . . . 0.0 111.152 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.594 ' N ' HG23 ' A' ' 141' ' ' THR . 23.5 m-85 -133.64 105.98 7.14 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.671 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.0 mm? -81.04 -14.75 57.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.738 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.649 ' HG3' ' N ' ' A' ' 145' ' ' GLN . 0.1 OUTLIER -134.67 -68.31 0.54 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.996 0.427 . . . . 0.0 109.92 179.439 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.649 ' N ' ' HG3' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -132.38 150.89 52.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.229 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.452 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 66.3 mt-10 -69.0 131.87 45.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.235 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.639 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 13.4 m-20 65.55 50.39 1.66 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.081 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.874 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 3.3 m-30 -143.03 -178.95 0.86 Allowed Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.874 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 11.9 Cg_endo -59.0 -36.59 96.52 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.599 2.199 . . . . 0.0 114.548 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.701 ' HD2' ' N ' ' A' ' 149' ' ' PRO . 39.0 Cg_endo -62.94 93.77 0.15 Allowed 'Trans proline' 0 CA--C 1.515 -0.465 0 C-N-CA 121.465 1.443 . . . . 0.0 111.221 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 150' ' ' PRO . 72.0 mt -132.54 123.49 26.63 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.513 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.709 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.0 OUTLIER -103.11 111.54 23.95 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.986 HD23 HG23 ' A' ' 140' ' ' ILE . 1.1 mt -94.07 159.35 15.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.458 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -147.2 23.62 1.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.662 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.514 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 55.84 -165.5 4.11 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.318 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.423 ' O ' HG23 ' A' ' 158' ' ' THR . . . 106.96 -2.38 35.59 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.64 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.698 ' HE1' ' HA ' ' A' ' 133' ' ' LEU . 40.9 t80 -63.44 111.92 2.53 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.029 0.442 . . . . 0.0 110.752 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.626 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 78.1 p -106.99 -47.64 3.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.462 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.62 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 140.09 -161.66 26.38 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.913 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.629 ' H ' ' HA ' ' A' ' 187' ' ' THR . . . 115.96 170.44 15.9 Favored Glycine 0 CA--C 1.519 0.289 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -66.51 123.26 19.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 117.056 0.428 . . . . 0.0 110.191 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.55 HG11 ' HB1' ' A' ' 132' ' ' ALA . 38.8 t -131.6 157.05 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 111.512 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.465 ' CG ' ' HG2' ' A' ' 190' ' ' ARG . 2.5 m-20 -120.97 115.24 22.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.606 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.594 HG21 ' CD1' ' A' ' 176' ' ' LEU . 0.5 OUTLIER -116.49 145.62 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 120.176 -0.609 . . . . 0.0 112.201 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.562 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.9 OUTLIER -82.9 132.86 35.14 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.925 179.3 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.684 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -74.61 -44.73 25.36 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.369 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.438 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 0.6 OUTLIER -52.02 165.71 0.19 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.879 0.371 . . . . 0.0 111.28 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.778 HG21 ' HE1' ' A' ' 128' ' ' HIS . 4.1 t 71.8 54.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.979 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.857 ' N ' HG11 ' A' ' 196' ' ' VAL . 69.6 m 59.26 160.02 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.266 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.726 ' HB2' ' HB2' ' A' ' 197' ' ' SER . 34.8 t -80.55 -1.63 42.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.918 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 2.2 mp0 -51.34 -22.16 2.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.671 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.666 ' HA ' HD13 ' A' ' 129' ' ' LEU . 2.7 m-85 -78.5 -54.94 5.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.942 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.748 HD23 HG12 ' A' ' 201' ' ' ILE . 32.1 tp -73.18 -41.04 64.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.399 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 170' ' ' SER . 14.7 t -58.64 -32.71 69.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.433 0.635 . . . . 0.0 109.499 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.691 ' HB1' ' CB ' ' A' ' 104' ' ' ALA . . . -64.88 -52.27 57.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.021 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.941 ' CD2' HD23 ' A' ' 133' ' ' LEU . 1.9 mt -71.28 -36.09 71.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.187 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.054 HD22 HD21 ' A' ' 205' ' ' LEU . 9.8 mt -66.2 -29.83 70.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.123 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.662 ' CE ' HD23 ' A' ' 30' ' ' LEU . 23.6 mtp -93.98 -27.54 16.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.259 0.552 . . . . 0.0 110.64 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.662 HG23 ' HG ' ' A' ' 108' ' ' LEU . 87.6 m -88.12 -46.83 8.96 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.141 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.954 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -62.28 -36.71 30.4 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.4 Cg_endo -54.46 -37.72 89.7 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 CA-C-N 120.297 1.142 . . . . 0.0 111.506 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.703 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -83.79 -5.74 59.27 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.229 -179.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.626 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -68.1 124.66 90.16 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.1 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 1.5 Cg_endo -43.74 -29.88 2.61 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.95 2.433 . . . . 0.0 113.535 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -107.75 151.53 25.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.067 0.46 . . . . 0.0 111.652 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.655 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 20.6 t0 -64.55 118.03 8.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.655 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.774 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 41.1 m -102.26 133.85 46.48 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.817 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 1.016 HG22 HG13 ' A' ' 224' ' ' VAL . 33.3 t -126.0 99.16 5.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.273 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.58 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.2 mt -91.71 145.94 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.116 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.842 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.1 OUTLIER -118.19 171.04 8.39 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.866 HD11 ' CD1' ' A' ' 223' ' ' PHE . 1.6 mm -111.69 98.17 6.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-O 121.096 0.474 . . . . 0.0 111.467 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -60.14 -81.01 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.381 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -81.09 166.75 48.74 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.422 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -57.61 126.32 26.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.65 0.262 . . . . 0.0 111.168 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.684 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 0.4 OUTLIER -62.48 147.21 49.48 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.013 0.435 . . . . 0.0 110.711 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.857 HG11 ' N ' ' A' ' 169' ' ' SER . 11.6 p -104.21 -20.55 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.797 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.726 ' HB2' ' HB2' ' A' ' 170' ' ' SER . 0.4 OUTLIER -128.28 45.32 2.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.378 0.608 . . . . 0.0 109.589 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.842 ' O ' HG22 ' A' ' 201' ' ' ILE . 0.0 OUTLIER -41.72 -63.9 0.76 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.541 -179.081 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 49.0 Cg_endo -68.42 -17.33 44.03 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 121.707 1.605 . . . . 0.0 111.479 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.87 ' HA ' HD12 ' A' ' 203' ' ' ILE . 17.2 m-85 -76.88 -26.74 54.55 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.264 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.905 HD11 HD12 ' A' ' 177' ' ' LEU . 6.3 tp -73.08 -33.61 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.847 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.1 OUTLIER -61.89 -35.0 77.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.226 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.87 HD12 ' HA ' ' A' ' 200' ' ' TYR . 10.1 mt -66.7 -28.67 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.175 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.582 HG22 ' SD ' ' A' ' 208' ' ' MET . 53.9 m -61.45 -55.16 34.29 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 1.054 HD21 HD22 ' A' ' 177' ' ' LEU . 41.3 mt -70.05 -34.28 73.02 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.549 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.62 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 8.8 t30 -64.84 -25.51 67.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.193 0.521 . . . . 0.0 109.839 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.779 HD11 ' CZ ' ' A' ' 237' ' ' TYR . 0.2 OUTLIER -83.9 -40.32 18.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.308 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.59 ' SD ' HD23 ' A' ' 205' ' ' LEU . 11.2 mtp -69.24 -39.41 78.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.018 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.62 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.1 OUTLIER -65.91 -44.45 85.16 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.53 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 207' ' ' LEU . 1.3 t -59.02 -28.98 66.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.426 0.632 . . . . 0.0 109.39 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.676 ' CE2' ' HA ' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -71.33 -51.41 24.42 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.926 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 157.39 -5.85 0.18 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.531 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.695 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 54.9 t -118.84 137.33 53.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.972 0.415 . . . . 0.0 111.857 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.405 ' HG3' ' HA ' ' A' ' 209' ' ' LYS . 5.8 mt-10 -135.05 156.13 49.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.629 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 1.07 HG21 HG12 ' A' ' 225' ' ' VAL . 2.0 pp -132.44 175.99 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.946 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.932 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.868 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 4.5 tt0 -88.02 122.94 32.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.161 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.61 100.88 10.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.274 0.559 . . . . 0.0 109.778 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.764 ' HB2' ' HG2' ' A' ' 222' ' ' GLN . 1.5 tm0? -72.92 -161.87 0.1 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.044 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.422 ' H ' ' CD ' ' A' ' 218' ' ' GLN . 18.7 m-70 -74.32 46.28 0.25 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.499 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.713 ' CE2' ' HD3' ' A' ' 198' ' ' LYS . 0.3 OUTLIER 58.45 22.37 9.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.143 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 191' ' ' ILE . 23.3 mt-30 -109.0 -37.39 5.84 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.021 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.797 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 5.0 pt20 -136.12 139.19 42.75 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.278 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.866 ' CD1' HD11 ' A' ' 191' ' ' ILE . 28.2 m-85 -108.93 95.57 5.73 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 1.016 HG13 HG22 ' A' ' 188' ' ' VAL . 81.3 t -86.11 112.94 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.265 -177.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 1.07 HG12 HG21 ' A' ' 215' ' ' ILE . 6.3 m -101.1 115.78 43.43 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.897 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.555 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.601 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -64.41 101.47 0.44 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.956 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.655 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -53.51 156.43 5.74 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.256 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 88.26 10.85 67.86 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.236 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 60.3 mm-40 -75.84 -179.63 4.93 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.53 0.681 . . . . 0.0 111.657 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.703 ' HA ' HD23 ' A' ' 182' ' ' LEU . 3.9 m -170.68 105.9 0.27 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.863 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.695 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 21.9 m-85 -53.64 149.13 8.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.933 0.397 . . . . 0.0 111.079 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.64 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 60.8 mt-30 -115.15 163.49 15.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.024 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 234' ' ' PRO . 15.2 t -82.61 98.88 0.53 Allowed Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.987 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.64 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 50.4 Cg_endo -66.52 -31.32 41.97 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.587 2.191 . . . . 0.0 112.384 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.86 -121.52 5.18 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.611 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -94.19 115.85 28.17 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.779 ' CZ ' HD11 ' A' ' 207' ' ' LEU . 0.0 OUTLIER -130.12 146.87 51.8 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.508 -178.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.982 HD12 HG23 ' A' ' 42' ' ' THR . 6.7 tp -95.22 117.71 30.74 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.043 0.449 . . . . 0.0 110.716 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.686 ' CG2' ' HB2' ' A' ' 41' ' ' LEU . 8.3 t -64.71 -73.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.009 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.427 ' H ' ' HB3' ' A' ' 43' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.378 -0.82 . . . . 0.0 111.078 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.731 ' HB3' ' H ' ' A' ' 45' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 121.208 0.528 . . . . 0.0 110.863 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.568 ' OD1' ' HA ' ' A' ' 50' ' ' VAL . 59.1 m-20 -76.53 -21.86 55.16 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.735 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 -65.59 -46.68 78.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.835 0.35 . . . . 0.0 110.767 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.982 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -69.39 -35.84 76.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.401 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.908 HD21 HD23 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -59.96 -53.96 51.76 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.237 0.542 . . . . 0.0 110.705 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.751 HD21 ' HB2' ' A' ' 105' ' ' ALA . 11.8 tp -63.54 -54.35 37.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.951 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.803 HD21 ' HG2' ' A' ' 178' ' ' MET . 78.0 mt -52.73 -34.1 51.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.929 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.711 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -78.09 -29.28 49.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.658 178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.781 ' HB3' HD21 ' A' ' 82' ' ' LEU . . . -73.89 -31.66 63.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.422 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.867 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -88.98 -12.04 42.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.362 . . . . 0.0 110.955 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -80.4 169.46 17.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.735 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.554 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 75.4 m80 -102.64 97.35 7.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.171 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.53 141.77 6.55 Favored Glycine 0 C--N 1.317 -0.519 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.257 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.73 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 7.1 tttt -64.28 134.92 55.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.083 0.468 . . . . 0.0 111.745 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.647 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.8 OUTLIER -131.59 155.08 48.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.616 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.778 ' HB ' ' HA ' ' A' ' 236' ' ' THR . 26.2 t -100.87 141.17 18.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.052 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.982 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -128.08 111.2 13.22 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.269 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.937 HG23 HD12 ' A' ' 238' ' ' LEU . 0.7 OUTLIER -103.79 164.73 11.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.323 0.582 . . . . 0.0 111.886 -179.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.623 ' HB2' HD11 ' A' ' 238' ' ' LEU . 27.9 t30 71.28 21.25 4.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.325 -177.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.67 HD22 HD11 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -58.51 160.35 5.51 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.296 178.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.731 ' H ' ' HB3' ' A' ' 25' ' ' SER . 25.6 tp -92.86 114.2 26.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.008 0.432 . . . . 0.0 111.415 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -75.0 68.78 1.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.599 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 t -129.34 -163.4 1.29 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.052 0.454 . . . . 0.0 111.322 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.581 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 48.9 m-20 -98.27 -20.65 17.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.714 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 3.7 p-10 -72.43 -27.03 62.08 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.007 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.654 HG21 ' HB3' ' A' ' 45' ' ' LEU . 17.8 t -89.07 -51.7 11.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.708 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.581 ' HG2' ' HA ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -51.25 -27.63 9.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.181 0.515 . . . . 0.0 110.015 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . 3.4 m-70 -73.35 -36.6 66.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.962 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.618 ' SD ' ' HB1' ' A' ' 98' ' ' ALA . 13.4 tpt -64.56 -50.62 66.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.908 HD23 HD21 ' A' ' 29' ' ' LEU . 1.4 mp -62.41 -48.93 77.53 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 17.7 t-20 -57.13 -22.35 39.28 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.99 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.686 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -75.08 -46.4 34.94 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.53 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.601 ' N ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -69.28 -49.46 55.87 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.861 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.48 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 4.9 t -50.8 -30.41 14.15 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.273 0.559 . . . . 0.0 110.298 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.729 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.83 -51.13 71.04 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.077 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.127 HD21 HD22 ' A' ' 106' ' ' LEU . 3.8 mp -66.1 -27.92 68.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.878 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.16 -0.9 5.73 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 114.77 -1.105 . . . . 0.0 113.67 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.645 HG21 HD11 ' A' ' 82' ' ' LEU . 12.0 t -58.34 149.71 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 117.695 0.747 . . . . 0.0 110.359 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.417 ' HB2' HD12 ' A' ' 76' ' ' ILE . 4.0 m -113.48 108.45 17.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.214 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.664 ' CZ ' ' HB3' ' A' ' 54' ' ' LEU . 12.9 p90 -126.67 159.75 32.75 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.173 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.634 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 72.3 m -149.76 116.78 5.97 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.984 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.829 HD22 ' SG ' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -88.2 173.24 8.91 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.332 0.587 . . . . 0.0 112.142 -179.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.691 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -82.51 178.57 8.15 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.621 178.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.56 -12.59 46.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.705 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.14 1.38 11.93 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.239 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.43 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 1.6 mmt180 63.54 44.51 5.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.59 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -123.08 -2.84 8.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.229 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.691 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.1 OUTLIER -141.65 112.32 7.16 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.829 ' SG ' HD22 ' A' ' 66' ' ' LEU . 2.3 t -116.38 147.25 41.81 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.653 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 1.6 mt-10 -112.51 103.07 11.13 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -96.8 126.68 49.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 38' ' ' LYS . 8.5 mt -80.96 102.89 7.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.007 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.711 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -46.6 113.0 1.01 Allowed Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.957 -0.565 . . . . 0.0 113.974 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.632 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -60.35 -16.81 38.59 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.969 0.414 . . . . 0.0 110.341 178.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.554 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 85.45 -20.64 16.79 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.348 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.867 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -138.46 -151.67 5.84 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.827 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 5.4 Cg_exo -75.88 170.73 19.55 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 CA-C-N 119.653 1.726 . . . . 0.0 109.167 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.781 HD21 ' HB3' ' A' ' 33' ' ' ALA . 4.3 mm? -67.84 89.68 0.28 Allowed 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.827 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 27.8 m170 -81.68 119.38 23.76 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.017 -1.901 . . . . 0.0 112.688 -176.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.73 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -145.9 111.2 5.37 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.952 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -112.46 88.79 2.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.511 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -176.18 20.16 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.701 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.45 49.99 15.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.412 0.625 . . . . 0.0 110.037 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.778 ' O ' HG23 ' A' ' 113' ' ' ILE . 5.6 tp -79.01 133.14 36.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.09 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.684 ' HB2' ' HB ' ' A' ' 114' ' ' VAL . 1.4 tm-20 -112.11 128.66 56.28 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.636 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.625 HD21 ' CB ' ' A' ' 59' ' ' ALA . 39.0 mt -110.37 158.59 18.28 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.448 ' CE1' ' CA ' ' A' ' 93' ' ' GLY . 21.5 t80 -126.51 106.63 9.58 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.844 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.074 HD23 ' HE1' ' A' ' 99' ' ' MET . 2.1 mm? -95.82 8.28 43.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.184 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.448 ' CA ' ' CE1' ' A' ' 91' ' ' PHE . . . 46.95 -142.55 5.8 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.724 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.467 HD22 ' HB3' ' A' ' 120' ' ' ARG . 17.0 t-20 -93.15 49.61 1.43 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.892 0.377 . . . . 0.0 111.039 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -86.77 -75.82 0.38 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.089 0.471 . . . . 0.0 111.156 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 171' ' ' GLN . . . 81.34 -17.46 13.39 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.089 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.531 HG22 ' NE2' ' A' ' 171' ' ' GLN . 3.9 p -94.06 -9.73 35.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.862 0.363 . . . . 0.0 111.052 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.618 ' HB1' ' SD ' ' A' ' 53' ' ' MET . . . -125.8 -22.45 4.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.524 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.074 ' HE1' HD23 ' A' ' 92' ' ' LEU . 5.5 tpp -66.11 -51.23 59.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.818 0.342 . . . . 0.0 110.75 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.804 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 0.0 OUTLIER -61.48 -56.11 36.49 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.283 -179.319 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.7 ' HD3' ' HB2' ' A' ' 100' ' ' ARG . 38.5 Cg_exo -59.43 -46.01 23.45 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.308 2.005 . . . . 0.0 112.668 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.666 ' O ' ' HG ' ' A' ' 106' ' ' LEU . 3.1 tm? -69.42 -35.28 75.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.481 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.92 -48.24 81.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.284 0.564 . . . . 0.0 110.79 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.826 ' O ' HG21 ' A' ' 179' ' ' THR . . . -72.17 -34.65 68.61 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.846 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.751 ' HB2' HD21 ' A' ' 30' ' ' LEU . . . -59.04 -44.12 91.72 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.95 0.405 . . . . 0.0 111.865 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.127 HD22 HD21 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -69.74 -22.44 63.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.373 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.576 ' SG ' HD11 ' A' ' 140' ' ' ILE . 23.1 m -60.26 -10.3 4.45 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.907 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.689 HD11 ' O ' ' A' ' 179' ' ' THR . 11.5 mt -82.86 169.68 15.82 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 51.87 -110.97 1.25 Allowed Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.406 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.437 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 62.7 m -162.73 99.42 1.0 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.753 0.311 . . . . 0.0 110.354 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 2.6 m-20 -138.18 135.33 35.54 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.625 ' C ' HD12 ' A' ' 113' ' ' ILE . 2.8 m-20 -102.41 111.1 23.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.292 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 88' ' ' LEU . 4.9 mp -144.39 142.74 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.202 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 21.7 t -113.87 112.51 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.844 0.354 . . . . 0.0 110.252 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.439 ' CD2' ' HB2' ' A' ' 90' ' ' LEU . 28.7 mt -83.91 156.93 22.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.565 0.697 . . . . 0.0 112.14 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 117' ' ' GLY . 1.9 m -160.55 174.89 13.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.813 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.474 ' H ' HG22 ' A' ' 116' ' ' THR . . . -160.65 -164.84 16.32 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.774 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.64 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 6.8 mt-10 -69.51 174.97 2.48 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.26 -0.47 . . . . 0.0 110.82 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 22.6 Cg_endo -61.81 -36.08 75.37 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.169 1.913 . . . . 0.0 112.077 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.542 ' O ' ' HG2' ' A' ' 123' ' ' GLU . 8.2 tpt180 -78.96 -31.08 44.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.815 0.341 . . . . 0.0 110.338 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.513 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 11.0 tpt -62.4 -16.12 52.94 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.261 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.658 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 10.3 mmtp -68.65 -8.98 47.16 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.649 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 0.3 OUTLIER -120.79 26.33 9.16 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.142 179.005 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.419 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 2.1 mmp_? -98.55 89.02 0.76 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.482 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.726 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 5.1 Cg_endo -47.85 135.72 22.82 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.582 2.188 . . . . 0.0 112.373 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.775 HD11 HD23 ' A' ' 129' ' ' LEU . 19.3 tt -142.21 32.42 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.735 0.779 . . . . 0.0 110.233 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.622 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -73.85 -51.13 9.54 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.889 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.715 ' HE1' HG21 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -52.15 -31.16 29.94 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.02 0.438 . . . . 0.0 110.653 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.778 ' CD1' HD21 ' A' ' 133' ' ' LEU . 22.8 tp -78.63 -62.93 1.53 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.798 HG13 HD12 ' A' ' 140' ' ' ILE . 67.2 t -52.33 -26.17 8.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.363 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.622 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -73.71 -43.81 58.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.675 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.957 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -65.87 -52.1 53.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.912 0.387 . . . . 0.0 111.322 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.914 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -56.3 -45.89 80.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.364 0.602 . . . . 0.0 109.641 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.411 ' CD ' HG12 ' A' ' 130' ' ' VAL . 9.9 mtp180 -58.91 -36.19 74.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.354 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.957 HD12 ' HA ' ' A' ' 132' ' ' ALA . 4.6 mt -65.76 -33.72 76.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.028 0.442 . . . . 0.0 110.077 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.491 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -74.6 -18.87 80.02 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.603 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 130.68 3.43 4.59 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.276 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.408 ' CB ' ' HB3' ' A' ' 107' ' ' CYS . . . -70.3 147.54 49.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.909 0.355 . . . . 0.0 111.225 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 155' ' ' GLY . 9.2 mtmm -114.15 94.32 4.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.962 HG23 HD23 ' A' ' 153' ' ' LEU . 11.1 mt -118.18 175.35 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.966 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.781 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -150.31 -167.97 2.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.037 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.698 ' N ' HG23 ' A' ' 141' ' ' THR . 24.6 m-85 -136.16 100.85 4.52 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.589 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.2 mm? -71.67 -12.97 61.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.846 -177.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.815 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 2.5 mt-10 -140.19 -71.57 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.92 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.515 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.0 OUTLIER -124.15 150.28 45.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.025 0.441 . . . . 0.0 111.426 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.46 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 61.3 mt-10 -69.38 130.4 42.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.809 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.726 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 6.6 m-20 67.49 50.04 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.418 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.683 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 2.8 m-30 -145.53 174.53 3.37 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.096 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.683 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 4.8 Cg_endo -45.7 -40.53 19.0 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.487 2.791 . . . . 0.0 114.904 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.815 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 36.9 Cg_endo -62.47 101.38 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.386 1.39 . . . . 0.0 111.26 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.542 HD23 ' O ' ' A' ' 150' ' ' PRO . 79.1 mt -139.23 123.61 18.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.734 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.736 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.6 OUTLIER -106.17 112.27 25.23 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.962 HD23 HG23 ' A' ' 140' ' ' ILE . 4.8 mt -94.18 158.92 15.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.33 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 3.6 mt-30 -146.12 24.67 1.29 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.522 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 58.26 -161.65 11.1 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.362 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 158' ' ' THR . . . 101.18 -3.94 55.17 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.742 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.682 ' CE1' ' HA ' ' A' ' 133' ' ' LEU . 3.4 t80 -61.39 107.48 0.78 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.984 0.421 . . . . 0.0 110.714 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.567 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 71.3 p -105.16 -50.83 3.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.173 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.575 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.08 -162.33 27.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.0 -1.095 . . . . 0.0 114.326 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.594 ' O ' HG23 ' A' ' 162' ' ' VAL . . . 116.26 169.43 15.41 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.92 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -61.97 126.67 28.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.934 0.367 . . . . 0.0 110.034 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.63 HG13 HD13 ' A' ' 135' ' ' LEU . 47.9 t -136.57 154.49 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-O 120.903 0.382 . . . . 0.0 111.793 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.487 ' HA ' ' CG ' ' A' ' 190' ' ' ARG . 0.6 OUTLIER -120.93 117.14 26.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.607 HG21 ' CD1' ' A' ' 176' ' ' LEU . 0.3 OUTLIER -118.72 140.79 41.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.939 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.709 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 0.5 OUTLIER -78.6 135.39 37.25 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.114 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.717 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -76.4 -44.62 16.41 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.061 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.469 ' HA ' ' HB ' ' A' ' 196' ' ' VAL . 3.2 m -49.1 164.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.918 0.39 . . . . 0.0 111.611 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.715 HG21 ' HE1' ' A' ' 128' ' ' HIS . 3.0 t 70.26 54.58 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.074 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.822 ' H ' HG11 ' A' ' 196' ' ' VAL . 6.4 m 59.86 154.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.934 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.455 ' HB3' ' CB ' ' A' ' 197' ' ' SER . 18.9 p -77.36 1.24 19.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.044 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.804 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 44.0 mm-40 -53.59 -23.27 10.37 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.874 0.368 . . . . 0.0 111.34 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.703 ' HA ' HD13 ' A' ' 129' ' ' LEU . 1.9 m-85 -76.43 -56.06 4.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.14 0.495 . . . . 0.0 110.572 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.576 HD13 HG11 ' A' ' 164' ' ' VAL . 37.4 tp -72.96 -41.04 64.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.309 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 38.2 m -55.94 -34.51 65.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.753 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.654 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -70.86 -50.87 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.108 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.914 ' CD2' HD23 ' A' ' 133' ' ' LEU . 1.4 mt -67.33 -38.07 84.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.609 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.018 HD22 HD21 ' A' ' 205' ' ' LEU . 8.9 mt -65.57 -25.29 67.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.686 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.803 ' HG2' HD21 ' A' ' 31' ' ' LEU . 9.8 mtp -96.64 -28.79 14.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.166 0.508 . . . . 0.0 111.031 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.826 HG21 ' O ' ' A' ' 104' ' ' ALA . 55.4 m -89.12 -46.19 9.01 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.815 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.749 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -60.74 -37.13 42.25 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.701 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 10.8 Cg_endo -53.15 -37.36 79.75 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 121.101 1.2 . . . . 0.0 111.967 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -84.48 -7.01 59.42 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.955 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -67.54 119.5 66.21 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.881 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 183' ' ' ALA . 2.7 Cg_exo -37.47 -32.68 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.684 2.922 . . . . 0.0 114.417 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.81 151.8 23.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.056 0.455 . . . . 0.0 111.616 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.67 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 3.6 t0 -65.74 116.92 7.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.481 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.724 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 28.2 m -102.63 134.94 45.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.339 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 1.104 HG22 HG13 ' A' ' 224' ' ' VAL . 41.1 t -125.45 99.3 5.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.091 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.605 ' O ' ' N ' ' A' ' 223' ' ' PHE . 4.0 mt -90.4 143.56 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.311 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.822 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -115.01 171.25 7.77 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 177.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.822 HD13 ' C ' ' A' ' 190' ' ' ARG . 1.2 mm -110.9 97.27 5.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 120.969 0.414 . . . . 0.0 111.314 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 12.3 mtmt -61.14 -80.96 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.468 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -79.23 167.84 52.65 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.212 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -60.48 124.67 21.05 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.879 HD23 ' HA ' ' A' ' 198' ' ' LYS . 1.5 tp -59.35 146.36 40.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.105 0.478 . . . . 0.0 110.539 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.822 HG11 ' H ' ' A' ' 169' ' ' SER . 12.6 p -104.45 -18.66 6.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.203 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.713 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.6 OUTLIER -129.29 45.63 2.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.498 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.879 ' HA ' HD23 ' A' ' 195' ' ' LEU . 3.8 ttpt -41.98 -60.87 1.75 Allowed Pre-proline 0 N--CA 1.466 0.338 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.784 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 12.1 Cg_exo -70.7 -16.44 33.61 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 121.871 1.714 . . . . 0.0 111.786 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.834 ' HA ' HD12 ' A' ' 203' ' ' ILE . 14.4 m-85 -76.36 -26.27 55.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.715 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.891 HD11 HD12 ' A' ' 177' ' ' LEU . 7.2 tp -75.19 -31.47 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.744 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 5.0 t70 -61.9 -34.25 75.69 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' A' ' 200' ' ' TYR . 4.8 mt -67.23 -27.35 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.259 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.62 HG22 ' SD ' ' A' ' 208' ' ' MET . 42.1 m -60.86 -57.45 12.6 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.541 0.686 . . . . 0.0 109.615 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 1.018 HD21 HD22 ' A' ' 177' ' ' LEU . 19.2 mt -70.32 -32.04 69.61 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.539 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.685 ' HA ' ' HG2' ' A' ' 209' ' ' LYS . 1.5 m-20 -66.73 -30.62 70.89 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.677 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -75.72 -46.23 32.27 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.154 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.62 ' SD ' HG22 ' A' ' 204' ' ' THR . 18.6 mtp -62.67 -39.57 94.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.318 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.685 ' HG2' ' HA ' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -68.04 -41.89 81.39 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.003 179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.544 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.4 OUTLIER -61.65 -28.15 69.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.126 0.489 . . . . 0.0 109.736 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.781 ' HA ' ' HG3' ' A' ' 234' ' ' PRO . 0.8 OUTLIER -76.04 -50.99 13.26 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.761 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 156.51 -1.59 0.14 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.283 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.574 HG13 ' CG ' ' A' ' 229' ' ' GLN . 61.1 t -117.54 139.05 46.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.968 0.413 . . . . 0.0 111.701 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -134.11 153.94 51.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.713 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.94 HD11 HD13 ' A' ' 205' ' ' LEU . 2.4 pp -131.81 175.16 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.611 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 1.006 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 30.5 tt0 -89.99 125.74 35.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.753 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -101.27 101.04 11.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.128 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.707 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 0.0 OUTLIER -67.02 -166.18 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.472 179.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -76.14 48.36 0.5 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.888 0.375 . . . . 0.0 110.362 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.547 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.1 OUTLIER 57.28 21.21 6.45 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.135 -179.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 191' ' ' ILE . 22.5 tt0 -113.11 -22.77 10.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.517 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.796 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 42.1 mt-30 -147.37 140.26 24.99 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 1.005 ' HB3' HD21 ' A' ' 177' ' ' LEU . 24.6 m-85 -112.59 96.73 6.15 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 1.104 HG13 HG22 ' A' ' 188' ' ' VAL . 42.5 t -84.05 111.13 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.06 0.457 . . . . 0.0 111.199 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.936 HG12 HG21 ' A' ' 215' ' ' ILE . 3.6 m -99.71 116.75 43.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.142 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.672 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 3.0 mptt -62.64 103.99 0.48 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.127 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.67 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -57.05 154.33 19.32 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.98 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.6 8.56 76.83 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.367 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.672 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 64.2 mm-40 -71.6 -179.57 2.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.421 0.629 . . . . 0.0 111.184 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.673 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.2 m -170.43 105.71 0.29 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.688 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.672 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 22.8 m-85 -53.58 146.03 13.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.085 0.469 . . . . 0.0 111.309 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.611 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 90.2 mt-30 -110.93 153.19 25.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.58 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 27.5 p -78.07 103.06 1.13 Allowed Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.231 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.781 ' HG3' ' HA ' ' A' ' 211' ' ' PHE . 10.5 Cg_exo -73.86 -37.16 3.04 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.849 2.366 . . . . 0.0 111.577 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 128.8 -120.24 3.24 Favored Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.418 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.778 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -91.08 116.52 28.87 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.588 ' CE2' HD11 ' A' ' 207' ' ' LEU . 67.1 t80 -124.08 141.49 52.01 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.644 -0.422 . . . . 0.0 112.085 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.937 HD12 HG23 ' A' ' 42' ' ' THR . 6.5 tp -95.49 118.69 32.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.134 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.555 HG11 ' N ' ' A' ' 25' ' ' SER . 21.8 t -59.3 -70.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.101 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.464 ' HG2' HD22 ' A' ' 43' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.9 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.572 ' HB3' ' H ' ' A' ' 45' ' ' LEU . 1.4 p . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.6 0.238 . . . . 0.0 111.294 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.885 ' HA ' HD12 ' A' ' 29' ' ' LEU . 13.6 p30 -76.45 -22.34 54.72 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.93 0.395 . . . . 0.0 111.039 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.431 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 3.0 mtm105 -62.02 -51.06 69.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.399 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.937 ' HB1' HD22 ' A' ' 41' ' ' LEU . . . -65.87 -41.11 92.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.379 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.885 HD12 ' HA ' ' A' ' 26' ' ' ASN . 12.1 mt -59.8 -50.6 73.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 0.0 110.81 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.4 tp -69.12 -46.15 68.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.976 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.617 ' CD1' ' HB3' ' A' ' 207' ' ' LEU . 65.2 mt -61.01 -28.68 69.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.736 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.648 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . . . -77.11 -28.72 54.53 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.552 179.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.881 ' HB2' HD23 ' A' ' 57' ' ' LEU . . . -68.57 -31.12 70.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.875 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.893 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -89.82 -11.67 41.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.016 0.436 . . . . 0.0 110.883 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 231' ' ' TYR . . . -79.85 167.77 20.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.764 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.572 ' CE1' ' O ' ' A' ' 79' ' ' GLY . 73.8 m80 -101.31 98.92 9.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.595 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 114.63 142.18 7.83 Favored Glycine 0 C--N 1.314 -0.643 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.568 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.844 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 3.3 tttt -64.27 128.7 36.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.248 0.547 . . . . 0.0 111.938 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.51 ' OG1' ' HD2' ' A' ' 234' ' ' PRO . 0.6 OUTLIER -123.6 160.9 26.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.06 178.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.705 HG22 ' HG3' ' A' ' 74' ' ' GLU . 91.9 t -110.99 140.78 28.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.32 . . . . 0.0 111.781 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.937 HD22 ' HB1' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -129.39 111.29 12.66 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.113 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.935 HG23 HD12 ' A' ' 238' ' ' LEU . 0.0 OUTLIER -96.04 172.14 8.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.188 0.518 . . . . 0.0 111.534 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.444 ' HB3' ' H ' ' A' ' 240' ' ' GLU . 0.1 OUTLIER 66.77 18.79 10.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.729 -178.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.955 HD22 HD11 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -58.73 164.43 2.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.868 179.078 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.572 ' H ' ' HB3' ' A' ' 25' ' ' SER . 27.7 tp -99.37 112.7 24.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.892 0.377 . . . . 0.0 111.721 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -71.69 68.14 0.59 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.555 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.455 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 12.8 t -129.48 -163.54 1.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.212 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.576 ' HA ' ' HE ' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -98.59 -22.87 15.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.768 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.649 ' OD1' HG23 ' A' ' 50' ' ' VAL . 2.1 p30 -69.05 -26.02 64.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.727 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.649 HG23 ' OD1' ' A' ' 49' ' ' ASP . 24.0 t -88.07 -56.59 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.295 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.576 ' HE ' ' HA ' ' A' ' 48' ' ' ASP . 1.8 ptt180 -52.83 -24.41 8.95 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.197 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 55' ' ' ASN . 4.6 m-70 -75.52 -38.08 59.63 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.748 ' O ' HD12 ' A' ' 57' ' ' LEU . 8.6 tpt -60.27 -54.65 43.17 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.788 ' HA ' HD13 ' A' ' 57' ' ' LEU . 1.9 mp -59.34 -47.97 83.4 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.712 177.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.565 ' HB2' ' O ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -48.51 -30.71 5.49 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.639 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.883 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -69.17 -51.36 38.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.298 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.881 HD23 ' HB2' ' A' ' 33' ' ' ALA . 3.4 mp -60.12 -49.18 78.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.812 0.339 . . . . 0.0 110.636 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.616 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 6.8 t -53.8 -30.79 46.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.095 0.474 . . . . 0.0 110.24 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.691 ' CB ' HD21 ' A' ' 88' ' ' LEU . . . -60.37 -50.88 71.84 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.168 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.97 HD21 HD22 ' A' ' 106' ' ' LEU . 3.9 mp -65.84 -27.75 68.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.484 0.659 . . . . 0.0 110.131 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.92 -0.0 7.13 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 114.725 -1.125 . . . . 0.0 113.03 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 13.5 t -55.19 159.99 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 117.216 0.508 . . . . 0.0 110.47 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.569 ' HB2' HD12 ' A' ' 76' ' ' ILE . 3.3 m -122.22 109.52 14.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.623 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.698 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 10.1 p90 -126.57 158.98 34.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.607 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 25.1 m -150.64 116.83 5.64 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.658 0.266 . . . . 0.0 111.267 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.955 HD11 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -86.38 178.09 7.24 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.216 0.532 . . . . 0.0 111.748 -179.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.723 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -90.1 178.58 6.15 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.811 179.122 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.24 -11.88 45.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.596 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.4 1.45 11.79 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.876 0.37 . . . . 0.0 110.462 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.451 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 3.1 mtt85 61.57 43.27 10.25 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.84 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.494 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -124.05 -2.27 8.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.293 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.723 ' HG3' ' HB2' ' A' ' 67' ' ' SER . 0.0 OUTLIER -143.0 111.13 6.06 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.968 0.413 . . . . 0.0 109.937 179.001 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.752 ' SG ' HD22 ' A' ' 66' ' ' LEU . 1.6 t -113.17 155.92 24.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.705 ' HG3' HG22 ' A' ' 40' ' ' VAL . 5.9 mt-10 -119.76 102.94 8.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.964 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.844 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 1.7 mp -102.32 129.26 54.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.569 HD12 ' HB2' ' A' ' 63' ' ' SER . 10.3 mt -82.16 102.3 7.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.351 178.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.635 ' HA2' ' O ' ' A' ' 32' ' ' ALA . . . -48.43 111.97 1.04 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.771 -0.65 . . . . 0.0 113.681 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.646 ' HB2' ' O ' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -57.2 -17.58 11.91 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 110.616 178.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.572 ' O ' ' CE1' ' A' ' 36' ' ' HIS . . . 88.12 -22.36 19.39 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.446 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.893 ' O ' ' HA ' ' A' ' 34' ' ' LEU . . . -139.96 -145.15 4.63 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.754 ' HD2' ' NE2' ' A' ' 83' ' ' HIS . 4.1 Cg_exo -79.15 168.24 20.68 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 121.969 1.779 . . . . 0.0 108.984 177.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.795 HD12 HD13 ' A' ' 60' ' ' LEU . 4.4 mm? -66.55 91.04 0.17 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.754 ' NE2' ' HD2' ' A' ' 81' ' ' PRO . 27.8 m170 -83.93 118.88 24.29 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 113.44 -1.709 . . . . 0.0 113.133 -175.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.846 ' HB3' HD11 ' A' ' 113' ' ' ILE . . . -148.84 110.58 4.52 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.898 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.4 87.88 2.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.59 0.233 . . . . 0.0 111.557 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -174.45 22.83 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.873 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 56.76 53.76 7.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.492 0.663 . . . . 0.0 110.096 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.703 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 5.2 tp -85.92 135.37 33.71 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.939 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.673 ' C ' HD23 ' A' ' 90' ' ' LEU . 4.0 tt0 -115.27 130.16 56.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.242 0.544 . . . . 0.0 110.689 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.883 HD13 ' HA ' ' A' ' 56' ' ' ALA . 3.5 mt -108.68 153.79 22.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.744 -178.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.468 ' CE1' ' CA ' ' A' ' 93' ' ' GLY . 53.8 t80 -118.52 106.59 12.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.817 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.842 HD23 ' HE2' ' A' ' 99' ' ' MET . 1.8 mm? -91.61 3.56 54.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.251 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.611 ' HA2' ' HG2' ' A' ' 118' ' ' GLU . . . 43.12 -140.34 2.59 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 116.207 -0.451 . . . . 0.0 113.625 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -93.54 52.03 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.07 0.462 . . . . 0.0 111.1 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 49' ' ' ASP . . . -94.05 -75.51 0.5 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.376 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.97 -19.78 9.27 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.392 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.508 ' HA ' ' HG2' ' A' ' 171' ' ' GLN . 0.2 OUTLIER -96.59 -9.56 29.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.772 0.32 . . . . 0.0 110.862 179.175 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.04 -19.99 5.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.773 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.842 ' HE2' HD23 ' A' ' 92' ' ' LEU . 9.7 ttm -70.72 -54.18 12.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.982 0.42 . . . . 0.0 111.164 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.774 ' HB2' ' HB3' ' A' ' 171' ' ' GLN . 1.2 mpt_? -57.72 -53.53 64.68 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.091 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.656 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 31.3 Cg_exo -59.3 -47.34 17.44 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.84 2.36 . . . . 0.0 113.135 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.68 HD11 HD12 ' A' ' 90' ' ' LEU . 3.0 tm? -66.67 -33.97 76.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.554 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.548 ' HB2' ' CD1' ' A' ' 115' ' ' LEU . . . -61.66 -47.37 85.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.464 0.649 . . . . 0.0 110.215 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.709 ' O ' HG21 ' A' ' 179' ' ' THR . . . -71.46 -37.33 71.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.749 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.522 ' HA ' ' OG1' ' A' ' 179' ' ' THR . . . -57.14 -43.4 82.41 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.897 0.38 . . . . 0.0 111.393 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.97 HD22 HD21 ' A' ' 60' ' ' LEU . 1.7 mt -70.58 -23.11 62.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.41 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.491 ' C ' ' HA2' ' A' ' 155' ' ' GLY . 87.7 m -59.33 -11.11 3.68 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.019 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.728 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 12.6 mt -83.33 166.11 18.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.67 0.271 . . . . 0.0 110.318 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 54.56 -112.1 2.52 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.272 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.5 97.74 0.99 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' A' ' 154' ' ' GLN . 2.8 m120 -138.32 138.35 38.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.775 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.899 ' O ' HD13 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -104.1 110.41 22.58 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.58 178.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.899 HD13 ' O ' ' A' ' 112' ' ' ASP . 25.1 mm -136.66 143.38 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.528 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.654 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 19.4 t -115.33 113.42 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.548 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 17.6 mt -82.42 152.98 25.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.495 0.664 . . . . 0.0 112.325 -178.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.615 HG22 ' O ' ' A' ' 90' ' ' LEU . 9.5 t -160.27 163.59 33.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.892 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -157.57 -167.54 18.72 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.647 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.611 ' HG2' ' HA2' ' A' ' 93' ' ' GLY . 8.4 mm-40 -67.67 172.98 3.29 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.846 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 33.0 Cg_exo -62.07 -23.8 75.99 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.364 2.043 . . . . 0.0 112.171 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.455 ' HD2' ' CG ' ' A' ' 123' ' ' GLU . 8.1 tpt180 -85.56 -39.47 17.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.836 0.35 . . . . 0.0 110.556 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.605 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 10.8 tpt -59.48 -20.18 53.34 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.651 ' HA ' ' CG ' ' A' ' 149' ' ' PRO . 20.6 mttt -68.8 -7.13 31.29 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.255 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.548 ' HA ' ' CE1' ' A' ' 148' ' ' TYR . 3.9 pt-20 -120.0 28.17 8.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.115 0.483 . . . . 0.0 110.728 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.415 ' HA ' ' NE ' ' A' ' 124' ' ' ARG . 6.5 mmp_? -103.51 112.97 65.94 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.582 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 147' ' ' ASN . 24.8 Cg_exo -60.84 137.01 69.79 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.274 1.983 . . . . 0.0 112.023 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.676 HD12 ' HD2' ' A' ' 100' ' ' ARG . 17.3 tt -145.01 30.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.849 0.833 . . . . 0.0 109.966 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 131' ' ' ASP . . . -77.0 -50.44 6.87 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 114.39 -1.277 . . . . 0.0 112.101 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.746 ' HE1' HG21 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -57.26 -28.4 62.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.865 0.364 . . . . 0.0 110.668 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.9 ' CD1' HD21 ' A' ' 133' ' ' LEU . 20.6 tp -79.14 -63.85 1.32 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.859 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 1.051 HG13 HD12 ' A' ' 140' ' ' ILE . 60.6 t -55.28 -24.61 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.337 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.593 ' O ' HD12 ' A' ' 135' ' ' LEU . 0.4 OUTLIER -70.6 -45.2 65.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.352 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.841 ' HA ' HD12 ' A' ' 135' ' ' LEU . . . -65.81 -53.25 42.65 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.418 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.994 HD23 ' CD2' ' A' ' 176' ' ' LEU . 0.0 OUTLIER -55.86 -44.23 77.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.101 0.477 . . . . 0.0 109.77 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -57.63 -38.99 75.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.449 179.267 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.841 HD12 ' HA ' ' A' ' 132' ' ' ALA . 2.4 mt -64.91 -30.6 71.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.436 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.487 ' HA3' ' CE1' ' A' ' 157' ' ' PHE . . . -78.22 -18.15 76.88 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.471 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.65 2.98 5.19 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.165 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.95 146.48 54.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.944 0.372 . . . . 0.0 111.248 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -114.75 88.72 2.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.241 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.051 HD12 HG13 ' A' ' 130' ' ' VAL . 6.3 mt -115.59 176.63 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.085 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.796 ' H ' HG22 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -154.45 -174.92 5.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.919 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.607 ' N ' HG23 ' A' ' 141' ' ' THR . 20.1 m-85 -126.63 106.98 9.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.049 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.67 HD21 ' N ' ' A' ' 152' ' ' ARG . 2.4 mm? -77.36 -18.65 57.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.389 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.652 ' HB2' ' HG3' ' A' ' 150' ' ' PRO . 1.7 mm-40 -134.71 -73.04 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.969 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.603 ' CB ' ' HD2' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -123.27 149.81 44.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.727 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.484 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 4.6 pt-20 -69.61 135.12 49.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.093 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 125' ' ' PRO . 12.1 m-20 64.92 46.99 2.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.48 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.828 ' HB3' ' HD2' ' A' ' 149' ' ' PRO . 4.6 m-85 -144.08 176.64 2.15 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.111 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.828 ' HD2' ' HB3' ' A' ' 148' ' ' TYR . 10.3 Cg_endo -52.01 -39.89 68.78 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.131 2.554 . . . . 0.0 115.629 -177.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.652 ' HG3' ' HB2' ' A' ' 144' ' ' GLU . 19.7 Cg_endo -61.9 100.4 0.2 Allowed 'Trans proline' 0 CA--C 1.515 -0.458 0 C-N-CA 120.861 1.041 . . . . 0.0 110.944 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 150' ' ' PRO . 84.1 mt -137.05 123.89 21.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.817 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.767 ' HB3' HG22 ' A' ' 141' ' ' THR . 1.6 ttm180 -105.03 111.83 24.74 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 1.028 HD23 HG23 ' A' ' 140' ' ' ILE . 1.5 mt -94.98 160.12 14.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.684 -178.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.588 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 4.1 mt-30 -148.86 25.69 0.92 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.906 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.491 ' HA2' ' C ' ' A' ' 107' ' ' CYS . . . 54.5 -166.45 2.44 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.477 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 109.84 -4.87 30.66 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.946 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.676 ' CD2' HG22 ' A' ' 179' ' ' THR . 2.3 t80 -60.89 106.99 0.64 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.783 0.325 . . . . 0.0 110.681 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' THR . . . . . 0.457 ' O ' ' HB1' ' A' ' 183' ' ' ALA . 43.5 p -104.97 -48.65 3.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.639 ' HA2' ' OG1' ' A' ' 187' ' ' THR . . . 143.53 -162.23 27.67 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 119.889 -1.148 . . . . 0.0 114.293 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' ' 162' ' ' VAL . . . 114.36 168.94 16.3 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 114.937 -0.632 . . . . 0.0 112.003 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -63.08 126.2 26.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.626 HG11 ' HB1' ' A' ' 132' ' ' ALA . 62.1 t -133.51 157.63 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.091 0.472 . . . . 0.0 111.578 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.478 ' N ' HG12 ' A' ' 162' ' ' VAL . 0.7 OUTLIER -124.31 116.12 22.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.891 179.267 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.851 HG11 HD13 ' A' ' 173' ' ' LEU . 0.3 OUTLIER -115.02 150.92 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.92 -179.005 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.68 ' HB2' ' HB3' ' A' ' 128' ' ' HIS . 2.7 t0 -89.83 127.36 35.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.667 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.712 ' HA3' ' HA ' ' A' ' 195' ' ' LEU . . . -70.16 -44.68 59.4 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.651 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.491 ' C ' HG23 ' A' ' 168' ' ' VAL . 1.4 m -50.91 164.76 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.837 0.351 . . . . 0.0 111.517 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.746 HG21 ' HE1' ' A' ' 128' ' ' HIS . 2.1 t 69.17 56.75 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 121.275 0.559 . . . . 0.0 111.112 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.807 ' H ' HG11 ' A' ' 196' ' ' VAL . 2.0 m 58.3 159.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.458 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.466 ' O ' HG22 ' A' ' 174' ' ' THR . 12.4 p -82.65 0.43 43.19 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.807 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.774 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 2.1 mp0 -51.12 -21.91 2.2 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.934 0.397 . . . . 0.0 111.049 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.553 ' O ' HD12 ' A' ' 176' ' ' LEU . 1.4 m-85 -78.96 -53.95 6.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.765 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.851 HD13 HG11 ' A' ' 164' ' ' VAL . 22.7 tp -74.71 -40.5 61.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.441 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 171' ' ' GLN . 13.6 t -57.96 -34.31 69.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' A' ' 104' ' ' ALA . . . -68.37 -51.12 47.83 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.497 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.994 ' CD2' HD23 ' A' ' 133' ' ' LEU . 2.6 mt -67.78 -37.0 81.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.541 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.992 HD11 ' CD2' ' A' ' 223' ' ' PHE . 8.2 mt -67.88 -24.63 65.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.075 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.525 ' HA ' ' OH ' ' A' ' 231' ' ' TYR . 13.5 ptp -98.92 -28.48 13.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.12 0.486 . . . . 0.0 110.811 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.709 HG21 ' O ' ' A' ' 104' ' ' ALA . 27.4 m -86.37 -46.22 10.47 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.991 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.879 ' CB ' HG21 ' A' ' 225' ' ' VAL . . . -60.94 -37.26 42.72 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.711 ' HD2' ' N ' ' A' ' 180' ' ' ALA . 12.1 Cg_endo -54.54 -36.69 89.43 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 121.232 1.288 . . . . 0.0 111.797 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.686 HD23 ' HA ' ' A' ' 230' ' ' SER . 1.0 OUTLIER -85.16 -6.48 59.29 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.828 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 158' ' ' THR . . . -66.9 114.99 20.51 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.16 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -31.09 -36.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.073 3.182 . . . . 0.0 114.642 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -105.47 153.34 21.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.968 0.413 . . . . 0.0 111.797 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.684 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 1.3 t0 -63.92 118.27 8.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.568 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.711 ' HB ' ' CG2' ' A' ' 225' ' ' VAL . 61.4 m -104.16 133.75 48.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.056 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 1.008 HG22 HG13 ' A' ' 224' ' ' VAL . 35.3 t -125.43 99.63 6.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.252 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 223' ' ' PHE . 3.1 mt -90.82 143.56 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.418 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.84 ' C ' HD13 ' A' ' 191' ' ' ILE . 0.0 OUTLIER -114.33 171.07 7.84 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.84 HD13 ' C ' ' A' ' 190' ' ' ARG . 1.1 mm -111.41 96.09 4.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 120.973 0.415 . . . . 0.0 111.17 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -60.83 -81.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.625 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.429 ' HA3' ' OD1' ' A' ' 165' ' ' ASP . . . -78.12 168.4 53.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.269 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -61.41 122.62 15.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.635 0.255 . . . . 0.0 110.856 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.81 HD23 ' HA ' ' A' ' 198' ' ' LYS . 0.8 OUTLIER -58.43 143.63 44.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.96 0.41 . . . . 0.0 110.577 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.807 HG11 ' H ' ' A' ' 169' ' ' SER . 13.1 p -103.58 -18.82 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.512 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.673 ' HB3' ' HB2' ' A' ' 200' ' ' TYR . 0.6 OUTLIER -126.6 45.62 2.64 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.489 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.81 ' HA ' HD23 ' A' ' 195' ' ' LEU . 0.4 OUTLIER -42.15 -60.44 2.07 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.196 -0.911 . . . . 0.0 113.122 -178.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' A' ' 198' ' ' LYS . 7.6 Cg_exo -72.68 -16.32 26.76 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 121.908 1.739 . . . . 0.0 111.987 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.739 ' HA ' HD12 ' A' ' 203' ' ' ILE . 16.5 m-85 -75.64 -29.91 59.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.255 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.92 HD11 HD12 ' A' ' 177' ' ' LEU . 6.2 tp -70.69 -35.64 61.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.947 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 206' ' ' ASN . 0.2 OUTLIER -59.35 -33.16 70.83 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.147 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.739 HD12 ' HA ' ' A' ' 200' ' ' TYR . 15.1 mt -67.71 -32.86 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.238 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.489 HG22 ' SD ' ' A' ' 208' ' ' MET . 52.4 m -57.44 -52.64 64.54 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.944 HD21 HD22 ' A' ' 177' ' ' LEU . 13.3 mt -73.82 -35.45 64.85 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.92 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 202' ' ' ASP . 0.7 OUTLIER -64.0 -28.03 69.53 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.171 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.617 ' HB3' ' CD1' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -79.17 -44.02 22.77 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.842 178.473 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.514 ' HG2' ' CZ ' ' A' ' 231' ' ' TYR . 22.4 mtp -65.0 -38.83 92.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.456 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.518 ' HG3' ' N ' ' A' ' 210' ' ' THR . 0.0 OUTLIER -65.21 -48.94 71.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.666 0.269 . . . . 0.0 110.64 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.518 ' N ' ' HG3' ' A' ' 209' ' ' LYS . 0.5 OUTLIER -56.53 -29.28 61.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.278 0.561 . . . . 0.0 109.843 179.064 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.648 ' CE2' ' HA ' ' A' ' 32' ' ' ALA . 1.1 m-85 -71.48 -48.84 46.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.002 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.474 ' HA3' ' HG2' ' A' ' 232' ' ' GLN . . . 153.21 -4.84 0.36 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.114 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.64 ' HB ' ' CE1' ' A' ' 231' ' ' TYR . 73.4 t -120.19 140.78 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.09 0.472 . . . . 0.0 111.823 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -134.08 156.0 49.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.662 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.925 HG21 HG12 ' A' ' 225' ' ' VAL . 2.3 pp -132.75 175.72 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.891 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.986 ' HB3' ' HB ' ' A' ' 224' ' ' VAL . 41.3 tt0 -90.36 124.66 35.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.068 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.437 HD22 ' HA ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER -100.99 100.87 11.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.003 178.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.733 ' HB2' ' O ' ' A' ' 222' ' ' GLN . 2.1 mm-40 -66.64 -166.72 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.612 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -74.74 48.58 0.37 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.884 0.373 . . . . 0.0 110.41 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.541 ' CE1' ' HG2' ' A' ' 198' ' ' LYS . 0.2 OUTLIER 57.47 20.66 6.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 -179.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 191' ' ' ILE . 66.3 mt-30 -112.69 -21.55 11.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.738 178.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . 0.784 ' HA ' ' HA ' ' A' ' 190' ' ' ARG . 46.6 mt-30 -149.04 141.34 24.1 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.902 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.992 ' CD2' HD11 ' A' ' 177' ' ' LEU . 19.7 m-85 -113.32 96.53 5.95 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 1.008 HG13 HG22 ' A' ' 188' ' ' VAL . 48.4 t -83.9 111.15 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 120.797 0.332 . . . . 0.0 111.429 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.925 HG12 HG21 ' A' ' 215' ' ' ILE . 5.5 m -99.68 117.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.931 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.828 ' O ' ' HG2' ' A' ' 229' ' ' GLN . 0.0 OUTLIER -61.71 103.07 0.3 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.009 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.684 ' H ' ' HA ' ' A' ' 186' ' ' ASP . . . -55.96 156.0 11.36 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.738 -0.665 . . . . 0.0 113.044 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 83.48 8.46 84.91 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.559 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . 0.828 ' HG2' ' O ' ' A' ' 226' ' ' LYS . 26.0 mm100 -71.05 -176.52 1.42 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.358 0.579 . . . . 0.0 110.781 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.686 ' HA ' HD23 ' A' ' 182' ' ' LEU . 2.5 m -177.1 104.91 0.06 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.39 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.64 ' CE1' ' HB ' ' A' ' 213' ' ' VAL . 21.2 m-85 -55.66 151.94 10.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.163 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . 0.673 ' O ' ' HD3' ' A' ' 234' ' ' PRO . 9.2 pt20 -123.01 154.76 38.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.42 ' HA ' ' HD2' ' A' ' 234' ' ' PRO . 68.7 p -67.6 101.11 0.27 Allowed Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.673 ' HD3' ' O ' ' A' ' 232' ' ' GLN . 59.5 Cg_endo -68.13 -27.94 34.97 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.656 2.237 . . . . 0.0 111.898 178.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.39 -125.26 6.53 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' THR . . . . . 0.535 ' HA ' ' HB ' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -92.0 116.54 29.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.626 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 63.5 t80 -124.73 143.2 50.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.331 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.935 HD12 HG23 ' A' ' 42' ' ' THR . 5.7 tp -96.6 118.23 32.65 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.145 0.498 . . . . 0.0 110.752 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 25' ' ' SER . 61.4 t -59.2 -83.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.038 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . 0.444 ' H ' ' HB3' ' A' ' 43' ' ' ASN . 4.0 tp10 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.927 179.891 . . . . . . . . 1 1 . 1 stop_ save_